<SEC-DOCUMENT>0001295947-22-000032.txt : 20221103
<SEC-HEADER>0001295947-22-000032.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103063720
ACCESSION NUMBER:		0001295947-22-000032
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		96
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prestige Consumer Healthcare Inc.
		CENTRAL INDEX KEY:			0001295947
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				201297589
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32433
		FILM NUMBER:		221356053

	BUSINESS ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591
		BUSINESS PHONE:		(914) 524-6800

	MAIL ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Brands Holdings, Inc.
		DATE OF NAME CHANGE:	20040727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Household Brands, Inc.
		DATE OF NAME CHANGE:	20040630
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pbh-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94,d:7a69802b3a0a4e4a9009235c8380d384--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:pbh="http://www.prestigebrandsinc.com/20220930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pbh-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF8zLTEtMS0xLTMzNzgy_b3fbb3e7-e484-49e6-a135-d4b08dc59eb4">0001295947</ix:nonNumeric><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF80LTItMS0xLTMzNzgy_f55fcbb3-913e-4244-8f63-8d525c790c3b">--03-31</ix:nonNumeric><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF81LTEtMS0xLTMzNzgy_96f406d6-929c-4235-bed7-69b494f1a4ef">2023</ix:nonNumeric><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF82LTEtMS0xLTMzNzgy_0d667e32-512d-4460-8ff7-5ce570fdd5e6">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF83LTEtMS0xLTMzNzgy_1bbcea68-2719-4996-a038-4ba8c49d08f6">FALSE</ix:nonNumeric><ix:nonFraction unitRef="agreement" contextRef="ibf00c0aedee84c69bbd5b799d12c794f_I20200131" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82MS9mcmFnOmY5OTI3NjU0NWI3NDRiNDdhNDdjNWQ1MDk0MWY4YTRlL3RleHRyZWdpb246Zjk5Mjc2NTQ1Yjc0NGI0N2E0N2M1ZDUwOTQxZjhhNGVfNA_caa37e5d-d74c-48f3-976d-3efc8e784ca4">one</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pbh-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b5cd7145aa748fb9457afb75bfb22a3_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5bee7c6863b44412bc884931f7b88a78_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="id39bec788f0b4db6a12131f87f82b94d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0caf19b36a0844e780c8b2020c00ce04_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5da56f011314bc89196844b2597e30e_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bccb62ff474647827368f1c0a570b9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae852b5e88a4d2881bfc94a55458c84_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7749c08a3942a98a4139f57288645b_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife92d668e4de4cc1ad969fd36c2572f3_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7e78fc711fb14c3494d63203d4920083_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a33afb528b42678a75f8d868dc2b94_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46763b8fa074769bcaaa4438d57b38d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f35434d33a648fa862d5c96f94944c9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e084b171fb4b8db0e35cea53a45b80_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad2e23cbb3348cc87b24030492dd5e7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id76154f8b5bf460ba7f5e1713e0f4b9b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6f6a31caa242a8b2653c643c896785_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6274cb788e2a4cd9aac84afce0d56e50_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2b997dc2a2a4bcfa90762d3f59e9f5c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie357f9389e29493d825baf6acc58956d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86aa80eb8f5d42178dc12c570932bcbc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id24db078a3ee463e901922ad206211f7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb607635f68941e384560e956f878d1c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0856c1935e8426aa05f2b92f1b4128b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a8960a5122443c944621c7077bf180_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ba0e1d1859416f8017159157d7454a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488aadb430a7489aac56d43528efd1e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb12bac2e3d41adbe1614c20b5dcc29_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d391f2095e244008323df736432422a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44d1ef5e11f44fa9de0ac543d1b12c4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8623c9c86ec48afbe97a3935315d44e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792d19a2000e4f1da418859eb0355822_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfba22679b040a6aeea7958f5629194_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f692c5e67345558d67487dab771c22_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfe143a6e35d4af08305f5de23360208_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e6014926544642b7769ed5b6fdf002_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48085cf8517740c3a4adf0d4a1f84e2e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca905416c0040288f44aa9524fe841a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f54d4cf1d841b38d61272505328c59_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75f07adc20848218d5fd541804deb0a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic68b77b69d164add899d2a619ff62119_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i060bb9404d074c528d1af49985d37955_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b4f3b5db698411ebb73710d058f54c2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb411ee072b942e5a2c9d5d3a2375bf0_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7b5e81d7a54212aea41081aa548202_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721f57024c7846249c67ed7b1117b908_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ef85cdea504b9799f6da4bfe4a5da8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f057b09b0354d10b776451cf542bfb4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea73937ee8d4f188daa2e67eb443344_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5490e98b3a7944b197ababef7f1cd3b6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57fd4571325741b291c09c0956211dc6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic95a52a138104e5393a29cb3a5612fa0_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic259b127e06248a0bb0af498b1a913ea_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed3ae73da4a4e93a4f0fea44d3a1651_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia582a4c76df748c291ab9a03c35e576f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ffbb068303406889ded3a6014f5317_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99e234235a614d2b8ba6a4040a513dcf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7983f141c6004f779d261c014c29aa28_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i092604083384497fa34d578392bb77bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id482c75e4518446e816d97e9e2c77f42_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7080be4bce4149a380535228f0bd124b_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e210be06bb946e0a077415537e12d74_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a8f20fda404be0a321899a6a0aaa28_D20211215-20211215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pbh:ZaditenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c82895d23b43b094aca7f0895f76ea_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7558ab4cd1534d24b525a049ad733f00_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6a38405494994ce1b5c3aab38c92de25_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9871dafd896a45e493ceb7df67951c71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c616be96d674e2998de9db27d2068b5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89ac26c1487c489296168379bd629daa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i144ad08b0f5f49afaa122bd98a2a1bc1_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cd84c34e88c4d2f9dc0e7f967aad239_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc8177d10de49bea9958fbb3d673d7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38cba7c0d2ce48268a9ea237fd0c1c0d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d3f3bbb024f46fa91a25d1c1ce64cae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia708754131aa4c4cadfdb34847429103_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd6d7d6775d456aab43522e8641590d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93c71c69cbd4f518813bf35d29567ff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c4abbe4c7a4c51ab953cfac5a719e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13229551ff74aac852ed82658c2bc5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb1ab25a9104ca786d77647d79f0750_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6a01a4639347e59ce1b6926fe770aa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209a7eca485c4ae089043ae691508354_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b38ddefea943b4a58f5c5e1837187e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fcb4c05211a4f52b3d328d6faa3c979_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i107654b9df4f4d36a2be4b1b29dbb756_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1cf43c2ca44eed91e983938f2fd966_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaee783e80be466aac335d1710829144_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c573dedd8d9443b9195d944fdb41808_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4ca14c8ca842d6b7d60e303216a672_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8145646a4620446cb3bb6c97a2b33b43_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b63503a525b4ad0ae2f49bbf0d38637_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7c577cd8d34acd9e144f85556f13fe_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f948f5963c423aa59b916bd733f299_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc2804a8cd20480092ebaac1665cb981_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a7c46e7cb4f4393bc9da7353259532f_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee68f53fac064ea6b3ca739ae5139369_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3ebdd1608049819d7960351aa8db35_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia469219d9c2a49a98e21464086b58660_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c497ac02c504e91b6ce612b29fc8a82_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a99b6fbe44645ad882a7a958382a827_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf00c0aedee84c69bbd5b799d12c794f_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>pbh:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>pbh:vote</xbrli:measure></xbrli:unit><xbrli:context id="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810dbd51386f4f1894a85343c5088368_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ac391963f848548a601af9567fbba9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205dff464c7245768d0c7263beceb556_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic536994b83bb485a862ea0e3393120d1_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia218ac2046f540c895fce30181f0a41e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f1b498eebb4cd883a3fa617593819a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be7898b214a428d8760e4a62973f03b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8326e328abad4478a736ff2103f13dad_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8883e67a6b294bb2b4988346e7c8bf37_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfd1c9c171164a8f9f0702ee5bb0710b_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44cc662485d34441b6e4321c121a9125_I20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cfb12ba748413e9a14ed4bcc0a4a0f_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59663672a2242a89e285a8508bacf1c_D20140531-20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-05-31</xbrli:startDate><xbrli:endDate>2014-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaf59758726f4998abd628904bf3be96_I20200623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9184f3b632646bebc4e3cd2872e2ba4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42333d378e9e4b66a3f698890196fcc6_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d07c6a04ba74840907835eea95e20cd_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b979b892ef4decba1bfef8062479dd_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i681c9643cccc46478279947213d2e17b_D20220802-20220802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-02</xbrli:startDate><xbrli:endDate>2022-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815f24f411e64db2828daba078c81281_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa98021577994bd988d17efb0ddce577_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f0f5de01544b1488a49d521bd4e50f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id405071995174d9a92bfacc37bad77cb_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2063782252c94eed817587f0ac1d141a_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1240337eaee64711a1a60d6c2e1b7e6c_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f22bd2d45941c7b1bc75e4966da7c7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d2317b145b7448e92da9f723d95918f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cba7d38b81045e787d4f104d9fb3eaa_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a0406745a24ccf85af84e2f238dafb_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213e57bd7c7b47edbccb40cf81cd0e0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ef8ba0f2404c738e6cf363025e958a_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ff1becf0f84b77a14626c31518df01_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib056427d825645d3a6d243d6f12ade35_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6351be3774e04b968ab085c80b3d6b0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093f3d98ccb14d9089261e76e6f7c5d6_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia36e7d927aba40fab88e45e3e3e41575_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalgreensMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="manufacturer"><xbrli:measure>pbh:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="i12a9fca5712b4984be4783b87d0d1895_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia687471f18b34360a6f6a50343be6ca3_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5c21dfca0f469999a785781e89c178_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ad6371c4b14f5782e971050830c85c_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia834815cf1604076a6c15f46da4bca86_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026667c5f30d40229f5ca1072dd36fb1_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907a70df628e4e48b75b67fd126aa346_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ea034b41f254bdca8406677654243b2_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb42bf6d38ee41da9172272d89d125f2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91733343cd3f4ed69349759a5007771f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5a4e1b1ddb48f58b2cba888ead4b2a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41fdf6285d3d4d4eae2b16526b8641c5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1012eb424f2b4a27a014e52c4a7811d9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i941a5663f483406585d5edf13941d483_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1beedb6cef7e452a85e8b6be83cf629b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe91143a1c704b018a3976eb5a01c8a4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9b16ec8347043ef89e62a09618575e5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb709d3222aa40d08b7528ab5869f491_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7cd02c9b2b42f5957d2a924601c171_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f86017bb774d3d842c01a04cc30417_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac26523f549e4adbaa8dd3618b500aa8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156269b4bc68478aaf0dd5842487d92d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea214aa8f2e4deb8d5ceaaf97d29c8c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6b5df992544fefa4e5d17749dfb237_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c739500f044451bbbcb4db0694d023_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2a752fd8ed4bd7a34663dc23e12f46_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508a38c03392406f8d6e294ca753433e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7e002d9ce94251906bbfa8507e0edb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4223591a1d49188b5b0bf13ac30c8c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf7c91c0d149454cab02b9c237ec63f9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d59461a5a2b46f094ca36900ef9e502_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d35b8a35e864ee698d7d3dae351ba18_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc08b763b1242c4ae090e4552cf7fe1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a99ba3fbd29462aa2fdd8aba546873e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6749959e270d484a8849ec9baeeb8726_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib03000714fd04461b44e3ed996bbdcb2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc1f391c4a14ce993aab75bb0e56b22_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05a53f6ddd84378a8b0e8ffe24ce1f8_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3890c9dec07642c388c1c5545eb77376_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67b8efa5861d4b22a06a49d48921e253_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd6d904e1c3451caf89d8a72a334070_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e3ef2deded4c839f83b082e1afc3c4_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a45b0f569b5480995950a7d10bbc8e8_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4abaf43271f54b92aab3fd11f43d7755_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9385a0d313844f70abb80799feab8302_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i952f5bd919b24d1db88ea63c4fbe1bc6_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if641448d42014771a833e92c731a8eaa_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6daec78175cd4f9d99c734cec1bd11c2_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce8bc57290b440981f94ecbbfac6d33_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c021d4c1f045f690a73afbd3a4cd6d_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4aa809e3674b859374a3de6a969618_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f8aa2313314f7d83e72570a64bb906_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd11ab63fa2b44a08ee05dc22f56913a_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79a221081d114432b4a27d7b40d183f7_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc1df03ae0a46c4825f6652f54f210d_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a5ffc00b62425ba1a88cc64cbd36e8_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7667f0de454eb79b0ad225eebdbae0_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f84cd10cc5345d09c2dd76fa06e00ad_D20220401-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd20649b7a574a058d933177cb7d6cdc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64a3ad1a593744bbb35935dcc3c1a3dd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if597e5a35cc541908f97df9d4ad7877a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e715778cd0e44a18645616c8df69ba1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0dfb7bd0c54a90992d0bfce4410815_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5de7468f634f76a808529f4f6971c3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04ec63a0cca14633bf006f38ec899a46_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966596af0d5149ca92ddbd71fbfd37d4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b73b63596724fc89c7cc257a90d4507_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i092e4d9253d2444c80fd19466e202ae2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0146ec3b014515a2ad85b80a0c2222_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e44a39fcd049b092a1c21fbe7a84da_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21693008f1de4e39a8cd0d000b9f2f07_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc54a38c56e845fcbb0e801b4552812b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d96da2f9524e769fd11ec5e90068a5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea51b409490b4d488139c17146926635_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac699f58a1a94fbc80b52040fffbb15c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e1c256b8811486db61c7a2fe6bb58f6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48aae1c5023a4f5b8ae3b7524d2fe2a6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01bd495866f74b2db9bb1e41ffab0e86_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36a20b01556341028361a20e77dd1d38_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b4cc1178ef43ddab6a471cf872e469_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdc2502c0c6e4a428c8e95e77c5aa35e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e3e7b22d27c4f5d9a8507e37f905566_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib60529f2161a445ab1e93ac7f996d24e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3685f44ac4054a6f9f2f5cbc54fb9e44_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a655f924b541c9867fa22141ff7d79_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b8a1903aee41588afc67cb5fd35651_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594a5a7ea66f4bf18ffa7ba9baaf6548_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fdb9a0b2635450380252cded493c8d8_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13e6a4210034ca49a0dd1f93399f945_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b1929a5adc4372b62c50ce12c1a55f_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf28338f91741c9a583ee1f11391d98_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f07f0b271c42408ac2cefda0abadac_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5158014abd84e34bc6cf3f536db8822_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf634010a44e415ea2149c5273a64f42_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fac7101ca624095a37b8838b7e370ba_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic095d7fd82584e46b46aef36eaf1309e_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c35bb9633841d3886e1e747017e734_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f27bafa6f93466284cbe1faacc2d6ff_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cca7e01971f4b2ab2205da66c2ff17d_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd607a224fa4d8896c1359ce5450557_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2963a340f2574654997fdd3323c114d8_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5607274c7e0f483abe26074eb0e5e120_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a95b1802134eaa80c0184052482422_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia252b0ef955b4546bc834792f1e46e8c_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1503156d93284b65b2b7ffeb0926be90_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb5eb987418746d580936607f4f6e710_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91d3b9d39ec4e5cbd1449174d4808d0_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a414c6a89f4bf6b73c26c8489e3c3a_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e429d25f01742dcb996639f98638232_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief270666f60b4f22aae84b337ecce732_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7a69802b3a0a4e4a9009235c8380d384_1"></div><div style="min-height:9pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                               <br/>&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      UNITED STATES SECURITIES AND EXCHANGE COMMISSION &#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-indent:396pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8zMzQ_c665ea7f-534c-4861-ae4b-c42295709ec1">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One)                                    &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:16pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmE0ZjVkNDk2YzA5NGExODkwNTlkNTZlMjEzNDUwZjkvdGFibGVyYW5nZTo2YTRmNWQ0OTZjMDk0YTE4OTA1OWQ1NmUyMTM0NTBmOV8wLTAtMS0xLTMzNzgy_a5daa6f8-5432-455f-b382-a2bd778076c6">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80MjY_c1caed07-5503-49a1-a2d4-429105e42928">September 30, 2022</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OR</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:16pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6OTg0Y2ExNjBkNzNkNGQwZmFlNGI5NWU3NGNjMjAwMjQvdGFibGVyYW5nZTo5ODRjYTE2MGQ3M2Q0ZDBmYWU0Yjk1ZTc0Y2MyMDAyNF8wLTAtMS0xLTMzNzgy_b66ca092-0714-4c9b-ab56-e16b6ce48aeb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the transition period from ____ to _____</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80NjA_79387758-03c3-4a7c-bde8-c4591209c762">001-32433</ix:nonNumeric></span></div><div style="text-align:center"><img src="pbh-20220930_g1.jpg" alt="pbh-20220930_g1.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80Njc_64aeeb4c-0bb6-41c5-909a-19c73dc1a3b9">PRESTIGE CONSUMER HEALTHCARE INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmFjNGI3OTlkN2EyNGUwOGI5MWM5NjgxYWMyYzk3ODcvdGFibGVyYW5nZTo2YWM0Yjc5OWQ3YTI0ZTA4YjkxYzk2ODFhYzJjOTc4N18wLTAtMS0xLTMzNzgy_941a96f3-9a41-4ae8-ade2-eb8f665f7ca3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmFjNGI3OTlkN2EyNGUwOGI5MWM5NjgxYWMyYzk3ODcvdGFibGVyYW5nZTo2YWM0Yjc5OWQ3YTI0ZTA4YjkxYzk2ODFhYzJjOTc4N18wLTItMS0xLTMzNzgy_b648598e-ac3f-40d2-aca6-ef7ee6e4bec1">20-1297589</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81Mjc_87d63f11-c33a-4e04-9caa-e7d3e56da533">660 White Plains Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81MzE_d4641ad7-2692-4d2e-81c2-42bc0481cfbe">Tarrytown</ix:nonNumeric>, <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81MzU_c403b7f8-faca-4e87-83e9-c98893751875">New York</ix:nonNumeric> <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81Mzg_fc632a13-27b3-41e2-8fd5-57470bfe229c">10591</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81OTU_04b6f51f-9362-49ee-9a23-06082a24a3a3">914</ix:nonNumeric>) <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81OTk_38338d8f-7d08-4efc-93b7-7f5973baf77b">524-6800</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant's Telephone Number, Including Area Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTAtMS0xLTMzNzgy_1ea16f54-cf9b-48f2-ae0a-474fd5dc10ce">Common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTEtMS0xLTMzNzgy_6a4a682e-536a-4867-ba1e-90582fc8c33f">PBH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTItMS0xLTMzNzgy_e1f31716-768e-4b75-a6d5-e05e8dda6aeb">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF85NTM_b388d112-6c93-465f-bd1d-2455a6819406">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8xMjc0_9c97f0cd-23cf-4d2e-9644-9ac4e0de7033">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.731%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8wLTAtMS0xLTMzNzgy_9d279991-6c33-4ce1-9ddb-aa1568144227">Large Accelerated Filer</ix:nonNumeric>   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated Filer   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Accelerated Filer   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company   </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8xLTUtMS0xLTMzNzgy_eed77cb3-fa70-4750-b0b8-8d9b1cbcfaeb">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8yLTUtMS0xLTMzNzgy_67d5a6a0-9540-44ad-9dad-e3625a7d4f36">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8yMDE0_b3e47de3-7e9e-472b-a85f-843493e2f45d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 28, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i2b5cd7145aa748fb9457afb75bfb22a3_I20221028" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8yMDU0_3cdcc3b6-35e3-4949-bd21-b32c3bcf2cda">49,525,952</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Income and Comprehensive Income for the three and six months ended September 30, 2022 and 2021 (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_16">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets as of September 30, 2022 and March 31, 2022 (unaudited) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_19">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and six months ended September 30, 2022 and 2021 (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_22">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2022 and 2021 (unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_28">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_94">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_112">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_115">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_121">35</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuer Purchases of Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_124">36</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_130">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_133">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARKS AND TRADE NAMES</span></div><div style="padding-left:72pt;padding-right:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade names used in this Quarterly Report on Form 10-Q are the property of Prestige Consumer Healthcare Inc. or its subsidiaries, as the case may be.&#160;&#160;We have italicized our trademarks or trade names when they appear in this Quarterly Report on Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_13"></div><div style="padding-left:63pt;text-indent:-63pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div style="padding-left:63pt;text-indent:-63pt"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income and Comprehensive Income </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bee7c6863b44412bc884931f7b88a78_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy0xLTEtMS0zMzc4Mg_ced064fb-0175-4ea3-bf1a-cfe78fd44210">289,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39bec788f0b4db6a12131f87f82b94d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy0zLTEtMS0zMzc4Mg_7b825f6d-0fd2-4ed0-b3b0-27fb17865e32">276,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0caf19b36a0844e780c8b2020c00ce04_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy01LTEtMS0zMzc4Mg_763d8c88-3605-4687-bb68-24b2858d549c">566,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5da56f011314bc89196844b2597e30e_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy03LTEtMS0zMzc4Mg_c3180657-370c-4738-87bb-1368ee4ed1de">545,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bccb62ff474647827368f1c0a570b9_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC0xLTEtMS0zMzc4Mg_2d05926b-d823-4262-9755-2e9da84e89ea">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae852b5e88a4d2881bfc94a55458c84_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC0zLTEtMS0zMzc4Mg_c5c91caf-ee22-47a5-ad50-2fa18d9fb0f8">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7749c08a3942a98a4139f57288645b_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC01LTEtMS0zMzc4Mg_365fa38d-e21b-448e-90be-b665aea9c197">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife92d668e4de4cc1ad969fd36c2572f3_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC03LTEtMS0zMzc4Mg_5d03f61e-44d9-4d25-a025-b316ae1cb287">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS0xLTEtMS0zMzc4Mg_8ff949a1-e313-4a87-9b57-24d7a85450e4">289,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS0zLTEtMS0zMzc4Mg_5a569e77-3e02-4a0f-aebb-f41d039a6e93">276,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS01LTEtMS0zMzc4Mg_37cc3abc-88cb-48f2-8110-b433e1038280">566,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS03LTEtMS0zMzc4Mg_fe5ac93e-6725-4d8e-87a2-818a128df70b">545,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales excluding depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC0xLTEtMS0zMzc4Mg_05ba9c4a-0a9a-4b19-8f1a-a4865268f4cd">126,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC0zLTEtMS0zMzc4Mg_7473dbf5-1731-46d7-bb16-f29db369e64e">116,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC01LTEtMS0zMzc4Mg_d752fe36-fbd3-46e6-b8ca-a28c5ff23558">241,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC03LTEtMS0zMzc4Mg_f9de17ed-a005-47e4-9f1b-61caef6f859f">225,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS0xLTEtMS0zMzc4Mg_b3f1a18e-cdac-4dae-8883-df22fbdfdc90">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS0zLTEtMS0zMzc4Mg_b70a41bf-db41-4469-a940-9c3cdd0aeb93">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS01LTEtMS0zMzc4Mg_b681d966-d887-4933-b4b7-b2b8f7d8b149">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS03LTEtMS0zMzc4Mg_3e1893e2-3ae1-48ac-8640-b48f1a271294">3,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtMS0xLTEtMzM3ODI_6af516db-1b7c-4a9b-b315-12eb5c25f2bc">128,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtMy0xLTEtMzM3ODI_5317dad0-fc55-4ffa-b1a6-b6f3d27913e5">118,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtNS0xLTEtMzM3ODI_0246e32a-14e6-44c6-9a5f-eb136b83d173">245,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtNy0xLTEtMzM3ODI_660675a8-320e-43ad-8d8d-a39937fc04e8">228,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtMS0xLTEtMzM3ODI_1e308340-e303-4cdc-98c5-24b88c068072">161,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtMy0xLTEtMzM3ODI_09f72bdf-ca9e-4ca9-b411-adbb5e730874">157,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtNS0xLTEtMzM3ODI_2f79a660-4958-488f-b4bb-769f96e6861f">321,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtNy0xLTEtMzM3ODI_88c38bce-2774-4fb3-a291-e182908f29fb">316,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtMS0xLTEtMzM3ODI_87429ef6-4f1e-4b76-b836-2a8887804906">43,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtMy0xLTEtMzM3ODI_00b3fdf7-9558-45f7-b7d9-0d4b5fa225ee">40,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtNS0xLTEtMzM3ODI_ee2e3b4d-8e8b-47db-b6c3-ec89b9fd07d4">83,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtNy0xLTEtMzM3ODI_c2dad35a-4821-4997-9549-0fec892c280f">80,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtMS0xLTEtMzM3ODI_46ce6da5-8573-4da0-b9b8-4ae545e9156a">26,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtMy0xLTEtMzM3ODI_87e579e6-4dfc-4d2d-989b-55d153ced3b2">32,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtNS0xLTEtMzM3ODI_1e6a7dba-a1cc-4a5d-a353-1cdcc6bec117">53,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtNy0xLTEtMzM3ODI_f24cd91e-658e-4d15-b8d7-f887d6ec750b">54,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtMS0xLTEtMzM3ODI_d6cae1cb-ff53-41a4-8c16-fb5873ab4ce1">6,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtMy0xLTEtMzM3ODI_c2adeff7-baed-4c1a-91af-423995fd1600">6,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtNS0xLTEtMzM3ODI_276649f9-474b-467a-aea7-f4d38345e926">12,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtNy0xLTEtMzM3ODI_e6e05d02-08ac-4294-9a02-30e83539ff1f">11,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktMS0xLTEtMzM3ODI_16dfe15b-f88f-49ae-83ec-2e549008cbc2">76,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktMy0xLTEtMzM3ODI_f234af58-b216-4a77-a0e2-b2687bf79c67">79,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktNS0xLTEtMzM3ODI_70ca7a4f-27d5-4e75-b2fc-e8a37d5e2793">149,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktNy0xLTEtMzM3ODI_5e3375fe-4505-4bf0-a4d1-390261f13968">146,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtMS0xLTEtMzM3ODI_a632ba05-f006-4a11-9fe0-dbcb64432977">84,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtMy0xLTEtMzM3ODI_c59dc819-48ff-4b73-b97f-92c0264dec46">78,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtNS0xLTEtMzM3ODI_7bde5838-6bd8-44fd-86b2-a8fef1acad9c">171,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtNy0xLTEtMzM3ODI_d97d7ebe-aa12-41f1-9b15-dabbb1fe46a6">169,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtMS0xLTEtMzM3ODI_765733e1-eaa0-4449-aafb-479f99a2284a">16,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtMy0xLTEtMzM3ODI_5d59ad52-3ed2-413b-85d8-c3a758f2ae3b">16,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtNS0xLTEtMzM3ODI_a33cb239-9dfa-4660-9140-745c90da5fff">32,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtNy0xLTEtMzM3ODI_0e40eb05-aecd-40bc-a356-c50244031aca">31,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtMS0xLTEtMzM3ODI_1b12c1b3-99da-47c7-ac46-e371affe4c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtMy0xLTEtMzM3ODI_386323dd-c506-48bd-845f-762cdd9ade2d">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtNS0xLTEtMzM3ODI_18717e28-87f4-4d68-9526-7751c90dc900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtNy0xLTEtMzM3ODI_22767489-f1f7-4b74-bf75-bc0266e1596e">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctMS0xLTEtMzM3ODI_e0d612be-0bbd-485a-ba51-1c484fb4016b">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctMy0xLTEtMzM3ODI_af1b5887-fba9-40ee-9691-9ade1f496072">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctNS0xLTEtMzM3ODI_4942f3cc-98ab-47d2-b57e-84765cfe53f0">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctNy0xLTEtMzM3ODI_bc571946-c92b-4c6c-bc4e-6f2209feb2ff">388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtMS0xLTEtMzM3ODI_463a39c4-9e1b-46ff-8b76-99bb044aeb8b">17,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtMy0xLTEtMzM3ODI_1d063165-a10a-42de-86dc-657d2e0cf07a">18,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtNS0xLTEtMzM3ODI_6a091730-fc2c-4ef5-a62b-6ee482f33cb8">33,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtNy0xLTEtMzM3ODI_ae392938-5206-4838-927c-b2d9f3ab18a6">33,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktMS0xLTEtMzM3ODI_c542e245-9d76-4fbe-add4-34cb26b2d8a6">66,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktMy0xLTEtMzM3ODI_5be6fe24-d7ba-48ef-818c-964bd3749072">59,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktNS0xLTEtMzM3ODI_b4cc8ea6-72f1-47de-9470-75a60fc96710">137,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktNy0xLTEtMzM3ODI_8484574b-c5b4-4ac7-97a4-d205c3645878">136,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtMS0xLTEtMzM3ODI_4f144e91-91f1-476b-ac0c-2d278b45a0be">15,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtMy0xLTEtMzM3ODI_788aebfa-caf5-453a-9965-a2126e5ab123">14,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtNS0xLTEtMzM3ODI_3b2c732a-e87b-448d-9459-511f1205b849">31,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtNy0xLTEtMzM3ODI_7c686f0f-503e-4195-8631-aa9aaf6c7f6c">32,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtMS0xLTEtMzM3ODI_83e81d9e-2da7-41be-b2a6-ea8924bb17d1">51,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtMy0xLTEtMzM3ODI_b98eb003-bef7-4cfa-9b69-1aacfa5a0550">45,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtNS0xLTEtMzM3ODI_0e2151b7-65c1-4b74-83d3-d98c0d221b88">106,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtNy0xLTEtMzM3ODI_2b03ceac-d307-4615-b4d2-71548146e2ea">103,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtMS0xLTEtMzM3ODI_5d259fc0-189a-46cd-a819-099d209bd152">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtMy0xLTEtMzM3ODI_0681b19f-2515-4c5e-8850-ce5c69533ca5">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtNS0xLTEtMzM3ODI_b6c26bf9-1733-478f-b481-e0e4f2c78c17">2.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtNy0xLTEtMzM3ODI_bdc064c3-6dab-444e-a513-3336080b515f">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktMS0xLTEtMzM3ODI_c3a6a207-6d9f-469e-ac15-a53a8c2a59a4">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktMy0xLTEtMzM3ODI_fa06db37-2220-4278-8fed-301e67aee777">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktNS0xLTEtMzM3ODI_e2b69525-b7b0-4036-8dd2-c335e37f1b09">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktNy0xLTEtMzM3ODI_1fec5643-7e4c-4b7f-9bdf-4fa1c4d23f19">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItMS0xLTEtMzM3ODI_a8b9f726-775a-4d9b-b180-f05de199fa5a">49,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItMy0xLTEtMzM3ODI_24f23474-f684-431d-b84d-ccd45296e691">50,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItNS0xLTEtMzM3ODI_f5d0bd24-f82d-4706-87d0-189af9662e71">50,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItNy0xLTEtMzM3ODI_f30a3893-bf88-42d9-9896-0eba53d97236">50,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtMS0xLTEtMzM3ODI_b3b6baa2-203a-4041-a6f7-9da674ae806a">50,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtMy0xLTEtMzM3ODI_beaa90ba-dafc-45cf-9878-8c52a4bc2dd7">50,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtNS0xLTEtMzM3ODI_47c68e91-f9de-4ffe-a230-4dc8d2d25bd8">50,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtNy0xLTEtMzM3ODI_0d172e8c-54af-4f5a-915f-624f2cd83698">50,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtMS0xLTEtMzM3ODI_5908076c-2c67-4a3d-a992-be9d37359b94">7,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtMy0xLTEtMzM3ODI_d57a4262-2ae6-40eb-925f-e1082f45e824">4,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtNS0xLTEtMzM3ODI_5e264e6d-85e2-4650-8ea0-b96b1e28e39b">16,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtNy0xLTEtMzM3ODI_fc684cf0-46e7-4c3a-91d2-e4bc89aec2bd">5,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctMS0xLTEtMzM3ODI_8d8dc8c0-f0ba-4c27-959e-bf23dabcf317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctMy0xLTEtMzM3ODI_25727e37-fa44-4f04-950d-3f63102c45f4">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctNS0xLTEtMzM3ODI_71ad9888-0e36-4af4-833e-9f3f9b3b67a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctNy0xLTEtMzM3ODI_94894490-1c4b-416e-bb6f-5bc80a564d9f">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on termination of pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtMS0xLTEtMzM3ODI_bcd84be6-3114-407c-b2d4-3f3d9d924b57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtMy0xLTEtMzM3ODI_880e5adc-f195-4571-ba26-54df97ec21a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtNS0xLTEtMzM3ODI_66746995-e80e-4b0c-b6c9-40884f5285bf">790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtNy0xLTEtMzM3ODI_b9be774f-137a-44c7-9d85-c1474a122023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtMS0xLTEtMzM3ODI_a67350fa-ac15-4d8f-a8f9-64399f9620d8">7,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtMy0xLTEtMzM3ODI_8a4164d9-be60-4ea3-84e5-f740ca352fcf">3,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtNS0xLTEtMzM3ODI_90bf377b-a499-4367-a42a-b8fb043e864f">17,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtNy0xLTEtMzM3ODI_aba36b55-082d-4c46-8084-438ba41dc059">4,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtMS0xLTEtMzM3ODI_c76d9a68-8438-4193-9a85-19ed55cb2335">43,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtMy0xLTEtMzM3ODI_6667e731-88a2-4a86-b3de-0e610e7a675b">41,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtNS0xLTEtMzM3ODI_c8b636d0-37dc-47a4-9585-62f1664d149f">88,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtNy0xLTEtMzM3ODI_84678bcd-2660-48de-86f3-afc44fd289ea">98,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">       See accompanying notes.</span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNC0xLTEtMS0zMzc4Mg_03ecf26d-ee7b-49a6-b08b-fb0b8e10c77b">42,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNC0zLTEtMS0zMzc4Mg_b00e3507-b36b-4afc-99a6-1bbeb9fd2279">27,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQxOTc3ZDdmNDI2ODQ3MjA4Nzc3MTUxZDQzOTAxNTlmXzQ1_97d216fe-2e96-4c25-a642-c97580cf39d5">20,673</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQxOTc3ZDdmNDI2ODQ3MjA4Nzc3MTUxZDQzOTAxNTlmXzUy_e9edef11-f3a9-49d4-9d55-ea2e04c59c6f">19,720</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0xLTEtMS0zMzc4Mg_c79fe2b3-3229-4098-8900-e8b158e171b7">145,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0zLTEtMS0zMzc4Mg_7a0de360-91b4-4303-9153-2cab59b85bfc">139,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNi0xLTEtMS0zMzc4Mg_4f301dba-3bf1-4f30-b2dd-3d9b33ab2765">140,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNi0zLTEtMS0zMzc4Mg_a76d90ac-918c-4953-baca-b54b5f94ed6c">120,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfOC0xLTEtMS0zMzc4Mg_c0306657-a7b5-4b25-8c0d-400168195311">7,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfOC0zLTEtMS0zMzc4Mg_64f85eb9-9d0f-4217-9c75-da79e866947e">6,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTAtMS0xLTEtMzM3ODI_c149e7b5-f5c2-4fc9-a3b1-2d7f3321d384">336,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTAtMy0xLTEtMzM3ODI_466917b9-6a79-4beb-bd88-0fe4b0144646">293,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTItMS0xLTEtMzM3ODI_fb1eab1e-7ca7-4b66-96f9-2d497f501470">69,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTItMy0xLTEtMzM3ODI_c16b027c-390d-423c-bb26-a667c2beae9b">71,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTMtMS0xLTEtMzM3ODI_1977bb88-895a-4c78-8561-821fa63cf646">17,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTMtMy0xLTEtMzM3ODI_2b8b3519-941f-4337-85b3-3df23bcb39a3">20,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTQtMS0xLTEtMzM3ODI_69da0154-f8cc-49c4-942f-3c493ef152c4">5,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTQtMy0xLTEtMzM3ODI_5f035df2-65d9-47ff-a732-6fee3afc7bd2">6,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTUtMS0xLTEtMzM3ODI_528384f6-5bbf-41b4-90e3-24c1bde1c9d6">575,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTUtMy0xLTEtMzM3ODI_b324e79d-7022-4747-b4b3-2d4fe64bbc37">578,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTYtMS0xLTEtMzM3ODI_2a928fc8-d150-406d-b33c-b1ad451359f2">2,670,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTYtMy0xLTEtMzM3ODI_f3b87e32-18ba-415d-b684-454e4e0a8003">2,696,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTctMS0xLTEtMzM3ODI_0e26e90c-75f4-4ce4-9bbd-54cb96526ff7">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTctMy0xLTEtMzM3ODI_4fa76bab-95bb-437c-bb7a-a56521a20bcc">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTktMS0xLTEtMzM3ODI_bc172e36-29ae-49ed-b4f2-bc423e5c92c0">3,678,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTktMy0xLTEtMzM3ODI_786e1099-4710-4525-b156-76935d778860">3,670,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjQtMS0xLTEtMzM3ODI_1943c29a-9961-44af-9492-ad2326def174">56,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjQtMy0xLTEtMzM3ODI_e1d2e9fc-5f38-4b55-8f38-cb1b5bd3e616">55,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InterestAndDividendsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjUtMS0xLTEtMzM3ODI_8811d35f-7e35-4903-a24b-45a55d38235a">15,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InterestAndDividendsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjUtMy0xLTEtMzM3ODI_dcb94701-ddf1-4012-941f-d4d6f0369501">4,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjYtMS0xLTEtMzM3ODI_b5ce7347-2624-44c1-a4f3-08c31bb51f4e">6,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjYtMy0xLTEtMzM3ODI_f21db9fd-7c01-4fac-a5fb-8938760fe224">6,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjctMS0xLTEtMzM3ODI_f3ac01fa-78dc-4128-b5f1-75eb70f55509">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjctMy0xLTEtMzM3ODI_6df0a1dc-3780-4d3e-8804-d9ef6521cd8d">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjgtMS0xLTEtMzM3ODI_cd0ac993-2a9d-42d6-8553-1e8ce2002e73">70,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjgtMy0xLTEtMzM3ODI_0fe7dc1a-fae4-41fa-99e2-d99ed5dfe8b0">74,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzAtMS0xLTEtMzM3ODI_6109a715-e2c4-4ca2-81c7-186dfddbe10c">152,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzAtMy0xLTEtMzM3ODI_d126d8b1-9e42-49f4-9692-727643e26057">143,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzUtMS0xLTEtMzM3ODI_76a3f1a6-adb0-4b58-8ff1-8d6c6ad27ce8">1,438,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzUtMy0xLTEtMzM3ODI_aa99ad08-6e28-4ebe-847c-c261284981d8">1,476,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzctMS0xLTEtMzM3ODI_f97a8d6e-7d99-476f-bd8b-8737e8bbe0ad">443,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzctMy0xLTEtMzM3ODI_7e4fc9d3-0bb7-4829-8a23-ceaf95600f79">444,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzgtMS0xLTEtMzM3ODI_99a25b71-3ec7-4f7c-9845-840b4d842a90">12,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzgtMy0xLTEtMzM3ODI_6787c7c8-442e-4595-9b39-cda64dfdb82a">16,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzktMS0xLTEtMzM3ODI_ec91ac10-2144-4888-b0a0-66b7e00e5bbd">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzktMy0xLTEtMzM3ODI_fdd06b13-373a-4c2a-9c31-356a130fb0ac">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDAtMS0xLTEtMzM3ODI_698cde3e-09d8-40eb-8da9-8aa2d37d3c51">8,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDAtMy0xLTEtMzM3ODI_e89d16b8-a653-4a4e-8240-78c36420f8db">7,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDEtMS0xLTEtMzM3ODI_5a9835b6-4688-4204-8bbf-ee675b53ea9d">2,058,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDEtMy0xLTEtMzM3ODI_9c90d06d-2e02-4a7f-a94a-538873036bf1">2,093,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies &#8212; Note 17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDMtMS0xLTEtMzM3ODI_d4c0b2e1-f854-4b24-87db-eaa6626b7f88"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDMtMy0xLTEtMzM3ODI_95b08209-e705-4bee-8e02-d384d829c034"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDYtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpjM2IxNDA5NzVmZTI0NGEwODMxYjdlNTY4NmY3MmJiOV8yMg_426e25e2-3895-45bc-8d25-e4cb9797eebd"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDYtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpjM2IxNDA5NzVmZTI0NGEwODMxYjdlNTY4NmY3MmJiOV8yMg_e7892f1c-18e1-486d-b584-ff284a542508">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized - <ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDctMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowMjA1NWM3OTY5YTQ0ZWM4YTk4NWYzM2Y1NjJlZmJlZF8xNw_55d44ff3-ee9e-4be4-b0f7-02c30e01557a"><ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDctMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowMjA1NWM3OTY5YTQ0ZWM4YTk4NWYzM2Y1NjJlZmJlZF8xNw_ab55ef87-c21d-4825-b04f-121f0cb4a864">5,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and outstanding - <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_259da967-902c-4089-bfc4-1e8ba63e5593"><ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_3b60b530-a8be-4e08-8e9d-1ceef5e8fad6"><ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_bbbb564b-9bf2-43f2-b363-cf893ccef058"><ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_f690ecc7-e9b1-426c-9c8d-b92821bfe4a7">None</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMS0xLTEtMzM3ODI_7d243bb0-a602-4ea8-8775-9e21936181c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMy0xLTEtMzM3ODI_7e78d72c-c3c4-4cd5-8e78-e99fce315c78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDktMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpkNDYzZWNiNzBmNmQ0ZDZlYjg5YTUzOTM0ZTZlYmM2Y18xOQ_5993049a-d918-4892-a840-e252e0d38abd"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDktMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpkNDYzZWNiNzBmNmQ0ZDZlYjg5YTUzOTM0ZTZlYmM2Y18xOQ_76e2dc70-28e3-4941-af01-5cfe7490933d">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized - <ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTAtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMzQ2YTVmOTg3YWU0NWFjOGVlMDdlNmQ0NGIxMmM4MV8xNw_76100926-95ed-44e9-8bf9-3ddc7fc9f66a"><ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTAtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMzQ2YTVmOTg3YWU0NWFjOGVlMDdlNmQ0NGIxMmM4MV8xNw_eacaa0cf-926f-401c-9f83-3b408b02300e">250,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued - <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjphYWVkMGFlY2RlYWU0MWMzOTBlOTgxODVkZTAzNDE0Nl8xMw_8c8ed9a7-e502-47fc-9ca1-26d037ae66fd">54,690</ix:nonFraction> shares at September 30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjphYWVkMGFlY2RlYWU0MWMzOTBlOTgxODVkZTAzNDE0Nl80NA_cba03f0f-2e91-4ddc-942c-34ef454490d7">54,430</ix:nonFraction> shares at March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMS0xLTEtMzM3ODI_03c51920-c457-4a89-b36d-be8fa59c1b05">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMy0xLTEtMzM3ODI_17d2b982-0527-44ab-b006-a5abcc04b795">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTItMS0xLTEtMzM3ODI_2c415068-abb9-4773-8fa3-e6fd5c9233a1">524,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTItMy0xLTEtMzM3ODI_77a2a842-4e20-4971-8a4d-b1a525f33dc3">515,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMGUzOTMzODBiYTU0MjQwOGNmOGZjYzA1OWE0MGMyOF8zMA_e762d0ce-a4d7-443f-adbf-642bae0d9e9e">5,164</ix:nonFraction> shares at September 30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMGUzOTMzODBiYTU0MjQwOGNmOGZjYzA1OWE0MGMyOF82MQ_d6b19e6b-936d-4aac-80f5-704cd9f4bfa1">4,151</ix:nonFraction> shares at March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMS0xLTEtMzM3ODI_a1bc8631-893c-4324-8928-c3b09526a666">189,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMy0xLTEtMzM3ODI_f0e40e12-e8d0-4d96-b1b0-b48a3cab2e6e">133,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTQtMS0xLTEtMzM3ODI_ac07b302-0464-487e-bb07-6ad97580401d">36,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTQtMy0xLTEtMzM3ODI_ab1c6755-50f0-49fd-811f-5a7add35f7f0">19,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTUtMS0xLTEtMzM3ODI_9ce2961b-f53e-49f5-aa7c-e39d313f4b65">1,320,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTUtMy0xLTEtMzM3ODI_a477b7c6-fb5f-442b-bf18-23df80f9f51d">1,214,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stockholders' Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTYtMS0xLTEtMzM3ODI_f393cb4f-8794-4cdd-a7a5-3cc9c70c8b17">1,619,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTYtMy0xLTEtMzM3ODI_81a466c7-8026-436c-a6d2-419564c1fee4">1,577,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Stockholders' Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTctMS0xLTEtMzM3ODI_438de0d0-1ab0-4bf6-9c93-4b45595459da">3,678,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTctMy0xLTEtMzM3ODI_c0c1fa06-7c3a-4e67-a72c-b756d1821fdf">3,670,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive <br/>(Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if46763b8fa074769bcaaa4438d57b38d_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xLTEtMS0zMzc4Mg_81deaf8e-1653-434f-bc46-dd07717adb0d">54,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46763b8fa074769bcaaa4438d57b38d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0zLTEtMS0zMzc4Mg_4fe35f1f-fe64-4e38-bb3d-0ec05928b3ba">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f35434d33a648fa862d5c96f94944c9_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy01LTEtMS0zMzc4Mg_83eeee5e-6f3d-401b-8b10-a24407838c7a">520,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy03LTEtMS0zMzc4Mg_14578684-74a0-47f5-95e0-10c6d5720637">4,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy05LTEtMS0zMzc4Mg_4fbe9931-89af-417c-b497-24001d101a96">176,825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e084b171fb4b8db0e35cea53a45b80_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xMS0xLTEtMzM3ODI_ae37dbf9-f579-4194-8725-860e507c6ba2">29,341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad2e23cbb3348cc87b24030492dd5e7_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xNS0xLTEtMzM3ODI_7d938bcc-acbc-4355-a57f-6c9af3ffde41">1,269,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76154f8b5bf460ba7f5e1713e0f4b9b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xNy0xLTEtMzM3ODI_ed7c2216-4cec-4bdb-9cf4-f35701a1fd5d">1,584,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6f6a31caa242a8b2653c643c896785_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfNS01LTEtMS0zMzc4Mg_e56bfcd0-b980-4195-b9a4-3799f92ae8d9">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfNS0xNy0xLTEtMzM3ODI_0e22c396-e57b-4f7b-bd35-9a7b47b115cc">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS03LTEtMS0zMzc4Mg_70ecd945-dfac-47a3-9dc1-f00bce21085c">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS05LTEtMS0zMzc4Mg_82078ea4-2b1b-44b3-8c49-64b8acefbcd7">12,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS0xNy0xLTEtMzM3ODI_a2abbd3c-bb15-4b8d-a042-43619af94e76">12,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6274cb788e2a4cd9aac84afce0d56e50_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTQtMTUtMS0xLTMzNzgy_d73db8b5-ba52-4aa6-b326-7515904de98c">51,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTQtMTctMS0xLTMzNzgy_11ebf2e8-72b9-4acf-9951-8f0fc068deb1">51,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b997dc2a2a4bcfa90762d3f59e9f5c_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTctMTEtMS0xLTMzNzgy_1bf8f385-c36a-4411-9343-4caf98c7415a">7,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTctMTctMS0xLTMzNzgy_08085ea7-6d57-4c7f-aad7-a4ad3673f7ef">7,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie357f9389e29493d825baf6acc58956d_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMS0xLTEtMzM3ODI_74904a59-c459-4133-be9e-e2bfde10e8f6">54,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie357f9389e29493d825baf6acc58956d_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMy0xLTEtMzM3ODI_597c0686-f132-455f-844f-0dee0ac34ead">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86aa80eb8f5d42178dc12c570932bcbc_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktNS0xLTEtMzM3ODI_a73d307c-81ed-4a53-a790-e34fa4bc0fe4">524,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id24db078a3ee463e901922ad206211f7_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktNy0xLTEtMzM3ODI_d0ff58c5-aa9d-48a7-8710-36638e2f9da4">5,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id24db078a3ee463e901922ad206211f7_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktOS0xLTEtMzM3ODI_faff61cb-28af-4457-9605-b2f2f02d4034">189,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTEtMS0xLTMzNzgy_d1df2ce8-fe3a-4455-836f-619507834de2">36,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTUtMS0xLTMzNzgy_d4fa5bb7-7129-4de8-936a-5ddab69a052d">1,320,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTctMS0xLTMzNzgy_2c919967-b81a-42e9-979c-08ae86611f0f">1,619,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive  (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb607635f68941e384560e956f878d1c_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xLTEtMS0zMzc4Mg_a59347fc-b26b-4cf6-b01a-2ad94e7b03e0">54,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb607635f68941e384560e956f878d1c_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0zLTEtMS0zMzc4Mg_89896f4c-7051-43ee-8764-4bbb5aa3a5eb">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0856c1935e8426aa05f2b92f1b4128b_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy01LTEtMS0zMzc4Mg_8c6b0502-9e0b-44a5-a7a8-98bf781b2012">503,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9a8960a5122443c944621c7077bf180_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy03LTEtMS0zMzc4Mg_6d9aca67-64fa-4991-87e8-b4e941bf2f05">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9a8960a5122443c944621c7077bf180_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy05LTEtMS0zMzc4Mg_39a0537f-8076-4c65-a88a-c52886ba4213">133,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22ba0e1d1859416f8017159157d7454a_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xMS0xLTEtMzM3ODI_243ad77e-c744-4d09-88e6-37765e2f38b9">20,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488aadb430a7489aac56d43528efd1e6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xNS0xLTEtMzM3ODI_c37608f7-ef8b-4acc-8615-870fb1f4e72b">1,066,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb12bac2e3d41adbe1614c20b5dcc29_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xNy0xLTEtMzM3ODI_c205332e-a1c1-445e-810c-e70a3de7fff0">1,416,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNi01LTEtMS0zMzc4Mg_aad62dcf-51e2-4079-8166-616a41438c1b">3,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNi0xNy0xLTEtMzM3ODI_f58711ce-61c6-4e20-9438-6689624c70fc">3,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy0xLTEtMS0zMzc4Mg_ff2799d2-6493-4f6c-a198-da18e50fa88d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy01LTEtMS0zMzc4Mg_dca199bc-ab74-439b-8f0d-aaaeebf1a614">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy0xNy0xLTEtMzM3ODI_f0bf8d1e-3101-400f-820a-4cfc2fcd39bb">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfOS0xLTEtMS0zMzc4Mg_bfcd5649-017d-42b4-917c-5779463e4357">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfOS0xNy0xLTEtMzM3ODI_742aa9df-42d2-468d-8a3a-6084d0bbf598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d391f2095e244008323df736432422a_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTMtMTUtMS0xLTMzNzgy_6852df98-be9b-456d-b131-742f73ba0bcf">45,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTMtMTctMS0xLTMzNzgy_3cbde6a7-3852-4632-9a8d-a5037c2c4540">45,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia44d1ef5e11f44fa9de0ac543d1b12c4_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTYtMTEtMS0xLTMzNzgy_c72a235d-0936-4be5-a1d1-d6864f60a1a3">3,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTYtMTctMS0xLTMzNzgy_cbf6063b-8859-4b30-8f8d-79c4dde2c87e">3,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMS0xLTEtMzM3ODI_f81621b3-91e0-4071-81d2-47ad6d12abbd">54,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMy0xLTEtMzM3ODI_b698347a-1c5b-4f8f-ae84-9189a1475d85">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792d19a2000e4f1da418859eb0355822_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtNS0xLTEtMzM3ODI_5ec39e8f-f078-47dd-8816-cefc021478ba">507,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtNy0xLTEtMzM3ODI_334e1c64-cbda-498f-8e45-faaf5b94470f">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtOS0xLTEtMzM3ODI_5c1be6e2-fcd0-46b5-9c38-2c7897f5e609">133,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25f692c5e67345558d67487dab771c22_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTEtMS0xLTMzNzgy_9815ef31-acb3-443c-b496-738cb1e15df4">24,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe143a6e35d4af08305f5de23360208_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTUtMS0xLTMzNzgy_e1ae070e-433e-4375-9c40-41b16a77172c">1,111,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTctMS0xLTMzNzgy_e5928042-b088-43ee-a940-be625bffe140">1,461,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:35pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4e6014926544642b7769ed5b6fdf002_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xLTEtMS0zMzc4Mg_b346ff27-8f11-42c1-a7b1-e7a03f8e3be0">54,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6014926544642b7769ed5b6fdf002_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0zLTEtMS0zMzc4Mg_17651f0a-14b1-42c7-82b3-162d16c0e165">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48085cf8517740c3a4adf0d4a1f84e2e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy01LTEtMS0zMzc4Mg_bf554706-bcfd-473e-b94b-807a81c59ad1">515,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieca905416c0040288f44aa9524fe841a_I20220331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy03LTEtMS0zMzc4Mg_b7d965df-79c4-4516-9d52-93a351b7a6b1">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieca905416c0040288f44aa9524fe841a_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy05LTEtMS0zMzc4Mg_3eb99301-c872-446b-bd96-a9d419ffe69a">133,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f54d4cf1d841b38d61272505328c59_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xMS0xLTEtMzM3ODI_b45430c5-19c3-4994-b786-afb71b8e2479">19,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75f07adc20848218d5fd541804deb0a_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xNS0xLTEtMzM3ODI_dc8f100c-67c1-40ff-9bb1-8dbe54bcffbc">1,214,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xNy0xLTEtMzM3ODI_678f8ecf-ff2d-4ddc-b6e5-383200c274cb">1,577,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNS01LTEtMS0zMzc4Mg_97e1b9cc-ef2d-4d52-932c-6a12f7e5c18c">7,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNS0xNy0xLTEtMzM3ODI_914d47e1-77f9-4c89-878b-4a93a5972376">7,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0xLTEtMS0zMzc4Mg_9f216d6f-d54a-44a5-af41-a66ebdc0375d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0zLTEtMS0zMzc4Mg_1ee3f1c6-1e51-4ce6-ad09-a960b1058f0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi01LTEtMS0zMzc4Mg_15746f1e-1a87-47f7-99d1-ae323afdd23f">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0xNy0xLTEtMzM3ODI_58c7474f-8ff5-4043-a0f6-9d0894452c61">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0xLTEtMS0zMzc4Mg_bb096e4f-f38c-434f-8086-e3622eb4b4fb">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0zLTEtMS0zMzc4Mg_eb06201b-b94f-4dac-ae18-2cfd987d368f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC01LTEtMS0zMzc4Mg_ce278cd8-1bc1-4ae7-a68f-ebdf18fe049c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0xNy0xLTEtMzM3ODI_9c8a8de8-472e-4880-b8cf-606987e67702">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i060bb9404d074c528d1af49985d37955_D20220401-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS03LTEtMS0zMzc4Mg_cd9a680d-f3e6-4ff2-9a00-745ecde4228d">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i060bb9404d074c528d1af49985d37955_D20220401-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS05LTEtMS0zMzc4Mg_35e9e8a8-395a-4727-87dd-d615650b044e">55,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS0xNy0xLTEtMzM3ODI_d5773759-02cb-46e2-bf0b-c5f9aba97839">55,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4f3b5db698411ebb73710d058f54c2_D20220401-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTQtMTUtMS0xLTMzNzgy_f269e24c-2aee-4fcc-aa66-1527cec37ba3">106,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTQtMTctMS0xLTMzNzgy_1bd7cb32-875b-40d0-bd09-0517d80cd1c2">106,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb411ee072b942e5a2c9d5d3a2375bf0_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTctMTEtMS0xLTMzNzgy_2d82ebde-71d6-4cb0-8e26-5af24119bc72">17,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTctMTctMS0xLTMzNzgy_f3a4f49c-2162-4f81-9141-ec18006596f1">17,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie357f9389e29493d825baf6acc58956d_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMS0xLTEtMzM3ODI_654e09ab-0516-4b8c-97d7-70aa94f25d8e">54,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie357f9389e29493d825baf6acc58956d_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMy0xLTEtMzM3ODI_80a98503-717c-4355-9f09-8124fa7a851a">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86aa80eb8f5d42178dc12c570932bcbc_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktNS0xLTEtMzM3ODI_5bf3d44b-b1b6-42bc-86d5-c48439923ad3">524,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id24db078a3ee463e901922ad206211f7_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktNy0xLTEtMzM3ODI_f81cfa60-0881-4822-be18-56b5219c7bb3">5,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id24db078a3ee463e901922ad206211f7_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktOS0xLTEtMzM3ODI_9a21e3d1-b8ec-4e92-9464-fb9afc7c138e">189,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTEtMS0xLTMzNzgy_13d4f602-b1f6-4de8-b5bb-07dd81bb5e23">36,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTUtMS0xLTMzNzgy_96a95a1b-72c6-4c2a-bde6-20d53250caa3">1,320,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTctMS0xLTMzNzgy_450e0cfd-3fe9-49b6-9662-63a6b487a2ba">1,619,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive <br/>(Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xLTEtMS0zMzc4Mg_678f7a2e-067b-4b31-a118-3f0ea7bca10d">53,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0zLTEtMS0zMzc4Mg_42845e0d-d9ca-4b89-a7f8-57ef9c0c12b8">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7b5e81d7a54212aea41081aa548202_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy01LTEtMS0zMzc4Mg_110b6577-a6ce-4d2a-9d64-23290465b6cb">499,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i721f57024c7846249c67ed7b1117b908_I20210331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy03LTEtMS0zMzc4Mg_f7dd17e8-7ba6-47ca-8e4f-75fbd9a48efd">4,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i721f57024c7846249c67ed7b1117b908_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy05LTEtMS0zMzc4Mg_8387782c-a2c2-4bd1-855d-64fab3a028aa">130,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53ef85cdea504b9799f6da4bfe4a5da8_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xMS0xLTEtMzM3ODI_2f8260fa-7767-4aa0-9e58-1eb13cfd081d">19,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f057b09b0354d10b776451cf542bfb4_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xNS0xLTEtMzM3ODI_51aee9f9-ab79-45b4-b36a-781e83efd4fd">1,008,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xNy0xLTEtMzM3ODI_21c2fd07-d7d5-4f6a-a768-bb81917fb61f">1,358,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNi01LTEtMS0zMzc4Mg_21c18125-36d9-4d4b-9424-efa4158a8587">5,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNi0xNy0xLTEtMzM3ODI_4da99a70-4de0-4746-a428-49bc42963b55">5,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy0xLTEtMS0zMzc4Mg_7d72b95c-4be5-4dfa-b1ac-aedffe3e7b8b">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy01LTEtMS0zMzc4Mg_6384cb99-e6b1-4262-9f8b-1db07585bb5f">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy0xNy0xLTEtMzM3ODI_86687bc8-8d02-45a1-bc46-fa016af549bf">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0xLTEtMS0zMzc4Mg_c60d8622-9954-4edb-b229-ad2c7c964253">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0zLTEtMS0zMzc4Mg_65485902-4c90-4179-88ac-3e0b7e71e0a6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS01LTEtMS0zMzc4Mg_5bc9c9dd-cfbf-4da1-9a56-ca3e278da1db">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0xNy0xLTEtMzM3ODI_e5ecfca5-ffc2-4d78-9a0d-c029a25f8442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtNy0xLTEtMzM3ODI_c1a8f033-788c-454b-acda-7551af825e84">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtOS0xLTEtMzM3ODI_3afac887-34ff-4c71-b187-1a4dc3dadb82">2,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtMTctMS0xLTMzNzgy_9ed28e46-f53c-4c07-a1c6-7887618f572d">2,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5490e98b3a7944b197ababef7f1cd3b6_D20210401-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTMtMTUtMS0xLTMzNzgy_a5374630-9b75-4e5d-914a-45e3ae9ab46a">103,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTMtMTctMS0xLTMzNzgy_2512a13f-45af-411d-b582-1fe78cd8e97d">103,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57fd4571325741b291c09c0956211dc6_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTYtMTEtMS0xLTMzNzgy_7c81ac5f-e1f0-410b-80b7-2b4fdb9a9e63">4,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTYtMTctMS0xLTMzNzgy_c22a16ef-cb72-4e61-807a-80592529cad5">4,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMS0xLTEtMzM3ODI_6302c0ff-e120-415a-91fe-1dd410655f42">54,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMy0xLTEtMzM3ODI_107ea5b6-0025-4ede-9d7f-a0cf223d7a08">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792d19a2000e4f1da418859eb0355822_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtNS0xLTEtMzM3ODI_2bf05e8a-2548-4330-92dd-a3279bece3eb">507,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtNy0xLTEtMzM3ODI_3d6ff228-7f6f-4da2-8cce-a6d8cdca4a97">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtOS0xLTEtMzM3ODI_8868a44a-ff47-4685-ae99-046f36bca69e">133,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25f692c5e67345558d67487dab771c22_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTEtMS0xLTMzNzgy_d6d2452c-ff76-44ac-995e-23e79508143d">24,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe143a6e35d4af08305f5de23360208_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTUtMS0xLTMzNzgy_503bbf21-1470-45e4-98e8-15aba0f5a697">1,111,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTctMS0xLTMzNzgy_dc2f5da2-21ca-4e65-ad4c-88d77f76de9c">1,461,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:67.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.854%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.856%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMy0xLTEtMS0zMzc4Mg_ca7d9ebe-ed1f-4304-a330-6b874b3b87e4">106,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMy0zLTEtMS0zMzc4Mg_71cc50e7-f4f6-433e-945a-1a22e757910d">103,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNS0xLTEtMS0zMzc4Mg_deaf4be0-e3b8-443b-bdb1-74b5dec74550">16,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNS0zLTEtMS0zMzc4Mg_dbf7f6df-8039-42dc-83e4-0a290405d34e">15,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNy0xLTEtMS0zMzc4Mg_ad3aeeac-4ace-4be8-becf-00bd6b80e5c7">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNy0zLTEtMS0zMzc4Mg_52bca6a2-6b49-45d0-8bb3-6c262e6ae183">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOC0xLTEtMS0zMzc4Mg_7f5756c6-807c-4878-8ef3-cb034aa151b6">4,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOC0zLTEtMS0zMzc4Mg_9485821f-0ce8-409c-bf9e-8ce2eeb23148">7,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt origination costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOS0xLTEtMS0zMzc4Mg_3f7cb91f-b889-4136-9ba3-c3dea7b3071a">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOS0zLTEtMS0zMzc4Mg_2be1ca23-a888-473a-acdc-70ac657bb843">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTEtMS0xLTEtMzM3ODI_0fa9e604-3577-46ac-a0a5-35ba864806db">7,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTEtMy0xLTEtMzM3ODI_3d0eb18d-99c4-4be1-9aec-8ce1052fb22b">5,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTItMS0xLTEtMzM3ODI_abb82c5b-8d45-4f29-b01d-6a74a2cb8f21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTItMy0xLTEtMzM3ODI_ec4790fb-18e2-44a6-b173-14f3aa4a91bf">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTYtMS0xLTEtMzM3ODI_4280b0bf-1e67-4dd1-8c9c-80b1d98b05bd">2,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTYtMy0xLTEtMzM3ODI_9a3ddbf0-daef-443f-8004-c9b94a299ec4">3,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTgtMS0xLTEtMzM3ODI_6806d788-9d8a-40c4-8989-ea7b1af4859c">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OtherNoncashExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTgtMy0xLTEtMzM3ODI_c92b2b1b-d10f-4ec9-b877-c7fc29827a57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effects from acquisition:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjAtMS0xLTEtMzM3ODI_1fcff168-6d8c-406f-b720-1887e9cc44a1">8,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjAtMy0xLTEtMzM3ODI_4cd2d8bc-23a3-4cc5-b4ef-5bb4b953a2c9">34,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjEtMS0xLTEtMzM3ODI_bb1b8a30-7611-410c-ba68-3bd993ebe1b6">21,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjEtMy0xLTEtMzM3ODI_0979a227-4ce7-4b4e-a90b-1de3e541a583">12,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjItMS0xLTEtMzM3ODI_bd132e21-daf6-431f-be95-beaf27471933">1,501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjItMy0xLTEtMzM3ODI_c59a784f-51d0-41ed-833c-fdefbe4f3d2c">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjMtMS0xLTEtMzM3ODI_55d642b5-c668-43ae-bfcc-e0fe73a3e24f">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjMtMy0xLTEtMzM3ODI_8c612169-2cf5-429b-8458-422ae041f11b">8,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjQtMS0xLTEtMzM3ODI_e27083a8-f881-4ff3-a233-d2762a582299">9,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjQtMy0xLTEtMzM3ODI_870dee34-2232-4db5-b049-b6fdcf87d3fb">24,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjUtMS0xLTEtMzM3ODI_5aeaa5f0-f13a-4d8d-a4c2-9beb555ac43c">3,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjUtMy0xLTEtMzM3ODI_ef47dd76-8f44-42c7-8f46-d3c2ccdc6401">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjctMS0xLTEtMzM3ODI_9685e2e8-3360-4227-a917-ae0cf862732c">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjctMy0xLTEtMzM3ODI_1022e485-66b9-47a7-80c0-d80013682d58">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjgtMS0xLTEtMzM3ODI_dc5a42f7-a76b-481e-b3f4-86809cf1aa61">115,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjgtMy0xLTEtMzM3ODI_2d4ac001-7c16-4aeb-8c9c-48874ebac705">130,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzEtMS0xLTEtMzM3ODI_6b023a27-ee92-4531-b8b1-6303dbb18b47">3,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzEtMy0xLTEtMzM3ODI_96817520-7068-45cf-b565-f6e5b536721b">4,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of Akorn</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzYtMS0xLTEtMzM3ODI_b45605f5-e58a-436f-8806-1a32275173b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzYtMy0xLTEtMzM3ODI_7517f158-6dec-44f9-8b2f-1d2d427b05d0">228,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzktMS0xLTEtMzM3ODI_5373ec8e-95a4-475d-b00f-d43076214ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzktMy0xLTEtMzM3ODI_5b59dbb0-8e31-4244-938d-b63fd2dfcfe9">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDAtMS0xLTEtMzM3ODI_133f8339-ae4a-418e-9a9f-4a25be0c0ce7">3,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDAtMy0xLTEtMzM3ODI_3f3f2e7a-636a-4cef-b86d-9164595bf805">232,989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan repayments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDYtMS0xLTEtMzM3ODI_4048a0b4-876e-4179-8438-64e24fa6b8be">40,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDYtMy0xLTEtMzM3ODI_e3689ab8-206a-45d1-990e-4cd0c2867461">495,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from refinancing of Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDctMS0xLTEtMzM3ODI_c86bde83-275d-4ad5-bd48-36cecd72c49c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDctMy0xLTEtMzQxNzE_59e1040e-f135-44dd-a4c2-ba5f0e5c4b38">597,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDgtMS0xLTEtMzM3ODI_c42c508e-bff7-408d-9c74-13becf44dfb6">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDgtMy0xLTEtMzM3ODI_e52012ed-d107-498d-9ef4-b5907834d948">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments under revolving credit agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDktMS0xLTEtMzM3ODI_826b1e89-1092-40eb-b3e6-cadbedcda3ba">20,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDktMy0xLTEtMzM3ODI_34195641-e00d-4d6f-98e9-fd3389a077eb">65,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTAtMS0xLTEtMzM3ODI_512efb84-0c4a-478c-b9d1-483581c059a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTAtMy0xLTEtMzM3ODI_66180ad7-056b-4b1c-8bd9-954db2869068">6,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTEtMS0xLTEtMzM3ODI_5692df64-c843-4a3d-b4d0-182ec22f1691">1,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTEtMy0xLTEtMzM3ODI_f1adc3ec-5bbe-45d9-84f4-2b5e22beec2a">1,496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTItMS0xLTEtMzM3ODI_85e2c2cd-2b5b-467d-9b72-a525b41700ae">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTItMy0xLTEtMzM3ODI_f4f97f64-8543-4620-b3a3-136c94c422cc">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of shares surrendered as payment of tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTUtMS0xLTEtMzM3ODI_b5c18897-e7b7-41f2-9699-704d7a3680ed">5,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTUtMy0xLTEtMzM3ODI_594e8344-046f-4fa3-8c87-22b56ded6e35">2,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTYtMS0xLTEtMzM3ODI_5ad0ea5d-abf8-41dc-9e34-09771cb38790">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTYtMy0xLTEtMzM3ODI_cf0f2e7b-5a50-4e75-85ae-cf974959785b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTctMS0xLTEtMzM3ODI_91348032-715a-46b3-9377-11b0a9bee19d">95,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTctMy0xLTEtMzM3ODI_624617e8-114a-49df-abc1-e006eefbe753">114,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTktMS0xLTEtMzM3ODI_6ba5aef1-8cb4-4e98-bf72-11c0cba2c3ee">1,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTktMy0xLTEtMzM3ODI_a67b6ce5-ac3a-42f6-b404-6a1a851cfb81">1,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjAtMS0xLTEtMzM3ODI_673ce9ad-cc81-4742-b227-f5ba96608373">15,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjAtMy0xLTEtMzM3ODI_2b00ebbe-5925-479c-a3b7-87b63927373c">10,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjEtMS0xLTEtMzM3ODI_1dd7ef2f-402a-415c-ba3c-e25680248d59">27,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjEtMy0xLTEtMzM3ODI_10892861-8c43-49bb-95f6-57cd628687cd">32,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjItMS0xLTEtMzM3ODI_2845ba09-e78a-44a2-bee1-0ec4654e1eaf">42,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjItMy0xLTEtMzM3ODI_755c8ea7-fac6-4990-9d77-2dda7bb89a25">42,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjQtMS0xLTEtMzM3ODI_a2d81bb7-280b-4953-8668-985807ad91a1">19,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjQtMy0xLTEtMzM3ODI_61d54497-176b-43fa-9e9f-09b4c4ceff84">18,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjUtMS0xLTEtMzM3ODI_0862b73a-3cb6-4492-8588-9392266a93e6">15,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjUtMy0xLTEtMzM3ODI_16c03202-9759-4769-bf09-b69351d256c6">21,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">   See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU0OA_5aec2776-3b5d-4409-bad4-11b08132b185" continuedAt="ib6ddbd0e162b4f649bc2bfe3d70866de" escape="true">Business and Basis of Presentation </ix:nonNumeric></span></div><div style="padding-left:18pt"><span><br/></span></div><ix:continuation id="ib6ddbd0e162b4f649bc2bfe3d70866de" continuedAt="i9ea986e18e244e71938ed1ffa48ecc12"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we,&#8221; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 8 to these Condensed Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There has been economic uncertainty in the United States and globally due to several factors including global supply chain constraints, rising interest rates, a high inflationary environment, geopolitical events and the effects from the COVID-19 pandemic.  We expect economic conditions will continue to be highly volatile and uncertain, put pressure on prices and supply and could affect demand for our products.  In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio, however, that may not be sustained at the same levels in the uncertain economic environment.  We have continued to see changes in the purchasing patterns of our consumers, including a reduction in the frequency of visits to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The volatile environment has impacted the supply of labor and raw materials and exacerbated rising input costs.  Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience shortages, delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.  We continue to generate operating cash flows to meet our short-term liquidity needs.  These circumstances could change, however, in this dynamic, unprecedented environment.  If conditions cause further disruption in the global supply chain, the availability of labor and materials or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreaks, global supply chain constraints, the high inflationary environment and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU2Mg_c8dce7b2-d24f-440c-adea-664210030341" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31st of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2023) mean our fiscal year ending or ended on March 31st of that year.  Operating results for the six months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2023.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU2NQ_64cae680-39cd-4773-9067-3194e655e029" continuedAt="ie3c3d26f35124a3d9ef7b7f103154859" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9ea986e18e244e71938ed1ffa48ecc12"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3c3d26f35124a3d9ef7b7f103154859">compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</ix:continuation>&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU3MQ_5f164696-dcee-42e8-bc49-feac7e24a658" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no accounting pronouncements adopted in fiscal 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020.  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjI4NA_aa12f5c7-9e5f-4385-bf09-0d672eec5095" continuedAt="i76fb3581b37d4deeb890d8c48a991e32" escape="true">Acquisition</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i76fb3581b37d4deeb890d8c48a991e32" continuedAt="ia2c2fb465e2146d895b77d18bbfd44f5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjY4_2985064c-c602-46d5-8d45-24928d64535c">228.9</ix:nonFraction> million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 8).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  In connection with the acquisition, we entered into a supply arrangement with Akorn for a term of <ix:nonNumeric contextRef="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930" name="pbh:SupplyCommitmentTermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTA4Nw_4a843641-b259-4930-9b3f-5ae25c58c0b6">three years</ix:nonNumeric> with optional renewals at prevailing market rates.   </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-8-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ia2c2fb465e2146d895b77d18bbfd44f5" continuedAt="i8c7f9844fefb4796bd0a47b041685e28"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We finalized our analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjI4NQ_030e8b31-ca79-4cf0-8ec1-f03279448b0c" continuedAt="ibe35eef02213492d97ec0ac53f51bc4a" escape="true">The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ibe35eef02213492d97ec0ac53f51bc4a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfNC0xLTEtMS0zMzc4Mg_81b0c66d-df1f-4bc7-b23f-881def5cc302">6,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfNy0xLTEtMS0zMzc4Mg_0a41cf9a-9fa7-4274-8447-9ca995624452">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfOC0xLTEtMS0zMzc4Mg_0d70352d-c8b5-4748-8d1d-26501083ef3c">225,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTAtMS0xLTEtMzM3ODI_7b213b25-8b50-440f-9d9e-f3e60f2726e6">232,963</ix:nonFraction></span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTItMS0xLTEtMzM3ODI_5515cb46-d5b7-4252-97be-9bbfb66ea8ab">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTMtMS0xLTEtMzM3ODI_76fe1246-370a-46b6-832c-6a92462266d0">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTQtMS0xLTEtMzM3ODI_c7ed5d9c-49dc-4c1d-aeae-2b68655f6bfc">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTctMS0xLTEtMzM3ODI_1fe63fee-1b82-40f9-918c-ec84f3711033">4,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTgtMS0xLTEtMzM3ODI_7dcb5ccb-c192-4be4-bbd1-63bb155f39b1">228,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this analysis, we allocated $<ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTQ0NA_dea43764-e78d-460d-80c4-46002a499da7">195.9</ix:nonFraction>&#160;million to non-amortizable intangible assets and $<ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-5" name="pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTQ4OA_f0e9488d-fc65-4ef9-99e2-7bb4726ae7b5">29.5</ix:nonFraction>&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $<ix:nonFraction unitRef="usd" contextRef="ic259b127e06248a0bb0af498b1a913ea_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTYzNg_e1a8361f-db93-4e21-8a6a-457035cda019">20.4</ix:nonFraction>&#160;million are classified as customer relationships and $<ix:nonFraction unitRef="usd" contextRef="i8ed3ae73da4a4e93a4f0fea44d3a1651_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTY4NA_cda4290b-34d8-4704-bae6-2caee0cd13c4">9.1</ix:nonFraction>&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of <ix:nonNumeric contextRef="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTg1NQ_37010aa6-de35-4219-803c-920fbe5a5589">12.5</ix:nonNumeric> years (see Note 5).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTkwMw_5d807d24-8e9e-43df-afe8-e9c8668d729d">1.1</ix:nonFraction>&#160;million based on the amount by which the purchase price exceeded the fair value of the net assets acquired (see Note 4).  Goodwill is deductible and is being amortized for income tax purposes. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i8c7f9844fefb4796bd0a47b041685e28">The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjg2_66f8d4e6-2a23-4a9a-89e2-034c42445426" continuedAt="i92bc361a606b432799062622ce91ae25" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i92bc361a606b432799062622ce91ae25" continuedAt="iaca554b22e4c4b0387a3ab4704b4ab92"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjY5_164cd6b5-2d7e-40ff-bff3-67c84e6cae86" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMi0xLTEtMS0zMzc4Mg_0fee9d98-fee1-434d-b606-ab647e1cc2d4">18,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMi0zLTEtMS0zMzc4Mg_8e98fbe6-ac69-4cf7-91bd-876dde34cc04">16,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMy0xLTEtMS0zMzc4Mg_9e35e1d5-ec05-4533-bda7-e38de9b9f072">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMy0zLTEtMS0zMzc4Mg_6268040e-e26d-4578-a6db-565ec673fc00">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNC0xLTEtMS0zMzc4Mg_d716e949-adfc-4d2b-ba73-fcfc29fd5720">121,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNC0zLTEtMS0zMzc4Mg_876a2b22-d2f1-430d-bb42-92f0f6b2cbdb">103,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNi0xLTEtMS0zMzc4Mg_9891dd85-31b9-48b1-b9cb-d29ccb02fff6">140,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNi0zLTEtMS0zMzc4Mg_1c38894a-8971-4542-a9d6-be0dc8b8e511">120,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaca554b22e4c4b0387a3ab4704b4ab92">Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjAx_843de89b-5673-49b6-91d0-d348a974a9c1">4.3</ix:nonFraction> million at September&#160;30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjE5OTAyMzI1NTg0OA_1c46e5a9-c319-4d3c-b086-6cab6cbf8327">4.9</ix:nonFraction> million at March&#160;31, 2022 related to obsolete and slow-moving inventory.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-9-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjEzNA_22f2d9cf-7b53-4273-9a7c-2059be8e0759" continuedAt="ia11e139b63c14c329c4788fc7ad974e1" escape="true">Goodwill </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia11e139b63c14c329c4788fc7ad974e1" continuedAt="i0e77cbb4be8c4a3d8c25a54ba66ff6ab"><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjE0Nw_7fd81dd0-5d8e-45b9-9d8c-75716d868665" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi0yLTEtMS0zMzc4Mg_caf59e26-9ef8-4b50-9954-d28ce4386346">712,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ffbb068303406889ded3a6014f5317_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi00LTEtMS0zMzc4Mg_c61fe3a6-8927-4028-85e2-52ca8d21bfee">32,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi04LTEtMS0zMzc4Mg_b5579948-e0d4-4121-bb46-c5bf360c2176">744,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy0yLTEtMS0zMzc4Mg_58081395-87e3-42d1-b946-228c31624e2c">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05ffbb068303406889ded3a6014f5317_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy00LTEtMS0zMzc4Mg_b4da6172-f65a-4133-9d6e-420d6f8d598f">1,587</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy04LTEtMS0zMzc4Mg_3cf553f9-bea7-4bfa-b18f-4cac1db6a7ce">165,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC0yLTEtMS0zMzc4Mg_f21443a5-0203-49d3-aa2e-b675568e3e60">548,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ffbb068303406889ded3a6014f5317_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC00LTEtMS0zMzc4Mg_7f99bc00-ca56-4111-9872-fc01724ae010">30,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC04LTEtMS0zMzc4Mg_ca8c7365-8262-4f96-9a1b-be117a1b638b">578,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Adjustment related to acquisition</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930" decimals="-3" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy0yLTEtMS0zMzc4Mg_99007500-9acf-4c43-a7bf-2d0db189c563">550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930" decimals="-3" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy00LTEtMS0zMzc4Mg_325d770b-96a0-40d1-ac26-7e541a43a52f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy04LTEtMS0zMzc4Mg_8d5cbfb6-ab80-4025-97c7-781ddcea47ee">550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS0yLTEtMS0zMzc4Mg_8f895618-867f-44ab-9b7e-5fec612a0c71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS00LTEtMS0zMzc4Mg_b1695093-ac70-45c2-9867-bb2d8d397cb6">2,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS04LTEtMS0zMzc4Mg_703bee21-a484-4bf3-b969-2006ad017d41">2,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtMi0xLTEtMzM3ODI_6b9aceda-f765-46be-b182-d912fb81013b">711,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtNC0xLTEtMzM3ODI_8f3543ea-857f-49e0-8db3-21c57f102b0b">29,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtOC0xLTEtMzM3ODI_5391d69e-0a9d-4946-b75b-1f80a5866c0f">740,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItMi0xLTEtMzM3ODI_68e737c2-d560-474a-becc-ccf9b906a253">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItNC0xLTEtMzM3ODI_c5a4b8fe-20ac-407c-8f03-02c7f3349811">1,587</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItOC0xLTEtMzM3ODI_51156eaa-266e-4cb2-ac8d-36b7ca6616c4">165,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtMi0xLTEtMzM3ODI_9fb6f63b-c02a-41b7-8825-97ac1738f130">547,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtNC0xLTEtMzM3ODI_91425445-3c17-4a6e-92bf-cfcc4bb0cf96">27,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtOC0xLTEtMzM3ODI_2fbf60b8-cdfb-4ae1-9fdc-134c412916d2">575,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2, on July 1, 2021, we completed the acquisition of certain assets from Akorn.  In connection with this acquisition, we recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjcx_25002edf-de3f-4c50-894c-5d9e4de93c46">1.1</ix:nonFraction>&#160;million based on the amount by which the purchase price exceeded the estimate of the fair value of the net assets acquired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  The date of our annual impairment review was February 28, 2022, and we recorded impairment charges to goodwill of $<ix:nonFraction unitRef="usd" contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfNzUz_84667fa4-6799-4b2b-90f0-371f7df17206">0.3</ix:nonFraction> million in our March 31, 2022 financial statements.  We utilized the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;28, 2022 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, or the potential impacts of COVID-19 and inflation.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  If these assumptions are adversely affected, we may be required to record impairment charges in the future.  We continuously monitor events that could trigger an interim impairment analysis, which included the impact of COVID-19 and inflation for the period ended September&#160;30, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i0e77cbb4be8c4a3d8c25a54ba66ff6ab">As of September&#160;30, 2022, we determined no events have occurred that would indicate potential impairment of goodwill.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4Ng_a2709afe-3ce1-4396-ac66-1bc15821f8f4" continuedAt="i32b38c96357d470383338ccd811b70bd" escape="true">Intangible Assets, net </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i32b38c96357d470383338ccd811b70bd" continuedAt="i4ced42a7ff2e4708bd5a05701187387f"><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4Nw_16e4952f-d0c2-499e-b841-47a899df5f3c" escape="true"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjYwMA_25ab8259-2f27-4a0f-846f-74e0b81faf30" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7983f141c6004f779d261c014c29aa28_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi0xLTEtMS0zMzc4Mg_0eddbc5c-f76e-42ed-b991-2c532f0fd411">2,476,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092604083384497fa34d578392bb77bf_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi0zLTEtMS0zMzc4Mg_8f6456a3-25f6-4799-8534-dd12e19dabf0">436,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi01LTEtMS0zMzc4Mg_6e03a241-85dc-4578-a8de-34789ae357bb">2,912,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id482c75e4518446e816d97e9e2c77f42_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy0xLTEtMS0zMzc4Mg_79efdb5c-ecb8-4c44-8278-e46d1e42ac99">11,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy0zLTEtMS0zMzc4Mg_4d0970db-61d4-45ab-b596-23de66f543ae">3,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" sign="-" name="pbh:IntangibleAssetsTranslationAdjustmentsGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy01LTEtMS0zMzc4Mg_d044ae72-2304-46c2-901e-cabfd48d44c5">14,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC0xLTEtMS0zMzc4Mg_ae0a4850-4331-47d0-9015-3cb1a5764c72">2,464,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e210be06bb946e0a077415537e12d74_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC0zLTEtMS0zMzc4Mg_b7d97cd4-9c6e-4d73-98d1-4d70aba244fd">433,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC01LTEtMS0zMzc4Mg_f42ff0ba-75a0-42fb-831f-b88e2befd0ab">2,897,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092604083384497fa34d578392bb77bf_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTEtMy0xLTEtMzM3ODI_a8f9ef7c-5363-4b8c-a198-52a14fea20c7">216,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTEtNS0xLTEtMzM3ODI_33594a7b-8101-44b7-9c11-32aac249c9a5">216,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTMtMy0xLTEtMzM3ODI_83d4b659-4dc6-484d-86e2-c21ccd47faa7">11,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTMtNS0xLTEtMzM3ODI_8f30d7d5-c978-46db-8fe6-77b83e362da5">11,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTUtMy0xLTEtMzM3ODI_e987f96f-01d8-4a9a-8faf-19c4d1666f55">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTUtNS0xLTEtMzM3ODI_34f6d1fb-3a7c-4b9f-932e-bb7a22e5ce56">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e210be06bb946e0a077415537e12d74_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTYtMy0xLTEtMzM3ODI_9a55b900-439e-4e7d-9940-0cb824146789">227,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTYtNS0xLTEtMzM3ODI_2ee79674-2d06-4624-81bc-9b47aaba6849">227,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtMS0xLTEtMzM3ODI_1cb221a8-d91c-41d0-8f72-1bb6dd606eea">2,464,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e210be06bb946e0a077415537e12d74_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtMy0xLTEtMzM3ODI_c33d2f6e-976e-46b3-b0e1-e99471fd1e59">206,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtNS0xLTEtMzM3ODI_608c68e0-7482-4212-ab25-e5977dc76919">2,670,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $<ix:nonFraction unitRef="usd" contextRef="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701" decimals="-5" name="pbh:IntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMzk4_25b168bb-de76-4fd8-88a7-72c112e63991">225.4</ix:nonFraction> million to intangible assets for Akorn and $<ix:nonFraction unitRef="usd" contextRef="ib2a8f20fda404be0a321899a6a0aaa28_D20211215-20211215" decimals="-5" name="pbh:IntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDM2_dd311e49-2da0-46c4-9334-8402af2d4660">18.1</ix:nonFraction> million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjE5OTAyMzI1ODE2MA_b5b813f2-3162-44d4-b7e4-1ed4994630f1">5.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDc4_83ec8558-cdce-4247-b8b4-604bb3cb7210">11.3</ix:nonFraction> million for the three and six months ended September 30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjE5OTAyMzI1ODE5Ng_a119e6a6-a625-4d38-b8c8-506322703d57">5.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDk2_7f8331ac-6e76-43a6-a46a-3db65cc69de8">10.2</ix:nonFraction> million for the three and six months ended September 30, 2021, respectively.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4OQ_25a47dd1-d4a9-4dae-931b-2b993e8708a1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of <ix:nonNumeric contextRef="i37c82895d23b43b094aca7f0895f76ea_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNjM4_315636d6-5338-40e0-a5de-60b54234b774">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i7558ab4cd1534d24b525a049ad733f00_D20220401-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNjQ0_84ae5456-d78a-4365-92cf-4428225b4ec6">30</ix:nonNumeric> years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ended March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfMi0xLTEtMS0zMzc4Mg_be4b11fc-fbee-437c-ba09-4b85242b2232">11,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfMy0xLTEtMS0zMzc4Mg_b2f39063-f4be-4e5b-9313-f5dfa180a92e">22,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNC0xLTEtMS0zMzc4Mg_61d22257-0407-48a5-a373-77aa14c29a8f">20,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNS0xLTEtMS0zMzc4Mg_d143a4f1-5759-404b-8d94-bc9ba71b0734">18,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNi0xLTEtMS0zMzc4Mg_9faf1318-3316-4a79-b8fa-84a2763d5327">16,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNy0xLTEtMS0zMzc4Mg_4cb86e4b-82ac-47f9-8c86-62fc88cf0502">117,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfOC0xLTEtMS0zMzc4Mg_27a071b8-f220-4141-b58c-991c9f1d1924">206,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date of our annual impairment review was February&#160;28, 2022, and we recorded impairment charges to intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMTE1Mg_4f0a8ece-7df8-422d-916f-a79317f462dd">0.7</ix:nonFraction> million in our March&#160;31, 2022 financial statements.  Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins, and advertising and marketing expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The discount rate assumption may be influenced by such factors as changes </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4ced42a7ff2e4708bd5a05701187387f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in interest rates and rates of inflation, which can have an impact on the determination of fair value.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, changes in advertising and marketing expenses, or the potential impacts of COVID-19 or inflation, we may be required to record impairment charges in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2022, no events have occurred that would indicate potential impairment of intangible assets.</span></div></ix:continuation><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzA5_bd9e4d5e-c5f9-4d19-ae6d-af0a67e5128a" continuedAt="i864a4cd007d94ff8b99ef2fcdff46969" escape="true"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzEy_e4209679-fc7d-4169-87ba-1d943cebfab8" continuedAt="i732ef651e5444d4d8e154230b489592c" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i864a4cd007d94ff8b99ef2fcdff46969"><ix:continuation id="i732ef651e5444d4d8e154230b489592c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzE0_62f6d952-dc2d-49c6-843a-f2afc6569bcf" continuedAt="i652750c8662c4287a3bae131e39dd49b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy0yLTEtMS0zMzc4Mg_ade35c51-2589-45c6-9c56-18d52a313212">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy00LTEtMS0zMzc4Mg_923e0865-fea3-45a5-b2a7-785c31f4e92a">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy02LTEtMS0zMzc4Mg_ffebf9e5-3b16-4a13-b321-91ddbc3be557">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy04LTEtMS0zMzc4Mg_980ac672-d06e-4421-ba21-c591098b41d2">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC0yLTEtMS0zMzc4Mg_0238c41b-1cd4-4edd-9b06-e94050c3b27c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC00LTEtMS0zMzc4Mg_1a4ddef9-e4e4-4ae5-8ecb-da83f834e016">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC02LTEtMS0zMzc4Mg_17603e26-6a1e-4af2-a653-108fc609f225">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC04LTEtMS0zMzc4Mg_13a9984b-3d03-40c8-b4c4-8e887e3918c5">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS0yLTEtMS0zMzc4Mg_eca0e154-7ca0-46a0-92a2-3e7ae55d4c9c">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS00LTEtMS0zMzc4Mg_5d2708e7-05c5-432c-85a5-f19cff7b4ddb">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS02LTEtMS0zMzc4Mg_20189f35-2280-43d8-ac56-515a9d3c168f">3,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS04LTEtMS0zMzc4Mg_b58a46c4-3401-4ea8-9772-b1eeaeeb0784">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi0yLTEtMS0zMzc4Mg_3b5ace7b-3fce-4938-81ff-47e389d150c9">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi00LTEtMS0zMzc4Mg_356ff816-915f-4cc3-980e-78ee4d977cd3">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi02LTEtMS0zMzc4Mg_af5b21a3-f1a1-4442-a340-b9b1e17b42dd">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi04LTEtMS0zMzc4Mg_dabfa58b-0a95-4256-ba0a-c3c2f166f5fe">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy0yLTEtMS0zMzc4Mg_387dd9f9-e449-4496-8410-e1293a39ba5a">17,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy00LTEtMS0zMzc4Mg_091e93ae-e478-4427-ac1d-0523e2ebcc72">11,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy02LTEtMS0zMzc4Mg_a2e15131-7212-4c8d-bc20-046eaa8fbb3b">29,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy04LTEtMS0zMzc4Mg_f425ba10-9308-4f67-9861-1102ada8dea9">23,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS0yLTEtMS0zMzc4Mg_5268afc8-2e04-4ce4-b824-197ab645f010">19,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS00LTEtMS0zMzc4Mg_c9060104-5187-4aa2-b731-2c070eee995a">14,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS02LTEtMS0zMzc4Mg_185f16ce-10e1-422a-adef-94a058e9dc31">33,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS04LTEtMS0zMzc4Mg_e59703b9-59bb-4c58-9e78-05739fa809e7">28,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzEw_9b8d3206-634f-4cc1-95bd-d9daca999ada" escape="true"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzE1_24605617-cd2e-4d3a-9e7f-3687d5acdf86" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:56.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (Remaining six months ending March 31, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi0yLTEtMS0zMzc4Mg_c5eb4748-2482-49f8-b328-1e4c83eac720">3,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi00LTEtMS0zMzc4Mg_ed8a1cd2-ce03-412c-920e-8f1151b0e3b0">1,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi02LTEtMS0zMzc4Mg_233c7907-34b0-402d-bf31-5e02f9ff9173">5,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy0yLTEtMS0zMzc4Mg_06d75a6b-b8cd-4b85-bb34-3a2b9676a57a">6,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy00LTEtMS0zMzc4Mg_36566d08-12b2-4417-9627-b55fc907bc57">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy02LTEtMS0zMzc4Mg_d0e02835-5001-4319-8db4-643f00809fd8">9,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC0yLTEtMS0zMzc4Mg_29b417c5-0492-4260-8cd9-4a7a9fc105f0">4,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC00LTEtMS0zMzc4Mg_714a6c00-4bc1-4c0d-b397-63c279eed329">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC02LTEtMS0zMzc4Mg_d89c0e1b-fccc-46ff-8477-52bdd87c5439">6,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS0yLTEtMS0zMzc4Mg_6c656c01-4eea-4a72-b240-f87013bdac61">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS00LTEtMS0zMzc4Mg_00a4568a-a283-48a7-a134-b663f60effd2">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS02LTEtMS0zMzc4Mg_0560cffe-1213-4e2c-b3a3-64aaf73be071">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi0yLTEtMS0zMzc4Mg_4f5fb120-d576-457e-9b3b-cf26a5e5a675">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi00LTEtMS0zMzc4Mg_9f230474-72c2-4cd0-9fdd-7970138772c9">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi02LTEtMS0zMzc4Mg_5c0ef8cd-c289-4984-b7ca-bf127fd07e76">1,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy0yLTEtMS0zMzc4Mg_b6c0c2a2-5a48-41c0-bfb3-1165dbe619f5">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy00LTEtMS0zMzc4Mg_cca76df5-314e-4a29-9aed-0750a503f0f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy02LTEtMS0zMzc4Mg_63a28e06-de53-4fe3-a397-f689321bacc1">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC0yLTEtMS0zMzc4Mg_95186cd4-d793-48bb-864c-0f6b58f5c1c1">20,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC00LTEtMS0zMzc4Mg_4e2d4301-bb4a-414a-a4e7-96730c9330fd">6,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC02LTEtMS0zMzc4Mg_f130374d-0caa-4726-8400-7e1649400b4c">26,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS0yLTEtMS0zMzc4Mg_b2bac5d1-0c64-474a-9c1c-c8bebfbbb390">1,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS00LTEtMS0zMzc4Mg_4b6dd2a2-86cf-43c5-a255-0ad40559a0fc">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS02LTEtMS0zMzc4Mg_aa38bc7d-0a16-46b3-adc4-3f0b56e916d6">1,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtMi0xLTEtMzM3ODI_b13487ae-3f94-4c3b-83fa-c9a81946a8f9">19,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtNC0xLTEtMzM3ODI_3b6a0aaa-3559-4a23-8bff-b53f42fafb93">5,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtNi0xLTEtMzM3ODI_3f154895-7b19-432c-8f10-f554da84d4f3">25,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="i652750c8662c4287a3bae131e39dd49b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfMi0zLTEtMS0zMzc4Mg_fa4b0d51-9296-44e7-8a76-752f375a5c49">3.61</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfMy0zLTEtMS0zMzc4Mg_01b73a91-428f-4bf0-a404-5ed5e4eee25b">2.16</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfNS0zLTEtMS0zMzc4Mg_92b36156-b0f5-455e-a7ca-2a9807f7afa3">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfNi0zLTEtMS0zMzc4Mg_07bf6732-99db-43c7-8877-8e290e4c75f2">2.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-12-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RleHRyZWdpb246ZDczZWY0MTY2MGI1NGIxYjg3YWU0NmFjMjIyMzcwNjJfOTE_81d583e7-3324-44c5-9fbd-920ae07ce438" continuedAt="i2601cd402f784594b2fe626b36d2d42f" escape="true">Other Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2601cd402f784594b2fe626b36d2d42f"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RleHRyZWdpb246ZDczZWY0MTY2MGI1NGIxYjg3YWU0NmFjMjIyMzcwNjJfMTA2_e3b3d2eb-7f9e-4f3a-9895-45cf740354e6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMS0xLTEtMS0zMzc4Mg_fa3e1412-184d-47a8-b7f3-09fab9a529c4">33,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMS0zLTEtMS0zMzc4Mg_36b1b4f5-e3d5-48de-afb2-f9ea766a63bb">36,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMi0xLTEtMS0zMzc4Mg_25544142-c964-4f3b-b332-3128369741ec">7,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMi0zLTEtMS0zMzc4Mg_d167f9d0-8a43-4735-a443-cb16d588a864">19,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMy0xLTEtMS0zMzc4Mg_209d3257-35ff-4566-b5e6-2ec2bfeaec43">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMy0zLTEtMS0zMzc4Mg_c81803de-8785-4bf6-9960-30ddd10e7b09">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNC0xLTEtMS0zMzc4Mg_b449f261-900e-4987-9fd2-80e8141ac777">12,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNC0zLTEtMS0zMzc4Mg_e0324783-7178-469d-8ab1-beed3d6d7595">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNS0xLTEtMS0zMzc4Mg_d02f1d5b-faff-41fa-963a-0259380c79e4">5,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNS0zLTEtMS0zMzc4Mg_c73305f3-ec6e-4017-af5c-25e40801336b">4,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:AccruedProductionCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNy0xLTEtMS0zMzc4Mg_0cb0db20-e67b-4af6-a47d-d38693b4a51b">3,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="pbh:AccruedProductionCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNy0zLTEtMS0zMzc4Mg_03c45681-5867-4be8-b8a5-3b13abebb152">3,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTEtMS0xLTEtMzM3ODI_7c7e6c14-fe5d-41ae-9bf5-3790774fc052">6,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTEtMy0xLTEtMzM3ODI_1b77887d-f548-4f5a-9c3e-c3b71930a17b">6,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTItMS0xLTEtMzM3ODI_dd7d437f-5060-4f80-b778-0a468493060f">70,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTItMy0xLTEtMzM3ODI_03d0b818-4c1d-4b47-9c2a-61ab16330098">74,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNTE3_4daddca3-d9af-4f95-a5e7-3a7dd3f644c0" continuedAt="ie8ff8dd0616b4d8a873a9d38ef4f9e27" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie8ff8dd0616b4d8a873a9d38ef4f9e27"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNTA0_cd06eb17-4b2b-4f93-bc84-6b4148627a4e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="i6a38405494994ce1b5c3aab38c92de25_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmI5ZDFkZTliMjc5NjQ2NzU4YzNlNzI4MmY0N2E0Yjg1XzQy_b6e549ad-b94f-48a7-a0e9-8c9cd2a1f633">3.750</ix:nonFraction>%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a38405494994ce1b5c3aab38c92de25_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi0yLTEtMS0zMzc4Mg_6b7f8976-4f9a-4878-b3f6-9c2b354510fd">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9871dafd896a45e493ceb7df67951c71_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi00LTEtMS0zMzc4Mg_1f7fa6ec-5511-4dd4-9414-baae8a904a73">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="i2c616be96d674e2998de9db27d2068b5_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjI4ZmMzZTY2NmZlMzRjMzI4N2ZjODEyOGZlMjg5N2QzXzQy_3a7a486a-358f-45b9-a104-0389499d5448">5.125</ix:nonFraction>%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c616be96d674e2998de9db27d2068b5_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy0yLTEtMS0zMzc4Mg_234e4625-a168-4453-a73b-30d668e28fe1">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ac26c1487c489296168379bd629daa_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy00LTEtMS0zMzc4Mg_f759a275-17c9-481c-b169-72d417851ac7">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0Xzk5_abe167b3-3bbd-45b8-81d5-2a3d4b467fba">2.00</ix:nonFraction>%, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930" decimals="INF" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0XzEyNQ_1c469abf-c623-4734-901e-ad209a1967d7">0.50</ix:nonFraction>%, or an alternate base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i144ad08b0f5f49afaa122bd98a2a1bc1_D20220401-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0XzE3Mg_6e707552-3e47-4a4b-8983-02c946321274">1.00</ix:nonFraction>% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cd84c34e88c4d2f9dc0e7f967aad239_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0yLTEtMS0zMzc4Mg_e8ec5517-d69b-414d-9501-4f6c2a7ea22f">455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc8177d10de49bea9958fbb3d673d7b_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS00LTEtMS0zMzc4Mg_6be6be37-8691-402d-bdb3-1996b1d7aa82">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38cba7c0d2ce48268a9ea237fd0c1c0d_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNi0yLTEtMS0zMzc4Mg_b59f8fac-5434-467b-8868-23c3f28a9ce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f3bbb024f46fa91a25d1c1ce64cae_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNi00LTEtMS0zMzc4Mg_62e00015-cf26-42c5-a5e9-ed050719697b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfOS0yLTEtMS0zMzc4Mg_6028ea37-0c0f-423c-9310-fbd93e1ce23a">1,455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfOS00LTEtMS0zMzc4Mg_831d101c-a1bb-41be-8d72-2cb887934f0d">1,495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTAtMi0xLTEtMzM3ODI_e60f4a92-1510-48d3-b1f9-8010fd60a1ec">16,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTAtNC0xLTEtMzM3ODI_9fac36a0-0a8b-4a28-9dbc-319e79f499b1">18,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTItMi0xLTEtMzM3ODI_e3b444a9-781c-4f08-827d-a4249fe6eae8">1,438,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTItNC0xLTEtMzM3ODI_39f097c0-0253-4dff-8eb9-3e847c3c74c4">1,476,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we had <ix:nonFraction unitRef="usd" contextRef="ia708754131aa4c4cadfdb34847429103_I20220930" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfMTEx_4b3d4245-64ae-4346-99ef-ddf8de8709a3">no</ix:nonFraction> balance outstanding on the 2012 ABL Revolver, and a borrowing capacity of $<ix:nonFraction unitRef="usd" contextRef="ia708754131aa4c4cadfdb34847429103_I20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfMTgw_a7abf380-1640-4b30-8579-5ed5eb013276">149.1</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNDk2_44199e7b-9834-47a7-9cd1-7924335e3eb5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2031 (the "2021 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfMi0yLTEtMS0zMzc4Mg_7d839ca3-aed5-4625-880b-2b9d1d8c5b7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfMy0yLTEtMS0zMzc4Mg_69a80936-2dea-4a48-b805-b9e64385a750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNC0yLTEtMS0zMzc4Mg_ba871aea-9efe-4b32-a145-c60fe1de4406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNS0yLTEtMS0zMzc4Mg_083ef119-9550-4db8-9ac8-38b4f7d296a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNi0yLTEtMS0zMzc4Mg_b6c8b4d4-a180-491e-af82-0dd2f75902e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="pbh:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNy0yLTEtMS0zMzc4Mg_e511f39d-42e9-40f0-b09d-47bc4c401d32">1,455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfOC0yLTEtMS0zMzc4Mg_8e6f8f07-185b-4648-ba53-c207ffa372b3">1,455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RleHRyZWdpb246YTlhZTA4MzFiZGEzNDg2MTg4N2FmZjA2OTI3Nzk4M2FfMTc4Mw_28129390-c412-4664-97b2-1f29d4fe673f" continuedAt="ifcba028fc1fb4297b2a6852bea975c58" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="ifcba028fc1fb4297b2a6852bea975c58" continuedAt="ib0d39a789cca4ba09b1564cd9b7df5e4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib0d39a789cca4ba09b1564cd9b7df5e4" continuedAt="i69f667a8b20e4ae6ba815e3b7ad17678"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB Accounting Standards Codification ("ASC") 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy.  <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RleHRyZWdpb246YTlhZTA4MzFiZGEzNDg2MTg4N2FmZjA2OTI3Nzk4M2FfMTc3OQ_3b616bdb-36fa-4a45-94f4-2643213bc411" continuedAt="ibf04c7fcc6d14e8f9e453ca0d3159301" escape="true">The summary below details the carrying amounts and estimated fair values of these instruments at September&#160;30, 2022 and March&#160;31, 2022. </ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="ibf04c7fcc6d14e8f9e453ca0d3159301"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd6d7d6775d456aab43522e8641590d_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi0yLTEtMS0zMzc4Mg_fc04158d-5163-4ad4-9504-86d2f76f282e">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93c71c69cbd4f518813bf35d29567ff_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi00LTEtMS0zMzc4Mg_815986cf-9354-4a63-953c-0b742cad56ab">466,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c4abbe4c7a4c51ab953cfac5a719e3_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi02LTEtMS0zMzc4Mg_e0f8d011-564d-415b-8645-e73721a870f8">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13229551ff74aac852ed82658c2bc5a_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi04LTEtMS0zMzc4Mg_4d08f833-f129-473a-8b8e-767db439079e">534,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb1ab25a9104ca786d77647d79f0750_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC0yLTEtMS0zMzc4Mg_739a49d1-b1a4-49c4-a2ae-81cc4cf0d8ca">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6a01a4639347e59ce1b6926fe770aa_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC00LTEtMS0zMzc4Mg_3d57156d-9a4f-46be-8492-b4b2ea366c32">361,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i209a7eca485c4ae089043ae691508354_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC02LTEtMS0zMzc4Mg_062eaa16-abca-4091-ba09-66661a305436">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b38ddefea943b4a58f5c5e1837187e_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC04LTEtMS0zMzc4Mg_21d3f84d-cfe8-4e2f-97ce-353621444f87">397,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcb4c05211a4f52b3d328d6faa3c979_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi0yLTEtMS0zMzc4Mg_ca0901f9-94dd-4656-b2da-5211e5e8a9b3">455,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107654b9df4f4d36a2be4b1b29dbb756_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi00LTEtMS0zMzc4Mg_2c56083f-306a-4c0d-be01-eab61a33fd0a">453,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1cf43c2ca44eed91e983938f2fd966_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi02LTEtMS0zMzc4Mg_f284e8e4-13f8-44e3-b3d2-d95db5566be6">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaee783e80be466aac335d1710829144_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi04LTEtMS0zMzc4Mg_486174f5-c6e9-45b0-ad7d-5864527208ad">493,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c573dedd8d9443b9195d944fdb41808_I20220930" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy0yLTEtMS0zMzc4Mg_ff96e6b0-326c-4ad8-b315-6c4cfbbc345b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f4ca14c8ca842d6b7d60e303216a672_I20220930" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy00LTEtMS0zMzc4Mg_9a84992c-420c-4a00-aa49-de3316074384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8145646a4620446cb3bb6c97a2b33b43_I20220331" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy02LTEtMS0zMzc4Mg_e024247a-a6ae-4b8c-a8ac-0edd4d865830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b63503a525b4ad0ae2f49bbf0d38637_I20220331" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy04LTEtMS0zMzc4Mg_f1e7bdcd-81c9-4a76-8998-5d0428c6d65d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i69f667a8b20e4ae6ba815e3b7ad17678">At September&#160;30, 2022 and March&#160;31, 2022, we did not have any assets or liabilities measured in Level 1 or 3.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMzk1_042dc775-d1c5-4712-a5c4-4938c6e31926" continuedAt="i0b1336593e944d3da5cc2c9f854f9a99" escape="true">Derivative Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0b1336593e944d3da5cc2c9f854f9a99"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into an interest rate swap to hedge a total of $<ix:nonFraction unitRef="usd" contextRef="ife7c577cd8d34acd9e144f85556f13fe_I20200131" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMTg1_b2b09a42-d4bc-439d-be5e-8b2956a26f54">200.0</ix:nonFraction> million of our variable interest debt, which settled on January 31, 2022.  We do not use derivatives for trading purposes.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMzk2_ff46a2fe-11d5-40bb-be19-b0385f387ea0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f948f5963c423aa59b916bd733f299_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi00LTEtMS0zMzc4Mg_04eecc4a-798b-477b-adbe-4ff88991be62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2804a8cd20480092ebaac1665cb981_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi02LTEtMS0zMzc4Mg_0264cbb5-d46e-45de-a6ca-d7192f45d29e">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7c46e7cb4f4393bc9da7353259532f_D20220401-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi04LTEtMS0zMzc4Mg_bd8a8b49-9b18-4683-8b25-9c8313293589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee68f53fac064ea6b3ca739ae5139369_D20210401-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi0xMC0xLTEtMzM3ODI_2155e0c6-61e8-489b-8f51-f108520b1537">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3ebdd1608049819d7960351aa8db35_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy00LTEtMS0zMzc4Mg_db53e5f4-9b45-4273-96a7-7bd149279701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia469219d9c2a49a98e21464086b58660_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy02LTEtMS0zMzc4Mg_00ba6e97-a06a-4d79-a1c1-ff965342e08b">732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c497ac02c504e91b6ce612b29fc8a82_D20220401-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy04LTEtMS0zMzc4Mg_c4919004-c21e-49f8-bc2c-74e14a40f0fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a99b6fbe44645ad882a7a958382a827_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy0xMC0xLTEtMzM3ODI_20183be6-78e7-41ab-9a77-7b9d2b6b6efb">1,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfOTQx_653294f5-18d7-478d-9521-d12f4901b9e0" continuedAt="id10233165b5c4a1296f9f4e57831fd99" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id10233165b5c4a1296f9f4e57831fd99" continuedAt="if6375a2baac64996900d249631ea0c1a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfNTg_a5dc880a-218f-45b5-8f25-2440c783d667">250.0</ix:nonFraction> million shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfODU_ab891662-304d-47d0-97fb-99aa3883fbcc">0.01</ix:nonFraction> par value per share, and <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMTEz_04f529e0-fbda-4bec-95ca-11c10a78a30e">5.0</ix:nonFraction> million shares of preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMTQz_959e476e-b616-4018-a141-3624345ad0f6">0.01</ix:nonFraction> par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to <ix:nonFraction unitRef="vote" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="pbh:VotingRightsNumberOfVotesPerCommonShareOwned" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMzgy_ee04a121-1e90-4c8d-8134-8833b31c5390">one</ix:nonFraction> vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="INF" name="us-gaap:DividendsCommonStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfNzA0_119cb801-1f1d-493c-8886-c0e643b3bc15">No</ix:nonFraction> dividends have been declared or paid on our common stock through September&#160;30, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="if6375a2baac64996900d249631ea0c1a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfOTM1_8bd5b972-511f-453b-a5de-e566c6f862d6" continuedAt="i05df17f638bb4be4ba03877a91f33d01" escape="true">Our share repurchases consisted of the following:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i05df17f638bb4be4ba03877a91f33d01"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy0xLTEtMS0zMzc4Mg_f332c104-dde3-4caf-89ba-2cf796890bef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy0zLTEtMS0zMzc4Mg_4edb2869-b621-45db-9d7e-04c38ab1dea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy01LTEtMS0zMzc4Mg_9ee5aa43-6475-4048-9a3c-59261aab1101">99,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy03LTEtMS0zMzc4Mg_ea569198-dbfe-40b8-bf92-1182c3218df0">63,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC0xLTEtMS0zMzc4Mg_c5499e9f-4665-4c7e-82ff-285fdd0688f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC0zLTEtMS0zMzc4Mg_28724849-fd84-46df-9526-e9a63288561e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC01LTEtMS0zMzc4Mg_89687dc8-07de-4453-97de-8edc8e852469">54.94</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC03LTEtMS0zMzc4Mg_3ec7bb1e-26e9-4c58-a4c4-e87a5c9a5e4b">46.04</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS0xLTEtMS0zMzc4Mg_d2488214-a82d-47c0-9119-e2b83702d65b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS0zLTEtMS0zMzc4Mg_c4454f4a-c155-42ef-84b5-54c105e99162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS01LTEtMS0zMzc4Mg_6521d9ba-de72-4feb-b27f-b7d8f6f6cc7c">5.5</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS03LTEtMS0zMzc4Mg_674bc84b-0a40-4cc0-b155-3dfcd35d17b4">2.9</ix:nonFraction> million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC0xLTEtMS0zMzc4Mg_0240a3bd-f5a7-4626-bec1-eeb8c934c394">236,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC0zLTEtMS0zMzc4Mg_97ee61f5-5252-466b-b2a5-7222909f289f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC01LTEtMS0zMzc4Mg_bee1d8ab-19ee-494b-ab63-4581630614c9">914,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC03LTEtMS0zMzc4Mg_c3162761-84c7-40d1-acba-9c35d233e4fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS0xLTEtMS0zMzc4Mg_313cecdc-9516-46e1-9601-1ea76d6f98c0">51.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS0zLTEtMS0zMzc4Mg_be140bb8-1b5c-4184-a280-47be7f948fa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS01LTEtMS0zMzc4Mg_75621698-936d-444d-98ef-024fb4282f87">54.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS03LTEtMS0zMzc4Mg_16dc2e65-0e5b-4bb2-a7e5-fe0362ca75aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtMS0xLTEtMzM3ODI_61457a37-fa35-45ee-abe4-9d691147fc09">12.3</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtMy0xLTEtMzM3ODI_20ac4104-35c4-4812-8e1d-521882ec72dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtNS0xLTEtMzM3ODI_81df3888-cfa7-40f4-a3b0-701fbecef280">50.0</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtNy0xLTEtMzM3ODI_f20ec566-9009-483f-8c97-e7490e3b5222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMjQ4_dc921c55-4a0c-486f-afb0-2013a26a9f79" continuedAt="ic724a1a0d7d74a90b7fad0e6c69aae3b" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ic724a1a0d7d74a90b7fad0e6c69aae3b" continuedAt="i59150f0c526e4bb5b2667477a10e7ac6"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMjQy_29ef312c-0241-4af3-a4be-c0d0ede77282" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at September&#160;30, 2022 and March&#160;31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7ac391963f848548a601af9567fbba9_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfMi0xLTEtMS0zMzc4Mg_8e2e655c-454b-49de-bf90-5684a707df3f">36,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i205dff464c7245768d0c7263beceb556_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfMi0zLTEtMS0zMzc4Mg_ea509c6c-6bef-43b1-915f-1b33968885f1">20,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain on pension plans, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="ic536994b83bb485a862ea0e3393120d1_D20220401-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmNjMDNmZDA2ZjBlNDQxZjE5YmU1NWJiOTgzN2Y3ODZiXzU4_38a31b9b-2909-4605-bcac-796a0621b218">114</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ia218ac2046f540c895fce30181f0a41e_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmNjMDNmZDA2ZjBlNDQxZjE5YmU1NWJiOTgzN2Y3ODZiXzY1_1a426e6c-7a37-4eb7-b46f-8a6a49a833e3">350</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f1b498eebb4cd883a3fa617593819a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0xLTEtMS0zMzc4Mg_6cf58b69-baf7-4f23-9dc1-9b693edfef3d">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5be7898b214a428d8760e4a62973f03b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0zLTEtMS0zMzc4Mg_1ec469b9-af5b-4019-9248-e51186c9fd92">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNS0xLTEtMS0zMzc4Mg_ea140d2a-1f66-4f05-9d8b-2464e3013ab6">36,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f54d4cf1d841b38d61272505328c59_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNS0zLTEtMS0zMzc4Mg_ef30d1db-da77-438d-a16d-02083ea1a09e">19,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i59150f0c526e4bb5b2667477a10e7ac6">As of September&#160;30, 2022 and March&#160;31, 2022, <ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="INF" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMTQ1_6728a2b2-b0f8-4ae2-a654-330cdc5be204"><ix:nonFraction unitRef="usd" contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331" decimals="INF" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMTQ1_ed621255-1f38-4c26-9e3f-8c423bd81647">no</ix:nonFraction></ix:nonFraction> amounts were reclassified from accumulated other comprehensive loss into earnings.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMTM2MQ_e1c92143-092f-46e4-bc0a-f2e983a7f1c0" continuedAt="ia7056193619b47858820520d2793b745" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia7056193619b47858820520d2793b745" continuedAt="ie0e037bead194c0881483423cf986fc0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options, restricted stock units ("RSUs") and performance stock units ("PSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><ix:continuation id="ie0e037bead194c0881483423cf986fc0" continuedAt="ia97abcf7134a407295fc8c1d68775eaa"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMTM2Nw_a5a5b42e-b41c-4e92-b3e4-698a64bc6dba" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy0yLTEtMS0zMzc4Mg_71abc0c9-3bd4-465e-8bb8-cfe134038e6f">51,023</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy00LTEtMS0zMzc4Mg_970aaf64-c4fb-4c0b-a2bb-8119337f4fdc">45,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy02LTEtMS0zMzc4Mg_1a9b9b3c-0476-4e55-bd19-fd65be3470fc">106,295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy04LTEtMS0zMzc4Mg_872a819d-8f91-4cca-a714-f9f3e61ac06b">103,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi0yLTEtMS0zMzc4Mg_6706fda7-6e34-4fab-a597-4cfd8f4751e0">49,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi00LTEtMS0zMzc4Mg_83f59092-ec5a-48df-8cbc-20906db68205">50,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi02LTEtMS0zMzc4Mg_43ff4287-fdba-4d5e-8dc6-5202a0803c78">50,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi04LTEtMS0zMzc4Mg_0eee4085-66b4-4d21-b630-12e96840b965">50,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy0yLTEtMS0zMzc4Mg_53207834-7291-450a-b94a-3221410418c4">461</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy00LTEtMS0zMzc4Mg_d8fea1db-dfc6-40cf-b809-428c54243f99">559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy02LTEtMS0zMzc4Mg_5c66f964-159c-48ac-b1e9-359283018388">463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy04LTEtMS0zMzc4Mg_77c13203-f485-49d0-a3f8-205fcb4c72f5">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC0yLTEtMS0zMzc4Mg_1e410716-0098-4200-94b8-2fd337fb5b5e">50,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC00LTEtMS0zMzc4Mg_0d98e676-4c4e-4411-a122-45e44104d69f">50,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC02LTEtMS0zMzc4Mg_cfe1f991-5021-4652-80bd-f081025fec12">50,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC04LTEtMS0zMzc4Mg_9bb6481f-fbc6-4e1d-932c-db2ce850b96d">50,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtMi0xLTEtMzM3ODI_4e6c4bcc-7d31-4d5b-993d-54e9abc8ad82">1.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtNC0xLTEtMzM3ODI_e8d472fd-085e-4281-b8e0-8a45c140408c">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtNi0xLTEtMzM3ODI_88ed392d-1a1b-45b8-adb9-e1d4ed256792">2.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtOC0xLTEtMzM3ODI_6672c8a4-9481-47a1-ade5-da015ad5fe6e">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtMi0xLTEtMzM3ODI_5a786b00-b5d7-49b2-a8f1-7dd6ff7ae328">1.02</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtNC0xLTEtMzM3ODI_bc492b25-a1bf-4c42-af48-2f9a006fe482">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtNi0xLTEtMzM3ODI_3ce2647d-1361-4775-9457-346a848395f0">2.11</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtOC0xLTEtMzM3ODI_54b1033b-1907-4c79-80b5-0eca35f125ee">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia97abcf7134a407295fc8c1d68775eaa">For all periods shown above, there were <ix:nonFraction unitRef="shares" contextRef="ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_608dfa9a-e8ab-4bde-a2fa-25168b7cc420"><ix:nonFraction unitRef="shares" contextRef="i8326e328abad4478a736ff2103f13dad_D20220401-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_74576df0-7478-4db8-bbca-29b52d9086ff"><ix:nonFraction unitRef="shares" contextRef="i8883e67a6b294bb2b4988346e7c8bf37_D20210701-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_aa7e0a9c-da19-47cb-af1e-048ba68f426b"><ix:nonFraction unitRef="shares" contextRef="icfd1c9c171164a8f9f0702ee5bb0710b_D20210401-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_e6b63d3d-b4ec-4dc1-97a6-4ba5812de071">0.4</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.</ix:continuation> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzEzMg_eae02dd1-3d97-476e-a9c5-c801c6fed981" continuedAt="i1a15d7d0882b4842a5e5902a9ac9d1ea" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1a15d7d0882b4842a5e5902a9ac9d1ea" continuedAt="i83b0da2194b8486381e1dd9212d74cbe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i44cc662485d34441b6e4321c121a9125_I20140531" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjIy_0a479dea-0fdd-44d8-a345-2ad2c0047959">5.0</ix:nonFraction> million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional <ix:nonFraction unitRef="shares" contextRef="i81cfb12ba748413e9a14ed4bcc0a4a0f_D20140601-20140630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNDI2_f7e20887-790c-4d6b-b39a-3727fd6d951d">1.8</ix:nonFraction> million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from <ix:nonFraction unitRef="shares" contextRef="if59663672a2242a89e285a8508bacf1c_D20140531-20140531" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNjYz_74b31983-ddae-4e15-98e4-77da8857c54f">1.0</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNjY5_67651757-014d-4762-aabb-a37c99d68f4c">2.5</ix:nonFraction> million shares, and an extension of the term of the 2005 Plan by <ix:nonNumeric contextRef="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0Ng_e6fa5801-72dd-4c53-bf66-c729788ac7c7">ten years</ix:nonNumeric>, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of <ix:nonFraction unitRef="shares" contextRef="ieaf59758726f4998abd628904bf3be96_I20200623" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTIxMA_15240d0e-a06c-4e15-a20b-717111faf3d5">2,827,210</ix:nonFraction> shares were available for issuance under the 2020 Plan (comprised of <ix:nonFraction unitRef="shares" contextRef="ieaf59758726f4998abd628904bf3be96_I20200623" decimals="INF" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTI4Mg_f6c9aad4-2377-43c2-8267-0e33e631c124">2,000,000</ix:nonFraction> new shares plus <ix:nonFraction unitRef="shares" contextRef="ieaf59758726f4998abd628904bf3be96_I20200623" decimals="INF" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTMwMQ_26ad8d62-382f-4d70-a620-e299aa5fef0a">827,210</ix:nonFraction> shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE1Nw_d3fe8a38-7dc7-4614-a6bf-c76b49050821" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi0yLTEtMS0zMzc4Mg_d3e9090b-a612-405a-9121-30e73d2e4128">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi00LTEtMS0zMzc4Mg_e1981d65-c357-4da0-938e-968d9e8b1b5a">3,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi02LTEtMS0zMzc4Mg_52d46170-7091-48c7-a28e-dde4e24dba99">7,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi04LTEtMS0zMzc4Mg_016684f5-43d4-4ef2-a1d7-7a052d216c26">5,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy0yLTEtMS0zMzc4Mg_e36fa329-a4dd-4c0c-ae90-69105e303fb9">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy00LTEtMS0zMzc4Mg_8213e2ea-bfc6-4f51-9bf8-63c4a74744a4">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy02LTEtMS0zMzc4Mg_ee3b02ad-07d8-439c-85ea-bd3d5713cda5">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy04LTEtMS0zMzc4Mg_b7a9710a-6d50-4317-abb5-3a32b62bbe54">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC0yLTEtMS0zMzc4Mg_6464682d-17ff-40b7-8bc6-d5d2e5712137">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC00LTEtMS0zMzc4Mg_db9a2c08-6b12-4834-9794-3c46be08a1f7">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC02LTEtMS0zMzc4Mg_c4bd2550-ec44-4e66-a9ef-420fcea14875">10,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC04LTEtMS0zMzc4Mg_3dd3f7cd-8b25-49dd-b38a-34df31c7a5ce">7,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS0yLTEtMS0zMzc4Mg_deecec70-429f-46ae-89a0-01a5b1f2b0a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS00LTEtMS0zMzc4Mg_86f617dc-b83e-4bdc-8e13-8c09beac8ac8">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS02LTEtMS0zMzc4Mg_9deccc2b-b1fc-4e6f-9eb5-e0aff6a4c245">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS04LTEtMS0zMzc4Mg_333b9591-10ea-4004-b84c-693ad7416efb">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi0yLTEtMS0zMzc4Mg_0ad051fa-023f-4e87-97bb-38d4be9bd887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi00LTEtMS0zMzc4Mg_702633eb-5a78-4528-8b8f-a2568171a8b0">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi02LTEtMS0zMzc4Mg_98f1010b-f3e3-48bc-ba3d-fe9b13cee0a2">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi04LTEtMS0zMzc4Mg_fb93d1da-4a3e-49cb-b3e3-f7d3e0ff336b">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i83b0da2194b8486381e1dd9212d74cbe" continuedAt="ie78b6dfd107449d99ca355ba59dbf53e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At September&#160;30, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTU4Nw_59b9034a-d749-4b5f-aec6-5bec9fe9ab8b">4.8</ix:nonFraction> million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTgyMg_a5fc40ef-8917-4f1d-a1b4-2277e75c790c">2.2</ix:nonNumeric> years.  At September&#160;30, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="ic9184f3b632646bebc4e3cd2872e2ba4_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTg1MQ_0e25c62a-248f-4bc3-8cd3-91b8ff7b3c07">13.2</ix:nonFraction> million of unrecognized compensation costs related to unvested RSUs and PSUs under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of <ix:nonNumeric contextRef="i42333d378e9e4b66a3f698890196fcc6_D20220401-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjA4Ng_6e6f70e7-7ed8-4065-b609-805a6ec59309">1.9</ix:nonNumeric> years.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At September&#160;30, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjExNw_0fc37189-5cff-460e-9862-79569af65f5b">2.1</ix:nonFraction> million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 2, 2022, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="i0d07c6a04ba74840907835eea95e20cd_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjI4OQ_13ea194f-cd36-4603-8727-69de069db712">67,959</ix:nonFraction> PSUs, <ix:nonFraction unitRef="shares" contextRef="i11b979b892ef4decba1bfef8062479dd_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjI5OA_081b28cf-8002-43e6-8621-b6196621c91b">65,721</ix:nonFraction> RSUs, and stock options to acquire <ix:nonFraction unitRef="shares" contextRef="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjMzNg_c3d94785-2d61-430d-bb68-33b4f1df72e7">195,526</ix:nonFraction> shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjQ4Nw_c0185859-7e39-4137-8365-931778b2f141">54.47</ix:nonFraction> per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Each of the independent members of the Board of Directors received a grant of <ix:nonFraction unitRef="shares" contextRef="i681c9643cccc46478279947213d2e17b_D20220802-20220802" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjE5OTAyMzI1OTM0Mw_5cb2a57b-d27b-4c5c-b88e-9c71a5843a1b">2,495</ix:nonFraction> RSUs on August 2, 2022.  The RSUs fully vest one year after receipt of the award, subject to the continued service of the director on such vesting date, and will be settled by delivery to each director of one share of our common stock for each vested RSU either (a) at the election of the director prior to the grant date, immediately upon vesting, or (b) promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Restricted Stock Units</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. <ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0Nw_0708a52e-2fb3-4719-9667-a8647238f34e" continuedAt="idf8d01a17195429b88494937c7ce3709" escape="true">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:justify"><ix:continuation id="idf8d01a17195429b88494937c7ce3709"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i815f24f411e64db2828daba078c81281_I20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMi0yLTEtMS0zMzc4Mg_c8c7b820-34fc-4bed-ad3e-55d7206b4493">457.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i815f24f411e64db2828daba078c81281_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMi00LTEtMS0zMzc4Mg_b7b915aa-3f41-45f0-92b7-e50c2cd01731">33.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMy0yLTEtMS0zMzc4Mg_ee0e923d-90c6-4fbf-b89b-f167c43e073e">170.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMy00LTEtMS0zMzc4Mg_0f413a53-6358-4557-bf01-12141bdccdb7">45.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNC0yLTEtMS0zMzc4Mg_dfad88bb-ac22-4238-86fa-bc194b4c8dc1">162.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNC00LTEtMS0zMzc4Mg_bd1e6692-aba1-4579-a035-60e14d5b0a32">32.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNS0yLTEtMS0zMzc4Mg_ab6fc623-905c-4f29-8913-4519a3535dee">24.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNS00LTEtMS0zMzc4Mg_690f402d-f85f-4b1a-8be6-9952fee33bf8">30.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa98021577994bd988d17efb0ddce577_I20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNi0yLTEtMS0zMzc4Mg_e814f41a-166e-423c-a8b9-4c6dd5daa3ed">440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa98021577994bd988d17efb0ddce577_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNi00LTEtMS0zMzc4Mg_85509904-3171-4c54-82d8-af5a83fbe9ef">38.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa98021577994bd988d17efb0ddce577_I20210930" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNy0yLTEtMS0zMzc4Mg_a6f55a35-fa82-48a9-93cd-15b339db5149">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa98021577994bd988d17efb0ddce577_I20210930" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNy00LTEtMS0zMzc4Mg_b062d84f-22cd-4e37-8ecf-bc746797c214">33.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3f0f5de01544b1488a49d521bd4e50f_I20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTAtMi0xLTEtMzM3ODI_1988c517-2dee-4b72-bb6d-e3e6e56674d1">440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if3f0f5de01544b1488a49d521bd4e50f_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTAtNC0xLTEtMzM3ODI_01795c99-a4ab-417f-b5ee-5769ff4e6cae">38.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTEtMi0xLTEtMzM3ODI_da3e6463-15ee-482e-9138-72b9095d3784">148.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTEtNC0xLTEtMzM3ODI_1a1eb0f5-84cf-4113-9dc9-ccd3c84d64d3">55.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental performance shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTItMi0xLTEtMzM3ODI_ab991bed-9626-4401-9fd9-8a098aeffb0e">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTMtMi0xLTEtMzM3ODI_f1ead6fe-0508-427b-a09e-c731329d2220">222.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTMtNC0xLTEtMzM3ODI_56f5b53c-b33c-4fe9-9ba8-9c30a7d55a8b">32.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTUtMi0xLTEtMzM3ODI_a1a409ef-951d-4073-a104-2cc7674ae44c">409.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTUtNC0xLTEtMzM3ODI_a396282d-64e4-4cef-aa1f-86996e16b71c">47.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTYtMi0xLTEtMzM3ODI_3a41c976-c96e-47c1-89f1-94d7d82354e0">108.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTYtNC0xLTEtMzM3ODI_93f6195d-aeb6-4d2c-9cc7-7e40531436b3">36.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0OA_82a1564a-55a5-42a9-a1ae-2f9da432053a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjczYmM5MmZhMGNkNjQwZmQ4YzkwNGU0N2FkMTRjYWE0XzQ_26d3bee5-d9e8-4c5f-a1ff-c95b39269fcf">30.8</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjczYmM5MmZhMGNkNjQwZmQ4YzkwNGU0N2FkMTRjYWE0Xzk_de18681d-0ea0-4150-9da2-9a4bdf69462c">30.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxNzVkM2JjYzI1ZDRhYjU5YmUwZjZjZmY0YjQyNjNjXzQ_9c155fb7-63a7-45ed-a5b2-6d96c06f0cf6">31.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxNzVkM2JjYzI1ZDRhYjU5YmUwZjZjZmY0YjQyNjNjXzk_73d562dd-0daa-4d89-bb83-ae76dee05199">31.9</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2063782252c94eed817587f0ac1d141a_D20220401-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMy0yLTEtMS0zMzc4Mg_e772cd70-6146-4b76-ac81-24834e7546cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMy00LTEtMS0zMzc4Mg_c5e8aec3-b354-4199-a7ec-ec8743057205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU5YTNlMTgxMzk3ZjQ2NzdiMzk0NmRmYTk1MTEyYjIzXzQ_cb459dcb-bf1a-4b55-87e2-cf29809a3861">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU5YTNlMTgxMzk3ZjQ2NzdiMzk0NmRmYTk1MTEyYjIzXzEw_d5c2b648-a110-4894-93b4-f3f676bd3385">7.0</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmRkZTkyZDAzZjE5MTRlODU4NmVmMzc3ODhlYzgyZTJiXzQ_9eb93366-6597-453c-8992-0168129cdfb0">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmRkZTkyZDAzZjE5MTRlODU4NmVmMzc3ODhlYzgyZTJiXzEw_ceecd4e1-683e-4955-90d9-8241cbfb155e">7.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjQwNjVhOGY4ZjA4MTRhNjJhODZmZGQ1ZGFiNWVhYTI4XzQ_3320097c-2128-4ace-9a32-1dc7e22ea64d">2.8</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjQwNjVhOGY4ZjA4MTRhNjJhODZmZGQ1ZGFiNWVhYTI4XzEw_2e54a7ee-66e3-43ce-917b-a132e650191b">2.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQyZjgyNjE4NTllZTQ3ZWU4YWFjYmM1MWVjMWRmYTJjXzQ_70ffad9a-704b-4766-88a0-cfe0f8a85129">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQyZjgyNjE4NTllZTQ3ZWU4YWFjYmM1MWVjMWRmYTJjXzIxOTkwMjMyNTU1NjQ_2e736249-fc12-4574-a97c-cbe705fadf4d">1.3</ix:nonFraction>% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2063782252c94eed817587f0ac1d141a_D20220401-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNi0yLTEtMS0zMzc4Mg_25bf5811-9b0c-499d-b386-1773f712b86f">20.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNi00LTEtMS0zMzc4Mg_5b8c904b-41eb-4af2-a8de-ba365710b5b8">14.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie78b6dfd107449d99ca355ba59dbf53e"><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0NA_e063ef0a-c5ae-42ec-a199-6f855b964c50" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMi0yLTEtMS0zMzc4Mg_94d41518-3e19-4599-b7ad-d061faae58fb">1,114.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMi00LTEtMS0zMzc4Mg_4469aefc-b6f3-494b-8caf-658fa92aa656">37.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMy0yLTEtMS0zMzc4Mg_133923b6-e869-499c-94ef-2c61962a2a50">234.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMy00LTEtMS0zMzc4Mg_d410d4fa-0e78-4913-a043-ba89d17180d4">44.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNC0yLTEtMS0zMzc4Mg_28063ea7-9c3e-4080-973f-9577074a7b2b">87.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNC00LTEtMS0zMzc4Mg_902072fe-4bd7-4413-8ec5-c4a736c85025">30.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNS0yLTEtMS0zMzc4Mg_896d8a64-1b90-4a3f-8ebe-0b56bd6f82ac">13.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNS00LTEtMS0zMzc4Mg_13073df2-0c05-4941-ab9a-c4350b88d68e">37.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNi0yLTEtMS0zMzc4Mg_61997814-13f4-4aa4-8ee7-12c5b6da35c6">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNi00LTEtMS0zMzc4Mg_1f24f795-2d98-4348-99d0-aabdedcbbfd8">56.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy0yLTEtMS0zMzc4Mg_49b00497-3c93-4ff1-9944-e77895dd9619">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy00LTEtMS0zMzc4Mg_949fdf67-93e4-45d5-9699-c99f3aaa80db">39.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy02LTEtMS0zMzc4Mg_1a7a386e-1fe8-42c9-a425-d7fa47660a8f">6.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy04LTEtMS0zMzc4Mg_ff9b7361-c3c2-4cfc-aa34-af27b08ef9b9">20,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC0yLTEtMS0zMzc4Mg_62db1ff9-3529-4786-9353-ee72239f285d">759.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC00LTEtMS0zMzc4Mg_5d09f641-3e1c-4cd3-b0b5-4aefed25f99c">39.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC02LTEtMS0zMzc4Mg_c9e984f4-1982-4d09-97cf-ad7714b5c948">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC04LTEtMS0zMzc4Mg_be0f86a4-e510-45d4-b0ba-5fc5d2c49df0">13,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTEtMi0xLTEtMzM3ODI_ba38adf8-fe32-4327-8e42-6ab67f6af326">1,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTEtNC0xLTEtMzM3ODI_d9036e28-7bdd-4ca9-9a73-a78316c72b77">40.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTItMi0xLTEtMzM3ODI_35cb5de4-823f-4718-876b-4a2a64eba61b">197.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTItNC0xLTEtMzM3ODI_a7e9a3a0-a2a7-4a72-8949-33d92007dcab">54.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTMtMi0xLTEtMzM3ODI_bdb8cdb4-3721-4c7d-8ec5-99af0c0d4d6a">39.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTMtNC0xLTEtMzM3ODI_610e2235-9783-49cc-aec1-db1e6a90cc82">38.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtMi0xLTEtMzM3ODI_0d7e7efc-3dc8-49da-9349-d0893724cf13">1,259.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtNC0xLTEtMzM3ODI_57f6ccc0-0dde-4b24-8000-87fdd157fd91">42.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtNi0xLTEtMzM3ODI_5a075f61-9546-41b6-930b-6cbde6b7e335">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtOC0xLTEtMzM3ODI_ec9a0f91-7e48-4694-92bc-4e31a84d38ec">10,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctMi0xLTEtMzM3ODI_4cb36975-f619-49b7-822f-255bf2b74678">830.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctNC0xLTEtMzM3ODI_0983bc28-08c9-43bd-b80c-7cabca7ae4d5">40.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctNi0xLTEtMzM3ODI_ed16218d-675f-4589-90af-0e5b3534935a">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctOC0xLTEtMzM3ODI_e20dadc9-8820-4aed-97b0-8240cb9e1639">9,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the six months ended September&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzEyOQ_a0b74cf6-7d86-433c-8da1-f2d6419b6519">0.7</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfNDcx_cc418eb1-85b8-459d-91c1-010056c837d4" continuedAt="i8a7fc6cf53234c808874056c7b7998cb" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i8a7fc6cf53234c808874056c7b7998cb">Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were <ix:nonFraction unitRef="number" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjE5OTAyMzI1NjM4MQ_1a0b49c1-ad9e-412b-8679-cb088fa92fc8">23.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjE5OTAyMzI1NjI2NQ_8a7a5c05-0d99-42e4-b832-cc5b533cdb31">24.0</ix:nonFraction>% for the three months ended September 30, 2022 and 2021, respectively.  The effective tax rates used in the calculation of income taxes were <ix:nonFraction unitRef="number" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjc3_7297b7f2-7d54-45b0-94fd-c735b095dda3">22.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjg0_871caeac-8aaa-4ce0-af90-3177a0d5b5fc">24.2</ix:nonFraction>% for the six months ended September 30, 2022 and 2021, respectively.  The decrease in the effective tax rate for the three and six months ended September 30, 2022 compared to the three and six months ended September 30, 2021 was due to discrete items primarily pertaining to state tax rate legislative changes and share based compensation.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTAzMA_cb1ac586-d14c-4d59-bc3b-e6f4d6782233" continuedAt="i0d6fd9a2bbcc43ab9110bc64acc2bc20" escape="true">Employee Retirement Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0d6fd9a2bbcc43ab9110bc64acc2bc20" continuedAt="ia4a2e0f753e744f19e99722982b9e45a"><div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTAyMw_7ed94ac2-0c02-420e-9ea3-f2ecce5a385f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi0yLTEtMS0zMzc4Mg_3e7106d2-286a-4b57-8c27-643b91029e70">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi00LTEtMS0zMzc4Mg_a884419f-c719-4ff0-a9e8-0b894af6a88f">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi02LTEtMS0zMzc4Mg_abfa9abb-64d5-4512-93c8-1a294b5a4c85">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi04LTEtMS0zMzc4Mg_0cde20b2-5b6b-4363-9ce6-e5a6a7001ea0">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy0yLTEtMS0zMzc4Mg_b42e121c-0000-405a-9262-6ccd11163aa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy00LTEtMS0zMzc4Mg_43db8f96-26a2-4fa5-ba04-e738ed1322ca">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy02LTEtMS0zMzc4Mg_a61e998e-2cab-42d0-8f0a-6d4098148868">252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy04LTEtMS0zMzc4Mg_97b2e1d8-a489-4016-ba7c-cb6b9f972947">580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit expense (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC0yLTEtMS0zMzc4Mg_358f90ca-15a2-4356-939d-a531ab912eab">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC00LTEtMS0zMzc4Mg_f6d1de15-fd5d-4f32-9f02-783f680d74ab">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC02LTEtMS0zMzc4Mg_d0eb098d-6628-4a55-afcf-c2797d9aeff4">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC04LTEtMS0zMzc4Mg_856675a1-14e1-40d0-b5d9-23cabddb9905">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended September 30, 2022, we contributed $<ix:nonFraction unitRef="usd" contextRef="i1240337eaee64711a1a60d6c2e1b7e6c_D20220401-20220930" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTQz_b6eed286-ccb9-4560-a451-381659a5ad4c">0.2</ix:nonFraction> million to our non-qualified defined benefit plan and made <ix:nonFraction unitRef="usd" contextRef="ib1f22bd2d45941c7b1bc75e4966da7c7_I20220930" decimals="INF" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTk3_e186bdf6-ad80-4f3e-9e0b-dd5963ee9990">no</ix:nonFraction> contributions to the qualified defined benefit plan.  During the remainder of fiscal 2023, we expect to contribute an additional $<ix:nonFraction unitRef="usd" contextRef="i3d2317b145b7448e92da9f723d95918f_I20220930" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMzI3_c734d68f-59b7-45ad-a84f-d9fc4ee5f35d">0.2</ix:nonFraction> million to our non-qualified plan and to make no contributions to the qualified plan.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ia4a2e0f753e744f19e99722982b9e45a">During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for our U.S. qualified defined benefit pension plan (the "Plan") and began the Plan termination process.  The settlements of the terminated Plan occurred during the first quarter of fiscal 2023 with lump sum settlements in the amount of $<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-5" name="pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfNzM0_2ce6a431-c66d-4563-ac4b-dde6db6ca536">13.8</ix:nonFraction> million being paid to eligible Plan participants who elected such payments and the purchase of annuity contracts for $<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-5" name="pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfODQ2_918687e8-a298-4ffa-8bee-468e673987bb">31.1</ix:nonFraction> million to the remaining participants.  These settlements were paid using Plan assets and resulted in a settlement loss of $<ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfOTY0_6a311c02-f36f-442a-b095-55953ea847c4">0.4</ix:nonFraction> million.  No further contributions to the Plan were necessary.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-18-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84Mi9mcmFnOmFkNTU0M2E0MmQwNTQ2OWVhOTM2NzE4MDc5NzQ2YWJkL3RleHRyZWdpb246YWQ1NTQzYTQyZDA1NDY5ZWE5MzY3MTgwNzk3NDZhYmRfMTI1MA_8d38c5be-1805-462b-87d8-9dbd0f1a4583" continuedAt="iec80d2fd7cde4c50ab8bdd0528d6cc01" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iec80d2fd7cde4c50ab8bdd0528d6cc01">We are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</ix:continuation></span></div><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjc4OQ_58b8b0da-026f-4621-877b-2d5a864b8fba" continuedAt="i748246df15974683873753c390111c62" escape="true">Concentrations of Risk</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:continuation id="i748246df15974683873753c390111c62"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.  During the three and six months ended September 30, 2022, approximately <ix:nonFraction unitRef="number" contextRef="i2cba7d38b81045e787d4f104d9fb3eaa_D20220701-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI2Mw_81f77c7e-9dca-48eb-b8c7-501d37143084">39.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia1a0406745a24ccf85af84e2f238dafb_D20220401-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI1OQ_eceb83e0-cad1-48d2-9c52-d419fba754f0">40.6</ix:nonFraction>%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and six months ended September 30, 2021, approximately <ix:nonFraction unitRef="number" contextRef="i213e57bd7c7b47edbccb40cf81cd0e0e_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI1NQ_a3282723-bc98-4a96-a7f5-5a56b9d80b22">41.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i25ef8ba0f2404c738e6cf363025e958a_D20210401-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDA4NA_b09cb95c-b87f-4b70-8020-2996c52b61f9">43.3</ix:nonFraction>%, respectively, of our gross revenues were derived from our five top selling brands.  Two customers, Walmart and Walgreens, accounted for more than 10% of our gross revenues in one or both of the periods presented.  Walmart accounted for approximately <ix:nonFraction unitRef="number" contextRef="ic9ff1becf0f84b77a14626c31518df01_D20220701-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDczMA_5e8c9122-1326-4c5f-8dc1-9fe33a5db79b">20.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib056427d825645d3a6d243d6f12ade35_D20220401-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDczOA_908a7724-31b2-4c76-aad1-ce1155e7c352">19.8</ix:nonFraction>%, respectively, of our gross revenues for the three and six months ended September 30, 2022. Walmart accounted for approximately <ix:nonFraction unitRef="number" contextRef="i6351be3774e04b968ab085c80b3d6b0c_D20210701-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDc0OA_1d0ec5b3-9e93-4107-81cf-26f32bf9a6d9">22.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i093f3d98ccb14d9089261e76e6f7c5d6_D20210401-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDc1Ng_8759f500-d52d-477b-b27b-6a479b7e8d16">21.2</ix:nonFraction>%, respectively, of our gross revenues for the three and six months ended September 30, 2021.  Walgreens accounted for approximately <ix:nonFraction unitRef="number" contextRef="ia36e7d927aba40fab88e45e3e3e41575_D20220701-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMTg1Mw_8f8a510b-26ce-41aa-b021-3b02091e257d">10.8</ix:nonFraction>% of our gross revenues for the second quarter of fiscal 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufactures many of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fleet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or various public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we had relationships with <ix:nonFraction unitRef="manufacturer" contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930" decimals="INF" name="pbh:NumberOfThirdPartyManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMTg1Nw_24e1b3e0-c3f6-412b-83c6-fac0f1b20dfb">130</ix:nonFraction> third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with <ix:nonFraction unitRef="manufacturer" contextRef="i12a9fca5712b4984be4783b87d0d1895_D20220401-20220930" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMTkzMA_43e72fe8-86ed-4aab-8156-0c3ec40aa10f">27</ix:nonFraction> manufacturers that produced items that accounted for approximately <ix:nonFraction unitRef="number" contextRef="ia687471f18b34360a6f6a50343be6ca3_D20220401-20220930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjAwMA_4b5cad45-1c5e-47ea-90c8-bd220ce47e7a">71.3</ix:nonFraction>% of gross sales for the six months ended September&#160;30, 2022.  At September&#160;30, 2021, we had relationships with <ix:nonFraction unitRef="manufacturer" contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930" decimals="INF" name="pbh:NumberOfThirdPartyManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjA2Nw_2a47d0b0-44d1-4d51-bbc8-20c37f22c17e">121</ix:nonFraction> third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with <ix:nonFraction unitRef="manufacturer" contextRef="i5a5c21dfca0f469999a785781e89c178_D20210401-20210930" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjE0MA_c5dbec88-d34f-49f5-b5dc-2b0b466db995">19</ix:nonFraction> manufacturers that produced items that accounted for approximately <ix:nonFraction unitRef="number" contextRef="i27ad6371c4b14f5782e971050830c85c_D20210401-20210930" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjIxMA_e223ec80-0f60-4fbf-8334-d0f46595177a">68.1</ix:nonFraction>% of gross sales for the six months ended September&#160;30, 2021.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjY3_85a42ce9-efd2-4f76-8d97-f23e166c286a" continuedAt="i9afd268ad9484857a4b2f9f617426800" escape="true">Business Segments</ix:nonNumeric></span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i9afd268ad9484857a4b2f9f617426800" continuedAt="id2930f76b8804142a562d583809163b8"> </ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id2930f76b8804142a562d583809163b8" continuedAt="i89f26fe20fbf4a9a93d79c02d5f6f28c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjUx_d7dc62e8-5c88-4e34-b836-210abacd0f23" continuedAt="i2542ad5e13024c4e8f47780d3d37bc43" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi0xLTEtMS0zMzc4Mg_e4f426ce-dae0-4d42-a4a4-7fccefd30a86">252,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi0zLTEtMS0zMzc4Mg_d4b14fd4-33d2-4313-b2dd-03100159074a">37,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi03LTEtMS0zMzc4Mg_32ae00ac-63ab-4140-9985-9cd6984b05cf">289,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy0xLTEtMS0zMzc4Mg_1f9a9beb-e1fd-44f7-bea5-b36deb9d10e5">113,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy0zLTEtMS0zMzc4Mg_2146e5a1-d09a-44ea-be27-f613bd525111">14,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy03LTEtMS0zMzc4Mg_3fc977fb-18a2-45d7-a7bc-5f16bd0191b2">128,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC0xLTEtMS0zMzc4Mg_00e2ea18-7880-4d98-b5d5-b72b82234875">138,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC0zLTEtMS0zMzc4Mg_087a0825-e0f6-46b0-8429-c7aa1547cebb">22,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC03LTEtMS0zMzc4Mg_4d888259-f3d5-473f-886d-02433f9676ad">161,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS0xLTEtMS0zMzc4Mg_e282685f-6a06-433a-8705-3afaeb297296">39,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS0zLTEtMS0zMzc4Mg_543f1df9-d414-4873-bf2b-2df49b4f2536">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS03LTEtMS0zMzc4Mg_7b59478c-8c34-41e5-a080-c2a41fc40adf">43,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi0xLTEtMS0zMzc4Mg_feef1e6e-db49-46fb-a96d-ec2b969dfc1a">99,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi0zLTEtMS0zMzc4Mg_edd6e56d-a884-4595-9856-66206b726181">17,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi03LTEtMS0zMzc4Mg_d545e39e-bafd-462d-ab8f-ab34e8ad3d7b">117,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNy03LTEtMS0zMzc4Mg_5faf24e0-05ba-4d64-9bff-74a98a65aaae">32,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfOC03LTEtMS0zMzc4Mg_6c6c9d12-6483-46a4-8b8d-ca30cc02e698">84,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="ia834815cf1604076a6c15f46da4bca86_D20220701-20220930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxZTE2NTJhOGE1MTQ3MzE4ZTg2NGM0NjRjYTZlNmI5XzMx_397d501f-8885-44fa-8461-3223074efb70">1.1</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi0xLTEtMS0zMzc4Mg_492b5873-f9b3-4752-8e3e-949abc61d2de">494,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi0zLTEtMS0zMzc4Mg_5de6c1c8-6273-4352-96c7-18c80de438e6">71,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi03LTEtMS0zMzc4Mg_8b895605-88af-44d3-bcdf-677fddda89fb">566,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy0xLTEtMS0zMzc4Mg_1a19f683-e14d-4395-b62f-914b1198d275">216,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy0zLTEtMS0zMzc4Mg_3f568f8a-7c61-487f-bf94-25ca36fc8b89">28,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy03LTEtMS0zMzc4Mg_feec15c0-28c7-4e55-9d95-b7670bfe9eb2">245,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC0xLTEtMS0zMzc4Mg_fc6470d4-8a94-4502-b42a-a7b4628edd16">278,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC0zLTEtMS0zMzc4Mg_4b622930-07a5-4fe9-8e83-beef9ae87449">43,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC03LTEtMS0zMzc4Mg_ed50aed6-2730-43bb-a9b8-0e9e8c3a5261">321,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS0xLTEtMS0zMzc4Mg_c752c0f3-9971-4c74-bed2-566acb36fabb">74,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS0zLTEtMS0zMzc4Mg_4eb2d3e5-c8ce-428a-bda1-3130b862615e">9,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS03LTEtMS0zMzc4Mg_f7d51198-7679-4f5b-ac3a-848b5aa364b6">83,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi0xLTEtMS0zMzc4Mg_8c710907-c767-4cee-91aa-eccc8c9602a2">203,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi0zLTEtMS0zMzc4Mg_afeab90c-e50c-4c7f-8a72-8f69cbb5fa2e">33,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi03LTEtMS0zMzc4Mg_5796aefe-6f30-40e5-92e5-6881598d9837">237,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNy03LTEtMS0zMzc4Mg_b3163712-4730-4888-afe3-611b1792fc08">65,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfOC03LTEtMS0zMzc4Mg_4e9882ad-60a0-445a-8719-a329285b574d">171,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i026667c5f30d40229f5ca1072dd36fb1_D20220401-20220930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjExYWJhOTVlOGE1MzRiNWQ5YzY2M2UyNWFjZDdlNjdhXzMx_75b9bfa1-b668-4b2f-a47d-514bd028ac53">1.7</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi0xLTEtMS0zMzc4Mg_f5ac50df-d586-4b5b-8690-b9d29ca9ebb9">251,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi0zLTEtMS0zMzc4Mg_b679678d-f31c-470d-add4-3a1d3d198317">24,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi03LTEtMS0zMzc4Mg_5fbbd504-b3ef-4c86-945d-7b5bc68ed3b2">276,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy0xLTEtMS0zMzc4Mg_96f246eb-6cef-40f8-a794-f3b2d66d4287">108,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy0zLTEtMS0zMzc4Mg_4b56c748-f7f3-4cbc-9607-475bf8935aaf">9,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy03LTEtMS0zMzc4Mg_db78d8dd-8e21-49fc-b386-afd5146b917c">118,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC0xLTEtMS0zMzc4Mg_3b476657-82ff-4e98-adad-a446f81e0933">143,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC0zLTEtMS0zMzc4Mg_30739dc9-b9b9-452f-82a7-26f6aa9ffb90">14,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC03LTEtMS0zMzc4Mg_c33fd060-705a-448a-a834-8f230745a597">157,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS0xLTEtMS0zMzc4Mg_4655e9a1-67c6-4797-8d8c-413d35dc8bbd">36,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS0zLTEtMS0zMzc4Mg_e4b9d6ba-5d12-4d3a-8f8b-54eef95c317a">4,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS03LTEtMS0zMzc4Mg_6ff7b016-ef04-4abe-a307-83e4441e9c90">40,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi0xLTEtMS0zMzc4Mg_f8cef3f3-66ad-4014-88e4-1b0a29e68abf">106,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi0zLTEtMS0zMzc4Mg_89d33eae-b063-4832-8591-77f02965b4a5">10,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi03LTEtMS0zMzc4Mg_305e0815-dbd3-455c-a13f-9267eeab1b81">116,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNy03LTEtMS0zMzc4Mg_e20becaa-2adc-47d8-8b57-f41ee7e999f9">38,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfOC03LTEtMS0zMzc4Mg_b3b2e90a-3aad-4247-b09e-56eb39d6d0ce">78,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i907a70df628e4e48b75b67fd126aa346_D20210701-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmFhMmQzMmM3MzM1YTRkYjQ5ODg5NWNlZDBkY2VlMTJlXzMx_e04b33c7-0159-4a50-a1a6-3f1f63c7e83b">0.7</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i89f26fe20fbf4a9a93d79c02d5f6f28c" continuedAt="ifd9436e62453452f8fd1ea99458d2a5a"><div style="text-align:justify"><ix:continuation id="i2542ad5e13024c4e8f47780d3d37bc43"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi0xLTEtMS0zMzc4Mg_c7c92b6d-6a5e-42c1-90bc-e2a31c12a3a9">494,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi0zLTEtMS0zMzc4Mg_e5655d8d-c933-44a8-9961-330a3913e302">51,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi03LTEtMS0zMzc4Mg_c3f74b75-b26f-4f61-b1ff-08d0b0e0cf6a">545,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy0xLTEtMS0zMzc4Mg_60f90c37-d4fc-4e4e-bf3d-409dc384efa5">208,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy0zLTEtMS0zMzc4Mg_82bfa324-22cd-4167-ba1b-ca85568e526e">20,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy03LTEtMS0zMzc4Mg_c70282d1-7a59-4398-846a-8a15a69d6c5e">228,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC0xLTEtMS0zMzc4Mg_d79f5065-9326-471a-a960-ef0b3c38dd29">286,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC0zLTEtMS0zMzc4Mg_dfaa29b5-85c4-4130-bae9-1766dd120148">30,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC03LTEtMS0zMzc4Mg_00843082-083a-47a1-b89e-ce90c3e72c31">316,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS0xLTEtMS0zMzc4Mg_9722b784-d613-4ce9-b687-ffff28ccc881">71,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS0zLTEtMS0zMzc4Mg_3ae0fad3-de2f-4fff-a180-2162dda0755f">8,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS03LTEtMS0zMzc4Mg_67e15f1a-65d8-4506-a992-013a75443693">80,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi0xLTEtMS0zMzc4Mg_0cd51aff-ca08-4458-a935-73a33983bb6a">214,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi0zLTEtMS0zMzc4Mg_8003a6d0-1c52-4f8c-86f6-ade48d403881">22,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi03LTEtMS0zMzc4Mg_38a4a24d-7505-4d41-9bdb-0e86cae83441">236,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNy03LTEtMS0zMzc4Mg_93ac766a-730d-433f-b07c-8c56d1c8ad8a">66,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfOC03LTEtMS0zMzc4Mg_d97d7ebe-aa12-41f1-9b15-dabbb1fe46a6">169,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i4ea034b41f254bdca8406677654243b2_D20210401-20210930" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU4NjgyYmI1MzA2ZDQ5MDNiMzk0NjEyMGYzZmU2MTQ0XzMx_234ed19b-f5dd-4cb8-8116-c6e8cc750159">1.7</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjc4_2d040a4e-1548-4eff-acfd-008b763c9752" continuedAt="i6b833e54450044efb3b5686c092cae32" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb42bf6d38ee41da9172272d89d125f2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi0xLTEtMS0zMzc4Mg_1e4ced55-a12c-4834-8b9f-82b4c0e78a43">32,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91733343cd3f4ed69349759a5007771f_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi0zLTEtMS0zMzc4Mg_10891f8a-f722-4361-8bdd-30bf2845f5a4">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5a4e1b1ddb48f58b2cba888ead4b2a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi03LTEtMS0zMzc4Mg_7f7aa51b-50de-4149-8697-8ae897a1c9cf">33,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fdf6285d3d4d4eae2b16526b8641c5_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy0xLTEtMS0zMzc4Mg_362d2078-ade7-413a-9181-cf273def6f6e">24,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1012eb424f2b4a27a014e52c4a7811d9_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy0zLTEtMS0zMzc4Mg_fcd27de8-795d-484a-8084-d7aefa529071">7,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941a5663f483406585d5edf13941d483_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy03LTEtMS0zMzc4Mg_ab310fe4-d2b2-455e-909d-508cf479668e">31,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1beedb6cef7e452a85e8b6be83cf629b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC0xLTEtMS0zMzc4Mg_75beea5e-c5c1-4e3e-9e32-82c1550bd450">59,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe91143a1c704b018a3976eb5a01c8a4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC0zLTEtMS0zMzc4Mg_c580e513-9e8d-40bc-8ecc-c9c0c01a6084">4,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b16ec8347043ef89e62a09618575e5_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC03LTEtMS0zMzc4Mg_66cb9536-e960-45d5-a9e4-30711030f4e3">64,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb709d3222aa40d08b7528ab5869f491_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS0xLTEtMS0zMzc4Mg_5dea06ee-8a17-48b5-862b-c218f3eff50c">41,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7cd02c9b2b42f5957d2a924601c171_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS0zLTEtMS0zMzc4Mg_1d310f8b-e957-4bdc-a10b-f2d7c3bac929">16,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f86017bb774d3d842c01a04cc30417_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS03LTEtMS0zMzc4Mg_fc589fa0-4a7f-44a6-8add-40b778568008">57,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac26523f549e4adbaa8dd3618b500aa8_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi0xLTEtMS0zMzc4Mg_5917c8e6-8fc8-406d-8677-dbbed95a1af9">37,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156269b4bc68478aaf0dd5842487d92d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi0zLTEtMS0zMzc4Mg_559fef5e-9293-48ff-9f20-39b78d651c1e">4,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea214aa8f2e4deb8d5ceaaf97d29c8c_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi03LTEtMS0zMzc4Mg_18f9ca84-3ab5-4b4b-ab78-9c9fb9aaae8c">42,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6b5df992544fefa4e5d17749dfb237_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy0xLTEtMS0zMzc4Mg_911fa4a8-00f3-4609-b4d7-7e4259e3ce3d">32,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c739500f044451bbbcb4db0694d023_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy0zLTEtMS0zMzc4Mg_cff0946a-c551-4aa4-aaf6-21f51bcb4b19">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2a752fd8ed4bd7a34663dc23e12f46_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy03LTEtMS0zMzc4Mg_4a4f16a3-737d-48fe-8909-59f83ea5ca2c">33,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508a38c03392406f8d6e294ca753433e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC0xLTEtMS0zMzc4Mg_40614cf8-4390-478f-accf-044a01cebf7a">21,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7e002d9ce94251906bbfa8507e0edb_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC0zLTEtMS0zMzc4Mg_84b91017-807f-4443-9952-fd662e0d4b3b">3,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c4223591a1d49188b5b0bf13ac30c8c_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC03LTEtMS0zMzc4Mg_23da7fe0-8565-4b6c-9e81-c1ff17f5e400">24,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf7c91c0d149454cab02b9c237ec63f9_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS0xLTEtMS0zMzc4Mg_2a89365b-53df-4673-871f-c5acf288617b">2,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d59461a5a2b46f094ca36900ef9e502_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS0zLTEtMS0zMzc4Mg_5597af72-a403-498a-a997-33edd7a1b541">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d35b8a35e864ee698d7d3dae351ba18_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS03LTEtMS0zMzc4Mg_43e2edca-4797-4619-ba4c-952d5f7da5a6">2,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc08b763b1242c4ae090e4552cf7fe1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtMS0xLTEtMzM3ODI_ed0f364d-46f8-4f10-b640-1ab2d45e8de4">252,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a99ba3fbd29462aa2fdd8aba546873e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtMy0xLTEtMzM3ODI_dfc45e15-6259-4c36-ac1a-5ae50d56e74b">37,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtNy0xLTEtMzM3ODI_5f45fbc7-ecff-418a-bc8e-5525f2c32888">289,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6749959e270d484a8849ec9baeeb8726_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi0xLTEtMS0zMzc4Mg_bf0a8cef-3402-47f1-b19e-24c2117efc10">60,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib03000714fd04461b44e3ed996bbdcb2_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi0zLTEtMS0zMzc4Mg_26933dc5-e1b5-46a5-a353-ce0fa25ff184">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc1f391c4a14ce993aab75bb0e56b22_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi03LTEtMS0zMzc4Mg_21cc0e51-9de8-4d18-88c7-9d5fb152ce40">61,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05a53f6ddd84378a8b0e8ffe24ce1f8_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy0xLTEtMS0zMzc4Mg_2e2109d0-982e-44b8-9a4c-7abdf1ff9b2a">45,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3890c9dec07642c388c1c5545eb77376_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy0zLTEtMS0zMzc4Mg_fc12c539-64cf-4586-81f8-6004baa63b64">13,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67b8efa5861d4b22a06a49d48921e253_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy03LTEtMS0zMzc4Mg_87ed5ff4-dd62-4b72-8074-34839fe41153">59,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd6d904e1c3451caf89d8a72a334070_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC0xLTEtMS0zMzc4Mg_40f9eeb6-3b7e-4df3-9b90-86fe4e9aa355">120,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e3ef2deded4c839f83b082e1afc3c4_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC0zLTEtMS0zMzc4Mg_c23011fb-c5ca-41fc-89d5-f17552f23981">9,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a45b0f569b5480995950a7d10bbc8e8_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC03LTEtMS0zMzc4Mg_8fd55fce-2812-4ccc-838d-b51ad823781b">130,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abaf43271f54b92aab3fd11f43d7755_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS0xLTEtMS0zMzc4Mg_b98ff888-4225-4808-881c-4c79bd0ab4cc">81,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9385a0d313844f70abb80799feab8302_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS0zLTEtMS0zMzc4Mg_11b0a888-bb17-4466-988b-192109f2492a">30,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i952f5bd919b24d1db88ea63c4fbe1bc6_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS03LTEtMS0zMzc4Mg_1bad9f6e-e68a-4b55-9630-3efab12d504f">111,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if641448d42014771a833e92c731a8eaa_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi0xLTEtMS0zMzc4Mg_49ed845e-2dab-4a3d-a65e-f6291bffcd8d">76,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6daec78175cd4f9d99c734cec1bd11c2_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi0zLTEtMS0zMzc4Mg_2f613ca0-2890-4cc7-8e78-180230f8e10b">9,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce8bc57290b440981f94ecbbfac6d33_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi03LTEtMS0zMzc4Mg_bfbc7e1e-940c-4b5f-a7d9-bbfb857c591d">86,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c021d4c1f045f690a73afbd3a4cd6d_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy0xLTEtMS0zMzc4Mg_9be55c96-be64-4887-a1c0-1f114b488075">62,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4aa809e3674b859374a3de6a969618_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy0zLTEtMS0zMzc4Mg_7035608b-be7e-4355-b3a1-8e97849bade9">1,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f8aa2313314f7d83e72570a64bb906_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy03LTEtMS0zMzc4Mg_3b1e1fce-5720-444f-9e3b-f48fb2690492">64,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd11ab63fa2b44a08ee05dc22f56913a_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC0xLTEtMS0zMzc4Mg_af56b04a-62e9-4113-ba31-840633199dec">42,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a221081d114432b4a27d7b40d183f7_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC0zLTEtMS0zMzc4Mg_99ca9bc9-de6e-44fd-a2c3-82a7941310b5">6,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc1df03ae0a46c4825f6652f54f210d_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC03LTEtMS0zMzc4Mg_5024b3a6-e1f4-4cf9-b3fe-39add3def6f8">48,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a5ffc00b62425ba1a88cc64cbd36e8_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS0xLTEtMS0zMzc4Mg_4ad72272-dd67-48a4-90ac-78a0e629f1d1">5,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7667f0de454eb79b0ad225eebdbae0_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS0zLTEtMS0zMzc4Mg_3b240e8f-0ad0-4c4e-af4b-3a18302128a8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f84cd10cc5345d09c2dd76fa06e00ad_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS03LTEtMS0zMzc4Mg_7877fb82-10a7-4d71-a3d1-03a14c519bd7">5,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtMS0xLTEtMzM3ODI_786fe3db-6ad6-4ed8-8c58-c078d05405bc">494,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtMy0xLTEtMzM3ODI_3eac89e5-e9c1-4762-ba0b-234cf7a92bd5">71,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtNy0xLTEtMzM3ODI_3af5cb61-1db8-4add-aafb-5adb6d83dc8a">566,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ifd9436e62453452f8fd1ea99458d2a5a"><div style="text-align:center"><ix:continuation id="i6b833e54450044efb3b5686c092cae32" continuedAt="i6c9580ff55694fc4aadb4dcfb161cf01"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd20649b7a574a058d933177cb7d6cdc_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi0xLTEtMS0zMzc4Mg_de719d8c-a489-44e2-9652-4968f04c49cb">29,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64a3ad1a593744bbb35935dcc3c1a3dd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi0zLTEtMS0zMzc4Mg_530adbc4-6a82-4b91-9035-ec17c0a5b445">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if597e5a35cc541908f97df9d4ad7877a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi03LTEtMS0zMzc4Mg_e5c6d1ef-4fda-4824-9d43-75509d6aae7d">30,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e715778cd0e44a18645616c8df69ba1_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy0xLTEtMS0zMzc4Mg_d7337865-e733-4169-84d2-b94e5218974b">23,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0dfb7bd0c54a90992d0bfce4410815_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy0zLTEtMS0zMzc4Mg_d6ae55b2-76f2-4e32-879d-912c39c5fe95">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5de7468f634f76a808529f4f6971c3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy03LTEtMS0zMzc4Mg_90b0d958-d920-4399-82e9-74d3312a0450">28,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ec63a0cca14633bf006f38ec899a46_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC0xLTEtMS0zMzc4Mg_ea71036b-d800-4d5f-875c-dd9de85e5383">65,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966596af0d5149ca92ddbd71fbfd37d4_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC0zLTEtMS0zMzc4Mg_1391f695-7083-492e-8dbe-ada3573ac84a">3,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b73b63596724fc89c7cc257a90d4507_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC03LTEtMS0zMzc4Mg_f09b03e9-9f53-404e-abe2-f9860468b444">68,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092e4d9253d2444c80fd19466e202ae2_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS0xLTEtMS0zMzc4Mg_35290e5e-29ca-4820-b574-a0c7545159c0">37,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0146ec3b014515a2ad85b80a0c2222_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS0zLTEtMS0zMzc4Mg_1a99e487-0c4a-4317-9185-f452a5bdca9c">8,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6e44a39fcd049b092a1c21fbe7a84da_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS03LTEtMS0zMzc4Mg_4ca0debd-d73c-444f-a02b-d6704d4c976f">46,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21693008f1de4e39a8cd0d000b9f2f07_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi0xLTEtMS0zMzc4Mg_c87843d1-3d41-4b45-9769-1ed4e95f1e3b">37,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc54a38c56e845fcbb0e801b4552812b_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi0zLTEtMS0zMzc4Mg_d1d04b60-224e-4b77-880c-411fdfb43d81">2,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d96da2f9524e769fd11ec5e90068a5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi03LTEtMS0zMzc4Mg_2b9ba7ee-0f5a-4fdc-913b-127e502d242e">40,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea51b409490b4d488139c17146926635_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy0xLTEtMS0zMzc4Mg_46ca28f2-9db5-4c5d-9258-49a22dbf65d1">32,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac699f58a1a94fbc80b52040fffbb15c_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy0zLTEtMS0zMzc4Mg_a98d53cf-7e2b-4f7a-8bbd-33aad3699402">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1c256b8811486db61c7a2fe6bb58f6_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy03LTEtMS0zMzc4Mg_1960ad0a-3861-438f-b6e1-ca5f009c87d2">33,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48aae1c5023a4f5b8ae3b7524d2fe2a6_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC0xLTEtMS0zMzc4Mg_90b76ec1-f186-486d-9e91-1c66fae61ae6">22,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd495866f74b2db9bb1e41ffab0e86_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC0zLTEtMS0zMzc4Mg_f71d194b-d7c0-480d-80c3-cdffc2aab4e4">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a20b01556341028361a20e77dd1d38_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC03LTEtMS0zMzc4Mg_fd8bb03c-2e5b-4000-b06d-be2bf7cfed95">26,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b4cc1178ef43ddab6a471cf872e469_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS0xLTEtMS0zMzc4Mg_c18ec314-00f5-46f6-a0a6-a161c631db59">2,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdc2502c0c6e4a428c8e95e77c5aa35e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS0zLTEtMS0zMzc4Mg_853e238f-a3fa-44d5-8e27-f4a9b326d4e2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3e7b22d27c4f5d9a8507e37f905566_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS03LTEtMS0zMzc4Mg_87f1dbb7-2f05-46d8-bd7b-3279273db901">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60529f2161a445ab1e93ac7f996d24e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtMS0xLTEtMzM3ODI_95e3032f-3654-4ab4-be25-b6a62a5fb559">251,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3685f44ac4054a6f9f2f5cbc54fb9e44_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtMy0xLTEtMzM3ODI_04e30603-5ce5-4797-bdcc-b4f3536c2606">24,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtNy0xLTEtMzM3ODI_3957383a-71b0-4de4-aaa8-bc4e58f780da">276,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-align:center"><ix:continuation id="i6c9580ff55694fc4aadb4dcfb161cf01"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a655f924b541c9867fa22141ff7d79_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi0xLTEtMS0zMzc4Mg_8a71995b-3cd7-418b-ac53-9556f0b93267">62,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b8a1903aee41588afc67cb5fd35651_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi0zLTEtMS0zMzc4Mg_37b687f3-11be-442b-b3ad-d8b2176651be">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594a5a7ea66f4bf18ffa7ba9baaf6548_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi03LTEtMS0zMzc4Mg_5899712f-25c2-42e2-a46b-6449b1c7f29a">63,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdb9a0b2635450380252cded493c8d8_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy0xLTEtMS0zMzc4Mg_39a58ee7-5596-449d-9dc8-51dad2069ca5">37,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13e6a4210034ca49a0dd1f93399f945_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy0zLTEtMS0zMzc4Mg_2d3b7da8-a4f8-42f9-b327-af705f0a6a29">9,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5b1929a5adc4372b62c50ce12c1a55f_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy03LTEtMS0zMzc4Mg_77d75d6b-ce59-40e4-8a3f-2ebfc77d1267">46,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddf28338f91741c9a583ee1f11391d98_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC0xLTEtMS0zMzc4Mg_6ff7bcc6-4502-4584-996f-25e3cab88849">128,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f07f0b271c42408ac2cefda0abadac_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC0zLTEtMS0zMzc4Mg_7453acd0-93ab-4553-b48c-45609fbc1c01">7,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5158014abd84e34bc6cf3f536db8822_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC03LTEtMS0zMzc4Mg_4bb0d6e0-1197-4a86-ac3a-2482107a65c7">135,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf634010a44e415ea2149c5273a64f42_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS0xLTEtMS0zMzc4Mg_688a2e6a-a83b-4c88-b9df-a184292588d4">80,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fac7101ca624095a37b8838b7e370ba_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS0zLTEtMS0zMzc4Mg_66cd6cfc-6f84-4ac1-a901-5ffb4d4efda1">18,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic095d7fd82584e46b46aef36eaf1309e_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS03LTEtMS0zMzc4Mg_c0a8b553-5d29-4490-8ef2-d55c84b0e3c3">99,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c35bb9633841d3886e1e747017e734_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi0xLTEtMS0zMzc4Mg_d8e8aeac-6d85-4975-bcba-8558ff59b04e">73,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f27bafa6f93466284cbe1faacc2d6ff_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi0zLTEtMS0zMzc4Mg_408b6f66-670e-4087-932e-b86de5a82046">6,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cca7e01971f4b2ab2205da66c2ff17d_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi03LTEtMS0zMzc4Mg_4771dfae-6cca-4dd6-92fa-e1c6175caaef">80,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd607a224fa4d8896c1359ce5450557_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy0xLTEtMS0zMzc4Mg_ef949e8b-d47e-4de1-b9fb-75b0de3cb103">63,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2963a340f2574654997fdd3323c114d8_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy0zLTEtMS0zMzc4Mg_e7f4d83a-ba9c-407c-ae09-ba9a49acc453">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5607274c7e0f483abe26074eb0e5e120_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy03LTEtMS0zMzc4Mg_c00d9421-9f06-4f8c-9f95-d6fff94e2b73">65,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a95b1802134eaa80c0184052482422_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC0xLTEtMS0zMzc4Mg_527c4895-06b3-4416-8816-b78aa74b2ca6">43,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia252b0ef955b4546bc834792f1e46e8c_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC0zLTEtMS0zMzc4Mg_f18f84be-5b86-4dce-b33b-814dc7d73bfa">6,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1503156d93284b65b2b7ffeb0926be90_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC03LTEtMS0zMzc4Mg_e827c812-b1e5-4955-94e3-7a804943d6c8">50,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5eb987418746d580936607f4f6e710_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS0xLTEtMS0zMzc4Mg_14c896e8-1b40-416e-a961-a2b9f629db1d">4,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91d3b9d39ec4e5cbd1449174d4808d0_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS0zLTEtMS0zMzc4Mg_7e1aa7d4-6365-4457-ac15-bb7a1d199094">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a414c6a89f4bf6b73c26c8489e3c3a_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS03LTEtMS0zMzc4Mg_4ddb5ed3-d81e-4a85-8b0f-0b25cc97a112">4,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e429d25f01742dcb996639f98638232_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtMS0xLTEtMzM3ODI_54a15883-0cf3-4f7c-bd7c-b0feb24a678c">494,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief270666f60b4f22aae84b337ecce732_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtMy0xLTEtMzM3ODI_c51774ac-333c-490e-adee-611b3f99e67a">51,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtNy0xLTEtMzM3ODI_a3f42094-355c-4b42-9c9d-d013b517e189">545,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-22-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read together with the Condensed Consolidated Financial Statements and the related notes included in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.&#160;&#160;This discussion and analysis may contain forward-looking statements that involve certain risks, assumptions and uncertainties.&#160;&#160;Future results could differ materially from the discussion that follows for many reasons, including the factors described in Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022 and in future reports filed with the U.S. Securities and Exchange Commission ("SEC").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See also &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; on page <a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i7a69802b3a0a4e4a9009235c8380d384_109">33</a> of this Quarterly Report on Form 10-Q.</span></div></td></tr></table></div><div style="margin-top:11.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated by the context, all references in this Quarterly Report on Form 10-Q to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;Prestige&#8221; refer to Prestige Consumer Healthcare Inc. and our subsidiaries.  Similarly, reference to a year (e.g., 2023) refers to our fiscal year ended March 31 of that year.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter ("OTC") healthcare products to mass merchandisers, drug, food, dollar, convenience, and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;We use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team to our competitive advantage.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown our brand portfolio both organically and through acquisitions.  We develop our existing brands by investing in new product lines, brand extensions and strong advertising support.  Acquisitions of OTC brands have also been an important part of our growth strategy.  We have acquired well-recognized brands from consumer products and pharmaceutical companies and private equity firms.  While many of these brands have long histories of brand development and investment, we believe that, at the time we acquired them, most were considered &#8220;non-core&#8221; by their previous owners.  As a result, these acquired brands did not benefit from adequate management focus and marketing support during the period prior to their acquisition, which created opportunities for us to reinvigorate these brands and improve their performance post-acquisition.  After adding a core brand to our portfolio, we seek to increase its sales, market share and distribution in both existing and new channels through our established retail distribution network.&#160; We pursue this growth through increased spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations, and innovative development of brand extensions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9 million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  In connection with the acquisition, we also entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.       </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-23-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,963</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $1.1 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There has been economic uncertainty in the United States and globally due to several factors including global supply chain constraints, rising interest rates, a high inflationary environment, geopolitical events and the effects from the COVID-19 pandemic.  We expect economic conditions will continue to be highly volatile and uncertain, put pressure on prices and supply and could affect demand for our products.  In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio, however, that may not be sustained at the same levels in the uncertain economic environment.  We have continued to see changes in the purchasing patterns of our consumers, including a reduction in the frequency of visits to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The volatile environment has impacted the supply of labor and raw materials and exacerbated rising input costs.  Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience shortages, delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.  We continue to generate operating cash flows to meet our short-term liquidity needs.  These circumstances could change, however, in this dynamic, unprecedented environment.  If conditions cause further disruption in the global supply chain, the availability of labor and materials or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreaks, global supply chain constraints, the high inflationary environment and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-24-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2022 compared to the Three Months Ended September 30, 2021</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Segment Revenues</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents total revenue by segment, including product groups, for the three months ended September 30, 2022 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total North American OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">International OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Total revenues for the three months ended September 30, 2022 were $289.3 million, an increase of $13.0 million, or 4.7%, versus the three months ended September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues for the North American OTC Healthcare segment increased $0.3 million, or 0.1%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021.  Revenues in the three months ended September 30, 2022 were driven by continued strong performance across many of our key brands, particularly in the Gastrointestinal and Analgesics categories, partially offset by a decline in sales in the Women's Health category, compared to the three months ended September 30, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues for the International OTC Healthcare segment increased $12.7 million, or 51.9%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021. The $12.7 million increase was mainly attributable to increased sales by our Australian subsidiary, primarily related to an increase in sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hydralyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (included in the Gastrointestinal category) as a result of easing COVID-19 restrictions, as well as an increase in consumer illnesses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,009&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the three months ended September 30, 2022 increased $3.3 million, or 2.1%, when compared with the three months ended September 30, 2021.&#160;&#160;As a percentage of total revenues, gross profit decreased to 55.7% during the three months ended September 30, 2022, from 57.1% during the three months ended September 30, 2021.  The decrease in gross profit as a percentage of revenues was primarily a result of increased supply chain costs and product mix.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gross profit for the North American OTC Healthcare segment decreased $4.6 million, or 3.2%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021.  As a percentage of North American OTC Healthcare revenues, gross profit decreased to 55.0% during the three months ended September 30, 2022 from 56.8% during the three months ended September 30, 2021, primarily due to increased supply chain costs and product mix, partly offset by pricing actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the International OTC Healthcare segment increased $7.9 million, or 54.0%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021.  As a percentage of International OTC Healthcare revenues, gross profit increased to 60.4% during the three months ended September 30, 2022 from 59.6% during the three months ended September 30, 2021, primarily due to product mix, partially offset by increased supply chain costs.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contribution Margin</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin is our segment measure of profitability.  It is defined as gross profit less advertising and marketing expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our contribution margin and contribution margin as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contribution Margin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,407)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contribution margin for the North American OTC Healthcare segment decreased $7.4 million, or 6.9%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021.  As a percentage of North American OTC Healthcare revenues, contribution margin decreased to 39.4% during the three months ended September 30, 2022 from 42.4% during the three months ended September 30, 2021.  The contribution margin decrease as a percentage of revenues was primarily due to the decrease in gross profit noted above, as well as an increase in advertising and marketing spend in the three months ended September 30, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contribution margin for the International OTC Healthcare segment increased $7.6 million, or 73.4%, during the three months ended September 30, 2022 versus the three months ended September 30, 2021.  As a percentage of International OTC Healthcare revenues, contribution margin increased to 48.3% during the three months ended September 30, 2022 from 42.3% </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-26-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">during the three months ended September 30, 2021.  The contribution margin increase as a percentage of revenues was primarily due to the increase in gross profit noted above.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative expenses were $26.4 million for the three months ended September 30, 2022 and $32.3 million for the three months ended September 30, 2021. The decrease in general and administrative expenses was primarily due to acquisition costs in the prior period associated with the Akorn acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $6.4 million for the three months ended September 30, 2022 and $6.2 million for the three months ended September 30, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $17.0 million during the three months ended September 30, 2022 versus $16.3 million during the three months ended September 30, 2021.  The average indebtedness decreased to $1.5 billion during the three months ended September 30, 2022 from $1.6 billion during the three months ended September 30, 2021.  The average cost of borrowing increased to 4.6% for the three months ended September 30, 2022 from 3.9% for the three months ended September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2021, we recorded a loss on extinguishment of debt of $2.1&#160;million related to the amendment of our 2012 Term Loan on July 1, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provision for income taxes during the three months ended September 30, 2022 was $15.6 million versus $14.3 million during the three months ended September 30, 2021.&#160;&#160;The effective tax rate during the three months ended September 30, 2022 was 23.4% versus 24.0% during the three months ended September 30, 2021.  The decrease in the effective tax rate in the three months ended September 30, 2022 was due to the impact of discrete items primarily pertaining to state tax rate legislative changes and share-based compensation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended September 30, 2022 compared to the Six Months Ended September 30, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Segment Revenues</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents total revenue by segment, including product groups, for the six months ended September&#160;30, 2022 and 2021.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total North American OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">International OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,926&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Total revenues for the six months ended September 30, 2022 were $566.3 million, an increase of $20.9 million, or 3.8%, versus the six months ended September 30, 2021.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues for the North American OTC Healthcare segment increased $0.5 million, or 0.1%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021. The increase in revenue in the six months ended September 30, 2022 was driven by increased demand for certain brands, categories and channels that had previously been impacted by the COVID-19 virus, particularly the Cough &amp; Cold and Eye &amp; Ear Care categories, partially offset by a decline in revenue in the Women's Health category.  The six months ended September 30, 2022 also benefited from the newly acquired brands as part of the Akorn acquisition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the International OTC Healthcare segment increased $20.5 million, or 39.9%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021. The $20.5 million increase was mainly attributable to increased sales in our Australian subsidiary, primarily related to an increase in sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hydralyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (included in the Gastrointestinal category) as a result of easing COVID-19 restrictions, as well as an increase in consumer illnesses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,976)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the six months ended September 30, 2022 increased $4.4 million, or 1.4%, when compared with the six months ended September 30, 2021.&#160;&#160;As a percentage of total revenues, gross profit decreased to 56.7% during the six months ended September 30, 2022, from 58.1% during the six months ended September 30, 2021, primarily due to increased supply chain costs and product mix.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gross profit for the North American OTC Healthcare segment decreased $8.0 million, or 2.8%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021.  As a percentage of North American OTC Healthcare revenues, gross profit decreased to 56.2% during the six months ended September 30, 2022 from 57.9% during the six months ended September 30, 2021, primarily due to increased supply chain costs and product mix, partly offset by pricing actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the International OTC Healthcare segment increased $12.4 million, or 40.4%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021.  As a percentage of International OTC Healthcare revenues, gross profit increased to 59.9% during the six months ended September 30, 2022 from 59.7% during the six months ended September 30, 2021, primarily due to product mix, partially offset by increased supply chain costs.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contribution Margin</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin is our segment measure of profitability.  It is defined as gross profit less advertising and marketing expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our contribution margin and contribution margin as a percentage of total segment revenues, by segment for each of the periods presented.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contribution Margin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contribution margin for the North American OTC Healthcare segment decreased $11.0 million, or 5.1%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021.  As a percentage of North American OTC Healthcare revenues, contribution margin decreased to 41.1% during the six months ended September 30, 2022 from 43.4% during the six months ended September 30, 2021.  The contribution margin decrease as a percentage of revenues was primarily due to the decrease in gross profit margin noted above, as well as an increase in advertising and marketing spend in the six months ended September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contribution margin for the International OTC Healthcare segment increased $11.8 million, or 53.1%, during the six months ended September 30, 2022 versus the six months ended September 30, 2021.  As a percentage of International OTC Healthcare revenues, contribution margin increased to 47.3% during the six months ended September 30, 2022 from 43.3% during the six months ended September 30, 2021.  The contribution margin increase as a percentage of revenues was primarily due to the increase in gross profit margin noted above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative expenses were $53.2 million for the six months ended September 30, 2022 and $54.7 million for the six months ended September 30, 2021.  The decrease in general and administrative expenses was primarily due to acquisition costs in the prior period associated with the Akorn acquisition, partially offset by increases in professional fees and compensation costs in the six months ended September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $12.8 million for the six months ended September 30, 2022 and $11.9 million for the six months ended September 30, 2021.  The increase in depreciation and amortization expenses was attributable to an increase in amortization expense due to the addition of certain brands purchased in conjunction with the Akorn and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $32.3 million during the six months ended September 30, 2022 versus $31.4 million during the six months ended September 30, 2021.  The average indebtedness decreased to $1.5 billion during the six months ended September 30, 2022 from $1.6 billion during the six months ended September 30, 2021. The average cost of borrowing increased to 4.3% for the six months ended September 30, 2022 compared to 4.0% for the six months ended September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended September 30, 2021, we recorded a loss on extinguishment of debt of $2.1&#160;million related to the amendment of our 2012 Term Loan on July 1, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provision for income taxes during the six months ended September 30, 2022 was $31.2 million versus $32.9 million during the six months ended September 30, 2021.&#160;&#160;The effective tax rate during the six months ended September 30, 2022 was 22.7% versus 24.2% during the six months ended September 30, 2021.  The decrease in the effective tax rate for the six months ended September 30, 2022 compared to the six months ended September 30, 2021 was due to the impact of discrete items primarily pertaining to state tax rate legislative changes and share-based compensation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of cash comes from our cash flow from operations.  In the past, we have supplemented this source of cash with various debt facilities, primarily in connection with acquisitions.  We have financed our operations, and expect to continue to finance our operations for the next twelve months and the foreseeable future, with a combination of funds generated from operations and borrowings.&#160; Our principal uses of cash are for operating expenses, debt service, share repurchases, capital expenditures, and acquisitions.  Based on our current levels of operations and anticipated growth, excluding acquisitions, we believe that our cash generated from operations and our existing credit facilities will be adequate to finance our working capital and capital expenditures through the next twelve months.  See "Economic Environment" above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had cash and cash equivalents of $42.4 million, an increase of $15.3 million from March&#160;31, 2022.  The following table summarizes the change: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,712)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232,989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $115.8 million for the six months ended September&#160;30, 2022, compared to $130.5 million for the six months ended September&#160;30, 2021.  The $14.7 million decrease was due to increased working capital, partly offset by an increase in net income before non-cash items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $3.4 million for the six months ended September&#160;30, 2022, compared to $233.0 million for the six months ended September&#160;30, 2021.  The decrease in net cash used in investing activities was due to the purchase of Akorn assets in the six months ended September&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $95.3 million for the six months ended September&#160;30, 2022, compared to net cash provided by financing activities of $114.2 million for the six months ended September&#160;30, 2021.&#160;This change was primarily due to lower net borrowings of $162.0 million, and the repurchase of shares of our common stock in conjunction with our share repurchase program of $50.0 million in the six months ended September&#160;30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had an aggregate of $1.5 billion of outstanding indebtedness, which consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$400.0 million of 5.125% 2019 Senior Notes, which mature on January 15, 2028;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$600.0 million of 3.750% 2021 Senior Notes, which mature on April 1, 2031; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$455.0 million of borrowings under the 2012 Term B-5 Loans due July 1, 2028.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had a no outstanding balance on our 2012 ABL Revolver and a borrowing capacity of $149.1 million.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March&#160;31, 2022, we made required repayments of $1.5 million as well as voluntary principal payments of $103.5 million against the outstanding balance under our 2012 Term Loan.  During the six months ended September 30, 2022, we made a voluntary principal repayment of $40.0 million against the outstanding balance under our 2012 Term Loan.  Since we have made optional payments that exceed all of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:40.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt facilities contain various financial covenants, including provisions that require us to maintain certain leverage, interest coverage and fixed charge ratios.&#160; The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and 2019 Senior Notes contain provisions that accelerate our indebtedness on certain changes in control and restrict us from undertaking specified corporate actions, including asset dispositions, acquisitions, payments of dividends and other specified payments, repurchasing our equity securities in the public markets, incurrence of indebtedness, creation of liens, making loans and investments and transactions with affiliates. Specifically, we must:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a leverage ratio of less than 6.50 to 1.0 for the quarter ended September&#160;30, 2022 and thereafter (defined as, with certain adjustments, the ratio of our consolidated total net debt as of the last day of the fiscal quarter to our trailing twelve month consolidated net income before interest, taxes, depreciation, amortization, non-cash charges and certain other items (&#8220;EBITDA&#8221;));</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have an interest coverage ratio of greater than 2.25 to 1.0 for the quarter ended September&#160;30, 2022 and thereafter (defined as, with certain adjustments, the ratio of our consolidated EBITDA to our trailing twelve month consolidated cash interest expense); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a fixed charge ratio of greater than 1.0 to 1.0 for the quarter ended September&#160;30, 2022 (defined as, with certain adjustments, the ratio of our consolidated EBITDA minus capital expenditures to our trailing twelve month consolidated interest paid, taxes paid and other specified payments).  Our fixed charge requirement remains level throughout the term of the debt facilities.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we were in compliance with the applicable financial and restrictive covenants under the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  Management anticipates that in the normal course of operations, we will be in compliance with the financial and restrictive covenants during the next twelve months. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160; Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160; A summary of our critical accounting policies is presented in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.&#160; There were no material changes to our critical accounting policies during the six months ended September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued and recently adopted accounting pronouncements is included in the notes to the unaudited Condensed Consolidated Financial Statements in Part I, Item I, Note 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-32-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;), including, without limitation, information within Management's Discussion and Analysis of Financial Condition and Results of Operations.&#160;&#160;The following cautionary statements are being made pursuant to the provisions of the PSLRA and with the intention of obtaining the benefits of the &#8220;safe harbor&#8221; provisions of the PSLRA.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q.&#160;&#160;Except as required under federal securities laws and the rules and regulations of the SEC, we do not intend to update any forward-looking statements to reflect events or circumstances arising after the date of this Quarterly Report on Form 10-Q, whether as a result of new information, future events or otherwise.&#160;&#160;As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on forward-looking statements included in this Quarterly Report on Form 10-Q or that may be made elsewhere from time to time by, or on behalf of, us.&#160;&#160;All forward-looking statements attributable to us are expressly qualified by these cautionary statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements generally can be identified by the use of words or phrases such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; "plan," &#8220;project,&#8221; "intend," "strategy," "goal," "objective," "future," "seek," "may," "might," "should," "would," "will," "will be," or other similar words and phrases.&#160;&#160;Forward-looking statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price increases for raw materials, labor, energy and transportation costs, and for other input costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions of supply of sourced goods or components;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic or other disease outbreaks on global economic conditions, consumer demand, retailer product availability, and business operations including manufacturing, supply chain and distribution;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The high level of competition in our industry and markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The success of new product introductions, line extensions, increased spending on advertising and marketing support, and other new sales and marketing strategies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of customers for a large portion of our sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to successfully identify, negotiate, complete and integrate suitable acquisition candidates and to obtain necessary financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes by retailers in inventory management practices, delivery requirements, and demands for marketing and promotional spending in order to retain or increase shelf space or online share;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to grow our international sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General economic conditions and incidence levels affecting sales of our products and their respective markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility in or worsening conditions from geopolitical conflicts, public health issues, and other factors beyond our control;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial factors, such as increases in interest rates and currency exchange rate fluctuations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing consumer trends, additional store brand or branded competition, accelerating shifts to online shopping or pricing pressures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party manufacturers to produce many of the products we sell and our ability to transfer production to our own facilities or other third-party suppliers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party logistics providers to distribute our products to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our distribution center or manufacturing facility;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential changes in export/import and trade laws, regulations and policies including any increased trade restrictions or tariffs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions, dispositions or other strategic transactions diverting managerial resources, and creating additional liabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actions of government agencies in connection with our manufacturing plant, products, advertising or regulatory matters governing our industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims, product recalls and related negative publicity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third parties for intellectual property relating to some of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our information technology systems from threats or disruptions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party information technology service providers and their ability to protect against security threats and disruptions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our assets being comprised virtually entirely of goodwill and intangibles and possible changes in their value based on adverse operating results and/or changes in the discount rate used to value our brands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on key personnel;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The costs associated with any claims in litigation or arbitration and any adverse judgments rendered in such litigation or arbitration;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our level of indebtedness and possible inability to service our debt or to obtain additional financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The restrictions imposed by our financing agreements on our operations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in federal, state and other geographic tax laws.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-34-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to changes in interest rates because our 2012 Term Loan and 2012 ABL Revolver are variable rate debt.  At September&#160;30, 2022, approximately $455.0 million of our debt carries a variable rate of interest.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holding other variables constant, including levels of indebtedness, a 1.0% increase in interest rates on our variable rate debt would have an adverse impact on pre-tax earnings and cash flows for the three and six months ended September 30, 2022 of approximately $1.2 million and $2.4 million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022, approximately 13.1% and 13.3%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  During the three and six months ended September 30, 2021, approximately 11.8% and 12.1%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar.  As such, we are exposed to transactions that are sensitive to foreign currency exchange rates.  These transactions are primarily with respect to the Canadian and Australian Dollars.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis with respect to exchange rates for the three and six months ended September 30, 2022 and 2021.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a less than 5.0% impact on pre-tax income of approximately $2.6 million for the three months ended September 30, 2022 and approximately $4.8 million for the six months ended September 30, 2022.  It represented a less than 5.0% impact on pre-tax income of approximately $1.8 million for the three months ended September 30, 2021 and approximately $3.4 million for the six months ended September 30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_115"></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures, as defined in Rule 13a&#8211;15(e) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), as of September&#160;30, 2022.&#160;&#160;Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of September&#160;30, 2022, the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_118"></div><div style="padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the risk factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended March&#160;31, 2022, which could materially affect our business, financial condition or results of operations.  The risk factors described in our Annual Report on Form 10-K have not materially changed in the period covered by this Quarterly Report on Form 10-Q, but such risks are not the only risks facing us.  Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly operating results and revenues may fluctuate as a result of any of these or other factors.  Accordingly, results for any one quarter are not necessarily indicative of results to be expected for any other quarter or for any year, and revenues for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-35-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any particular future period may decrease.&#160;&#160;In the future, operating results may fall below the expectations of securities analysts and investors.&#160;&#160;In that event, the market price of our outstanding securities could be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i7a69802b3a0a4e4a9009235c8380d384_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1 to July 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,273,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1 to August 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,862,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1 to September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) These purchases were made pursuant to our share repurchase program, which was announced in May 2022 and permits the repurchase of up to $50.0 million of our common stock through May 2023.  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-36-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.017%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000104746905002633/a2149526zex-3_1.txt">Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare Inc. (filed as Exhibit 3.1 to the Company's Form S-1/A filed with the SEC on February 8, 2005).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594718000018/exhibit31certofamendment.htm">Amendment to Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare Inc. (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 2, 2018).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594719000007/exhibit32redlinepbhbylaw.htm">Amended and Restated Bylaws of Prestige Consumer Healthcare Inc., as amended, effective October 29, 2018 (filed as Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q filed with the SEC on February 7, 2019).</a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-pbhdirector2022.htm">Form of Award Agreement for Non-Employee Director Restricted Stock Units for grants beginning Fiscal 2023.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> #</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3112022-09x30.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3122022-09x30.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3212022-09x30.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit3222022-09x30.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated herein by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a compensatory plan.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-37-</span></div></div></div><div id="i7a69802b3a0a4e4a9009235c8380d384_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESTIGE CONSUMER HEALTHCARE INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/&#160;Christine Sacco</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</span></td><td colspan="3" style="border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Duly Authorized Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-38-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-pbhdirector2022.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8e0ca93587c04f8ca66657df9cd6b341_1"></div><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2020 LTIP &#8211; DIRECTOR RSU (2022 FORM)</font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PRESTIGE CONSUMER HEALTHCARE INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2020 LONG-TERM EQUITY INCENTIVE PLAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AWARD AGREEMENT FOR RESTRICTED STOCK UNITS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS AWARD AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;Agreement&#8221;) is made and entered into effective as of _____ __, 20__, by and between PRESTIGE CONSUMER HEALTHCARE INC., a Delaware corporation (together with its subsidiaries, the &#8220;Company&#8221;), and &#171;Grantee1&#187; (the &#8220;Participant&#8221;), pursuant to the Prestige Consumer Healthcare Inc. 2020 Long-Term Equity Incentive Plan, as it may be amended and restated from time to time (the &#8220;Plan&#8221;).  Capitalized terms used but not defined herein shall have the meanings set forth in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Participant is eligible to receive an Award under the terms of the Plan&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WHEREAS,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> pursuant to the Plan and subject to the execution of this Agreement, the Committee has granted, and the Participant desires to receive, an Award&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> for and in consideration of the premises, the mutual promises and covenants herein contained, and other good and valuable consideration, the receipt, adequacy and sufficiency of which are hereby acknowledged, the parties hereto do hereby agree as follows&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">AWARD OF RESTRICTED STOCK UNITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  On the date specified on Exhibit A attached hereto (the &#8220;Date of Grant&#8221;) but subject to the execution of this Agreement, the Company granted to the Participant an Award in the form of Restricted Stock Units (&#8220;RSUs&#8221;) entitling the Participant to receive from the Company, without payment, one share of Common Stock (a &#8220;Share&#8221;) for each RSU set forth on said Exhibit A.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">EFFECT OF PLAN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs are in all respects subject to, and shall be governed and determined by, the provisions of the Plan (all of the terms of which are incorporated herein by reference) and to any rules which might be adopted by the Board or the Committee with respect to the Plan to the same extent and with the same effect as if set forth fully herein.  The Participant hereby acknowledges that all decisions and determinations of the Committee shall be final and binding on the Participant, his beneficiaries and any other person having or claiming an interest in the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">VESTING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  The RSUs shall become fully vested on the earliest to occur of the following (each, a &#8220;Vesting Date&#8221;)&#58; (i) the first anniversary of the Date of Grant, subject to  the Participant&#8217;s continued service on the Board as of such Vesting Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the death of Participant during the Participant&#8217;s service on the Board, (iii) the termination of the Participant&#8217;s service on the Board as a result of not being nominated for or elected by the stockholders to a new term as a member of the Board, or (iv) the occurrence of a Change in Control during the Participant&#8217;s service on the Board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant&#8217;s service on the Board terminates prior to a Vesting Date for any reason other than as described in (ii) or (iii) of the prior sentence, the Participant shall forfeit all right, title and interest in and to the then unvested RSUs as of the date of such termination and the unvested RSUs will be reconveyed to the Company without further consideration or any act or action by the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">SETTLEMENT OF VESTED RSUS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless the Participant makes a timely election in the form provided by the Company, each vested RSU will be settled by delivery to the Participant, or in the event of the Participant&#8217;s death to the Participant&#8217;s legal representative, of one Share for each vested RSU no later than thirty (30) days following the earliest of&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.61pt">the Participant&#8217;s death&#59; or</font></div><div style="margin-bottom:12pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.97pt">the Participant&#8217;s Separation from Service (as defined in Section 409A of the Code)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:5.26pt">a Change in Control of the Company (as defined in Section 409A of the Code).</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">SECURITIES LAW RESTRICTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Acceptance of this Agreement shall be deemed to constitute the Participant&#8217;s acknowledgement that the RSUs shall be subject to such restrictions and conditions on any resale and on any other disposition as the Company shall deem necessary under any applicable laws or regulations or in light of any stock exchange requirements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">NO ASSIGNMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs are personal to the Participant and may not in any manner or respect be assigned or transferred otherwise than by will or the laws of descent and distribution. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">NO RIGHT TO CONTINUED SERVICE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Plan nor this Agreement shall give the Participant the right to continued service with the Company or shall adversely affect the right of the Company to terminate the Participant&#8217;s service at any time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, applied without giving effect to any conflict-of-law principles.  The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27.38pt;text-decoration:underline">BINDING EFFECT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective executors, administrators, personal representatives, legal representatives, heirs, and successors in interest.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21.63pt;text-decoration:underline">COUNTERPART EXECUTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in any number of counterparts, each of which shall be considered an original, and such counterparts shall, together, constitute and be one and the same instrument.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Participant have executed and delivered this Agreement as of the day and year first written above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PRESTIGE CONSUMER HEALTHCARE INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Ronald M. Lombardi&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Executive Officer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:-9pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#171;Grantee1&#187;</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11.5pt;font-weight:400;line-height:100%">2</font></div></div></div><div id="i8e0ca93587c04f8ca66657df9cd6b341_4"></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AWARD AGREEMENT, dated as of ______ __, 20__, between PRESTIGE CONSUMER HEALTHCARE INC. and &#171;Grantee1&#187;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Date of Grant&#58; _____ ___, 20__</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Number of Restricted Stock Units*&#58;  &#171;Shares1&#187;</font></div><div style="padding-right:-14.4pt"><font><br></font></div><div><font><br></font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exhibit3112022-09x30.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i863ecac5b2ad4129a22713b70fdbb3e7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of Prestige Consumer Healthcare Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47; Ronald M. Lombardi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald M. Lombardi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exhibit3122022-09x30.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic6ea0f28a08b4ebcadc8000d44f46463_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of Prestige Consumer Healthcare Inc.&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47;&#160;Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exhibit3212022-09x30.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if4cdaa17366042538191cea255ae83f5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Prestige Consumer Healthcare Inc. on Form 10-Q for the quarter ended September&#160;30, 2022, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#47;s&#47; Ronald M. Lombardi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Ronald M. Lombardi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>exhibit3222022-09x30.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i02dbc11be16048d9b97b025414c0e16d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Prestige Consumer Healthcare Inc. on Form 10-Q for the quarter ended September&#160;30, 2022, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc.</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:54.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#47;s&#47; Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Christine Sacco</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>pbh-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pbh="http://www.prestigebrandsinc.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.prestigebrandsinc.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.prestigebrandsinc.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentation" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation">
        <link:definition>0000007 - Disclosure - Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisition" roleURI="http://www.prestigebrandsinc.com/role/Acquisition">
        <link:definition>0000008 - Disclosure - Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.prestigebrandsinc.com/role/Inventories">
        <link:definition>0000009 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.prestigebrandsinc.com/role/Goodwill">
        <link:definition>0000010 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnet" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet">
        <link:definition>0000011 - Disclosure - Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.prestigebrandsinc.com/role/Leases">
        <link:definition>0000012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilities" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities">
        <link:definition>0000013 - Disclosure - Other Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt">
        <link:definition>0000014 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements">
        <link:definition>0000015 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments">
        <link:definition>0000016 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000018 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare">
        <link:definition>0000019 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation">
        <link:definition>0000020 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes">
        <link:definition>0000021 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlans" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans">
        <link:definition>0000022 - Disclosure - Employee Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies">
        <link:definition>0000023 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRisk" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk">
        <link:definition>0000024 - Disclosure - Concentrations of Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegments" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments">
        <link:definition>0000025 - Disclosure - Business Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationPolicies" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies">
        <link:definition>0000026 - Disclosure - Business and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionTables" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionTables">
        <link:definition>0000027 - Disclosure - Acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables">
        <link:definition>0000028 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables">
        <link:definition>0000029 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetTables" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables">
        <link:definition>0000030 - Disclosure - Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.prestigebrandsinc.com/role/LeasesTables">
        <link:definition>0000031 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesTables" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables">
        <link:definition>0000032 - Disclosure - Other Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables">
        <link:definition>0000033 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables">
        <link:definition>0000034 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables">
        <link:definition>0000035 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables">
        <link:definition>0000036 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>0000037 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables">
        <link:definition>0000038 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables">
        <link:definition>0000039 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansTables" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables">
        <link:definition>0000040 - Disclosure - Employee Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsTables" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables">
        <link:definition>0000041 - Disclosure - Business Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails">
        <link:definition>0000042 - Disclosure - Acquisition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000043 - Disclosure - Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesSummaryofInventoriesDetails" roleURI="http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails">
        <link:definition>0000044 - Disclosure - Inventories - Summary of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails">
        <link:definition>0000045 - Disclosure - Inventories - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofChangesDetails" roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails">
        <link:definition>0000046 - Disclosure - Goodwill - Schedule of Changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails">
        <link:definition>0000047 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails">
        <link:definition>0000048 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails">
        <link:definition>0000049 - Disclosure - Intangible Assets, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails">
        <link:definition>0000050 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails">
        <link:definition>0000051 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails">
        <link:definition>0000052 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>0000052 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_2" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2">
        <link:definition>0000052 - Disclosure - Leases - Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails">
        <link:definition>0000053 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails">
        <link:definition>0000054 - Disclosure - Other Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails">
        <link:definition>0000055 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000056 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtMaturitiesofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails">
        <link:definition>0000057 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails">
        <link:definition>0000058 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>0000059 - Disclosure - Derivative Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsSummaryofInterestRateSwapsDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails">
        <link:definition>0000060 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000061 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofRepurchasedSharesDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails">
        <link:definition>0000062 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails">
        <link:definition>0000063 - Disclosure - Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails">
        <link:definition>0000064 - Disclosure - Accumulated Other Comprehensive Loss - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails">
        <link:definition>0000065 - Disclosure - Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAntidilutiveSecuritiesDetails" roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails">
        <link:definition>0000066 - Disclosure - Earnings Per Share - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>0000067 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockBasedCompensationInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails">
        <link:definition>0000068 - Disclosure - Share-Based Compensation - Stock Based Compensation Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockUnitsActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails">
        <link:definition>0000069 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionValuationAssumptionsDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails">
        <link:definition>0000070 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>0000071 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails">
        <link:definition>0000072 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails">
        <link:definition>0000073 - Disclosure - Employee Retirement Plans - Expected Return on Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails">
        <link:definition>0000074 - Disclosure - Employee Retirement Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRiskDetails" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails">
        <link:definition>0000075 - Disclosure - Concentrations of Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
        <link:definition>0000076 - Disclosure - Business Segments - Information on Operating and Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsRevenueDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails">
        <link:definition>0000077 - Disclosure - Business Segments - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pbh_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsRSUsStockOptionsMember" abstract="true" name="RestrictedStockUnitsRSUsStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LongtermEquityIncentivePlan2005Member" abstract="true" name="LongtermEquityIncentivePlan2005Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_AccruedAndOtherLiabilitiesCurrent" abstract="false" name="AccruedAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IntangibleAssetsRollForward" abstract="true" name="IntangibleAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_GastrointestinalMember" abstract="true" name="GastrointestinalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LongTermIncentivePlan2020Member" abstract="true" name="LongTermIncentivePlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_SupplyCommitmentTermOfAgreement" abstract="false" name="SupplyCommitmentTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturers" abstract="false" name="NumberOfThirdPartyManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_TopFiveBrandsMember" abstract="true" name="TopFiveBrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsLineItems" abstract="true" name="ScheduleOfIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EyeAndEarCareMember" abstract="true" name="EyeAndEarCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_AdditionsToOperatingLeaseRightOfUseAssets" abstract="false" name="AdditionsToOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OtherOtcMember" abstract="true" name="OtherOtcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WeightedAverageDiscountRateAbstract" abstract="true" name="WeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_LoansPayableTermB5AmendmentNo6Member" abstract="true" name="LoansPayableTermB5AmendmentNo6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_CoughAndColdMember" abstract="true" name="CoughAndColdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" abstract="true" name="FiniteLivedTradenamesandCustomerRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DermatologicalsMember" abstract="true" name="DermatologicalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IntangibleAssetsGrossAbstract" abstract="true" name="IntangibleAssetsGrossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_AccruedProductionCostsCurrent" abstract="false" name="AccruedProductionCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_VotingRightsNumberOfVotesPerCommonShareOwned" abstract="false" name="VotingRightsNumberOfVotesPerCommonShareOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="pbh_WalmartMember" abstract="true" name="WalmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ZaditenMember" abstract="true" name="ZaditenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" abstract="true" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentVariableRateMinimum" abstract="false" name="DebtInstrumentVariableRateMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_IndefinitelivedTradenamesMember" abstract="true" name="IndefinitelivedTradenamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_IntangibleAssetsAcquired" abstract="false" name="IntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_AblRevolver2012Member" abstract="true" name="AblRevolver2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" abstract="false" name="GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" abstract="false" name="BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WalgreensMember" abstract="true" name="WalgreensMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_TotalOtherIncomeExpense" abstract="false" name="TotalOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" abstract="false" name="BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceNewShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_AnalgesicsMember" abstract="true" name="AnalgesicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pbh_A2019SeniorNotesMember" abstract="true" name="A2019SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" abstract="true" name="FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CostOfSalesExclusiveOfDepreciation" abstract="false" name="CostOfSalesExclusiveOfDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_InternationalOTCHealthcareMember" abstract="true" name="InternationalOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" abstract="false" name="IntangibleAssetsTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" abstract="true" name="OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_AkornOperatingCompanyLLCMember" abstract="true" name="AkornOperatingCompanyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_IncreaseDecreaseInOperatingLeasesLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeasesLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="pbh_A2021SeniorNotesMember" abstract="true" name="A2021SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pbh_NorthAmericanOTCHealthcareMember" abstract="true" name="NorthAmericanOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" abstract="false" name="NumberOfThirdPartyManufacturersWithLongTermContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" abstract="true" name="RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ManufacturesMember" abstract="true" name="ManufacturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>pbh-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_661fd141-e441-49e3-afa2-5d4c8ff20d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8a1f6f6-806a-460b-ac3d-1e9d10bd30ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_661fd141-e441-49e3-afa2-5d4c8ff20d6a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8a1f6f6-806a-460b-ac3d-1e9d10bd30ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b38bb50e-0718-4b8b-b91d-b425409a729a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_661fd141-e441-49e3-afa2-5d4c8ff20d6a" xlink:to="loc_us-gaap_CostOfRevenue_b38bb50e-0718-4b8b-b91d-b425409a729a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0ba3c84e-231f-48ed-ae53-35cac9401cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_3fcb85bb-1fe8-4565-893d-935218644841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0ba3c84e-231f-48ed-ae53-35cac9401cbe" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_3fcb85bb-1fe8-4565-893d-935218644841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_39ce26fc-a910-4f4e-8bdd-81c5e8d0dba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0ba3c84e-231f-48ed-ae53-35cac9401cbe" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_39ce26fc-a910-4f4e-8bdd-81c5e8d0dba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_fc77dba0-134e-4bc8-81f8-34f40264edf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0ba3c84e-231f-48ed-ae53-35cac9401cbe" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_fc77dba0-134e-4bc8-81f8-34f40264edf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6312024d-2b1f-404d-ae12-cf8f99dda039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_58807aa6-496c-4ee6-94cf-f66194a43a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6312024d-2b1f-404d-ae12-cf8f99dda039" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_58807aa6-496c-4ee6-94cf-f66194a43a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_5516dc29-9b58-4904-8793-de609ed2661f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6312024d-2b1f-404d-ae12-cf8f99dda039" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_5516dc29-9b58-4904-8793-de609ed2661f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ce9308c4-186d-4f98-a0df-e5cd94cd4823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5d4799c5-6420-4af8-82fc-4061bda89c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ce9308c4-186d-4f98-a0df-e5cd94cd4823" xlink:to="loc_us-gaap_GrossProfit_5d4799c5-6420-4af8-82fc-4061bda89c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_845699a0-11ab-407b-ba49-2f592546812d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ce9308c4-186d-4f98-a0df-e5cd94cd4823" xlink:to="loc_us-gaap_OperatingExpenses_845699a0-11ab-407b-ba49-2f592546812d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e0dba7e-7cd8-4f4a-9763-2b0453f604a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0dd0ee05-bcf5-4111-bb2e-4fa4456af197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e0dba7e-7cd8-4f4a-9763-2b0453f604a8" xlink:to="loc_us-gaap_NetIncomeLoss_0dd0ee05-bcf5-4111-bb2e-4fa4456af197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4fde553-a22b-4788-b881-488abcea5d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3e0dba7e-7cd8-4f4a-9763-2b0453f604a8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e4fde553-a22b-4788-b881-488abcea5d76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_5c5917b0-2572-4208-9557-d9a2c185cb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_7d562aa4-971c-43c7-914d-e307e342a339" xlink:href="pbh-20220930.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_5c5917b0-2572-4208-9557-d9a2c185cb44" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_7d562aa4-971c-43c7-914d-e307e342a339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_c00099cd-4229-4c61-8ae1-1e389dc09565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_5c5917b0-2572-4208-9557-d9a2c185cb44" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_c00099cd-4229-4c61-8ae1-1e389dc09565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e007ab18-c78b-4ff6-b35b-da83c223bd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_889bad36-ebcd-48dc-b327-822caf5d237c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e007ab18-c78b-4ff6-b35b-da83c223bd44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_889bad36-ebcd-48dc-b327-822caf5d237c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2318cf28-82da-479f-808e-eebce21313c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e007ab18-c78b-4ff6-b35b-da83c223bd44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2318cf28-82da-479f-808e-eebce21313c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fec73ffd-5fd2-49fc-89f9-19d37e89a675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e007ab18-c78b-4ff6-b35b-da83c223bd44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_fec73ffd-5fd2-49fc-89f9-19d37e89a675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_13c0bd94-7471-4828-9c4c-623c7dbf53d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_68d7c606-4034-4927-bd85-592c4c5ff005" xlink:href="pbh-20220930.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_13c0bd94-7471-4828-9c4c-623c7dbf53d2" xlink:to="loc_pbh_TotalOtherIncomeExpense_68d7c606-4034-4927-bd85-592c4c5ff005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b8bb5d22-15d9-4b9b-8ec8-b7c2bc4571d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_13c0bd94-7471-4828-9c4c-623c7dbf53d2" xlink:to="loc_us-gaap_OperatingIncomeLoss_b8bb5d22-15d9-4b9b-8ec8-b7c2bc4571d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_249fb5bf-cb3d-4608-85aa-339560760367" xlink:href="pbh-20220930.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fe7c52d2-2c7c-46b4-af13-9f17245ff30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_249fb5bf-cb3d-4608-85aa-339560760367" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fe7c52d2-2c7c-46b4-af13-9f17245ff30e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ba2d8327-c954-4532-acd3-bab9568e994c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_249fb5bf-cb3d-4608-85aa-339560760367" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ba2d8327-c954-4532-acd3-bab9568e994c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_0ce02bbb-7b98-498e-87e4-42e577ae7333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_249fb5bf-cb3d-4608-85aa-339560760367" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_0ce02bbb-7b98-498e-87e4-42e577ae7333" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c5b27162-63ea-4d6b-bf7c-39487f869a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_PreferredStockValue_c5b27162-63ea-4d6b-bf7c-39487f869a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_77fb9e99-17c9-45b0-9c6b-39ab7941bfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_CommonStockValue_77fb9e99-17c9-45b0-9c6b-39ab7941bfe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c395e42b-e39f-4c96-8023-2f14deef9dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c395e42b-e39f-4c96-8023-2f14deef9dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_fa0bd9f9-b0cf-4547-b5c1-b5174df81476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_TreasuryStockValue_fa0bd9f9-b0cf-4547-b5c1-b5174df81476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8895b561-2ee5-4f8c-adb8-2562ea783001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8895b561-2ee5-4f8c-adb8-2562ea783001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f1355d8-91db-4df9-828e-8afb6f851cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c221937a-003f-41e0-aacb-ce59da2e83ee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3f1355d8-91db-4df9-828e-8afb6f851cea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_349eb894-c4ef-447e-957f-e00a5033de49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_LiabilitiesCurrent_349eb894-c4ef-447e-957f-e00a5033de49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_50959c21-7abc-43fb-8469-b94f1bc8f150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_LongTermDebt_50959c21-7abc-43fb-8469-b94f1bc8f150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8ff7f95a-82f6-4c23-a9e9-2e71c3a6ec3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8ff7f95a-82f6-4c23-a9e9-2e71c3a6ec3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c933ed-6cdc-43fe-a3c9-c63f8b6d0c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c933ed-6cdc-43fe-a3c9-c63f8b6d0c08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eb49e183-29f1-4c60-ad1a-f8fd9061a9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eb49e183-29f1-4c60-ad1a-f8fd9061a9fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e53324c4-e0f0-4b63-914c-dc5b78463142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6a74e9e1-4ed6-40f7-b80f-edc43d162d37" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e53324c4-e0f0-4b63-914c-dc5b78463142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e3ea87ce-d008-44c2-8e0d-f78bf540cb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:to="loc_us-gaap_AccountsPayableCurrent_e3ea87ce-d008-44c2-8e0d-f78bf540cb5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_9ec71491-4f29-48e9-8a50-b0c30e9fa996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_9ec71491-4f29-48e9-8a50-b0c30e9fa996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b63888a-abf9-4870-b086-2b9d9582a8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b63888a-abf9-4870-b086-2b9d9582a8b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_72d3e8c8-6ced-42cc-8cb7-d980fd6dcbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_72d3e8c8-6ced-42cc-8cb7-d980fd6dcbb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_0e3bcf85-b8bb-42bc-8bc9-4ed8dd151f6d" xlink:href="pbh-20220930.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c123dd5a-af7f-456f-a689-b83555a76592" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_0e3bcf85-b8bb-42bc-8bc9-4ed8dd151f6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f85a0b-6028-4e9f-b022-7920a0a22461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_815c8436-c5b9-446e-8789-513892534a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f85a0b-6028-4e9f-b022-7920a0a22461" xlink:to="loc_us-gaap_Liabilities_815c8436-c5b9-446e-8789-513892534a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2cdc93f4-4038-4fa3-83c4-3f31c85848d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f85a0b-6028-4e9f-b022-7920a0a22461" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2cdc93f4-4038-4fa3-83c4-3f31c85848d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e68d867-3d54-47a7-b4ae-63226fd1fbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f85a0b-6028-4e9f-b022-7920a0a22461" xlink:to="loc_us-gaap_StockholdersEquity_2e68d867-3d54-47a7-b4ae-63226fd1fbec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5adfc4af-931d-4133-b00f-6a56a00cc162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_AssetsCurrent_5adfc4af-931d-4133-b00f-6a56a00cc162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10ecf120-9134-4bb1-b41d-aed48835a4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10ecf120-9134-4bb1-b41d-aed48835a4b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a4e058d5-a92e-4c3c-b327-e0f0a272857b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a4e058d5-a92e-4c3c-b327-e0f0a272857b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_bceaef2e-a92f-4a8b-a4e7-b1f0a077dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_bceaef2e-a92f-4a8b-a4e7-b1f0a077dce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_600e2613-cbfb-449a-9544-c88a0dd1e663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_Goodwill_600e2613-cbfb-449a-9544-c88a0dd1e663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3638059a-d12d-47b0-818b-269e161952df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3638059a-d12d-47b0-818b-269e161952df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c0054f46-852e-4882-897b-6a62b346ed27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_db499363-11fa-47d8-8236-25500865042d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c0054f46-852e-4882-897b-6a62b346ed27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f4294fc0-9eac-4de4-8931-c133d049e200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_03f74fdc-7b27-4c4f-bddc-d71ccf82271e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4294fc0-9eac-4de4-8931-c133d049e200" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_03f74fdc-7b27-4c4f-bddc-d71ccf82271e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a03006ba-7b06-49c0-a2f6-aeacc841cfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4294fc0-9eac-4de4-8931-c133d049e200" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a03006ba-7b06-49c0-a2f6-aeacc841cfd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e20fd6bb-4283-4742-a45b-136f7a8821b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4294fc0-9eac-4de4-8931-c133d049e200" xlink:to="loc_us-gaap_InventoryNet_e20fd6bb-4283-4742-a45b-136f7a8821b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2353be4d-1cd5-463c-a657-88bcb0346754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4294fc0-9eac-4de4-8931-c133d049e200" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2353be4d-1cd5-463c-a657-88bcb0346754" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1d6fc427-1e75-4ba7-885f-9b8dc66535f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1d6fc427-1e75-4ba7-885f-9b8dc66535f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f8df9ebf-106f-42c3-b004-e03504adb27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f8df9ebf-106f-42c3-b004-e03504adb27e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d1dfe76b-13dc-49c2-91f4-9dd0f48268ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d1dfe76b-13dc-49c2-91f4-9dd0f48268ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_aa571738-89b0-437f-9b9f-951b6ca7db3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_aa571738-89b0-437f-9b9f-951b6ca7db3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_6dfef854-63e3-4319-b8c5-de92b266c336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_6dfef854-63e3-4319-b8c5-de92b266c336" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bdbafd45-2d0d-4339-bb8c-7079aaca8692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bdbafd45-2d0d-4339-bb8c-7079aaca8692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_41e1fd68-379a-41b1-a3a5-2c2b41f46ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_41e1fd68-379a-41b1-a3a5-2c2b41f46ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_22692d5c-20be-4793-acb6-53c1bffc99d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_22692d5c-20be-4793-acb6-53c1bffc99d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_20b533d6-eb84-43e2-881e-5a2e737c7a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_73f591c6-be11-4adb-8128-836e33d5a177" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_20b533d6-eb84-43e2-881e-5a2e737c7a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95e1602e-af6a-4dc7-b59a-c51f9b745073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_24d703c0-3ad1-4f9e-845b-864ac92822fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95e1602e-af6a-4dc7-b59a-c51f9b745073" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_24d703c0-3ad1-4f9e-845b-864ac92822fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_432f1e12-61e5-4c74-90b4-2161861eb231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95e1602e-af6a-4dc7-b59a-c51f9b745073" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_432f1e12-61e5-4c74-90b4-2161861eb231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8acc4dbe-959d-48ef-a8df-8d9a8fdd8713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95e1602e-af6a-4dc7-b59a-c51f9b745073" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8acc4dbe-959d-48ef-a8df-8d9a8fdd8713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_495be331-4c9d-4156-8769-07978fe4421b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_495be331-4c9d-4156-8769-07978fe4421b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_742f3028-8925-43f2-b6fb-8bf458975e61" xlink:href="pbh-20220930.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_742f3028-8925-43f2-b6fb-8bf458975e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c0dcddf0-adc3-42e4-b2ad-067a871b6974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_ShareBasedCompensation_c0dcddf0-adc3-42e4-b2ad-067a871b6974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_de8c3af2-1839-45b4-afa0-915696d41db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_de8c3af2-1839-45b4-afa0-915696d41db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5b89ee58-7637-4645-955a-75826df69bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_NetIncomeLoss_5b89ee58-7637-4645-955a-75826df69bb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1a9497f3-4c70-4d1e-ae67-53b17dcef2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1a9497f3-4c70-4d1e-ae67-53b17dcef2c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cf9a086f-ab55-4940-96de-884232ab2d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cf9a086f-ab55-4940-96de-884232ab2d3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5e44107b-0f06-49c1-8575-15c655a57c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5e44107b-0f06-49c1-8575-15c655a57c9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_febc394d-650a-4093-91c3-326c9368ec55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_febc394d-650a-4093-91c3-326c9368ec55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_675e4215-860e-48cf-98ec-5e165e2a7eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_675e4215-860e-48cf-98ec-5e165e2a7eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6c9f5848-48de-4e75-9509-25d2fc3af890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6c9f5848-48de-4e75-9509-25d2fc3af890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_67f1b4e5-bfff-43b1-8a84-ac20a5619be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_67f1b4e5-bfff-43b1-8a84-ac20a5619be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f42208a-ebd3-4a39-9b93-89fa2474947e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f42208a-ebd3-4a39-9b93-89fa2474947e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_ce5e33c4-0397-4984-9404-8412285b5967" xlink:href="pbh-20220930.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_ce5e33c4-0397-4984-9404-8412285b5967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_52b627fe-4a6f-48d1-952f-c7bc4937a70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_52b627fe-4a6f-48d1-952f-c7bc4937a70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_2ac2624b-9f35-42f5-a59e-2ee67086e460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9973927c-393a-4734-93f0-3235e1233c61" xlink:to="loc_us-gaap_OtherNoncashExpense_2ac2624b-9f35-42f5-a59e-2ee67086e460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f2f5ee0-424a-4659-9b5b-eb992f606712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5c21c30-9b2b-45c8-a58d-bc3f0bde42ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f2f5ee0-424a-4659-9b5b-eb992f606712" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5c21c30-9b2b-45c8-a58d-bc3f0bde42ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6b365c1-4414-40b7-9d19-07923b6e4e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f2f5ee0-424a-4659-9b5b-eb992f606712" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6b365c1-4414-40b7-9d19-07923b6e4e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c4232995-1127-49dc-a82c-172871c8bc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f2f5ee0-424a-4659-9b5b-eb992f606712" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c4232995-1127-49dc-a82c-172871c8bc5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd482328-b221-4f97-91b3-d83e4d01c997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5f2f5ee0-424a-4659-9b5b-eb992f606712" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd482328-b221-4f97-91b3-d83e4d01c997" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1b95aa9b-b749-4b74-9ed8-f609bf86a56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a7f4420a-5c5f-46c7-a5b5-4fefb750af28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1b95aa9b-b749-4b74-9ed8-f609bf86a56b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a7f4420a-5c5f-46c7-a5b5-4fefb750af28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_59f995af-a572-4db8-acbc-cc3af4da2e08" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1b95aa9b-b749-4b74-9ed8-f609bf86a56b" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_59f995af-a572-4db8-acbc-cc3af4da2e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_3ef1f8e6-6161-4c9d-b9fe-b2582fd98a22" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b66276a6-ce63-4772-9fe0-085b8173e354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_3ef1f8e6-6161-4c9d-b9fe-b2582fd98a22" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b66276a6-ce63-4772-9fe0-085b8173e354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d1237d5-ea22-4487-8f42-b0b744ae9b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_3ef1f8e6-6161-4c9d-b9fe-b2582fd98a22" xlink:to="loc_us-gaap_Goodwill_7d1237d5-ea22-4487-8f42-b0b744ae9b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1b10afc6-02a9-4c64-bf2e-43c967194cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_3ef1f8e6-6161-4c9d-b9fe-b2582fd98a22" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1b10afc6-02a9-4c64-bf2e-43c967194cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e0882bb8-c919-45b4-8e03-dec8769e279b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_95b4378c-960c-436c-8ece-25f8e81ae6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e0882bb8-c919-45b4-8e03-dec8769e279b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_95b4378c-960c-436c-8ece-25f8e81ae6de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_d687de61-38ab-464e-bb5d-58b902e30181" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e0882bb8-c919-45b4-8e03-dec8769e279b" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_d687de61-38ab-464e-bb5d-58b902e30181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8463099e-4ffc-47be-81ac-60623935efbf" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e0882bb8-c919-45b4-8e03-dec8769e279b" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8463099e-4ffc-47be-81ac-60623935efbf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#InventoriesSummaryofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_deff19d5-a31d-4408-bed9-135b61401f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_d380329f-18ec-4153-bc73-e6b67d9f4757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_deff19d5-a31d-4408-bed9-135b61401f3d" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_d380329f-18ec-4153-bc73-e6b67d9f4757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_00b9dc64-b20c-421d-a3b2-117072f3658c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_deff19d5-a31d-4408-bed9-135b61401f3d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_00b9dc64-b20c-421d-a3b2-117072f3658c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_353faa08-df55-46f5-8ea8-624884d7806e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_deff19d5-a31d-4408-bed9-135b61401f3d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_353faa08-df55-46f5-8ea8-624884d7806e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf028e45-cd6c-4a4a-8947-fd284b73c526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_607b2915-c38d-4629-ba6c-df9a4175d89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf028e45-cd6c-4a4a-8947-fd284b73c526" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_607b2915-c38d-4629-ba6c-df9a4175d89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f78ffab6-c395-40de-b47f-3ca7545f7695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf028e45-cd6c-4a4a-8947-fd284b73c526" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f78ffab6-c395-40de-b47f-3ca7545f7695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_496043c3-e992-4e36-91f7-04761065f89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0205d29-d4aa-4e24-8165-ceec1983e1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_496043c3-e992-4e36-91f7-04761065f89d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0205d29-d4aa-4e24-8165-ceec1983e1d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e361145-2be9-4a40-84f5-5daa307176de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_496043c3-e992-4e36-91f7-04761065f89d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e361145-2be9-4a40-84f5-5daa307176de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_332263cd-eaae-41b4-99e2-61eb17d83677" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_7cb71c75-f393-4c81-867a-c246ce4f30d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_332263cd-eaae-41b4-99e2-61eb17d83677" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_7cb71c75-f393-4c81-867a-c246ce4f30d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_2468f280-a090-462a-83e9-08c2c9177459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_332263cd-eaae-41b4-99e2-61eb17d83677" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_2468f280-a090-462a-83e9-08c2c9177459" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_71b856cf-7a2c-4906-b8c4-38d6d9c022f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_71b856cf-7a2c-4906-b8c4-38d6d9c022f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5f41eed3-eed7-4181-9117-ea71aa524de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5f41eed3-eed7-4181-9117-ea71aa524de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cee93350-8f51-43da-aefa-def5d29b6e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cee93350-8f51-43da-aefa-def5d29b6e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_75e5cf58-5b9a-46a8-aafc-d6c5f2d867db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_75e5cf58-5b9a-46a8-aafc-d6c5f2d867db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4977c9e8-aede-40f0-b643-fd6a335a7f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4977c9e8-aede-40f0-b643-fd6a335a7f02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_cb68c569-2828-4b8d-81e0-5f432a7b02bd" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_de71e9d2-5c8e-4267-9449-6b7e4fd23fb4" xlink:to="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_cb68c569-2828-4b8d-81e0-5f432a7b02bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c81a3d55-4357-4baa-a109-9fbdb6056884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c81a3d55-4357-4baa-a109-9fbdb6056884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_08de495a-85f1-4f47-aa36-aa6b7e2ba33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_08de495a-85f1-4f47-aa36-aa6b7e2ba33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_de327f95-8cd9-47c8-b649-f2c55c22dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:to="loc_us-gaap_OperatingLeaseCost_de327f95-8cd9-47c8-b649-f2c55c22dd97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_0bea8214-279d-4190-a1f6-680de43ad119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:to="loc_us-gaap_ShortTermLeaseCost_0bea8214-279d-4190-a1f6-680de43ad119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_8be0a28a-9275-41ba-a71b-271d322ee84d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3bc5caf0-0fb0-4f6f-b5c6-76db9193cfdc" xlink:to="loc_us-gaap_VariableLeaseCost_8be0a28a-9275-41ba-a71b-271d322ee84d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_86f165c5-96b2-40bb-8106-d42deb4f4135" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2a10d689-2dc9-4da0-a628-3b72066f0714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_86f165c5-96b2-40bb-8106-d42deb4f4135" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2a10d689-2dc9-4da0-a628-3b72066f0714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cfc84549-c6cc-4f7d-af6a-3bf85412d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_86f165c5-96b2-40bb-8106-d42deb4f4135" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cfc84549-c6cc-4f7d-af6a-3bf85412d30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_56a6c586-fd88-4670-9da7-b242a201f437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bf0a2e9e-5426-416a-87e5-f943eea9a0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_56a6c586-fd88-4670-9da7-b242a201f437" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bf0a2e9e-5426-416a-87e5-f943eea9a0bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a408248f-4950-4869-9c40-b081fc81a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_56a6c586-fd88-4670-9da7-b242a201f437" xlink:to="loc_us-gaap_OperatingLeaseLiability_a408248f-4950-4869-9c40-b081fc81a0dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_a3e39d77-7d02-44da-86f3-1a5e90dd4b7d" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_9a087b42-6d5d-4b2a-9bb3-ac8d544b26e6" xlink:href="pbh-20220930.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_a3e39d77-7d02-44da-86f3-1a5e90dd4b7d" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_9a087b42-6d5d-4b2a-9bb3-ac8d544b26e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_bf045c8a-d376-4549-aa6c-79e2f722edbf" xlink:href="pbh-20220930.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_a3e39d77-7d02-44da-86f3-1a5e90dd4b7d" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_bf045c8a-d376-4549-aa6c-79e2f722edbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_d704d0af-9d17-4775-bd69-1d35584a480f" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_520b9077-53e5-4282-97ba-afb7201d3e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_d704d0af-9d17-4775-bd69-1d35584a480f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_520b9077-53e5-4282-97ba-afb7201d3e70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8e79f204-df17-4115-bf17-dfbd15bd37e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_d704d0af-9d17-4775-bd69-1d35584a480f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8e79f204-df17-4115-bf17-dfbd15bd37e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_49297c54-101b-4a4d-9321-3ad0d6c7048c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_49297c54-101b-4a4d-9321-3ad0d6c7048c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c51de264-4233-46ab-9c89-bd3fd68e229b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c51de264-4233-46ab-9c89-bd3fd68e229b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ca51e6e4-f691-4836-b5d1-0fa173084133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ca51e6e4-f691-4836-b5d1-0fa173084133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7a5e1208-5981-42b1-b729-81fe42034780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7a5e1208-5981-42b1-b729-81fe42034780" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_85b3df3c-2846-4f35-a11c-f8a73d22f88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_85b3df3c-2846-4f35-a11c-f8a73d22f88f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_e7d1e0f0-be6d-4cd1-a04b-9703fcf4a0df" xlink:href="pbh-20220930.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_42a3995b-728c-48e3-955a-22c6c78a2803" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_e7d1e0f0-be6d-4cd1-a04b-9703fcf4a0df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_b8f64783-06d7-46b5-936b-bf97665e1e9a" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_d89a4004-0d28-45fc-b17f-f1799790b974" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_b8f64783-06d7-46b5-936b-bf97665e1e9a" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_d89a4004-0d28-45fc-b17f-f1799790b974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_2e1e1b1f-6a3c-4f57-bb19-9b70a432cffd" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_b8f64783-06d7-46b5-936b-bf97665e1e9a" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_2e1e1b1f-6a3c-4f57-bb19-9b70a432cffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_a999f86f-2f27-4cf5-b9ae-6112c6e478d6" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_96b64b2e-36f9-40b6-a9bf-a6e6e35af671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_a999f86f-2f27-4cf5-b9ae-6112c6e478d6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_96b64b2e-36f9-40b6-a9bf-a6e6e35af671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f76757b-91b5-4a42-9fcb-e7fd60d31887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_a999f86f-2f27-4cf5-b9ae-6112c6e478d6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f76757b-91b5-4a42-9fcb-e7fd60d31887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_530e8f8a-8c22-43c5-86e5-ff9ceffeeb5b" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2a0f2b1-fc3f-4eae-a308-21b4a3ca48b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_530e8f8a-8c22-43c5-86e5-ff9ceffeeb5b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2a0f2b1-fc3f-4eae-a308-21b4a3ca48b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_21a8292e-9a20-4132-b1ba-64e80bc4ebca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_530e8f8a-8c22-43c5-86e5-ff9ceffeeb5b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_21a8292e-9a20-4132-b1ba-64e80bc4ebca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_b3c81660-2c4b-419a-a6b2-e774d313e072" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_944a6c55-90f5-4c24-8cbc-40d37e6dff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_b3c81660-2c4b-419a-a6b2-e774d313e072" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_944a6c55-90f5-4c24-8cbc-40d37e6dff3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b330bbe9-7429-4b4b-985d-2d6636b540eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_b3c81660-2c4b-419a-a6b2-e774d313e072" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b330bbe9-7429-4b4b-985d-2d6636b540eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_d6386609-3532-45cf-b7eb-e52bf9dc34da" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de82b62a-7f44-482d-938f-e6b2d979a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_d6386609-3532-45cf-b7eb-e52bf9dc34da" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de82b62a-7f44-482d-938f-e6b2d979a50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_93185ef8-6fa6-4ae1-94ff-a07bcdb856bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_d6386609-3532-45cf-b7eb-e52bf9dc34da" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_93185ef8-6fa6-4ae1-94ff-a07bcdb856bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_863d8967-5f9d-4249-8869-57a50336e011" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d6de1e57-1494-4817-aa74-266a8aa515cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_863d8967-5f9d-4249-8869-57a50336e011" xlink:to="loc_us-gaap_FinanceLeaseLiability_d6de1e57-1494-4817-aa74-266a8aa515cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ba31ca63-702e-401f-8307-94a73d786697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_863d8967-5f9d-4249-8869-57a50336e011" xlink:to="loc_us-gaap_OperatingLeaseLiability_ba31ca63-702e-401f-8307-94a73d786697" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_65f95ac8-6cf4-4740-8a5e-b5af518663fc" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_65f95ac8-6cf4-4740-8a5e-b5af518663fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_5f0d66a5-bbb7-4c64-aa91-e47310e95e7b" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_5f0d66a5-bbb7-4c64-aa91-e47310e95e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_713da517-fc22-4e50-8fab-1e1ab7c88962" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_713da517-fc22-4e50-8fab-1e1ab7c88962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_a0bee69a-26bb-4716-b1c5-3be5762f32fd" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_a0bee69a-26bb-4716-b1c5-3be5762f32fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_815255f3-0dd3-43a3-8bb6-c31308d614fb" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_815255f3-0dd3-43a3-8bb6-c31308d614fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_2fdac717-f997-4a8a-8290-86542d426e0b" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_24eece5d-babe-44bc-bbd8-a500692bcde9" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_2fdac717-f997-4a8a-8290-86542d426e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5c30ad3b-1c01-4893-8d6b-f50d150b9dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_70f82027-0393-4fbf-8ce2-63f1b3cdfd72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5c30ad3b-1c01-4893-8d6b-f50d150b9dc6" xlink:to="loc_us-gaap_FinanceLeaseLiability_70f82027-0393-4fbf-8ce2-63f1b3cdfd72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6c33c921-1801-4c41-ad58-8646e919374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5c30ad3b-1c01-4893-8d6b-f50d150b9dc6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6c33c921-1801-4c41-ad58-8646e919374c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7d5e75d6-e4e7-440c-9d0a-ddb3bc064be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7d5e75d6-e4e7-440c-9d0a-ddb3bc064be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d9466918-2987-4753-8001-81de8f15cc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d9466918-2987-4753-8001-81de8f15cc62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_83967277-7dd6-498a-a82a-e0c3e721dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_83967277-7dd6-498a-a82a-e0c3e721dfd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d0113255-8469-40cf-85b7-1b8aa7eaac70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d0113255-8469-40cf-85b7-1b8aa7eaac70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_698bcead-62e5-42b5-b252-e271d9f3d16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_698bcead-62e5-42b5-b252-e271d9f3d16f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_d5842ca0-168f-4390-8386-9ef97a73685a" xlink:href="pbh-20220930.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ab70d66-16dc-4034-b6dd-bf1e12746b64" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_d5842ca0-168f-4390-8386-9ef97a73685a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_23898f21-78b5-4dd9-924a-8737a82d8976" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0be3b439-7ff2-44b8-97ed-e0d734dce79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_23898f21-78b5-4dd9-924a-8737a82d8976" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0be3b439-7ff2-44b8-97ed-e0d734dce79d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2970859b-2da3-43f6-ac7b-71987613e15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_23898f21-78b5-4dd9-924a-8737a82d8976" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2970859b-2da3-43f6-ac7b-71987613e15f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:href="pbh-20220930.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_3c8651c1-eeeb-4133-a4f4-e6b3466ecf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_3c8651c1-eeeb-4133-a4f4-e6b3466ecf5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_612f827f-ccdc-4f64-bdd3-7e5d24462a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_612f827f-ccdc-4f64-bdd3-7e5d24462a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_2616b077-c1a0-4c6d-96b3-d5d765702aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_2616b077-c1a0-4c6d-96b3-d5d765702aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_973d10a2-09e6-4bcc-9359-1ddd645e3168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_973d10a2-09e6-4bcc-9359-1ddd645e3168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1e1a170f-9644-4330-a4d4-cb8248856da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1e1a170f-9644-4330-a4d4-cb8248856da6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_51da06d1-bd3b-46e3-b343-47426facce06" xlink:href="pbh-20220930.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_pbh_AccruedProductionCostsCurrent_51da06d1-bd3b-46e3-b343-47426facce06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_36392291-785b-4a30-b61f-9db3e098cfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1e9e07aa-dc93-40f4-b24c-076e64c3b0c7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_36392291-785b-4a30-b61f-9db3e098cfc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_73a9548c-f9c2-403f-a26d-388b926c98c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f4a80256-5703-4459-8d14-1910dd7281f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_73a9548c-f9c2-403f-a26d-388b926c98c7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f4a80256-5703-4459-8d14-1910dd7281f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7472902d-d89c-4b00-8003-8c965dc8d526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_73a9548c-f9c2-403f-a26d-388b926c98c7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7472902d-d89c-4b00-8003-8c965dc8d526" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b0d14221-2b3e-4f36-a42c-8ca5861bab86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b0d14221-2b3e-4f36-a42c-8ca5861bab86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_062fb9e9-50f1-4ad0-8923-c83902318b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_062fb9e9-50f1-4ad0-8923-c83902318b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ec7de0e1-b094-4679-9460-4a82607bb5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ec7de0e1-b094-4679-9460-4a82607bb5dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4ba40fc-d412-40ad-9dcd-38260c9dc10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4ba40fc-d412-40ad-9dcd-38260c9dc10b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7c7a8f34-cd32-44c7-99d9-4c7005ce3d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7c7a8f34-cd32-44c7-99d9-4c7005ce3d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour_1142a932-6080-489a-b4d4-7524703aab09" xlink:href="pbh-20220930.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6fae8ad7-92aa-48fe-b71f-b1c0ce1c11c8" xlink:to="loc_pbh_LongTermDebtMaturityAfterYearFour_1142a932-6080-489a-b4d4-7524703aab09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cc381e4-1a50-462c-8dc6-5927bddd6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e53f3b51-11fd-4a32-8d53-8359a64e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cc381e4-1a50-462c-8dc6-5927bddd6be0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e53f3b51-11fd-4a32-8d53-8359a64e04a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7bd96ece-ae8b-490c-b88f-f7282a4ea5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cc381e4-1a50-462c-8dc6-5927bddd6be0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7bd96ece-ae8b-490c-b88f-f7282a4ea5f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_be2d733a-8f87-4510-9f7e-d5c72e447403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c868031e-2a45-422a-a65f-821e4142d991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_be2d733a-8f87-4510-9f7e-d5c72e447403" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c868031e-2a45-422a-a65f-821e4142d991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_10e89793-21db-419b-b282-b8f3978b5304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_be2d733a-8f87-4510-9f7e-d5c72e447403" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_10e89793-21db-419b-b282-b8f3978b5304" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_052856a9-3e18-4c46-b08b-baad26f07a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_22fa9418-91ef-4d21-a70d-58948511eb23" xlink:href="pbh-20220930.xsd#pbh_ContributionMargin"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_052856a9-3e18-4c46-b08b-baad26f07a13" xlink:to="loc_pbh_ContributionMargin_22fa9418-91ef-4d21-a70d-58948511eb23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_82077189-767d-40a8-80c3-7c205d11340e" xlink:href="pbh-20220930.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_052856a9-3e18-4c46-b08b-baad26f07a13" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_82077189-767d-40a8-80c3-7c205d11340e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_afcf4ae6-de43-44e6-b688-14eceb4d585b" xlink:href="pbh-20220930.xsd#pbh_ContributionMargin"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b86d704b-bb6c-4716-bc8f-0ffbf3310b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_afcf4ae6-de43-44e6-b688-14eceb4d585b" xlink:to="loc_us-gaap_GrossProfit_b86d704b-bb6c-4716-bc8f-0ffbf3310b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_e16fcda4-2af3-49d6-b446-dd105d85e896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_afcf4ae6-de43-44e6-b688-14eceb4d585b" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_e16fcda4-2af3-49d6-b446-dd105d85e896" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>pbh-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended" id="i2e392aec78b84577a363df5bdbb17888_CondensedConsolidatedStatementsofIncomeandComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9642085c-d036-460c-877e-19a33a96f29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9642085c-d036-460c-877e-19a33a96f29a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_f0f53ad1-f6ff-4280-8119-3f870fbd763d" xlink:href="pbh-20220930.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_f0f53ad1-f6ff-4280-8119-3f870fbd763d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1cb8044c-db60-4f70-9e72-334b0473d981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1cb8044c-db60-4f70-9e72-334b0473d981" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ce56f14d-17ca-44db-b39f-7c1953c8505b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_us-gaap_CostOfRevenue_ce56f14d-17ca-44db-b39f-7c1953c8505b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c9ae294f-8a6d-4190-ba1a-a31036c55e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_GrossProfit_c9ae294f-8a6d-4190-ba1a-a31036c55e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_d66b91c5-9fee-4342-afcf-2a4ee4ddc0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_d66b91c5-9fee-4342-afcf-2a4ee4ddc0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e32b15d1-0de6-4e31-8091-d01611f036a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e32b15d1-0de6-4e31-8091-d01611f036a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_ef16f3a8-822f-48db-b5d7-c553f95a1479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_ef16f3a8-822f-48db-b5d7-c553f95a1479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2ecbe234-7cf3-422c-8bac-794c683587cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_OperatingExpenses_2ecbe234-7cf3-422c-8bac-794c683587cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e8a40f32-c2f8-4855-82f1-b43223c2f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_OperatingIncomeLoss_e8a40f32-c2f8-4855-82f1-b43223c2f3d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a1510d62-4db9-4aa2-98e3-ef10663684a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a1510d62-4db9-4aa2-98e3-ef10663684a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d40d31a0-4ab6-457d-b1e8-e4b26c2c5d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d40d31a0-4ab6-457d-b1e8-e4b26c2c5d97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a767c2ac-25af-4b5a-97a1-4c12d65f2b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a767c2ac-25af-4b5a-97a1-4c12d65f2b26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_e63d2ead-42e6-46ad-8ef0-c4cb96211729" xlink:href="pbh-20220930.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_pbh_TotalOtherIncomeExpense_e63d2ead-42e6-46ad-8ef0-c4cb96211729" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_e52e381c-e43b-40cc-89aa-10cd46f9a62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_e52e381c-e43b-40cc-89aa-10cd46f9a62e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a24777d8-fa0a-4afd-b2fa-7d95aae1b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a24777d8-fa0a-4afd-b2fa-7d95aae1b59b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_04793a7e-ac9c-4fa4-8104-805872f9ff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_NetIncomeLoss_04793a7e-ac9c-4fa4-8104-805872f9ff3d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_df72a71c-29f2-4d4e-a1b8-aa7007f1d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:to="loc_us-gaap_EarningsPerShareBasic_df72a71c-29f2-4d4e-a1b8-aa7007f1d9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e34d6e25-53b3-4437-9258-c981e9d9a030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e34d6e25-53b3-4437-9258-c981e9d9a030" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6ec0ad1-7112-498d-94f0-b0aa1bc09f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6ec0ad1-7112-498d-94f0-b0aa1bc09f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef5cdcc5-822e-4570-984c-56ca4a0556df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef5cdcc5-822e-4570-984c-56ca4a0556df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6eea54a0-89a1-4d78-b019-eb095ad7330c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6eea54a0-89a1-4d78-b019-eb095ad7330c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c3dbbeeb-2f12-44a3-89c5-bf1f9d7dd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c3dbbeeb-2f12-44a3-89c5-bf1f9d7dd70f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8fb9112e-b68e-4882-81ca-77a2ee961552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8fb9112e-b68e-4882-81ca-77a2ee961552" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad0de8c7-3652-4497-9ac3-99443e03ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad0de8c7-3652-4497-9ac3-99443e03ba10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ad0cf59d-54b7-45d9-979b-e50607719606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ad0cf59d-54b7-45d9-979b-e50607719606" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:to="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:to="loc_srt_ProductsAndServicesDomain_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:to="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3894a4ff-37ec-452b-b927-571b9fcff40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:to="loc_us-gaap_ProductMember_3894a4ff-37ec-452b-b927-571b9fcff40a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_94cbac8f-251b-430f-bfaf-9d45203c59d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_94cbac8f-251b-430f-bfaf-9d45203c59d5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended" id="i180d036ad556480d9193a92e52c90178_CondensedConsolidatedStatementsofChangesinStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b9659eea-0a2e-4932-ae80-a5112f8a8a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b9659eea-0a2e-4932-ae80-a5112f8a8a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e3465b3-4cdf-4f5b-9f7a-c365d6c4308b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockholdersEquity_5e3465b3-4cdf-4f5b-9f7a-c365d6c4308b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_56be8bd5-57d2-4538-9f14-7343200c215b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockCommonShares_56be8bd5-57d2-4538-9f14-7343200c215b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d721b7d-8432-4b1a-ab9b-26c513499823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d721b7d-8432-4b1a-ab9b-26c513499823" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbbb3277-91f0-4acc-9ed4-f53da0e546a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbbb3277-91f0-4acc-9ed4-f53da0e546a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_97638a2b-63c0-410d-bb13-09fb2d30e36b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_97638a2b-63c0-410d-bb13-09fb2d30e36b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_eab554c4-1776-47f3-afdf-f30ed07cf4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_eab554c4-1776-47f3-afdf-f30ed07cf4f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b3a29851-fbe4-48d9-9564-067b3123ee6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b3a29851-fbe4-48d9-9564-067b3123ee6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3c29c147-b4e3-47b8-a611-121d6e7645b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3c29c147-b4e3-47b8-a611-121d6e7645b1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_899685a6-f261-433c-907c-f2cfea4e0ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_899685a6-f261-433c-907c-f2cfea4e0ce8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e706dd4b-afc8-479d-9740-e568aa8af00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_NetIncomeLoss_e706dd4b-afc8-479d-9740-e568aa8af00f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f8011e11-0cbe-42fc-b8cf-e794b184defa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f8011e11-0cbe-42fc-b8cf-e794b184defa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5c780dba-8a51-40aa-bb4c-d0727dd5a3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b2c7634-0fbe-4024-86c7-d892f9069f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_ddec57da-31e1-43be-9213-4c2ca416565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:to="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4a2a7919-6fc9-4773-9955-603b60eacf51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:to="loc_us-gaap_EquityComponentDomain_4a2a7919-6fc9-4773-9955-603b60eacf51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:to="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_986f1be9-ac23-489b-b51e-4830892563c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_CommonStockMember_986f1be9-ac23-489b-b51e-4830892563c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1ebe1761-fa01-4c0c-8863-0880877cdf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1ebe1761-fa01-4c0c-8863-0880877cdf4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_42019945-b46f-4986-8233-d8931cb413bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_42019945-b46f-4986-8233-d8931cb413bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c6d040-aed5-4a43-a8a1-aec2db9901d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c6d040-aed5-4a43-a8a1-aec2db9901d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1fde48c1-16c7-4690-8e35-df1454ac77a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_RetainedEarningsMember_1fde48c1-16c7-4690-8e35-df1454ac77a2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="extended" id="i4562167068a04a1a80004aa3d1a0c417_AcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9279a6da-cb53-4dec-8e38-4b4b9b652a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9279a6da-cb53-4dec-8e38-4b4b9b652a88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement_639ac058-c691-4b59-9252-ef34bbfcef1b" xlink:href="pbh-20220930.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_SupplyCommitmentTermOfAgreement_639ac058-c691-4b59-9252-ef34bbfcef1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_6c8c2c5e-ea0c-4dc3-b175-c0b9ef1d7deb" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_6c8c2c5e-ea0c-4dc3-b175-c0b9ef1d7deb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_c806273d-4334-45b2-b6f1-28a5b23ffb48" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_c806273d-4334-45b2-b6f1-28a5b23ffb48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_75db7832-ab3e-4eb6-a88b-d2fab659a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_75db7832-ab3e-4eb6-a88b-d2fab659a6c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_60c6232e-49ae-4521-af8f-737f5130459b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_Goodwill_60c6232e-49ae-4521-af8f-737f5130459b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d49f7055-5179-42a9-a7cf-70cdaabb0a12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d49f7055-5179-42a9-a7cf-70cdaabb0a12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e4d6d86d-0d84-462a-ae79-bde653e975ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e4d6d86d-0d84-462a-ae79-bde653e975ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_9742be6e-5176-4e7f-9754-9af416900b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:to="loc_us-gaap_TrademarksMember_9742be6e-5176-4e7f-9754-9af416900b3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d53c766-44b8-430d-89f3-e7163af367a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d53c766-44b8-430d-89f3-e7163af367a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_34d70a97-fec6-4d4b-a8ae-dbfc5f16b45e" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_34d70a97-fec6-4d4b-a8ae-dbfc5f16b45e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="id0186077f5404d7c899aa30edaff77ad_AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_910cdc12-0366-402d-9a02-988bad9f7d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_910cdc12-0366-402d-9a02-988bad9f7d09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_610f065b-d8ae-41aa-ba05-bff964b60aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_Goodwill_610f065b-d8ae-41aa-ba05-bff964b60aa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a2922d16-988f-406a-94c2-f0d3f5e9ee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a2922d16-988f-406a-94c2-f0d3f5e9ee4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cfac030f-420e-4a4d-b170-184d22dcc075" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cfac030f-420e-4a4d-b170-184d22dcc075" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ebfb14a1-c0ca-4249-813b-0cc273958317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ebfb14a1-c0ca-4249-813b-0cc273958317" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_41c70a8f-3355-4ffc-8d7a-62805177214c" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_41c70a8f-3355-4ffc-8d7a-62805177214c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8a4d2b7d-c243-4d79-bee7-460c877cc6d6" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8a4d2b7d-c243-4d79-bee7-460c877cc6d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7ca4e664-bbd6-4096-81b2-00c553635532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7ca4e664-bbd6-4096-81b2-00c553635532" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c1f50500-7692-43f0-a1c4-23b29b82a903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c1f50500-7692-43f0-a1c4-23b29b82a903" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_853f8aa9-1395-4d6c-a961-1a9c4af29d1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_853f8aa9-1395-4d6c-a961-1a9c4af29d1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_0d73aa87-c670-4071-b2b3-5bb23a8395d3" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_0d73aa87-c670-4071-b2b3-5bb23a8395d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#GoodwillScheduleofChangesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="extended" id="iec9960be2a004e57af8d47c9a4e7429b_GoodwillScheduleofChangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:to="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_da5ceaae-074b-4271-b60c-e6d539e663a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillGross_da5ceaae-074b-4271-b60c-e6d539e663a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2b163d9f-da14-4aca-9b5b-7b3088f5e652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2b163d9f-da14-4aca-9b5b-7b3088f5e652" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_10d13fd3-85fb-4f18-a655-c23d1b689309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_Goodwill_10d13fd3-85fb-4f18-a655-c23d1b689309" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c93e29fd-6e82-4c6c-94bf-38d9d77a5d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillTransfers_c93e29fd-6e82-4c6c-94bf-38d9d77a5d92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c70058c1-ccf7-4b50-ab70-80377a40a43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c70058c1-ccf7-4b50-ab70-80377a40a43e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_fbf720a6-bd28-4836-aea0-147df7734cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c9a07040-37a3-4ce5-903f-d75dcb50f741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_338093e2-1499-44b2-9729-4e646fbeb556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f19b481e-8131-4ad8-956e-93f9c155e17f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:to="loc_us-gaap_SegmentDomain_f19b481e-8131-4ad8-956e-93f9c155e17f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:to="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_5ca02b66-46d1-46d5-82db-3b655e6bbdb7" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_5ca02b66-46d1-46d5-82db-3b655e6bbdb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_6018eead-b92c-4baa-a832-db93ed8c8ad0" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:to="loc_pbh_InternationalOTCHealthcareMember_6018eead-b92c-4baa-a832-db93ed8c8ad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161889c7-8c3a-4c6e-81e7-ab871e0819c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_161889c7-8c3a-4c6e-81e7-ab871e0819c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_32083347-7784-498e-a159-ee6b6ea46c7f" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_32083347-7784-498e-a159-ee6b6ea46c7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#GoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="extended" id="i1fe5e74749324527bf241e14f492453a_GoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_271eb4c9-c6a0-4d7b-9d1f-227791042326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:to="loc_us-gaap_Goodwill_271eb4c9-c6a0-4d7b-9d1f-227791042326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_64eda75b-2c7e-4a94-b974-9c9c3ff67edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_64eda75b-2c7e-4a94-b974-9c9c3ff67edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_498c1bfb-9f26-43da-affa-0b84319a4fe8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_498c1bfb-9f26-43da-affa-0b84319a4fe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_d84b3f92-b840-4523-bf00-9e6ff5aee65a" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_d84b3f92-b840-4523-bf00-9e6ff5aee65a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended" id="ib5fc419aa2ea4a608f985f676747562a_IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ff4ea826-dbf9-4db1-a81a-8922fe4c3024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ff4ea826-dbf9-4db1-a81a-8922fe4c3024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_bdbc3b91-7a4d-4537-8666-6792f9b12b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_bdbc3b91-7a4d-4537-8666-6792f9b12b9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_05bbdde5-9473-4210-9c8c-515bbf8ceb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c28a34c6-7ca4-4276-a1aa-1a06df322952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c28a34c6-7ca4-4276-a1aa-1a06df322952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_38572fb8-14b3-4d39-bce8-0efd6f1e6b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_38572fb8-14b3-4d39-bce8-0efd6f1e6b5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1783aa3f-2189-4f5f-b97f-f4da057faf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:to="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c027c97b-bb68-48ab-935a-3dfc79b06683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c027c97b-bb68-48ab-935a-3dfc79b06683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_635e3688-1e14-4ba5-b2a4-6e4f3420ad80" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_635e3688-1e14-4ba5-b2a4-6e4f3420ad80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bd1bf43d-3fa0-449d-8b6b-ff97163a1cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:href="pbh-20220930.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e4d48cd-14b9-42f8-b7e8-5834271a9917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e4d48cd-14b9-42f8-b7e8-5834271a9917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_23a9e4a7-90f8-44ab-b7d4-9c2618add496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_23a9e4a7-90f8-44ab-b7d4-9c2618add496" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_5a5f1cb2-54eb-4b03-bfb1-8fb49bdaac57" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_5a5f1cb2-54eb-4b03-bfb1-8fb49bdaac57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_13dec9f9-e148-4346-89ff-5d472b952fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9af45ed4-2ce7-4678-ac7c-81a3e79addcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9af45ed4-2ce7-4678-ac7c-81a3e79addcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17a74a50-5bb5-4c1c-9014-f5daf5fe6939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17a74a50-5bb5-4c1c-9014-f5daf5fe6939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a6905402-f3e4-4dbb-a254-b386b3bb856b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a6905402-f3e4-4dbb-a254-b386b3bb856b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_ab51da54-5275-4398-8fbc-0ff46c2d55a4" xlink:href="pbh-20220930.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_ab51da54-5275-4398-8fbc-0ff46c2d55a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5d58372-2dae-499b-9426-3f29f9649fff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5d58372-2dae-499b-9426-3f29f9649fff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_4ca0079a-b14e-4ef7-b661-15c21e19834c" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_4ca0079a-b14e-4ef7-b661-15c21e19834c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f38f8307-817c-4ed0-b375-bdbc60e354e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f38f8307-817c-4ed0-b375-bdbc60e354e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_b1dc6e15-2147-4c90-8280-e216919ca0a1" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_b1dc6e15-2147-4c90-8280-e216919ca0a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_7548ed1e-70d0-44aa-8e25-8a9c9520577c" xlink:href="pbh-20220930.xsd#pbh_ZaditenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:to="loc_pbh_ZaditenMember_7548ed1e-70d0-44aa-8e25-8a9c9520577c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="i9b522267df9a4fd28a9c47006e0b3b49_IntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired_07650694-a57f-4d61-9846-d3b1bec2c6dd" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_pbh_IntangibleAssetsAcquired_07650694-a57f-4d61-9846-d3b1bec2c6dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7bd76f2b-2604-4ff1-a9d6-972a3e8f60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7bd76f2b-2604-4ff1-a9d6-972a3e8f60bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_064e7ba1-1cbc-4489-b3e7-47ee2d8d5a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_064e7ba1-1cbc-4489-b3e7-47ee2d8d5a8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_608f0520-77bd-4020-ab4f-275cc31c274a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_608f0520-77bd-4020-ab4f-275cc31c274a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:to="loc_srt_RangeMember_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:to="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1c926c2-07e0-439e-83e0-890546ac3bf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:to="loc_srt_MinimumMember_d1c926c2-07e0-439e-83e0-890546ac3bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dff632fb-2e2f-4011-80a8-f69e5643fd46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:to="loc_srt_MaximumMember_dff632fb-2e2f-4011-80a8-f69e5643fd46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e299851b-9c9b-4adf-a5eb-062c2a730f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e299851b-9c9b-4adf-a5eb-062c2a730f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_e07eb911-a73a-4330-bd9e-a5fab1cf2a65" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_e07eb911-a73a-4330-bd9e-a5fab1cf2a65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_a423feae-067e-409b-bf88-2f50c7d13ebb" xlink:href="pbh-20220930.xsd#pbh_ZaditenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:to="loc_pbh_ZaditenMember_a423feae-067e-409b-bf88-2f50c7d13ebb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended" id="i8f6af6289c3b40429563ec25835823ca_LongTermDebtScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4444a7a9-77bd-4773-a24c-3ac4255d9c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4444a7a9-77bd-4773-a24c-3ac4255d9c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc80808d-f6da-4aae-8c85-f5ab0a232a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc80808d-f6da-4aae-8c85-f5ab0a232a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_75de8b01-4a01-4d94-b21a-79fd3b967dd3" xlink:href="pbh-20220930.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_75de8b01-4a01-4d94-b21a-79fd3b967dd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fd6558ee-437d-475e-a30f-92aa8beb1ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_fd6558ee-437d-475e-a30f-92aa8beb1ac2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6e1c3bec-bd7b-4ca0-a201-dd758c83d658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6e1c3bec-bd7b-4ca0-a201-dd758c83d658" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5949054b-e9ae-4f52-92cf-1accd7291bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5949054b-e9ae-4f52-92cf-1accd7291bbe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a38c424-7b82-4066-b9ac-fc3c5ca89315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_LongTermDebt_4a38c424-7b82-4066-b9ac-fc3c5ca89315" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cdc4874c-cccd-4443-9b62-ddd84f085633_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cdc4874c-cccd-4443-9b62-ddd84f085633_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2d108380-6b45-4667-a656-b04fdd8e3850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_SeniorNotesMember_2d108380-6b45-4667-a656-b04fdd8e3850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_8587e99e-95b2-4846-999e-675455fd235d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_LoansPayableMember_8587e99e-95b2-4846-999e-675455fd235d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a1fcaac3-9172-46eb-8651-4ae0fdf7a678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a1fcaac3-9172-46eb-8651-4ae0fdf7a678" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_e2f10efa-1324-4f2e-8ca2-96630225e19a" xlink:href="pbh-20220930.xsd#pbh_A2021SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_A2021SeniorNotesMember_e2f10efa-1324-4f2e-8ca2-96630225e19a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_c4faf6bd-6a02-4d50-931d-58b3583c2b3d" xlink:href="pbh-20220930.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_A2019SeniorNotesMember_c4faf6bd-6a02-4d50-931d-58b3583c2b3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5f5330e6-aa3b-4975-b6bc-4148bb35a8ec" xlink:href="pbh-20220930.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5f5330e6-aa3b-4975-b6bc-4148bb35a8ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_6499bbcd-485b-4077-bd19-447c66081444" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_AblRevolver2012Member_6499bbcd-485b-4077-bd19-447c66081444" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e9c86292-8091-412d-b347-a6e318b680b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:to="loc_us-gaap_VariableRateDomain_e9c86292-8091-412d-b347-a6e318b680b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:to="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_17c3459d-8ced-471f-9928-5c762fa87d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_17c3459d-8ced-471f-9928-5c762fa87d08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7c001621-9eff-4f95-9373-037d0d274177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:to="loc_us-gaap_BaseRateMember_7c001621-9eff-4f95-9373-037d0d274177" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="ia3f87f32c8144e58be11c102ea7db2f2_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_adb291ec-5532-4def-80cc-8e899e39bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_adb291ec-5532-4def-80cc-8e899e39bed6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_93a53e51-14d9-4ee2-b9c9-5db50c5931fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_93a53e51-14d9-4ee2-b9c9-5db50c5931fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:to="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:to="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:to="loc_us-gaap_CreditFacilityDomain_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:to="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_76c0ce32-63bf-402c-a6f3-09241420f608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_76c0ce32-63bf-402c-a6f3-09241420f608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:to="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08ee7caa-2cc1-4673-97fd-a9bca95c9714_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08ee7caa-2cc1-4673-97fd-a9bca95c9714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_1dda682f-4bcb-45b0-93ad-b23549e70d8b" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:to="loc_pbh_AblRevolver2012Member_1dda682f-4bcb-45b0-93ad-b23549e70d8b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i1a436ff9ef6348e69c545332c97768c4_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_eb880816-9fd3-47d4-b015-5824d306e5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:to="loc_us-gaap_LongTermDebtFairValue_eb880816-9fd3-47d4-b015-5824d306e5c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_8cb48462-bcf5-49e1-b73b-7f82c00a0d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_8cb48462-bcf5-49e1-b73b-7f82c00a0d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_436b73a7-3ca3-4a27-9e5e-706c2286bf01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_436b73a7-3ca3-4a27-9e5e-706c2286bf01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5c99c73a-c13d-4836-a0d1-c5b96bb40f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5c99c73a-c13d-4836-a0d1-c5b96bb40f37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a78edf35-fa32-4910-9ecc-54d0d567f112_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a78edf35-fa32-4910-9ecc-54d0d567f112_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_66310c5b-f46d-4a51-9f9f-88e60c0a83ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_SeniorNotesMember_66310c5b-f46d-4a51-9f9f-88e60c0a83ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_f0378ef6-5b21-47f2-8122-30c8b890a0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_LoansPayableMember_f0378ef6-5b21-47f2-8122-30c8b890a0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f3832d99-e641-40e3-a527-9febeaa780db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f3832d99-e641-40e3-a527-9febeaa780db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f772652e-7ab7-470f-a042-8a8e2cfb8b64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f772652e-7ab7-470f-a042-8a8e2cfb8b64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_59d0b94d-c2e6-4708-92b8-6e327c808a23" xlink:href="pbh-20220930.xsd#pbh_A2021SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_A2021SeniorNotesMember_59d0b94d-c2e6-4708-92b8-6e327c808a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_08b9c596-a316-4fcf-b409-af6d64bebfc5" xlink:href="pbh-20220930.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_A2019SeniorNotesMember_08b9c596-a316-4fcf-b409-af6d64bebfc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5227419b-a82a-4780-9f3c-2f1528a6c76e" xlink:href="pbh-20220930.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5227419b-a82a-4780-9f3c-2f1528a6c76e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_5cbf4da0-e46b-4312-8b21-d252f125f9ad" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_AblRevolver2012Member_5cbf4da0-e46b-4312-8b21-d252f125f9ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_72045994-f901-4091-a461-ca8377289dc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_72045994-f901-4091-a461-ca8377289dc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6095ca7b-5971-4ded-a50e-23525a32d86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6095ca7b-5971-4ded-a50e-23525a32d86e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1b260e2a-28cc-4c56-a8fe-f224798dc977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1b260e2a-28cc-4c56-a8fe-f224798dc977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad705a3e-5261-41ea-826a-31713e5b7af5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad705a3e-5261-41ea-826a-31713e5b7af5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_30ea21a3-8ee1-45be-a580-37200852ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_30ea21a3-8ee1-45be-a580-37200852ddd3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended" id="i344a22c557f049db9e2bcb84aeb61dd1_DerivativeInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_625214ee-bb1e-4c0c-a1ae-c3b2e2162456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_625214ee-bb1e-4c0c-a1ae-c3b2e2162456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_02c092c9-a44a-4e78-a926-71d16cc7cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:to="loc_us-gaap_DerivativeNotionalAmount_02c092c9-a44a-4e78-a926-71d16cc7cf58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_450a6a3f-d448-4502-b5da-05d49337fce3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_450a6a3f-d448-4502-b5da-05d49337fce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fdb41377-4227-459b-913c-04e4a45a5b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:to="loc_us-gaap_InterestRateSwapMember_fdb41377-4227-459b-913c-04e4a45a5b83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d5a16054-e852-44c4-8127-e620d67db968_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:to="loc_us-gaap_HedgingDesignationDomain_d5a16054-e852-44c4-8127-e620d67db968_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:to="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33e8624d-d6e1-431f-a089-01a82f154f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33e8624d-d6e1-431f-a089-01a82f154f10" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstrumentsSummaryofInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="extended" id="icc9a4202b8d2421b8b119e0628006043_DerivativeInstrumentsSummaryofInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_34bcb740-f365-43b0-a028-f8cb015574b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_34bcb740-f365-43b0-a028-f8cb015574b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_039c67cb-d7a7-4c45-ad33-8c4a9f20cccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_039c67cb-d7a7-4c45-ad33-8c4a9f20cccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b3f80dcd-4061-4ba3-8a04-52028935a4ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:to="loc_us-gaap_HedgingDesignationDomain_b3f80dcd-4061-4ba3-8a04-52028935a4ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:to="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5d499ad5-21f3-4b41-a75d-482132c6af30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5d499ad5-21f3-4b41-a75d-482132c6af30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_57257292-c03d-4b19-bc9d-0c311789fb71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_57257292-c03d-4b19-bc9d-0c311789fb71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8a2b083e-7037-48e5-9a47-de612f3ad09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:to="loc_us-gaap_InterestRateSwapMember_8a2b083e-7037-48e5-9a47-de612f3ad09f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d109cc4a-e90c-4bf9-b169-84c0e6eaac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:to="loc_us-gaap_InterestExpenseMember_d109cc4a-e90c-4bf9-b169-84c0e6eaac7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#StockholdersEquityScheduleofRepurchasedSharesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="extended" id="i702d11c386454c3fb8300f2e95e1b024_StockholdersEquityScheduleofRepurchasedSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9a749f7f-7932-4e15-baa2-5f83e1b298c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9a749f7f-7932-4e15-baa2-5f83e1b298c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_430d973b-2f3d-410d-9011-8172f56f71ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_430d973b-2f3d-410d-9011-8172f56f71ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_fdc5a913-d1be-4f74-bddf-4d79ef785709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_fdc5a913-d1be-4f74-bddf-4d79ef785709" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:to="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_24ed4421-742e-45b7-8105-0789377ef274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_24ed4421-742e-45b7-8105-0789377ef274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ea0f72e1-5ea0-43c5-80f5-d89df76600ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:to="loc_us-gaap_RestrictedStockMember_ea0f72e1-5ea0-43c5-80f5-d89df76600ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_ad22b2a0-d637-43ed-be0a-12606224934c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_ad22b2a0-d637-43ed-be0a-12606224934c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_a7693cb8-e93f-4003-921b-489bbb8aa850" xlink:href="pbh-20220930.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:to="loc_pbh_ShareRepurchaseProgramMember_a7693cb8-e93f-4003-921b-489bbb8aa850" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i17f7b4cb1cb54fa09ff978dbbf5fe6f7_AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_222cd745-e432-4ce1-be5a-1838f665f7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:to="loc_us-gaap_StockholdersEquity_222cd745-e432-4ce1-be5a-1838f665f7ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_cdf164ad-4525-4c42-8481-e8e4148f177b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_cdf164ad-4525-4c42-8481-e8e4148f177b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a686cca3-b89e-4f7d-bc83-2f77f3ab9716_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:to="loc_us-gaap_EquityComponentDomain_a686cca3-b89e-4f7d-bc83-2f77f3ab9716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:to="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d9e234ba-e559-48bb-bd98-74a926233e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d9e234ba-e559-48bb-bd98-74a926233e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0104a565-3394-4308-a1a5-65ef92f7f82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0104a565-3394-4308-a1a5-65ef92f7f82e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShareAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" id="i759fa4eb4dfb49518fa5e3851feb4850_EarningsPerShareAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee31f3bf-9fa5-4682-8cfd-0e6f8405ad58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee31f3bf-9fa5-4682-8cfd-0e6f8405ad58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87a328d1-b41b-4136-b8a2-b6ffc3201a60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87a328d1-b41b-4136-b8a2-b6ffc3201a60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_0b73e81d-2b5a-42d9-a087-8c6affb7e5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:to="loc_us-gaap_StockCompensationPlanMember_0b73e81d-2b5a-42d9-a087-8c6affb7e5b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i65d47c77f8784dd7a836b705a70f537a_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5d0b6a65-b2d7-45ea-8df6-6cdf3c0cdc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5d0b6a65-b2d7-45ea-8df6-6cdf3c0cdc83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_52a4ed1a-373c-4c6d-93c6-d6bcbf1b2d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_52a4ed1a-373c-4c6d-93c6-d6bcbf1b2d54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_880ea8f1-3762-40ec-a829-abd218025079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_880ea8f1-3762-40ec-a829-abd218025079" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_52e8eb28-9050-48f7-84b1-ccb2a8baf0e0" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_52e8eb28-9050-48f7-84b1-ccb2a8baf0e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fb5caaab-5c54-4802-b74d-aeaa956b65c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fb5caaab-5c54-4802-b74d-aeaa956b65c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_c7ec8494-7f16-48ab-bba7-1b05a4a4a6c8" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_c7ec8494-7f16-48ab-bba7-1b05a4a4a6c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_dd2d16f3-5859-4279-9c51-29b692fbdd15" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_dd2d16f3-5859-4279-9c51-29b692fbdd15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_198c1230-4150-47ee-ab2f-1fc065fc60b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_198c1230-4150-47ee-ab2f-1fc065fc60b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4c1295ab-f930-4710-a6f7-7ece7d185e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4c1295ab-f930-4710-a6f7-7ece7d185e27" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e1427b4b-a15b-4653-9de4-3ddb891eefd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e1427b4b-a15b-4653-9de4-3ddb891eefd0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b5ca7d-662e-4e70-9ebf-53f3f5749731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b5ca7d-662e-4e70-9ebf-53f3f5749731" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dbc75c2c-ccff-408a-bb09-58b38f196c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dbc75c2c-ccff-408a-bb09-58b38f196c1f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_2ce8bb25-2121-4c5e-9b2d-ec01e69de2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_2ce8bb25-2121-4c5e-9b2d-ec01e69de2f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bc6ec0c7-c181-4766-a60f-2be34670c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bc6ec0c7-c181-4766-a60f-2be34670c23a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:to="loc_us-gaap_PlanNameDomain_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:to="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_42dc7ed3-7b3c-4468-bb1e-fde744b174e5" xlink:href="pbh-20220930.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_42dc7ed3-7b3c-4468-bb1e-fde744b174e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_17a756e5-efe4-4f1e-ba83-3e384def8a21" xlink:href="pbh-20220930.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_17a756e5-efe4-4f1e-ba83-3e384def8a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be15ae3c-cb67-4a77-a88a-b237f9995b2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be15ae3c-cb67-4a77-a88a-b237f9995b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_e537c8ea-b26d-48bb-b1d1-b5c94f42e580" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_e537c8ea-b26d-48bb-b1d1-b5c94f42e580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_e63ac426-e38c-4c63-9a01-91c9df0a325b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_us-gaap_PerformanceSharesMember_e63ac426-e38c-4c63-9a01-91c9df0a325b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_bf332247-c191-4015-8582-278fe0c9c73b" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_bf332247-c191-4015-8582-278fe0c9c73b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_43f6d560-146d-49b5-a71c-6990feee5179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_us-gaap_EmployeeStockOptionMember_43f6d560-146d-49b5-a71c-6990feee5179" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_382ca116-42a5-40d5-a1f1-1a8d0002055e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_382ca116-42a5-40d5-a1f1-1a8d0002055e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_233c131a-f060-409c-85ac-905cafde695c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:to="loc_srt_DirectorMember_233c131a-f060-409c-85ac-905cafde695c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended" id="i97653b6afb924aa1bf0f1c7573b10225_ShareBasedCompensationRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2a373ec-b025-481a-b6b7-e2aa3579e496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2a373ec-b025-481a-b6b7-e2aa3579e496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1603ab53-988a-4b29-88a7-57323d6ec741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1603ab53-988a-4b29-88a7-57323d6ec741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_26744f1d-c9c0-4d92-b3c7-b2ebef036b13" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_26744f1d-c9c0-4d92-b3c7-b2ebef036b13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_6eed3de3-3f5d-4ee0-bb6c-e20f3df0098c" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_6eed3de3-3f5d-4ee0-bb6c-e20f3df0098c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e21c89ee-6be5-4d91-9ae3-e33c2b287724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e21c89ee-6be5-4d91-9ae3-e33c2b287724" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_18cba313-b065-4b78-9893-cf0af89f44d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_5a866309-0a43-43ed-956f-d39ca21858ef" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_5a866309-0a43-43ed-956f-d39ca21858ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_93c80140-42c1-4c36-a8ff-39c3848295d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_93c80140-42c1-4c36-a8ff-39c3848295d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db0ac3a7-659f-49a1-aae7-4188c39e9a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db0ac3a7-659f-49a1-aae7-4188c39e9a11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_f4f437a0-22da-4689-b7e9-d06e587048ac" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_f4f437a0-22da-4689-b7e9-d06e587048ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_be1aa49e-7f5c-4263-b6ac-6c3a431c72d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_be1aa49e-7f5c-4263-b6ac-6c3a431c72d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8ab3352c-2718-4eda-bd8a-0109540e2d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_bd041e30-593d-4061-9b1a-9d09bfbaa602" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_bd041e30-593d-4061-9b1a-9d09bfbaa602" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:to="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f6d84a15-e613-49a0-aa30-5a504b2c765f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f6d84a15-e613-49a0-aa30-5a504b2c765f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_10eee0dd-ce26-484e-b040-0e6dc28a4942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_10eee0dd-ce26-484e-b040-0e6dc28a4942" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended" id="i57b390260efe433bb1d5108ef25f1866_ShareBasedCompensationStockOptionValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6ff5f1be-78c0-4a3f-bf92-cd28c8d46ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6ff5f1be-78c0-4a3f-bf92-cd28c8d46ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_f8936a4f-e8f4-4a5d-a1ae-c0aeb20c125d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_f8936a4f-e8f4-4a5d-a1ae-c0aeb20c125d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0616baed-c621-4cb0-8431-f2db65dfbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0616baed-c621-4cb0-8431-f2db65dfbe7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4505a153-3278-4842-af5c-c160ee78cbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4505a153-3278-4842-af5c-c160ee78cbed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52923a37-78d9-47a0-b69a-a0ac596d247d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52923a37-78d9-47a0-b69a-a0ac596d247d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:to="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f61de086-a7bf-4b8f-9716-9b5ceef01b34_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:to="loc_srt_RangeMember_f61de086-a7bf-4b8f-9716-9b5ceef01b34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:to="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_153c36f9-0357-4b66-aabb-d2b191a9dda7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:to="loc_srt_MinimumMember_153c36f9-0357-4b66-aabb-d2b191a9dda7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b1730af3-e95d-4828-bc24-fa78d6d37715" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:to="loc_srt_MaximumMember_b1730af3-e95d-4828-bc24-fa78d6d37715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:to="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44c8b56c-9ddb-4379-910f-19ce8c69da64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44c8b56c-9ddb-4379-910f-19ce8c69da64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5c96abdf-6f54-498e-8929-c6f6b472700d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5c96abdf-6f54-498e-8929-c6f6b472700d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended" id="i6359868fb7df4845ae9270d8f1d0005e_EmployeeRetirementPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_28cac052-04a2-487b-8cca-69470e08dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_28cac052-04a2-487b-8cca-69470e08dc55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_c025450e-4c86-42f9-a1fe-728ceedfb171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_c025450e-4c86-42f9-a1fe-728ceedfb171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_eb688baf-b34b-4675-a4f9-b026b0a295f2" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_eb688baf-b34b-4675-a4f9-b026b0a295f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_3d4ba158-62cf-4337-a148-628a8326aef4" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_3d4ba158-62cf-4337-a148-628a8326aef4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_93ae0903-2339-4ae3-8983-3d2d5ed60876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_93ae0903-2339-4ae3-8983-3d2d5ed60876" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_72d2343c-1a50-47a4-b909-d760a301ea29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_72d2343c-1a50-47a4-b909-d760a301ea29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_55a60965-6221-4887-bdaf-a1876c8f76c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:to="loc_us-gaap_NonqualifiedPlanMember_55a60965-6221-4887-bdaf-a1876c8f76c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_9cae47e0-e430-4c42-a1fd-b5bfbbc5832e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:to="loc_us-gaap_QualifiedPlanMember_9cae47e0-e430-4c42-a1fd-b5bfbbc5832e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ConcentrationsofRiskDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended" id="i0430763aefdc4d738987a3a561797391_ConcentrationsofRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f7f0631-61e6-4d82-b41b-e2606c4c2d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f7f0631-61e6-4d82-b41b-e2606c4c2d55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_06d610d0-39f5-47e2-9e0d-b363575b516a" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_06d610d0-39f5-47e2-9e0d-b363575b516a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_5d7ab340-6685-43c9-a333-17ea7d2b0f6a" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_5d7ab340-6685-43c9-a333-17ea7d2b0f6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8cc033b9-9f4b-4a6f-a74b-07edf7f81484_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:to="loc_srt_ProductsAndServicesDomain_8cc033b9-9f4b-4a6f-a74b-07edf7f81484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:to="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember_c795a8e0-50c8-468a-b591-2cf121110638" xlink:href="pbh-20220930.xsd#pbh_TopFiveBrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:to="loc_pbh_TopFiveBrandsMember_c795a8e0-50c8-468a-b591-2cf121110638" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember_71c1415d-89a1-43e8-8078-fb07abb197e1" xlink:href="pbh-20220930.xsd#pbh_ManufacturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:to="loc_pbh_ManufacturesMember_71c1415d-89a1-43e8-8078-fb07abb197e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f34978e2-04df-4ab3-91bd-ba231bbbfbab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f34978e2-04df-4ab3-91bd-ba231bbbfbab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_a2cf4391-821b-4468-abc1-5d907ddccdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:to="loc_us-gaap_SalesMember_a2cf4391-821b-4468-abc1-5d907ddccdfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_622d6517-3fc1-4ceb-8b12-26c8486143c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_622d6517-3fc1-4ceb-8b12-26c8486143c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_e386b69b-4790-441a-8af1-2246bc6a1eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_e386b69b-4790-441a-8af1-2246bc6a1eb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_af23a945-a54a-4f86-a6d2-cbdc154d3382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_af23a945-a54a-4f86-a6d2-cbdc154d3382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_07e8b08d-dfd3-4b68-b9a1-29a729a885cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_07e8b08d-dfd3-4b68-b9a1-29a729a885cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f481d793-7d8b-49d4-a40d-39080e021999_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:to="loc_srt_NameOfMajorCustomerDomain_f481d793-7d8b-49d4-a40d-39080e021999_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:to="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_0da73e18-b33d-417f-851b-f3712244c8d7" xlink:href="pbh-20220930.xsd#pbh_WalmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:to="loc_pbh_WalmartMember_0da73e18-b33d-417f-851b-f3712244c8d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalgreensMember_bd02c6ce-be50-4e42-99f1-ade1048a4ed4" xlink:href="pbh-20220930.xsd#pbh_WalgreensMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:to="loc_pbh_WalgreensMember_bd02c6ce-be50-4e42-99f1-ade1048a4ed4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended" id="i93f7692fcef44665a167ba006708503b_BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fb63572-253a-45a8-80e0-f0f6ad798e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fb63572-253a-45a8-80e0-f0f6ad798e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ff338d28-6063-41fc-be93-9ad2a812f0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_CostOfRevenue_ff338d28-6063-41fc-be93-9ad2a812f0c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bd3cfa6e-7666-4596-818b-26dfccab8eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_GrossProfit_bd3cfa6e-7666-4596-818b-26dfccab8eae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_489b755e-6fdf-493b-8778-4e8359095806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_489b755e-6fdf-493b-8778-4e8359095806" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_f89309fc-68f6-4b7c-9e88-50da628c102d" xlink:href="pbh-20220930.xsd#pbh_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_pbh_ContributionMargin_f89309fc-68f6-4b7c-9e88-50da628c102d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_734cbe10-1419-44bd-a597-5ad9c6adb390" xlink:href="pbh-20220930.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_734cbe10-1419-44bd-a597-5ad9c6adb390" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0519740-3654-4992-8836-86df7ddf54b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_OperatingIncomeLoss_c0519740-3654-4992-8836-86df7ddf54b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:to="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99117f36-132f-40c4-8588-4135ccfed778_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:to="loc_srt_ConsolidationItemsDomain_99117f36-132f-40c4-8588-4135ccfed778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:to="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_20f90f19-7bf5-4f21-9a93-63ce08f72485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:to="loc_us-gaap_OperatingSegmentsMember_20f90f19-7bf5-4f21-9a93-63ce08f72485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0f5a8487-5596-4b0b-b5e4-9292bcfa7936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0f5a8487-5596-4b0b-b5e4-9292bcfa7936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bda378c7-9012-4946-8847-09db1b131ccb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:to="loc_us-gaap_SegmentDomain_bda378c7-9012-4946-8847-09db1b131ccb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:to="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_7b58812d-62e2-4553-9cb9-8c917728236b" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_7b58812d-62e2-4553-9cb9-8c917728236b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_2a107da5-2f13-4d8d-b959-272842b3bf98" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:to="loc_pbh_InternationalOTCHealthcareMember_2a107da5-2f13-4d8d-b959-272842b3bf98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="extended" id="i4059a6660b0f49b9b2aaf017a7a5d17e_BusinessSegmentsRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58716732-992b-4547-a405-aa4ea65bc6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58716732-992b-4547-a405-aa4ea65bc6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7e24c53e-6412-43d3-bc91-3634acf1d17a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:to="loc_us-gaap_SegmentDomain_7e24c53e-6412-43d3-bc91-3634acf1d17a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:to="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_23a2baa5-610e-4372-97f1-39898148f4ea" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_23a2baa5-610e-4372-97f1-39898148f4ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_1215c721-906e-4c86-9207-3b3647eb862f" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:to="loc_pbh_InternationalOTCHealthcareMember_1215c721-906e-4c86-9207-3b3647eb862f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:to="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f88083e2-04d3-4e4a-bf01-ab9f224d166e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:to="loc_srt_ProductsAndServicesDomain_f88083e2-04d3-4e4a-bf01-ab9f224d166e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:to="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_6aea3a45-4a39-49f6-8350-9ddfd7a79aba" xlink:href="pbh-20220930.xsd#pbh_AnalgesicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_AnalgesicsMember_6aea3a45-4a39-49f6-8350-9ddfd7a79aba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f4cdf94b-f663-4160-89df-5e67879d6997" xlink:href="pbh-20220930.xsd#pbh_CoughAndColdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_CoughAndColdMember_f4cdf94b-f663-4160-89df-5e67879d6997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_e19d794c-bc0c-4100-8855-05a94d576267" xlink:href="pbh-20220930.xsd#pbh_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_WomensHealthMember_e19d794c-bc0c-4100-8855-05a94d576267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_818e62b1-09d3-4e41-a3e0-b241520e1813" xlink:href="pbh-20220930.xsd#pbh_GastrointestinalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_GastrointestinalMember_818e62b1-09d3-4e41-a3e0-b241520e1813" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_152a29be-785f-48ae-8005-f40c22c287d8" xlink:href="pbh-20220930.xsd#pbh_EyeAndEarCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_EyeAndEarCareMember_152a29be-785f-48ae-8005-f40c22c287d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_888382f7-7861-4406-aa31-9f0507ab5f26" xlink:href="pbh-20220930.xsd#pbh_DermatologicalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_DermatologicalsMember_888382f7-7861-4406-aa31-9f0507ab5f26" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_092bffae-c22e-4401-b82a-81ab033a67d7" xlink:href="pbh-20220930.xsd#pbh_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_OralCareMember_092bffae-c22e-4401-b82a-81ab033a67d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_612921bf-9b15-4fdc-8c32-ead8efe600fe" xlink:href="pbh-20220930.xsd#pbh_OtherOtcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_OtherOtcMember_612921bf-9b15-4fdc-8c32-ead8efe600fe" xlink:type="arc" order="7"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>pbh-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_02b5f500-4d48-4ec4-b88b-adc0ca65f699_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b2c509f5-22eb-42dd-aa1e-1b1a66470e3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9aa0283-ac14-4016-81e0-1f784673a80b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_93d8f9ba-fb9b-4621-9c2c-f78745732059_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt (including current portion)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_df0905a3-0f1e-4297-88ac-2eec1f1598d2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_f06b2658-a7f9-471a-8f81-894c513b9f47_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt (including current portion)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3da75f8b-e533-4325-9b84-48ee6803a860_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_3067e744-e8ab-46ba-8cc9-9e8ddcfc0ae4_terseLabel_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:label id="lab_pbh_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour" xlink:href="pbh-20220930.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongTermDebtMaturityAfterYearFour" xlink:to="lab_pbh_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_7d5bd0a9-9900-4ac2-a62a-935124a1da77_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_00ef9114-e2ef-4617-b8cd-693b1fd2c33c_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:to="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_20abe2d4-0793-41ac-976d-b32213a6328b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AnalgesicsMember_b7721cdb-5be5-43fc-bd6b-fe65a58b5f04_terseLabel_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_label_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_documentation_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember" xlink:href="pbh-20220930.xsd#pbh_AnalgesicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AnalgesicsMember" xlink:to="lab_pbh_AnalgesicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_db3a3fc9-d9b8-4d91-9734-44f012ba7baa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_82025eda-4f61-4ee7-ad9b-701746a0ec06_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_ef7f197e-a6dd-42e8-89de-8f20850dbad7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_69e00d96-fdfd-4510-a390-e7c12efc240f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4abc9e88-a54e-4bab-a754-0fdb2fa0f40c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4ae662b8-a380-43f9-8211-07df0e8b0620_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_67d0ee90-3a2c-4df1-b75e-f474526ffeda_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued And Other Liabilities [Table Text Block]</link:label>
    <link:label id="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:to="lab_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_44b10e15-2509-4505-8a7b-60467bf8506e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d2564f14-cd0a-4bad-bc86-a3de8cbfd95a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Disclosure Item Amounts [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_fc980031-5420-4a19-b3b4-fcda2e8bc5c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_20936a66-ad74-4f09-b837-e6635e77ab75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bb94666a-cb45-446e-b42a-ba860c1348b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0669e4e8-8299-4340-87a9-1cc7e9472e61_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ea2d9fea-12c6-4eb1-86ca-f080442d5e4e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a297d210-6f21-4eb4-be98-471179049ded_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3be63888-aa58-4827-9fe5-eca79023704f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f39b6ac2-7b1b-4b2c-b1e2-4a2d443ffa00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_6ced95e8-474a-4e66-9251-579d5e174675_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e0104675-522b-40bd-bc32-2ef40be881ae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_84093c63-792a-4a23-bf96-595a95c26911_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e2635959-fca1-4184-880b-d7267d1f5581_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_79279317-aaf1-4925-b9a6-84432eb6d1db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Swaps, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a868eb5-f1bf-444f-a772-f1402c3aed33_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7e020922-3317-4fdb-b836-e09cb315a654_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit expense (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f8621c9a-a1b6-4329-a7a9-47e0ce587245_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_f5d5e4d7-3ee2-40cf-98a7-a962d9ca3f38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_def123b6-5cd2-48a9-8de6-204182026c31_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_def4a2d4-0952-4308-9061-6e16b5f10d00_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amount repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7127b224-304a-4db4-84fc-f2d43deafd14_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_51b74d9e-b766-46de-a3d1-2dcd0deb83ce_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_146fac61-175e-453d-a7e0-9eb2a116b2d2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_62f60571-6a2b-472c-b151-d4b95241e831_terseLabel_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply commitment, term of agreement</link:label>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_label_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment, Term of Agreement</link:label>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_documentation_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment, Term of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement" xlink:href="pbh-20220930.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SupplyCommitmentTermOfAgreement" xlink:to="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_6496427b-35b9-4a3e-8295-4885dbd1f34c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss):</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_07fededc-bbe8-49f8-9e5e-91d2b5e09803_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9f2d0199-d883-460e-88f4-42e14191048a_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_3121ec8c-ec54-4157-905e-06b0da2aa1be_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_222c0905-930c-466e-a55d-bab08f9f5f7a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (Remaining six months ending March 31, 2023)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OralCareMember_c96cbbed-1ccc-4580-8cfe-7024736243ac_terseLabel_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_pbh_OralCareMember_label_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_pbh_OralCareMember_documentation_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember" xlink:href="pbh-20220930.xsd#pbh_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OralCareMember" xlink:to="lab_pbh_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_63ec6514-bad2-4aa9-826e-d831462f1bfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_67bd6556-e621-48b0-8cb8-7173a48c2dc0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WalmartMember_af77e25e-6306-4df1-b560-07ab408c0688_terseLabel_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart</link:label>
    <link:label id="lab_pbh_WalmartMember_label_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:label id="lab_pbh_WalmartMember_documentation_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember" xlink:href="pbh-20220930.xsd#pbh_WalmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WalmartMember" xlink:to="lab_pbh_WalmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_88994cf6-8486-4784-8f02-e9d8822c6e51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_45cf3ce2-d427-4133-8847-74c53d30a7a3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_752d7ef4-01ff-455c-8dcd-b72f880bcc21_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_fcd2f541-4162-4667-8f66-b0c1f4b17ad6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_193955f5-b6f6-4ecf-a93f-3f206be8d519_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_483a4304-ec4d-4298-9022-3b26c6a782f6_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:to="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_dea4fe03-86e4-47d0-8eac-91f3365145fc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_b98cb207-36f8-4924-aa40-6bad3f5ba437_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_label_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsGrossAbstract_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract" xlink:to="lab_pbh_IntangibleAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2a6c880e-8f75-4202-9cbe-97183b282e04_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a8588f55-4b7d-428e-b95d-fb5e737eda47_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_be35534b-f94f-4bef-9cdd-dc4f6b69f5af_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e30bd06e-0039-4e85-96e7-41eaa097e5d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_07ba21e3-40f8-47cb-b2f7-888caa98952d_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_db68de2e-c1ce-41c8-851e-9229bec93aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_7ebeed29-ad21-43a2-ab09-5cb4e66c69cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_65fb019b-c60a-4b7e-97fc-8065e39555a0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ec6fc910-131f-45b6-a134-26c6f6299f28_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (Remaining six months ending March 31, 2023)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_dbd17847-a179-401f-98d3-c8df142f47b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8159cefb-ff22-4046-abc8-886551223df6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_40fe0511-27d8-488f-819c-f415ff12c065_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ac5b8de7-cd13-4967-aa20-5b8c3f2aba08_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_3a593704-9d96-4a3d-9312-4af9b5f1fe0f_terseLabel_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_label_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_documentation_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:href="pbh-20220930.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:to="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4ca42c61-5c81-4362-840a-dca32efac0a8_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd8162ff-ea2b-4d00-8421-336ae841c3c6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashExpense_5bd340ed-18c0-4638-b7b7-34d416f51e81_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashExpense" xlink:to="lab_us-gaap_OtherNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_014314fa-3eb3-411e-9a05-809c35e2775a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_4871d60a-5ee7-403e-8294-793eb155ff74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_257d2c02-a37e-41b4-85aa-b6b04516cbba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_0937572d-de4e-45e9-b08b-c15f95cc0df5_terseLabel_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease cost</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:href="pbh-20220930.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:to="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_56c8812e-550f-4007-a197-57ca4f26c451_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_c5ccfc2e-13c1-4b06-9c04-bf82a01032a9_totalLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals, effects of foreign currency exchange rate</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_93c192f7-981b-4b00-b7cd-66e4ec1f9211_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_4373bd92-5eef-405c-84d3-4e1cc352c4ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employer contributions, remainder of fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5b79911b-d9d4-4c09-b906-2afb3b0e2e69_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GastrointestinalMember_741478dd-12df-46a0-8e56-125f88a5a443_terseLabel_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_label_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_documentation_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember" xlink:href="pbh-20220930.xsd#pbh_GastrointestinalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GastrointestinalMember" xlink:to="lab_pbh_GastrointestinalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9690ec74-714e-48e4-a9b7-f475c3ccd40d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_157b5b78-138b-48f2-9f15-076b522aa989_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WomensHealthMember_a18b1c3b-00c9-4e4c-acc2-263a66c7bd5a_terseLabel_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_pbh_WomensHealthMember_label_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_pbh_WomensHealthMember_documentation_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember" xlink:href="pbh-20220930.xsd#pbh_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WomensHealthMember" xlink:to="lab_pbh_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_ba109292-79df-45b3-ac35-1637f44aa6a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted, exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_40ff5ce9-c5e6-4a60-ab75-de785c2bf754_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_11f32233-3223-41bf-98fc-29c3f3038440_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Reclassified from Accumulated Other Comprehensive Loss into Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8d43993-853b-4903-b47c-c021228e580f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c93e5bb3-bb58-4266-b97a-de9d5708c0cd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e88492c8-8bb5-4c75-8581-5ed05b1d30d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_fe5e55c2-5197-4620-9173-0ce16d7673c8_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_71584984-92f4-4d44-b2cd-f96406c37579_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_c3633946-8643-4cfc-a2ca-fc20782e02cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_65a70df6-a515-4060-9fc3-6ccb126b4560_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b95c2d16-f9d8-4d27-a6e6-5570310e9f23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_5fae9aa4-3062-4995-9899-15fbd6908bee_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_d2b6e576-9db6-43fb-8381-943135cc581f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7925beee-7a5e-4fce-88a9-bb1324cc5243_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_5847eda0-135c-4a93-8349-37f5f4318052_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0cf9b5d0-cd1a-4eb5-9619-7e2b96249147_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_a53e64e8-2a94-4491-a3d6-bfdee8b8a09d_terseLabel_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_label_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020 [Member]</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_documentation_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member" xlink:href="pbh-20220930.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongTermIncentivePlan2020Member" xlink:to="lab_pbh_LongTermIncentivePlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215e7363-f606-421c-bde9-6302244a5651_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_84e2c329-af07-4272-8b25-dd2d83c194a3_negatedTerseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a7dbb4ea-d06c-49e3-aa4a-583b2c8f6807_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ba3168e9-9b06-48ee-ba1f-88e91be60b2a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_eef9cee8-a6dc-4d64-bdfa-d7a904be1e21_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_30c3a840-3b37-48af-a9b8-eae62c480370_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_02ff32dd-b2f6-4c8a-8e0e-7952c4ae3683_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e2300382-199e-4f57-ba25-04ccd497e787_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d8ffbb8f-ca5f-4368-911d-e6bf84a8aa94_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4ab1ee0e-7feb-40a5-8db5-5ee4c819f23d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_1bede6c1-a81e-4fce-9307-63be4a815a72_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_e3b15193-5903-4946-879c-046b94e99f37_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4328dc03-d4fe-48d8-bdf2-35311b0b775c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8cce0aa3-39c1-4902-a2a9-c78101c7763e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_64dde6d5-540e-48d0-bcbd-075684c054eb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3a558fc7-2274-43bc-b470-ae2d54ca756e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Recognized in Other Comprehensive Loss (effective portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_bb7b5368-57e1-4814-bbf9-fb98b1e9d638_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5a10efe6-274c-4852-bd9c-84d09acef954_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_447cf5a9-1c7d-40a3-bb6e-7c8748c77996_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_b21b623d-aff5-4cc0-9f42-6065117591b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Primary Components of Net Periodic Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_759de34a-5960-45f4-8b3b-c634e2893a95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_34563b65-f05c-4788-a036-5dd133240d88_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_957fdae2-a505-4f5d-a03a-10b999ee5f37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_522ba2ba-22bf-4dc6-bec1-f6d69b7581af_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_6fb0fe55-5356-4f9f-a217-8098c3bfb705_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_c4a190c3-752e-4c81-9bee-f586c446811d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_1acd0903-e4ad-414b-8b98-3b7e33f21241_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_241d7e2b-ab9e-459a-b579-5f7ec4e82405_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_1f15e35d-a07b-4226-9df8-a3ba3e5f1bca_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_cedf48e4-66ed-4063-8f0b-4e243c025f98_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4a340770-a180-4953-acb2-844c5980b10c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc5b331f-b085-4976-9a84-fc34dde7b4d1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_f243baf7-641b-45c7-8781-205eef8e67b9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, senior notes and term loans</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_28f26977-d5c1-437b-8b6a-8c40868cfd00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_5324ec09-6a69-4d0f-b398-2cb8537589ed_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_36fe80bf-83cc-4a12-bf45-9aefb90d5973_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive loss into earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3c2befd8-0595-4e44-a179-07ca46b03b64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_1776e5d2-6076-4352-8434-9233811c7d7a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8c8d9201-55b3-4693-83e9-068f95f0bd02_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6fac7a92-bc70-4d91-b8a1-ea198e3caa13_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ca994304-3aff-473c-aecb-458e4a4ee943_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_486a1616-0fe9-40a9-b081-2cd6e17e687c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fbac9fdc-1fe3-4deb-80fc-20b71616be52_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt origination costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_bb979786-0232-4a33-ae5d-252cf77166eb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_8d74cac1-6eb9-4752-875c-9d843797c8a3_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_230afb56-9b9b-4373-abbe-1b6aa2b35a30_terseLabel_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC</link:label>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_label_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC [Member]</link:label>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_documentation_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AkornOperatingCompanyLLCMember" xlink:to="lab_pbh_AkornOperatingCompanyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_20420155-deba-4c1f-84b6-9e75aa7db8ae_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_dadd51ee-c3a7-4b37-aa10-b609875e2334_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_8d391aaf-f602-4ba1-ba78-45e92aa2d331_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_f16fd281-3687-44f1-9866-7ad31571877a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued broker commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_42239c4e-b3d3-4104-a92e-dc08e71c94e9_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_35280214-54be-4d9a-af88-4e4c9065f7d8_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, ending</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b671d744-f9ef-4a87-b608-9311093d3749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_86bb8347-84fc-4061-95f7-1b4ef8dc27e9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to nonvested awards, weighted average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_24ded674-e602-4d8b-bc3a-98da73b3e55d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f83e6bef-c8aa-41b4-815d-b95003956740_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b82de796-d57a-45e0-898b-880d07c8a2b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Finite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_2c25e3ca-9ae5-493b-bb95-fe5f26058224_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of Akorn</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_81245612-d005-49d5-ad8a-6b46e4550daa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a018a133-1a9c-45e5-877e-56616f3ff3ba_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_af50109e-e986-413f-a9db-dba45b3e3261_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_6e850f95-32ba-4b63-8a55-a71deb879594_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ZaditenMember_db500cec-7822-4328-b080-46cc48124c45_terseLabel_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen</link:label>
    <link:label id="lab_pbh_ZaditenMember_label_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen [Member]</link:label>
    <link:label id="lab_pbh_ZaditenMember_documentation_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember" xlink:href="pbh-20220930.xsd#pbh_ZaditenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ZaditenMember" xlink:to="lab_pbh_ZaditenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_efad4adc-2a5e-497c-a657-4e72b6687d42_terseLabel_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-qualified Plan</link:label>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonqualifiedPlanMember" xlink:to="lab_us-gaap_NonqualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_4fd67bac-cd9c-4f24-a91b-9e6328bbfa53_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental performance shares</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Incremental Performance Shares</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Incremental Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_f1f1b2ca-d2d6-4f99-a6d9-455549cd9569_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b4def279-9d28-4168-bda1-e691bab5b420_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f19d508a-8466-48a5-b6e3-e3abb8827f05_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a0b3e53e-d7aa-4a20-800e-78e441b6d0b8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_83cff2e1-e936-4a43-893b-6596363241b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_f15eb18b-fe3a-4e24-b1ea-d2b112e5a30c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bebd3019-06cc-407c-8c7c-2e537e29c9d2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a1cea68b-3778-42cf-ba2e-05410fa00a81_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_9029be5d-78b1-4d1a-ae76-ccdef859ba21_terseLabel_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_InternationalOTCHealthcareMember" xlink:to="lab_pbh_InternationalOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_b9d32a62-7fed-46ac-a43b-90b47c11c52d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_08aa0cdb-5f3c-4c80-bbc3-451a5ea99003_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_eb86d4f4-b26e-42cc-adfe-6b7584028f78_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_6e42ff66-2af2-4a0f-9acb-3a5eb356af7b_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_62bd1d3c-0fa5-424c-a6a6-0ca94530868f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e139c633-78f4-4f5d-8ecf-d145d740db4d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f9d3960b-69bb-40cc-a40d-79970a05ee38_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_13d5bb3d-c67e-4fe0-85ee-b7fe916b0279_terseLabel_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_label_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_documentation_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:href="pbh-20220930.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:to="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ce4175c6-96d5-4636-8cc0-f5b44b69ba07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_8b23d361-952e-4156-826f-d127f11dd918_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from refinancing of Term Loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_938bc1ff-3748-4ff6-8204-841b76e949ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_8b18b5d5-31f7-4c83-b650-65f7305e9f13_negatedLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, effects of foreign exchange rates</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_334e4c66-7669-49f6-b0f4-828f82f6626b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_09403b7d-ae17-428b-bce3-5b3b69502171_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_9643f3ac-830b-41d6-ad0a-9436711b4f7e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_48d274e0-5e85-4e8e-80cc-dae552fe397a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b7e2eb6c-1a98-4236-acbd-b9fbca2c7344_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_119cc081-1e95-4e65-9b3f-f9fa42638ffe_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9e1ef6d2-9170-46b3-949e-fda8609052f6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_941d6428-7ace-40b2-b337-03013a48e70d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_2a61cbe6-22e3-4f3c-b085-efb83cd776d0_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_f6213af5-118d-4b5e-88db-e8bda5d55558_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c7f09f7f-a32a-4cdd-88d9-0b2b1b96f64d_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a72d75bd-99e9-42f1-9dcc-dbb9f9c22920_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2a4e29be-6c02-43e4-8c5c-f1874fe53336_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_f0412663-a866-4601-a8cc-45dba0a50eef_negatedTotalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_2110590a-cf1a-43ba-bbf9-c30d0542eb80_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_2a7f2e32-d24a-433f-bf58-64d106d80278_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-5 Loans</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 6 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:href="pbh-20220930.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:to="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_d795bcf8-1c36-43f6-bdd1-4651938798ff_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5e1f942c-fe9f-4d71-98c9-087ec7b2192d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e2c56f30-4465-4621-b158-02d91b4872cf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share grants in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_46f08f0d-d441-4ded-9ee9-4cf569303bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5a3975a9-fafd-40eb-8c4a-d396a8cab30d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_e11fc598-7e45-4277-8f25-40e4a7a14f38_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_99fb9303-de52-4d1e-ade6-c5fd16bd035c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DermatologicalsMember_ff9417b3-16a8-4a42-8115-8aa0fc9a805c_terseLabel_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_label_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_documentation_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember" xlink:href="pbh-20220930.xsd#pbh_DermatologicalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DermatologicalsMember" xlink:to="lab_pbh_DermatologicalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_eba650a2-17df-436d-a27c-56d764591104_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b82e2818-5314-46e7-afbc-cd7865d57911_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ContributionMargin_a75acf62-973b-40d2-b4f5-58cd347317f6_totalLabel_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_label_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_documentation_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin" xlink:href="pbh-20220930.xsd#pbh_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ContributionMargin" xlink:to="lab_pbh_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_1caed6b7-9894-4471-817a-7ac8970d4310_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_3260de1b-6350-4b2c-a222-bf34da24b66b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6e6949a4-cbd7-486b-89ed-98ace3083318_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_17bd77fe-7c88-4a29-b6bf-4b697a6ea044_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_7a4b8b8d-a1d8-4734-9df2-2466be69c14c_terseLabel_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_label_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:label id="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:href="pbh-20220930.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_dd64c497-9693-4013-8359-ad0c59628cea_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_7d8e4795-664d-443a-bb51-27b0d662429b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising and marketing</link:label>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c735ddff-242f-43d1-a84c-72e9e53e0a10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_d7983e2a-102c-4d3c-86d1-363248cebf89_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_de249c1b-f5cb-4f1b-8737-1410bebaebe0_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, additions</link:label>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_label_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Acquired</link:label>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsAcquired" xlink:to="lab_pbh_IntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_888fb4f6-3e5f-4e63-9c41-3bbb1447497f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0850e40a-2e5a-436f-8c2b-d2f03818ae4d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_784cd434-0f6e-4354-a737-df38981fd96c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_bce8de47-ae4e-44a8-b3e3-8bf657b6a252_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_847b707a-6197-46ab-9da1-472b38968a04_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, additions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c6f13a02-3c7b-477d-af43-ad6d7bde1d8c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_61e1968e-5080-453b-8d11-38c4aba73275_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals, gross, beginning balance</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6b56d2b6-748e-442b-931a-4d6593d44485_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Totals, gross, ending balance</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_416f1d92-91e5-4d16-bd79-77140ea63487_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_95501853-bd9e-4321-a811-feecf4265247_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_79cd4bfa-d748-480d-baef-2354da337381_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cea8eaf3-965c-4c92-8939-fe758c0a20ce_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_0af13628-b80a-4da8-a723-0426c492f97e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3c8d8bd8-97a1-4f09-8ffe-8eee7169f11f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_180ce18d-3a91-4ea3-9619-405457299d75_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension of plan term</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_cd97dd5c-04b4-4d73-be71-60d1a8f94992_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_e1913e8c-fd78-43d2-9f8a-7f7b99f999d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_47619e49-288e-46e1-8646-28d4014f3366_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_1af03847-9215-408d-abee-7508f86d965f_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for sales allowances</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_44be708e-1ac2-4d3c-b722-773311ae027d_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unissued shares reserved for 2020 long-term incentive plans</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c908f3f-fd2b-4d2a-972a-e6837413e10d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_29330c09-2968-48ee-93f6-8e2db78c0f87_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e166570a-8ce1-4226-a30d-2f923088c427_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e650b77e-654e-49c1-b5f9-f34a573cc9bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_19344bdf-54d2-4c9b-bcda-1b79d344d110_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_87e8c955-f36f-46ae-a186-85fb4e2bd830_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_e306d97c-d513-4c2e-b707-2a5da0d58b22_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e0b291c5-4140-452b-9ec9-f26385ddbad4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_bdaf78d3-8fa7-4dcc-bc7d-6b12703add02_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_2107dc8e-906b-481b-8d2d-b8b970a4d875_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1c0fd5f5-124a-4626-a5d6-b037a908b7ad_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_c71e07e1-c00f-4e9a-98d4-21e2cfbcddc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_54f0f7ad-b069-469a-9acd-fc5c60ca0627_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, beginning balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c2f25c51-e1d6-41dc-8065-cfa1bfcf3778_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, ending balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9ccc2e8-a927-41e4-896e-c594d2a5e227_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effects from acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_f8dbc007-0581-4aec-a559-83d8b6627afc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1f6ad1dd-257c-4c23-97c9-263ae7d66013_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ad55d1-e455-40cf-b15e-caef58494c65_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_81dfe233-099b-4c76-88f4-e9d9194dd728_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d54dc956-7092-4627-9197-47d60efc6bb5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_0896df0d-e6f2-4905-8838-4c31085d5a3f_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3b416ca1-c4f6-4f76-96f3-8ddf64ad0d28_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5d1b81fd-b945-4f5a-9c7f-b545702e0fb6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_112cf687-58b8-4ab6-ad26-c1b22cff8fe8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8c6c0a6f-c5b4-40a3-a280-f6a99414b680_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d8fd00aa-c318-48ca-8d5d-52f7e3ce483c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9612f176-0462-47ae-bc2f-beb24464a8c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_551a52f3-4a04-4c2e-8953-a063d7aafb56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_2ba490a3-cdd5-4a1d-9b82-a331d6590c9b_negatedTotalLabel_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_label_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Income (Expense)</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_documentation_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense" xlink:href="pbh-20220930.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TotalOtherIncomeExpense" xlink:to="lab_pbh_TotalOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_977ceb6b-13d7-4242-b6e1-e484538d71c2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_37009828-bcee-4e21-aa0d-960883284965_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_326a1392-8f0f-4011-bed8-277afb4606f5_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers with long-term contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:to="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5333d8f9-4669-4bcd-a2d0-173030ef86af_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4aac7033-787e-49bc-8c0c-026aa1f3da01_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_118ccb62-a2ae-45d0-b7ec-2d1e2fbdb03b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_7813f60b-c323-401d-8bdf-ec929b05b952_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_92e48d99-46c6-432b-9f0b-7f70ccebbe26_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss on termination of pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a2b45e5e-a944-4e63-be24-02272c883358_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_f4b1dade-4805-4286-b702-6411e9106bdd_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturers" xlink:to="lab_pbh_NumberOfThirdPartyManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_c2eb450a-eeb9-4a24-a1db-4bd70368b3bb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_efea847e-b693-4297-a4b4-83b832a4f6eb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_4477a896-5882-4b86-b9b7-1d311992263b_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_95f647e4-fabe-423d-a48c-bfee5522f8c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived trademarks, beginning balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4803984a-7515-4a49-8b0a-1d053e32a01e_periodEndLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived trademarks, ending balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4e431279-eaa7-4a13-9ede-7c78737b4880_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_818e5eb8-9a4e-4e20-af27-da4a29911c8f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $20,673 and $19,720, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4e3a646e-0f15-4b68-86a4-d42d6601b56a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_23540743-0d27-4eb0-a394-9642f7557bde_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_2740cd28-e4a5-457c-ac20-04ddfa87acaf_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_a755e5c4-9ff0-4f49-b457-622a37a20b2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_81651b8e-44b5-4206-9d45-329937597111_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7f1d5a76-5677-4f83-b0bc-abce3cacab93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c586565f-0bba-47fc-8a8d-366c8df23624_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51aed231-2ea8-4aeb-8cf6-94e220124960_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_1dc958a0-1980-44b8-8270-eda7129d333b_terseLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due [Abstract]</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9a1b27f1-b236-4d18-bd51-5f55c70fd57a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_bef27cb4-9065-4a07-8cff-f796959446a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_8a88f32a-1013-4cb8-ba21-8171c7933d24_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_770560f3-9990-400b-98c1-93a734129df8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4de77ce2-cde9-4db9-abfa-edb3e0d9c07e_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, beginning balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_bc958345-30f3-4d68-9f0c-911126d68992_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, ending balance</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_0c66edbe-2dd4-481c-9e72-3796c09dce3a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_32295992-c5c5-42fd-a121-f4a47d2ac3ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_72229fde-fee9-47d3-9fb6-ae51a2069910_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c4851ac5-1f5b-46c8-b972-abe359d294c5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0f31bd94-4c3b-4a9f-b2f3-fcad6680a80f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_2e2cd787-eac0-4e5e-ac02-e64c322f47ce_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_86d5a7b1-183d-470a-8bca-150a5bc8a2a0_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (Remaining six months ending March 31, 2023)</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_65ff21d6-fe13-4a70-86f4-df40f9a2ae49_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2021SeniorNotesMember_367ed005-d090-4946-9e9a-95ea938f9e71_terseLabel_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes</link:label>
    <link:label id="lab_pbh_A2021SeniorNotesMember_label_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes [Member]</link:label>
    <link:label id="lab_pbh_A2021SeniorNotesMember_documentation_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember" xlink:href="pbh-20220930.xsd#pbh_A2021SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2021SeniorNotesMember" xlink:to="lab_pbh_A2021SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_aeca2da9-e4c2-4bb9-b864-889494f171e4_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_24669383-276b-4944-a8fa-8e5317113b0e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4329d06d-ed2f-4365-9516-1e6d58b3be3b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_27ee3ab6-ae32-4650-b28e-caccafdd269e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_37e45067-fd63-4f10-bdb1-e72e5657cbac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_501ab620-6410-4be5-a6d2-ba7288b6d7e9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_5b0ad981-8bab-460a-a050-5e0bf4e84f9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f647a17f-e9c5-4144-8660-6146a9923650_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_70621591-4e71-4c0c-972b-dc1ff4d989e0_totalLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fff1acb2-915a-45af-ab3a-361900ff5810_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a6dd483f-15ad-4d51-a724-908afb7a321b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8912f184-4fdf-480c-8f5b-fb2fe3b0bcde_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3558871c-afc7-4bc7-886d-c410e3403daf_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_a40ac99e-9756-423a-b0e8-fabb347918e9_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_99589432-9ce6-4af0-8d97-4d124a331fca_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_0f38635b-581c-4a71-8235-5dcd9754ebfb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived trademarks, effects of foreign currency exchange rate</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_6a1b1a70-1407-4778-89da-eb4ea3d235b5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_953ee434-0707-45d0-a44d-d02d8c52fb04_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5560e6cd-8637-4464-907d-3283393f9ed8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cf7c4552-e1ac-44c9-9b44-da99475b8292_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b96337ff-9cf4-4a96-8cc1-6719eb1e1439_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fcefd1f4-2563-456b-afbd-c824e576e432_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_bb28a9cc-c7fc-49fd-8062-def0216b105d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_030a7e68-d8fe-4456-a255-d52febecb7a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a72a07ef-a578-44db-a27a-f998ea7af8e1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e0651237-ab6e-4dfc-a347-0a74e8e02743_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fe7a874c-8c60-4f46-a261-71a1b375432d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_027115ea-44db-43d6-a8bc-5e8dc2c69d6e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bedd138d-208b-4216-bdda-47cd733db91c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8be69978-4eb5-4c67-a5f0-4df0771b4b6a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f7fa4270-24d8-4cd0-85fb-2948e786fa48_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_640e8539-8a3a-42bb-b4f8-0b71ef296e92_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dd35903d-3b55-4e75-b6c2-d5a52ff9a87d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f0dce40d-bb07-42e8-80bd-4c535c7fce17_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_90138728-2f51-41bb-9cba-bcf72b774700_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per participant, 12 month period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_57de08f2-493c-4b84-947e-db4324562cf8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:to="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_f33a1c37-c8d6-43cd-846d-2c0be23cdfd9_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ade12d89-13c7-400e-92b0-ce5c8118aa3a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 54,690 shares at September 30, 2022 and 54,430 shares at March 31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_be9934a7-7655-43b9-b3a1-19823fe9484b_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0aad1e48-9381-4e43-bc5a-1f431693138d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5941aabc-0814-482c-9d53-fd898653a202_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_8b0842ac-5aee-4577-b1dc-075675ef026d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_edddc8a0-5aa2-4c29-9222-39c4f0c04f78_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_2a624b5f-88f7-4ca6-9b9b-60942f41422a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b01332e6-9b9f-4e51-b4b5-ca132e753a55_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_ab548981-3e9a-4004-9c52-67418955ae1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_abf08518-0e0e-46b9-90ac-082b7d331cc3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_767e7ff1-89b6-4522-a02d-7b105a62fcf5_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ecf8acd-e66a-4e89-858d-2e8df9830f7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b1bbc0b-0d5f-4325-8f12-c0a3b5c2d6cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_64a0ca5d-ced5-486f-991f-0b788c77403e_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options [Member]</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:to="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_45e5ac8f-aaad-4794-8161-343a2537fb75_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ff4ceeda-2df7-4e5c-80b4-7140274a1235_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_383c743e-8ef7-4db9-9e45-37b412158914_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, beginning</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c07c568d-ffce-4f42-a7b3-05686d1fc914_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, ending</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_709a2287-5b57-4b12-9ab1-f8d60c2a1d7d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_3fee874a-9f98-4d85-9c1c-be6415a22a3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_cba49514-705a-490f-82fd-ff865913ea68_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7e104eb8-f7cb-43c0-804b-36689937d457_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_35954790-cbd8-4666-9e9b-6bed75ca48c0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_5e98ad63-7837-41a4-bfb0-1b0f8f7fdc73_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:href="pbh-20220930.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_9312968e-0ea1-4ac7-b589-bb64d9aa3978_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5d5e840c-0c05-4322-abaa-5a2b5b9b4073_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_f7c302be-3291-4d8b-b75e-13ce758beba4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_6272967d-f2a5-4015-a7e8-d8b7144c64cb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_e2d965e5-6c22-41bc-8d3b-a372620f34af_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Trademarks and Customer Relationships</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_label_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_documentation_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:to="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9dee7a0f-e317-4a37-845f-43cebbc1949e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_68684f1e-d8cc-427e-8d35-c2bc10f5abed_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_33370d09-0eef-4cc8-b41b-ce8f678d9af7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_7eb7df71-555b-45b7-adb8-642e807b14c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_50e4016a-4814-43fe-b9fb-68e38b3159a3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9be3ce4d-2bcd-491a-93a2-6030b1bd765e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_dd0765db-aee1-4a50-8387-8c39affede2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ba8d415a-24b3-46f1-a111-769e4d475ded_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e5269fe0-8d69-41f6-a8b6-03286ce8f2ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_440557b4-45d0-401e-a725-8342a14712d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_8517f539-87ec-42d0-bdf0-9b9024ab27da_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eb13ebe8-65fb-451b-ac1f-165b469b38be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Additional Disclosures:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e04b9af0-6a50-4771-b3f4-4a0d022ceaae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3afca78d-ab57-498a-826f-50c770f3539f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_fe1d5641-1374-4f70-9191-90f328ff043c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QualifiedPlanMember_07a95753-bc3b-4fe1-a4eb-11ce1e9530fc_terseLabel_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan</link:label>
    <link:label id="lab_us-gaap_QualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QualifiedPlanMember" xlink:to="lab_us-gaap_QualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_16ceae7e-d7c3-4dd5-b287-45b73edbf4d8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_c0ff3160-4026-48f7-8fe1-a7b02f733d46_terseLabel_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for settlement, lump sum</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_label_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Settlement, Lump Sum</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_documentation_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Settlement, Lump Sum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:to="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_86b8e54b-7a12-4a39-a067-cfcc21c8df7f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7a8b7a39-3667-4260-a1c9-a7b91073a4e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d954208b-6193-4ac3-88ba-9ea01c7c724e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1cac3457-3afa-459c-8269-636d6c7b6544_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_269d246b-1857-40a8-88c9-89a0699ccdb5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_ed725f4a-2818-46d4-986a-2493d4ad4ac5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_9d90dbfe-547e-42c3-93e9-e996291eff00_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing costs</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_8eceffcb-1a25-488c-8820-fa07c4f5c407_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of new shares for future issuance under 2020 long-term incentive plans</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_20c40cc1-0682-4965-8eb1-89fe304afe2a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c9886d68-7a27-4f56-b0c0-213de9a7c101_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_166785f0-1847-4346-923d-15f7782aff80_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_14efdec1-e415-4d67-a97b-fa97ab706940_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8e672802-c226-466f-9b68-5ad610f40e7d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_96c7c7d6-64ad-4ce4-b0a3-76e6c028cecf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d807c787-a0bb-486d-ac06-0c43e931a5d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3b6b65be-7555-42b3-87e4-5a08f4ca2f3a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_fe20b0ca-2595-4960-b2a1-92f95b00db15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 5,164 shares at September 30, 2022 and 4,151 shares at March 31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0d4bcc39-e29f-4c22-a737-b2a628c8b4ee_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b0424414-da3f-47db-b88e-e2ab826a8938_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_c7a0c4df-41d5-4f47-bcfe-ba0f1e388fd5_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_aae306a2-0388-47d5-9de4-a24e2259794c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts receivable, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9fa5bcff-cfb0-4d7c-8702-fbd4018e5fb6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_17e5e9a4-3406-4b60-8331-d02c33f42bda_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_0cadbda0-2d9b-4ff9-af24-e238e4dd0b3a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_d63bcaad-5c6e-4bc4-9c74-b0367eaf620d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c93cc74b-5f74-4af6-a86a-6bbd1cb64be8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_fc7e1bc1-958e-403d-8860-6e5d6afc2ee0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest payable</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:to="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OtherOtcMember_d8dc9c6f-de6e-4a22-baf0-b448bd14c0b8_terseLabel_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC</link:label>
    <link:label id="lab_pbh_OtherOtcMember_label_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:label id="lab_pbh_OtherOtcMember_documentation_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember" xlink:href="pbh-20220930.xsd#pbh_OtherOtcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OtherOtcMember" xlink:to="lab_pbh_OtherOtcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d1d92b7b-5a65-4d84-b4de-be1aae4405aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_46f6959e-46d4-400d-b4cf-a435654d3354_terseLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_b043e507-382c-4675-b878-ba52a36b0e80_totalLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:href="pbh-20220930.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:to="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_63966c39-33e4-4c75-9938-39ce3a43f4dc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CoughAndColdMember_cd6011e5-c168-4739-a6c5-bffca764684b_terseLabel_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough &amp; Cold</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_label_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_documentation_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember" xlink:href="pbh-20220930.xsd#pbh_CoughAndColdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CoughAndColdMember" xlink:to="lab_pbh_CoughAndColdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e246aa8d-46d7-480b-ab09-16756644b8ba_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_79f0a5a5-5086-447e-b902-db47c03620b2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8cc929ea-299c-43f9-838d-92b147af9770_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cdea5bbd-1f06-49af-94a9-a2c16bfa699b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Similar Product Groups</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a17df66a-e21a-4611-a557-20bc6480b648_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_806d8e15-aa6f-4ad4-b30a-45475badaad8_terseLabel_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales excluding depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_label_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Exclusive Of Depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_documentation_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:href="pbh-20220930.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:to="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a06cc501-51bf-44a2-81c9-a9e0ab480288_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_236f0059-2fb9-4a25-84a1-adaaa7574795_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_8a8592f3-8520-407f-b27c-f602e5588b72_terseLabel_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting rights, number of votes per common share owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_label_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_documentation_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:href="pbh-20220930.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:to="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_43834f72-b241-44ec-9e2b-3b02be53ccd7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_936da1d2-10d1-4d8f-bcaa-74e6186ea147_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4740ad4d-866c-41ce-85bf-2ed525cdb87c_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_83314e5b-4910-4a6e-a721-05f4287d160f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_479e395e-391f-4ede-8304-01ccfe9e4d4e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_50e6bde2-0661-44c7-bd6c-2f8273273935_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ff5234f5-6e65-41ba-8359-4328c08bd881_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_b7d1ca54-e568-40f2-ade1-54ec16dac1cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_c2e3a1cd-d1f4-4f32-a982-648a437c8b85_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_aaca7c03-5879-4ca3-abaa-80bac857d631_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_47e60ebe-00f7-4518-a9a3-8285157870f9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5911702d-1f03-430f-960a-edbb80bec55f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b18fb511-cbee-4cad-8cb7-e0b7539d7fc9_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_96e64167-b1f1-41dd-9bf9-f6e34c02992c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_77ff2d21-6910-4736-bf87-6dc5360608f7_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, variable rate, minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_label_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:href="pbh-20220930.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:to="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fd340008-c179-44db-b112-7b5bd5b58a65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_43d16bd4-eebb-4ffd-b3b8-a0436b807f04_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit recognized on compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4fca19d5-878b-4c43-a10b-c9402e71b658_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_48a5cf1d-da95-4842-85ea-6bb811beb05a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_92860033-ec3d-439f-995c-b1bd4fae5526_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_1e457b28-e1e2-47fc-9a19-e3a4a7c30d19_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_2ece3ec2-9572-4c73-9ecb-01893690bdcd_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_97c15af9-b473-4efb-8d03-433474179fd8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_28ceeba8-bddb-45c4-a07c-4fd10ebaecab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_7b473b27-fcb8-4f9a-b106-8a2e05243904_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_472a89cf-2786-4154-8949-50bfbe71ac1d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_b3a15471-aa77-4d9a-9918-5cef2af6073e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1b65ac08-eb82-42ac-980b-bffee3176d0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_b7567432-c71f-40b6-aa48-8babeffe31c3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d5bff6b6-3e68-46fe-ac9a-31c7f5b563bc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_b9c26168-7469-452a-b1fa-04c27de4ade3_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_a69a4cfc-7082-4cae-8d27-1505a2a12c7b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_54a3427b-b226-4cb5-8eb4-7c3fa4b2a4f8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_820ccf87-c7b0-4ceb-ad36-6d7984af1032_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c6dc9add-b3a8-4eab-bf9e-9607516c6019_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d22680da-0d9d-485d-8149-b5d82d1aa3c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e168dc9d-5883-4cb4-9ebf-49afcc77e4f0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c875d9a0-161f-4e29-af66-9528e7d50953_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0d6bce41-33c4-4265-b3cd-624a56c1a3d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (remaining six months ending March 31, 2023)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_0e9b9a47-d120-4e0e-94a5-9e2d39fdfd70_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TopFiveBrandsMember_e0a83639-10aa-44df-a12b-0fd5b1adb55d_terseLabel_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top 5 brands</link:label>
    <link:label id="lab_pbh_TopFiveBrandsMember_label_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Five Brands [Member]</link:label>
    <link:label id="lab_pbh_TopFiveBrandsMember_documentation_en-US" xlink:label="lab_pbh_TopFiveBrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Five Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember" xlink:href="pbh-20220930.xsd#pbh_TopFiveBrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TopFiveBrandsMember" xlink:to="lab_pbh_TopFiveBrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fcd2a15e-d938-43a6-ad21-d89ff4bcceeb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5057b662-d6f2-4f90-bd57-c3bc6334a38e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0aa226d6-f60b-4e18-afe9-aaf5cdea7415_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_6157bd41-a5f4-41f1-af7e-ef92e344bfab_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_df3d62a6-4067-4274-9692-8d197e51597b_terseLabel_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued production costs</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_label_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent" xlink:href="pbh-20220930.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedProductionCostsCurrent" xlink:to="lab_pbh_AccruedProductionCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_878b77d4-fdf7-42da-9d99-b879e59f123f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_8ca9cd44-597c-4b15-a5d7-4eb9b0708a63_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:to="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_ce638f12-5f19-4864-a023-a28fe8170038_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_824a7199-d5dc-4608-b018-4b6213cb283a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b147e75-652b-4476-9e75-e50c50b14f80_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_63cca69b-f3ed-4d7b-8af9-4594fc72c556_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic earnings per share &#8212; weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_0f7c2489-e89f-48da-9644-d34051a3e7ab_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_1dad5648-2905-41fd-8d68-f98d7d9e37ee_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax share-based compensation costs charged against income</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_3fa0d380-cea9-4f09-b4b3-e58151d08f7d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies &#8212; Note 17</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c478842f-d159-438a-8d71-823d5392983c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b08eeea9-0d86-42bb-aa1b-3f49fac531b3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16ee491e-085e-4913-b067-630e74ff55c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_67d55b48-7a2f-4a50-87fb-b3fa73bd8d2d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_90cf46df-a954-448a-ab67-5597715c1472_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_c4f7f865-5a91-476a-807e-420f1934d099_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_689e1f45-0591-4650-952f-53a2dbe2730c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_00171adb-3a6b-469e-8ddf-f07b14994f8e_terseLabel_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="pbh-20220930.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_8aebd01c-c6c9-4b8f-85b0-e5df04f28899_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4f2b9fcd-e482-4a9e-ae9c-3ce608878594_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_8caebb9a-16fe-4713-822b-6e1ac22f2f29_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, amortizable intangible assets, allocated amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_label_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:to="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_db355996-60fa-470c-82fb-272661f4d64d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, capital shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6b321c00-d5da-463e-a20c-c9fda1cb8fcf_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5b34c529-48b5-4905-9c2c-0b93602b634b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_5e86f801-168b-4ab7-a39d-c82ddaa83c26_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_faff15fb-e25a-419f-9595-44898f33c884_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bc63d548-be8d-4cac-ae4a-fcf95ee14d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_c28fe281-0dae-4cc7-bf6b-dec197eecaa0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_7c95c106-3e08-4e5c-815e-3eb2f9047e92_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_69665d0f-6dbe-4030-bb0a-9b3a891aee56_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_56d00132-13b0-4214-82a0-fc95c9f315bd_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, non-amortizable intangible assets, allocated amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_label_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:to="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_328c990e-d13b-46c8-96b9-a32e9488fd38_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_2ab480fc-b220-4867-8846-f8a8858e76f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Carry Amounts and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_2b8a5564-750c-40d8-85ee-cb74185304d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e8bbdeab-426c-408d-b0ce-631ad35b68b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_7a8fcbf1-62d8-4938-8b85-7e8b7b66bfa8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_214ec4f4-e76d-41d3-9126-322dc96379a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares surrendered as payment of tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1f542dd4-f969-4520-83d1-1d01ca47ac27_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_1594eead-6a23-4f93-a0b8-88fd51682700_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_34b56594-fdf7-4a36-be87-d3761e519e60_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging and raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_6a1380ab-a39d-4199-a6f0-27c2e6e9c101_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_464584f5-0a55-4612-924a-6a937736804a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_2449c7a5-93be-473a-9158-3ec0c36f49e4_terseLabel_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:to="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ab804bed-ad4a-41e6-834e-9c21ad5d0721_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_3554bf75-2ae5-4967-b8cd-df43e911e17a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54d7aa93-8663-480b-8a8a-d5990dff1d70_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_ec043419-7ed6-41e8-adb8-cd6e20f1746d_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_b1eb57ba-1cb5-4904-b19d-9925df71d755_terseLabel_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember" xlink:href="pbh-20220930.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareRepurchaseProgramMember" xlink:to="lab_pbh_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ff2c358f-e8f0-44c6-999f-ce1f1fdd8d79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9ac69415-46d9-4964-a005-8ab3784957c5_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cd11ad19-0c7d-455c-8fe6-b35174f3eb29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5f3c3d09-7596-48c4-9303-83306d1125ba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4ee1027-3a29-4937-8668-07f98bd05b43_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8d296819-5cbe-489d-8548-b5ef410183b4_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill), Total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4167ee07-f788-4270-a5a5-7e8c03a17a36_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1a5b9218-a184-4549-91de-2b3bd47740a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a9b414bf-d40c-46ef-be5d-13049625b803_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_92565bc4-1998-450c-8201-62f98ce660e9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_3952ead3-76c9-48bb-a18d-9e80f87a2b4b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_04936903-3246-4ec6-89d9-6bcde7c8632d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_aaaf6d20-80ee-42b8-a13f-4860dca92a66_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_93984477-f173-4fe1-a8ef-56c68f44ab1f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_d1e71ba0-1f10-4a50-a7af-ea5f864a2805_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_e10d5c23-651e-45d3-98a5-b9f2293d04b1_verboseLabel_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_label_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_documentation_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:href="pbh-20220930.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:to="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_b400508e-ad95-4878-99bf-d06c5c4f2743_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_b5868e3a-7cb2-4c41-b637-eb755f3d72c5_terseLabel_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite- Lived Trademarks</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_label_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_documentation_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember" xlink:href="pbh-20220930.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IndefinitelivedTradenamesMember" xlink:to="lab_pbh_IndefinitelivedTradenamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7b062f7f-5eee-41ad-8212-889c29fc0db2_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_2964e93d-3236-475e-acbf-5ca538901540_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of options and RSUs vested during the period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f82b932e-b140-4599-a098-3a0107f6fef0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_eb22889d-dd95-4d5a-a593-6c49dbaf5418_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_0a1d6b14-316f-4259-8b75-02e2915a1abb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, cash flow hedge, reclassification tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_f7bb4290-f14e-478a-9301-8db51370d052_terseLabel_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_label_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:label id="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_documentation_en-US" xlink:label="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:href="pbh-20220930.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:to="lab_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_e494b6da-d702-4520-8c7a-155df0979b3b_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_1ee153b3-4ac9-4544-badd-36e057499cce_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_375f0e0e-769f-4b51-bbd5-860e8b3d226f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_316b5875-44f0-48d0-83ae-86b1cbd77023_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_05f383d2-c9e3-4221-b2fb-bd1bb8580638_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_abd4993b-1ada-4ad6-b5b7-5129343cb68d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_da7258d5-4a8d-4d46-9551-2e6626d6f574_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_c3477519-2942-4ab3-9e53-54efb11552a7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves related to obsolete and slow-moving inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_8b61b173-6d39-40bb-ba38-e84e1f5bb709_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_b6b62166-625d-4806-b683-c998481dbf63_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:to="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f7caf2d1-2567-4d42-af38-a410cbb4a5f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b15e5a44-53d9-4b41-b7ae-c0de869ec8c7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_5acfe583-a46c-4ddf-9b7f-ceb4f4c331e4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ed42b8ee-f0d6-4d45-acad-a8b8e5d83c3b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d258be14-f426-454d-b61f-557f4a4df814_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_1c967b37-a67d-48bf-b0c7-6a62333094ec_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ManufacturesMember_545fd4d9-76ba-44dd-b305-d1e6445edc58_terseLabel_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures</link:label>
    <link:label id="lab_pbh_ManufacturesMember_label_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures [Member]</link:label>
    <link:label id="lab_pbh_ManufacturesMember_documentation_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember" xlink:href="pbh-20220930.xsd#pbh_ManufacturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ManufacturesMember" xlink:to="lab_pbh_ManufacturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ca344ddc-daa5-442c-9d26-3292a4f4e78a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_65ecefbd-bcb4-44d0-b108-e9255e86564c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3cc960b2-17e9-4aea-838e-b6dd06ef898d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (remaining six months ended March 31, 2023)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_36c868bf-af94-4e6d-b268-cd706b742bc2_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_label_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsRollForward" xlink:to="lab_pbh_IntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ff9148f1-d79b-4112-98fe-d8f62bce060c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_184b6405-510e-4938-a255-9c85ccc30ae0_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_ee2c79ff-aa91-4fc2-ba5c-3854e7c29ca8_terseLabel_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for settlement, purchase of annuity contract</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_label_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Settlement, Purchase Of Annuity Contract</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_documentation_en-US" xlink:label="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Settlement, Purchase Of Annuity Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:to="lab_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a4b94f7a-de95-4392-8acd-0b6a22944655_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_612ba96a-9846-4089-96bc-47cddbd22da8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_276cfbaf-3d79-4ef4-af89-9ee7953aa634_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_03d0399e-c0d0-4eac-a8cd-9278e9b34a73_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97431c48-f152-48a6-9297-75b1e0814669_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99a88969-e776-468e-b853-697336d991d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f6ada8f2-92c4-4956-8544-0defa8f73cd7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_7ccaaa4c-df9d-45df-9db8-9465958593ee_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Four</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_558ae61a-7beb-479a-9818-e24661394370_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AblRevolver2012Member_7724ce31-ceca-4cd1-b704-f60fd82b9e39_terseLabel_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_label_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_documentation_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AblRevolver2012Member" xlink:to="lab_pbh_AblRevolver2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cd9cadd2-77e0-490e-90c1-353bf111d306_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_7aebec86-af06-4d56-86d4-a280049cd7a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cd2fdeac-9256-4d75-bac2-5143ba85be97_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_593580a3-bec2-41e4-a0ac-a56214c5b0e8_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_6b2efdae-3bf0-4262-92e4-1d0d598e53b9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0c8c4e4e-7c05-4fc2-931b-9edd813609fe_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7b52fd64-af11-441b-9bd1-f7134d6541b9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2019SeniorNotesMember_da46011e-55d3-4146-b491-0815768fd96a_terseLabel_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_label_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes [Member]</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_documentation_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember" xlink:href="pbh-20220930.xsd#pbh_A2019SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2019SeniorNotesMember" xlink:to="lab_pbh_A2019SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1e532286-5524-4b00-9862-a1e0de9381c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_a261b325-77a4-4e69-a47c-3e4337b5c6b7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales depreciation</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WalgreensMember_f3bc8a29-7c26-4f73-a58e-d9f00e1f788b_terseLabel_en-US" xlink:label="lab_pbh_WalgreensMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens</link:label>
    <link:label id="lab_pbh_WalgreensMember_label_en-US" xlink:label="lab_pbh_WalgreensMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens [Member]</link:label>
    <link:label id="lab_pbh_WalgreensMember_documentation_en-US" xlink:label="lab_pbh_WalgreensMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalgreensMember" xlink:href="pbh-20220930.xsd#pbh_WalgreensMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WalgreensMember" xlink:to="lab_pbh_WalgreensMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_10ed0c0e-305b-4535-895d-384fb325eede_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d01fd321-97ae-4552-b9cd-8ba02bc894a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7bfa8e7d-9434-4969-ae74-8eac1422ad19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ec112839-3aa0-4394-a644-f28a2c7510a3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7b72dce7-9b3f-496f-8092-a982282598fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_15a0ff8c-fe2c-43fc-8bf6-917ce03f2bc7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_beec3874-1388-4dce-ab8b-181517cf1104_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EyeAndEarCareMember_7104b429-b9d7-4aa4-b8d4-52324ecb540f_terseLabel_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye &amp; Ear Care</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_label_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_documentation_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember" xlink:href="pbh-20220930.xsd#pbh_EyeAndEarCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EyeAndEarCareMember" xlink:to="lab_pbh_EyeAndEarCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6d0bef53-e60d-4430-bb7f-6b8c13e86370_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ef0a11d5-a274-403f-b38b-8eacd0f4c0b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c3709f93-3d5e-48f1-b0be-f98be50cd890_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>pbh-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ca0e16ac-3b01-4c52-a1f5-69f10f317ba3,g:ba139a42-8e7e-4530-a142-b5960ae74a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="simple" xlink:href="pbh-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_13d334cf-eb16-4a87-a949-cef9efca3dce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentType_13d334cf-eb16-4a87-a949-cef9efca3dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a3430e6b-fb20-4fa0-9038-91d3ebcefe27" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentQuarterlyReport_a3430e6b-fb20-4fa0-9038-91d3ebcefe27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90d827fc-59ad-4a1c-aea2-d173e60ea229" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentPeriodEndDate_90d827fc-59ad-4a1c-aea2-d173e60ea229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_02ae3021-26cc-4f40-9fc1-182cb56fd278" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentTransitionReport_02ae3021-26cc-4f40-9fc1-182cb56fd278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_98465b2a-699c-42b8-8157-8b974b2f2669" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityFileNumber_98465b2a-699c-42b8-8157-8b974b2f2669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_81f51933-4d6a-45ad-be30-a8154149cde7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityRegistrantName_81f51933-4d6a-45ad-be30-a8154149cde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_264567bc-6d24-4bc3-81e7-bd2d88cb162c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityCentralIndexKey_264567bc-6d24-4bc3-81e7-bd2d88cb162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_127031c1-a178-4a53-927d-674b72ad4303" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_CurrentFiscalYearEndDate_127031c1-a178-4a53-927d-674b72ad4303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0adad154-790a-44be-8fef-837908db72f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentFiscalYearFocus_0adad154-790a-44be-8fef-837908db72f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b6ef4d55-518a-42a4-8d38-cdcfef55fa29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b6ef4d55-518a-42a4-8d38-cdcfef55fa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_afcc1fc9-34fe-4677-8be5-85e3b8c2055c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_AmendmentFlag_afcc1fc9-34fe-4677-8be5-85e3b8c2055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_32ec7077-70b9-42cc-a883-347214c09edb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityIncorporationStateCountryCode_32ec7077-70b9-42cc-a883-347214c09edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4e72f472-39b6-4b9a-9f98-7dabe5c6f922" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityTaxIdentificationNumber_4e72f472-39b6-4b9a-9f98-7dabe5c6f922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6b25cfad-b4a8-4d0e-8a78-7b74c6ff1507" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityAddressAddressLine1_6b25cfad-b4a8-4d0e-8a78-7b74c6ff1507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_27d28316-a0a2-4c93-9ec7-58932b3947f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityAddressCityOrTown_27d28316-a0a2-4c93-9ec7-58932b3947f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f88bdec3-aba8-4fa6-a1be-8700633d66f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityAddressStateOrProvince_f88bdec3-aba8-4fa6-a1be-8700633d66f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f8640624-84c0-4bf5-aedf-5b908aad6efc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityAddressPostalZipCode_f8640624-84c0-4bf5-aedf-5b908aad6efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8c6f8ec3-9d3f-4348-80b4-c0ba7b20240d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_CityAreaCode_8c6f8ec3-9d3f-4348-80b4-c0ba7b20240d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2e0acbe6-1003-4f3d-abab-1e99e4dbfa67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_LocalPhoneNumber_2e0acbe6-1003-4f3d-abab-1e99e4dbfa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3adea1ce-1dfc-4af5-8c5f-2d756801bd66" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_Security12bTitle_3adea1ce-1dfc-4af5-8c5f-2d756801bd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b645dab7-ee4e-4eba-adb4-f9b7a432890d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_TradingSymbol_b645dab7-ee4e-4eba-adb4-f9b7a432890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e52f3186-46e6-4d68-9a6c-8580f86d2202" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_SecurityExchangeName_e52f3186-46e6-4d68-9a6c-8580f86d2202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9e9bb16d-5f8e-49d1-99ec-f77bc0251092" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityCurrentReportingStatus_9e9bb16d-5f8e-49d1-99ec-f77bc0251092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6693cc2f-9a41-4604-9593-0a365dfdfc6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityInteractiveDataCurrent_6693cc2f-9a41-4604-9593-0a365dfdfc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_dfe7e58a-493b-423d-a2c6-bbb10202e9f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityFilerCategory_dfe7e58a-493b-423d-a2c6-bbb10202e9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8778c23b-d882-48f9-8367-ed57b36df0d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntitySmallBusiness_8778c23b-d882-48f9-8367-ed57b36df0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8246b64b-2f97-499a-9e01-d9d6d237a5d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityEmergingGrowthCompany_8246b64b-2f97-499a-9e01-d9d6d237a5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ed6da671-ef97-4449-be1c-79c12f8d4397" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityShellCompany_ed6da671-ef97-4449-be1c-79c12f8d4397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_414d22f3-40c2-4731-9fb1-61535b427f50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0dd5fc43-82f5-47df-88aa-0a9d1b187c50" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_414d22f3-40c2-4731-9fb1-61535b427f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a0be2674-b328-47d5-a5d9-b1b4566045f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a0be2674-b328-47d5-a5d9-b1b4566045f1" xlink:to="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:to="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b1a6b1ba-d8b7-4f8b-bf56-d061c168d20f" xlink:to="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3894a4ff-37ec-452b-b927-571b9fcff40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:to="loc_us-gaap_ProductMember_3894a4ff-37ec-452b-b927-571b9fcff40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_94cbac8f-251b-430f-bfaf-9d45203c59d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_16f938e3-861b-4fa4-bee7-4d7fe81c94a4" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_94cbac8f-251b-430f-bfaf-9d45203c59d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4f48afa-7ba1-42bb-bda4-03c3f1fc81f6" xlink:to="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9642085c-d036-460c-877e-19a33a96f29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b4daeb7e-5073-4607-9211-1eb1ebfd79a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9642085c-d036-460c-877e-19a33a96f29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_f0f53ad1-f6ff-4280-8119-3f870fbd763d" xlink:href="pbh-20220930.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_f0f53ad1-f6ff-4280-8119-3f870fbd763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1cb8044c-db60-4f70-9e72-334b0473d981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1cb8044c-db60-4f70-9e72-334b0473d981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ce56f14d-17ca-44db-b39f-7c1953c8505b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_89995c04-9a2e-46e1-b5e5-03484ce9f263" xlink:to="loc_us-gaap_CostOfRevenue_ce56f14d-17ca-44db-b39f-7c1953c8505b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c9ae294f-8a6d-4190-ba1a-a31036c55e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_GrossProfit_c9ae294f-8a6d-4190-ba1a-a31036c55e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_d66b91c5-9fee-4342-afcf-2a4ee4ddc0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_d66b91c5-9fee-4342-afcf-2a4ee4ddc0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e32b15d1-0de6-4e31-8091-d01611f036a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e32b15d1-0de6-4e31-8091-d01611f036a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_ef16f3a8-822f-48db-b5d7-c553f95a1479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_ef16f3a8-822f-48db-b5d7-c553f95a1479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2ecbe234-7cf3-422c-8bac-794c683587cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bc8bb2c3-b80d-4957-9955-aa3f181a36b0" xlink:to="loc_us-gaap_OperatingExpenses_2ecbe234-7cf3-422c-8bac-794c683587cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e8a40f32-c2f8-4855-82f1-b43223c2f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_OperatingIncomeLoss_e8a40f32-c2f8-4855-82f1-b43223c2f3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a1510d62-4db9-4aa2-98e3-ef10663684a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a1510d62-4db9-4aa2-98e3-ef10663684a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d40d31a0-4ab6-457d-b1e8-e4b26c2c5d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d40d31a0-4ab6-457d-b1e8-e4b26c2c5d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a767c2ac-25af-4b5a-97a1-4c12d65f2b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a767c2ac-25af-4b5a-97a1-4c12d65f2b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_e63d2ead-42e6-46ad-8ef0-c4cb96211729" xlink:href="pbh-20220930.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a7cbe3ef-933c-45cb-b702-9c80aa4678a6" xlink:to="loc_pbh_TotalOtherIncomeExpense_e63d2ead-42e6-46ad-8ef0-c4cb96211729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_e52e381c-e43b-40cc-89aa-10cd46f9a62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_e52e381c-e43b-40cc-89aa-10cd46f9a62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a24777d8-fa0a-4afd-b2fa-7d95aae1b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a24777d8-fa0a-4afd-b2fa-7d95aae1b59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_04793a7e-ac9c-4fa4-8104-805872f9ff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_NetIncomeLoss_04793a7e-ac9c-4fa4-8104-805872f9ff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_df72a71c-29f2-4d4e-a1b8-aa7007f1d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:to="loc_us-gaap_EarningsPerShareBasic_df72a71c-29f2-4d4e-a1b8-aa7007f1d9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e34d6e25-53b3-4437-9258-c981e9d9a030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ff756a49-006a-4ef6-af0a-c7b089f13bf1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e34d6e25-53b3-4437-9258-c981e9d9a030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6ec0ad1-7112-498d-94f0-b0aa1bc09f33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d6ec0ad1-7112-498d-94f0-b0aa1bc09f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef5cdcc5-822e-4570-984c-56ca4a0556df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_19106280-c812-4f9a-8337-dd40f8cb05f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ef5cdcc5-822e-4570-984c-56ca4a0556df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6eea54a0-89a1-4d78-b019-eb095ad7330c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6eea54a0-89a1-4d78-b019-eb095ad7330c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c3dbbeeb-2f12-44a3-89c5-bf1f9d7dd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c3dbbeeb-2f12-44a3-89c5-bf1f9d7dd70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8fb9112e-b68e-4882-81ca-77a2ee961552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8fb9112e-b68e-4882-81ca-77a2ee961552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad0de8c7-3652-4497-9ac3-99443e03ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9a3a0a0f-6599-41a9-8924-7ad6def18bd5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ad0de8c7-3652-4497-9ac3-99443e03ba10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ad0cf59d-54b7-45d9-979b-e50607719606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531a4089-5c24-4344-9c1a-2243b24012bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ad0cf59d-54b7-45d9-979b-e50607719606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b4a34b08-a262-449e-917f-f694cef01376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4a34b08-a262-449e-917f-f694cef01376" xlink:to="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_165048fa-c9af-4f87-aa87-fccfbc580455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_165048fa-c9af-4f87-aa87-fccfbc580455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5e0fb444-d615-45d5-a2ef-176c53514d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5e0fb444-d615-45d5-a2ef-176c53514d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_178d2f23-ce6b-4fbe-893b-b44a0ee88585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:to="loc_us-gaap_InventoryNet_178d2f23-ce6b-4fbe-893b-b44a0ee88585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a3a2dde1-dbfb-4dde-a76e-723624af7d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a3a2dde1-dbfb-4dde-a76e-723624af7d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40f0c3ad-93ba-4c9e-b265-88b0fffc2229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_30b1c22a-ecdb-4693-b390-6b2ca6e3bf8b" xlink:to="loc_us-gaap_AssetsCurrent_40f0c3ad-93ba-4c9e-b265-88b0fffc2229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b88bd25-63bc-4c02-b09d-92b87ac1324c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b88bd25-63bc-4c02-b09d-92b87ac1324c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_055409f8-3758-4b36-931a-6eb58782263d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_055409f8-3758-4b36-931a-6eb58782263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_90795a88-1b6a-4a27-9e03-82403157b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_90795a88-1b6a-4a27-9e03-82403157b4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_47fb0148-dd78-4826-af01-34293dda2df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_Goodwill_47fb0148-dd78-4826-af01-34293dda2df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_46dc6087-e50c-42b8-972d-c2779487430c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_46dc6087-e50c-42b8-972d-c2779487430c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c7270c98-c086-485d-b9f4-07f49d2fa723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c7270c98-c086-485d-b9f4-07f49d2fa723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4dd021df-6e8a-4347-890b-9756fe128a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9934cd30-bd82-4eef-a76e-af585015d6d1" xlink:to="loc_us-gaap_Assets_4dd021df-6e8a-4347-890b-9756fe128a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4a34b08-a262-449e-917f-f694cef01376" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d64c5db6-68b2-4319-9e80-735f9c988065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_us-gaap_AccountsPayableCurrent_d64c5db6-68b2-4319-9e80-735f9c988065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_59042503-81ba-4f12-b051-7d62fbdd601a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_59042503-81ba-4f12-b051-7d62fbdd601a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8e1afb8-e3d0-4413-893f-dc54287923aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8e1afb8-e3d0-4413-893f-dc54287923aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f17e7081-9632-43ba-96b1-bf98996808a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f17e7081-9632-43ba-96b1-bf98996808a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_981da98e-e12e-49ea-807c-b9f2d0eefa31" xlink:href="pbh-20220930.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_981da98e-e12e-49ea-807c-b9f2d0eefa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_903c8179-ee38-40ab-800a-ab58b4db45ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_a7ae374d-49c1-4b40-8f94-f21b577ab6ed" xlink:to="loc_us-gaap_LiabilitiesCurrent_903c8179-ee38-40ab-800a-ab58b4db45ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2785e037-25de-43d5-89e7-a42b432921e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_LongTermDebt_2785e037-25de-43d5-89e7-a42b432921e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1dbb5fa2-b450-4037-b893-a99855823fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1dbb5fa2-b450-4037-b893-a99855823fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_06198e97-f531-48c7-b903-3e6cdfa6bf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_06198e97-f531-48c7-b903-3e6cdfa6bf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_74db76b0-8dfa-4d55-bf34-f182a1275808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_74db76b0-8dfa-4d55-bf34-f182a1275808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fc5d2341-e76b-47f6-bbb6-1f725a584a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fc5d2341-e76b-47f6-bbb6-1f725a584a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_41040803-bf88-49d9-b0b7-f65cdc0aa320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_Liabilities_41040803-bf88-49d9-b0b7-f65cdc0aa320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_31f5d537-f7a4-4f50-bbb4-f349c47f5919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_31f5d537-f7a4-4f50-bbb4-f349c47f5919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_81f0cdbc-385b-4fb8-b42c-9ca29620d332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_PreferredStockValue_81f0cdbc-385b-4fb8-b42c-9ca29620d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f6eb0133-3b86-4ecf-9dcd-cbb8f2b9dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_CommonStockValue_f6eb0133-3b86-4ecf-9dcd-cbb8f2b9dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_54a4f256-b940-4109-9adf-0092688db8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_AdditionalPaidInCapital_54a4f256-b940-4109-9adf-0092688db8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d57a4b7d-acc3-4271-87e7-778bf59f088c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_TreasuryStockValue_d57a4b7d-acc3-4271-87e7-778bf59f088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_23d5555a-47d0-4415-884b-d4d8e9c8460f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_23d5555a-47d0-4415-884b-d4d8e9c8460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c7dbdbb7-1861-44d2-8545-981dab91c320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c7dbdbb7-1861-44d2-8545-981dab91c320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_55e61996-9d59-4172-bbeb-a578e31a8dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25659d74-3fcc-4348-a93e-80b5795bb824" xlink:to="loc_us-gaap_StockholdersEquity_55e61996-9d59-4172-bbeb-a578e31a8dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_907c73b7-81ba-433b-972d-71a254c477c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac6920e5-ff8a-41fb-8f1f-4580c7d0580b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_907c73b7-81ba-433b-972d-71a254c477c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_316d17c6-af85-4995-832d-78850dc9b434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_658cb41b-e45e-4165-bd76-ee3e8951c5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_316d17c6-af85-4995-832d-78850dc9b434" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_658cb41b-e45e-4165-bd76-ee3e8951c5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_316d17c6-af85-4995-832d-78850dc9b434" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4373f4e-78af-409d-8a29-eeb874df3c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f4373f4e-78af-409d-8a29-eeb874df3c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0632f4ca-05ce-4c2e-a8ba-7923081e40e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0632f4ca-05ce-4c2e-a8ba-7923081e40e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_dbd9c92b-68b1-4b87-b588-b61c02ba2db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_PreferredStockSharesIssued_dbd9c92b-68b1-4b87-b588-b61c02ba2db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_8e896f85-1ad6-4552-af33-3676b5656a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_8e896f85-1ad6-4552-af33-3676b5656a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b204c22b-f93b-4560-a3ee-673b8dfca981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b204c22b-f93b-4560-a3ee-673b8dfca981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_31b7f6e0-53bb-435b-96ff-dd3f04c9e1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_31b7f6e0-53bb-435b-96ff-dd3f04c9e1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_317ca912-55e4-47f7-b436-1a41bf05c98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_CommonStockSharesIssued_317ca912-55e4-47f7-b436-1a41bf05c98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_47637ec6-d560-458b-9914-6c4306b1a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_40d1b457-cc8e-47c4-8729-4de5ff37f7b5" xlink:to="loc_us-gaap_TreasuryStockShares_47637ec6-d560-458b-9914-6c4306b1a1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e30da251-00cc-468f-82d4-7aaeec7280b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e30da251-00cc-468f-82d4-7aaeec7280b6" xlink:to="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4a2a7919-6fc9-4773-9955-603b60eacf51" xlink:to="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_986f1be9-ac23-489b-b51e-4830892563c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_CommonStockMember_986f1be9-ac23-489b-b51e-4830892563c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1ebe1761-fa01-4c0c-8863-0880877cdf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1ebe1761-fa01-4c0c-8863-0880877cdf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_42019945-b46f-4986-8233-d8931cb413bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_42019945-b46f-4986-8233-d8931cb413bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c6d040-aed5-4a43-a8a1-aec2db9901d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c6d040-aed5-4a43-a8a1-aec2db9901d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1fde48c1-16c7-4690-8e35-df1454ac77a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea381ad3-3444-4aa1-8336-ac7d047a4c3d" xlink:to="loc_us-gaap_RetainedEarningsMember_1fde48c1-16c7-4690-8e35-df1454ac77a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a8f6fd47-11f7-43de-a78a-c75f7576ca23" xlink:to="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_317b3888-8cfb-4214-a295-00ec11b193b7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b9659eea-0a2e-4932-ae80-a5112f8a8a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b9659eea-0a2e-4932-ae80-a5112f8a8a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e3465b3-4cdf-4f5b-9f7a-c365d6c4308b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockholdersEquity_5e3465b3-4cdf-4f5b-9f7a-c365d6c4308b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_56be8bd5-57d2-4538-9f14-7343200c215b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockCommonShares_56be8bd5-57d2-4538-9f14-7343200c215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d721b7d-8432-4b1a-ab9b-26c513499823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d721b7d-8432-4b1a-ab9b-26c513499823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbbb3277-91f0-4acc-9ed4-f53da0e546a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fbbb3277-91f0-4acc-9ed4-f53da0e546a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_97638a2b-63c0-410d-bb13-09fb2d30e36b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_97638a2b-63c0-410d-bb13-09fb2d30e36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_eab554c4-1776-47f3-afdf-f30ed07cf4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_eab554c4-1776-47f3-afdf-f30ed07cf4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b3a29851-fbe4-48d9-9564-067b3123ee6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_b3a29851-fbe4-48d9-9564-067b3123ee6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3c29c147-b4e3-47b8-a611-121d6e7645b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3c29c147-b4e3-47b8-a611-121d6e7645b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_899685a6-f261-433c-907c-f2cfea4e0ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_899685a6-f261-433c-907c-f2cfea4e0ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e706dd4b-afc8-479d-9740-e568aa8af00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_NetIncomeLoss_e706dd4b-afc8-479d-9740-e568aa8af00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f8011e11-0cbe-42fc-b8cf-e794b184defa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f8011e11-0cbe-42fc-b8cf-e794b184defa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5c780dba-8a51-40aa-bb4c-d0727dd5a3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5c780dba-8a51-40aa-bb4c-d0727dd5a3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b2c7634-0fbe-4024-86c7-d892f9069f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_StockholdersEquity_4b2c7634-0fbe-4024-86c7-d892f9069f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_ddec57da-31e1-43be-9213-4c2ca416565e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1b22d781-3dd5-415c-876a-db114fd2d137" xlink:to="loc_us-gaap_TreasuryStockCommonShares_ddec57da-31e1-43be-9213-4c2ca416565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20220930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f0c3a1-9495-4da6-8cd5-771156e95a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f0c3a1-9495-4da6-8cd5-771156e95a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7413252-341d-47a1-bd66-547934445f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f0c3a1-9495-4da6-8cd5-771156e95a95" xlink:to="loc_us-gaap_NetIncomeLoss_d7413252-341d-47a1-bd66-547934445f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f0c3a1-9495-4da6-8cd5-771156e95a95" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_274ca7a8-96fe-4371-b2bb-0801e2df4fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_274ca7a8-96fe-4371-b2bb-0801e2df4fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_323746de-13a0-4d72-a71b-6830ebbc3090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_323746de-13a0-4d72-a71b-6830ebbc3090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5b21d4bd-1d44-43a2-9430-d2193f383731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5b21d4bd-1d44-43a2-9430-d2193f383731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_94f1ceff-f113-4048-b4f5-ed18d111f104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_94f1ceff-f113-4048-b4f5-ed18d111f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a62bdaa8-0f65-4f95-8a73-372257b912b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_ShareBasedCompensation_a62bdaa8-0f65-4f95-8a73-372257b912b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42614566-1225-40d1-aa35-a8ca44b8a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_42614566-1225-40d1-aa35-a8ca44b8a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_02dc8b0c-c73b-4553-8b4f-c04101337cb1" xlink:href="pbh-20220930.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_02dc8b0c-c73b-4553-8b4f-c04101337cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_cf016250-5a06-4775-ac72-d13dfa3afe03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_OtherNoncashExpense_cf016250-5a06-4775-ac72-d13dfa3afe03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_326e38c1-e691-47ac-a497-03124dd0de9b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3bf2b74d-b1c7-42ab-b223-4c21e611e2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3bf2b74d-b1c7-42ab-b223-4c21e611e2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_518687ee-b75e-4565-af98-3a589efbb864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_518687ee-b75e-4565-af98-3a589efbb864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1662ec69-93d7-459c-8314-4781825ef30b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1662ec69-93d7-459c-8314-4781825ef30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_14b46c2e-dc11-4308-8d7b-88a256d7e896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_14b46c2e-dc11-4308-8d7b-88a256d7e896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b5790b16-1bfb-4233-b40e-69a0d1851a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b5790b16-1bfb-4233-b40e-69a0d1851a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_35c1fb1a-894c-49fa-90af-2a6386c7803d" xlink:href="pbh-20220930.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_35c1fb1a-894c-49fa-90af-2a6386c7803d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_fe944d18-12c3-4d5d-982b-c7583f081d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4d4111cd-a117-4caa-b71b-a68c93b276a2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_fe944d18-12c3-4d5d-982b-c7583f081d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_754a7f56-da16-4044-8c70-e2b71559c009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f0c3a1-9495-4da6-8cd5-771156e95a95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_754a7f56-da16-4044-8c70-e2b71559c009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2017d047-bedf-4e8c-92fc-fe5eb3ebbd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2017d047-bedf-4e8c-92fc-fe5eb3ebbd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_00159fde-5430-4ba8-9291-11d59c997455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_00159fde-5430-4ba8-9291-11d59c997455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_dcfa23d3-44dc-4486-b0e4-82d8464c7fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_dcfa23d3-44dc-4486-b0e4-82d8464c7fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f04f8ad-ca3d-4bbb-a59f-0c4fee276c07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_84241401-5b16-4679-9e60-83b7f4e546ff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7f04f8ad-ca3d-4bbb-a59f-0c4fee276c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_c5c929e9-86a1-4697-9e4a-202757340565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_c5c929e9-86a1-4697-9e4a-202757340565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_e67489b0-4581-4f61-a049-b990c0a741c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_e67489b0-4581-4f61-a049-b990c0a741c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_42615de1-cade-4154-8f58-12262526004a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_42615de1-cade-4154-8f58-12262526004a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_89aa3d6b-1616-4f67-8049-926397211c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_89aa3d6b-1616-4f67-8049-926397211c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_71d450af-a441-4512-990f-1b6854444a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_71d450af-a441-4512-990f-1b6854444a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_516aae1b-e4b2-4228-8e40-f152a0fbd6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_516aae1b-e4b2-4228-8e40-f152a0fbd6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_df48f752-e09f-4f08-970b-e060ec522035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_df48f752-e09f-4f08-970b-e060ec522035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0a102fb7-ac8b-4641-b388-406b46da5127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0a102fb7-ac8b-4641-b388-406b46da5127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7155f12b-c4f9-4b77-88a0-adf0b1c31747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7155f12b-c4f9-4b77-88a0-adf0b1c31747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2585d552-dde4-4d82-bee7-dcb81a6d6c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eed52ffe-3673-4749-b637-434823dec69c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2585d552-dde4-4d82-bee7-dcb81a6d6c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94260049-6086-4c39-b704-d5c26d97ad35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94260049-6086-4c39-b704-d5c26d97ad35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fdad7eb4-e440-4a59-9d2c-1abdee4b09b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fdad7eb4-e440-4a59-9d2c-1abdee4b09b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_13e5b599-baaa-45c6-9b44-722b1d04127e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_13e5b599-baaa-45c6-9b44-722b1d04127e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bad6bae4-53a9-4cc8-a98c-6fe06759d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bad6bae4-53a9-4cc8-a98c-6fe06759d67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1b6746d9-22be-4ae0-8cfb-4d589cee1255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1173ff75-b215-497c-84ca-4528c79b16b9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_1b6746d9-22be-4ae0-8cfb-4d589cee1255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_64a2a31f-a2d6-4fc2-a328-77c5028a057d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1b6746d9-22be-4ae0-8cfb-4d589cee1255" xlink:to="loc_us-gaap_InterestPaidNet_64a2a31f-a2d6-4fc2-a328-77c5028a057d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_d52654c8-255f-4717-890f-d8273ac0f458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1b6746d9-22be-4ae0-8cfb-4d589cee1255" xlink:to="loc_us-gaap_IncomeTaxesPaid_d52654c8-255f-4717-890f-d8273ac0f458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d8434bb-613d-4a42-9500-5d40580bc96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_f3efa42c-6ade-4689-86d3-249a039f6070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d8434bb-613d-4a42-9500-5d40580bc96c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_f3efa42c-6ade-4689-86d3-249a039f6070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Acquisition" xlink:type="simple" xlink:href="pbh-20220930.xsd#Acquisition"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Acquisition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d97ae814-d13e-4e28-b7ab-5c8760e847b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e034e6ec-58af-41e9-9b23-69e633807624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d97ae814-d13e-4e28-b7ab-5c8760e847b7" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e034e6ec-58af-41e9-9b23-69e633807624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="simple" xlink:href="pbh-20220930.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8868f220-9886-4925-a4c3-1a3de0ed65fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_13d50f6c-8bbe-4576-b611-92f878a189ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8868f220-9886-4925-a4c3-1a3de0ed65fb" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_13d50f6c-8bbe-4576-b611-92f878a189ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="simple" xlink:href="pbh-20220930.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe299abe-d1f0-4037-9c31-5f806f49bf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_48a9043e-0f7e-40d3-96e1-79a94c4756a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe299abe-d1f0-4037-9c31-5f806f49bf50" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_48a9043e-0f7e-40d3-96e1-79a94c4756a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d8358e2b-9585-4136-9ef1-da7f910dd485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_d2769bbc-ad3e-431a-a0d2-09df702f3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d8358e2b-9585-4136-9ef1-da7f910dd485" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_d2769bbc-ad3e-431a-a0d2-09df702f3e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Leases" xlink:type="simple" xlink:href="pbh-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4d8c8f3c-c27b-4c1a-aa2f-836d9bd8f360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_bcd1927d-74bd-4b37-a136-1dd0881c2917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4d8c8f3c-c27b-4c1a-aa2f-836d9bd8f360" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_bcd1927d-74bd-4b37-a136-1dd0881c2917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_e2f2357c-2795-406f-9196-c80db8f27130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4d8c8f3c-c27b-4c1a-aa2f-836d9bd8f360" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_e2f2357c-2795-406f-9196-c80db8f27130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="simple" xlink:href="pbh-20220930.xsd#OtherAccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_850724a3-ba83-488a-896b-004cf1c61636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_49ed0367-49e4-49b1-889a-30fafe74f68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_850724a3-ba83-488a-896b-004cf1c61636" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_49ed0367-49e4-49b1-889a-30fafe74f68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_731ddb36-c530-4480-b1b4-632b12a2e47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_9dbdc45b-76a7-4d05-a17d-44555a85a16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_731ddb36-c530-4480-b1b4-632b12a2e47b" xlink:to="loc_us-gaap_LongTermDebtTextBlock_9dbdc45b-76a7-4d05-a17d-44555a85a16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pbh-20220930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1bd99a62-2f5f-4227-b2d3-d6804aa4fd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_ebe710bd-bb2d-410b-a2e9-ee943f4c0891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1bd99a62-2f5f-4227-b2d3-d6804aa4fd53" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_ebe710bd-bb2d-410b-a2e9-ee943f4c0891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b67a8f2f-c1b8-42b2-8b8d-19bcf4a2b005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3dd575ef-3e34-499f-94f7-448d8f94e8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b67a8f2f-c1b8-42b2-8b8d-19bcf4a2b005" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3dd575ef-3e34-499f-94f7-448d8f94e8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="pbh-20220930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7fddd522-13ba-4783-ab79-3bdaa30b0355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_57212b73-4f52-4fd7-a2f7-847e76ee8003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7fddd522-13ba-4783-ab79-3bdaa30b0355" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_57212b73-4f52-4fd7-a2f7-847e76ee8003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="pbh-20220930.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5ca2494f-640c-4e5e-b859-90ed87bf608e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_67aee755-b45a-49b2-96ff-56f11cf6d718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5ca2494f-640c-4e5e-b859-90ed87bf608e" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_67aee755-b45a-49b2-96ff-56f11cf6d718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1afa9cb1-c126-4ca0-8f4f-b58847b0bd33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_05bc1446-e01e-4ec7-ae01-36d05d5f23ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1afa9cb1-c126-4ca0-8f4f-b58847b0bd33" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_05bc1446-e01e-4ec7-ae01-36d05d5f23ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57949829-6fa9-4853-859b-018a5f4d6700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee4b4e7b-c60a-4816-8193-39d58ce1bce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57949829-6fa9-4853-859b-018a5f4d6700" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee4b4e7b-c60a-4816-8193-39d58ce1bce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pbh-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2e346003-2f52-4103-b54a-6c76ded06a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f37aa19a-dc4c-407c-8253-aea274cb3d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2e346003-2f52-4103-b54a-6c76ded06a6a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f37aa19a-dc4c-407c-8253-aea274cb3d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlans"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4aaeb3a-29e4-4818-81b3-59b93781a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_24b8437d-307d-4314-b83f-7263fddc785d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4aaeb3a-29e4-4818-81b3-59b93781a5dc" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_24b8437d-307d-4314-b83f-7263fddc785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pbh-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cd922968-9816-4767-8fb5-c409a7e79ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c4da222-374a-4331-ad19-1f4a14b50240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cd922968-9816-4767-8fb5-c409a7e79ed6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c4da222-374a-4331-ad19-1f4a14b50240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="simple" xlink:href="pbh-20220930.xsd#ConcentrationsofRisk"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_60c46944-6a57-4c1d-a651-adbee8f30912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_82baf7b7-d5ea-47a9-b543-bb3f17eac44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_60c46944-6a57-4c1d-a651-adbee8f30912" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_82baf7b7-d5ea-47a9-b543-bb3f17eac44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fdb22016-93c5-4ee5-b786-4f427394a0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_90ad456f-c493-4782-a7b7-b0991eb88ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fdb22016-93c5-4ee5-b786-4f427394a0bf" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_90ad456f-c493-4782-a7b7-b0991eb88ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b003f13f-3044-4280-99df-f0de886ebe73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40534786-85e4-4ee2-874b-55774ee2cbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b003f13f-3044-4280-99df-f0de886ebe73" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40534786-85e4-4ee2-874b-55774ee2cbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0b044f35-4e9b-44f0-a829-e20bfd1f91d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b003f13f-3044-4280-99df-f0de886ebe73" xlink:to="loc_us-gaap_UseOfEstimates_0b044f35-4e9b-44f0-a829-e20bfd1f91d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_65f03c4d-fd37-4e51-ad21-4ecf740a2be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b003f13f-3044-4280-99df-f0de886ebe73" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_65f03c4d-fd37-4e51-ad21-4ecf740a2be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_55e74746-983d-42b5-a315-8d3564fa2afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9e6f3529-664f-4259-b134-c8d2d6c7cda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_55e74746-983d-42b5-a315-8d3564fa2afc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_9e6f3529-664f-4259-b134-c8d2d6c7cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_115e22ea-9077-4dd1-a30f-305e9bb8258a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a2f7d626-c592-43c8-8eae-e9a4606d12e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_115e22ea-9077-4dd1-a30f-305e9bb8258a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a2f7d626-c592-43c8-8eae-e9a4606d12e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18ccd512-a10b-4676-9c50-91f9ae46e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b3360522-abd0-4ab0-85fa-68e95575a11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18ccd512-a10b-4676-9c50-91f9ae46e5c9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b3360522-abd0-4ab0-85fa-68e95575a11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c61f2098-8687-4725-b3e7-ec008d48e639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0eeddfe3-d61e-47ab-91c6-81120f551779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c61f2098-8687-4725-b3e7-ec008d48e639" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0eeddfe3-d61e-47ab-91c6-81120f551779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_26d1fe3a-396b-4f1d-9ae0-8a0134c023c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c61f2098-8687-4725-b3e7-ec008d48e639" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_26d1fe3a-396b-4f1d-9ae0-8a0134c023c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c77a706c-679b-41f5-b430-532357cf740c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c61f2098-8687-4725-b3e7-ec008d48e639" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c77a706c-679b-41f5-b430-532357cf740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a4a031a3-7c38-4714-b47f-76425f8bf0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_97c125d4-52af-494a-93db-38faa50715da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a4a031a3-7c38-4714-b47f-76425f8bf0f4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_97c125d4-52af-494a-93db-38faa50715da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c000746d-088c-4839-9a81-4307c6a761ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a4a031a3-7c38-4714-b47f-76425f8bf0f4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c000746d-088c-4839-9a81-4307c6a761ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5fbf606c-e14f-46cb-8d26-a79e4eb6b2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a4a031a3-7c38-4714-b47f-76425f8bf0f4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5fbf606c-e14f-46cb-8d26-a79e4eb6b2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#OtherAccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_fef29b29-5c7f-4257-b917-921e519ee969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_a082e3ef-17ae-4fcb-93d2-c7eaacaff966" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fef29b29-5c7f-4257-b917-921e519ee969" xlink:to="loc_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock_a082e3ef-17ae-4fcb-93d2-c7eaacaff966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_04620d3f-32d2-445a-9c8d-e0b7e094a05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e46f2b35-7817-4fa0-bbc8-ecdf6b39d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_04620d3f-32d2-445a-9c8d-e0b7e094a05a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e46f2b35-7817-4fa0-bbc8-ecdf6b39d1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_a4721f9f-a43c-4b2b-965b-2805d43d76df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_04620d3f-32d2-445a-9c8d-e0b7e094a05a" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_a4721f9f-a43c-4b2b-965b-2805d43d76df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_18cb26fe-615d-44ea-ad6a-b0e0279bd18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_376321f0-068d-4b06-b226-260e505f2bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18cb26fe-615d-44ea-ad6a-b0e0279bd18c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_376321f0-068d-4b06-b226-260e505f2bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0030c055-15bd-47c8-9269-095ac41ea238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_5eab74bd-dae1-46ff-8d0c-9adaf8160525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0030c055-15bd-47c8-9269-095ac41ea238" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_5eab74bd-dae1-46ff-8d0c-9adaf8160525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_38d3c660-dbec-4491-921c-e27363d7a6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_45e257fa-efff-44be-80bd-25bf9314aa8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_38d3c660-dbec-4491-921c-e27363d7a6f4" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_45e257fa-efff-44be-80bd-25bf9314aa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e8add021-68d3-4ad8-8e5c-40d871bc8b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_32b8fff6-7e40-4d94-b62d-964a5346c5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e8add021-68d3-4ad8-8e5c-40d871bc8b50" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_32b8fff6-7e40-4d94-b62d-964a5346c5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_66dac1c4-0cbf-4720-8686-8b4bde092eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3d45534b-e741-45ed-8b7a-81f0d9f4ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_66dac1c4-0cbf-4720-8686-8b4bde092eff" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3d45534b-e741-45ed-8b7a-81f0d9f4ed62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_566149c9-52f0-492f-bf75-a7dbbda5b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_80bdd5ff-d644-4837-b008-7bb701d68727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_566149c9-52f0-492f-bf75-a7dbbda5b08a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_80bdd5ff-d644-4837-b008-7bb701d68727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0db2b18f-5502-4f22-a9be-1e2611b78ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_566149c9-52f0-492f-bf75-a7dbbda5b08a" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0db2b18f-5502-4f22-a9be-1e2611b78ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9b89433-87ff-47db-b500-164709371502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_566149c9-52f0-492f-bf75-a7dbbda5b08a" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9b89433-87ff-47db-b500-164709371502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6bd1bd38-9edc-4061-bec9-3ef33634cad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_566149c9-52f0-492f-bf75-a7dbbda5b08a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6bd1bd38-9edc-4061-bec9-3ef33634cad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a75de158-8fce-449c-844f-20c1de677e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_13c9bec2-f17a-4370-b30b-c5cd8a228a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a75de158-8fce-449c-844f-20c1de677e57" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_13c9bec2-f17a-4370-b30b-c5cd8a228a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f4470120-fc89-43b7-a453-5ad0394a1a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c5416505-776b-4cd3-ba8e-98b8da4f03f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4470120-fc89-43b7-a453-5ad0394a1a56" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c5416505-776b-4cd3-ba8e-98b8da4f03f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_aa353d7b-b7e7-48e2-929a-8aefbe278bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4470120-fc89-43b7-a453-5ad0394a1a56" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_aa353d7b-b7e7-48e2-929a-8aefbe278bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_57d15148-a1a2-4947-be20-1d4524c90994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_57d15148-a1a2-4947-be20-1d4524c90994" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d49f7055-5179-42a9-a7cf-70cdaabb0a12" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e4d6d86d-0d84-462a-ae79-bde653e975ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e4d6d86d-0d84-462a-ae79-bde653e975ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_9742be6e-5176-4e7f-9754-9af416900b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b5497b02-61a3-4b63-bae4-0984d7b723d8" xlink:to="loc_us-gaap_TrademarksMember_9742be6e-5176-4e7f-9754-9af416900b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2d53c766-44b8-430d-89f3-e7163af367a9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_34d70a97-fec6-4d4b-a8ae-dbfc5f16b45e" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b07a3414-4e19-4e7d-911d-d80b96cfe83d" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_34d70a97-fec6-4d4b-a8ae-dbfc5f16b45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b99ff3c8-b159-4923-82b0-400ef753626d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9279a6da-cb53-4dec-8e38-4b4b9b652a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9279a6da-cb53-4dec-8e38-4b4b9b652a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement_639ac058-c691-4b59-9252-ef34bbfcef1b" xlink:href="pbh-20220930.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_SupplyCommitmentTermOfAgreement_639ac058-c691-4b59-9252-ef34bbfcef1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_6c8c2c5e-ea0c-4dc3-b175-c0b9ef1d7deb" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_6c8c2c5e-ea0c-4dc3-b175-c0b9ef1d7deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_c806273d-4334-45b2-b6f1-28a5b23ffb48" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_c806273d-4334-45b2-b6f1-28a5b23ffb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_75db7832-ab3e-4eb6-a88b-d2fab659a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_75db7832-ab3e-4eb6-a88b-d2fab659a6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_60c6232e-49ae-4521-af8f-737f5130459b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29664293-41a0-44f6-9b5d-c291ae0154f8" xlink:to="loc_us-gaap_Goodwill_60c6232e-49ae-4521-af8f-737f5130459b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9d09c586-3e4a-4c66-945c-e3f3857ea6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9d09c586-3e4a-4c66-945c-e3f3857ea6c5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_853f8aa9-1395-4d6c-a961-1a9c4af29d1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_0d73aa87-c670-4071-b2b3-5bb23a8395d3" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16324fdd-f3f2-4e62-bfe8-79ac7a323334" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_0d73aa87-c670-4071-b2b3-5bb23a8395d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a9ce9f9d-2720-4209-b484-6afe0976781c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14c5346b-0ddf-46d6-94c2-0cd829af2c4b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_910cdc12-0366-402d-9a02-988bad9f7d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_910cdc12-0366-402d-9a02-988bad9f7d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_610f065b-d8ae-41aa-ba05-bff964b60aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_Goodwill_610f065b-d8ae-41aa-ba05-bff964b60aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a2922d16-988f-406a-94c2-f0d3f5e9ee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a2922d16-988f-406a-94c2-f0d3f5e9ee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cfac030f-420e-4a4d-b170-184d22dcc075" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cfac030f-420e-4a4d-b170-184d22dcc075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ebfb14a1-c0ca-4249-813b-0cc273958317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ebfb14a1-c0ca-4249-813b-0cc273958317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_41c70a8f-3355-4ffc-8d7a-62805177214c" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_41c70a8f-3355-4ffc-8d7a-62805177214c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8a4d2b7d-c243-4d79-bee7-460c877cc6d6" xlink:href="pbh-20220930.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_8a4d2b7d-c243-4d79-bee7-460c877cc6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7ca4e664-bbd6-4096-81b2-00c553635532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7ca4e664-bbd6-4096-81b2-00c553635532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c1f50500-7692-43f0-a1c4-23b29b82a903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_2e950969-c0cf-4271-9009-cbffb8fd260a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c1f50500-7692-43f0-a1c4-23b29b82a903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#InventoriesSummaryofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e6fefa08-eab5-4dab-bf97-a90aed8fd7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a56b9d62-d9ab-425f-b729-e5b908e9b35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6fefa08-eab5-4dab-bf97-a90aed8fd7b6" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_a56b9d62-d9ab-425f-b729-e5b908e9b35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_107d81a2-9866-46cb-8960-f594abb4059f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6fefa08-eab5-4dab-bf97-a90aed8fd7b6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_107d81a2-9866-46cb-8960-f594abb4059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa365c6b-0338-4e35-9275-e6f7e33900f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6fefa08-eab5-4dab-bf97-a90aed8fd7b6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa365c6b-0338-4e35-9275-e6f7e33900f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_949f3579-b8ad-42bf-a741-950db2c4f7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6fefa08-eab5-4dab-bf97-a90aed8fd7b6" xlink:to="loc_us-gaap_InventoryNet_949f3579-b8ad-42bf-a741-950db2c4f7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#InventoriesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e0b04d38-d8cf-4871-a99e-e35ce041864a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_9e1a12ea-5012-4568-b24a-8ad2a9528ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e0b04d38-d8cf-4871-a99e-e35ce041864a" xlink:to="loc_us-gaap_InventoryValuationReserves_9e1a12ea-5012-4568-b24a-8ad2a9528ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#GoodwillScheduleofChangesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff6aaede-5108-4f1c-8c00-ce1514a80f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff6aaede-5108-4f1c-8c00-ce1514a80f8e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f19b481e-8131-4ad8-956e-93f9c155e17f" xlink:to="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_5ca02b66-46d1-46d5-82db-3b655e6bbdb7" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_5ca02b66-46d1-46d5-82db-3b655e6bbdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_6018eead-b92c-4baa-a832-db93ed8c8ad0" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f4998c7-0c96-47db-96fb-514618b6859a" xlink:to="loc_pbh_InternationalOTCHealthcareMember_6018eead-b92c-4baa-a832-db93ed8c8ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_161889c7-8c3a-4c6e-81e7-ab871e0819c0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_32083347-7784-498e-a159-ee6b6ea46c7f" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b0d5c87-0d19-4208-bb12-494e040663ab" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_32083347-7784-498e-a159-ee6b6ea46c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_60aec1c4-35bc-417a-9991-ef38539c7d11" xlink:to="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a734ee11-821d-4fc6-99b9-f129a8c99b6f" xlink:to="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_da5ceaae-074b-4271-b60c-e6d539e663a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillGross_da5ceaae-074b-4271-b60c-e6d539e663a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2b163d9f-da14-4aca-9b5b-7b3088f5e652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_2b163d9f-da14-4aca-9b5b-7b3088f5e652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_10d13fd3-85fb-4f18-a655-c23d1b689309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_Goodwill_10d13fd3-85fb-4f18-a655-c23d1b689309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c93e29fd-6e82-4c6c-94bf-38d9d77a5d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillTransfers_c93e29fd-6e82-4c6c-94bf-38d9d77a5d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c70058c1-ccf7-4b50-ab70-80377a40a43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c70058c1-ccf7-4b50-ab70-80377a40a43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_fbf720a6-bd28-4836-aea0-147df7734cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillGross_fbf720a6-bd28-4836-aea0-147df7734cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c9a07040-37a3-4ce5-903f-d75dcb50f741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c9a07040-37a3-4ce5-903f-d75dcb50f741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_338093e2-1499-44b2-9729-4e646fbeb556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9280b699-7e09-46d0-9adb-6209e2aea9d5" xlink:to="loc_us-gaap_Goodwill_338093e2-1499-44b2-9729-4e646fbeb556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0dc04306-fa94-4fff-b446-6fee8fb7f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0dc04306-fa94-4fff-b446-6fee8fb7f954" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_498c1bfb-9f26-43da-affa-0b84319a4fe8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_d84b3f92-b840-4523-bf00-9e6ff5aee65a" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6b824f84-bc46-419c-9717-8a6675d2c2f3" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_d84b3f92-b840-4523-bf00-9e6ff5aee65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_56f61e68-7d7e-4f7c-a878-95f07d7588da" xlink:to="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_271eb4c9-c6a0-4d7b-9d1f-227791042326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:to="loc_us-gaap_Goodwill_271eb4c9-c6a0-4d7b-9d1f-227791042326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_64eda75b-2c7e-4a94-b974-9c9c3ff67edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_579ccc19-54b1-45ce-a686-321c1ed1eba8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_64eda75b-2c7e-4a94-b974-9c9c3ff67edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0342e31-d1e9-4d51-844c-ee3597a6ba56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0342e31-d1e9-4d51-844c-ee3597a6ba56" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6905402-f3e4-4dbb-a254-b386b3bb856b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_ab51da54-5275-4398-8fbc-0ff46c2d55a4" xlink:href="pbh-20220930.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24f8feb4-056d-4053-868b-7b6603db729d" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_ab51da54-5275-4398-8fbc-0ff46c2d55a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5d58372-2dae-499b-9426-3f29f9649fff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_4ca0079a-b14e-4ef7-b661-15c21e19834c" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_87baf531-dee8-4c13-8219-fca1f8c139a9" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_4ca0079a-b14e-4ef7-b661-15c21e19834c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f38f8307-817c-4ed0-b375-bdbc60e354e1" xlink:to="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_b1dc6e15-2147-4c90-8280-e216919ca0a1" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_b1dc6e15-2147-4c90-8280-e216919ca0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_7548ed1e-70d0-44aa-8e25-8a9c9520577c" xlink:href="pbh-20220930.xsd#pbh_ZaditenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_986b9dd6-240a-4ed5-a7da-44663af1da4a" xlink:to="loc_pbh_ZaditenMember_7548ed1e-70d0-44aa-8e25-8a9c9520577c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:href="pbh-20220930.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_07dea73e-60f7-439f-a7eb-5c9e96cd9962" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_c4e482a2-65d8-4be3-b916-53cd4be32f57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ff4ea826-dbf9-4db1-a81a-8922fe4c3024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ff4ea826-dbf9-4db1-a81a-8922fe4c3024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_bdbc3b91-7a4d-4537-8666-6792f9b12b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_bdbc3b91-7a4d-4537-8666-6792f9b12b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_05bbdde5-9473-4210-9c8c-515bbf8ceb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_9278ea9b-2c96-4721-a061-33693ebf6b8c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_05bbdde5-9473-4210-9c8c-515bbf8ceb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_f5af4d6d-7f90-4081-ae7f-ac89b58aa78d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c28a34c6-7ca4-4276-a1aa-1a06df322952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c28a34c6-7ca4-4276-a1aa-1a06df322952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_38572fb8-14b3-4d39-bce8-0efd6f1e6b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_38572fb8-14b3-4d39-bce8-0efd6f1e6b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1783aa3f-2189-4f5f-b97f-f4da057faf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_4d952b43-da50-4bbb-956c-8dec88d58da6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1783aa3f-2189-4f5f-b97f-f4da057faf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_761b3b18-90b4-4079-856b-2c4892c57f1e" xlink:to="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c027c97b-bb68-48ab-935a-3dfc79b06683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c027c97b-bb68-48ab-935a-3dfc79b06683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_635e3688-1e14-4ba5-b2a4-6e4f3420ad80" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_635e3688-1e14-4ba5-b2a4-6e4f3420ad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bd1bf43d-3fa0-449d-8b6b-ff97163a1cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsGrossAbstract_58e35e2d-1ba1-47ea-827f-7b4dc9d9ff68" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bd1bf43d-3fa0-449d-8b6b-ff97163a1cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:href="pbh-20220930.xsd#pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward_d835ce1a-8aec-4c9e-8efb-03808a7a9034" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e4d48cd-14b9-42f8-b7e8-5834271a9917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0e4d48cd-14b9-42f8-b7e8-5834271a9917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_23a9e4a7-90f8-44ab-b7d4-9c2618add496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_23a9e4a7-90f8-44ab-b7d4-9c2618add496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_5a5f1cb2-54eb-4b03-bfb1-8fb49bdaac57" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_5a5f1cb2-54eb-4b03-bfb1-8fb49bdaac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_13dec9f9-e148-4346-89ff-5d472b952fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_8e2bfa5a-cd41-4286-aa58-f56ec8435efd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_13dec9f9-e148-4346-89ff-5d472b952fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9af45ed4-2ce7-4678-ac7c-81a3e79addcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_78a50218-d147-4a03-8e3e-727db8406472" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9af45ed4-2ce7-4678-ac7c-81a3e79addcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_0b45a1d5-8aeb-4093-b266-6604acbaf7ae" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17a74a50-5bb5-4c1c-9014-f5daf5fe6939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_59a00c4f-bc38-49c6-8bcc-221c845b2af4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_17a74a50-5bb5-4c1c-9014-f5daf5fe6939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7640bd62-a5f0-4aac-8ce1-7b93154cbbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7640bd62-a5f0-4aac-8ce1-7b93154cbbb4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_04bf2f75-4b74-4fd3-bca0-6baaf183ffe8" xlink:to="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d1c926c2-07e0-439e-83e0-890546ac3bf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:to="loc_srt_MinimumMember_d1c926c2-07e0-439e-83e0-890546ac3bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dff632fb-2e2f-4011-80a8-f69e5643fd46" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae027615-9b74-4c60-ad67-4ee0ea83be83" xlink:to="loc_srt_MaximumMember_dff632fb-2e2f-4011-80a8-f69e5643fd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e299851b-9c9b-4adf-a5eb-062c2a730f7d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_e07eb911-a73a-4330-bd9e-a5fab1cf2a65" xlink:href="pbh-20220930.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09ae3aa0-a343-4137-8038-67244dce522f" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_e07eb911-a73a-4330-bd9e-a5fab1cf2a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_3f2ea172-fe29-4fd0-a6a1-d11d1af7aaa6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_a423feae-067e-409b-bf88-2f50c7d13ebb" xlink:href="pbh-20220930.xsd#pbh_ZaditenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_3d91968b-64ea-4735-9787-0fa955de0822" xlink:to="loc_pbh_ZaditenMember_a423feae-067e-409b-bf88-2f50c7d13ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db80111d-2ccc-4c4a-892d-20c0c07daa90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired_07650694-a57f-4d61-9846-d3b1bec2c6dd" xlink:href="pbh-20220930.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_pbh_IntangibleAssetsAcquired_07650694-a57f-4d61-9846-d3b1bec2c6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7bd76f2b-2604-4ff1-a9d6-972a3e8f60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7bd76f2b-2604-4ff1-a9d6-972a3e8f60bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_064e7ba1-1cbc-4489-b3e7-47ee2d8d5a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_064e7ba1-1cbc-4489-b3e7-47ee2d8d5a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_608f0520-77bd-4020-ab4f-275cc31c274a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3f248358-a691-40db-9546-aace8bc0cd7a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_608f0520-77bd-4020-ab4f-275cc31c274a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_07197b16-828f-4aa5-a58a-3b52c21f287c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_07197b16-828f-4aa5-a58a-3b52c21f287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ace342c9-5e2d-4bfe-8667-e8035fa78fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ace342c9-5e2d-4bfe-8667-e8035fa78fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a534a09b-046b-4ba7-ba64-0e0d256d343e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a534a09b-046b-4ba7-ba64-0e0d256d343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b8b63bc8-e7c9-4095-9550-8c08545267ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b8b63bc8-e7c9-4095-9550-8c08545267ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aac1bd21-4cbb-4808-9093-16260e3e2cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aac1bd21-4cbb-4808-9093-16260e3e2cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_df7b86b4-9a4a-4042-a390-05be5a6c3246" xlink:href="pbh-20220930.xsd#pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_df7b86b4-9a4a-4042-a390-05be5a6c3246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ecaee57-368c-465f-986a-c333673c88da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c4195698-786b-44fd-8bec-a02461d5a790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ecaee57-368c-465f-986a-c333673c88da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_581216e6-9ffa-4d4c-bcb3-cf2b51666a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_581216e6-9ffa-4d4c-bcb3-cf2b51666a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_cd7e8b2e-69ae-461c-ae7b-845d683ab3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_cd7e8b2e-69ae-461c-ae7b-845d683ab3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_63d60444-8791-4432-bb44-6cd1491bcecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_OperatingLeaseCost_63d60444-8791-4432-bb44-6cd1491bcecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_1306c1d3-a518-4d06-bb74-bcea93fca4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_ShortTermLeaseCost_1306c1d3-a518-4d06-bb74-bcea93fca4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_d9933ccc-84de-46e8-8a93-f30a7bbceb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_VariableLeaseCost_d9933ccc-84de-46e8-8a93-f30a7bbceb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a4d760d1-c1a2-4f95-96d8-cdcc55273da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_18a2ffda-fa46-43ec-9349-ecd53ed2c926" xlink:to="loc_us-gaap_LeaseCost_a4d760d1-c1a2-4f95-96d8-cdcc55273da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d1f7cdbb-1acb-422a-9b90-7f8a587f2364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1f7cdbb-1acb-422a-9b90-7f8a587f2364" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4c2c0b5e-990d-4156-b453-8c5c713a6695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4c2c0b5e-990d-4156-b453-8c5c713a6695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5e36ef5e-9cb2-453b-af62-4423c8317a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5e36ef5e-9cb2-453b-af62-4423c8317a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b2974600-ed7e-4fca-a3f0-44ad400988f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b2974600-ed7e-4fca-a3f0-44ad400988f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7b9da1d9-ef67-4a0c-bb02-ddc37978f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7b9da1d9-ef67-4a0c-bb02-ddc37978f7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_557accd4-1480-4ec9-b3ed-a3ebef127818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_557accd4-1480-4ec9-b3ed-a3ebef127818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_10f742a5-0ef4-4d0b-83c2-2ed004fbed20" xlink:href="pbh-20220930.xsd#pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_10f742a5-0ef4-4d0b-83c2-2ed004fbed20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1f9f9cb-3e25-45db-8aa4-ee4d0e839495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1f9f9cb-3e25-45db-8aa4-ee4d0e839495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6c5b9b07-caf3-47ca-9186-43bd44b51c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6c5b9b07-caf3-47ca-9186-43bd44b51c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8e94a22b-a011-4ebe-a04f-35ceb16d676f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7209865e-6bab-4b41-81c5-8862b1dbe043" xlink:to="loc_us-gaap_OperatingLeaseLiability_8e94a22b-a011-4ebe-a04f-35ceb16d676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1f7cdbb-1acb-422a-9b90-7f8a587f2364" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ca83e34e-d76d-4596-90cf-c8c79869354c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ca83e34e-d76d-4596-90cf-c8c79869354c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b829308d-85a7-4c7a-9a4b-aa2dbe4c0bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b829308d-85a7-4c7a-9a4b-aa2dbe4c0bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_331df200-fa9f-4b9b-9691-a72202b398ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_331df200-fa9f-4b9b-9691-a72202b398ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f052e841-00e9-4759-b071-5b4a0119cfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f052e841-00e9-4759-b071-5b4a0119cfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ccd84bc9-9874-4f25-94d6-eed06fee58d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ccd84bc9-9874-4f25-94d6-eed06fee58d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_cb572a98-3a98-4bad-8a9e-69c2e5ea26ad" xlink:href="pbh-20220930.xsd#pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour_cb572a98-3a98-4bad-8a9e-69c2e5ea26ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2808b80f-60af-4045-b05d-6f79e1db714a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2808b80f-60af-4045-b05d-6f79e1db714a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f0c830b4-8686-4f64-8687-6793507d31ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f0c830b4-8686-4f64-8687-6793507d31ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_54a34e90-eb39-4bd2-8c06-18a560d5a0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_eb07fe61-1878-4540-9e72-ce05e7eab716" xlink:to="loc_us-gaap_FinanceLeaseLiability_54a34e90-eb39-4bd2-8c06-18a560d5a0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d1f7cdbb-1acb-422a-9b90-7f8a587f2364" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_006256ec-2244-4009-9c7f-b926f578f752" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_006256ec-2244-4009-9c7f-b926f578f752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_9154f612-ca89-4935-8011-6039554b6aa4" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_9154f612-ca89-4935-8011-6039554b6aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_fddacd8f-d02b-4f6a-9ef6-ba28c234d27d" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_fddacd8f-d02b-4f6a-9ef6-ba28c234d27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_b821788c-224f-4190-9c1b-e872ca650efa" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_b821788c-224f-4190-9c1b-e872ca650efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_a5499365-a373-4612-803a-e2cd00c75f4e" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_a5499365-a373-4612-803a-e2cd00c75f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_ef5f973d-405c-4bf9-8183-d144f87d83ba" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour_ef5f973d-405c-4bf9-8183-d144f87d83ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ef4a0bbb-4fb9-4d5f-9e12-caec5bc40bcc" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ef4a0bbb-4fb9-4d5f-9e12-caec5bc40bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_a57cc5a8-17a2-4906-a6bd-278cb088a651" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_a57cc5a8-17a2-4906-a6bd-278cb088a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_506bc095-ddb6-4ccd-a097-2b52193e9855" xlink:href="pbh-20220930.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9c355f39-1c38-4eba-8330-1b7ca25c5b68" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_506bc095-ddb6-4ccd-a097-2b52193e9855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_36ffe8a1-31f2-4848-b0e5-d68e5a9375a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_d794b24a-77cd-4769-8f5f-36a68409d00d" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ffe8a1-31f2-4848-b0e5-d68e5a9375a1" xlink:to="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_d794b24a-77cd-4769-8f5f-36a68409d00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e12a04f-a086-49df-911e-09e69ec77150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_d794b24a-77cd-4769-8f5f-36a68409d00d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e12a04f-a086-49df-911e-09e69ec77150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_31d81d70-7f1f-469b-aad3-86db946d3056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_d794b24a-77cd-4769-8f5f-36a68409d00d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_31d81d70-7f1f-469b-aad3-86db946d3056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract_1f40601f-4848-4862-a14c-3103fe030a3a" xlink:href="pbh-20220930.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ffe8a1-31f2-4848-b0e5-d68e5a9375a1" xlink:to="loc_pbh_WeightedAverageDiscountRateAbstract_1f40601f-4848-4862-a14c-3103fe030a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_adaa25bb-983b-4b5a-ac25-04c5326c7323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_1f40601f-4848-4862-a14c-3103fe030a3a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_adaa25bb-983b-4b5a-ac25-04c5326c7323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_4cac242c-d8b0-48dc-a672-9b9cd9086f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_1f40601f-4848-4862-a14c-3103fe030a3a" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_4cac242c-d8b0-48dc-a672-9b9cd9086f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_beb58f46-4079-4122-8da7-a92a93046243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_beb58f46-4079-4122-8da7-a92a93046243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7684dc79-bd50-4677-bf04-b2247caca7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7684dc79-bd50-4677-bf04-b2247caca7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_c8e34dd8-68eb-48d0-b293-682bb12763c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_c8e34dd8-68eb-48d0-b293-682bb12763c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e31c9ba2-3357-4e72-a4d5-17c6dbaabddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e31c9ba2-3357-4e72-a4d5-17c6dbaabddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_8c3bdced-8aee-4f49-bbf0-25dd7afa3e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_8c3bdced-8aee-4f49-bbf0-25dd7afa3e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_24ff140e-d6f5-461a-90f0-4286e7bbe32d" xlink:href="pbh-20220930.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_pbh_AccruedProductionCostsCurrent_24ff140e-d6f5-461a-90f0-4286e7bbe32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dfcef794-10d2-45f7-b75f-95dd09017452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dfcef794-10d2-45f7-b75f-95dd09017452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_140fbb86-1e21-4c02-b139-43bcc201adc4" xlink:href="pbh-20220930.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1fe9c5a5-564a-43fe-b862-368c0993b56e" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_140fbb86-1e21-4c02-b139-43bcc201adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6ceb9b4-97b4-491b-9c5c-0d4540b16fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6ceb9b4-97b4-491b-9c5c-0d4540b16fa2" xlink:to="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cdc4874c-cccd-4443-9b62-ddd84f085633" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2d108380-6b45-4667-a656-b04fdd8e3850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_SeniorNotesMember_2d108380-6b45-4667-a656-b04fdd8e3850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_8587e99e-95b2-4846-999e-675455fd235d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_LoansPayableMember_8587e99e-95b2-4846-999e-675455fd235d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a1fcaac3-9172-46eb-8651-4ae0fdf7a678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ec75aad2-09e2-486d-8f53-e071cd7b24bb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a1fcaac3-9172-46eb-8651-4ae0fdf7a678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a16f53ee-4c7b-4c8b-97b1-d19f3e002e50" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_e2f10efa-1324-4f2e-8ca2-96630225e19a" xlink:href="pbh-20220930.xsd#pbh_A2021SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_A2021SeniorNotesMember_e2f10efa-1324-4f2e-8ca2-96630225e19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_c4faf6bd-6a02-4d50-931d-58b3583c2b3d" xlink:href="pbh-20220930.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_A2019SeniorNotesMember_c4faf6bd-6a02-4d50-931d-58b3583c2b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5f5330e6-aa3b-4975-b6bc-4148bb35a8ec" xlink:href="pbh-20220930.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5f5330e6-aa3b-4975-b6bc-4148bb35a8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_6499bbcd-485b-4077-bd19-447c66081444" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0ebda502-72f1-484b-a482-a1b46e850347" xlink:to="loc_pbh_AblRevolver2012Member_6499bbcd-485b-4077-bd19-447c66081444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e9c86292-8091-412d-b347-a6e318b680b5" xlink:to="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_17c3459d-8ced-471f-9928-5c762fa87d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_17c3459d-8ced-471f-9928-5c762fa87d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_7c001621-9eff-4f95-9373-037d0d274177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_148eb86e-0e19-4c38-9d00-b21539309ad5" xlink:to="loc_us-gaap_BaseRateMember_7c001621-9eff-4f95-9373-037d0d274177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6f7ceb09-4b86-40e4-9e9c-1cb88c78f3ee" xlink:to="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4444a7a9-77bd-4773-a24c-3ac4255d9c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4444a7a9-77bd-4773-a24c-3ac4255d9c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc80808d-f6da-4aae-8c85-f5ab0a232a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc80808d-f6da-4aae-8c85-f5ab0a232a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_75de8b01-4a01-4d94-b21a-79fd3b967dd3" xlink:href="pbh-20220930.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_75de8b01-4a01-4d94-b21a-79fd3b967dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fd6558ee-437d-475e-a30f-92aa8beb1ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_fd6558ee-437d-475e-a30f-92aa8beb1ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6e1c3bec-bd7b-4ca0-a201-dd758c83d658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6e1c3bec-bd7b-4ca0-a201-dd758c83d658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5949054b-e9ae-4f52-92cf-1accd7291bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_5949054b-e9ae-4f52-92cf-1accd7291bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a38c424-7b82-4066-b9ac-fc3c5ca89315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_15721f93-6a1d-4161-9607-baaab2438ac6" xlink:to="loc_us-gaap_LongTermDebt_4a38c424-7b82-4066-b9ac-fc3c5ca89315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cc58bad9-688c-4636-877a-b82a2039e565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cc58bad9-688c-4636-877a-b82a2039e565" xlink:to="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:to="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d30197bc-dcf9-4ac7-872c-f3c8bd330e4f" xlink:to="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_76c0ce32-63bf-402c-a6f3-09241420f608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_268476a4-db22-49ee-b1a2-a86d943f23c4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_76c0ce32-63bf-402c-a6f3-09241420f608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:to="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_08ee7caa-2cc1-4673-97fd-a9bca95c9714" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_1dda682f-4bcb-45b0-93ad-b23549e70d8b" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e37f7afd-ee38-489e-8142-2b5d6c9281ce" xlink:to="loc_pbh_AblRevolver2012Member_1dda682f-4bcb-45b0-93ad-b23549e70d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3ad9df21-0981-4f54-9c57-526752e35066" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_adb291ec-5532-4def-80cc-8e899e39bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_adb291ec-5532-4def-80cc-8e899e39bed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_93a53e51-14d9-4ee2-b9c9-5db50c5931fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a7cdfb8a-3776-452c-a5c9-d0159aaf9421" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_93a53e51-14d9-4ee2-b9c9-5db50c5931fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e2711c6a-1e41-4007-9085-cbaa79900cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e2711c6a-1e41-4007-9085-cbaa79900cc9" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_dd07fe03-50d6-4b03-87fc-8a5985d2d491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_dd07fe03-50d6-4b03-87fc-8a5985d2d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_63b35a8f-e72b-476a-a19e-66e0712ac0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_63b35a8f-e72b-476a-a19e-66e0712ac0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_7f0dcd94-3475-46ec-ad62-9acd55f24ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_7f0dcd94-3475-46ec-ad62-9acd55f24ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7da825a7-7845-4017-858f-782c88a2c972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7da825a7-7845-4017-858f-782c88a2c972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_8ef1351c-f2de-4eaf-baab-d443f1f65e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_8ef1351c-f2de-4eaf-baab-d443f1f65e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermDebtMaturityAfterYearFour_3eae3e08-cdfe-40ca-abe6-808d7a57785c" xlink:href="pbh-20220930.xsd#pbh_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_pbh_LongTermDebtMaturityAfterYearFour_3eae3e08-cdfe-40ca-abe6-808d7a57785c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5cbeb250-0aca-4c61-918a-e075f0b4b2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3b9e4019-8404-4c6b-9e5d-824f8642cb2d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5cbeb250-0aca-4c61-918a-e075f0b4b2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_91cbb621-f85b-44c2-b78c-ae174d547bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_91cbb621-f85b-44c2-b78c-ae174d547bc2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_436b73a7-3ca3-4a27-9e5e-706c2286bf01" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5c99c73a-c13d-4836-a0d1-c5b96bb40f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d43fa25-bff5-4bcc-8c38-d1acda6f7a1c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5c99c73a-c13d-4836-a0d1-c5b96bb40f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a78edf35-fa32-4910-9ecc-54d0d567f112" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_66310c5b-f46d-4a51-9f9f-88e60c0a83ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_SeniorNotesMember_66310c5b-f46d-4a51-9f9f-88e60c0a83ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_f0378ef6-5b21-47f2-8122-30c8b890a0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_LoansPayableMember_f0378ef6-5b21-47f2-8122-30c8b890a0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f3832d99-e641-40e3-a527-9febeaa780db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_53c0754f-c500-49bd-a76b-7fca4999bb65" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f3832d99-e641-40e3-a527-9febeaa780db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f772652e-7ab7-470f-a042-8a8e2cfb8b64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_59d0b94d-c2e6-4708-92b8-6e327c808a23" xlink:href="pbh-20220930.xsd#pbh_A2021SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_A2021SeniorNotesMember_59d0b94d-c2e6-4708-92b8-6e327c808a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_08b9c596-a316-4fcf-b409-af6d64bebfc5" xlink:href="pbh-20220930.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_A2019SeniorNotesMember_08b9c596-a316-4fcf-b409-af6d64bebfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5227419b-a82a-4780-9f3c-2f1528a6c76e" xlink:href="pbh-20220930.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_5227419b-a82a-4780-9f3c-2f1528a6c76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_5cbf4da0-e46b-4312-8b21-d252f125f9ad" xlink:href="pbh-20220930.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbb21d53-751c-4515-b2eb-59969e8d50c1" xlink:to="loc_pbh_AblRevolver2012Member_5cbf4da0-e46b-4312-8b21-d252f125f9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_72045994-f901-4091-a461-ca8377289dc1" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e1c70d9f-ea47-4a1f-bc8b-f457c2c93379" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6095ca7b-5971-4ded-a50e-23525a32d86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_6095ca7b-5971-4ded-a50e-23525a32d86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1b260e2a-28cc-4c56-a8fe-f224798dc977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_41498f0b-6339-4c10-81fe-4efc2ec00710" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1b260e2a-28cc-4c56-a8fe-f224798dc977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad705a3e-5261-41ea-826a-31713e5b7af5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_30ea21a3-8ee1-45be-a580-37200852ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_916f9a9b-a6f3-481c-9d7c-dd6f354f9582" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_30ea21a3-8ee1-45be-a580-37200852ddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4c0e8bbb-0231-49aa-9e93-46212b3b6397" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_eb880816-9fd3-47d4-b015-5824d306e5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:to="loc_us-gaap_LongTermDebtFairValue_eb880816-9fd3-47d4-b015-5824d306e5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_8cb48462-bcf5-49e1-b73b-7f82c00a0d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_049d12ba-fabf-4307-b5a7-832af12acf14" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_8cb48462-bcf5-49e1-b73b-7f82c00a0d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f02649b5-bcb5-4269-8263-01d0451184a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f02649b5-bcb5-4269-8263-01d0451184a5" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_450a6a3f-d448-4502-b5da-05d49337fce3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fdb41377-4227-459b-913c-04e4a45a5b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bdf5e9fe-ea39-4272-ab28-a05d02ed6a1e" xlink:to="loc_us-gaap_InterestRateSwapMember_fdb41377-4227-459b-913c-04e4a45a5b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:to="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d5a16054-e852-44c4-8127-e620d67db968" xlink:to="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33e8624d-d6e1-431f-a089-01a82f154f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_46da20c0-2128-49f1-add6-30ddef83d1d6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_33e8624d-d6e1-431f-a089-01a82f154f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_c391e80b-0a25-486b-ab9a-7afdc210c2ed" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_625214ee-bb1e-4c0c-a1ae-c3b2e2162456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_625214ee-bb1e-4c0c-a1ae-c3b2e2162456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_02c092c9-a44a-4e78-a926-71d16cc7cf58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_97218f86-1c18-4687-b796-006a800eab46" xlink:to="loc_us-gaap_DerivativeNotionalAmount_02c092c9-a44a-4e78-a926-71d16cc7cf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#DerivativeInstrumentsSummaryofInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4b95a19-dc3b-47e5-abd6-035bea5e5d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4b95a19-dc3b-47e5-abd6-035bea5e5d1d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3f80dcd-4061-4ba3-8a04-52028935a4ed" xlink:to="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5d499ad5-21f3-4b41-a75d-482132c6af30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2fd9ffbf-81e3-4310-ba76-7c46b0434369" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5d499ad5-21f3-4b41-a75d-482132c6af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_57257292-c03d-4b19-bc9d-0c311789fb71" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8a2b083e-7037-48e5-9a47-de612f3ad09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20333a8f-ba75-4018-8af8-0b855ca08573" xlink:to="loc_us-gaap_InterestRateSwapMember_8a2b083e-7037-48e5-9a47-de612f3ad09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2cd4c334-75f7-4ef6-bff7-3cbf4c6ebc19" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d109cc4a-e90c-4bf9-b169-84c0e6eaac7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_edd3ebcf-dde3-4828-8fac-1f1ab5426e8f" xlink:to="loc_us-gaap_InterestExpenseMember_d109cc4a-e90c-4bf9-b169-84c0e6eaac7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_d60a21de-ebec-4d47-849f-ce1b758f7300" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_34bcb740-f365-43b0-a028-f8cb015574b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_34bcb740-f365-43b0-a028-f8cb015574b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_039c67cb-d7a7-4c45-ad33-8c4a9f20cccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5d9c9dd9-fde5-49f3-9a16-ed8b36dc0450" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_039c67cb-d7a7-4c45-ad33-8c4a9f20cccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0994a69d-4f1e-4765-b3c0-673344b7c61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0994a69d-4f1e-4765-b3c0-673344b7c61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_02b87c81-4de4-48af-b9c4-902deb1d8a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_02b87c81-4de4-48af-b9c4-902deb1d8a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7f80dbdb-3a16-4aec-a93d-5ecf1da670e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7f80dbdb-3a16-4aec-a93d-5ecf1da670e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_25ea4cf4-5c07-4f06-8c2d-dc6e7ab6f26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_25ea4cf4-5c07-4f06-8c2d-dc6e7ab6f26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_fa50e288-24d3-4fdd-a528-a8c0fbfef2f0" xlink:href="pbh-20220930.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_fa50e288-24d3-4fdd-a528-a8c0fbfef2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_27555425-b4da-429f-9a43-6889a01a8756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_90b55693-2e34-4e6b-a906-d11f5248496c" xlink:to="loc_us-gaap_DividendsCommonStock_27555425-b4da-429f-9a43-6889a01a8756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#StockholdersEquityScheduleofRepurchasedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2fc9c4d1-b9cd-4d2e-a154-e318178f710a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2fc9c4d1-b9cd-4d2e-a154-e318178f710a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:to="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_24ed4421-742e-45b7-8105-0789377ef274" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ea0f72e1-5ea0-43c5-80f5-d89df76600ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37782234-f23a-4435-b9c8-68b460abefdb" xlink:to="loc_us-gaap_RestrictedStockMember_ea0f72e1-5ea0-43c5-80f5-d89df76600ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_ad22b2a0-d637-43ed-be0a-12606224934c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_a7693cb8-e93f-4003-921b-489bbb8aa850" xlink:href="pbh-20220930.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3c343213-5c92-4c2e-bc59-28fbab9eaa36" xlink:to="loc_pbh_ShareRepurchaseProgramMember_a7693cb8-e93f-4003-921b-489bbb8aa850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6c8c5822-4ed7-4709-b66c-2ade6c757d7f" xlink:to="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9a749f7f-7932-4e15-baa2-5f83e1b298c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9a749f7f-7932-4e15-baa2-5f83e1b298c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_430d973b-2f3d-410d-9011-8172f56f71ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_430d973b-2f3d-410d-9011-8172f56f71ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_fdc5a913-d1be-4f74-bddf-4d79ef785709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_10ff0293-191f-4789-abf0-1ab79179d054" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_fdc5a913-d1be-4f74-bddf-4d79ef785709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_022d624b-5696-4518-aebb-56af0a9e9940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_022d624b-5696-4518-aebb-56af0a9e9940" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a686cca3-b89e-4f7d-bc83-2f77f3ab9716" xlink:to="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4d33222b-8639-4062-89b4-14c5dd0579ac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d9e234ba-e559-48bb-bd98-74a926233e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d9e234ba-e559-48bb-bd98-74a926233e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0104a565-3394-4308-a1a5-65ef92f7f82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c9e4c5fa-90fd-407b-9b42-2099c2dc34f8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0104a565-3394-4308-a1a5-65ef92f7f82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_42378724-18d0-4d15-ab61-5c5f9fb9fa05" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_222cd745-e432-4ce1-be5a-1838f665f7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:to="loc_us-gaap_StockholdersEquity_222cd745-e432-4ce1-be5a-1838f665f7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_cdf164ad-4525-4c42-8481-e8e4148f177b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_92333627-87e3-4ed4-b464-e702b75d6af3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_cdf164ad-4525-4c42-8481-e8e4148f177b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#AccumulatedOtherComprehensiveLossNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_424be631-042e-45cc-a48f-d1dacc9b6fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2e374d2b-ea01-4b16-ae09-5de4bb3b8037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_424be631-042e-45cc-a48f-d1dacc9b6fc3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2e374d2b-ea01-4b16-ae09-5de4bb3b8037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6e28fe5f-2e2e-42c8-9b9a-0be7f7cd9ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_f722954e-6ee6-4875-b0e6-85d60dd89255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6e28fe5f-2e2e-42c8-9b9a-0be7f7cd9ed3" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_f722954e-6ee6-4875-b0e6-85d60dd89255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_9e36d066-accc-47d6-9ae0-40886c97b1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_f722954e-6ee6-4875-b0e6-85d60dd89255" xlink:to="loc_us-gaap_NetIncomeLossAbstract_9e36d066-accc-47d6-9ae0-40886c97b1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4c2ceb3-2745-41d2-a61e-4e6113b83169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_9e36d066-accc-47d6-9ae0-40886c97b1d8" xlink:to="loc_us-gaap_NetIncomeLoss_b4c2ceb3-2745-41d2-a61e-4e6113b83169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_80b0e49f-9f89-4702-9e76-c31d4282ade3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_f722954e-6ee6-4875-b0e6-85d60dd89255" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_80b0e49f-9f89-4702-9e76-c31d4282ade3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8dfb5a3d-cf7f-4200-8287-d2638e00a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_80b0e49f-9f89-4702-9e76-c31d4282ade3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8dfb5a3d-cf7f-4200-8287-d2638e00a1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_35d89e55-f89f-4607-b5c4-7fb6c5292abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_80b0e49f-9f89-4702-9e76-c31d4282ade3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_35d89e55-f89f-4607-b5c4-7fb6c5292abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2886c166-c83f-4b68-bdfa-e09996f97305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_80b0e49f-9f89-4702-9e76-c31d4282ade3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2886c166-c83f-4b68-bdfa-e09996f97305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_72f6bbb3-40ae-46d0-886c-1b3da785fe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_f722954e-6ee6-4875-b0e6-85d60dd89255" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_72f6bbb3-40ae-46d0-886c-1b3da785fe9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_375b8c87-1ae9-4370-941b-fe78358f05fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_72f6bbb3-40ae-46d0-886c-1b3da785fe9b" xlink:to="loc_us-gaap_EarningsPerShareBasic_375b8c87-1ae9-4370-941b-fe78358f05fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b7b6f8d1-5662-4c67-95d3-7c835210c53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_72f6bbb3-40ae-46d0-886c-1b3da785fe9b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b7b6f8d1-5662-4c67-95d3-7c835210c53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EarningsPerShareAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_414cd93f-e06e-47e9-9d92-e5c4ba969b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_414cd93f-e06e-47e9-9d92-e5c4ba969b42" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87a328d1-b41b-4136-b8a2-b6ffc3201a60" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_0b73e81d-2b5a-42d9-a087-8c6affb7e5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6718c0a2-bb51-49d8-b195-9588b2c0374c" xlink:to="loc_us-gaap_StockCompensationPlanMember_0b73e81d-2b5a-42d9-a087-8c6affb7e5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fce7b54-9786-485c-90af-d868e15452de" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee31f3bf-9fa5-4682-8cfd-0e6f8405ad58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_876f93a6-709a-486b-8efc-756ebbc053cb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee31f3bf-9fa5-4682-8cfd-0e6f8405ad58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61ecf5f4-839d-4fa9-810a-d276706934a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61ecf5f4-839d-4fa9-810a-d276706934a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1a61dac1-656c-48d2-81ac-6c3bf5d4f3b7" xlink:to="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_42dc7ed3-7b3c-4468-bb1e-fde744b174e5" xlink:href="pbh-20220930.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_42dc7ed3-7b3c-4468-bb1e-fde744b174e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_17a756e5-efe4-4f1e-ba83-3e384def8a21" xlink:href="pbh-20220930.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fb2127a6-b82c-435b-8042-be8b2617603a" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_17a756e5-efe4-4f1e-ba83-3e384def8a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_be15ae3c-cb67-4a77-a88a-b237f9995b2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_e537c8ea-b26d-48bb-b1d1-b5c94f42e580" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_e537c8ea-b26d-48bb-b1d1-b5c94f42e580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_e63ac426-e38c-4c63-9a01-91c9df0a325b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_us-gaap_PerformanceSharesMember_e63ac426-e38c-4c63-9a01-91c9df0a325b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_bf332247-c191-4015-8582-278fe0c9c73b" xlink:href="pbh-20220930.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_bf332247-c191-4015-8582-278fe0c9c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_43f6d560-146d-49b5-a71c-6990feee5179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d0cab8a-7fd3-416f-a763-f39e03e47429" xlink:to="loc_us-gaap_EmployeeStockOptionMember_43f6d560-146d-49b5-a71c-6990feee5179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_382ca116-42a5-40d5-a1f1-1a8d0002055e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_233c131a-f060-409c-85ac-905cafde695c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e16c32e3-a02b-41b7-b936-a9f290efb510" xlink:to="loc_srt_DirectorMember_233c131a-f060-409c-85ac-905cafde695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f6217f40-9a1f-4485-9944-176c6078fa62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5d0b6a65-b2d7-45ea-8df6-6cdf3c0cdc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5d0b6a65-b2d7-45ea-8df6-6cdf3c0cdc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_52a4ed1a-373c-4c6d-93c6-d6bcbf1b2d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_52a4ed1a-373c-4c6d-93c6-d6bcbf1b2d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_880ea8f1-3762-40ec-a829-abd218025079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_880ea8f1-3762-40ec-a829-abd218025079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_52e8eb28-9050-48f7-84b1-ccb2a8baf0e0" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_52e8eb28-9050-48f7-84b1-ccb2a8baf0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fb5caaab-5c54-4802-b74d-aeaa956b65c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_fb5caaab-5c54-4802-b74d-aeaa956b65c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_c7ec8494-7f16-48ab-bba7-1b05a4a4a6c8" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_c7ec8494-7f16-48ab-bba7-1b05a4a4a6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_dd2d16f3-5859-4279-9c51-29b692fbdd15" xlink:href="pbh-20220930.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_dd2d16f3-5859-4279-9c51-29b692fbdd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_198c1230-4150-47ee-ab2f-1fc065fc60b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_198c1230-4150-47ee-ab2f-1fc065fc60b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4c1295ab-f930-4710-a6f7-7ece7d185e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4c1295ab-f930-4710-a6f7-7ece7d185e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e1427b4b-a15b-4653-9de4-3ddb891eefd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e1427b4b-a15b-4653-9de4-3ddb891eefd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b5ca7d-662e-4e70-9ebf-53f3f5749731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_09b5ca7d-662e-4e70-9ebf-53f3f5749731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dbc75c2c-ccff-408a-bb09-58b38f196c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dbc75c2c-ccff-408a-bb09-58b38f196c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_2ce8bb25-2121-4c5e-9b2d-ec01e69de2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_2ce8bb25-2121-4c5e-9b2d-ec01e69de2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bc6ec0c7-c181-4766-a60f-2be34670c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb296532-6163-4ccc-aa71-d38b18dfbb50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bc6ec0c7-c181-4766-a60f-2be34670c23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0f58318b-817e-42ab-9629-823d86a1192f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0f58318b-817e-42ab-9629-823d86a1192f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3ef8c419-f944-4709-9a68-d24bcfa1116b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3ef8c419-f944-4709-9a68-d24bcfa1116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_1741af89-69f7-4a2b-aa97-5bbe139aa988" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_1741af89-69f7-4a2b-aa97-5bbe139aa988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4e54cc2c-639c-4e30-a702-e6dde0123fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4e54cc2c-639c-4e30-a702-e6dde0123fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_9aae144e-0743-45d3-ab7b-e0234f16de4b" xlink:href="pbh-20220930.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_efa2edb1-137b-4509-a996-e8e6cbb27a49" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_9aae144e-0743-45d3-ab7b-e0234f16de4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_70b66add-5c29-48ee-b750-042e8405dec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_70b66add-5c29-48ee-b750-042e8405dec2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:to="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f6d84a15-e613-49a0-aa30-5a504b2c765f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_10eee0dd-ce26-484e-b040-0e6dc28a4942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82e1af84-efff-4a0d-bd20-9e851a91e8c8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_10eee0dd-ce26-484e-b040-0e6dc28a4942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8158161-fa35-40b1-a086-94e45d8b9cfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2a373ec-b025-481a-b6b7-e2aa3579e496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c2a373ec-b025-481a-b6b7-e2aa3579e496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1603ab53-988a-4b29-88a7-57323d6ec741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1603ab53-988a-4b29-88a7-57323d6ec741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_26744f1d-c9c0-4d92-b3c7-b2ebef036b13" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares_26744f1d-c9c0-4d92-b3c7-b2ebef036b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_6eed3de3-3f5d-4ee0-bb6c-e20f3df0098c" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_6eed3de3-3f5d-4ee0-bb6c-e20f3df0098c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e21c89ee-6be5-4d91-9ae3-e33c2b287724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e21c89ee-6be5-4d91-9ae3-e33c2b287724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_18cba313-b065-4b78-9893-cf0af89f44d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_405fa987-a29a-4dd1-9162-411decc7a77b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_18cba313-b065-4b78-9893-cf0af89f44d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_5a866309-0a43-43ed-956f-d39ca21858ef" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_5a866309-0a43-43ed-956f-d39ca21858ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_93c80140-42c1-4c36-a8ff-39c3848295d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_93c80140-42c1-4c36-a8ff-39c3848295d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db0ac3a7-659f-49a1-aae7-4188c39e9a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db0ac3a7-659f-49a1-aae7-4188c39e9a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_f4f437a0-22da-4689-b7e9-d06e587048ac" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_f4f437a0-22da-4689-b7e9-d06e587048ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_be1aa49e-7f5c-4263-b6ac-6c3a431c72d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_be1aa49e-7f5c-4263-b6ac-6c3a431c72d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8ab3352c-2718-4eda-bd8a-0109540e2d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_965750d1-8fa7-4d1b-ba35-43df58ede570" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8ab3352c-2718-4eda-bd8a-0109540e2d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_bd041e30-593d-4061-9b1a-9d09bfbaa602" xlink:href="pbh-20220930.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dce66b67-6b6c-4a05-be62-7000e11e02ff" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_bd041e30-593d-4061-9b1a-9d09bfbaa602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6d594862-acf6-4c41-8d08-a1c0a75933c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6d594862-acf6-4c41-8d08-a1c0a75933c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:to="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f61de086-a7bf-4b8f-9716-9b5ceef01b34" xlink:to="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_153c36f9-0357-4b66-aabb-d2b191a9dda7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:to="loc_srt_MinimumMember_153c36f9-0357-4b66-aabb-d2b191a9dda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b1730af3-e95d-4828-bc24-fa78d6d37715" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7cad59f-cc1a-4586-9f40-041799d0417e" xlink:to="loc_srt_MaximumMember_b1730af3-e95d-4828-bc24-fa78d6d37715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:to="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_44c8b56c-9ddb-4379-910f-19ce8c69da64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5c96abdf-6f54-498e-8929-c6f6b472700d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5ebbaf0-43da-4281-9270-74d9b89d2731" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5c96abdf-6f54-498e-8929-c6f6b472700d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84f98bcd-07ce-49c9-a3af-d0d98ad8e164" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6ff5f1be-78c0-4a3f-bf92-cd28c8d46ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6ff5f1be-78c0-4a3f-bf92-cd28c8d46ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_f8936a4f-e8f4-4a5d-a1ae-c0aeb20c125d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_f8936a4f-e8f4-4a5d-a1ae-c0aeb20c125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0616baed-c621-4cb0-8431-f2db65dfbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0616baed-c621-4cb0-8431-f2db65dfbe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4505a153-3278-4842-af5c-c160ee78cbed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4505a153-3278-4842-af5c-c160ee78cbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52923a37-78d9-47a0-b69a-a0ac596d247d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8b03e010-9607-46c9-bfdf-3d4d7ab77c61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52923a37-78d9-47a0-b69a-a0ac596d247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b6cbd7d6-76ee-44ca-b4cd-edfdb38bba5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b6cbd7d6-76ee-44ca-b4cd-edfdb38bba5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f9b43040-4f8e-42aa-ac71-0dec6dfe3697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f9b43040-4f8e-42aa-ac71-0dec6dfe3697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fa41d88-be7d-4dc7-94a9-de62c693ebaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4fa41d88-be7d-4dc7-94a9-de62c693ebaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bc5a8c34-7c0a-4f60-9b05-4f8be8dbd549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bc5a8c34-7c0a-4f60-9b05-4f8be8dbd549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f78066b6-b93a-4ae1-a935-cceedb320381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f78066b6-b93a-4ae1-a935-cceedb320381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3f54975-30c5-4955-9ee9-a23d48a5df14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_06ce72b8-6d6d-4e4d-84a8-39fe4dea396a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3f54975-30c5-4955-9ee9-a23d48a5df14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_befda723-1fae-4e7e-a7a3-84019505a254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_befda723-1fae-4e7e-a7a3-84019505a254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5061516c-d381-47a3-93a1-d99b31191158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5061516c-d381-47a3-93a1-d99b31191158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d7b4623a-4a71-4608-a8f1-b23587b27dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d7b4623a-4a71-4608-a8f1-b23587b27dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6adf9538-6598-408e-842b-992e2d9709f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6adf9538-6598-408e-842b-992e2d9709f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f78c752d-dc0c-41f0-95a1-0857d687c2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f78c752d-dc0c-41f0-95a1-0857d687c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_74044042-d3a7-44a9-a7fc-63ce7a0d5c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_74044042-d3a7-44a9-a7fc-63ce7a0d5c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2d8228c-80d0-4d64-8584-fc40dec8164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c1dd1610-c759-4ba2-adcb-859039f5a96c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2d8228c-80d0-4d64-8584-fc40dec8164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_09bc88ab-2d25-4775-9cd4-b6a34099d066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_09bc88ab-2d25-4775-9cd4-b6a34099d066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b2b5eeb-8c5b-4b43-b276-891180c33e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b2b5eeb-8c5b-4b43-b276-891180c33e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_27d4666c-9549-455d-b283-c8ab179772c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b2b5eeb-8c5b-4b43-b276-891180c33e72" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_27d4666c-9549-455d-b283-c8ab179772c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_47907c39-489d-4674-8c1b-f32681d8ceda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b2b5eeb-8c5b-4b43-b276-891180c33e72" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_47907c39-489d-4674-8c1b-f32681d8ceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a1159b13-b59a-4603-9f79-fa97b93f145d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b2b5eeb-8c5b-4b43-b276-891180c33e72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a1159b13-b59a-4603-9f79-fa97b93f145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a9380660-6076-43ca-8bac-90ba50242f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9966b47-6636-4cc8-bed8-99c5005c28b8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a9380660-6076-43ca-8bac-90ba50242f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dea2323a-7db7-4c20-829d-8022a7cfae80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ea5016a7-1ad2-4bfe-b1d9-18e0437c3436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dea2323a-7db7-4c20-829d-8022a7cfae80" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ea5016a7-1ad2-4bfe-b1d9-18e0437c3436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b38bb45f-5991-455f-a38b-ff9299053d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a67db7c5-9ce4-458e-82c6-cb9c2d7b7bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b38bb45f-5991-455f-a38b-ff9299053d09" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a67db7c5-9ce4-458e-82c6-cb9c2d7b7bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5cf0e8fb-881a-423b-bc9a-bbf9b0c2cebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b38bb45f-5991-455f-a38b-ff9299053d09" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5cf0e8fb-881a-423b-bc9a-bbf9b0c2cebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dc208c9d-2a58-4488-b8a1-cca928cd2a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b38bb45f-5991-455f-a38b-ff9299053d09" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_dc208c9d-2a58-4488-b8a1-cca928cd2a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_463df172-e6fe-4b37-99a0-21d8f2b40cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_463df172-e6fe-4b37-99a0-21d8f2b40cf7" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_72d2343c-1a50-47a4-b909-d760a301ea29" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_55a60965-6221-4887-bdaf-a1876c8f76c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:to="loc_us-gaap_NonqualifiedPlanMember_55a60965-6221-4887-bdaf-a1876c8f76c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_9cae47e0-e430-4c42-a1fd-b5bfbbc5832e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_9d0451f1-ee56-44d8-96bf-6aeba0ed33a9" xlink:to="loc_us-gaap_QualifiedPlanMember_9cae47e0-e430-4c42-a1fd-b5bfbbc5832e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8e2401b8-7e38-4247-93fc-6e9faf0e3090" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_28cac052-04a2-487b-8cca-69470e08dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_28cac052-04a2-487b-8cca-69470e08dc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_c025450e-4c86-42f9-a1fe-728ceedfb171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_c025450e-4c86-42f9-a1fe-728ceedfb171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_eb688baf-b34b-4675-a4f9-b026b0a295f2" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum_eb688baf-b34b-4675-a4f9-b026b0a295f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_3d4ba158-62cf-4337-a148-628a8326aef4" xlink:href="pbh-20220930.xsd#pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract_3d4ba158-62cf-4337-a148-628a8326aef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_93ae0903-2339-4ae3-8983-3d2d5ed60876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0d7ec0e4-7432-43a9-aa03-b86f4314b5f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_93ae0903-2339-4ae3-8983-3d2d5ed60876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#ConcentrationsofRiskDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_d4b1c31c-6d80-461d-878e-2f404e5bd92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_d4b1c31c-6d80-461d-878e-2f404e5bd92b" xlink:to="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8cc033b9-9f4b-4a6f-a74b-07edf7f81484" xlink:to="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TopFiveBrandsMember_c795a8e0-50c8-468a-b591-2cf121110638" xlink:href="pbh-20220930.xsd#pbh_TopFiveBrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:to="loc_pbh_TopFiveBrandsMember_c795a8e0-50c8-468a-b591-2cf121110638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember_71c1415d-89a1-43e8-8078-fb07abb197e1" xlink:href="pbh-20220930.xsd#pbh_ManufacturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4f8153a2-2785-4c48-869f-76bc5eef08f8" xlink:to="loc_pbh_ManufacturesMember_71c1415d-89a1-43e8-8078-fb07abb197e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f34978e2-04df-4ab3-91bd-ba231bbbfbab" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_a2cf4391-821b-4468-abc1-5d907ddccdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0009bd-60f9-4cda-909d-202a5bc89bed" xlink:to="loc_us-gaap_SalesMember_a2cf4391-821b-4468-abc1-5d907ddccdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_622d6517-3fc1-4ceb-8b12-26c8486143c3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_e386b69b-4790-441a-8af1-2246bc6a1eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_e386b69b-4790-441a-8af1-2246bc6a1eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_af23a945-a54a-4f86-a6d2-cbdc154d3382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_af23a945-a54a-4f86-a6d2-cbdc154d3382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_07e8b08d-dfd3-4b68-b9a1-29a729a885cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b7f1e148-b9a9-4011-aa17-d8595391e07e" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_07e8b08d-dfd3-4b68-b9a1-29a729a885cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_f481d793-7d8b-49d4-a40d-39080e021999" xlink:to="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_0da73e18-b33d-417f-851b-f3712244c8d7" xlink:href="pbh-20220930.xsd#pbh_WalmartMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:to="loc_pbh_WalmartMember_0da73e18-b33d-417f-851b-f3712244c8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalgreensMember_bd02c6ce-be50-4e42-99f1-ade1048a4ed4" xlink:href="pbh-20220930.xsd#pbh_WalgreensMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9c43a694-40cb-4e7c-8abd-d3f32d86a733" xlink:to="loc_pbh_WalgreensMember_bd02c6ce-be50-4e42-99f1-ade1048a4ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_8f4a50f1-d0b6-44c4-9bd2-949da246627f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f7f0631-61e6-4d82-b41b-e2606c4c2d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f7f0631-61e6-4d82-b41b-e2606c4c2d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_06d610d0-39f5-47e2-9e0d-b363575b516a" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_06d610d0-39f5-47e2-9e0d-b363575b516a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_5d7ab340-6685-43c9-a333-17ea7d2b0f6a" xlink:href="pbh-20220930.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c93d5264-7783-4dd8-8b33-3dc5cda1795e" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_5d7ab340-6685-43c9-a333-17ea7d2b0f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3175e06a-d140-448a-975a-7ea3f0ef4cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3175e06a-d140-448a-975a-7ea3f0ef4cd1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:to="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_99117f36-132f-40c4-8588-4135ccfed778" xlink:to="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_20f90f19-7bf5-4f21-9a93-63ce08f72485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:to="loc_us-gaap_OperatingSegmentsMember_20f90f19-7bf5-4f21-9a93-63ce08f72485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0f5a8487-5596-4b0b-b5e4-9292bcfa7936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9edaed1a-730c-45a4-8200-dadc1478e83d" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0f5a8487-5596-4b0b-b5e4-9292bcfa7936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bda378c7-9012-4946-8847-09db1b131ccb" xlink:to="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_7b58812d-62e2-4553-9cb9-8c917728236b" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_7b58812d-62e2-4553-9cb9-8c917728236b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_2a107da5-2f13-4d8d-b959-272842b3bf98" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2a009ec6-b8d6-4445-b65d-bfc6375e9b51" xlink:to="loc_pbh_InternationalOTCHealthcareMember_2a107da5-2f13-4d8d-b959-272842b3bf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_75d88648-7709-4c43-9456-ca34d593a998" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe0a5947-e25f-4e89-b955-a51248afb18c" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fb63572-253a-45a8-80e0-f0f6ad798e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fb63572-253a-45a8-80e0-f0f6ad798e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ff338d28-6063-41fc-be93-9ad2a812f0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_CostOfRevenue_ff338d28-6063-41fc-be93-9ad2a812f0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bd3cfa6e-7666-4596-818b-26dfccab8eae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_GrossProfit_bd3cfa6e-7666-4596-818b-26dfccab8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_489b755e-6fdf-493b-8778-4e8359095806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_489b755e-6fdf-493b-8778-4e8359095806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_f89309fc-68f6-4b7c-9e88-50da628c102d" xlink:href="pbh-20220930.xsd#pbh_ContributionMargin"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_pbh_ContributionMargin_f89309fc-68f6-4b7c-9e88-50da628c102d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_734cbe10-1419-44bd-a597-5ad9c6adb390" xlink:href="pbh-20220930.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_734cbe10-1419-44bd-a597-5ad9c6adb390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0519740-3654-4992-8836-86df7ddf54b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_bd74bda7-d709-4c9c-b69b-e232ee9a8073" xlink:to="loc_us-gaap_OperatingIncomeLoss_c0519740-3654-4992-8836-86df7ddf54b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="simple" xlink:href="pbh-20220930.xsd#BusinessSegmentsRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9519c02e-6007-41fd-a0c7-2bc43d45e756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9519c02e-6007-41fd-a0c7-2bc43d45e756" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7e24c53e-6412-43d3-bc91-3634acf1d17a" xlink:to="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_23a2baa5-610e-4372-97f1-39898148f4ea" xlink:href="pbh-20220930.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_23a2baa5-610e-4372-97f1-39898148f4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_1215c721-906e-4c86-9207-3b3647eb862f" xlink:href="pbh-20220930.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d1c9e55-7fe4-4583-9526-e49ca0fd046d" xlink:to="loc_pbh_InternationalOTCHealthcareMember_1215c721-906e-4c86-9207-3b3647eb862f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:to="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f88083e2-04d3-4e4a-bf01-ab9f224d166e" xlink:to="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_6aea3a45-4a39-49f6-8350-9ddfd7a79aba" xlink:href="pbh-20220930.xsd#pbh_AnalgesicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_AnalgesicsMember_6aea3a45-4a39-49f6-8350-9ddfd7a79aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f4cdf94b-f663-4160-89df-5e67879d6997" xlink:href="pbh-20220930.xsd#pbh_CoughAndColdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_CoughAndColdMember_f4cdf94b-f663-4160-89df-5e67879d6997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_e19d794c-bc0c-4100-8855-05a94d576267" xlink:href="pbh-20220930.xsd#pbh_WomensHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_WomensHealthMember_e19d794c-bc0c-4100-8855-05a94d576267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_818e62b1-09d3-4e41-a3e0-b241520e1813" xlink:href="pbh-20220930.xsd#pbh_GastrointestinalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_GastrointestinalMember_818e62b1-09d3-4e41-a3e0-b241520e1813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_152a29be-785f-48ae-8005-f40c22c287d8" xlink:href="pbh-20220930.xsd#pbh_EyeAndEarCareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_EyeAndEarCareMember_152a29be-785f-48ae-8005-f40c22c287d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_888382f7-7861-4406-aa31-9f0507ab5f26" xlink:href="pbh-20220930.xsd#pbh_DermatologicalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_DermatologicalsMember_888382f7-7861-4406-aa31-9f0507ab5f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_092bffae-c22e-4401-b82a-81ab033a67d7" xlink:href="pbh-20220930.xsd#pbh_OralCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_OralCareMember_092bffae-c22e-4401-b82a-81ab033a67d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_612921bf-9b15-4fdc-8c32-ead8efe600fe" xlink:href="pbh-20220930.xsd#pbh_OtherOtcMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_882cdf39-6fe9-4a75-9365-befaafe26224" xlink:to="loc_pbh_OtherOtcMember_612921bf-9b15-4fdc-8c32-ead8efe600fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4e2718f5-848b-4a57-b422-9cd124533bb5" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_b7865528-a683-48c2-a917-88e32fe89ba4" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58716732-992b-4547-a405-aa4ea65bc6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_94c4b1e7-4e91-4cc6-828c-14e7e7145674" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58716732-992b-4547-a405-aa4ea65bc6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>pbh-20220930_g1.jpg
<TEXT>
begin 644 pbh-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-A;6%N=&AA
M+D-H:71T96YD96X   60 P "    %   $*R0!  "    %   $,"2D0 "
M S4R  "2D@ "     S4R  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **9)*D,9>5U1%Y+,< ?C6->>-/#-@I-UKVGICJHN59OR!)II-[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK,S'+$D^YI***HD**** "BBB@ HHHH **** "BBB@ HHIZ02R?ZN)V_W5)H
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MQB*JH,(H4>@&*6BBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=E**70K6^G6=HV;6T@A(Z&.)5_E5FBBH*"BBB@ HHHH **** "BBB@ HHHH
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MS.*]\Q163Q$V:*E%'EVG? ;PY;8-]=7=X?3<$'Z5U6G?#CPEIA4VVB6S.O\
M%,OF$_\ ?6173T5DZDWNRU&*V1%;VT%I%Y5K#'!'UV1H%'Y"I,4M%04%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<8I6N,UJ***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX_M*Z7CR[4@J#[MT_+->0W6N>//B?<-;VR7$EJ3S!;C9"O\ O'O^)-=?X;^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\][&CGV.I5E;!!'(.:^M-*_Y UE_U[Q_^@BII+FNC7-ZCI2I5(]&W^1\W_\
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MBLCVCI?!7@N[\9:H\$$GD6T(#3W!7.P'H .Y/I7M^@?#3PUH&R2*S^UW"_\
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M16BITZJO'0ESG!ZGVK17AOPS^+TBSQ:+XLGWQMA+>^<\J>RO[>_;OZCW$$$
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MQ!8W"KKL4.IVY/S$((I!]"O'YC\:I>+O@WK7AC39=1M[F+4K.$9D:-2CHO\
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M# ]JEHH ^3_B%X0?P;XKFLDW-9R_O;60]T/8^X/'Z]Z^F_"__(HZ1_UY0_\
MH KC_C1X;&L^"VOH8]USIS>:I'4H>&']?PKL?#''A/2<\'[%#_Z *Z*D^>"N
M91CRR9J5S_CQ0W@#7 1D?8I/_0:Z"L#QU_R(.M_]>4G_ *#6,?B1H]CY%KU?
M]G]0?%^HG'(LN#_P-:\HKUC]G[_D;M2_Z\O_ &=:]&M_#9R4_C1] T445YAV
M!1110!Y3^T H/@_3R1R+T8/_  !J^?*^A/C_ /\ (FV'_7Z/_0&KY[KT</\
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M'_7I'_Z#7RM7U3X/_P"1+TC_ *](_P#T&MZ'Q'BYY_#AZFS11176?*A1110
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M/^WN/^35Z!7G_P :/^1 _P"WN/\ DU54^!F.!_WJGZH^?:***X#[X]]^"/\
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MS!?OQGAXSZ,O;^5;-<[33LS8*P/'7_(@ZW_UY2?^@UOU@>.O^1!UO_KRD_\
M0:<=T)['R+7K'[/W_(W:E_UY?^SK7D]>L?L_?\C=J7_7E_[.M>C6_ALY*?QH
M^@:***\P[ HHHH \J^/_ /R)MA_U^C_T!J^>Z^A/C_\ \B;8?]?H_P#0&KY[
MKT</\!R5?B/H[X$?\D\D_P"OV3^2UZ77FGP(_P"2>2?]?LG\EKTNN*K\;.F'
MPH****S*/D#QE_R/&M_]?TW_ *&:E\"_\C[HO_7Y'_.HO&7_ "/&M_\ 7]-_
MZ&:E\"_\C[HO_7Y'_.O5^Q\CB^V?75%%%>4=H4444 <_X\_Y)[K_ /V#YO\
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M_P"@[)_WY%<-J'<ZKU.QT?\ PO'P=_STO?\ P'_^O1_PO'P=_P ]+W_P'_\
MKUSG_#/4/_0=D_[\BC_AGJ'_ *#LG_?D46H=QWJ=CH)OCIX1CA9HOMTK@<((
M ,GZDUX9XS\4S>+_ !+/JD\?E*P"QQ9SL4=!7J?_  SU#_T'9/\ OR*/^&>H
M?^@[)_WY%7"5&#NF1)5)*S/#J]P_9ZN6-MK%M_"'23\<$4O_  SU!_T'9/\
MOR*[/X?_  [3P*]XR7[7?VH*#N3;MQ15JPE!I!"G*,KL[6N7^)7_ "3;6_\
MKW_J*ZBN7^)7_)-M;_Z]_P"HKDA\2-WL?)U>O?L]_P#(PZM_UZK_ .ABO(:]
M>_9[_P"1AU;_ *]5_P#0Q7HUOX;.2G\:/>Z***\P[ HHHH **** "BBB@#Y;
M\<_\C[K?_7[)_P"A5@UO>.?^1]UO_K]D_P#0JP:\T_1*'\&/HOR"OJGP?_R)
M>D?]>D?_ *#7RM7U3X/_ .1+TC_KTC_]!K>A\1XN>?PX>ILT445UGRH4444
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MXUY;7:?"74AIOQ*TPNVU+@M;L?7<.!_WUBN^HKP9RP=I(^I:***\L[0HHHH
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MM>3UZO\ L_L!XPU%>YL21_WVO^->C6_ALY*?QH^@J***\P[ HHHH \J^/_\
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MPK_Q&:TO@"BBBL#0*\?_ &A/^0#I'_7R_P#Z#7L%>/\ [0G_ " =(_Z^7_\
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MY9*S"BBBF2%%%% !112$@ DG '4T +7S?\5[E+KXC7YCZ1A(S]0H!KV'Q/\
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M\$[OQ[5U'P_^%MUJ]S#J6OPM!IZ$,L+C#3^V.RUU/QM18_"-@D:A46Y 50,
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MS3/$>CZQ"LNFZE;7"MTVR#/Y=:TR<#)KCV.D**Q]5\5Z%HL)EU+5+:$#/'F
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M\B&TA>WLX89)FG>.-4:5_O2$#!8^YZU-116IP/4**** "BBB@#F?$7P_\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX,_Y^+O_ ,!FH_X7?X,_Y^+O_P !FH]G/L'/'N>AT5YY_P +O\&?\_%W_P"
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M10 4451UG5K70M'N-3U!F6VMEW2%%W$#..GXT;@7J*\\_P"%W^#/^?B[_P#
M9J/^%W^#/^?B[_\  9JT]G/L1SQ[GH=%>>?\+O\ !G_/Q=_^ S4?\+O\&?\
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MZV&&1]D<\_2M(2:DK$R2:/D>O2_@SX+L/%&KWEWK$ N+6Q5<0L?E=VSC/J,
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M&^W3RF'OE<5U%%8<S74ULCYB^)'PVF\%7"W-G(]SI<S821Q\T9_NMC^=>C_
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M%&  .E.KS6[NYUI65@HHHI#"BBB@#)\4:+'XB\+ZAI<H'^DP,J$_POC*G\&
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M:76=2C,=W?J!'&PP8XNHS[D\X],5Z%:2C!G)33<CU&BBBO-.P**** "BBB@
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MD=OJ6)K1\#)YGCS15QG_ $R,X'LV:RM20QZK=HXPRS."/0[C6MX%D\KQ]HK
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M )'C6/\ K[?^==6&^)F%;8Z/X*?\E0L_^N,W_H!KZ:KYE^"G_)4+/_KC-_Z
M:^FJG$?&52^$****YS4**** /CSQ5_R-^K?]?DO_ *$:ZWX(?\E+@_Z]Y?\
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M._7),AC@SSMSV'T4 5K3TO/L1+7W3='P+\(;1G[>3W_T@?X4O_"B_!_I?_\
M@0/\*]'%%+VL^X<D>QYQ_P *+\'^E_\ ^! _PIK_  +\(E&V?;@V#@FX[_E7
MI-%'M9]PY(]CXTUG2YM%UJ[TZY!$EM*T9SWP>#^5=U\$_$@T?QH-.G?;;ZFO
ME#/02#[GY\C\16I\>?#GV/6K778$Q%>+Y4I X$BCC\Q_(UY/!/);7$<\#E)8
MG#HRG!4@Y!%=ZM5IG,_<F?:M%8WA+7H_$OA>QU2,C=-$/, _A<<,/SK9KS6F
MG9G8%%%%( HHHH **** /-OCM_R3E?\ K]C_ )-7S?7TA\=O^2<K_P!?L?\
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MNO,T^U++!$%&%VMMSGJ>AKK?&GB%/#'A&_U-R/,CC*PJ?XI#PH_/GZ UX]\
MG:3Q;J3N2S-;9)/<[JVA&\)2,Y2]Y(]_HHHK$T"BBB@ HHHH *\Z^-'B,Z/X
M+;3[9\76J-Y("GD1_P ?YCC\37HM>+2'_A/OCTD3?O-.T/YBIY4E#T_%\<>@
M-:TU[UWT(D]+&GHGP-\/OH=F^L?;/MS1*TX2;: QY(QCMTJ__P *+\'^E_\
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M;>#O^A?L_P#OD_XT44<\NX60?\*V\'?]"_9_]\G_ !H_X5MX._Z%^S_[Y/\
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@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329555698000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRESTIGE CONSUMER HEALTHCARE INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001295947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1297589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">660 White Plains Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tarrytown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">524-6800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PBH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,525,952<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559134624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income and Comprehensive Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 289,273<span></span>
</td>
<td class="nump">$ 276,225<span></span>
</td>
<td class="nump">$ 566,332<span></span>
</td>
<td class="nump">$ 545,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_CostOfSalesExclusiveOfDepreciation', window );">Cost of sales excluding depreciation</a></td>
<td class="nump">126,384<span></span>
</td>
<td class="nump">116,722<span></span>
</td>
<td class="nump">241,380<span></span>
</td>
<td class="nump">225,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Cost of sales depreciation</a></td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,791<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">3,625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">128,264<span></span>
</td>
<td class="nump">118,513<span></span>
</td>
<td class="nump">245,204<span></span>
</td>
<td class="nump">228,682<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">161,009<span></span>
</td>
<td class="nump">157,712<span></span>
</td>
<td class="nump">321,128<span></span>
</td>
<td class="nump">316,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">43,819<span></span>
</td>
<td class="nump">40,730<span></span>
</td>
<td class="nump">83,770<span></span>
</td>
<td class="nump">80,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">26,438<span></span>
</td>
<td class="nump">32,252<span></span>
</td>
<td class="nump">53,152<span></span>
</td>
<td class="nump">54,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,368<span></span>
</td>
<td class="nump">6,172<span></span>
</td>
<td class="nump">12,808<span></span>
</td>
<td class="nump">11,932<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">76,625<span></span>
</td>
<td class="nump">79,154<span></span>
</td>
<td class="nump">149,730<span></span>
</td>
<td class="nump">146,824<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">84,384<span></span>
</td>
<td class="nump">78,558<span></span>
</td>
<td class="nump">171,398<span></span>
</td>
<td class="nump">169,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">16,979<span></span>
</td>
<td class="nump">16,313<span></span>
</td>
<td class="nump">32,271<span></span>
</td>
<td class="nump">31,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_TotalOtherIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">17,791<span></span>
</td>
<td class="nump">18,928<span></span>
</td>
<td class="nump">33,908<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income before income taxes</a></td>
<td class="nump">66,593<span></span>
</td>
<td class="nump">59,630<span></span>
</td>
<td class="nump">137,490<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">15,570<span></span>
</td>
<td class="nump">14,305<span></span>
</td>
<td class="nump">31,195<span></span>
</td>
<td class="nump">32,920<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 51,023<span></span>
</td>
<td class="nump">$ 45,325<span></span>
</td>
<td class="nump">$ 106,295<span></span>
</td>
<td class="nump">$ 103,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 2.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">49,804<span></span>
</td>
<td class="nump">50,232<span></span>
</td>
<td class="nump">50,033<span></span>
</td>
<td class="nump">50,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">50,265<span></span>
</td>
<td class="nump">50,791<span></span>
</td>
<td class="nump">50,496<span></span>
</td>
<td class="nump">50,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="num">$ (7,118)<span></span>
</td>
<td class="num">$ (4,197)<span></span>
</td>
<td class="num">$ (16,637)<span></span>
</td>
<td class="num">$ (5,689)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized gain on interest rate swaps</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Net loss on termination of pension plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(790)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss</a></td>
<td class="num">(7,118)<span></span>
</td>
<td class="num">(3,647)<span></span>
</td>
<td class="num">(17,427)<span></span>
</td>
<td class="num">(4,619)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">43,905<span></span>
</td>
<td class="nump">41,678<span></span>
</td>
<td class="nump">88,868<span></span>
</td>
<td class="nump">98,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">289,264<span></span>
</td>
<td class="nump">276,217<span></span>
</td>
<td class="nump">566,288<span></span>
</td>
<td class="nump">545,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CostOfSalesExclusiveOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CostOfSalesExclusiveOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_TotalOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_TotalOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Shares Outstanding [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558233632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 42,442<span></span>
</td>
<td class="nump">$ 27,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $20,673 and $19,720, respectively</a></td>
<td class="nump">145,992<span></span>
</td>
<td class="nump">139,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">140,505<span></span>
</td>
<td class="nump">120,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">7,714<span></span>
</td>
<td class="nump">6,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">336,653<span></span>
</td>
<td class="nump">293,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">69,947<span></span>
</td>
<td class="nump">71,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">17,300<span></span>
</td>
<td class="nump">20,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">5,529<span></span>
</td>
<td class="nump">6,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">575,566<span></span>
</td>
<td class="nump">578,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,670,942<span></span>
</td>
<td class="nump">2,696,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">2,577<span></span>
</td>
<td class="nump">3,273<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,678,514<span></span>
</td>
<td class="nump">3,670,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">56,196<span></span>
</td>
<td class="nump">55,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendsPayableCurrent', window );">Accrued interest payable</a></td>
<td class="nump">15,688<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">6,647<span></span>
</td>
<td class="nump">6,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current portion</a></td>
<td class="nump">2,793<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">70,984<span></span>
</td>
<td class="nump">74,113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">152,308<span></span>
</td>
<td class="nump">143,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">1,438,338<span></span>
</td>
<td class="nump">1,476,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">443,271<span></span>
</td>
<td class="nump">444,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities, net of current portion</a></td>
<td class="nump">12,785<span></span>
</td>
<td class="nump">16,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities, net of current portion</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">8,877<span></span>
</td>
<td class="nump">7,484<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,058,673<span></span>
</td>
<td class="nump">2,093,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies &#8212; Note 17</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 54,690 shares at September 30, 2022 and 54,430 shares at March 31, 2022</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">524,392<span></span>
</td>
<td class="nump">515,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 5,164 shares at September 30, 2022 and 4,151 shares at March 31, 2022</a></td>
<td class="num">(189,098)<span></span>
</td>
<td class="num">(133,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(36,459)<span></span>
</td>
<td class="num">(19,032)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,320,459<span></span>
</td>
<td class="nump">1,214,164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">1,619,841<span></span>
</td>
<td class="nump">1,577,611<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 3,678,514<span></span>
</td>
<td class="nump">$ 3,670,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558367104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts receivable, current</a></td>
<td class="nump">$ 20,673<span></span>
</td>
<td class="nump">$ 19,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">54,690,000<span></span>
</td>
<td class="nump">54,430,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">5,164,000<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552719440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,358,298<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
<td class="nump">$ 499,508<span></span>
</td>
<td class="num">$ (130,732)<span></span>
</td>
<td class="num">$ (19,801)<span></span>
</td>
<td class="nump">$ 1,008,783<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,088,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 5,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">87,600<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 2,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(2,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">103,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive loss</a></td>
<td class="num">(4,619)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,619)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2021</a></td>
<td class="nump">1,461,647<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">507,310<span></span>
</td>
<td class="num">$ (133,648)<span></span>
</td>
<td class="num">(24,420)<span></span>
</td>
<td class="nump">1,111,863<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Jun. 30, 2021</a></td>
<td class="nump">1,416,247<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">503,588<span></span>
</td>
<td class="num">$ (133,648)<span></span>
</td>
<td class="num">(20,773)<span></span>
</td>
<td class="nump">1,066,538<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">45,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive loss</a></td>
<td class="num">(3,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,647)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2021</a></td>
<td class="nump">1,461,647<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">507,310<span></span>
</td>
<td class="num">$ (133,648)<span></span>
</td>
<td class="num">(24,420)<span></span>
</td>
<td class="nump">1,111,863<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,430,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Mar. 31, 2022</a></td>
<td class="nump">1,577,611<span></span>
</td>
<td class="nump">$ 544<span></span>
</td>
<td class="nump">515,583<span></span>
</td>
<td class="num">$ (133,648)<span></span>
</td>
<td class="num">(19,032)<span></span>
</td>
<td class="nump">1,214,164<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 7,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">39,100<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,489<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,013,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(55,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (55,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">106,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive loss</a></td>
<td class="num">(17,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2022</a></td>
<td class="nump">1,619,841<span></span>
</td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">524,392<span></span>
</td>
<td class="num">$ (189,098)<span></span>
</td>
<td class="num">(36,459)<span></span>
</td>
<td class="nump">1,320,459<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, beginning balance at Jun. 30, 2022</a></td>
<td class="nump">1,584,743<span></span>
</td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">520,926<span></span>
</td>
<td class="num">$ (176,825)<span></span>
</td>
<td class="num">(29,341)<span></span>
</td>
<td class="nump">1,269,436<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(12,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">51,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Comprehensive loss</a></td>
<td class="num">(7,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 1,619,841<span></span>
</td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">$ 524,392<span></span>
</td>
<td class="num">$ (189,098)<span></span>
</td>
<td class="num">$ (36,459)<span></span>
</td>
<td class="nump">$ 1,320,459<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558319984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 106,295<span></span>
</td>
<td class="nump">$ 103,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">16,632<span></span>
</td>
<td class="nump">15,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">4,211<span></span>
</td>
<td class="nump">7,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt origination costs</a></td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation costs</a></td>
<td class="nump">7,323<span></span>
</td>
<td class="nump">5,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets', window );">Non-cash operating lease cost</a></td>
<td class="nump">2,984<span></span>
</td>
<td class="nump">3,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effects from acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(8,276)<span></span>
</td>
<td class="num">(34,322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(21,810)<span></span>
</td>
<td class="nump">12,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,501)<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="num">(8,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">9,788<span></span>
</td>
<td class="nump">24,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(3,201)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">115,787<span></span>
</td>
<td class="nump">130,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(3,423)<span></span>
</td>
<td class="num">(4,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisition of Akorn</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(228,914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,423)<span></span>
</td>
<td class="num">(232,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Term loan repayments</a></td>
<td class="num">(40,000)<span></span>
</td>
<td class="num">(495,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from refinancing of Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">597,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under revolving credit agreement</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">85,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit agreement</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(65,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments of finance leases</a></td>
<td class="num">(1,369)<span></span>
</td>
<td class="num">(1,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,489<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Fair value of shares surrendered as payment of tax withholding</a></td>
<td class="num">(5,450)<span></span>
</td>
<td class="num">(2,916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(95,330)<span></span>
</td>
<td class="nump">114,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(1,777)<span></span>
</td>
<td class="num">(1,178)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">15,257<span></span>
</td>
<td class="nump">10,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">27,185<span></span>
</td>
<td class="nump">32,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">42,442<span></span>
</td>
<td class="nump">42,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">19,016<span></span>
</td>
<td class="nump">18,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 15,689<span></span>
</td>
<td class="nump">$ 21,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions To Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AdditionsToOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Leases Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncreaseDecreaseInOperatingLeasesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556607712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Business and Basis of Presentation</a></td>
<td class="text">Business and Basis of Presentation <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we,&#8221; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 8 to these Condensed Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There has been economic uncertainty in the United States and globally due to several factors including global supply chain constraints, rising interest rates, a high inflationary environment, geopolitical events and the effects from the COVID-19 pandemic.  We expect economic conditions will continue to be highly volatile and uncertain, put pressure on prices and supply and could affect demand for our products.  In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio, however, that may not be sustained at the same levels in the uncertain economic environment.  We have continued to see changes in the purchasing patterns of our consumers, including a reduction in the frequency of visits to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The volatile environment has impacted the supply of labor and raw materials and exacerbated rising input costs.  Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience shortages, delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.  We continue to generate operating cash flows to meet our short-term liquidity needs.  These circumstances could change, however, in this dynamic, unprecedented environment.  If conditions cause further disruption in the global supply chain, the availability of labor and materials or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreaks, global supply chain constraints, the high inflationary environment and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31st of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2023) mean our fiscal year ending or ended on March 31st of that year.  Operating results for the six months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2023.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no accounting pronouncements adopted in fiscal 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020.  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556818816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisition</a></td>
<td class="text">Acquisition<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9 million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 8).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  In connection with the acquisition, we entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We finalized our analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,963</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years (see Note 5).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $1.1&#160;million based on the amount by which the purchase price exceeded the fair value of the net assets acquired (see Note 4).  Goodwill is deductible and is being amortized for income tax purposes. </span></div>The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558352144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,342&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.3 million at September&#160;30, 2022 and $4.9 million at March&#160;31, 2022 related to obsolete and slow-moving inventory.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558364000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.392%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Adjustment related to acquisition</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,566&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2, on July 1, 2021, we completed the acquisition of certain assets from Akorn.  In connection with this acquisition, we recorded goodwill of $1.1&#160;million based on the amount by which the purchase price exceeded the estimate of the fair value of the net assets acquired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  The date of our annual impairment review was February 28, 2022, and we recorded impairment charges to goodwill of $0.3 million in our March 31, 2022 financial statements.  We utilized the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;28, 2022 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, or the potential impacts of COVID-19 and inflation.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  If these assumptions are adversely affected, we may be required to record impairment charges in the future.  We continuously monitor events that could trigger an interim impairment analysis, which included the impact of COVID-19 and inflation for the period ended September&#160;30, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div>As of September&#160;30, 2022, we determined no events have occurred that would indicate potential impairment of goodwill.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329642648736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, net</a></td>
<td class="text">Intangible Assets, net <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,084&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets for Akorn and $18.1 million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $5.6 million and $11.3 million for the three and six months ended September 30, 2022, respectively, and $5.3 million and $10.2 million for the three and six months ended September 30, 2021, respectively.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ended March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date of our annual impairment review was February&#160;28, 2022, and we recorded impairment charges to intangible assets of $0.7 million in our March&#160;31, 2022 financial statements.  Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins, and advertising and marketing expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The discount rate assumption may be influenced by such factors as changes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in interest rates and rates of inflation, which can have an impact on the determination of fair value.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, changes in advertising and marketing expenses, or the potential impacts of COVID-19 or inflation, we may be required to record impairment charges in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2022, no events have occurred that would indicate potential impairment of intangible assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556851920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (Remaining six months ending March 31, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,432&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (Remaining six months ending March 31, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,432&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556843040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text">Other Accrued Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329572685632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,662)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we had no balance outstanding on the 2012 ABL Revolver, and a borrowing capacity of $149.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2031 (the "2021 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:40.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.347%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329555703440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB Accounting Standards Codification ("ASC") 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy.  The summary below details the carrying amounts and estimated fair values of these instruments at September&#160;30, 2022 and March&#160;31, 2022. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>At September&#160;30, 2022 and March&#160;31, 2022, we did not have any assets or liabilities measured in Level 1 or 3.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556679040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">Derivative Instruments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into an interest rate swap to hedge a total of $200.0 million of our variable interest debt, which settled on January 31, 2022.  We do not use derivatives for trading purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556708816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on our common stock through September&#160;30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended September 30, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.04</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.5 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.3 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.0 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556716080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at September&#160;30, 2022 and March&#160;31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,459)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,032)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of September&#160;30, 2022 and March&#160;31, 2022, no amounts were reclassified from accumulated other comprehensive loss into earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556594256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options, restricted stock units ("RSUs") and performance stock units ("PSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,023&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>For all periods shown above, there were 0.4 million shares attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556630832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and an extension of the term of the 2005 Plan by ten years, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of 2,827,210 shares were available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At September&#160;30, 2022, there were $4.8 million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of 2.2 years.  At September&#160;30, 2022, there were $13.2 million of unrecognized compensation costs related to unvested RSUs and PSUs under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of 1.9 years.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">At September&#160;30, 2022, there were 2.1 million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 2, 2022, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 67,959 PSUs, 65,721 RSUs, and stock options to acquire 195,526 shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $54.47 per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Each of the independent members of the Board of Directors received a grant of 2,495 RSUs on August 2, 2022.  The RSUs fully vest one year after receipt of the award, subject to the continued service of the director on such vesting date, and will be settled by delivery to each director of one share of our common stock for each vested RSU either (a) at the election of the director prior to the grant date, immediately upon vesting, or (b) promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Restricted Stock Units</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:</span></div><div style="margin-bottom:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental performance shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8% - 30.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1% - 31.9%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8% to 2.9%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0% to 1.3% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the six months ended September&#160;30, 2022 was $0.7 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556595488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesIncome taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were 23.4% and 24.0% for the three months ended September 30, 2022 and 2021, respectively.  The effective tax rates used in the calculation of income taxes were 22.7% and 24.2% for the six months ended September 30, 2022 and 2021, respectively.  The decrease in the effective tax rate for the three and six months ended September 30, 2022 compared to the three and six months ended September 30, 2021 was due to discrete items primarily pertaining to state tax rate legislative changes and share based compensation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556597488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Retirement Plans</a></td>
<td class="text">Employee Retirement Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit expense (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended September 30, 2022, we contributed $0.2 million to our non-qualified defined benefit plan and made no contributions to the qualified defined benefit plan.  During the remainder of fiscal 2023, we expect to contribute an additional $0.2 million to our non-qualified plan and to make no contributions to the qualified plan.</span></div>During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for our U.S. qualified defined benefit pension plan (the "Plan") and began the Plan termination process.  The settlements of the terminated Plan occurred during the first quarter of fiscal 2023 with lump sum settlements in the amount of $13.8 million being paid to eligible Plan participants who elected such payments and the purchase of annuity contracts for $31.1 million to the remaining participants.  These settlements were paid using Plan assets and resulted in a settlement loss of $0.4 million.  No further contributions to the Plan were necessary.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556526832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and ContingenciesWe are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556594256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations of Risk</a></td>
<td class="text">Concentrations of Risk<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.  During the three and six months ended September 30, 2022, approximately 39.7% and 40.6%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and six months ended September 30, 2021, approximately 41.3% and 43.3%, respectively, of our gross revenues were derived from our five top selling brands.  Two customers, Walmart and Walgreens, accounted for more than 10% of our gross revenues in one or both of the periods presented.  Walmart accounted for approximately 20.3% and 19.8%, respectively, of our gross revenues for the three and six months ended September 30, 2022. Walmart accounted for approximately 22.7% and 21.2%, respectively, of our gross revenues for the three and six months ended September 30, 2021.  Walgreens accounted for approximately 10.8% of our gross revenues for the second quarter of fiscal 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufactures many of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fleet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or various public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we had relationships with 130 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 27 manufacturers that produced items that accounted for approximately 71.3% of gross sales for the six months ended September&#160;30, 2022.  At September&#160;30, 2021, we had relationships with 121 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 19 manufacturers that produced items that accounted for approximately 68.1% of gross sales for the six months ended September&#160;30, 2021.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556679040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments</a></td>
<td class="text">Business Segments <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.738%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552974384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31st of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2023) mean our fiscal year ending or ended on March 31st of that year.  Operating results for the six months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2023.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based </span></div>compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no accounting pronouncements adopted in fiscal 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020.  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556716080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text">The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,963</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556594256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,342&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557672848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Reconciliation of the Activity Affecting Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting goodwill by operating segment is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:6.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.392%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Adjustment related to acquisition</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,566&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558220640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Reconciliation of the Activity Affecting Finite Lived Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,084&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Trademarks</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Trademarks and Customer Relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,897,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; March&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8212; September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net - September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,858&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,084&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ended March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558220512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (Remaining six months ending March 31, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,432&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Finance Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance <br/>Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (Remaining six months ending March 31, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,432&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556674320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued and Other Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558410480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,662)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate Future Principal Payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2031 (the "2021 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:40.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.347%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending March 31, 2023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557749856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Summary of Carry Amounts and Fair Value Measurements</a></td>
<td class="text">The summary below details the carrying amounts and estimated fair values of these instruments at September&#160;30, 2022 and March&#160;31, 2022. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:33.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556538992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Interest Rate Swaps, Net of Tax</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain Recognized in Other Comprehensive Loss (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss Reclassified from Accumulated Other Comprehensive Loss into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556630832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock</a></td>
<td class="text">Our share repurchases consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.04</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.5 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54.69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.3 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.0 million</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556679040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consisted of the following at September&#160;30, 2022 and March&#160;31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,459)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,032)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557672848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,023&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share &#8212; weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557648896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Compensation Expense Information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Shares</a></td>
<td class="text">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental performance shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Options Granted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8% - 30.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1% - 31.9%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8% to 2.9%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0% to 1.3% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759.7&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329556714416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Primary Components of Net Periodic Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefits consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit expense (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557685536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Operating and Reportable Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our reportable segments.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenues from Similar Product Groups</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559143088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,566<span></span>
</td>
<td class="nump">$ 578,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 228,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_SupplyCommitmentTermOfAgreement', window );">Supply commitment, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">195,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, amortizable intangible assets, allocated amount</a></td>
<td class="nump">29,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">20,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks | Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Amortizable Intangible Assets, Allocated Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_SupplyCommitmentTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supply Commitment, Term of Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_SupplyCommitmentTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552669312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 575,566<span></span>
</td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves', window );">Reserves for sales allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,049<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559043440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Summary of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Packaging and raw materials</a></td>
<td class="nump">$ 18,733<span></span>
</td>
<td class="nump">$ 16,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">121,235<span></span>
</td>
<td class="nump">103,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 140,505<span></span>
</td>
<td class="nump">$ 120,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329557646896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves related to obsolete and slow-moving inventory</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329555817616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Changes (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">$ 744,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="num">(165,298)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">578,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, transfers</a></td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="num">(2,860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="nump">740,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="num">(165,298)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="nump">575,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">712,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">548,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, transfers</a></td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="nump">711,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="nump">547,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill</a></td>
<td class="nump">32,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="num">(1,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">30,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, transfers</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="num">(2,860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="nump">29,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="num">(1,587)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="nump">$ 27,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552272720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="nump">$ 575,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552815488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Activity Affecting Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_IntangibleAssetsGrossAbstract', window );"><strong>Intangible Assets, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Totals, gross, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,912,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss', window );">Totals, effects of foreign currency exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Totals, gross, ending balance</a></td>
<td class="nump">$ 2,897,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,897,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated amortization, additions</a></td>
<td class="nump">5,600<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="nump">11,257<span></span>
</td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Accumulated amortization, effects of foreign exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, ending balance</a></td>
<td class="nump">227,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">206,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill), Total</a></td>
<td class="nump">2,670,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,696,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Trademarks and Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract', window );"><strong>Finite-Lived Intangible Assets, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived trademarks and customer relationships, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived trademarks and customer relationships, ending balance</a></td>
<td class="nump">433,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated amortization, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Accumulated amortization, effects of foreign exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, ending balance</a></td>
<td class="nump">227,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">206,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,476,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Indefinite lived trademarks, effects of foreign currency exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,701)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived trademarks, ending balance</a></td>
<td class="nump">$ 2,464,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,464,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Gross [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559076288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="nump">$ 11,257<span></span>
</td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember', window );">Zaditen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_IntangibleAssetsAcquired', window );">Intangible assets, additions</a></td>
<td class="nump">$ 18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_IntangibleAssetsAcquired', window );">Intangible assets, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329560557792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, net - Future Amortization of Intangible Assets (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023 (remaining six months ended March 31, 2023)</a></td>
<td class="nump">$ 11,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">22,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">20,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">18,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">16,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">117,644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 206,084<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552345152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 664<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">$ 1,329<span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">1,617<span></span>
</td>
<td class="nump">1,683<span></span>
</td>
<td class="nump">3,251<span></span>
</td>
<td class="nump">3,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">17,016<span></span>
</td>
<td class="nump">11,998<span></span>
</td>
<td class="nump">29,015<span></span>
</td>
<td class="nump">23,649<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total net lease cost</a></td>
<td class="nump">$ 19,393<span></span>
</td>
<td class="nump">$ 14,410<span></span>
</td>
<td class="nump">$ 33,775<span></span>
</td>
<td class="nump">$ 28,478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558172656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (Remaining six months ending March 31, 2023)</a></td>
<td class="nump">$ 3,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">6,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">4,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,655<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">20,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(1,399)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">19,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (Remaining six months ending March 31, 2023)</a></td>
<td class="nump">1,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">6,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">5,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (Remaining six months ending March 31, 2023)</a></td>
<td class="nump">5,229<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne', window );">2024</a></td>
<td class="nump">9,742<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">6,065<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,253<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,955<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,655<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">26,899<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(1,580)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">$ 25,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329555665360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">3 years 7 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">2 years 1 month 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_WeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">3.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">2.95%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552323504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing costs</a></td>
<td class="nump">$ 33,684<span></span>
</td>
<td class="nump">$ 36,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation costs</a></td>
<td class="nump">7,218<span></span>
</td>
<td class="nump">19,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Accrued broker commissions</a></td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">12,455<span></span>
</td>
<td class="nump">2,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">5,127<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_AccruedProductionCostsCurrent', window );">Accrued production costs</a></td>
<td class="nump">3,775<span></span>
</td>
<td class="nump">3,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">6,647<span></span>
</td>
<td class="nump">6,692<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Total other accrued liabilities</a></td>
<td class="nump">$ 70,984<span></span>
</td>
<td class="nump">$ 74,113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedProductionCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Production Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedProductionCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552796384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 1,455,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">1,455,000<span></span>
</td>
<td class="nump">$ 1,495,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt costs</a></td>
<td class="num">(16,662)<span></span>
</td>
<td class="num">(18,342)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">$ 1,438,338<span></span>
</td>
<td class="nump">1,476,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2021 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loans | 2012 Term B-5 Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 455,000<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loans | 2012 Term B-5 Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loans | 2012 Term B-5 Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentVariableRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentVariableRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558346448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 1,455,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 149,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558267248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate Future Principal Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2023 (remaining six months ending March 31, 2023)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,455,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt (including current portion)</a></td>
<td class="nump">$ 1,455,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559427312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2021 Senior Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2019 Senior Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loans | 2012 Term B-5 Loans | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">455,000<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | 2012 ABL Revolver | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">2012 ABL Revolver</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Senior Notes | 2021 Senior Notes | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">466,500<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Senior Notes | 2019 Senior Notes | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">361,000<span></span>
</td>
<td class="nump">397,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Term Loans | 2012 Term B-5 Loans | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, senior notes and term loans</a></td>
<td class="nump">453,294<span></span>
</td>
<td class="nump">493,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Revolving Credit Facility | 2012 ABL Revolver | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">2012 ABL Revolver</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329560499376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | agreement</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | $</a></td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329551392176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments - Summary of Interest Rate Swaps (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain Recognized in Other Comprehensive Loss (effective portion)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain Recognized in Other Comprehensive Loss (effective portion)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Loss Reclassified from Accumulated Other Comprehensive Loss into Income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (732)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,450)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329551405456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized | shares</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned', window );">Voting rights, number of votes per common share owned | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Voting Rights, Number of Votes Per Common Share Owned</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_VotingRightsNumberOfVotesPerCommonShareOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559105168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Repurchased Shares (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 12,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,450<span></span>
</td>
<td class="nump">$ 2,916<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares</a></td>
<td class="nump">236,681<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">914,236<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in USD per share)</a></td>
<td class="nump">$ 51.85<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 54.69<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">99,219<span></span>
</td>
<td class="nump">63,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 54.94<span></span>
</td>
<td class="nump">$ 46.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Total amount repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558174848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">$ 1,619,841<span></span>
</td>
<td class="nump">$ 1,577,611<span></span>
</td>
<td class="nump">$ 1,584,743<span></span>
</td>
<td class="nump">$ 1,461,647<span></span>
</td>
<td class="nump">$ 1,416,247<span></span>
</td>
<td class="nump">$ 1,358,298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="num">(36,459)<span></span>
</td>
<td class="num">(19,032)<span></span>
</td>
<td class="num">$ (29,341)<span></span>
</td>
<td class="num">$ (24,420)<span></span>
</td>
<td class="num">$ (20,773)<span></span>
</td>
<td class="num">$ (19,801)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="num">(36,841)<span></span>
</td>
<td class="num">(20,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive loss, cash flow hedge, reclassification tax</a></td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329561363808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from accumulated other comprehensive loss into earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552819360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 51,023<span></span>
</td>
<td class="nump">$ 45,325<span></span>
</td>
<td class="nump">$ 106,295<span></span>
</td>
<td class="nump">$ 103,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic earnings per share &#8212; weighted average shares outstanding (in shares)</a></td>
<td class="nump">49,804<span></span>
</td>
<td class="nump">50,232<span></span>
</td>
<td class="nump">50,033<span></span>
</td>
<td class="nump">50,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">559<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share (in shares)</a></td>
<td class="nump">50,265<span></span>
</td>
<td class="nump">50,791<span></span>
</td>
<td class="nump">50,496<span></span>
</td>
<td class="nump">50,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per Common Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in USD per share)</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in USD per share)</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 0.89<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 2.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329571934576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Antidilutive Securities (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552097728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2022</div></th>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>May 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per participant, 12 month period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod', window );">Extension of plan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to nonvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation costs related to nonvested awards, weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,600<span></span>
</td>
<td class="nump">234,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">2,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember', window );">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to nonvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation costs related to nonvested awards, weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member', window );">Long-term Equity Incentive Plan, 2005</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,827,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares', window );">Number of new shares for future issuance under 2020 long-term incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares', window );">Number of unissued shares reserved for 2020 long-term incentive plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">827,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020 | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020 | Restricted Stock Units (RSUs) &amp; Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share grants in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020 | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Stock options granted, exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559049920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Based Compensation Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pre-tax share-based compensation costs charged against income</a></td>
<td class="nump">$ 3,466<span></span>
</td>
<td class="nump">$ 3,219<span></span>
</td>
<td class="nump">$ 7,323<span></span>
</td>
<td class="nump">$ 5,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit recognized on compensation costs</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue', window );">Total fair value of options and RSUs vested during the period</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">10,289<span></span>
</td>
<td class="nump">7,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount', window );">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 2,895<span></span>
</td>
<td class="nump">$ 2,071<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558392384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">440,900<span></span>
</td>
<td class="nump">457,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">148,900<span></span>
</td>
<td class="nump">170,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares', window );">Incremental performance shares</a></td>
<td class="nump">42,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued', window );">Vested (in shares)</a></td>
<td class="num">(222,400)<span></span>
</td>
<td class="num">(162,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">409,800<span></span>
</td>
<td class="nump">440,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber', window );">Vested, end of period (in shares)</a></td>
<td class="nump">108,500<span></span>
</td>
<td class="nump">152,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">$ 38.45<span></span>
</td>
<td class="nump">$ 33.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">55.04<span></span>
</td>
<td class="nump">45.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">32.05<span></span>
</td>
<td class="nump">32.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">47.14<span></span>
</td>
<td class="nump">38.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">$ 36.54<span></span>
</td>
<td class="nump">$ 33.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Incremental Performance Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329558216288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Option Valuation Assumptions (Details) - Stock Options - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="nump">$ 20.10<span></span>
</td>
<td class="nump">$ 14.87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">30.80%<span></span>
</td>
<td class="nump">31.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">30.90%<span></span>
</td>
<td class="nump">31.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329559106400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Option Activity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">1,100,900<span></span>
</td>
<td class="nump">1,114,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">197,600<span></span>
</td>
<td class="nump">234,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(39,100)<span></span>
</td>
<td class="num">(87,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">1,259,400<span></span>
</td>
<td class="nump">1,239,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period (in shares) | shares</a></td>
<td class="nump">830,800<span></span>
</td>
<td class="nump">759,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 40.62<span></span>
</td>
<td class="nump">$ 37.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">54.48<span></span>
</td>
<td class="nump">44.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">38.04<span></span>
</td>
<td class="nump">30.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">42.88<span></span>
</td>
<td class="nump">39.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of period, weighted-average exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 40.04<span></span>
</td>
<td class="nump">$ 39.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options, Additional Disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, end of period, weighted-average remaining contractual term</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, end of period, weighted-average remaining contractual term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, end of period, aggregate intrinsic value | $</a></td>
<td class="nump">$ 10,963<span></span>
</td>
<td class="nump">$ 20,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, end of period, aggregate intrinsic value | $</a></td>
<td class="nump">$ 9,403<span></span>
</td>
<td class="nump">$ 13,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329555664464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.40%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">22.70%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329560390800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans - Expected Return on Plan Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
<td class="nump">$ 556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(290)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(580)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit expense (income)</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552813424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum', window );">Payment for settlement, lump sum</a></td>
<td class="nump">$ 13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract', window );">Payment for settlement, purchase of annuity contract</a></td>
<td class="nump">31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement loss, before tax</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember', window );">Non-qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected employer contributions, remainder of fiscal year</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember', window );">Qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Expected employer contributions, remainder of fiscal year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Settlement, Lump Sum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Settlement, Purchase Of Annuity Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552522784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk (Details) - manufacturer<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturers', window );">Number of third-party manufacturers</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Customer Concentration Risk | Walmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">22.70%<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Customer Concentration Risk | Walgreens</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Supplier Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts', window );">Number of third-party manufacturers with long-term contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember', window );">Top 5 brands | Sales | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">39.70%<span></span>
</td>
<td class="nump">41.30%<span></span>
</td>
<td class="nump">40.60%<span></span>
</td>
<td class="nump">43.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_ManufacturesMember', window );">Manufactures | Sales | Supplier Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.30%<span></span>
</td>
<td class="nump">68.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers with Long-term Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturersWithLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pbh_WalmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pbh_WalmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pbh_WalgreensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pbh_WalgreensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_ManufacturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_ManufacturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329552846592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments - Information on Operating and Reportable Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 289,273<span></span>
</td>
<td class="nump">$ 276,225<span></span>
</td>
<td class="nump">$ 566,332<span></span>
</td>
<td class="nump">$ 545,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">128,264<span></span>
</td>
<td class="nump">118,513<span></span>
</td>
<td class="nump">245,204<span></span>
</td>
<td class="nump">228,682<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">161,009<span></span>
</td>
<td class="nump">157,712<span></span>
</td>
<td class="nump">321,128<span></span>
</td>
<td class="nump">316,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">43,819<span></span>
</td>
<td class="nump">40,730<span></span>
</td>
<td class="nump">83,770<span></span>
</td>
<td class="nump">80,169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">117,190<span></span>
</td>
<td class="nump">116,982<span></span>
</td>
<td class="nump">237,358<span></span>
</td>
<td class="nump">236,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense', window );">Other operating expenses</a></td>
<td class="nump">32,806<span></span>
</td>
<td class="nump">38,424<span></span>
</td>
<td class="nump">65,960<span></span>
</td>
<td class="nump">66,655<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">84,384<span></span>
</td>
<td class="nump">78,558<span></span>
</td>
<td class="nump">171,398<span></span>
</td>
<td class="nump">169,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">252,054<span></span>
</td>
<td class="nump">251,728<span></span>
</td>
<td class="nump">494,572<span></span>
</td>
<td class="nump">494,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">37,219<span></span>
</td>
<td class="nump">24,497<span></span>
</td>
<td class="nump">71,760<span></span>
</td>
<td class="nump">51,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">252,054<span></span>
</td>
<td class="nump">251,728<span></span>
</td>
<td class="nump">494,572<span></span>
</td>
<td class="nump">494,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">113,533<span></span>
</td>
<td class="nump">108,623<span></span>
</td>
<td class="nump">216,454<span></span>
</td>
<td class="nump">208,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">138,521<span></span>
</td>
<td class="nump">143,105<span></span>
</td>
<td class="nump">278,118<span></span>
</td>
<td class="nump">286,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">39,316<span></span>
</td>
<td class="nump">36,493<span></span>
</td>
<td class="nump">74,728<span></span>
</td>
<td class="nump">71,723<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">99,205<span></span>
</td>
<td class="nump">106,612<span></span>
</td>
<td class="nump">203,390<span></span>
</td>
<td class="nump">214,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">37,219<span></span>
</td>
<td class="nump">24,497<span></span>
</td>
<td class="nump">71,760<span></span>
</td>
<td class="nump">51,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">14,731<span></span>
</td>
<td class="nump">9,890<span></span>
</td>
<td class="nump">28,750<span></span>
</td>
<td class="nump">20,655<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">22,488<span></span>
</td>
<td class="nump">14,607<span></span>
</td>
<td class="nump">43,010<span></span>
</td>
<td class="nump">30,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">4,503<span></span>
</td>
<td class="nump">4,237<span></span>
</td>
<td class="nump">9,042<span></span>
</td>
<td class="nump">8,446<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">17,985<span></span>
</td>
<td class="nump">10,370<span></span>
</td>
<td class="nump">33,968<span></span>
</td>
<td class="nump">22,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contribution Margin</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and Administrative, and Depreciation and Amortization Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140329483492768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments - Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 289,273<span></span>
</td>
<td class="nump">$ 276,225<span></span>
</td>
<td class="nump">$ 566,332<span></span>
</td>
<td class="nump">$ 545,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember', window );">Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">33,291<span></span>
</td>
<td class="nump">30,339<span></span>
</td>
<td class="nump">61,541<span></span>
</td>
<td class="nump">63,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember', window );">Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">31,226<span></span>
</td>
<td class="nump">28,028<span></span>
</td>
<td class="nump">59,089<span></span>
</td>
<td class="nump">46,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember', window );">Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">64,124<span></span>
</td>
<td class="nump">68,365<span></span>
</td>
<td class="nump">130,175<span></span>
</td>
<td class="nump">135,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember', window );">Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">57,309<span></span>
</td>
<td class="nump">46,605<span></span>
</td>
<td class="nump">111,403<span></span>
</td>
<td class="nump">99,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember', window );">Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">42,695<span></span>
</td>
<td class="nump">40,806<span></span>
</td>
<td class="nump">86,042<span></span>
</td>
<td class="nump">80,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember', window );">Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">33,774<span></span>
</td>
<td class="nump">33,204<span></span>
</td>
<td class="nump">64,235<span></span>
</td>
<td class="nump">65,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OralCareMember', window );">Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">24,331<span></span>
</td>
<td class="nump">26,171<span></span>
</td>
<td class="nump">48,476<span></span>
</td>
<td class="nump">50,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember', window );">Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,523<span></span>
</td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">5,371<span></span>
</td>
<td class="nump">4,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">252,054<span></span>
</td>
<td class="nump">251,728<span></span>
</td>
<td class="nump">494,572<span></span>
</td>
<td class="nump">494,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">32,750<span></span>
</td>
<td class="nump">29,943<span></span>
</td>
<td class="nump">60,547<span></span>
</td>
<td class="nump">62,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">24,058<span></span>
</td>
<td class="nump">23,022<span></span>
</td>
<td class="nump">45,650<span></span>
</td>
<td class="nump">37,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">59,379<span></span>
</td>
<td class="nump">65,020<span></span>
</td>
<td class="nump">120,563<span></span>
</td>
<td class="nump">128,268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">41,272<span></span>
</td>
<td class="nump">37,964<span></span>
</td>
<td class="nump">81,339<span></span>
</td>
<td class="nump">80,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">37,961<span></span>
</td>
<td class="nump">37,818<span></span>
</td>
<td class="nump">76,572<span></span>
</td>
<td class="nump">73,805<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">32,872<span></span>
</td>
<td class="nump">32,365<span></span>
</td>
<td class="nump">62,327<span></span>
</td>
<td class="nump">63,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">21,251<span></span>
</td>
<td class="nump">22,893<span></span>
</td>
<td class="nump">42,226<span></span>
</td>
<td class="nump">43,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,511<span></span>
</td>
<td class="nump">2,703<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">4,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">37,219<span></span>
</td>
<td class="nump">24,497<span></span>
</td>
<td class="nump">71,760<span></span>
</td>
<td class="nump">51,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">7,168<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
<td class="nump">13,439<span></span>
</td>
<td class="nump">9,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">4,745<span></span>
</td>
<td class="nump">3,345<span></span>
</td>
<td class="nump">9,612<span></span>
</td>
<td class="nump">7,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">16,037<span></span>
</td>
<td class="nump">8,641<span></span>
</td>
<td class="nump">30,064<span></span>
</td>
<td class="nump">18,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">4,734<span></span>
</td>
<td class="nump">2,988<span></span>
</td>
<td class="nump">9,470<span></span>
</td>
<td class="nump">6,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">839<span></span>
</td>
<td class="nump">1,908<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">3,080<span></span>
</td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
<td class="nump">6,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_AnalgesicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_CoughAndColdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_GastrointestinalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_DermatologicalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OtherOtcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>pbh-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pbh="http://www.prestigebrandsinc.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pbh-20220930.xsd" xlink:type="simple"/>
    <context id="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2b5cd7145aa748fb9457afb75bfb22a3_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i5bee7c6863b44412bc884931f7b88a78_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id39bec788f0b4db6a12131f87f82b94d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0caf19b36a0844e780c8b2020c00ce04_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5da56f011314bc89196844b2597e30e_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0bccb62ff474647827368f1c0a570b9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieae852b5e88a4d2881bfc94a55458c84_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f7749c08a3942a98a4139f57288645b_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ife92d668e4de4cc1ad969fd36c2572f3_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e78fc711fb14c3494d63203d4920083_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i44a33afb528b42678a75f8d868dc2b94_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if46763b8fa074769bcaaa4438d57b38d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9f35434d33a648fa862d5c96f94944c9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i50e084b171fb4b8db0e35cea53a45b80_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibad2e23cbb3348cc87b24030492dd5e7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id76154f8b5bf460ba7f5e1713e0f4b9b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0a6f6a31caa242a8b2653c643c896785_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6274cb788e2a4cd9aac84afce0d56e50_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic2b997dc2a2a4bcfa90762d3f59e9f5c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie357f9389e29493d825baf6acc58956d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i86aa80eb8f5d42178dc12c570932bcbc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id24db078a3ee463e901922ad206211f7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idb607635f68941e384560e956f878d1c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia0856c1935e8426aa05f2b92f1b4128b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if9a8960a5122443c944621c7077bf180_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i22ba0e1d1859416f8017159157d7454a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i488aadb430a7489aac56d43528efd1e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8fb12bac2e3d41adbe1614c20b5dcc29_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d391f2095e244008323df736432422a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia44d1ef5e11f44fa9de0ac543d1b12c4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie8623c9c86ec48afbe97a3935315d44e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i792d19a2000e4f1da418859eb0355822_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3bfba22679b040a6aeea7958f5629194_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i25f692c5e67345558d67487dab771c22_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idfe143a6e35d4af08305f5de23360208_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic4e6014926544642b7769ed5b6fdf002_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i48085cf8517740c3a4adf0d4a1f84e2e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieca905416c0040288f44aa9524fe841a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i97f54d4cf1d841b38d61272505328c59_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia75f07adc20848218d5fd541804deb0a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic68b77b69d164add899d2a619ff62119_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i060bb9404d074c528d1af49985d37955_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b4f3b5db698411ebb73710d058f54c2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icb411ee072b942e5a2c9d5d3a2375bf0_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc7b5e81d7a54212aea41081aa548202_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i721f57024c7846249c67ed7b1117b908_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i53ef85cdea504b9799f6da4bfe4a5da8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6f057b09b0354d10b776451cf542bfb4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifea73937ee8d4f188daa2e67eb443344_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5490e98b3a7944b197ababef7f1cd3b6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i57fd4571325741b291c09c0956211dc6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic95a52a138104e5393a29cb3a5612fa0_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ic259b127e06248a0bb0af498b1a913ea_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i8ed3ae73da4a4e93a4f0fea44d3a1651_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ia582a4c76df748c291ab9a03c35e576f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i05ffbb068303406889ded3a6014f5317_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i99e234235a614d2b8ba6a4040a513dcf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7983f141c6004f779d261c014c29aa28_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i092604083384497fa34d578392bb77bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id482c75e4518446e816d97e9e2c77f42_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7080be4bce4149a380535228f0bd124b_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1e210be06bb946e0a077415537e12d74_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2a8f20fda404be0a321899a6a0aaa28_D20211215-20211215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pbh:ZaditenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="i37c82895d23b43b094aca7f0895f76ea_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7558ab4cd1534d24b525a049ad733f00_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a38405494994ce1b5c3aab38c92de25_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9871dafd896a45e493ceb7df67951c71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2c616be96d674e2998de9db27d2068b5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i89ac26c1487c489296168379bd629daa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i144ad08b0f5f49afaa122bd98a2a1bc1_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0cd84c34e88c4d2f9dc0e7f967aad239_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7cc8177d10de49bea9958fbb3d673d7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38cba7c0d2ce48268a9ea237fd0c1c0d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7d3f3bbb024f46fa91a25d1c1ce64cae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia708754131aa4c4cadfdb34847429103_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iffd6d7d6775d456aab43522e8641590d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia93c71c69cbd4f518813bf35d29567ff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i81c4abbe4c7a4c51ab953cfac5a719e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib13229551ff74aac852ed82658c2bc5a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5bb1ab25a9104ca786d77647d79f0750_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ica6a01a4639347e59ce1b6926fe770aa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i209a7eca485c4ae089043ae691508354_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie4b38ddefea943b4a58f5c5e1837187e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6fcb4c05211a4f52b3d328d6faa3c979_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i107654b9df4f4d36a2be4b1b29dbb756_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ife1cf43c2ca44eed91e983938f2fd966_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifaee783e80be466aac335d1710829144_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c573dedd8d9443b9195d944fdb41808_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0f4ca14c8ca842d6b7d60e303216a672_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8145646a4620446cb3bb6c97a2b33b43_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b63503a525b4ad0ae2f49bbf0d38637_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ife7c577cd8d34acd9e144f85556f13fe_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i39f948f5963c423aa59b916bd733f299_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibc2804a8cd20480092ebaac1665cb981_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5a7c46e7cb4f4393bc9da7353259532f_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee68f53fac064ea6b3ca739ae5139369_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f3ebdd1608049819d7960351aa8db35_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia469219d9c2a49a98e21464086b58660_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c497ac02c504e91b6ce612b29fc8a82_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a99b6fbe44645ad882a7a958382a827_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf00c0aedee84c69bbd5b799d12c794f_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i810dbd51386f4f1894a85343c5088368_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7ac391963f848548a601af9567fbba9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i205dff464c7245768d0c7263beceb556_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic536994b83bb485a862ea0e3393120d1_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia218ac2046f540c895fce30181f0a41e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if1f1b498eebb4cd883a3fa617593819a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5be7898b214a428d8760e4a62973f03b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8326e328abad4478a736ff2103f13dad_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8883e67a6b294bb2b4988346e7c8bf37_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icfd1c9c171164a8f9f0702ee5bb0710b_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44cc662485d34441b6e4321c121a9125_I20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="i81cfb12ba748413e9a14ed4bcc0a4a0f_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="if59663672a2242a89e285a8508bacf1c_D20140531-20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-05-31</startDate>
            <endDate>2014-05-31</endDate>
        </period>
    </context>
    <context id="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="ieaf59758726f4998abd628904bf3be96_I20200623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-23</instant>
        </period>
    </context>
    <context id="ic9184f3b632646bebc4e3cd2872e2ba4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i42333d378e9e4b66a3f698890196fcc6_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0d07c6a04ba74840907835eea95e20cd_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i11b979b892ef4decba1bfef8062479dd_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i681c9643cccc46478279947213d2e17b_D20220802-20220802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-02</startDate>
            <endDate>2022-08-02</endDate>
        </period>
    </context>
    <context id="i815f24f411e64db2828daba078c81281_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifa98021577994bd988d17efb0ddce577_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if3f0f5de01544b1488a49d521bd4e50f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id405071995174d9a92bfacc37bad77cb_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2063782252c94eed817587f0ac1d141a_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1240337eaee64711a1a60d6c2e1b7e6c_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib1f22bd2d45941c7b1bc75e4966da7c7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3d2317b145b7448e92da9f723d95918f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2cba7d38b81045e787d4f104d9fb3eaa_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia1a0406745a24ccf85af84e2f238dafb_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i213e57bd7c7b47edbccb40cf81cd0e0e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i25ef8ba0f2404c738e6cf363025e958a_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:TopFiveBrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic9ff1becf0f84b77a14626c31518df01_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib056427d825645d3a6d243d6f12ade35_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6351be3774e04b968ab085c80b3d6b0c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i093f3d98ccb14d9089261e76e6f7c5d6_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia36e7d927aba40fab88e45e3e3e41575_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalgreensMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i12a9fca5712b4984be4783b87d0d1895_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia687471f18b34360a6f6a50343be6ca3_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5a5c21dfca0f469999a785781e89c178_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i27ad6371c4b14f5782e971050830c85c_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92a17492201d453a8cc5b811656651c5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia834815cf1604076a6c15f46da4bca86_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe73f08e6843453c8b833a024999d919_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i026667c5f30d40229f5ca1072dd36fb1_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ee703b3c6224e53919817395112fc83_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i907a70df628e4e48b75b67fd126aa346_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ea034b41f254bdca8406677654243b2_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieb42bf6d38ee41da9172272d89d125f2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i91733343cd3f4ed69349759a5007771f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd5a4e1b1ddb48f58b2cba888ead4b2a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i41fdf6285d3d4d4eae2b16526b8641c5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1012eb424f2b4a27a014e52c4a7811d9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i941a5663f483406585d5edf13941d483_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1beedb6cef7e452a85e8b6be83cf629b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe91143a1c704b018a3976eb5a01c8a4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib9b16ec8347043ef89e62a09618575e5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb709d3222aa40d08b7528ab5869f491_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1e7cd02c9b2b42f5957d2a924601c171_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98f86017bb774d3d842c01a04cc30417_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac26523f549e4adbaa8dd3618b500aa8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i156269b4bc68478aaf0dd5842487d92d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ea214aa8f2e4deb8d5ceaaf97d29c8c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifa6b5df992544fefa4e5d17749dfb237_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i49c739500f044451bbbcb4db0694d023_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iba2a752fd8ed4bd7a34663dc23e12f46_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i508a38c03392406f8d6e294ca753433e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc7e002d9ce94251906bbfa8507e0edb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1c4223591a1d49188b5b0bf13ac30c8c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf7c91c0d149454cab02b9c237ec63f9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d59461a5a2b46f094ca36900ef9e502_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9d35b8a35e864ee698d7d3dae351ba18_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idcc08b763b1242c4ae090e4552cf7fe1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8a99ba3fbd29462aa2fdd8aba546873e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6749959e270d484a8849ec9baeeb8726_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib03000714fd04461b44e3ed996bbdcb2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iddc1f391c4a14ce993aab75bb0e56b22_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib05a53f6ddd84378a8b0e8ffe24ce1f8_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3890c9dec07642c388c1c5545eb77376_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67b8efa5861d4b22a06a49d48921e253_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iafd6d904e1c3451caf89d8a72a334070_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia3e3ef2deded4c839f83b082e1afc3c4_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3a45b0f569b5480995950a7d10bbc8e8_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4abaf43271f54b92aab3fd11f43d7755_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9385a0d313844f70abb80799feab8302_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i952f5bd919b24d1db88ea63c4fbe1bc6_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if641448d42014771a833e92c731a8eaa_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6daec78175cd4f9d99c734cec1bd11c2_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5ce8bc57290b440981f94ecbbfac6d33_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i77c021d4c1f045f690a73afbd3a4cd6d_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iae4aa809e3674b859374a3de6a969618_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib5f8aa2313314f7d83e72570a64bb906_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibd11ab63fa2b44a08ee05dc22f56913a_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79a221081d114432b4a27d7b40d183f7_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifdc1df03ae0a46c4825f6652f54f210d_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i59a5ffc00b62425ba1a88cc64cbd36e8_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b7667f0de454eb79b0ad225eebdbae0_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f84cd10cc5345d09c2dd76fa06e00ad_D20220401-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icd20649b7a574a058d933177cb7d6cdc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i64a3ad1a593744bbb35935dcc3c1a3dd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if597e5a35cc541908f97df9d4ad7877a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e715778cd0e44a18645616c8df69ba1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2e0dfb7bd0c54a90992d0bfce4410815_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f5de7468f634f76a808529f4f6971c3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i04ec63a0cca14633bf006f38ec899a46_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i966596af0d5149ca92ddbd71fbfd37d4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b73b63596724fc89c7cc257a90d4507_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i092e4d9253d2444c80fd19466e202ae2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd0146ec3b014515a2ad85b80a0c2222_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic6e44a39fcd049b092a1c21fbe7a84da_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21693008f1de4e39a8cd0d000b9f2f07_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc54a38c56e845fcbb0e801b4552812b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6d96da2f9524e769fd11ec5e90068a5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea51b409490b4d488139c17146926635_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iac699f58a1a94fbc80b52040fffbb15c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8e1c256b8811486db61c7a2fe6bb58f6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48aae1c5023a4f5b8ae3b7524d2fe2a6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01bd495866f74b2db9bb1e41ffab0e86_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36a20b01556341028361a20e77dd1d38_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i95b4cc1178ef43ddab6a471cf872e469_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibdc2502c0c6e4a428c8e95e77c5aa35e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e3e7b22d27c4f5d9a8507e37f905566_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib60529f2161a445ab1e93ac7f996d24e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3685f44ac4054a6f9f2f5cbc54fb9e44_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i16a655f924b541c9867fa22141ff7d79_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i10b8a1903aee41588afc67cb5fd35651_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i594a5a7ea66f4bf18ffa7ba9baaf6548_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5fdb9a0b2635450380252cded493c8d8_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia13e6a4210034ca49a0dd1f93399f945_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5b1929a5adc4372b62c50ce12c1a55f_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iddf28338f91741c9a583ee1f11391d98_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i24f07f0b271c42408ac2cefda0abadac_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if5158014abd84e34bc6cf3f536db8822_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf634010a44e415ea2149c5273a64f42_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5fac7101ca624095a37b8838b7e370ba_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic095d7fd82584e46b46aef36eaf1309e_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97c35bb9633841d3886e1e747017e734_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f27bafa6f93466284cbe1faacc2d6ff_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cca7e01971f4b2ab2205da66c2ff17d_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iafd607a224fa4d8896c1359ce5450557_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2963a340f2574654997fdd3323c114d8_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5607274c7e0f483abe26074eb0e5e120_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i52a95b1802134eaa80c0184052482422_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia252b0ef955b4546bc834792f1e46e8c_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1503156d93284b65b2b7ffeb0926be90_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb5eb987418746d580936607f4f6e710_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie91d3b9d39ec4e5cbd1449174d4808d0_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i43a414c6a89f4bf6b73c26c8489e3c3a_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4e429d25f01742dcb996639f98638232_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief270666f60b4f22aae84b337ecce732_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>pbh:agreement</measure>
    </unit>
    <unit id="vote">
        <measure>pbh:vote</measure>
    </unit>
    <unit id="manufacturer">
        <measure>pbh:manufacturer</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF8zLTEtMS0xLTMzNzgy_b3fbb3e7-e484-49e6-a135-d4b08dc59eb4">0001295947</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF80LTItMS0xLTMzNzgy_f55fcbb3-913e-4244-8f63-8d525c790c3b">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF81LTEtMS0xLTMzNzgy_96f406d6-929c-4235-bed7-69b494f1a4ef">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF82LTEtMS0xLTMzNzgy_0d667e32-512d-4460-8ff7-5ce570fdd5e6">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80L2ZyYWc6YTVmYzNmYzk5MDEwNDE3NjgyY2FkNGRmODY4MWM4NmQvdGFibGU6YTkxY2Q4ZjZlZjk1NDJhMzgzZjM4NDE1Mzk4NGRmMTQvdGFibGVyYW5nZTphOTFjZDhmNmVmOTU0MmEzODNmMzg0MTUzOTg0ZGYxNF83LTEtMS0xLTMzNzgy_1bbcea68-2719-4996-a038-4ba8c49d08f6">false</dei:AmendmentFlag>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ibf00c0aedee84c69bbd5b799d12c794f_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82MS9mcmFnOmY5OTI3NjU0NWI3NDRiNDdhNDdjNWQ1MDk0MWY4YTRlL3RleHRyZWdpb246Zjk5Mjc2NTQ1Yjc0NGI0N2E0N2M1ZDUwOTQxZjhhNGVfNA_caa37e5d-d74c-48f3-976d-3efc8e784ca4"
      unitRef="agreement">1</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <dei:DocumentType
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8zMzQ_c665ea7f-534c-4861-ae4b-c42295709ec1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmE0ZjVkNDk2YzA5NGExODkwNTlkNTZlMjEzNDUwZjkvdGFibGVyYW5nZTo2YTRmNWQ0OTZjMDk0YTE4OTA1OWQ1NmUyMTM0NTBmOV8wLTAtMS0xLTMzNzgy_a5daa6f8-5432-455f-b382-a2bd778076c6">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80MjY_c1caed07-5503-49a1-a2d4-429105e42928">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6OTg0Y2ExNjBkNzNkNGQwZmFlNGI5NWU3NGNjMjAwMjQvdGFibGVyYW5nZTo5ODRjYTE2MGQ3M2Q0ZDBmYWU0Yjk1ZTc0Y2MyMDAyNF8wLTAtMS0xLTMzNzgy_b66ca092-0714-4c9b-ab56-e16b6ce48aeb">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80NjA_79387758-03c3-4a7c-bde8-c4591209c762">001-32433</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF80Njc_64aeeb4c-0bb6-41c5-909a-19c73dc1a3b9">PRESTIGE CONSUMER HEALTHCARE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmFjNGI3OTlkN2EyNGUwOGI5MWM5NjgxYWMyYzk3ODcvdGFibGVyYW5nZTo2YWM0Yjc5OWQ3YTI0ZTA4YjkxYzk2ODFhYzJjOTc4N18wLTAtMS0xLTMzNzgy_941a96f3-9a41-4ae8-ade2-eb8f665f7ca3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmFjNGI3OTlkN2EyNGUwOGI5MWM5NjgxYWMyYzk3ODcvdGFibGVyYW5nZTo2YWM0Yjc5OWQ3YTI0ZTA4YjkxYzk2ODFhYzJjOTc4N18wLTItMS0xLTMzNzgy_b648598e-ac3f-40d2-aca6-ef7ee6e4bec1">20-1297589</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81Mjc_87d63f11-c33a-4e04-9caa-e7d3e56da533">660 White Plains Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81MzE_d4641ad7-2692-4d2e-81c2-42bc0481cfbe">Tarrytown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81MzU_c403b7f8-faca-4e87-83e9-c98893751875">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81Mzg_fc632a13-27b3-41e2-8fd5-57470bfe229c">10591</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81OTU_04b6f51f-9362-49ee-9a23-06082a24a3a3">914</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF81OTk_38338d8f-7d08-4efc-93b7-7f5973baf77b">524-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTAtMS0xLTMzNzgy_1ea16f54-cf9b-48f2-ae0a-474fd5dc10ce">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTEtMS0xLTMzNzgy_6a4a682e-536a-4867-ba1e-90582fc8c33f">PBH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6ZTRmMjY2Y2Y3OWI1NDAyNjhlM2I5ZmFlNmU0ODI1YmIvdGFibGVyYW5nZTplNGYyNjZjZjc5YjU0MDI2OGUzYjlmYWU2ZTQ4MjViYl8yLTItMS0xLTMzNzgy_e1f31716-768e-4b75-a6d5-e05e8dda6aeb">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF85NTM_b388d112-6c93-465f-bd1d-2455a6819406">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8xMjc0_9c97f0cd-23cf-4d2e-9644-9ac4e0de7033">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8wLTAtMS0xLTMzNzgy_9d279991-6c33-4ce1-9ddb-aa1568144227">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8xLTUtMS0xLTMzNzgy_eed77cb3-fa70-4750-b0b8-8d9b1cbcfaeb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGFibGU6NmQ0NzhlZTM3YjIwNGFmZDg4MmQzMmI4NjQ4NTE3MjUvdGFibGVyYW5nZTo2ZDQ3OGVlMzdiMjA0YWZkODgyZDMyYjg2NDg1MTcyNV8yLTUtMS0xLTMzNzgy_67d5a6a0-9540-44ad-9dad-e3625a7d4f36">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8yMDE0_b3e47de3-7e9e-472b-a85f-843493e2f45d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2b5cd7145aa748fb9457afb75bfb22a3_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xL2ZyYWc6ZTcyZmM0YjkyOTY5NGEwNzlhNTU3MTE4MTE3ZTQyOTAvdGV4dHJlZ2lvbjplNzJmYzRiOTI5Njk0YTA3OWE1NTcxMTgxMTdlNDI5MF8yMDU0_3cdcc3b6-35e3-4949-bd21-b32c3bcf2cda"
      unitRef="shares">49525952</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bee7c6863b44412bc884931f7b88a78_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy0xLTEtMS0zMzc4Mg_ced064fb-0175-4ea3-bf1a-cfe78fd44210"
      unitRef="usd">289264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id39bec788f0b4db6a12131f87f82b94d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy0zLTEtMS0zMzc4Mg_7b825f6d-0fd2-4ed0-b3b0-27fb17865e32"
      unitRef="usd">276217000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0caf19b36a0844e780c8b2020c00ce04_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy01LTEtMS0zMzc4Mg_763d8c88-3605-4687-bb68-24b2858d549c"
      unitRef="usd">566288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5da56f011314bc89196844b2597e30e_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMy03LTEtMS0zMzc4Mg_c3180657-370c-4738-87bb-1368ee4ed1de"
      unitRef="usd">545389000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0bccb62ff474647827368f1c0a570b9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC0xLTEtMS0zMzc4Mg_2d05926b-d823-4262-9755-2e9da84e89ea"
      unitRef="usd">9000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieae852b5e88a4d2881bfc94a55458c84_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC0zLTEtMS0zMzc4Mg_c5c91caf-ee22-47a5-ad50-2fa18d9fb0f8"
      unitRef="usd">8000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f7749c08a3942a98a4139f57288645b_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC01LTEtMS0zMzc4Mg_365fa38d-e21b-448e-90be-b665aea9c197"
      unitRef="usd">44000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife92d668e4de4cc1ad969fd36c2572f3_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNC03LTEtMS0zMzc4Mg_5d03f61e-44d9-4d25-a025-b316ae1cb287"
      unitRef="usd">17000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS0xLTEtMS0zMzc4Mg_8ff949a1-e313-4a87-9b57-24d7a85450e4"
      unitRef="usd">289273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS0zLTEtMS0zMzc4Mg_5a569e77-3e02-4a0f-aebb-f41d039a6e93"
      unitRef="usd">276225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS01LTEtMS0zMzc4Mg_37cc3abc-88cb-48f2-8110-b433e1038280"
      unitRef="usd">566332000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNS03LTEtMS0zMzc4Mg_fe5ac93e-6725-4d8e-87a2-818a128df70b"
      unitRef="usd">545406000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC0xLTEtMS0zMzc4Mg_05ba9c4a-0a9a-4b19-8f1a-a4865268f4cd"
      unitRef="usd">126384000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC0zLTEtMS0zMzc4Mg_7473dbf5-1731-46d7-bb16-f29db369e64e"
      unitRef="usd">116722000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC01LTEtMS0zMzc4Mg_d752fe36-fbd3-46e6-b8ca-a28c5ff23558"
      unitRef="usd">241380000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOC03LTEtMS0zMzc4Mg_f9de17ed-a005-47e4-9f1b-61caef6f859f"
      unitRef="usd">225057000</pbh:CostOfSalesExclusiveOfDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS0xLTEtMS0zMzc4Mg_b3f1a18e-cdac-4dae-8883-df22fbdfdc90"
      unitRef="usd">1880000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS0zLTEtMS0zMzc4Mg_b70a41bf-db41-4469-a940-9c3cdd0aeb93"
      unitRef="usd">1791000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS01LTEtMS0zMzc4Mg_b681d966-d887-4933-b4b7-b2b8f7d8b149"
      unitRef="usd">3824000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfOS03LTEtMS0zMzc4Mg_3e1893e2-3ae1-48ac-8640-b48f1a271294"
      unitRef="usd">3625000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfRevenue
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtMS0xLTEtMzM3ODI_6af516db-1b7c-4a9b-b315-12eb5c25f2bc"
      unitRef="usd">128264000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtMy0xLTEtMzM3ODI_5317dad0-fc55-4ffa-b1a6-b6f3d27913e5"
      unitRef="usd">118513000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtNS0xLTEtMzM3ODI_0246e32a-14e6-44c6-9a5f-eb136b83d173"
      unitRef="usd">245204000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTAtNy0xLTEtMzM3ODI_660675a8-320e-43ad-8d8d-a39937fc04e8"
      unitRef="usd">228682000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtMS0xLTEtMzM3ODI_1e308340-e303-4cdc-98c5-24b88c068072"
      unitRef="usd">161009000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtMy0xLTEtMzM3ODI_09f72bdf-ca9e-4ca9-b411-adbb5e730874"
      unitRef="usd">157712000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtNS0xLTEtMzM3ODI_2f79a660-4958-488f-b4bb-769f96e6861f"
      unitRef="usd">321128000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTEtNy0xLTEtMzM3ODI_88c38bce-2774-4fb3-a291-e182908f29fb"
      unitRef="usd">316724000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtMS0xLTEtMzM3ODI_87429ef6-4f1e-4b76-b836-2a8887804906"
      unitRef="usd">43819000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtMy0xLTEtMzM3ODI_00b3fdf7-9558-45f7-b7d9-0d4b5fa225ee"
      unitRef="usd">40730000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtNS0xLTEtMzM3ODI_ee2e3b4d-8e8b-47db-b6c3-ec89b9fd07d4"
      unitRef="usd">83770000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTQtNy0xLTEtMzM3ODI_c2dad35a-4821-4997-9549-0fec892c280f"
      unitRef="usd">80169000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtMS0xLTEtMzM3ODI_46ce6da5-8573-4da0-b9b8-4ae545e9156a"
      unitRef="usd">26438000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtMy0xLTEtMzM3ODI_87e579e6-4dfc-4d2d-989b-55d153ced3b2"
      unitRef="usd">32252000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtNS0xLTEtMzM3ODI_1e6a7dba-a1cc-4a5d-a353-1cdcc6bec117"
      unitRef="usd">53152000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTUtNy0xLTEtMzM3ODI_f24cd91e-658e-4d15-b8d7-f887d6ec750b"
      unitRef="usd">54723000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtMS0xLTEtMzM3ODI_d6cae1cb-ff53-41a4-8c16-fb5873ab4ce1"
      unitRef="usd">6368000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtMy0xLTEtMzM3ODI_c2adeff7-baed-4c1a-91af-423995fd1600"
      unitRef="usd">6172000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtNS0xLTEtMzM3ODI_276649f9-474b-467a-aea7-f4d38345e926"
      unitRef="usd">12808000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTYtNy0xLTEtMzM3ODI_e6e05d02-08ac-4294-9a02-30e83539ff1f"
      unitRef="usd">11932000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktMS0xLTEtMzM3ODI_16dfe15b-f88f-49ae-83ec-2e549008cbc2"
      unitRef="usd">76625000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktMy0xLTEtMzM3ODI_f234af58-b216-4a77-a0e2-b2687bf79c67"
      unitRef="usd">79154000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktNS0xLTEtMzM3ODI_70ca7a4f-27d5-4e75-b2fc-e8a37d5e2793"
      unitRef="usd">149730000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMTktNy0xLTEtMzM3ODI_5e3375fe-4505-4bf0-a4d1-390261f13968"
      unitRef="usd">146824000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtMS0xLTEtMzM3ODI_a632ba05-f006-4a11-9fe0-dbcb64432977"
      unitRef="usd">84384000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtMy0xLTEtMzM3ODI_c59dc819-48ff-4b73-b97f-92c0264dec46"
      unitRef="usd">78558000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtNS0xLTEtMzM3ODI_7bde5838-6bd8-44fd-86b2-a8fef1acad9c"
      unitRef="usd">171398000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjAtNy0xLTEtMzM3ODI_d97d7ebe-aa12-41f1-9b15-dabbb1fe46a6"
      unitRef="usd">169900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtMS0xLTEtMzM3ODI_765733e1-eaa0-4449-aafb-479f99a2284a"
      unitRef="usd">-16979000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtMy0xLTEtMzM3ODI_5d59ad52-3ed2-413b-85d8-c3a758f2ae3b"
      unitRef="usd">-16313000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtNS0xLTEtMzM3ODI_a33cb239-9dfa-4660-9140-745c90da5fff"
      unitRef="usd">-32271000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjUtNy0xLTEtMzM3ODI_0e40eb05-aecd-40bc-a356-c50244031aca"
      unitRef="usd">-31390000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtMS0xLTEtMzM3ODI_1b12c1b3-99da-47c7-ac46-e371affe4c84"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtMy0xLTEtMzM3ODI_386323dd-c506-48bd-845f-762cdd9ade2d"
      unitRef="usd">-2122000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtNS0xLTEtMzM3ODI_18717e28-87f4-4d68-9526-7751c90dc900"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjYtNy0xLTEtMzM3ODI_22767489-f1f7-4b74-bf75-bc0266e1596e"
      unitRef="usd">-2122000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctMS0xLTEtMzM3ODI_e0d612be-0bbd-485a-ba51-1c484fb4016b"
      unitRef="usd">-812000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctMy0xLTEtMzM3ODI_af1b5887-fba9-40ee-9691-9ade1f496072"
      unitRef="usd">-493000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctNS0xLTEtMzM3ODI_4942f3cc-98ab-47d2-b57e-84765cfe53f0"
      unitRef="usd">-1637000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjctNy0xLTEtMzM3ODI_bc571946-c92b-4c6c-bc4e-6f2209feb2ff"
      unitRef="usd">-388000</us-gaap:OtherNonoperatingIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtMS0xLTEtMzM3ODI_463a39c4-9e1b-46ff-8b76-99bb044aeb8b"
      unitRef="usd">-17791000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtMy0xLTEtMzM3ODI_1d063165-a10a-42de-86dc-657d2e0cf07a"
      unitRef="usd">-18928000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtNS0xLTEtMzM3ODI_6a091730-fc2c-4ef5-a62b-6ee482f33cb8"
      unitRef="usd">-33908000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjgtNy0xLTEtMzM3ODI_ae392938-5206-4838-927c-b2d9f3ab18a6"
      unitRef="usd">-33900000</pbh:TotalOtherIncomeExpense>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktMS0xLTEtMzM3ODI_c542e245-9d76-4fbe-add4-34cb26b2d8a6"
      unitRef="usd">66593000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktMy0xLTEtMzM3ODI_5be6fe24-d7ba-48ef-818c-964bd3749072"
      unitRef="usd">59630000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktNS0xLTEtMzM3ODI_b4cc8ea6-72f1-47de-9470-75a60fc96710"
      unitRef="usd">137490000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMjktNy0xLTEtMzM3ODI_8484574b-c5b4-4ac7-97a4-d205c3645878"
      unitRef="usd">136000000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtMS0xLTEtMzM3ODI_4f144e91-91f1-476b-ac0c-2d278b45a0be"
      unitRef="usd">15570000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtMy0xLTEtMzM3ODI_788aebfa-caf5-453a-9965-a2126e5ab123"
      unitRef="usd">14305000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtNS0xLTEtMzM3ODI_3b2c732a-e87b-448d-9459-511f1205b849"
      unitRef="usd">31195000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzAtNy0xLTEtMzM3ODI_7c686f0f-503e-4195-8631-aa9aaf6c7f6c"
      unitRef="usd">32920000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtMS0xLTEtMzM3ODI_83e81d9e-2da7-41be-b2a6-ea8924bb17d1"
      unitRef="usd">51023000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtMy0xLTEtMzM3ODI_b98eb003-bef7-4cfa-9b69-1aacfa5a0550"
      unitRef="usd">45325000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtNS0xLTEtMzM3ODI_0e2151b7-65c1-4b74-83d3-d98c0d221b88"
      unitRef="usd">106295000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzUtNy0xLTEtMzM3ODI_2b03ceac-d307-4615-b4d2-71548146e2ea"
      unitRef="usd">103080000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtMS0xLTEtMzM3ODI_5d259fc0-189a-46cd-a819-099d209bd152"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtMy0xLTEtMzM3ODI_0681b19f-2515-4c5e-8850-ce5c69533ca5"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtNS0xLTEtMzM3ODI_b6c26bf9-1733-478f-b481-e0e4f2c78c17"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzgtNy0xLTEtMzM3ODI_bdc064c3-6dab-444e-a513-3336080b515f"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktMS0xLTEtMzM3ODI_c3a6a207-6d9f-469e-ac15-a53a8c2a59a4"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktMy0xLTEtMzM3ODI_fa06db37-2220-4278-8fed-301e67aee777"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktNS0xLTEtMzM3ODI_e2b69525-b7b0-4036-8dd2-c335e37f1b09"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfMzktNy0xLTEtMzM3ODI_1fec5643-7e4c-4b7f-9bdf-4fa1c4d23f19"
      unitRef="usdPerShare">2.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItMS0xLTEtMzM3ODI_a8b9f726-775a-4d9b-b180-f05de199fa5a"
      unitRef="shares">49804000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItMy0xLTEtMzM3ODI_24f23474-f684-431d-b84d-ccd45296e691"
      unitRef="shares">50232000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItNS0xLTEtMzM3ODI_f5d0bd24-f82d-4706-87d0-189af9662e71"
      unitRef="shares">50033000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDItNy0xLTEtMzM3ODI_f30a3893-bf88-42d9-9896-0eba53d97236"
      unitRef="shares">50186000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtMS0xLTEtMzM3ODI_b3b6baa2-203a-4041-a6f7-9da674ae806a"
      unitRef="shares">50265000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtMy0xLTEtMzM3ODI_beaa90ba-dafc-45cf-9878-8c52a4bc2dd7"
      unitRef="shares">50791000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtNS0xLTEtMzM3ODI_47c68e91-f9de-4ffe-a230-4dc8d2d25bd8"
      unitRef="shares">50496000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDMtNy0xLTEtMzM3ODI_0d172e8c-54af-4f5a-915f-624f2cd83698"
      unitRef="shares">50731000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtMS0xLTEtMzM3ODI_5908076c-2c67-4a3d-a992-be9d37359b94"
      unitRef="usd">-7118000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtMy0xLTEtMzM3ODI_d57a4262-2ae6-40eb-925f-e1082f45e824"
      unitRef="usd">-4197000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtNS0xLTEtMzM3ODI_5e264e6d-85e2-4650-8ea0-b96b1e28e39b"
      unitRef="usd">-16637000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDYtNy0xLTEtMzM3ODI_fc684cf0-46e7-4c3a-91d2-e4bc89aec2bd"
      unitRef="usd">-5689000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctMS0xLTEtMzM3ODI_8d8dc8c0-f0ba-4c27-959e-bf23dabcf317"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctMy0xLTEtMzM3ODI_25727e37-fa44-4f04-950d-3f63102c45f4"
      unitRef="usd">550000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctNS0xLTEtMzM3ODI_71ad9888-0e36-4af4-833e-9f3f9b3b67a1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDctNy0xLTEtMzM3ODI_94894490-1c4b-416e-bb6f-5bc80a564d9f"
      unitRef="usd">1070000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtMS0xLTEtMzM3ODI_bcd84be6-3114-407c-b2d4-3f3d9d924b57"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtMy0xLTEtMzM3ODI_880e5adc-f195-4571-ba26-54df97ec21a5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtNS0xLTEtMzM3ODI_66746995-e80e-4b0c-b6c9-40884f5285bf"
      unitRef="usd">790000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNDgtNy0xLTEtMzM3ODI_b9be774f-137a-44c7-9d85-c1474a122023"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtMS0xLTEtMzM3ODI_a67350fa-ac15-4d8f-a8f9-64399f9620d8"
      unitRef="usd">-7118000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtMy0xLTEtMzM3ODI_8a4164d9-be60-4ea3-84e5-f740ca352fcf"
      unitRef="usd">-3647000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtNS0xLTEtMzM3ODI_90bf377b-a499-4367-a42a-b8fb043e864f"
      unitRef="usd">-17427000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTAtNy0xLTEtMzM3ODI_aba36b55-082d-4c46-8084-438ba41dc059"
      unitRef="usd">-4619000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtMS0xLTEtMzM3ODI_c76d9a68-8438-4193-9a85-19ed55cb2335"
      unitRef="usd">43905000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtMy0xLTEtMzM3ODI_6667e731-88a2-4a86-b3de-0e610e7a675b"
      unitRef="usd">41678000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtNS0xLTEtMzM3ODI_c8b636d0-37dc-47a4-9585-62f1664d149f"
      unitRef="usd">88868000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xNi9mcmFnOjYwMzY4Y2UxNGUzMzRhYmU4M2IyNDE2YTU5YjA5NmE3L3RhYmxlOmMwMmMwNjNlM2UzMTRlM2ViZWE1MmZlMTg5NmEyMjVjL3RhYmxlcmFuZ2U6YzAyYzA2M2UzZTMxNGUzZWJlYTUyZmUxODk2YTIyNWNfNTEtNy0xLTEtMzM3ODI_84678bcd-2660-48de-86f3-afc44fd289ea"
      unitRef="usd">98461000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNC0xLTEtMS0zMzc4Mg_03ecf26d-ee7b-49a6-b08b-fb0b8e10c77b"
      unitRef="usd">42442000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNC0zLTEtMS0zMzc4Mg_b00e3507-b36b-4afc-99a6-1bbeb9fd2279"
      unitRef="usd">27185000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQxOTc3ZDdmNDI2ODQ3MjA4Nzc3MTUxZDQzOTAxNTlmXzQ1_97d216fe-2e96-4c25-a642-c97580cf39d5"
      unitRef="usd">20673000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQxOTc3ZDdmNDI2ODQ3MjA4Nzc3MTUxZDQzOTAxNTlmXzUy_e9edef11-f3a9-49d4-9d55-ea2e04c59c6f"
      unitRef="usd">19720000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0xLTEtMS0zMzc4Mg_c79fe2b3-3229-4098-8900-e8b158e171b7"
      unitRef="usd">145992000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNS0zLTEtMS0zMzc4Mg_7a0de360-91b4-4303-9153-2cab59b85bfc"
      unitRef="usd">139330000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNi0xLTEtMS0zMzc4Mg_4f301dba-3bf1-4f30-b2dd-3d9b33ab2765"
      unitRef="usd">140505000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNi0zLTEtMS0zMzc4Mg_a76d90ac-918c-4953-baca-b54b5f94ed6c"
      unitRef="usd">120342000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfOC0xLTEtMS0zMzc4Mg_c0306657-a7b5-4b25-8c0d-400168195311"
      unitRef="usd">7714000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfOC0zLTEtMS0zMzc4Mg_64f85eb9-9d0f-4217-9c75-da79e866947e"
      unitRef="usd">6410000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTAtMS0xLTEtMzM3ODI_c149e7b5-f5c2-4fc9-a3b1-2d7f3321d384"
      unitRef="usd">336653000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTAtMy0xLTEtMzM3ODI_466917b9-6a79-4beb-bd88-0fe4b0144646"
      unitRef="usd">293267000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTItMS0xLTEtMzM3ODI_fb1eab1e-7ca7-4b66-96f9-2d497f501470"
      unitRef="usd">69947000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTItMy0xLTEtMzM3ODI_c16b027c-390d-423c-bb26-a667c2beae9b"
      unitRef="usd">71300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTMtMS0xLTEtMzM3ODI_1977bb88-895a-4c78-8561-821fa63cf646"
      unitRef="usd">17300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTMtMy0xLTEtMzM3ODI_2b8b3519-941f-4337-85b3-3df23bcb39a3"
      unitRef="usd">20372000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTQtMS0xLTEtMzM3ODI_69da0154-f8cc-49c4-942f-3c493ef152c4"
      unitRef="usd">5529000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTQtMy0xLTEtMzM3ODI_5f035df2-65d9-47ff-a732-6fee3afc7bd2"
      unitRef="usd">6858000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTUtMS0xLTEtMzM3ODI_528384f6-5bbf-41b4-90e3-24c1bde1c9d6"
      unitRef="usd">575566000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTUtMy0xLTEtMzM3ODI_b324e79d-7022-4747-b4b3-2d4fe64bbc37"
      unitRef="usd">578976000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTYtMS0xLTEtMzM3ODI_2a928fc8-d150-406d-b33c-b1ad451359f2"
      unitRef="usd">2670942000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTYtMy0xLTEtMzM3ODI_f3b87e32-18ba-415d-b684-454e4e0a8003"
      unitRef="usd">2696635000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTctMS0xLTEtMzM3ODI_0e26e90c-75f4-4ce4-9bbd-54cb96526ff7"
      unitRef="usd">2577000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTctMy0xLTEtMzM3ODI_4fa76bab-95bb-437c-bb7a-a56521a20bcc"
      unitRef="usd">3273000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTktMS0xLTEtMzM3ODI_bc172e36-29ae-49ed-b4f2-bc423e5c92c0"
      unitRef="usd">3678514000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMTktMy0xLTEtMzM3ODI_786e1099-4710-4525-b156-76935d778860"
      unitRef="usd">3670681000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjQtMS0xLTEtMzM3ODI_1943c29a-9961-44af-9492-ad2326def174"
      unitRef="usd">56196000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjQtMy0xLTEtMzM3ODI_e1d2e9fc-5f38-4b55-8f38-cb1b5bd3e616"
      unitRef="usd">55760000</us-gaap:AccountsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjUtMS0xLTEtMzM3ODI_8811d35f-7e35-4903-a24b-45a55d38235a"
      unitRef="usd">15688000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjUtMy0xLTEtMzM3ODI_dcb94701-ddf1-4012-941f-d4d6f0369501"
      unitRef="usd">4437000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjYtMS0xLTEtMzM3ODI_b5ce7347-2624-44c1-a4f3-08c31bb51f4e"
      unitRef="usd">6647000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjYtMy0xLTEtMzM3ODI_f21db9fd-7c01-4fac-a5fb-8938760fe224"
      unitRef="usd">6360000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjctMS0xLTEtMzM3ODI_f3ac01fa-78dc-4128-b5f1-75eb70f55509"
      unitRef="usd">2793000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjctMy0xLTEtMzM3ODI_6df0a1dc-3780-4d3e-8804-d9ef6521cd8d"
      unitRef="usd">2752000</us-gaap:FinanceLeaseLiabilityCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjgtMS0xLTEtMzM3ODI_cd0ac993-2a9d-42d6-8553-1e8ce2002e73"
      unitRef="usd">70984000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMjgtMy0xLTEtMzM3ODI_0fe7dc1a-fae4-41fa-99e2-d99ed5dfe8b0"
      unitRef="usd">74113000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzAtMS0xLTEtMzM3ODI_6109a715-e2c4-4ca2-81c7-186dfddbe10c"
      unitRef="usd">152308000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzAtMy0xLTEtMzM3ODI_d126d8b1-9e42-49f4-9692-727643e26057"
      unitRef="usd">143422000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebt
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzUtMS0xLTEtMzM3ODI_76a3f1a6-adb0-4b58-8ff1-8d6c6ad27ce8"
      unitRef="usd">1438338000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzUtMy0xLTEtMzM3ODI_aa99ad08-6e28-4ebe-847c-c261284981d8"
      unitRef="usd">1476658000</us-gaap:LongTermDebt>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzctMS0xLTEtMzM3ODI_f97a8d6e-7d99-476f-bd8b-8737e8bbe0ad"
      unitRef="usd">443271000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzctMy0xLTEtMzM3ODI_7e4fc9d3-0bb7-4829-8a23-ceaf95600f79"
      unitRef="usd">444917000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzgtMS0xLTEtMzM3ODI_99a25b71-3ec7-4f7c-9845-840b4d842a90"
      unitRef="usd">12785000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzgtMy0xLTEtMzM3ODI_6787c7c8-442e-4595-9b39-cda64dfdb82a"
      unitRef="usd">16088000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzktMS0xLTEtMzM3ODI_ec91ac10-2144-4888-b0a0-66b7e00e5bbd"
      unitRef="usd">3094000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfMzktMy0xLTEtMzM3ODI_fdd06b13-373a-4c2a-9c31-356a130fb0ac"
      unitRef="usd">4501000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDAtMS0xLTEtMzM3ODI_698cde3e-09d8-40eb-8da9-8aa2d37d3c51"
      unitRef="usd">8877000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDAtMy0xLTEtMzM3ODI_e89d16b8-a653-4a4e-8240-78c36420f8db"
      unitRef="usd">7484000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDEtMS0xLTEtMzM3ODI_5a9835b6-4688-4204-8bbf-ee675b53ea9d"
      unitRef="usd">2058673000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDEtMy0xLTEtMzM3ODI_9c90d06d-2e02-4a7f-a94a-538873036bf1"
      unitRef="usd">2093070000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDMtMS0xLTEtMzM3ODI_d4c0b2e1-f854-4b24-87db-eaa6626b7f88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDMtMy0xLTEtMzM3ODI_95b08209-e705-4bee-8e02-d384d829c034"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDYtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpjM2IxNDA5NzVmZTI0NGEwODMxYjdlNTY4NmY3MmJiOV8yMg_426e25e2-3895-45bc-8d25-e4cb9797eebd"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDYtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpjM2IxNDA5NzVmZTI0NGEwODMxYjdlNTY4NmY3MmJiOV8yMg_e7892f1c-18e1-486d-b584-ff284a542508"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDctMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowMjA1NWM3OTY5YTQ0ZWM4YTk4NWYzM2Y1NjJlZmJlZF8xNw_55d44ff3-ee9e-4be4-b0f7-02c30e01557a"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDctMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowMjA1NWM3OTY5YTQ0ZWM4YTk4NWYzM2Y1NjJlZmJlZF8xNw_ab55ef87-c21d-4825-b04f-121f0cb4a864"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_259da967-902c-4089-bfc4-1e8ba63e5593"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_3b60b530-a8be-4e08-8e9d-1ceef5e8fad6"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_bbbb564b-9bf2-43f2-b363-cf893ccef058"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjowNzYzMGViMTQ0OTk0NmNkOTZlMDM1M2Y0MWNjNmZmYV8yOQ_f690ecc7-e9b1-426c-9c8d-b92821bfe4a7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMS0xLTEtMzM3ODI_7d243bb0-a602-4ea8-8775-9e21936181c2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDgtMy0xLTEtMzM3ODI_7e78d72c-c3c4-4cd5-8e78-e99fce315c78"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDktMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpkNDYzZWNiNzBmNmQ0ZDZlYjg5YTUzOTM0ZTZlYmM2Y18xOQ_5993049a-d918-4892-a840-e252e0d38abd"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNDktMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjpkNDYzZWNiNzBmNmQ0ZDZlYjg5YTUzOTM0ZTZlYmM2Y18xOQ_76e2dc70-28e3-4941-af01-5cfe7490933d"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTAtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMzQ2YTVmOTg3YWU0NWFjOGVlMDdlNmQ0NGIxMmM4MV8xNw_76100926-95ed-44e9-8bf9-3ddc7fc9f66a"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTAtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMzQ2YTVmOTg3YWU0NWFjOGVlMDdlNmQ0NGIxMmM4MV8xNw_eacaa0cf-926f-401c-9f83-3b408b02300e"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjphYWVkMGFlY2RlYWU0MWMzOTBlOTgxODVkZTAzNDE0Nl8xMw_8c8ed9a7-e502-47fc-9ca1-26d037ae66fd"
      unitRef="shares">54690000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjphYWVkMGFlY2RlYWU0MWMzOTBlOTgxODVkZTAzNDE0Nl80NA_cba03f0f-2e91-4ddc-942c-34ef454490d7"
      unitRef="shares">54430000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMS0xLTEtMzM3ODI_03c51920-c457-4a89-b36d-be8fa59c1b05"
      unitRef="usd">547000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTEtMy0xLTEtMzM3ODI_17d2b982-0527-44ab-b006-a5abcc04b795"
      unitRef="usd">544000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTItMS0xLTEtMzM3ODI_2c415068-abb9-4773-8fa3-e6fd5c9233a1"
      unitRef="usd">524392000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTItMy0xLTEtMzM3ODI_77a2a842-4e20-4971-8a4d-b1a525f33dc3"
      unitRef="usd">515583000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMGUzOTMzODBiYTU0MjQwOGNmOGZjYzA1OWE0MGMyOF8zMA_e762d0ce-a4d7-443f-adbf-642bae0d9e9e"
      unitRef="shares">5164000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMC0xLTEtMzM3ODIvdGV4dHJlZ2lvbjoxMGUzOTMzODBiYTU0MjQwOGNmOGZjYzA1OWE0MGMyOF82MQ_d6b19e6b-936d-4aac-80f5-704cd9f4bfa1"
      unitRef="shares">4151000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMS0xLTEtMzM3ODI_a1bc8631-893c-4324-8928-c3b09526a666"
      unitRef="usd">189098000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTMtMy0xLTEtMzM3ODI_f0e40e12-e8d0-4d96-b1b0-b48a3cab2e6e"
      unitRef="usd">133648000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTQtMS0xLTEtMzM3ODI_ac07b302-0464-487e-bb07-6ad97580401d"
      unitRef="usd">-36459000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTQtMy0xLTEtMzM3ODI_ab1c6755-50f0-49fd-811f-5a7add35f7f0"
      unitRef="usd">-19032000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTUtMS0xLTEtMzM3ODI_9ce2961b-f53e-49f5-aa7c-e39d313f4b65"
      unitRef="usd">1320459000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTUtMy0xLTEtMzM3ODI_a477b7c6-fb5f-442b-bf18-23df80f9f51d"
      unitRef="usd">1214164000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTYtMS0xLTEtMzM3ODI_f393cb4f-8794-4cdd-a7a5-3cc9c70c8b17"
      unitRef="usd">1619841000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTYtMy0xLTEtMzM3ODI_81a466c7-8026-436c-a6d2-419564c1fee4"
      unitRef="usd">1577611000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTctMS0xLTEtMzM3ODI_438de0d0-1ab0-4bf6-9c93-4b45595459da"
      unitRef="usd">3678514000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8xOS9mcmFnOjgwNWNmMDJhNTEwYTQ2NDhhYmU1ZDVjYmMyNDdlYmNjL3RhYmxlOjUzZjhmZDEyY2YxYzRkYmNiNjRmNGQ3ZTU2NGU1ZmRkL3RhYmxlcmFuZ2U6NTNmOGZkMTJjZjFjNGRiY2I2NGY0ZDdlNTY0ZTVmZGRfNTctMy0xLTEtMzM3ODI_c0c1fa06-7c3a-4e67-a72c-b756d1821fdf"
      unitRef="usd">3670681000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if46763b8fa074769bcaaa4438d57b38d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xLTEtMS0zMzc4Mg_81deaf8e-1653-434f-bc46-dd07717adb0d"
      unitRef="shares">54690000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if46763b8fa074769bcaaa4438d57b38d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0zLTEtMS0zMzc4Mg_4fe35f1f-fe64-4e38-bb3d-0ec05928b3ba"
      unitRef="usd">547000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f35434d33a648fa862d5c96f94944c9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy01LTEtMS0zMzc4Mg_83eeee5e-6f3d-401b-8b10-a24407838c7a"
      unitRef="usd">520926000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy03LTEtMS0zMzc4Mg_14578684-74a0-47f5-95e0-10c6d5720637"
      unitRef="shares">4928000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ia9a9dc50ac04422a9d69c58d6ce968e9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy05LTEtMS0zMzc4Mg_4fbe9931-89af-417c-b497-24001d101a96"
      unitRef="usd">-176825000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50e084b171fb4b8db0e35cea53a45b80_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xMS0xLTEtMzM3ODI_ae37dbf9-f579-4194-8725-860e507c6ba2"
      unitRef="usd">-29341000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibad2e23cbb3348cc87b24030492dd5e7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xNS0xLTEtMzM3ODI_7d938bcc-acbc-4355-a57f-6c9af3ffde41"
      unitRef="usd">1269436000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id76154f8b5bf460ba7f5e1713e0f4b9b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMy0xNy0xLTEtMzM3ODI_ed7c2216-4cec-4bdb-9cf4-f35701a1fd5d"
      unitRef="usd">1584743000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0a6f6a31caa242a8b2653c643c896785_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfNS01LTEtMS0zMzc4Mg_e56bfcd0-b980-4195-b9a4-3799f92ae8d9"
      unitRef="usd">3466000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfNS0xNy0xLTEtMzM3ODI_0e22c396-e57b-4f7b-bd35-9a7b47b115cc"
      unitRef="usd">3466000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS03LTEtMS0zMzc4Mg_70ecd945-dfac-47a3-9dc1-f00bce21085c"
      unitRef="shares">236000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if55413f39dd14f1a9ca898cbcd302668_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS05LTEtMS0zMzc4Mg_82078ea4-2b1b-44b3-8c49-64b8acefbcd7"
      unitRef="usd">12273000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfOS0xNy0xLTEtMzM3ODI_a2abbd3c-bb15-4b8d-a042-43619af94e76"
      unitRef="usd">12273000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i6274cb788e2a4cd9aac84afce0d56e50_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTQtMTUtMS0xLTMzNzgy_d73db8b5-ba52-4aa6-b326-7515904de98c"
      unitRef="usd">51023000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTQtMTctMS0xLTMzNzgy_11ebf2e8-72b9-4acf-9951-8f0fc068deb1"
      unitRef="usd">51023000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic2b997dc2a2a4bcfa90762d3f59e9f5c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTctMTEtMS0xLTMzNzgy_1bf8f385-c36a-4411-9343-4caf98c7415a"
      unitRef="usd">-7118000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTctMTctMS0xLTMzNzgy_08085ea7-6d57-4c7f-aad7-a4ad3673f7ef"
      unitRef="usd">-7118000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie357f9389e29493d825baf6acc58956d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMS0xLTEtMzM3ODI_74904a59-c459-4133-be9e-e2bfde10e8f6"
      unitRef="shares">54690000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie357f9389e29493d825baf6acc58956d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMy0xLTEtMzM3ODI_597c0686-f132-455f-844f-0dee0ac34ead"
      unitRef="usd">547000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i86aa80eb8f5d42178dc12c570932bcbc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktNS0xLTEtMzM3ODI_a73d307c-81ed-4a53-a790-e34fa4bc0fe4"
      unitRef="usd">524392000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="id24db078a3ee463e901922ad206211f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktNy0xLTEtMzM3ODI_d0ff58c5-aa9d-48a7-8710-36638e2f9da4"
      unitRef="shares">5164000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="id24db078a3ee463e901922ad206211f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktOS0xLTEtMzM3ODI_faff61cb-28af-4457-9605-b2f2f02d4034"
      unitRef="usd">-189098000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTEtMS0xLTMzNzgy_d1df2ce8-fe3a-4455-836f-619507834de2"
      unitRef="usd">-36459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTUtMS0xLTMzNzgy_d4fa5bb7-7129-4de8-936a-5ddab69a052d"
      unitRef="usd">1320459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjhlYmUyYmZkYmU2MTQ1NDM4MWYxZGNhODFhNGQyOWM5L3RhYmxlcmFuZ2U6OGViZTJiZmRiZTYxNDU0MzgxZjFkY2E4MWE0ZDI5YzlfMTktMTctMS0xLTMzNzgy_2c919967-b81a-42e9-979c-08ae86611f0f"
      unitRef="usd">1619841000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idb607635f68941e384560e956f878d1c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xLTEtMS0zMzc4Mg_a59347fc-b26b-4cf6-b01a-2ad94e7b03e0"
      unitRef="shares">54211000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="idb607635f68941e384560e956f878d1c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0zLTEtMS0zMzc4Mg_89896f4c-7051-43ee-8764-4bbb5aa3a5eb"
      unitRef="usd">542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia0856c1935e8426aa05f2b92f1b4128b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy01LTEtMS0zMzc4Mg_8c6b0502-9e0b-44a5-a7a8-98bf781b2012"
      unitRef="usd">503588000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="if9a8960a5122443c944621c7077bf180_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy03LTEtMS0zMzc4Mg_6d9aca67-64fa-4991-87e8-b4e941bf2f05"
      unitRef="shares">4151000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="if9a8960a5122443c944621c7077bf180_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy05LTEtMS0zMzc4Mg_39a0537f-8076-4c65-a88a-c52886ba4213"
      unitRef="usd">-133648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22ba0e1d1859416f8017159157d7454a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xMS0xLTEtMzM3ODI_243ad77e-c744-4d09-88e6-37765e2f38b9"
      unitRef="usd">-20773000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i488aadb430a7489aac56d43528efd1e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xNS0xLTEtMzM3ODI_c37608f7-ef8b-4acc-8615-870fb1f4e72b"
      unitRef="usd">1066538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fb12bac2e3d41adbe1614c20b5dcc29_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMy0xNy0xLTEtMzM3ODI_c205332e-a1c1-445e-810c-e70a3de7fff0"
      unitRef="usd">1416247000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNi01LTEtMS0zMzc4Mg_aad62dcf-51e2-4079-8166-616a41438c1b"
      unitRef="usd">3219000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNi0xNy0xLTEtMzM3ODI_f58711ce-61c6-4e20-9438-6689624c70fc"
      unitRef="usd">3219000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy0xLTEtMS0zMzc4Mg_ff2799d2-6493-4f6c-a198-da18e50fa88d"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6188156e393946e3bba3e6a98cd25473_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy01LTEtMS0zMzc4Mg_dca199bc-ab74-439b-8f0d-aaaeebf1a614"
      unitRef="usd">503000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfNy0xNy0xLTEtMzM3ODI_f0bf8d1e-3101-400f-820a-4cfc2fcd39bb"
      unitRef="usd">503000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="id7e8dadb775545bebaf67094da7df63d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfOS0xLTEtMS0zMzc4Mg_bfcd5649-017d-42b4-917c-5779463e4357"
      unitRef="shares">16000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfOS0xNy0xLTEtMzM3ODI_742aa9df-42d2-468d-8a3a-6084d0bbf598"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:NetIncomeLoss
      contextRef="i1d391f2095e244008323df736432422a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTMtMTUtMS0xLTMzNzgy_6852df98-be9b-456d-b131-742f73ba0bcf"
      unitRef="usd">45325000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTMtMTctMS0xLTMzNzgy_3cbde6a7-3852-4632-9a8d-a5037c2c4540"
      unitRef="usd">45325000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia44d1ef5e11f44fa9de0ac543d1b12c4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTYtMTEtMS0xLTMzNzgy_c72a235d-0936-4be5-a1d1-d6864f60a1a3"
      unitRef="usd">-3647000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTYtMTctMS0xLTMzNzgy_cbf6063b-8859-4b30-8f8d-79c4dde2c87e"
      unitRef="usd">-3647000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMS0xLTEtMzM3ODI_f81621b3-91e0-4071-81d2-47ad6d12abbd"
      unitRef="shares">54247000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMy0xLTEtMzM3ODI_b698347a-1c5b-4f8f-ae84-9189a1475d85"
      unitRef="usd">542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i792d19a2000e4f1da418859eb0355822_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtNS0xLTEtMzM3ODI_5ec39e8f-f078-47dd-8816-cefc021478ba"
      unitRef="usd">507310000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtNy0xLTEtMzM3ODI_334e1c64-cbda-498f-8e45-faaf5b94470f"
      unitRef="shares">4151000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtOS0xLTEtMzM3ODI_5c1be6e2-fcd0-46b5-9c38-2c7897f5e609"
      unitRef="usd">-133648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25f692c5e67345558d67487dab771c22_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTEtMS0xLTMzNzgy_9815ef31-acb3-443c-b496-738cb1e15df4"
      unitRef="usd">-24420000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idfe143a6e35d4af08305f5de23360208_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTUtMS0xLTMzNzgy_e1ae070e-433e-4375-9c40-41b16a77172c"
      unitRef="usd">1111863000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOmEyNmM1NDQ2ZmQ0ZjQzMGQ4NzJjM2Q4ZjdhYmVlYzRhL3RhYmxlcmFuZ2U6YTI2YzU0NDZmZDRmNDMwZDg3MmMzZDhmN2FiZWVjNGFfMTgtMTctMS0xLTMzNzgy_e5928042-b088-43ee-a940-be625bffe140"
      unitRef="usd">1461647000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic4e6014926544642b7769ed5b6fdf002_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xLTEtMS0zMzc4Mg_b346ff27-8f11-42c1-a7b1-e7a03f8e3be0"
      unitRef="shares">54430000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic4e6014926544642b7769ed5b6fdf002_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0zLTEtMS0zMzc4Mg_17651f0a-14b1-42c7-82b3-162d16c0e165"
      unitRef="usd">544000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48085cf8517740c3a4adf0d4a1f84e2e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy01LTEtMS0zMzc4Mg_bf554706-bcfd-473e-b94b-807a81c59ad1"
      unitRef="usd">515583000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ieca905416c0040288f44aa9524fe841a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy03LTEtMS0zMzc4Mg_b7d965df-79c4-4516-9d52-93a351b7a6b1"
      unitRef="shares">4151000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ieca905416c0040288f44aa9524fe841a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy05LTEtMS0zMzc4Mg_3eb99301-c872-446b-bd96-a9d419ffe69a"
      unitRef="usd">-133648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97f54d4cf1d841b38d61272505328c59_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xMS0xLTEtMzM3ODI_b45430c5-19c3-4994-b786-afb71b8e2479"
      unitRef="usd">-19032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia75f07adc20848218d5fd541804deb0a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xNS0xLTEtMzM3ODI_dc8f100c-67c1-40ff-9bb1-8dbe54bcffbc"
      unitRef="usd">1214164000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMy0xNy0xLTEtMzM3ODI_678f8ecf-ff2d-4ddc-b6e5-383200c274cb"
      unitRef="usd">1577611000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNS01LTEtMS0zMzc4Mg_97e1b9cc-ef2d-4d52-932c-6a12f7e5c18c"
      unitRef="usd">7323000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNS0xNy0xLTEtMzM3ODI_914d47e1-77f9-4c89-878b-4a93a5972376"
      unitRef="usd">7323000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0xLTEtMS0zMzc4Mg_9f216d6f-d54a-44a5-af41-a66ebdc0375d"
      unitRef="shares">39000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0zLTEtMS0zMzc4Mg_1ee3f1c6-1e51-4ce6-ad09-a960b1058f0c"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi01LTEtMS0zMzc4Mg_15746f1e-1a87-47f7-99d1-ae323afdd23f"
      unitRef="usd">1488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfNi0xNy0xLTEtMzM3ODI_58c7474f-8ff5-4043-a0f6-9d0894452c61"
      unitRef="usd">1489000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0xLTEtMS0zMzc4Mg_bb096e4f-f38c-434f-8086-e3622eb4b4fb"
      unitRef="shares">221000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ic68b77b69d164add899d2a619ff62119_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0zLTEtMS0zMzc4Mg_eb06201b-b94f-4dac-ae18-2cfd987d368f"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i95d2dbbdf3754b1c9b6c414fa076ca34_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC01LTEtMS0zMzc4Mg_ce278cd8-1bc1-4ae7-a68f-ebdf18fe049c"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOC0xNy0xLTEtMzM3ODI_9c8a8de8-472e-4880-b8cf-606987e67702"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i060bb9404d074c528d1af49985d37955_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS03LTEtMS0zMzc4Mg_cd9a680d-f3e6-4ff2-9a00-745ecde4228d"
      unitRef="shares">1013000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i060bb9404d074c528d1af49985d37955_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS05LTEtMS0zMzc4Mg_35e9e8a8-395a-4727-87dd-d615650b044e"
      unitRef="usd">55450000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfOS0xNy0xLTEtMzM3ODI_d5773759-02cb-46e2-bf0b-c5f9aba97839"
      unitRef="usd">55450000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i8b4f3b5db698411ebb73710d058f54c2_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTQtMTUtMS0xLTMzNzgy_f269e24c-2aee-4fcc-aa66-1527cec37ba3"
      unitRef="usd">106295000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTQtMTctMS0xLTMzNzgy_1bd7cb32-875b-40d0-bd09-0517d80cd1c2"
      unitRef="usd">106295000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icb411ee072b942e5a2c9d5d3a2375bf0_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTctMTEtMS0xLTMzNzgy_2d82ebde-71d6-4cb0-8e26-5af24119bc72"
      unitRef="usd">-17427000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTctMTctMS0xLTMzNzgy_f3a4f49c-2162-4f81-9141-ec18006596f1"
      unitRef="usd">-17427000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie357f9389e29493d825baf6acc58956d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMS0xLTEtMzM3ODI_654e09ab-0516-4b8c-97d7-70aa94f25d8e"
      unitRef="shares">54690000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie357f9389e29493d825baf6acc58956d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMy0xLTEtMzM3ODI_80a98503-717c-4355-9f09-8124fa7a851a"
      unitRef="usd">547000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i86aa80eb8f5d42178dc12c570932bcbc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktNS0xLTEtMzM3ODI_5bf3d44b-b1b6-42bc-86d5-c48439923ad3"
      unitRef="usd">524392000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="id24db078a3ee463e901922ad206211f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktNy0xLTEtMzM3ODI_f81cfa60-0881-4822-be18-56b5219c7bb3"
      unitRef="shares">5164000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="id24db078a3ee463e901922ad206211f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktOS0xLTEtMzM3ODI_9a21e3d1-b8ec-4e92-9464-fb9afc7c138e"
      unitRef="usd">-189098000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTEtMS0xLTMzNzgy_13d4f602-b1f6-4de8-b5bb-07dd81bb5e23"
      unitRef="usd">-36459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c261f014fde4ca9a2683ed6f4d0f55f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTUtMS0xLTMzNzgy_96a95a1b-72c6-4c2a-bde6-20d53250caa3"
      unitRef="usd">1320459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjk4ODM1NWM2ZTY3YzQ3N2E5YjFmMDAyOWYyNWRmZjEzL3RhYmxlcmFuZ2U6OTg4MzU1YzZlNjdjNDc3YTliMWYwMDI5ZjI1ZGZmMTNfMTktMTctMS0xLTMzNzgy_450e0cfd-3fe9-49b6-9662-63a6b487a2ba"
      unitRef="usd">1619841000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xLTEtMS0zMzc4Mg_678f7a2e-067b-4b31-a118-3f0ea7bca10d"
      unitRef="shares">53999000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifd7dc8e8f3b642559cfd89d9830a9388_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0zLTEtMS0zMzc4Mg_42845e0d-d9ca-4b89-a7f8-57ef9c0c12b8"
      unitRef="usd">540000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc7b5e81d7a54212aea41081aa548202_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy01LTEtMS0zMzc4Mg_110b6577-a6ce-4d2a-9d64-23290465b6cb"
      unitRef="usd">499508000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i721f57024c7846249c67ed7b1117b908_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy03LTEtMS0zMzc4Mg_f7dd17e8-7ba6-47ca-8e4f-75fbd9a48efd"
      unitRef="shares">4088000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i721f57024c7846249c67ed7b1117b908_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy05LTEtMS0zMzc4Mg_8387782c-a2c2-4bd1-855d-64fab3a028aa"
      unitRef="usd">-130732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i53ef85cdea504b9799f6da4bfe4a5da8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xMS0xLTEtMzM3ODI_2f8260fa-7767-4aa0-9e58-1eb13cfd081d"
      unitRef="usd">-19801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f057b09b0354d10b776451cf542bfb4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xNS0xLTEtMzM3ODI_51aee9f9-ab79-45b4-b36a-781e83efd4fd"
      unitRef="usd">1008783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMy0xNy0xLTEtMzM3ODI_21c2fd07-d7d5-4f6a-a768-bb81917fb61f"
      unitRef="usd">1358298000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNi01LTEtMS0zMzc4Mg_21c18125-36d9-4d4b-9424-efa4158a8587"
      unitRef="usd">5097000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNi0xNy0xLTEtMzM3ODI_4da99a70-4de0-4746-a428-49bc42963b55"
      unitRef="usd">5097000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy0xLTEtMS0zMzc4Mg_7d72b95c-4be5-4dfa-b1ac-aedffe3e7b8b"
      unitRef="shares">88000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy01LTEtMS0zMzc4Mg_6384cb99-e6b1-4262-9f8b-1db07585bb5f"
      unitRef="usd">2707000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfNy0xNy0xLTEtMzM3ODI_86687bc8-8d02-45a1-bc46-fa016af549bf"
      unitRef="usd">2707000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0xLTEtMS0zMzc4Mg_c60d8622-9954-4edb-b229-ad2c7c964253"
      unitRef="shares">160000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i7e3a0235bcb341edaa10f708c9840119_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0zLTEtMS0zMzc4Mg_65485902-4c90-4179-88ac-3e0b7e71e0a6"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i38972cfea9464f77ab2eae2104bae911_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS01LTEtMS0zMzc4Mg_5bc9c9dd-cfbf-4da1-9a56-ca3e278da1db"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfOS0xNy0xLTEtMzM3ODI_e5ecfca5-ffc2-4d78-9a0d-c029a25f8442"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtNy0xLTEtMzM3ODI_c1a8f033-788c-454b-acda-7551af825e84"
      unitRef="shares">63000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7b8278b269a74436bcfe9bb122631ebf_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtOS0xLTEtMzM3ODI_3afac887-34ff-4c71-b187-1a4dc3dadb82"
      unitRef="usd">2916000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTAtMTctMS0xLTMzNzgy_9ed28e46-f53c-4c07-a1c6-7887618f572d"
      unitRef="usd">2916000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i5490e98b3a7944b197ababef7f1cd3b6_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTMtMTUtMS0xLTMzNzgy_a5374630-9b75-4e5d-914a-45e3ae9ab46a"
      unitRef="usd">103080000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTMtMTctMS0xLTMzNzgy_2512a13f-45af-411d-b582-1fe78cd8e97d"
      unitRef="usd">103080000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i57fd4571325741b291c09c0956211dc6_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTYtMTEtMS0xLTMzNzgy_7c81ac5f-e1f0-410b-80b7-2b4fdb9a9e63"
      unitRef="usd">-4619000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTYtMTctMS0xLTMzNzgy_c22a16ef-cb72-4e61-807a-80592529cad5"
      unitRef="usd">-4619000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMS0xLTEtMzM3ODI_6302c0ff-e120-415a-91fe-1dd410655f42"
      unitRef="shares">54247000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie8623c9c86ec48afbe97a3935315d44e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMy0xLTEtMzM3ODI_107ea5b6-0025-4ede-9d7f-a0cf223d7a08"
      unitRef="usd">542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i792d19a2000e4f1da418859eb0355822_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtNS0xLTEtMzM3ODI_2bf05e8a-2548-4330-92dd-a3279bece3eb"
      unitRef="usd">507310000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtNy0xLTEtMzM3ODI_3d6ff228-7f6f-4da2-8cce-a6d8cdca4a97"
      unitRef="shares">4151000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i3bfba22679b040a6aeea7958f5629194_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtOS0xLTEtMzM3ODI_8868a44a-ff47-4685-ae99-046f36bca69e"
      unitRef="usd">-133648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i25f692c5e67345558d67487dab771c22_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTEtMS0xLTMzNzgy_d6d2452c-ff76-44ac-995e-23e79508143d"
      unitRef="usd">-24420000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idfe143a6e35d4af08305f5de23360208_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTUtMS0xLTMzNzgy_503bbf21-1470-45e4-98e8-15aba0f5a697"
      unitRef="usd">1111863000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yMi9mcmFnOmJmZmM1MDQ1N2RkNDQwOTI4Yzg3NTg2YjQ4ZmY1Y2UxL3RhYmxlOjZjMjQxMGM3ZTY3ODRmODY4MmRjNDE5MzQyNTFlZWMzL3RhYmxlcmFuZ2U6NmMyNDEwYzdlNjc4NGY4NjgyZGM0MTkzNDI1MWVlYzNfMTgtMTctMS0xLTMzNzgy_dc2f5da2-21ca-4e65-ad4c-88d77f76de9c"
      unitRef="usd">1461647000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMy0xLTEtMS0zMzc4Mg_ca7d9ebe-ed1f-4304-a330-6b874b3b87e4"
      unitRef="usd">106295000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMy0zLTEtMS0zMzc4Mg_71cc50e7-f4f6-433e-945a-1a22e757910d"
      unitRef="usd">103080000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNS0xLTEtMS0zMzc4Mg_deaf4be0-e3b8-443b-bdb1-74b5dec74550"
      unitRef="usd">16632000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNS0zLTEtMS0zMzc4Mg_dbf7f6df-8039-42dc-83e4-0a290405d34e"
      unitRef="usd">15557000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNy0xLTEtMS0zMzc4Mg_ad3aeeac-4ace-4be8-becf-00bd6b80e5c7"
      unitRef="usd">-94000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNy0zLTEtMS0zMzc4Mg_52bca6a2-6b49-45d0-8bb3-6c262e6ae183"
      unitRef="usd">-27000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOC0xLTEtMS0zMzc4Mg_7f5756c6-807c-4878-8ef3-cb034aa151b6"
      unitRef="usd">4211000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOC0zLTEtMS0zMzc4Mg_9485821f-0ce8-409c-bf9e-8ce2eeb23148"
      unitRef="usd">7639000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOS0xLTEtMS0zMzc4Mg_3f7cb91f-b889-4136-9ba3-c3dea7b3071a"
      unitRef="usd">1798000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfOS0zLTEtMS0zMzc4Mg_2be1ca23-a888-473a-acdc-70ac657bb843"
      unitRef="usd">1435000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:ShareBasedCompensation
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTEtMS0xLTEtMzM3ODI_0fa9e604-3577-46ac-a0a5-35ba864806db"
      unitRef="usd">7323000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTEtMy0xLTEtMzM3ODI_3d0eb18d-99c4-4be1-9aec-8ce1052fb22b"
      unitRef="usd">5097000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTItMS0xLTEtMzM3ODI_abb82c5b-8d45-4f29-b01d-6a74a2cb8f21"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTItMy0xLTEtMzM3ODI_ec4790fb-18e2-44a6-b173-14f3aa4a91bf"
      unitRef="usd">-2122000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTYtMS0xLTEtMzM3ODI_4280b0bf-1e67-4dd1-8c9c-80b1d98b05bd"
      unitRef="usd">2984000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTYtMy0xLTEtMzM3ODI_9a3ddbf0-daef-443f-8004-c9b94a299ec4"
      unitRef="usd">3351000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <us-gaap:OtherNoncashExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTgtMS0xLTEtMzM3ODI_6806d788-9d8a-40c4-8989-ea7b1af4859c"
      unitRef="usd">447000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMTgtMy0xLTEtMzM3ODI_c92b2b1b-d10f-4ec9-b877-c7fc29827a57"
      unitRef="usd">0</us-gaap:OtherNoncashExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjAtMS0xLTEtMzM3ODI_1fcff168-6d8c-406f-b720-1887e9cc44a1"
      unitRef="usd">8276000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjAtMy0xLTEtMzM3ODI_4cd2d8bc-23a3-4cc5-b4ef-5bb4b953a2c9"
      unitRef="usd">34322000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjEtMS0xLTEtMzM3ODI_bb1b8a30-7611-410c-ba68-3bd993ebe1b6"
      unitRef="usd">21810000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjEtMy0xLTEtMzM3ODI_0979a227-4ce7-4b4e-a90b-1de3e541a583"
      unitRef="usd">-12978000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjItMS0xLTEtMzM3ODI_bd132e21-daf6-431f-be95-beaf27471933"
      unitRef="usd">1501000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjItMy0xLTEtMzM3ODI_c59a784f-51d0-41ed-833c-fdefbe4f3d2c"
      unitRef="usd">-473000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjMtMS0xLTEtMzM3ODI_55d642b5-c668-43ae-bfcc-e0fe73a3e24f"
      unitRef="usd">1016000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjMtMy0xLTEtMzM3ODI_8c612169-2cf5-429b-8458-422ae041f11b"
      unitRef="usd">-8275000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjQtMS0xLTEtMzM3ODI_e27083a8-f881-4ff3-a233-d2762a582299"
      unitRef="usd">9788000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjQtMy0xLTEtMzM3ODI_870dee34-2232-4db5-b049-b6fdcf87d3fb"
      unitRef="usd">24570000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjUtMS0xLTEtMzM3ODI_5aeaa5f0-f13a-4d8d-a4c2-9beb555ac43c"
      unitRef="usd">-3201000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjUtMy0xLTEtMzM3ODI_ef47dd76-8f44-42c7-8f46-d3c2ccdc6401"
      unitRef="usd">-3150000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjctMS0xLTEtMzM3ODI_9685e2e8-3360-4227-a917-ae0cf862732c"
      unitRef="usd">13000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjctMy0xLTEtMzM3ODI_1022e485-66b9-47a7-80c0-d80013682d58"
      unitRef="usd">83000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjgtMS0xLTEtMzM3ODI_dc5a42f7-a76b-481e-b3f4-86809cf1aa61"
      unitRef="usd">115787000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMjgtMy0xLTEtMzM3ODI_2d4ac001-7c16-4aeb-8c9c-48874ebac705"
      unitRef="usd">130499000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzEtMS0xLTEtMzM3ODI_6b023a27-ee92-4531-b8b1-6303dbb18b47"
      unitRef="usd">3423000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzEtMy0xLTEtMzM3ODI_96817520-7068-45cf-b565-f6e5b536721b"
      unitRef="usd">4252000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzYtMS0xLTEtMzM3ODI_b45605f5-e58a-436f-8806-1a32275173b6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzYtMy0xLTEtMzM3ODI_7517f158-6dec-44f9-8b2f-1d2d427b05d0"
      unitRef="usd">228914000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzktMS0xLTEtMzM3ODI_5373ec8e-95a4-475d-b00f-d43076214ccc"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfMzktMy0xLTEtMzM3ODI_5b59dbb0-8e31-4244-938d-b63fd2dfcfe9"
      unitRef="usd">-177000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDAtMS0xLTEtMzM3ODI_133f8339-ae4a-418e-9a9f-4a25be0c0ce7"
      unitRef="usd">-3423000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDAtMy0xLTEtMzM3ODI_3f3f2e7a-636a-4cef-b86d-9164595bf805"
      unitRef="usd">-232989000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDYtMS0xLTEtMzM3ODI_4048a0b4-876e-4179-8438-64e24fa6b8be"
      unitRef="usd">40000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDYtMy0xLTEtMzM3ODI_e3689ab8-206a-45d1-990e-4cd0c2867461"
      unitRef="usd">495000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDctMS0xLTEtMzM3ODI_c86bde83-275d-4ad5-bd48-36cecd72c49c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDctMy0xLTEtMzQxNzE_59e1040e-f135-44dd-a4c2-ba5f0e5c4b38"
      unitRef="usd">597000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDgtMS0xLTEtMzM3ODI_c42c508e-bff7-408d-9c74-13becf44dfb6"
      unitRef="usd">20000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDgtMy0xLTEtMzM3ODI_e52012ed-d107-498d-9ef4-b5907834d948"
      unitRef="usd">85000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDktMS0xLTEtMzM3ODI_826b1e89-1092-40eb-b3e6-cadbedcda3ba"
      unitRef="usd">20000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNDktMy0xLTEtMzM3ODI_34195641-e00d-4d6f-98e9-fd3389a077eb"
      unitRef="usd">65000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTAtMS0xLTEtMzM3ODI_512efb84-0c4a-478c-b9d1-483581c059a0"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTAtMy0xLTEtMzM3ODI_66180ad7-056b-4b1c-8bd9-954db2869068"
      unitRef="usd">6111000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTEtMS0xLTEtMzM3ODI_5692df64-c843-4a3d-b4d0-182ec22f1691"
      unitRef="usd">1369000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTEtMy0xLTEtMzM3ODI_f1adc3ec-5bbe-45d9-84f4-2b5e22beec2a"
      unitRef="usd">1496000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTItMS0xLTEtMzM3ODI_85e2c2cd-2b5b-467d-9b72-a525b41700ae"
      unitRef="usd">1489000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTItMy0xLTEtMzM3ODI_f4f97f64-8543-4620-b3a3-136c94c422cc"
      unitRef="usd">2707000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTUtMS0xLTEtMzM3ODI_b5c18897-e7b7-41f2-9699-704d7a3680ed"
      unitRef="usd">5450000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTUtMy0xLTEtMzM3ODI_594e8344-046f-4fa3-8c87-22b56ded6e35"
      unitRef="usd">2916000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTYtMS0xLTEtMzM3ODI_5ad0ea5d-abf8-41dc-9e34-09771cb38790"
      unitRef="usd">50000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTYtMy0xLTEtMzM3ODI_cf0f2e7b-5a50-4e75-85ae-cf974959785b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTctMS0xLTEtMzM3ODI_91348032-715a-46b3-9377-11b0a9bee19d"
      unitRef="usd">-95330000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTctMy0xLTEtMzM3ODI_624617e8-114a-49df-abc1-e006eefbe753"
      unitRef="usd">114184000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTktMS0xLTEtMzM3ODI_6ba5aef1-8cb4-4e98-bf72-11c0cba2c3ee"
      unitRef="usd">-1777000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNTktMy0xLTEtMzM3ODI_a67b6ce5-ac3a-42f6-b404-6a1a851cfb81"
      unitRef="usd">-1178000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjAtMS0xLTEtMzM3ODI_673ce9ad-cc81-4742-b227-f5ba96608373"
      unitRef="usd">15257000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjAtMy0xLTEtMzM3ODI_2b00ebbe-5925-479c-a3b7-87b63927373c"
      unitRef="usd">10516000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjEtMS0xLTEtMzM3ODI_1dd7ef2f-402a-415c-ba3c-e25680248d59"
      unitRef="usd">27185000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjEtMy0xLTEtMzM3ODI_10892861-8c43-49bb-95f6-57cd628687cd"
      unitRef="usd">32302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjItMS0xLTEtMzM3ODI_2845ba09-e78a-44a2-bee1-0ec4654e1eaf"
      unitRef="usd">42442000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjItMy0xLTEtMzM3ODI_755c8ea7-fac6-4990-9d77-2dda7bb89a25"
      unitRef="usd">42818000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjQtMS0xLTEtMzM3ODI_a2d81bb7-280b-4953-8668-985807ad91a1"
      unitRef="usd">19016000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjQtMy0xLTEtMzM3ODI_61d54497-176b-43fa-9e9f-09b4c4ceff84"
      unitRef="usd">18481000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjUtMS0xLTEtMzM3ODI_0862b73a-3cb6-4492-8588-9392266a93e6"
      unitRef="usd">15689000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8yNS9mcmFnOmU4M2JiMDAwYjE3NDRiOWY4OTg1MWI1YWI4MTFhYTM2L3RhYmxlOjYwYmQ2NzM3YTg4ZDRmM2U5NGY0NzU4OGVkZjVlMjJmL3RhYmxlcmFuZ2U6NjBiZDY3MzdhODhkNGYzZTk0ZjQ3NTg4ZWRmNWUyMmZfNjUtMy0xLTEtMzM3ODI_16c03202-9759-4769-bf09-b69351d256c6"
      unitRef="usd">21141000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU0OA_5aec2776-3b5d-4409-bad4-11b08132b185">Business and Basis of Presentation &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prestige Consumer Healthcare Inc. (referred to herein as the &#x201c;Company&#x201d; or &#x201c;we,&#x201d; which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#x201c;OTC&#x201d;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 8 to these Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Economic Environment  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There has been economic uncertainty in the United States and globally due to several factors including global supply chain constraints, rising interest rates, a high inflationary environment, geopolitical events and the effects from the COVID-19 pandemic.  We expect economic conditions will continue to be highly volatile and uncertain, put pressure on prices and supply and could affect demand for our products.  In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio, however, that may not be sustained at the same levels in the uncertain economic environment.  We have continued to see changes in the purchasing patterns of our consumers, including a reduction in the frequency of visits to retailers and a shift in many markets to purchasing our products online.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The volatile environment has impacted the supply of labor and raw materials and exacerbated rising input costs.  Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience shortages, delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.  We continue to generate operating cash flows to meet our short-term liquidity needs.  These circumstances could change, however, in this dynamic, unprecedented environment.  If conditions cause further disruption in the global supply chain, the availability of labor and materials or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreaks, global supply chain constraints, the high inflationary environment and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31st of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2023) mean our fiscal year ending or ended on March 31st of that year.  Operating results for the six months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2023.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There have been no accounting pronouncements adopted in fiscal 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which we adopted effective April 1, 2020.  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The purpose of the ASU is to address questions raised on ASU 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  This ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#x201c;IBORs&#x201d;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU2Mg_c8dce7b2-d24f-440c-adea-664210030341">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;&#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;In the opinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented.&#160;&#160;Our fiscal year ends on March 31st of each year.  References in these Condensed Consolidated Financial Statements or related notes to a year (e.g., 2023) mean our fiscal year ending or ended on March 31st of that year.  Operating results for the six months ended September 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending March&#160;31, 2023.&#160;&#160;These unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2022.&lt;/span&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU2NQ_64cae680-39cd-4773-9067-3194e655e029">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based &lt;/span&gt;&lt;/div&gt;compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zMS9mcmFnOjhhZDEyYzI4NzA3NDQwMGRiODRlMGMzYjQxYzUwODQyL3RleHRyZWdpb246OGFkMTJjMjg3MDc0NDAwZGI4NGUwYzNiNDFjNTA4NDJfOTU3MQ_5f164696-dcee-42e8-bc49-feac7e24a658">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There have been no accounting pronouncements adopted in fiscal 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which we adopted effective April 1, 2020.  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The purpose of the ASU is to address questions raised on ASU 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  This ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#x201c;IBORs&#x201d;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjI4NA_aa12f5c7-9e5f-4385-bf09-0d672eec5095">Acquisition&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Akorn&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9 million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility entered into January 31, 2012, as amended (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 8).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was accounted for as a business combination.  In connection with the acquisition, we entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We finalized our analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,963&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales allowances &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on this analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years (see Note 5).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded goodwill of $1.1&#160;million based on the amount by which the purchase price exceeded the fair value of the net assets acquired (see Note 4).  Goodwill is deductible and is being amortized for income tax purposes. &lt;/span&gt;&lt;/div&gt;The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjY4_2985064c-c602-46d5-8d45-24928d64535c"
      unitRef="usd">228900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <pbh:SupplyCommitmentTermOfAgreement
      contextRef="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTA4Nw_4a843641-b259-4930-9b3f-5ae25c58c0b6">P3Y</pbh:SupplyCommitmentTermOfAgreement>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMjI4NQ_030e8b31-ca79-4cf0-8ec1-f03279448b0c">The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,963&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales allowances &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfNC0xLTEtMS0zMzc4Mg_81b0c66d-df1f-4bc7-b23f-881def5cc302"
      unitRef="usd">6455000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:Goodwill
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfNy0xLTEtMS0zMzc4Mg_0a41cf9a-9fa7-4274-8447-9ca995624452"
      unitRef="usd">1098000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfOC0xLTEtMS0zMzc4Mg_0d70352d-c8b5-4748-8d1d-26501083ef3c"
      unitRef="usd">225410000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTAtMS0xLTEtMzM3ODI_7b213b25-8b50-440f-9d9e-f3e60f2726e6"
      unitRef="usd">232963000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTItMS0xLTEtMzM3ODI_5515cb46-d5b7-4252-97be-9bbfb66ea8ab"
      unitRef="usd">428000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTMtMS0xLTEtMzM3ODI_76fe1246-370a-46b6-832c-6a92462266d0"
      unitRef="usd">497000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTQtMS0xLTEtMzM3ODI_c7ed5d9c-49dc-4c1d-aeae-2b68655f6bfc"
      unitRef="usd">3124000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTctMS0xLTEtMzM3ODI_1fe63fee-1b82-40f9-918c-ec84f3711033"
      unitRef="usd">4049000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RhYmxlOmUxMDI2ZDM5NmU2ZDRhNzk5ZmY1YmI4NzY3Mzg0M2JjL3RhYmxlcmFuZ2U6ZTEwMjZkMzk2ZTZkNGE3OTlmZjViYjg3NjczODQzYmNfMTgtMS0xLTEtMzM3ODI_7dcb5ccb-c192-4be4-bbd1-63bb155f39b1"
      unitRef="usd">228914000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTQ0NA_dea43764-e78d-460d-80c4-46002a499da7"
      unitRef="usd">195900000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTQ4OA_f0e9488d-fc65-4ef9-99e2-7bb4726ae7b5"
      unitRef="usd">29500000</pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="ic259b127e06248a0bb0af498b1a913ea_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTYzNg_e1a8361f-db93-4e21-8a6a-457035cda019"
      unitRef="usd">20400000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="i8ed3ae73da4a4e93a4f0fea44d3a1651_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTY4NA_cda4290b-34d8-4704-bae6-2caee0cd13c4"
      unitRef="usd">9100000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7f8206f495dc4d968bda2919161c0bad_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTg1NQ_37010aa6-de35-4219-803c-920fbe5a5589">P12Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:Goodwill
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNC9mcmFnOjFlNWQxY2Y0NjNhNTRhMDliNTA2Y2E3YjU3NTM5MGZhL3RleHRyZWdpb246MWU1ZDFjZjQ2M2E1NGEwOWI1MDZjYTdiNTc1MzkwZmFfMTkwMw_5d807d24-8e9e-43df-afe8-e9c8668d729d"
      unitRef="usd">1100000</us-gaap:Goodwill>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjg2_66f8d4e6-2a23-4a9a-89e2-034c42445426">Inventories&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.3 million at September&#160;30, 2022 and $4.9 million at March&#160;31, 2022 related to obsolete and slow-moving inventory.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjY5_164cd6b5-2d7e-40ff-bff3-67c84e6cae86">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMi0xLTEtMS0zMzc4Mg_0fee9d98-fee1-434d-b606-ab647e1cc2d4"
      unitRef="usd">18733000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMi0zLTEtMS0zMzc4Mg_8e98fbe6-ac69-4cf7-91bd-876dde34cc04"
      unitRef="usd">16984000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMy0xLTEtMS0zMzc4Mg_9e35e1d5-ec05-4533-bda7-e38de9b9f072"
      unitRef="usd">537000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfMy0zLTEtMS0zMzc4Mg_6268040e-e26d-4578-a6db-565ec673fc00"
      unitRef="usd">338000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNC0xLTEtMS0zMzc4Mg_d716e949-adfc-4d2b-ba73-fcfc29fd5720"
      unitRef="usd">121235000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNC0zLTEtMS0zMzc4Mg_876a2b22-d2f1-430d-bb42-92f0f6b2cbdb"
      unitRef="usd">103020000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNi0xLTEtMS0zMzc4Mg_9891dd85-31b9-48b1-b9cb-d29ccb02fff6"
      unitRef="usd">140505000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RhYmxlOjBhZjUwZWZkOGNiZjRkNjI4MzNiYjNhNzYyMWQzMTIzL3RhYmxlcmFuZ2U6MGFmNTBlZmQ4Y2JmNGQ2MjgzM2JiM2E3NjIxZDMxMjNfNi0zLTEtMS0zMzc4Mg_1c38894a-8971-4542-a9d6-be0dc8b8e511"
      unitRef="usd">120342000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjAx_843de89b-5673-49b6-91d0-d348a974a9c1"
      unitRef="usd">4300000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF8zNy9mcmFnOjdmZTUyYWU3ZDRmMjQxN2VhMjBhMmEzMGEyMjZiZjMyL3RleHRyZWdpb246N2ZlNTJhZTdkNGYyNDE3ZWEyMGEyYTMwYTIyNmJmMzJfMjE5OTAyMzI1NTg0OA_1c46e5a9-c319-4d3c-b086-6cab6cbf8327"
      unitRef="usd">4900000</us-gaap:InventoryValuationReserves>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjEzNA_22f2d9cf-7b53-4273-9a7c-2059be8e0759">Goodwill &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting goodwill by operating segment is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC &lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Adjustment related to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As discussed in Note 2, on July 1, 2021, we completed the acquisition of certain assets from Akorn.  In connection with this acquisition, we recorded goodwill of $1.1&#160;million based on the amount by which the purchase price exceeded the estimate of the fair value of the net assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment.  The date of our annual impairment review was February 28, 2022, and we recorded impairment charges to goodwill of $0.3 million in our March 31, 2022 financial statements.  We utilized the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test.  We also considered our market capitalization at February&#160;28, 2022 as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, or the potential impacts of COVID-19 and inflation.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  If these assumptions are adversely affected, we may be required to record impairment charges in the future.  We continuously monitor events that could trigger an interim impairment analysis, which included the impact of COVID-19 and inflation for the period ended September&#160;30, 2022.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;/div&gt;As of September&#160;30, 2022, we determined no events have occurred that would indicate potential impairment of goodwill.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjE0Nw_7fd81dd0-5d8e-45b9-9d8c-75716d868665">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting goodwill by operating segment is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC &lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Adjustment related to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi0yLTEtMS0zMzc4Mg_caf59e26-9ef8-4b50-9954-d28ce4386346"
      unitRef="usd">712002000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i05ffbb068303406889ded3a6014f5317_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi00LTEtMS0zMzc4Mg_c61fe3a6-8927-4028-85e2-52ca8d21bfee"
      unitRef="usd">32272000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMi04LTEtMS0zMzc4Mg_b5579948-e0d4-4121-bb46-c5bf360c2176"
      unitRef="usd">744274000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy0yLTEtMS0zMzc4Mg_58081395-87e3-42d1-b946-228c31624e2c"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i05ffbb068303406889ded3a6014f5317_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy00LTEtMS0zMzc4Mg_b4da6172-f65a-4133-9d6e-420d6f8d598f"
      unitRef="usd">1587000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMy04LTEtMS0zMzc4Mg_3cf553f9-bea7-4bfa-b18f-4cac1db6a7ce"
      unitRef="usd">165298000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia582a4c76df748c291ab9a03c35e576f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC0yLTEtMS0zMzc4Mg_f21443a5-0203-49d3-aa2e-b675568e3e60"
      unitRef="usd">548291000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i05ffbb068303406889ded3a6014f5317_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC00LTEtMS0zMzc4Mg_7f99bc00-ca56-4111-9872-fc01724ae010"
      unitRef="usd">30685000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNC04LTEtMS0zMzc4Mg_ca8c7365-8262-4f96-9a1b-be117a1b638b"
      unitRef="usd">578976000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy0yLTEtMS0zMzc4Mg_99007500-9acf-4c43-a7bf-2d0db189c563"
      unitRef="usd">550000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy00LTEtMS0zMzc4Mg_325d770b-96a0-40d1-ac26-7e541a43a52f"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfNy04LTEtMS0zMzc4Mg_8d5cbfb6-ab80-4025-97c7-781ddcea47ee"
      unitRef="usd">550000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS0yLTEtMS0zMzc4Mg_8f895618-867f-44ab-9b7e-5fec612a0c71"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS00LTEtMS0zMzc4Mg_b1695093-ac70-45c2-9867-bb2d8d397cb6"
      unitRef="usd">-2860000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfOS04LTEtMS0zMzc4Mg_703bee21-a484-4bf3-b969-2006ad017d41"
      unitRef="usd">-2860000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillGross
      contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtMi0xLTEtMzM3ODI_6b9aceda-f765-46be-b182-d912fb81013b"
      unitRef="usd">711452000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtNC0xLTEtMzM3ODI_8f3543ea-857f-49e0-8db3-21c57f102b0b"
      unitRef="usd">29412000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTEtOC0xLTEtMzM3ODI_5391d69e-0a9d-4946-b75b-1f80a5866c0f"
      unitRef="usd">740864000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItMi0xLTEtMzM3ODI_68e737c2-d560-474a-becc-ccf9b906a253"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItNC0xLTEtMzM3ODI_c5a4b8fe-20ac-407c-8f03-02c7f3349811"
      unitRef="usd">1587000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTItOC0xLTEtMzM3ODI_51156eaa-266e-4cb2-ac8d-36b7ca6616c4"
      unitRef="usd">165298000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i0975fbb7bb584a868c8f04eaa575ac8e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtMi0xLTEtMzM3ODI_9fb6f63b-c02a-41b7-8825-97ac1738f130"
      unitRef="usd">547741000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i99e234235a614d2b8ba6a4040a513dcf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtNC0xLTEtMzM3ODI_91425445-3c17-4a6e-92bf-cfcc4bb0cf96"
      unitRef="usd">27825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RhYmxlOjc1ODM3MTZiZDFlMTRhOWI4MTM4NGUzM2MwMTc3MzM0L3RhYmxlcmFuZ2U6NzU4MzcxNmJkMWUxNGE5YjgxMzg0ZTMzYzAxNzczMzRfMTMtOC0xLTEtMzM3ODI_2fbf60b8-cdfb-4ae1-9fdc-134c412916d2"
      unitRef="usd">575566000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic95a52a138104e5393a29cb3a5612fa0_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfMjcx_25002edf-de3f-4c50-894c-5d9e4de93c46"
      unitRef="usd">1100000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80MC9mcmFnOjFlN2ZmYzU0ZjdhYzQ0M2RiZGQ4MjRjYzhiNmQ4YmY3L3RleHRyZWdpb246MWU3ZmZjNTRmN2FjNDQzZGJkZDgyNGNjOGI2ZDhiZjdfNzUz_84667fa4-6799-4b2b-90f0-371f7df17206"
      unitRef="usd">300000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4Ng_a2709afe-3ce1-4396-ac66-1bc15821f8f4">Intangible Assets, net &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,897,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets for Akorn and $18.1 million for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $5.6 million and $11.3 million for the three and six months ended September 30, 2022, respectively, and $5.3 million and $10.2 million for the three and six months ended September 30, 2021, respectively.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ended March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The date of our annual impairment review was February&#160;28, 2022, and we recorded impairment charges to intangible assets of $0.7 million in our March&#160;31, 2022 financial statements.  Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins, and advertising and marketing expenses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The discount rate assumption may be influenced by such factors as changes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in interest rates and rates of inflation, which can have an impact on the determination of fair value.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, changes in advertising and marketing expenses, or the potential impacts of COVID-19 or inflation, we may be required to record impairment charges in the future.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of September&#160;30, 2022, no events have occurred that would indicate potential impairment of intangible assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4Nw_16e4952f-d0c2-499e-b841-47a899df5f3c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,897,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjYwMA_25ab8259-2f27-4a0f-846f-74e0b81faf30">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Trademarks and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,897,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2014; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net - September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7983f141c6004f779d261c014c29aa28_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi0xLTEtMS0zMzc4Mg_0eddbc5c-f76e-42ed-b991-2c532f0fd411"
      unitRef="usd">2476559000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i092604083384497fa34d578392bb77bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi0zLTEtMS0zMzc4Mg_8f6456a3-25f6-4799-8534-dd12e19dabf0"
      unitRef="usd">436174000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMi01LTEtMS0zMzc4Mg_6e03a241-85dc-4578-a8de-34789ae357bb"
      unitRef="usd">2912733000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="id482c75e4518446e816d97e9e2c77f42_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy0xLTEtMS0zMzc4Mg_79efdb5c-ecb8-4c44-8278-e46d1e42ac99"
      unitRef="usd">-11701000</us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy0zLTEtMS0zMzc4Mg_4d0970db-61d4-45ab-b596-23de66f543ae"
      unitRef="usd">-3081000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <pbh:IntangibleAssetsTranslationAdjustmentsGainLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfNy01LTEtMS0zMzc4Mg_d044ae72-2304-46c2-901e-cabfd48d44c5"
      unitRef="usd">-14782000</pbh:IntangibleAssetsTranslationAdjustmentsGainLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC0xLTEtMS0zMzc4Mg_ae0a4850-4331-47d0-9015-3cb1a5764c72"
      unitRef="usd">2464858000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e210be06bb946e0a077415537e12d74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC0zLTEtMS0zMzc4Mg_b7d97cd4-9c6e-4d73-98d1-4d70aba244fd"
      unitRef="usd">433093000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfOC01LTEtMS0zMzc4Mg_f42ff0ba-75a0-42fb-831f-b88e2befd0ab"
      unitRef="usd">2897951000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i092604083384497fa34d578392bb77bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTEtMy0xLTEtMzM3ODI_a8f9ef7c-5363-4b8c-a198-52a14fea20c7"
      unitRef="usd">216098000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTEtNS0xLTEtMzM3ODI_33594a7b-8101-44b7-9c11-32aac249c9a5"
      unitRef="usd">216098000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTMtMy0xLTEtMzM3ODI_83d4b659-4dc6-484d-86e2-c21ccd47faa7"
      unitRef="usd">11257000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTMtNS0xLTEtMzM3ODI_8f30d7d5-c978-46db-8fe6-77b83e362da5"
      unitRef="usd">11257000</us-gaap:AmortizationOfIntangibleAssets>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="i7080be4bce4149a380535228f0bd124b_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTUtMy0xLTEtMzM3ODI_e987f96f-01d8-4a9a-8faf-19c4d1666f55"
      unitRef="usd">346000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTUtNS0xLTEtMzM3ODI_34f6d1fb-3a7c-4b9f-932e-bb7a22e5ce56"
      unitRef="usd">346000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e210be06bb946e0a077415537e12d74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTYtMy0xLTEtMzM3ODI_9a55b900-439e-4e7d-9940-0cb824146789"
      unitRef="usd">227009000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTYtNS0xLTEtMzM3ODI_2ee79674-2d06-4624-81bc-9b47aaba6849"
      unitRef="usd">227009000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i94ee55765fd84bfb8447b921c9ce6ef0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtMS0xLTEtMzM3ODI_1cb221a8-d91c-41d0-8f72-1bb6dd606eea"
      unitRef="usd">2464858000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1e210be06bb946e0a077415537e12d74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtMy0xLTEtMzM3ODI_c33d2f6e-976e-46b3-b0e1-e99471fd1e59"
      unitRef="usd">206084000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjNjZjYxMzQ1YmRhNTQ0YjhhNWUwODU0ZmJlM2U4NDVjL3RhYmxlcmFuZ2U6M2NmNjEzNDViZGE1NDRiOGE1ZTA4NTRmYmUzZTg0NWNfMTgtNS0xLTEtMzM3ODI_608c68e0-7482-4212-ab25-e5977dc76919"
      unitRef="usd">2670942000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <pbh:IntangibleAssetsAcquired
      contextRef="i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMzk4_25b168bb-de76-4fd8-88a7-72c112e63991"
      unitRef="usd">225400000</pbh:IntangibleAssetsAcquired>
    <pbh:IntangibleAssetsAcquired
      contextRef="ib2a8f20fda404be0a321899a6a0aaa28_D20211215-20211215"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDM2_dd311e49-2da0-46c4-9334-8402af2d4660"
      unitRef="usd">18100000</pbh:IntangibleAssetsAcquired>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjE5OTAyMzI1ODE2MA_b5b813f2-3162-44d4-b7e4-1ed4994630f1"
      unitRef="usd">5600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDc4_83ec8558-cdce-4247-b8b4-604bb3cb7210"
      unitRef="usd">11300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjE5OTAyMzI1ODE5Ng_a119e6a6-a625-4d38-b8c8-506322703d57"
      unitRef="usd">5300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNDk2_7f8331ac-6e76-43a6-a46a-3db65cc69de8"
      unitRef="usd">10200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMjU4OQ_25a47dd1-d4a9-4dae-931b-2b993e8708a1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and the periods thereafter is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ended March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i37c82895d23b43b094aca7f0895f76ea_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNjM4_315636d6-5338-40e0-a5de-60b54234b774">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7558ab4cd1534d24b525a049ad733f00_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfNjQ0_84ae5456-d78a-4365-92cf-4428225b4ec6">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfMi0xLTEtMS0zMzc4Mg_be4b11fc-fbee-437c-ba09-4b85242b2232"
      unitRef="usd">11210000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfMy0xLTEtMS0zMzc4Mg_b2f39063-f4be-4e5b-9313-f5dfa180a92e"
      unitRef="usd">22381000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNC0xLTEtMS0zMzc4Mg_61d22257-0407-48a5-a373-77aa14c29a8f"
      unitRef="usd">20328000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNS0xLTEtMS0zMzc4Mg_d143a4f1-5759-404b-8d94-bc9ba71b0734"
      unitRef="usd">18081000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNi0xLTEtMS0zMzc4Mg_9faf1318-3316-4a79-b8fa-84a2763d5327"
      unitRef="usd">16440000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfNy0xLTEtMS0zMzc4Mg_4cb86e4b-82ac-47f9-8c86-62fc88cf0502"
      unitRef="usd">117644000</pbh:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RhYmxlOjBmZGJlMmMyZDBmNDQ4YTA5MmM3NTk4YjBlOTBkM2Y5L3RhYmxlcmFuZ2U6MGZkYmUyYzJkMGY0NDhhMDkyYzc1OThiMGU5MGQzZjlfOC0xLTEtMS0zMzc4Mg_27a071b8-f220-4141-b58c-991c9f1d1924"
      unitRef="usd">206084000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80My9mcmFnOmMwNzBlNjc4ODkwNDRlYzRiYjk4YWZmMzFiYzUxYjNmL3RleHRyZWdpb246YzA3MGU2Nzg4OTA0NGVjNGJiOThhZmYzMWJjNTFiM2ZfMTE1Mg_4f0a8ece-7df8-422d-916f-a79317f462dd"
      unitRef="usd">700000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzA5_bd9e4d5e-c5f9-4d19-ae6d-af0a67e5128a">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (Remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzEy_e4209679-fc7d-4169-87ba-1d943cebfab8">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (Remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzE0_62f6d952-dc2d-49c6-843a-f2afc6569bcf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the three and six months ended September 30, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy0yLTEtMS0zMzc4Mg_ade35c51-2589-45c6-9c56-18d52a313212"
      unitRef="usd">664000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy00LTEtMS0zMzc4Mg_923e0865-fea3-45a5-b2a7-785c31f4e92a"
      unitRef="usd">642000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy02LTEtMS0zMzc4Mg_ffebf9e5-3b16-4a13-b321-91ddbc3be557"
      unitRef="usd">1329000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfMy04LTEtMS0zMzc4Mg_980ac672-d06e-4421-ba21-c591098b41d2"
      unitRef="usd">1284000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC0yLTEtMS0zMzc4Mg_0238c41b-1cd4-4edd-9b06-e94050c3b27c"
      unitRef="usd">45000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC00LTEtMS0zMzc4Mg_1a4ddef9-e4e4-4ae5-8ecb-da83f834e016"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC02LTEtMS0zMzc4Mg_17603e26-6a1e-4af2-a653-108fc609f225"
      unitRef="usd">95000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNC04LTEtMS0zMzc4Mg_13a9984b-3d03-40c8-b4c4-8e887e3918c5"
      unitRef="usd">129000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS0yLTEtMS0zMzc4Mg_eca0e154-7ca0-46a0-92a2-3e7ae55d4c9c"
      unitRef="usd">1617000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS00LTEtMS0zMzc4Mg_5d2708e7-05c5-432c-85a5-f19cff7b4ddb"
      unitRef="usd">1683000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS02LTEtMS0zMzc4Mg_20189f35-2280-43d8-ac56-515a9d3c168f"
      unitRef="usd">3251000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNS04LTEtMS0zMzc4Mg_b58a46c4-3401-4ea8-9772-b1eeaeeb0784"
      unitRef="usd">3370000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi0yLTEtMS0zMzc4Mg_3b5ace7b-3fce-4938-81ff-47e389d150c9"
      unitRef="usd">51000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi00LTEtMS0zMzc4Mg_356ff816-915f-4cc3-980e-78ee4d977cd3"
      unitRef="usd">24000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi02LTEtMS0zMzc4Mg_af5b21a3-f1a1-4442-a340-b9b1e17b42dd"
      unitRef="usd">85000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNi04LTEtMS0zMzc4Mg_dabfa58b-0a95-4256-ba0a-c3c2f166f5fe"
      unitRef="usd">46000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy0yLTEtMS0zMzc4Mg_387dd9f9-e449-4496-8410-e1293a39ba5a"
      unitRef="usd">17016000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy00LTEtMS0zMzc4Mg_091e93ae-e478-4427-ac1d-0523e2ebcc72"
      unitRef="usd">11998000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy02LTEtMS0zMzc4Mg_a2e15131-7212-4c8d-bc20-046eaa8fbb3b"
      unitRef="usd">29015000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfNy04LTEtMS0zMzc4Mg_f425ba10-9308-4f67-9861-1102ada8dea9"
      unitRef="usd">23649000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS0yLTEtMS0zMzc4Mg_5268afc8-2e04-4ce4-b824-197ab645f010"
      unitRef="usd">19393000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS00LTEtMS0zMzc4Mg_c9060104-5187-4aa2-b731-2c070eee995a"
      unitRef="usd">14410000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS02LTEtMS0zMzc4Mg_185f16ce-10e1-422a-adef-94a058e9dc31"
      unitRef="usd">33775000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjBhZjUxZjlhMjFjNjQzYjM5MTkyMmE4NmUxZjJkY2RiL3RhYmxlcmFuZ2U6MGFmNTFmOWEyMWM2NDNiMzkxOTIyYTg2ZTFmMmRjZGJfOS04LTEtMS0zMzc4Mg_e59703b9-59bb-4c58-9e78-05739fa809e7"
      unitRef="usd">28478000</us-gaap:LeaseCost>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzEw_9b8d3206-634f-4cc1-95bd-d9daca999ada">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (Remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RleHRyZWdpb246YzNkYTM4YjZjZWI3NDE4NTgwZmVmMGY1MGRkZWRjMjRfMzE1_24605617-cd2e-4d3a-9e7f-3687d5acdf86">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance &lt;br/&gt;Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (Remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi0yLTEtMS0zMzc4Mg_c5eb4748-2482-49f8-b328-1e4c83eac720"
      unitRef="usd">3768000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi00LTEtMS0zMzc4Mg_ed8a1cd2-ce03-412c-920e-8f1151b0e3b0"
      unitRef="usd">1461000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMi02LTEtMS0zMzc4Mg_233c7907-34b0-402d-bf31-5e02f9ff9173"
      unitRef="usd">5229000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy0yLTEtMS0zMzc4Mg_06d75a6b-b8cd-4b85-bb34-3a2b9676a57a"
      unitRef="usd">6820000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy00LTEtMS0zMzc4Mg_36566d08-12b2-4417-9627-b55fc907bc57"
      unitRef="usd">2922000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMy02LTEtMS0zMzc4Mg_d0e02835-5001-4319-8db4-643f00809fd8"
      unitRef="usd">9742000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC0yLTEtMS0zMzc4Mg_29b417c5-0492-4260-8cd9-4a7a9fc105f0"
      unitRef="usd">4556000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC00LTEtMS0zMzc4Mg_714a6c00-4bc1-4c0d-b397-63c279eed329"
      unitRef="usd">1509000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNC02LTEtMS0zMzc4Mg_d89c0e1b-fccc-46ff-8477-52bdd87c5439"
      unitRef="usd">6065000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS0yLTEtMS0zMzc4Mg_6c656c01-4eea-4a72-b240-f87013bdac61"
      unitRef="usd">2157000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS00LTEtMS0zMzc4Mg_00a4568a-a283-48a7-a134-b663f60effd2"
      unitRef="usd">96000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNS02LTEtMS0zMzc4Mg_0560cffe-1213-4e2c-b3a3-64aaf73be071"
      unitRef="usd">2253000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi0yLTEtMS0zMzc4Mg_4f5fb120-d576-457e-9b3b-cf26a5e5a675"
      unitRef="usd">1875000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi00LTEtMS0zMzc4Mg_9f230474-72c2-4cd0-9fdd-7970138772c9"
      unitRef="usd">80000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNi02LTEtMS0zMzc4Mg_5c0ef8cd-c289-4984-b7ca-bf127fd07e76"
      unitRef="usd">1955000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour>
    <pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy0yLTEtMS0zMzc4Mg_b6c0c2a2-5a48-41c0-bfb3-1165dbe619f5"
      unitRef="usd">1655000</pbh:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy00LTEtMS0zMzc4Mg_cca76df5-314e-4a29-9aed-0750a503f0f1"
      unitRef="usd">0</pbh:FinanceLeaseLiabilityToBePaidDueAfterYearFour>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfNy02LTEtMS0zMzc4Mg_63a28e06-de53-4fe3-a397-f689321bacc1"
      unitRef="usd">1655000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC0yLTEtMS0zMzc4Mg_95186cd4-d793-48bb-864c-0f6b58f5c1c1"
      unitRef="usd">20831000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC00LTEtMS0zMzc4Mg_4e2d4301-bb4a-414a-a4e7-96730c9330fd"
      unitRef="usd">6068000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentDue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOC02LTEtMS0zMzc4Mg_f130374d-0caa-4726-8400-7e1649400b4c"
      unitRef="usd">26899000</pbh:OperatingAndFinanceLeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS0yLTEtMS0zMzc4Mg_b2bac5d1-0c64-474a-9c1c-c8bebfbbb390"
      unitRef="usd">1399000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS00LTEtMS0zMzc4Mg_4b6dd2a2-86cf-43c5-a255-0ad40559a0fc"
      unitRef="usd">181000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfOS02LTEtMS0zMzc4Mg_aa38bc7d-0a16-46b3-adc4-3f0b56e916d6"
      unitRef="usd">1580000</pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtMi0xLTEtMzM3ODI_b13487ae-3f94-4c3b-83fa-c9a81946a8f9"
      unitRef="usd">19432000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtNC0xLTEtMzM3ODI_3b6a0aaa-3559-4a23-8bff-b53f42fafb93"
      unitRef="usd">5887000</us-gaap:FinanceLeaseLiability>
    <pbh:OperatingAndFinanceLeaseLiability
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOjkyNTE3OTllYTFmOTQzOGE4ZmM4NTg4ZDJjY2E4NDJmL3RhYmxlcmFuZ2U6OTI1MTc5OWVhMWY5NDM4YThmYzg1ODhkMmNjYTg0MmZfMTAtNi0xLTEtMzM3ODI_3f154895-7b19-432c-8f10-f554da84d4f3"
      unitRef="usd">25319000</pbh:OperatingAndFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfMi0zLTEtMS0zMzc4Mg_fa4b0d51-9296-44e7-8a76-752f375a5c49">P3Y7M9D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfMy0zLTEtMS0zMzc4Mg_01b73a91-428f-4bf0-a404-5ed5e4eee25b">P2Y1M28D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfNS0zLTEtMS0zMzc4Mg_92b36156-b0f5-455e-a7ca-2a9807f7afa3"
      unitRef="number">0.0314</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80Ni9mcmFnOmMzZGEzOGI2Y2ViNzQxODU4MGZlZjBmNTBkZGVkYzI0L3RhYmxlOmMzMGY1ZjAyMGQyZDQwMGQ5OTYxMTc4YmY5ZDBkMGViL3RhYmxlcmFuZ2U6YzMwZjVmMDIwZDJkNDAwZDk5NjExNzhiZjlkMGQwZWJfNi0zLTEtMS0zMzc4Mg_07bf6732-99db-43c7-8877-8e290e4c75f2"
      unitRef="number">0.0295</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RleHRyZWdpb246ZDczZWY0MTY2MGI1NGIxYjg3YWU0NmFjMjIyMzcwNjJfOTE_81d583e7-3324-44c5-9fbd-920ae07ce438">Other Accrued Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RleHRyZWdpb246ZDczZWY0MTY2MGI1NGIxYjg3YWU0NmFjMjIyMzcwNjJfMTA2_e3b3d2eb-7f9e-4f3a-9895-45cf740354e6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMS0xLTEtMS0zMzc4Mg_fa3e1412-184d-47a8-b7f3-09fab9a529c4"
      unitRef="usd">33684000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMS0zLTEtMS0zMzc4Mg_36b1b4f5-e3d5-48de-afb2-f9ea766a63bb"
      unitRef="usd">36149000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMi0xLTEtMS0zMzc4Mg_25544142-c964-4f3b-b332-3128369741ec"
      unitRef="usd">7218000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMi0zLTEtMS0zMzc4Mg_d167f9d0-8a43-4735-a443-cb16d588a864"
      unitRef="usd">19587000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMy0xLTEtMS0zMzc4Mg_209d3257-35ff-4566-b5e6-2ec2bfeaec43"
      unitRef="usd">2078000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMy0zLTEtMS0zMzc4Mg_c81803de-8785-4bf6-9960-30ddd10e7b09"
      unitRef="usd">1179000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNC0xLTEtMS0zMzc4Mg_b449f261-900e-4987-9fd2-80e8141ac777"
      unitRef="usd">12455000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNC0zLTEtMS0zMzc4Mg_e0324783-7178-469d-8ab1-beed3d6d7595"
      unitRef="usd">2670000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNS0xLTEtMS0zMzc4Mg_d02f1d5b-faff-41fa-963a-0259380c79e4"
      unitRef="usd">5127000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNS0zLTEtMS0zMzc4Mg_c73305f3-ec6e-4017-af5c-25e40801336b"
      unitRef="usd">4150000</us-gaap:AccruedProfessionalFeesCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNy0xLTEtMS0zMzc4Mg_0cb0db20-e67b-4af6-a47d-d38693b4a51b"
      unitRef="usd">3775000</pbh:AccruedProductionCostsCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfNy0zLTEtMS0zMzc4Mg_03c45681-5867-4be8-b8a5-3b13abebb152"
      unitRef="usd">3686000</pbh:AccruedProductionCostsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTEtMS0xLTEtMzM3ODI_7c7e6c14-fe5d-41ae-9bf5-3790774fc052"
      unitRef="usd">6647000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTEtMy0xLTEtMzM3ODI_1b77887d-f548-4f5a-9c3e-c3b71930a17b"
      unitRef="usd">6692000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTItMS0xLTEtMzM3ODI_dd7d437f-5060-4f80-b778-0a468493060f"
      unitRef="usd">70984000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF80OS9mcmFnOmQ3M2VmNDE2NjBiNTRiMWI4N2FlNDZhYzIyMjM3MDYyL3RhYmxlOjhhM2RiY2VkYTIzMDRkMGM5Njk0YzI1OTIzODA3MTI3L3RhYmxlcmFuZ2U6OGEzZGJjZWRhMjMwNGQwYzk2OTRjMjU5MjM4MDcxMjdfMTItMy0xLTEtMzM3ODI_03d0b818-4c1d-4b47-9c2a-61ab16330098"
      unitRef="usd">74113000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNTE3_4daddca3-d9af-4f95-a5e7-3a7dd3f644c0">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, we had no balance outstanding on the 2012 ABL Revolver, and a borrowing capacity of $149.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2031 (the "2021 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNTA0_cd06eb17-4b2b-4f93-bc84-6b4148627a4e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin.  Any unpaid balance is due on December 11, 2024.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a38405494994ce1b5c3aab38c92de25_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmI5ZDFkZTliMjc5NjQ2NzU4YzNlNzI4MmY0N2E0Yjg1XzQy_b6e549ad-b94f-48a7-a0e9-8c9cd2a1f633"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6a38405494994ce1b5c3aab38c92de25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi0yLTEtMS0zMzc4Mg_6b7f8976-4f9a-4878-b3f6-9c2b354510fd"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9871dafd896a45e493ceb7df67951c71_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMi00LTEtMS0zMzc4Mg_1f7fa6ec-5511-4dd4-9414-baae8a904a73"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c616be96d674e2998de9db27d2068b5_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjI4ZmMzZTY2NmZlMzRjMzI4N2ZjODEyOGZlMjg5N2QzXzQy_3a7a486a-358f-45b9-a104-0389499d5448"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2c616be96d674e2998de9db27d2068b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy0yLTEtMS0zMzc4Mg_234e4625-a168-4453-a73b-30d668e28fe1"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i89ac26c1487c489296168379bd629daa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMy00LTEtMS0zMzc4Mg_f759a275-17c9-481c-b169-72d417851ac7"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0Xzk5_abe167b3-3bbd-45b8-81d5-2a3d4b467fba"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="i3e70c39771804c098a923c5ca7c67408_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0XzEyNQ_1c469abf-c623-4734-901e-ad209a1967d7"
      unitRef="number">0.0050</pbh:DebtInstrumentVariableRateMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i144ad08b0f5f49afaa122bd98a2a1bc1_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjM4MmI1YTYwMzE0MzQ4ZjM5MTA1ZDk5MjQwZWViNzc0XzE3Mg_6e707552-3e47-4a4b-8983-02c946321274"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0cd84c34e88c4d2f9dc0e7f967aad239_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS0yLTEtMS0zMzc4Mg_e8ec5517-d69b-414d-9501-4f6c2a7ea22f"
      unitRef="usd">455000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7cc8177d10de49bea9958fbb3d673d7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNS00LTEtMS0zMzc4Mg_6be6be37-8691-402d-bdb3-1996b1d7aa82"
      unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i38cba7c0d2ce48268a9ea237fd0c1c0d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNi0yLTEtMS0zMzc4Mg_b59f8fac-5434-467b-8868-23c3f28a9ce7"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7d3f3bbb024f46fa91a25d1c1ce64cae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfNi00LTEtMS0zMzc4Mg_62e00015-cf26-42c5-a5e9-ed050719697b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfOS0yLTEtMS0zMzc4Mg_6028ea37-0c0f-423c-9310-fbd93e1ce23a"
      unitRef="usd">1455000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfOS00LTEtMS0zMzc4Mg_831d101c-a1bb-41be-8d72-2cb887934f0d"
      unitRef="usd">1495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTAtMi0xLTEtMzM3ODI_e60f4a92-1510-48d3-b1f9-8010fd60a1ec"
      unitRef="usd">16662000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTAtNC0xLTEtMzM3ODI_9fac36a0-0a8b-4a28-9dbc-319e79f499b1"
      unitRef="usd">18342000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTItMi0xLTEtMzM3ODI_e3b444a9-781c-4f08-827d-a4249fe6eae8"
      unitRef="usd">1438338000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjg2ZmQ1MjcyMTAwYTQ3NjY4ZTMyMzljMDEwZWU2ZWEwL3RhYmxlcmFuZ2U6ODZmZDUyNzIxMDBhNDc2NjhlMzIzOWMwMTBlZTZlYTBfMTItNC0xLTEtMzM3ODI_39f097c0-0253-4dff-8eb9-3e847c3c74c4"
      unitRef="usd">1476658000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia708754131aa4c4cadfdb34847429103_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfMTEx_4b3d4245-64ae-4346-99ef-ddf8de8709a3"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia708754131aa4c4cadfdb34847429103_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfMTgw_a7abf380-1640-4b30-8579-5ed5eb013276"
      unitRef="usd">149100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RleHRyZWdpb246N2UwMDM2MTM4OTIxNGM1ZGFkZjg0N2IzYzk0NGUwZTBfNDk2_44199e7b-9834-47a7-9cd1-7924335e3eb5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term B-5 Loans, 2012 ABL Revolver and the indentures governing the senior unsecured notes due 2031 (the "2021 Senior Notes") and the senior unsecured notes due 2028 (the "2019 Senior Notes") are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ending March 31, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfMi0yLTEtMS0zMzc4Mg_7d839ca3-aed5-4625-880b-2b9d1d8c5b7f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfMy0yLTEtMS0zMzc4Mg_69a80936-2dea-4a48-b805-b9e64385a750"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNC0yLTEtMS0zMzc4Mg_ba871aea-9efe-4b32-a145-c60fe1de4406"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNS0yLTEtMS0zMzc4Mg_083ef119-9550-4db8-9ac8-38b4f7d296a2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNi0yLTEtMS0zMzc4Mg_b6c8b4d4-a180-491e-af82-0dd2f75902e6"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <pbh:LongTermDebtMaturityAfterYearFour
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfNy0yLTEtMS0zMzc4Mg_e511f39d-42e9-40f0-b09d-47bc4c401d32"
      unitRef="usd">1455000000</pbh:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81Mi9mcmFnOjdlMDAzNjEzODkyMTRjNWRhZGY4NDdiM2M5NDRlMGUwL3RhYmxlOjk1MDg4YjlhZTBhZDQxMzdhMjVjZWNhMDQ2NTdhMzFiL3RhYmxlcmFuZ2U6OTUwODhiOWFlMGFkNDEzN2EyNWNlY2EwNDY1N2EzMWJfOC0yLTEtMS0zMzc4Mg_8e6f8f07-185b-4648-ba53-c207ffa372b3"
      unitRef="usd">1455000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RleHRyZWdpb246YTlhZTA4MzFiZGEzNDg2MTg4N2FmZjA2OTI3Nzk4M2FfMTc4Mw_28129390-c412-4664-97b2-1f29d4fe673f">Fair Value Measurements &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB Accounting Standards Codification ("ASC") 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  ASC 820 established market (observable inputs) as the preferred source of fair value, to be followed by our assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Quoted market prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs developed by us using estimates and assumptions reflective of those that would be utilized by a market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the 2012 Term B-5 Loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy.  The summary below details the carrying amounts and estimated fair values of these instruments at September&#160;30, 2022 and March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;At September&#160;30, 2022 and March&#160;31, 2022, we did not have any assets or liabilities measured in Level 1 or 3.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RleHRyZWdpb246YTlhZTA4MzFiZGEzNDg2MTg4N2FmZjA2OTI3Nzk4M2FfMTc3OQ_3b616bdb-36fa-4a45-94f4-2643213bc411">The summary below details the carrying amounts and estimated fair values of these instruments at September&#160;30, 2022 and March&#160;31, 2022. &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="iffd6d7d6775d456aab43522e8641590d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi0yLTEtMS0zMzc4Mg_fc04158d-5163-4ad4-9504-86d2f76f282e"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia93c71c69cbd4f518813bf35d29567ff_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi00LTEtMS0zMzc4Mg_815986cf-9354-4a63-953c-0b742cad56ab"
      unitRef="usd">466500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i81c4abbe4c7a4c51ab953cfac5a719e3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi02LTEtMS0zMzc4Mg_e0f8d011-564d-415b-8645-e73721a870f8"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib13229551ff74aac852ed82658c2bc5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfMi04LTEtMS0zMzc4Mg_4d08f833-f129-473a-8b8e-767db439079e"
      unitRef="usd">534000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5bb1ab25a9104ca786d77647d79f0750_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC0yLTEtMS0zMzc4Mg_739a49d1-b1a4-49c4-a2ae-81cc4cf0d8ca"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ica6a01a4639347e59ce1b6926fe770aa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC00LTEtMS0zMzc4Mg_3d57156d-9a4f-46be-8492-b4b2ea366c32"
      unitRef="usd">361000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i209a7eca485c4ae089043ae691508354_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC02LTEtMS0zMzc4Mg_062eaa16-abca-4091-ba09-66661a305436"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ie4b38ddefea943b4a58f5c5e1837187e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNC04LTEtMS0zMzc4Mg_21d3f84d-cfe8-4e2f-97ce-353621444f87"
      unitRef="usd">397000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i6fcb4c05211a4f52b3d328d6faa3c979_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi0yLTEtMS0zMzc4Mg_ca0901f9-94dd-4656-b2da-5211e5e8a9b3"
      unitRef="usd">455000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i107654b9df4f4d36a2be4b1b29dbb756_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi00LTEtMS0zMzc4Mg_2c56083f-306a-4c0d-be01-eab61a33fd0a"
      unitRef="usd">453294000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ife1cf43c2ca44eed91e983938f2fd966_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi02LTEtMS0zMzc4Mg_f284e8e4-13f8-44e3-b3d2-d95db5566be6"
      unitRef="usd">495000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ifaee783e80be466aac335d1710829144_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNi04LTEtMS0zMzc4Mg_486174f5-c6e9-45b0-ad7d-5864527208ad"
      unitRef="usd">493144000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i9c573dedd8d9443b9195d944fdb41808_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy0yLTEtMS0zMzc4Mg_ff96e6b0-326c-4ad8-b315-6c4cfbbc345b"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i0f4ca14c8ca842d6b7d60e303216a672_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy00LTEtMS0zMzc4Mg_9a84992c-420c-4a00-aa49-de3316074384"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i8145646a4620446cb3bb6c97a2b33b43_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy02LTEtMS0zMzc4Mg_e024247a-a6ae-4b8c-a8ac-0edd4d865830"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i4b63503a525b4ad0ae2f49bbf0d38637_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81NS9mcmFnOmE5YWUwODMxYmRhMzQ4NjE4ODdhZmYwNjkyNzc5ODNhL3RhYmxlOmI0NTczY2NjMDAzOTQ3OTNhMDhjMGMyNzRlMGMzZDYzL3RhYmxlcmFuZ2U6YjQ1NzNjY2MwMDM5NDc5M2EwOGMwYzI3NGUwYzNkNjNfNy04LTEtMS0zMzc4Mg_f1e7bdcd-81c9-4a76-8998-5d0428c6d65d"
      unitRef="usd">0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMzk1_042dc775-d1c5-4712-a5c4-4938c6e31926">Derivative Instruments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020 we entered into an interest rate swap to hedge a total of $200.0 million of our variable interest debt, which settled on January 31, 2022.  We do not use derivatives for trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain Recognized in Other Comprehensive Loss (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss Reclassified from Accumulated Other Comprehensive Loss into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife7c577cd8d34acd9e144f85556f13fe_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMTg1_b2b09a42-d4bc-439d-be5e-8b2956a26f54"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RleHRyZWdpb246ZWMyOTNjM2NlNThhNDVhMmFiMDU4NmMwY2MzODg4YWFfMzk2_ff46a2fe-11d5-40bb-be19-b0385f387ea0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain Recognized in Other Comprehensive Loss (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss Reclassified from Accumulated Other Comprehensive Loss into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i39f948f5963c423aa59b916bd733f299_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi00LTEtMS0zMzc4Mg_04eecc4a-798b-477b-adbe-4ff88991be62"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibc2804a8cd20480092ebaac1665cb981_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi02LTEtMS0zMzc4Mg_0264cbb5-d46e-45de-a6ca-d7192f45d29e"
      unitRef="usd">550000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5a7c46e7cb4f4393bc9da7353259532f_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi04LTEtMS0zMzc4Mg_bd8a8b49-9b18-4683-8b25-9c8313293589"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iee68f53fac064ea6b3ca739ae5139369_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMi0xMC0xLTEtMzM3ODI_2155e0c6-61e8-489b-8f51-f108520b1537"
      unitRef="usd">1070000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8f3ebdd1608049819d7960351aa8db35_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy00LTEtMS0zMzc4Mg_db53e5f4-9b45-4273-96a7-7bd149279701"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia469219d9c2a49a98e21464086b58660_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy02LTEtMS0zMzc4Mg_00ba6e97-a06a-4d79-a1c1-ff965342e08b"
      unitRef="usd">-732000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9c497ac02c504e91b6ce612b29fc8a82_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy04LTEtMS0zMzc4Mg_c4919004-c21e-49f8-bc2c-74e14a40f0fc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9a99b6fbe44645ad882a7a958382a827_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF81OC9mcmFnOmVjMjkzYzNjZTU4YTQ1YTJhYjA1ODZjMGNjMzg4OGFhL3RhYmxlOmExOWNlNGJiOGQxYzRiYzBhYmE5Yjk1YTNmOTJmYzYyL3RhYmxlcmFuZ2U6YTE5Y2U0YmI4ZDFjNGJjMGFiYTliOTVhM2Y5MmZjNjJfMy0xMC0xLTEtMzM3ODI_20183be6-78e7-41ab-9a77-7b9d2b6b6efb"
      unitRef="usd">-1450000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfOTQx_653294f5-18d7-478d-9521-d12f4901b9e0">Stockholders' Equity&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on our common stock through September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended September 30, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.04&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.5 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.9 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.3 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.0 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfNTg_a5dc880a-218f-45b5-8f25-2440c783d667"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfODU_ab891662-304d-47d0-97fb-99aa3883fbcc"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMTEz_04f529e0-fbda-4bec-95ca-11c10a78a30e"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMTQz_959e476e-b616-4018-a141-3624345ad0f6"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <pbh:VotingRightsNumberOfVotesPerCommonShareOwned
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfMzgy_ee04a121-1e90-4c8d-8134-8833b31c5390"
      unitRef="vote">1</pbh:VotingRightsNumberOfVotesPerCommonShareOwned>
    <us-gaap:DividendsCommonStock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfNzA0_119cb801-1f1d-493c-8886-c0e643b3bc15"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RleHRyZWdpb246MjY4MmE4OTU4YjhhNGFhOGEyODI4ZjJlZGUxODAzNGZfOTM1_8bd5b972-511f-453b-a5de-e566c6f862d6">Our share repurchases consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.04&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.5 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.9 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$54.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.3 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$50.0 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy0xLTEtMS0zMzc4Mg_f332c104-dde3-4caf-89ba-2cf796890bef"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy0zLTEtMS0zMzc4Mg_4edb2869-b621-45db-9d7e-04c38ab1dea4"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy01LTEtMS0zMzc4Mg_9ee5aa43-6475-4048-9a3c-59261aab1101"
      unitRef="shares">99219</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMy03LTEtMS0zMzc4Mg_ea569198-dbfe-40b8-bf92-1182c3218df0"
      unitRef="shares">63614</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC0xLTEtMS0zMzc4Mg_c5499e9f-4665-4c7e-82ff-285fdd0688f0"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC0zLTEtMS0zMzc4Mg_28724849-fd84-46df-9526-e9a63288561e"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC01LTEtMS0zMzc4Mg_89687dc8-07de-4453-97de-8edc8e852469"
      unitRef="usdPerShare">54.94</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNC03LTEtMS0zMzc4Mg_3ec7bb1e-26e9-4c58-a4c4-e87a5c9a5e4b"
      unitRef="usdPerShare">46.04</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i02d68774d3f54a7c993bde12acc841ae_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS0xLTEtMS0zMzc4Mg_d2488214-a82d-47c0-9119-e2b83702d65b"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i05f1ce1d71c6464a8655300519ec3551_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS0zLTEtMS0zMzc4Mg_c4454f4a-c155-42ef-84b5-54c105e99162"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5ae4c09d27054be696368f8a05bffad6_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS01LTEtMS0zMzc4Mg_6521d9ba-de72-4feb-b27f-b7d8f6f6cc7c"
      unitRef="usd">5500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i676788134c864eb7b1ab80fafec47be7_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfNS03LTEtMS0zMzc4Mg_674bc84b-0a40-4cc0-b155-3dfcd35d17b4"
      unitRef="usd">2900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC0xLTEtMS0zMzc4Mg_0240a3bd-f5a7-4626-bec1-eeb8c934c394"
      unitRef="shares">236681</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC0zLTEtMS0zMzc4Mg_97ee61f5-5252-466b-b2a5-7222909f289f"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC01LTEtMS0zMzc4Mg_bee1d8ab-19ee-494b-ab63-4581630614c9"
      unitRef="shares">914236</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOC03LTEtMS0zMzc4Mg_c3162761-84c7-40d1-acba-9c35d233e4fa"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS0xLTEtMS0zMzc4Mg_313cecdc-9516-46e1-9601-1ea76d6f98c0"
      unitRef="usdPerShare">51.85</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS0zLTEtMS0zMzc4Mg_be140bb8-1b5c-4184-a280-47be7f948fa5"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS01LTEtMS0zMzc4Mg_75621698-936d-444d-98ef-024fb4282f87"
      unitRef="usdPerShare">54.69</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfOS03LTEtMS0zMzc4Mg_16dc2e65-0e5b-4bb2-a7e5-fe0362ca75aa"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i810dbd51386f4f1894a85343c5088368_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtMS0xLTEtMzM3ODI_61457a37-fa35-45ee-abe4-9d691147fc09"
      unitRef="usd">12300000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i82a56246d4d84fa9b08325ce384fb6e2_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtMy0xLTEtMzM3ODI_20ac4104-35c4-4812-8e1d-521882ec72dd"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0d351c63957547debe99cb364e73c2fc_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtNS0xLTEtMzM3ODI_81df3888-cfa7-40f4-a3b0-701fbecef280"
      unitRef="usd">50000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6004b1fe992642b9afbc611b86206b53_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82NC9mcmFnOjI2ODJhODk1OGI4YTRhYThhMjgyOGYyZWRlMTgwMzRmL3RhYmxlOmNjZmJhZDcyMmM2NDQ3Y2Q4MjI4YTUzNTA2ODczMTQwL3RhYmxlcmFuZ2U6Y2NmYmFkNzIyYzY0NDdjZDgyMjhhNTM1MDY4NzMxNDBfMTAtNy0xLTEtMzM3ODI_f20ec566-9009-483f-8c97-e7490e3b5222"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMjQ4_dc921c55-4a0c-486f-afb0-2013a26a9f79">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consisted of the following at September&#160;30, 2022 and March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of September&#160;30, 2022 and March&#160;31, 2022, no amounts were reclassified from accumulated other comprehensive loss into earnings.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMjQy_29ef312c-0241-4af3-a4be-c0d0ede77282">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consisted of the following at September&#160;30, 2022 and March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ia7ac391963f848548a601af9567fbba9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfMi0xLTEtMS0zMzc4Mg_8e2e655c-454b-49de-bf90-5684a707df3f"
      unitRef="usd">-36841000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i205dff464c7245768d0c7263beceb556_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfMi0zLTEtMS0zMzc4Mg_ea509c6c-6bef-43b1-915f-1b33968885f1"
      unitRef="usd">-20204000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ic536994b83bb485a862ea0e3393120d1_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmNjMDNmZDA2ZjBlNDQxZjE5YmU1NWJiOTgzN2Y3ODZiXzU4_38a31b9b-2909-4605-bcac-796a0621b218"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ia218ac2046f540c895fce30181f0a41e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmNjMDNmZDA2ZjBlNDQxZjE5YmU1NWJiOTgzN2Y3ODZiXzY1_1a426e6c-7a37-4eb7-b46f-8a6a49a833e3"
      unitRef="usd">-350000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:StockholdersEquity
      contextRef="if1f1b498eebb4cd883a3fa617593819a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0xLTEtMS0zMzc4Mg_6cf58b69-baf7-4f23-9dc1-9b693edfef3d"
      unitRef="usd">382000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5be7898b214a428d8760e4a62973f03b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNC0zLTEtMS0zMzc4Mg_1ec469b9-af5b-4019-9248-e51186c9fd92"
      unitRef="usd">1172000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d43e5e4038b4af5b3f8ba6bd0a665be_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNS0xLTEtMS0zMzc4Mg_ea140d2a-1f66-4f05-9d8b-2464e3013ab6"
      unitRef="usd">-36459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97f54d4cf1d841b38d61272505328c59_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RhYmxlOmYwMTNlYWVkYzI4MjQzMzg4NDI4OTJkMDFjZDI1OWM2L3RhYmxlcmFuZ2U6ZjAxM2VhZWRjMjgyNDMzODg0Mjg5MmQwMWNkMjU5YzZfNS0zLTEtMS0zMzc4Mg_ef30d1db-da77-438d-a16d-02083ea1a09e"
      unitRef="usd">-19032000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMTQ1_6728a2b2-b0f8-4ae2-a654-330cdc5be204"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ia313af41482841d0aadf96bac88e4b64_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF82Ny9mcmFnOmM4ZWFiNTYyM2ExZDRiNGE4NTNlNDQxZGU3ZDQ3ODg1L3RleHRyZWdpb246YzhlYWI1NjIzYTFkNGI0YTg1M2U0NDFkZTdkNDc4ODVfMTQ1_ed621255-1f38-4c26-9e3f-8c423bd81647"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMTM2MQ_e1c92143-092f-46e4-bc0a-f2e983a7f1c0">Earnings Per Share&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options, restricted stock units ("RSUs") and performance stock units ("PSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an anti-dilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2014; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;For all periods shown above, there were 0.4 million shares attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMTM2Nw_a5a5b42e-b41c-4e92-b3e4-698a64bc6dba">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share &#x2014; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy0yLTEtMS0zMzc4Mg_71abc0c9-3bd4-465e-8bb8-cfe134038e6f"
      unitRef="usd">51023000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy00LTEtMS0zMzc4Mg_970aaf64-c4fb-4c0b-a2bb-8119337f4fdc"
      unitRef="usd">45325000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy02LTEtMS0zMzc4Mg_1a9b9b3c-0476-4e55-bd19-fd65be3470fc"
      unitRef="usd">106295000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMy04LTEtMS0zMzc4Mg_872a819d-8f91-4cca-a714-f9f3e61ac06b"
      unitRef="usd">103080000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi0yLTEtMS0zMzc4Mg_6706fda7-6e34-4fab-a597-4cfd8f4751e0"
      unitRef="shares">49804000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi00LTEtMS0zMzc4Mg_83f59092-ec5a-48df-8cbc-20906db68205"
      unitRef="shares">50232000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi02LTEtMS0zMzc4Mg_43ff4287-fdba-4d5e-8dc6-5202a0803c78"
      unitRef="shares">50033000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNi04LTEtMS0zMzc4Mg_0eee4085-66b4-4d21-b630-12e96840b965"
      unitRef="shares">50186000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy0yLTEtMS0zMzc4Mg_53207834-7291-450a-b94a-3221410418c4"
      unitRef="shares">461000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy00LTEtMS0zMzc4Mg_d8fea1db-dfc6-40cf-b809-428c54243f99"
      unitRef="shares">559000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy02LTEtMS0zMzc4Mg_5c66f964-159c-48ac-b1e9-359283018388"
      unitRef="shares">463000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfNy04LTEtMS0zMzc4Mg_77c13203-f485-49d0-a3f8-205fcb4c72f5"
      unitRef="shares">545000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC0yLTEtMS0zMzc4Mg_1e410716-0098-4200-94b8-2fd337fb5b5e"
      unitRef="shares">50265000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC00LTEtMS0zMzc4Mg_0d98e676-4c4e-4411-a122-45e44104d69f"
      unitRef="shares">50791000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC02LTEtMS0zMzc4Mg_cfe1f991-5021-4652-80bd-f081025fec12"
      unitRef="shares">50496000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfOC04LTEtMS0zMzc4Mg_9bb6481f-fbc6-4e1d-932c-db2ce850b96d"
      unitRef="shares">50731000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtMi0xLTEtMzM3ODI_4e6c4bcc-7d31-4d5b-993d-54e9abc8ad82"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtNC0xLTEtMzM3ODI_e8d472fd-085e-4281-b8e0-8a45c140408c"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtNi0xLTEtMzM3ODI_88ed392d-1a1b-45b8-adb9-e1d4ed256792"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTEtOC0xLTEtMzM3ODI_6672c8a4-9481-47a1-ade5-da015ad5fe6e"
      unitRef="usdPerShare">2.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtMi0xLTEtMzM3ODI_5a786b00-b5d7-49b2-a8f1-7dd6ff7ae328"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtNC0xLTEtMzM3ODI_bc492b25-a1bf-4c42-af48-2f9a006fe482"
      unitRef="usdPerShare">0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtNi0xLTEtMzM3ODI_3ce2647d-1361-4775-9457-346a848395f0"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RhYmxlOmY2YzlmNzhkMjgyMDQ3MGI4Yzc0NGFiNjk1M2MwZDJmL3RhYmxlcmFuZ2U6ZjZjOWY3OGQyODIwNDcwYjhjNzQ0YWI2OTUzYzBkMmZfMTMtOC0xLTEtMzM3ODI_54b1033b-1907-4c79-80b5-0eca35f125ee"
      unitRef="usdPerShare">2.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_608dfa9a-e8ab-4bde-a2fa-25168b7cc420"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8326e328abad4478a736ff2103f13dad_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_74576df0-7478-4db8-bbca-29b52d9086ff"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8883e67a6b294bb2b4988346e7c8bf37_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_aa7e0a9c-da19-47cb-af1e-048ba68f426b"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icfd1c9c171164a8f9f0702ee5bb0710b_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83MC9mcmFnOjhkMDA1NzRlMmU4MjQ1ODViOTNjNmE0YjZiN2JjMmE3L3RleHRyZWdpb246OGQwMDU3NGUyZTgyNDU4NWI5M2M2YTRiNmI3YmMyYTdfMjE5OTAyMzI1NzE4NA_e6b63d3d-b4ec-4dc1-97a6-4ba5812de071"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzEzMg_eae02dd1-3d97-476e-a9c5-c801c6fed981">Share-Based Compensation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#x201c;2005 Plan&#x201d;), which provided for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0 million to 2.5 million shares, and an extension of the term of the 2005 Plan by ten years, to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#x201c;2020 Plan&#x201d;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of 2,827,210 shares were available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;At September&#160;30, 2022, there were $4.8 million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of 2.2 years.  At September&#160;30, 2022, there were $13.2 million of unrecognized compensation costs related to unvested RSUs and PSUs under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a weighted average period of 1.9 years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;At September&#160;30, 2022, there were 2.1 million shares available for issuance under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;On May 2, 2022, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 67,959 PSUs, 65,721 RSUs, and stock options to acquire 195,526 shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $54.47 per share, which was equal to the closing price for our common stock on the date of the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;Each of the independent members of the Board of Directors received a grant of 2,495 RSUs on August 2, 2022.  The RSUs fully vest one year after receipt of the award, subject to the continued service of the director on such vesting date, and will be settled by delivery to each director of one share of our common stock for each vested RSU either (a) at the election of the director prior to the grant date, immediately upon vesting, or (b) promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental performance shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8% - 30.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1% - 31.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8% to 2.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0% to 1.3% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options exercised during the six months ended September&#160;30, 2022 was $0.7 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i44cc662485d34441b6e4321c121a9125_I20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjIy_0a479dea-0fdd-44d8-a345-2ad2c0047959"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i81cfb12ba748413e9a14ed4bcc0a4a0f_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNDI2_f7e20887-790c-4d6b-b39a-3727fd6d951d"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="if59663672a2242a89e285a8508bacf1c_D20140531-20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNjYz_74b31983-ddae-4e15-98e4-77da8857c54f"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfNjY5_67651757-014d-4762-aabb-a37c99d68f4c"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod
      contextRef="ifb80509de95148cc9d1b66a6c9fc8daf_D20140601-20140630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0Ng_e6fa5801-72dd-4c53-bf66-c729788ac7c7">P10Y</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ieaf59758726f4998abd628904bf3be96_I20200623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTIxMA_15240d0e-a06c-4e15-a20b-717111faf3d5"
      unitRef="shares">2827210</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares
      contextRef="ieaf59758726f4998abd628904bf3be96_I20200623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTI4Mg_f6c9aad4-2377-43c2-8267-0e33e631c124"
      unitRef="shares">2000000</pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares
      contextRef="ieaf59758726f4998abd628904bf3be96_I20200623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTMwMQ_26ad8d62-382f-4d70-a620-e299aa5fef0a"
      unitRef="shares">827210</pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE1Nw_d3fe8a38-7dc7-4614-a6bf-c76b49050821">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi0yLTEtMS0zMzc4Mg_d3e9090b-a612-405a-9121-30e73d2e4128"
      unitRef="usd">3466000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi00LTEtMS0zMzc4Mg_e1981d65-c357-4da0-938e-968d9e8b1b5a"
      unitRef="usd">3219000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi02LTEtMS0zMzc4Mg_52d46170-7091-48c7-a28e-dde4e24dba99"
      unitRef="usd">7323000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMi04LTEtMS0zMzc4Mg_016684f5-43d4-4ef2-a1d7-7a052d216c26"
      unitRef="usd">5097000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy0yLTEtMS0zMzc4Mg_e36fa329-a4dd-4c0c-ae90-69105e303fb9"
      unitRef="usd">338000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy00LTEtMS0zMzc4Mg_8213e2ea-bfc6-4f51-9bf8-63c4a74744a4"
      unitRef="usd">369000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy02LTEtMS0zMzc4Mg_ee3b02ad-07d8-439c-85ea-bd3d5713cda5"
      unitRef="usd">875000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfMy04LTEtMS0zMzc4Mg_b7a9710a-6d50-4317-abb5-3a32b62bbe54"
      unitRef="usd">512000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC0yLTEtMS0zMzc4Mg_6464682d-17ff-40b7-8bc6-d5d2e5712137"
      unitRef="usd">64000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC00LTEtMS0zMzc4Mg_db9a2c08-6b12-4834-9794-3c46be08a1f7"
      unitRef="usd">937000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC02LTEtMS0zMzc4Mg_c4bd2550-ec44-4e66-a9ef-420fcea14875"
      unitRef="usd">10289000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNC04LTEtMS0zMzc4Mg_3dd3f7cd-8b25-49dd-b38a-34df31c7a5ce"
      unitRef="usd">7943000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS0yLTEtMS0zMzc4Mg_deecec70-429f-46ae-89a0-01a5b1f2b0a4"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS00LTEtMS0zMzc4Mg_86f617dc-b83e-4bdc-8e13-8c09beac8ac8"
      unitRef="usd">503000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS02LTEtMS0zMzc4Mg_9deccc2b-b1fc-4e6f-9eb5-e0aff6a4c245"
      unitRef="usd">1489000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNS04LTEtMS0zMzc4Mg_333b9591-10ea-4004-b84c-693ad7416efb"
      unitRef="usd">2707000</us-gaap:ProceedsFromStockOptionsExercised>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi0yLTEtMS0zMzc4Mg_0ad051fa-023f-4e87-97bb-38d4be9bd887"
      unitRef="usd">0</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi00LTEtMS0zMzc4Mg_702633eb-5a78-4528-8b8f-a2568171a8b0"
      unitRef="usd">350000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi02LTEtMS0zMzc4Mg_98f1010b-f3e3-48bc-ba3d-fe9b13cee0a2"
      unitRef="usd">2895000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjkwYTFlZDBlZmVkNDRlYWQ4ZWE2NTA1NmViZDBiN2ZjL3RhYmxlcmFuZ2U6OTBhMWVkMGVmZWQ0NGVhZDhlYTY1MDU2ZWJkMGI3ZmNfNi04LTEtMS0zMzc4Mg_fb93d1da-4a3e-49cb-b3e3-f7d3e0ff336b"
      unitRef="usd">2071000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTU4Nw_59b9034a-d749-4b5f-aec6-5bec9fe9ab8b"
      unitRef="usd">4800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTgyMg_a5fc40ef-8917-4f1d-a1b4-2277e75c790c">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ic9184f3b632646bebc4e3cd2872e2ba4_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMTg1MQ_0e25c62a-248f-4bc3-8cd3-91b8ff7b3c07"
      unitRef="usd">13200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i42333d378e9e4b66a3f698890196fcc6_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjA4Ng_6e6f70e7-7ed8-4065-b609-805a6ec59309">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjExNw_0fc37189-5cff-460e-9862-79569af65f5b"
      unitRef="shares">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0d07c6a04ba74840907835eea95e20cd_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjI4OQ_13ea194f-cd36-4603-8727-69de069db712"
      unitRef="shares">67959</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i11b979b892ef4decba1bfef8062479dd_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjI5OA_081b28cf-8002-43e6-8621-b6196621c91b"
      unitRef="shares">65721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjMzNg_c3d94785-2d61-430d-bb68-33b4f1df72e7"
      unitRef="shares">195526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="i0a2e89a4fcdd4809a1935a46bc56d27b_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjQ4Nw_c0185859-7e39-4137-8365-931778b2f141"
      unitRef="usdPerShare">54.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i681c9643cccc46478279947213d2e17b_D20220802-20220802"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMjE5OTAyMzI1OTM0Mw_5cb2a57b-d27b-4c5c-b88e-9c71a5843a1b"
      unitRef="shares">2495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0Nw_0708a52e-2fb3-4719-9667-a8647238f34e">A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental performance shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i815f24f411e64db2828daba078c81281_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMi0yLTEtMS0zMzc4Mg_c8c7b820-34fc-4bed-ad3e-55d7206b4493"
      unitRef="shares">457000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i815f24f411e64db2828daba078c81281_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMi00LTEtMS0zMzc4Mg_b7b915aa-3f41-45f0-92b7-e50c2cd01731"
      unitRef="usdPerShare">33.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMy0yLTEtMS0zMzc4Mg_ee0e923d-90c6-4fbf-b89b-f167c43e073e"
      unitRef="shares">170800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMy00LTEtMS0zMzc4Mg_0f413a53-6358-4557-bf01-12141bdccdb7"
      unitRef="usdPerShare">45.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNC0yLTEtMS0zMzc4Mg_dfad88bb-ac22-4238-86fa-bc194b4c8dc1"
      unitRef="shares">162300</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNC00LTEtMS0zMzc4Mg_bd1e6692-aba1-4579-a035-60e14d5b0a32"
      unitRef="usdPerShare">32.99</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNS0yLTEtMS0zMzc4Mg_ab6fc623-905c-4f29-8913-4519a3535dee"
      unitRef="shares">24600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5da7fbd032b94e90afd796fd194163ca_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNS00LTEtMS0zMzc4Mg_690f402d-f85f-4b1a-8be6-9952fee33bf8"
      unitRef="usdPerShare">30.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ifa98021577994bd988d17efb0ddce577_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNi0yLTEtMS0zMzc4Mg_e814f41a-166e-423c-a8b9-4c6dd5daa3ed"
      unitRef="shares">440900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifa98021577994bd988d17efb0ddce577_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNi00LTEtMS0zMzc4Mg_85509904-3171-4c54-82d8-af5a83fbe9ef"
      unitRef="usdPerShare">38.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="ifa98021577994bd988d17efb0ddce577_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNy0yLTEtMS0zMzc4Mg_a6f55a35-fa82-48a9-93cd-15b339db5149"
      unitRef="shares">152300</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="ifa98021577994bd988d17efb0ddce577_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfNy00LTEtMS0zMzc4Mg_b062d84f-22cd-4e37-8ecf-bc746797c214"
      unitRef="usdPerShare">33.92</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="if3f0f5de01544b1488a49d521bd4e50f_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTAtMi0xLTEtMzM3ODI_1988c517-2dee-4b72-bb6d-e3e6e56674d1"
      unitRef="shares">440900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if3f0f5de01544b1488a49d521bd4e50f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTAtNC0xLTEtMzM3ODI_01795c99-a4ab-417f-b5ee-5769ff4e6cae"
      unitRef="usdPerShare">38.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTEtMi0xLTEtMzM3ODI_da3e6463-15ee-482e-9138-72b9095d3784"
      unitRef="shares">148900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTEtNC0xLTEtMzM3ODI_1a1eb0f5-84cf-4113-9dc9-ccd3c84d64d3"
      unitRef="usdPerShare">55.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares
      contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTItMi0xLTEtMzM3ODI_ab991bed-9626-4401-9fd9-8a098aeffb0e"
      unitRef="shares">42400</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTMtMi0xLTEtMzM3ODI_f1ead6fe-0508-427b-a09e-c731329d2220"
      unitRef="shares">222400</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12a0b1d9ab004bb7b15a5eecf2224d87_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTMtNC0xLTEtMzM3ODI_56f5b53c-b33c-4fe9-9ba8-9c30a7d55a8b"
      unitRef="usdPerShare">32.05</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTUtMi0xLTEtMzM3ODI_a1a409ef-951d-4073-a104-2cc7674ae44c"
      unitRef="shares">409800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTUtNC0xLTEtMzM3ODI_a396282d-64e4-4cef-aa1f-86996e16b71c"
      unitRef="usdPerShare">47.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTYtMi0xLTEtMzM3ODI_3a41c976-c96e-47c1-89f1-94d7d82354e0"
      unitRef="shares">108500</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i5cd609ce88ce48c9a8c0561a8002ea8e_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjQ0N2NhZTMyYzc5OTQ0NjRiNzBjNzE0ZmY3YTU3ODYyL3RhYmxlcmFuZ2U6NDQ3Y2FlMzJjNzk5NDQ2NGI3MGM3MTRmZjdhNTc4NjJfMTYtNC0xLTEtMzM3ODI_93f6195d-aeb6-4d2c-9cc7-7e40531436b3"
      unitRef="usdPerShare">36.54</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0OA_82a1564a-55a5-42a9-a1ae-2f9da432053a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8% - 30.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1% - 31.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8% to 2.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0% to 1.3% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjczYmM5MmZhMGNkNjQwZmQ4YzkwNGU0N2FkMTRjYWE0XzQ_26d3bee5-d9e8-4c5f-a1ff-c95b39269fcf"
      unitRef="number">0.308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjczYmM5MmZhMGNkNjQwZmQ4YzkwNGU0N2FkMTRjYWE0Xzk_de18681d-0ea0-4150-9da2-9a4bdf69462c"
      unitRef="number">0.309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxNzVkM2JjYzI1ZDRhYjU5YmUwZjZjZmY0YjQyNjNjXzQ_9c155fb7-63a7-45ed-a5b2-6d96c06f0cf6"
      unitRef="number">0.311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMi00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxNzVkM2JjYzI1ZDRhYjU5YmUwZjZjZmY0YjQyNjNjXzk_73d562dd-0daa-4d89-bb83-ae76dee05199"
      unitRef="number">0.319</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i2063782252c94eed817587f0ac1d141a_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMy0yLTEtMS0zMzc4Mg_e772cd70-6146-4b76-ac81-24834e7546cc"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfMy00LTEtMS0zMzc4Mg_c5e8aec3-b354-4199-a7ec-ec8743057205"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU5YTNlMTgxMzk3ZjQ2NzdiMzk0NmRmYTk1MTEyYjIzXzQ_cb459dcb-bf1a-4b55-87e2-cf29809a3861">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU5YTNlMTgxMzk3ZjQ2NzdiMzk0NmRmYTk1MTEyYjIzXzEw_d5c2b648-a110-4894-93b4-f3f676bd3385">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmRkZTkyZDAzZjE5MTRlODU4NmVmMzc3ODhlYzgyZTJiXzQ_9eb93366-6597-453c-8992-0168129cdfb0">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNC00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmRkZTkyZDAzZjE5MTRlODU4NmVmMzc3ODhlYzgyZTJiXzEw_ceecd4e1-683e-4955-90d9-8241cbfb155e">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9c85646ef19948e7a18d4f14c24d05c5_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjQwNjVhOGY4ZjA4MTRhNjJhODZmZGQ1ZGFiNWVhYTI4XzQ_3320097c-2128-4ace-9a32-1dc7e22ea64d"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i43a0f8264a584d6086fed34f7bd652f1_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS0yLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjQwNjVhOGY4ZjA4MTRhNjJhODZmZGQ1ZGFiNWVhYTI4XzEw_2e54a7ee-66e3-43ce-917b-a132e650191b"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0d9553dc221140a49d48f4e0ca40a8df_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQyZjgyNjE4NTllZTQ3ZWU4YWFjYmM1MWVjMWRmYTJjXzQ_70ffad9a-704b-4766-88a0-cfe0f8a85129"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id405071995174d9a92bfacc37bad77cb_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNS00LTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmQyZjgyNjE4NTllZTQ3ZWU4YWFjYmM1MWVjMWRmYTJjXzIxOTkwMjMyNTU1NjQ_2e736249-fc12-4574-a97c-cbe705fadf4d"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2063782252c94eed817587f0ac1d141a_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNi0yLTEtMS0zMzc4Mg_25bf5811-9b0c-499d-b386-1773f712b86f"
      unitRef="usdPerShare">20.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaf19c926d9984ed9a050bba2c8ee58ea_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjM2YTcwODU0OTYwMDRmMTU5M2RmZmY5NTI3Y2M2MTRiL3RhYmxlcmFuZ2U6MzZhNzA4NTQ5NjAwNGYxNTkzZGZmZjk1MjdjYzYxNGJfNi00LTEtMS0zMzc4Mg_5b8c904b-41eb-4af2-a8de-ba365710b5b8"
      unitRef="usdPerShare">14.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzE0NA_e063ef0a-c5ae-42ec-a199-6f855b964c50">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMi0yLTEtMS0zMzc4Mg_94d41518-3e19-4599-b7ad-d061faae58fb"
      unitRef="shares">1114900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifea73937ee8d4f188daa2e67eb443344_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMi00LTEtMS0zMzc4Mg_4469aefc-b6f3-494b-8caf-658fa92aa656"
      unitRef="usdPerShare">37.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMy0yLTEtMS0zMzc4Mg_133923b6-e869-499c-94ef-2c61962a2a50"
      unitRef="shares">234200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMy00LTEtMS0zMzc4Mg_d410d4fa-0e78-4913-a043-ba89d17180d4"
      unitRef="usdPerShare">44.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNC0yLTEtMS0zMzc4Mg_28063ea7-9c3e-4080-973f-9577074a7b2b"
      unitRef="shares">87600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNC00LTEtMS0zMzc4Mg_902072fe-4bd7-4413-8ec5-c4a736c85025"
      unitRef="usdPerShare">30.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNS0yLTEtMS0zMzc4Mg_896d8a64-1b90-4a3f-8ebe-0b56bd6f82ac"
      unitRef="shares">13700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNS00LTEtMS0zMzc4Mg_13073df2-0c05-4941-ab9a-c4350b88d68e"
      unitRef="usdPerShare">37.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNi0yLTEtMS0zMzc4Mg_61997814-13f4-4aa4-8ee7-12c5b6da35c6"
      unitRef="shares">8500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNi00LTEtMS0zMzc4Mg_1f24f795-2d98-4348-99d0-aabdedcbbfd8"
      unitRef="usdPerShare">56.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy0yLTEtMS0zMzc4Mg_49b00497-3c93-4ff1-9944-e77895dd9619"
      unitRef="shares">1239300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy00LTEtMS0zMzc4Mg_949fdf67-93e4-45d5-9699-c99f3aaa80db"
      unitRef="usdPerShare">39.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy02LTEtMS0zMzc4Mg_1a7a386e-1fe8-42c9-a425-d7fa47660a8f">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfNy04LTEtMS0zMzc4Mg_ff9b7361-c3c2-4cfc-aa34-af27b08ef9b9"
      unitRef="usd">20593000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC0yLTEtMS0zMzc4Mg_62db1ff9-3529-4786-9353-ee72239f285d"
      unitRef="shares">759700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC00LTEtMS0zMzc4Mg_5d09f641-3e1c-4cd3-b0b5-4aefed25f99c"
      unitRef="usdPerShare">39.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC02LTEtMS0zMzc4Mg_c9e984f4-1982-4d09-97cf-ad7714b5c948">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfOC04LTEtMS0zMzc4Mg_be0f86a4-e510-45d4-b0ba-5fc5d2c49df0"
      unitRef="usd">13060000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTEtMi0xLTEtMzM3ODI_ba38adf8-fe32-4327-8e42-6ab67f6af326"
      unitRef="shares">1100900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i44a33afb528b42678a75f8d868dc2b94_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTEtNC0xLTEtMzM3ODI_d9036e28-7bdd-4ca9-9a73-a78316c72b77"
      unitRef="usdPerShare">40.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTItMi0xLTEtMzM3ODI_35cb5de4-823f-4718-876b-4a2a64eba61b"
      unitRef="shares">197600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTItNC0xLTEtMzM3ODI_a7e9a3a0-a2a7-4a72-8949-33d92007dcab"
      unitRef="usdPerShare">54.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTMtMi0xLTEtMzM3ODI_bdb8cdb4-3721-4c7d-8ec5-99af0c0d4d6a"
      unitRef="shares">39100</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTMtNC0xLTEtMzM3ODI_610e2235-9783-49cc-aec1-db1e6a90cc82"
      unitRef="usdPerShare">38.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtMi0xLTEtMzM3ODI_0d7e7efc-3dc8-49da-9349-d0893724cf13"
      unitRef="shares">1259400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtNC0xLTEtMzM3ODI_57f6ccc0-0dde-4b24-8000-87fdd157fd91"
      unitRef="usdPerShare">42.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtNi0xLTEtMzM3ODI_5a075f61-9546-41b6-930b-6cbde6b7e335">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTYtOC0xLTEtMzM3ODI_ec9a0f91-7e48-4694-92bc-4e31a84d38ec"
      unitRef="usd">10963000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctMi0xLTEtMzM3ODI_4cb36975-f619-49b7-822f-255bf2b74678"
      unitRef="shares">830800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctNC0xLTEtMzM3ODI_0983bc28-08c9-43bd-b80c-7cabca7ae4d5"
      unitRef="usdPerShare">40.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctNi0xLTEtMzM3ODI_ed16218d-675f-4589-90af-0e5b3534935a">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RhYmxlOjRjZjQ2MWVhODI1ZTQxYzA4NDFjYjViZmVjOTJkYjMwL3RhYmxlcmFuZ2U6NGNmNDYxZWE4MjVlNDFjMDg0MWNiNWJmZWM5MmRiMzBfMTctOC0xLTEtMzM3ODI_e20dadc9-8820-4aed-97b0-8240cb9e1639"
      unitRef="usd">9403000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83My9mcmFnOmY3ZGMzZDMyNmM4NDRmOTdiNzI1NDZmMDFiMTdlMWUyL3RleHRyZWdpb246ZjdkYzNkMzI2Yzg0NGY5N2I3MjU0NmYwMWIxN2UxZTJfMzEyOQ_a0b74cf6-7d86-433c-8da1-f2d6419b6519"
      unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfNDcx_cc418eb1-85b8-459d-91c1-010056c837d4">Income TaxesIncome taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur.  The effective tax rates used in the calculation of income taxes were 23.4% and 24.0% for the three months ended September 30, 2022 and 2021, respectively.  The effective tax rates used in the calculation of income taxes were 22.7% and 24.2% for the six months ended September 30, 2022 and 2021, respectively.  The decrease in the effective tax rate for the three and six months ended September 30, 2022 compared to the three and six months ended September 30, 2021 was due to discrete items primarily pertaining to state tax rate legislative changes and share based compensation.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjE5OTAyMzI1NjM4MQ_1a0b49c1-ad9e-412b-8679-cb088fa92fc8"
      unitRef="number">0.234</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjE5OTAyMzI1NjI2NQ_8a7a5c05-0d99-42e4-b832-cc5b533cdb31"
      unitRef="number">0.240</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjc3_7297b7f2-7d54-45b0-94fd-c735b095dda3"
      unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83Ni9mcmFnOmViMThkMmI2NDc5ZDQ1NjM5YTQ3MzY3NTM1N2M4OWQzL3RleHRyZWdpb246ZWIxOGQyYjY0NzlkNDU2MzlhNDczNjc1MzU3Yzg5ZDNfMjg0_871caeac-8aaa-4ce0-af90-3177a0d5b5fc"
      unitRef="number">0.242</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTAzMA_cb1ac586-d14c-4d59-bc3b-e6f4d6782233">Employee Retirement Plans&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefits consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended September 30, 2022, we contributed $0.2 million to our non-qualified defined benefit plan and made no contributions to the qualified defined benefit plan.  During the remainder of fiscal 2023, we expect to contribute an additional $0.2 million to our non-qualified plan and to make no contributions to the qualified plan.&lt;/span&gt;&lt;/div&gt;During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for our U.S. qualified defined benefit pension plan (the "Plan") and began the Plan termination process.  The settlements of the terminated Plan occurred during the first quarter of fiscal 2023 with lump sum settlements in the amount of $13.8 million being paid to eligible Plan participants who elected such payments and the purchase of annuity contracts for $31.1 million to the remaining participants.  These settlements were paid using Plan assets and resulted in a settlement loss of $0.4 million.  No further contributions to the Plan were necessary.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTAyMw_7ed94ac2-0c02-420e-9ea3-f2ecce5a385f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefits consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi0yLTEtMS0zMzc4Mg_3e7106d2-286a-4b57-8c27-643b91029e70"
      unitRef="usd">29000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi00LTEtMS0zMzc4Mg_a884419f-c719-4ff0-a9e8-0b894af6a88f"
      unitRef="usd">278000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi02LTEtMS0zMzc4Mg_abfa9abb-64d5-4512-93c8-1a294b5a4c85"
      unitRef="usd">360000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMi04LTEtMS0zMzc4Mg_0cde20b2-5b6b-4363-9ce6-e5a6a7001ea0"
      unitRef="usd">556000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy0yLTEtMS0zMzc4Mg_b42e121c-0000-405a-9262-6ccd11163aa4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy00LTEtMS0zMzc4Mg_43db8f96-26a2-4fa5-ba04-e738ed1322ca"
      unitRef="usd">290000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy02LTEtMS0zMzc4Mg_a61e998e-2cab-42d0-8f0a-6d4098148868"
      unitRef="usd">252000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfMy04LTEtMS0zMzc4Mg_97b2e1d8-a489-4016-ba7c-cb6b9f972947"
      unitRef="usd">580000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC0yLTEtMS0zMzc4Mg_358f90ca-15a2-4356-939d-a531ab912eab"
      unitRef="usd">29000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC00LTEtMS0zMzc4Mg_f6d1de15-fd5d-4f32-9f02-783f680d74ab"
      unitRef="usd">-12000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC02LTEtMS0zMzc4Mg_d0eb098d-6628-4a55-afcf-c2797d9aeff4"
      unitRef="usd">108000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RhYmxlOmVlZThjMWI5OTliNzQxNDY5Y2YyMzY2YzRiYTQ4NDM2L3RhYmxlcmFuZ2U6ZWVlOGMxYjk5OWI3NDE0NjljZjIzNjZjNGJhNDg0MzZfNC04LTEtMS0zMzc4Mg_856675a1-14e1-40d0-b5d9-23cabddb9905"
      unitRef="usd">-24000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1240337eaee64711a1a60d6c2e1b7e6c_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTQz_b6eed286-ccb9-4560-a451-381659a5ad4c"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="ib1f22bd2d45941c7b1bc75e4966da7c7_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMTk3_e186bdf6-ad80-4f3e-9e0b-dd5963ee9990"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i3d2317b145b7448e92da9f723d95918f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfMzI3_c734d68f-59b7-45ad-a84f-d9fc4ee5f35d"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfNzM0_2ce6a431-c66d-4563-ac4b-dde6db6ca536"
      unitRef="usd">13800000</pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum>
    <pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfODQ2_918687e8-a298-4ffa-8bee-468e673987bb"
      unitRef="usd">31100000</pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF83OS9mcmFnOjdkNTRmYTZhOWZmODQxMTNiZWZkOGYyOWZhMjJlN2Q1L3RleHRyZWdpb246N2Q1NGZhNmE5ZmY4NDExM2JlZmQ4ZjI5ZmEyMmU3ZDVfOTY0_6a311c02-f36f-442a-b095-55953ea847c4"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84Mi9mcmFnOmFkNTU0M2E0MmQwNTQ2OWVhOTM2NzE4MDc5NzQ2YWJkL3RleHRyZWdpb246YWQ1NTQzYTQyZDA1NDY5ZWE5MzY3MTgwNzk3NDZhYmRfMTI1MA_8d38c5be-1805-462b-87d8-9dbd0f1a4583">Commitments and ContingenciesWe are involved from time to time in legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the reasonably possible losses from resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjc4OQ_58b8b0da-026f-4621-877b-2d5a864b8fba">Concentrations of Risk&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our revenues are concentrated in the area of OTC Healthcare.  We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.  During the three and six months ended September 30, 2022, approximately 39.7% and 40.6%, respectively, of our gross revenues were derived from our five top selling brands.  During the three and six months ended September 30, 2021, approximately 41.3% and 43.3%, respectively, of our gross revenues were derived from our five top selling brands.  Two customers, Walmart and Walgreens, accounted for more than 10% of our gross revenues in one or both of the periods presented.  Walmart accounted for approximately 20.3% and 19.8%, respectively, of our gross revenues for the three and six months ended September 30, 2022. Walmart accounted for approximately 22.7% and 21.2%, respectively, of our gross revenues for the three and six months ended September 30, 2021.  Walgreens accounted for approximately 10.8% of our gross revenues for the second quarter of fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our product distribution in the United States is managed by a third party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufactures many of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Summer's Eve&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Fleet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or various public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, we had relationships with 130 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 27 manufacturers that produced items that accounted for approximately 71.3% of gross sales for the six months ended September&#160;30, 2022.  At September&#160;30, 2021, we had relationships with 121 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 19 manufacturers that produced items that accounted for approximately 68.1% of gross sales for the six months ended September&#160;30, 2021.  The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2cba7d38b81045e787d4f104d9fb3eaa_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI2Mw_81f77c7e-9dca-48eb-b8c7-501d37143084"
      unitRef="number">0.397</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia1a0406745a24ccf85af84e2f238dafb_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI1OQ_eceb83e0-cad1-48d2-9c52-d419fba754f0"
      unitRef="number">0.406</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i213e57bd7c7b47edbccb40cf81cd0e0e_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDI1NQ_a3282723-bc98-4a96-a7f5-5a56b9d80b22"
      unitRef="number">0.413</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i25ef8ba0f2404c738e6cf363025e958a_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDA4NA_b09cb95c-b87f-4b70-8020-2996c52b61f9"
      unitRef="number">0.433</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic9ff1becf0f84b77a14626c31518df01_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDczMA_5e8c9122-1326-4c5f-8dc1-9fe33a5db79b"
      unitRef="number">0.203</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib056427d825645d3a6d243d6f12ade35_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDczOA_908a7724-31b2-4c76-aad1-ce1155e7c352"
      unitRef="number">0.198</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6351be3774e04b968ab085c80b3d6b0c_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDc0OA_1d0ec5b3-9e93-4107-81cf-26f32bf9a6d9"
      unitRef="number">0.227</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i093f3d98ccb14d9089261e76e6f7c5d6_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMDc1Ng_8759f500-d52d-477b-b27b-6a479b7e8d16"
      unitRef="number">0.212</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia36e7d927aba40fab88e45e3e3e41575_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMzg0ODI5MDcwMTg1Mw_8f8a510b-26ce-41aa-b021-3b02091e257d"
      unitRef="number">0.108</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturers
      contextRef="i7e78fc711fb14c3494d63203d4920083_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMTg1Nw_24e1b3e0-c3f6-412b-83c6-fac0f1b20dfb"
      unitRef="manufacturer">130</pbh:NumberOfThirdPartyManufacturers>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="i12a9fca5712b4984be4783b87d0d1895_D20220401-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMTkzMA_43e72fe8-86ed-4aab-8156-0c3ec40aa10f"
      unitRef="manufacturer">27</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia687471f18b34360a6f6a50343be6ca3_D20220401-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjAwMA_4b5cad45-1c5e-47ea-90c8-bd220ce47e7a"
      unitRef="number">0.713</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturers
      contextRef="i3371a37e1b1f49d8bcb577f8d2a4f0bb_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjA2Nw_2a47d0b0-44d1-4d51-bbc8-20c37f22c17e"
      unitRef="manufacturer">121</pbh:NumberOfThirdPartyManufacturers>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="i5a5c21dfca0f469999a785781e89c178_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjE0MA_c5dbec88-d34f-49f5-b5dc-2b0b466db995"
      unitRef="manufacturer">19</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i27ad6371c4b14f5782e971050830c85c_D20210401-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84NS9mcmFnOjhjZjZiZDdlODgzMjQ3YzY5NGJiMzBlZDBhNGU4MGU0L3RleHRyZWdpb246OGNmNmJkN2U4ODMyNDdjNjk0YmIzMGVkMGE0ZTgwZTRfMjIxMA_e223ec80-0f60-4fbf-8334-d0f46595177a"
      unitRef="number">0.681</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjY3_85a42ce9-efd2-4f76-8d97-f23e166c286a">Business Segments &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280.  Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjUx_d7dc62e8-5c88-4e34-b836-210abacd0f23">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi0xLTEtMS0zMzc4Mg_e4f426ce-dae0-4d42-a4a4-7fccefd30a86"
      unitRef="usd">252054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi0zLTEtMS0zMzc4Mg_d4b14fd4-33d2-4313-b2dd-03100159074a"
      unitRef="usd">37219000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMi03LTEtMS0zMzc4Mg_32ae00ac-63ab-4140-9985-9cd6984b05cf"
      unitRef="usd">289273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy0xLTEtMS0zMzc4Mg_1f9a9beb-e1fd-44f7-bea5-b36deb9d10e5"
      unitRef="usd">113533000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy0zLTEtMS0zMzc4Mg_2146e5a1-d09a-44ea-be27-f613bd525111"
      unitRef="usd">14731000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfMy03LTEtMS0zMzc4Mg_3fc977fb-18a2-45d7-a7bc-5f16bd0191b2"
      unitRef="usd">128264000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC0xLTEtMS0zMzc4Mg_00e2ea18-7880-4d98-b5d5-b72b82234875"
      unitRef="usd">138521000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC0zLTEtMS0zMzc4Mg_087a0825-e0f6-46b0-8429-c7aa1547cebb"
      unitRef="usd">22488000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNC03LTEtMS0zMzc4Mg_4d888259-f3d5-473f-886d-02433f9676ad"
      unitRef="usd">161009000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS0xLTEtMS0zMzc4Mg_e282685f-6a06-433a-8705-3afaeb297296"
      unitRef="usd">39316000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS0zLTEtMS0zMzc4Mg_543f1df9-d414-4873-bf2b-2df49b4f2536"
      unitRef="usd">4503000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNS03LTEtMS0zMzc4Mg_7b59478c-8c34-41e5-a080-c2a41fc40adf"
      unitRef="usd">43819000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i92a17492201d453a8cc5b811656651c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi0xLTEtMS0zMzc4Mg_feef1e6e-db49-46fb-a96d-ec2b969dfc1a"
      unitRef="usd">99205000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i197a6184216f4bf683aadc51e3d301f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi0zLTEtMS0zMzc4Mg_edd6e56d-a884-4595-9856-66206b726181"
      unitRef="usd">17985000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNi03LTEtMS0zMzc4Mg_d545e39e-bafd-462d-ab8f-ab34e8ad3d7b"
      unitRef="usd">117190000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfNy03LTEtMS0zMzc4Mg_5faf24e0-05ba-4d64-9bff-74a98a65aaae"
      unitRef="usd">32806000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfOC03LTEtMS0zMzc4Mg_6c6c9d12-6483-46a4-8b8d-ca30cc02e698"
      unitRef="usd">84384000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia834815cf1604076a6c15f46da4bca86_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjBmN2E1MGYwNTVjMDQ2ZjFiZDJkM2ZkODQ1M2E0ZGZmL3RhYmxlcmFuZ2U6MGY3YTUwZjA1NWMwNDZmMWJkMmQzZmQ4NDUzYTRkZmZfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjgxZTE2NTJhOGE1MTQ3MzE4ZTg2NGM0NjRjYTZlNmI5XzMx_397d501f-8885-44fa-8461-3223074efb70"
      unitRef="usd">1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi0xLTEtMS0zMzc4Mg_492b5873-f9b3-4752-8e3e-949abc61d2de"
      unitRef="usd">494572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi0zLTEtMS0zMzc4Mg_5de6c1c8-6273-4352-96c7-18c80de438e6"
      unitRef="usd">71760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMi03LTEtMS0zMzc4Mg_8b895605-88af-44d3-bcdf-677fddda89fb"
      unitRef="usd">566332000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy0xLTEtMS0zMzc4Mg_1a19f683-e14d-4395-b62f-914b1198d275"
      unitRef="usd">216454000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy0zLTEtMS0zMzc4Mg_3f568f8a-7c61-487f-bf94-25ca36fc8b89"
      unitRef="usd">28750000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfMy03LTEtMS0zMzc4Mg_feec15c0-28c7-4e55-9d95-b7670bfe9eb2"
      unitRef="usd">245204000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC0xLTEtMS0zMzc4Mg_fc6470d4-8a94-4502-b42a-a7b4628edd16"
      unitRef="usd">278118000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC0zLTEtMS0zMzc4Mg_4b622930-07a5-4fe9-8e83-beef9ae87449"
      unitRef="usd">43010000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNC03LTEtMS0zMzc4Mg_ed50aed6-2730-43bb-a9b8-0e9e8c3a5261"
      unitRef="usd">321128000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS0xLTEtMS0zMzc4Mg_c752c0f3-9971-4c74-bed2-566acb36fabb"
      unitRef="usd">74728000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS0zLTEtMS0zMzc4Mg_4eb2d3e5-c8ce-428a-bda1-3130b862615e"
      unitRef="usd">9042000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNS03LTEtMS0zMzc4Mg_f7d51198-7679-4f5b-ac3a-848b5aa364b6"
      unitRef="usd">83770000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="ibe73f08e6843453c8b833a024999d919_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi0xLTEtMS0zMzc4Mg_8c710907-c767-4cee-91aa-eccc8c9602a2"
      unitRef="usd">203390000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i78a4c45a3a6b4f709c51daecff490632_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi0zLTEtMS0zMzc4Mg_afeab90c-e50c-4c7f-8a72-8f69cbb5fa2e"
      unitRef="usd">33968000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNi03LTEtMS0zMzc4Mg_5796aefe-6f30-40e5-92e5-6881598d9837"
      unitRef="usd">237358000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfNy03LTEtMS0zMzc4Mg_b3163712-4730-4888-afe3-611b1792fc08"
      unitRef="usd">65960000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfOC03LTEtMS0zMzc4Mg_4e9882ad-60a0-445a-8719-a329285b574d"
      unitRef="usd">171398000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i026667c5f30d40229f5ca1072dd36fb1_D20220401-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjhjYWI1MjkyNTY1MTQ0Y2M4YWE4MWQ1MjMzYjRhNTIyL3RhYmxlcmFuZ2U6OGNhYjUyOTI1NjUxNDRjYzhhYTgxZDUyMzNiNGE1MjJfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOjExYWJhOTVlOGE1MzRiNWQ5YzY2M2UyNWFjZDdlNjdhXzMx_75b9bfa1-b668-4b2f-a47d-514bd028ac53"
      unitRef="usd">1700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi0xLTEtMS0zMzc4Mg_f5ac50df-d586-4b5b-8690-b9d29ca9ebb9"
      unitRef="usd">251728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi0zLTEtMS0zMzc4Mg_b679678d-f31c-470d-add4-3a1d3d198317"
      unitRef="usd">24497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMi03LTEtMS0zMzc4Mg_5fbbd504-b3ef-4c86-945d-7b5bc68ed3b2"
      unitRef="usd">276225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy0xLTEtMS0zMzc4Mg_96f246eb-6cef-40f8-a794-f3b2d66d4287"
      unitRef="usd">108623000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy0zLTEtMS0zMzc4Mg_4b56c748-f7f3-4cbc-9607-475bf8935aaf"
      unitRef="usd">9890000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfMy03LTEtMS0zMzc4Mg_db78d8dd-8e21-49fc-b386-afd5146b917c"
      unitRef="usd">118513000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC0xLTEtMS0zMzc4Mg_3b476657-82ff-4e98-adad-a446f81e0933"
      unitRef="usd">143105000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC0zLTEtMS0zMzc4Mg_30739dc9-b9b9-452f-82a7-26f6aa9ffb90"
      unitRef="usd">14607000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNC03LTEtMS0zMzc4Mg_c33fd060-705a-448a-a834-8f230745a597"
      unitRef="usd">157712000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS0xLTEtMS0zMzc4Mg_4655e9a1-67c6-4797-8d8c-413d35dc8bbd"
      unitRef="usd">36493000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS0zLTEtMS0zMzc4Mg_e4b9d6ba-5d12-4d3a-8f8b-54eef95c317a"
      unitRef="usd">4237000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNS03LTEtMS0zMzc4Mg_6ff7b016-ef04-4abe-a307-83e4441e9c90"
      unitRef="usd">40730000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="id6d749dc3a694972b8fc7af69db9e8fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi0xLTEtMS0zMzc4Mg_f8cef3f3-66ad-4014-88e4-1b0a29e68abf"
      unitRef="usd">106612000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i4ee703b3c6224e53919817395112fc83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi0zLTEtMS0zMzc4Mg_89d33eae-b063-4832-8591-77f02965b4a5"
      unitRef="usd">10370000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNi03LTEtMS0zMzc4Mg_305e0815-dbd3-455c-a13f-9267eeab1b81"
      unitRef="usd">116982000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfNy03LTEtMS0zMzc4Mg_e20becaa-2adc-47d8-8b57-f41ee7e999f9"
      unitRef="usd">38424000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfOC03LTEtMS0zMzc4Mg_b3b2e90a-3aad-4247-b09e-56eb39d6d0ce"
      unitRef="usd">78558000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i907a70df628e4e48b75b67fd126aa346_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjY4MzRlMzY3NTM5YTQzMGViOGQwODNmODU1NDE1MDRmL3RhYmxlcmFuZ2U6NjgzNGUzNjc1MzlhNDMwZWI4ZDA4M2Y4NTU0MTUwNGZfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmFhMmQzMmM3MzM1YTRkYjQ5ODg5NWNlZDBkY2VlMTJlXzMx_e04b33c7-0159-4a50-a1a6-3f1f63c7e83b"
      unitRef="usd">700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi0xLTEtMS0zMzc4Mg_c7c92b6d-6a5e-42c1-90bc-e2a31c12a3a9"
      unitRef="usd">494121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi0zLTEtMS0zMzc4Mg_e5655d8d-c933-44a8-9961-330a3913e302"
      unitRef="usd">51285000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMi03LTEtMS0zMzc4Mg_c3f74b75-b26f-4f61-b1ff-08d0b0e0cf6a"
      unitRef="usd">545406000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy0xLTEtMS0zMzc4Mg_60f90c37-d4fc-4e4e-bf3d-409dc384efa5"
      unitRef="usd">208027000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy0zLTEtMS0zMzc4Mg_82bfa324-22cd-4167-ba1b-ca85568e526e"
      unitRef="usd">20655000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfMy03LTEtMS0zMzc4Mg_c70282d1-7a59-4398-846a-8a15a69d6c5e"
      unitRef="usd">228682000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC0xLTEtMS0zMzc4Mg_d79f5065-9326-471a-a960-ef0b3c38dd29"
      unitRef="usd">286094000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC0zLTEtMS0zMzc4Mg_dfaa29b5-85c4-4130-bae9-1766dd120148"
      unitRef="usd">30630000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNC03LTEtMS0zMzc4Mg_00843082-083a-47a1-b89e-ce90c3e72c31"
      unitRef="usd">316724000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS0xLTEtMS0zMzc4Mg_9722b784-d613-4ce9-b687-ffff28ccc881"
      unitRef="usd">71723000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS0zLTEtMS0zMzc4Mg_3ae0fad3-de2f-4fff-a180-2162dda0755f"
      unitRef="usd">8446000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNS03LTEtMS0zMzc4Mg_67e15f1a-65d8-4506-a992-013a75443693"
      unitRef="usd">80169000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i7c3eb040a39948f98235a36595febc7c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi0xLTEtMS0zMzc4Mg_0cd51aff-ca08-4458-a935-73a33983bb6a"
      unitRef="usd">214371000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i27e94dd8ae6842418eb1d6197bc586e9_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi0zLTEtMS0zMzc4Mg_8003a6d0-1c52-4f8c-86f6-ade48d403881"
      unitRef="usd">22184000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNi03LTEtMS0zMzc4Mg_38a4a24d-7505-4d41-9bdb-0e86cae83441"
      unitRef="usd">236555000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfNy03LTEtMS0zMzc4Mg_93ac766a-730d-433f-b07c-8c56d1c8ad8a"
      unitRef="usd">66655000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfOC03LTEtMS0zMzc4Mg_d97d7ebe-aa12-41f1-9b15-dabbb1fe46a6"
      unitRef="usd">169900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ea034b41f254bdca8406677654243b2_D20210401-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjk5ODM0Y2NiMzk2MjQ0YTQ5NmEyNTQ4MWU5Njg1ZmZkL3RhYmxlcmFuZ2U6OTk4MzRjY2IzOTYyNDRhNDk2YTI1NDgxZTk2ODVmZmRfOS0wLTEtMS0zMzc4Mi90ZXh0cmVnaW9uOmU4NjgyYmI1MzA2ZDQ5MDNiMzk0NjEyMGYzZmU2MTQ0XzMx_234ed19b-f5dd-4cb8-8116-c6e8cc750159"
      unitRef="usd">1700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RleHRyZWdpb246ZGMwZmJjOWIyZWU0NDg1Mzg2OWNhZmExYWVkZDVlNDhfNjc4_2d040a4e-1548-4eff-acfd-008b763c9752">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb42bf6d38ee41da9172272d89d125f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi0xLTEtMS0zMzc4Mg_1e4ced55-a12c-4834-8b9f-82b4c0e78a43"
      unitRef="usd">32750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91733343cd3f4ed69349759a5007771f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi0zLTEtMS0zMzc4Mg_10891f8a-f722-4361-8bdd-30bf2845f5a4"
      unitRef="usd">541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd5a4e1b1ddb48f58b2cba888ead4b2a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMi03LTEtMS0zMzc4Mg_7f7aa51b-50de-4149-8697-8ae897a1c9cf"
      unitRef="usd">33291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41fdf6285d3d4d4eae2b16526b8641c5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy0xLTEtMS0zMzc4Mg_362d2078-ade7-413a-9181-cf273def6f6e"
      unitRef="usd">24058000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1012eb424f2b4a27a014e52c4a7811d9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy0zLTEtMS0zMzc4Mg_fcd27de8-795d-484a-8084-d7aefa529071"
      unitRef="usd">7168000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i941a5663f483406585d5edf13941d483_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMy03LTEtMS0zMzc4Mg_ab310fe4-d2b2-455e-909d-508cf479668e"
      unitRef="usd">31226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1beedb6cef7e452a85e8b6be83cf629b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC0xLTEtMS0zMzc4Mg_75beea5e-c5c1-4e3e-9e32-82c1550bd450"
      unitRef="usd">59379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe91143a1c704b018a3976eb5a01c8a4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC0zLTEtMS0zMzc4Mg_c580e513-9e8d-40bc-8ecc-c9c0c01a6084"
      unitRef="usd">4745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9b16ec8347043ef89e62a09618575e5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNC03LTEtMS0zMzc4Mg_66cb9536-e960-45d5-a9e4-30711030f4e3"
      unitRef="usd">64124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb709d3222aa40d08b7528ab5869f491_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS0xLTEtMS0zMzc4Mg_5dea06ee-8a17-48b5-862b-c218f3eff50c"
      unitRef="usd">41272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e7cd02c9b2b42f5957d2a924601c171_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS0zLTEtMS0zMzc4Mg_1d310f8b-e957-4bdc-a10b-f2d7c3bac929"
      unitRef="usd">16037000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98f86017bb774d3d842c01a04cc30417_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNS03LTEtMS0zMzc4Mg_fc589fa0-4a7f-44a6-8add-40b778568008"
      unitRef="usd">57309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac26523f549e4adbaa8dd3618b500aa8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi0xLTEtMS0zMzc4Mg_5917c8e6-8fc8-406d-8677-dbbed95a1af9"
      unitRef="usd">37961000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i156269b4bc68478aaf0dd5842487d92d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi0zLTEtMS0zMzc4Mg_559fef5e-9293-48ff-9f20-39b78d651c1e"
      unitRef="usd">4734000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ea214aa8f2e4deb8d5ceaaf97d29c8c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNi03LTEtMS0zMzc4Mg_18f9ca84-3ab5-4b4b-ab78-9c9fb9aaae8c"
      unitRef="usd">42695000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa6b5df992544fefa4e5d17749dfb237_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy0xLTEtMS0zMzc4Mg_911fa4a8-00f3-4609-b4d7-7e4259e3ce3d"
      unitRef="usd">32872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49c739500f044451bbbcb4db0694d023_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy0zLTEtMS0zMzc4Mg_cff0946a-c551-4aa4-aaf6-21f51bcb4b19"
      unitRef="usd">902000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba2a752fd8ed4bd7a34663dc23e12f46_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfNy03LTEtMS0zMzc4Mg_4a4f16a3-737d-48fe-8909-59f83ea5ca2c"
      unitRef="usd">33774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i508a38c03392406f8d6e294ca753433e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC0xLTEtMS0zMzc4Mg_40614cf8-4390-478f-accf-044a01cebf7a"
      unitRef="usd">21251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc7e002d9ce94251906bbfa8507e0edb_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC0zLTEtMS0zMzc4Mg_84b91017-807f-4443-9952-fd662e0d4b3b"
      unitRef="usd">3080000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c4223591a1d49188b5b0bf13ac30c8c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOC03LTEtMS0zMzc4Mg_23da7fe0-8565-4b6c-9e81-c1ff17f5e400"
      unitRef="usd">24331000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf7c91c0d149454cab02b9c237ec63f9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS0xLTEtMS0zMzc4Mg_2a89365b-53df-4673-871f-c5acf288617b"
      unitRef="usd">2511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d59461a5a2b46f094ca36900ef9e502_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS0zLTEtMS0zMzc4Mg_5597af72-a403-498a-a997-33edd7a1b541"
      unitRef="usd">12000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d35b8a35e864ee698d7d3dae351ba18_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfOS03LTEtMS0zMzc4Mg_43e2edca-4797-4619-ba4c-952d5f7da5a6"
      unitRef="usd">2523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcc08b763b1242c4ae090e4552cf7fe1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtMS0xLTEtMzM3ODI_ed0f364d-46f8-4f10-b640-1ab2d45e8de4"
      unitRef="usd">252054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a99ba3fbd29462aa2fdd8aba546873e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtMy0xLTEtMzM3ODI_dfc45e15-6259-4c36-ac1a-5ae50d56e74b"
      unitRef="usd">37219000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjI5Y2Q1ZGZiYjk3NjQxYjI4MzI0NDM4ZjRiYjY0NDFlL3RhYmxlcmFuZ2U6MjljZDVkZmJiOTc2NDFiMjgzMjQ0MzhmNGJiNjQ0MWVfMTEtNy0xLTEtMzM3ODI_5f45fbc7-ecff-418a-bc8e-5525f2c32888"
      unitRef="usd">289273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6749959e270d484a8849ec9baeeb8726_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi0xLTEtMS0zMzc4Mg_bf0a8cef-3402-47f1-b19e-24c2117efc10"
      unitRef="usd">60547000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib03000714fd04461b44e3ed996bbdcb2_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi0zLTEtMS0zMzc4Mg_26933dc5-e1b5-46a5-a353-ce0fa25ff184"
      unitRef="usd">994000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddc1f391c4a14ce993aab75bb0e56b22_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMi03LTEtMS0zMzc4Mg_21cc0e51-9de8-4d18-88c7-9d5fb152ce40"
      unitRef="usd">61541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib05a53f6ddd84378a8b0e8ffe24ce1f8_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy0xLTEtMS0zMzc4Mg_2e2109d0-982e-44b8-9a4c-7abdf1ff9b2a"
      unitRef="usd">45650000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3890c9dec07642c388c1c5545eb77376_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy0zLTEtMS0zMzc4Mg_fc12c539-64cf-4586-81f8-6004baa63b64"
      unitRef="usd">13439000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67b8efa5861d4b22a06a49d48921e253_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMy03LTEtMS0zMzc4Mg_87ed5ff4-dd62-4b72-8074-34839fe41153"
      unitRef="usd">59089000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafd6d904e1c3451caf89d8a72a334070_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC0xLTEtMS0zMzc4Mg_40f9eeb6-3b7e-4df3-9b90-86fe4e9aa355"
      unitRef="usd">120563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3e3ef2deded4c839f83b082e1afc3c4_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC0zLTEtMS0zMzc4Mg_c23011fb-c5ca-41fc-89d5-f17552f23981"
      unitRef="usd">9612000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a45b0f569b5480995950a7d10bbc8e8_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNC03LTEtMS0zMzc4Mg_8fd55fce-2812-4ccc-838d-b51ad823781b"
      unitRef="usd">130175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4abaf43271f54b92aab3fd11f43d7755_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS0xLTEtMS0zMzc4Mg_b98ff888-4225-4808-881c-4c79bd0ab4cc"
      unitRef="usd">81339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9385a0d313844f70abb80799feab8302_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS0zLTEtMS0zMzc4Mg_11b0a888-bb17-4466-988b-192109f2492a"
      unitRef="usd">30064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i952f5bd919b24d1db88ea63c4fbe1bc6_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNS03LTEtMS0zMzc4Mg_1bad9f6e-e68a-4b55-9630-3efab12d504f"
      unitRef="usd">111403000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if641448d42014771a833e92c731a8eaa_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi0xLTEtMS0zMzc4Mg_49ed845e-2dab-4a3d-a65e-f6291bffcd8d"
      unitRef="usd">76572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6daec78175cd4f9d99c734cec1bd11c2_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi0zLTEtMS0zMzc4Mg_2f613ca0-2890-4cc7-8e78-180230f8e10b"
      unitRef="usd">9470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ce8bc57290b440981f94ecbbfac6d33_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNi03LTEtMS0zMzc4Mg_bfbc7e1e-940c-4b5f-a7d9-bbfb857c591d"
      unitRef="usd">86042000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77c021d4c1f045f690a73afbd3a4cd6d_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy0xLTEtMS0zMzc4Mg_9be55c96-be64-4887-a1c0-1f114b488075"
      unitRef="usd">62327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae4aa809e3674b859374a3de6a969618_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy0zLTEtMS0zMzc4Mg_7035608b-be7e-4355-b3a1-8e97849bade9"
      unitRef="usd">1908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5f8aa2313314f7d83e72570a64bb906_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfNy03LTEtMS0zMzc4Mg_3b1e1fce-5720-444f-9e3b-f48fb2690492"
      unitRef="usd">64235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd11ab63fa2b44a08ee05dc22f56913a_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC0xLTEtMS0zMzc4Mg_af56b04a-62e9-4113-ba31-840633199dec"
      unitRef="usd">42226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79a221081d114432b4a27d7b40d183f7_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC0zLTEtMS0zMzc4Mg_99ca9bc9-de6e-44fd-a2c3-82a7941310b5"
      unitRef="usd">6250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdc1df03ae0a46c4825f6652f54f210d_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOC03LTEtMS0zMzc4Mg_5024b3a6-e1f4-4cf9-b3fe-39add3def6f8"
      unitRef="usd">48476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59a5ffc00b62425ba1a88cc64cbd36e8_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS0xLTEtMS0zMzc4Mg_4ad72272-dd67-48a4-90ac-78a0e629f1d1"
      unitRef="usd">5348000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b7667f0de454eb79b0ad225eebdbae0_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS0zLTEtMS0zMzc4Mg_3b240e8f-0ad0-4c4e-af4b-3a18302128a8"
      unitRef="usd">23000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f84cd10cc5345d09c2dd76fa06e00ad_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfOS03LTEtMS0zMzc4Mg_7877fb82-10a7-4d71-a3d1-03a14c519bd7"
      unitRef="usd">5371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedd0d72857e8467d808891d4ae7c76f0_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtMS0xLTEtMzM3ODI_786fe3db-6ad6-4ed8-8c58-c078d05405bc"
      unitRef="usd">494572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcd57181c512447ba916c4d2e8d2837e_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtMy0xLTEtMzM3ODI_3eac89e5-e9c1-4762-ba0b-234cf7a92bd5"
      unitRef="usd">71760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOjg5YjE2NWI0NWE2ZjRjN2Y5YjBiNjg5M2Q1MDE0NGU3L3RhYmxlcmFuZ2U6ODliMTY1YjQ1YTZmNGM3ZjliMGI2ODkzZDUwMTQ0ZTdfMTEtNy0xLTEtMzM3ODI_3af5cb61-1db8-4add-aafb-5adb6d83dc8a"
      unitRef="usd">566332000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd20649b7a574a058d933177cb7d6cdc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi0xLTEtMS0zMzc4Mg_de719d8c-a489-44e2-9652-4968f04c49cb"
      unitRef="usd">29943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64a3ad1a593744bbb35935dcc3c1a3dd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi0zLTEtMS0zMzc4Mg_530adbc4-6a82-4b91-9035-ec17c0a5b445"
      unitRef="usd">396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if597e5a35cc541908f97df9d4ad7877a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMi03LTEtMS0zMzc4Mg_e5c6d1ef-4fda-4824-9d43-75509d6aae7d"
      unitRef="usd">30339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e715778cd0e44a18645616c8df69ba1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy0xLTEtMS0zMzc4Mg_d7337865-e733-4169-84d2-b94e5218974b"
      unitRef="usd">23022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e0dfb7bd0c54a90992d0bfce4410815_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy0zLTEtMS0zMzc4Mg_d6ae55b2-76f2-4e32-879d-912c39c5fe95"
      unitRef="usd">5006000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f5de7468f634f76a808529f4f6971c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMy03LTEtMS0zMzc4Mg_90b0d958-d920-4399-82e9-74d3312a0450"
      unitRef="usd">28028000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04ec63a0cca14633bf006f38ec899a46_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC0xLTEtMS0zMzc4Mg_ea71036b-d800-4d5f-875c-dd9de85e5383"
      unitRef="usd">65020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i966596af0d5149ca92ddbd71fbfd37d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC0zLTEtMS0zMzc4Mg_1391f695-7083-492e-8dbe-ada3573ac84a"
      unitRef="usd">3345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b73b63596724fc89c7cc257a90d4507_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNC03LTEtMS0zMzc4Mg_f09b03e9-9f53-404e-abe2-f9860468b444"
      unitRef="usd">68365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i092e4d9253d2444c80fd19466e202ae2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS0xLTEtMS0zMzc4Mg_35290e5e-29ca-4820-b574-a0c7545159c0"
      unitRef="usd">37964000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd0146ec3b014515a2ad85b80a0c2222_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS0zLTEtMS0zMzc4Mg_1a99e487-0c4a-4317-9185-f452a5bdca9c"
      unitRef="usd">8641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6e44a39fcd049b092a1c21fbe7a84da_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNS03LTEtMS0zMzc4Mg_4ca0debd-d73c-444f-a02b-d6704d4c976f"
      unitRef="usd">46605000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21693008f1de4e39a8cd0d000b9f2f07_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi0xLTEtMS0zMzc4Mg_c87843d1-3d41-4b45-9769-1ed4e95f1e3b"
      unitRef="usd">37818000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc54a38c56e845fcbb0e801b4552812b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi0zLTEtMS0zMzc4Mg_d1d04b60-224e-4b77-880c-411fdfb43d81"
      unitRef="usd">2988000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6d96da2f9524e769fd11ec5e90068a5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNi03LTEtMS0zMzc4Mg_2b9ba7ee-0f5a-4fdc-913b-127e502d242e"
      unitRef="usd">40806000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea51b409490b4d488139c17146926635_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy0xLTEtMS0zMzc4Mg_46ca28f2-9db5-4c5d-9258-49a22dbf65d1"
      unitRef="usd">32365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac699f58a1a94fbc80b52040fffbb15c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy0zLTEtMS0zMzc4Mg_a98d53cf-7e2b-4f7a-8bbd-33aad3699402"
      unitRef="usd">839000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e1c256b8811486db61c7a2fe6bb58f6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfNy03LTEtMS0zMzc4Mg_1960ad0a-3861-438f-b6e1-ca5f009c87d2"
      unitRef="usd">33204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48aae1c5023a4f5b8ae3b7524d2fe2a6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC0xLTEtMS0zMzc4Mg_90b76ec1-f186-486d-9e91-1c66fae61ae6"
      unitRef="usd">22893000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01bd495866f74b2db9bb1e41ffab0e86_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC0zLTEtMS0zMzc4Mg_f71d194b-d7c0-480d-80c3-cdffc2aab4e4"
      unitRef="usd">3278000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36a20b01556341028361a20e77dd1d38_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOC03LTEtMS0zMzc4Mg_fd8bb03c-2e5b-4000-b06d-be2bf7cfed95"
      unitRef="usd">26171000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95b4cc1178ef43ddab6a471cf872e469_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS0xLTEtMS0zMzc4Mg_c18ec314-00f5-46f6-a0a6-a161c631db59"
      unitRef="usd">2703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdc2502c0c6e4a428c8e95e77c5aa35e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS0zLTEtMS0zMzc4Mg_853e238f-a3fa-44d5-8e27-f4a9b326d4e2"
      unitRef="usd">4000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e3e7b22d27c4f5d9a8507e37f905566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfOS03LTEtMS0zMzc4Mg_87f1dbb7-2f05-46d8-bd7b-3279273db901"
      unitRef="usd">2707000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib60529f2161a445ab1e93ac7f996d24e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtMS0xLTEtMzM3ODI_95e3032f-3654-4ab4-be25-b6a62a5fb559"
      unitRef="usd">251728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3685f44ac4054a6f9f2f5cbc54fb9e44_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtMy0xLTEtMzM3ODI_04e30603-5ce5-4797-bdcc-b4f3536c2606"
      unitRef="usd">24497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i931403a0a67546ee847c6d22df8cf7d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmViOTk2N2RhODEwYzRhNmNiZjhjNDQ5OTFkMWUxODkyL3RhYmxlcmFuZ2U6ZWI5OTY3ZGE4MTBjNGE2Y2JmOGM0NDk5MWQxZTE4OTJfMTEtNy0xLTEtMzM3ODI_3957383a-71b0-4de4-aaa8-bc4e58f780da"
      unitRef="usd">276225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16a655f924b541c9867fa22141ff7d79_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi0xLTEtMS0zMzc4Mg_8a71995b-3cd7-418b-ac53-9556f0b93267"
      unitRef="usd">62764000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10b8a1903aee41588afc67cb5fd35651_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi0zLTEtMS0zMzc4Mg_37b687f3-11be-442b-b3ad-d8b2176651be"
      unitRef="usd">802000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i594a5a7ea66f4bf18ffa7ba9baaf6548_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMi03LTEtMS0zMzc4Mg_5899712f-25c2-42e2-a46b-6449b1c7f29a"
      unitRef="usd">63566000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fdb9a0b2635450380252cded493c8d8_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy0xLTEtMS0zMzc4Mg_39a58ee7-5596-449d-9dc8-51dad2069ca5"
      unitRef="usd">37067000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia13e6a4210034ca49a0dd1f93399f945_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy0zLTEtMS0zMzc4Mg_2d3b7da8-a4f8-42f9-b327-af705f0a6a29"
      unitRef="usd">9853000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5b1929a5adc4372b62c50ce12c1a55f_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMy03LTEtMS0zMzc4Mg_77d75d6b-ce59-40e4-8a3f-2ebfc77d1267"
      unitRef="usd">46920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddf28338f91741c9a583ee1f11391d98_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC0xLTEtMS0zMzc4Mg_6ff7bcc6-4502-4584-996f-25e3cab88849"
      unitRef="usd">128268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24f07f0b271c42408ac2cefda0abadac_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC0zLTEtMS0zMzc4Mg_7453acd0-93ab-4553-b48c-45609fbc1c01"
      unitRef="usd">7289000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5158014abd84e34bc6cf3f536db8822_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNC03LTEtMS0zMzc4Mg_4bb0d6e0-1197-4a86-ac3a-2482107a65c7"
      unitRef="usd">135557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf634010a44e415ea2149c5273a64f42_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS0xLTEtMS0zMzc4Mg_688a2e6a-a83b-4c88-b9df-a184292588d4"
      unitRef="usd">80330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fac7101ca624095a37b8838b7e370ba_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS0zLTEtMS0zMzc4Mg_66cd6cfc-6f84-4ac1-a901-5ffb4d4efda1"
      unitRef="usd">18845000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic095d7fd82584e46b46aef36eaf1309e_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNS03LTEtMS0zMzc4Mg_c0a8b553-5d29-4490-8ef2-d55c84b0e3c3"
      unitRef="usd">99175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97c35bb9633841d3886e1e747017e734_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi0xLTEtMS0zMzc4Mg_d8e8aeac-6d85-4975-bcba-8558ff59b04e"
      unitRef="usd">73805000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f27bafa6f93466284cbe1faacc2d6ff_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi0zLTEtMS0zMzc4Mg_408b6f66-670e-4087-932e-b86de5a82046"
      unitRef="usd">6446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cca7e01971f4b2ab2205da66c2ff17d_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNi03LTEtMS0zMzc4Mg_4771dfae-6cca-4dd6-92fa-e1c6175caaef"
      unitRef="usd">80251000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafd607a224fa4d8896c1359ce5450557_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy0xLTEtMS0zMzc4Mg_ef949e8b-d47e-4de1-b9fb-75b0de3cb103"
      unitRef="usd">63515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2963a340f2574654997fdd3323c114d8_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy0zLTEtMS0zMzc4Mg_e7f4d83a-ba9c-407c-ae09-ba9a49acc453"
      unitRef="usd">1778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5607274c7e0f483abe26074eb0e5e120_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfNy03LTEtMS0zMzc4Mg_c00d9421-9f06-4f8c-9f95-d6fff94e2b73"
      unitRef="usd">65293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52a95b1802134eaa80c0184052482422_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC0xLTEtMS0zMzc4Mg_527c4895-06b3-4416-8816-b78aa74b2ca6"
      unitRef="usd">43860000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia252b0ef955b4546bc834792f1e46e8c_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC0zLTEtMS0zMzc4Mg_f18f84be-5b86-4dce-b33b-814dc7d73bfa"
      unitRef="usd">6267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1503156d93284b65b2b7ffeb0926be90_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOC03LTEtMS0zMzc4Mg_e827c812-b1e5-4955-94e3-7a804943d6c8"
      unitRef="usd">50127000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb5eb987418746d580936607f4f6e710_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS0xLTEtMS0zMzc4Mg_14c896e8-1b40-416e-a961-a2b9f629db1d"
      unitRef="usd">4512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie91d3b9d39ec4e5cbd1449174d4808d0_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS0zLTEtMS0zMzc4Mg_7e1aa7d4-6365-4457-ac15-bb7a1d199094"
      unitRef="usd">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43a414c6a89f4bf6b73c26c8489e3c3a_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfOS03LTEtMS0zMzc4Mg_4ddb5ed3-d81e-4a85-8b0f-0b25cc97a112"
      unitRef="usd">4517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e429d25f01742dcb996639f98638232_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtMS0xLTEtMzM3ODI_54a15883-0cf3-4f7c-bd7c-b0feb24a678c"
      unitRef="usd">494121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief270666f60b4f22aae84b337ecce732_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtMy0xLTEtMzM3ODI_c51774ac-333c-490e-adee-611b3f99e67a"
      unitRef="usd">51285000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f2d886245e4403b9f0ca6310a5459a7_D20210401-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdhNjk4MDJiM2EwYTRlNGE5MDA5MjM1YzgzODBkMzg0L3NlYzo3YTY5ODAyYjNhMGE0ZTRhOTAwOTIzNWM4MzgwZDM4NF84OC9mcmFnOmRjMGZiYzliMmVlNDQ4NTM4NjljYWZhMWFlZGQ1ZTQ4L3RhYmxlOmUyMzlkYmMzODVkOTQ2ZjQ5Mzk3MzA5NjdiMjgzMzg1L3RhYmxlcmFuZ2U6ZTIzOWRiYzM4NWQ5NDZmNDkzOTczMDk2N2IyODMzODVfMTEtNy0xLTEtMzM3ODI_a3f42094-355c-4b42-9c9d-d013b517e189"
      unitRef="usd">545406000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;V335-JL_G;+[!O9FCDOV@(XHY]_R@@F']"_I!;(O%R.'(+QW68).3>D_O]
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M][4$Y[$_,=\8#]^45_\#4$L#!!0    ( *8T8U5#_&H?= ,  ,L+   8
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M_G@G>1S'ON_?C#Z>Q@;2:H*$I4B8 L&,0.''0.'.0-FG"2I$K@F+/3L\\63
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MQD'0?2*.VU9OYT)+1Z&T]+H)42BCIG-;64^Z93VHP.ZVU?LD3@AGM$@#M9M
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M,8#/5T+HPX7Y@OXYG>7?4$L#!!0    ( *8T8U4CMKV'!Q   .(J   8
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M^>+PY ]P#.P&-8_47_'8AX[)6%3'?[A%'+JS2&""@VVCA@ #"@0=KATE:F)
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MW3_)BN3(?$3:#B2@3Y&4HS[3HQCOL0R,**)KR!]N@\@R]6ZST?:@][JS/9;
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MY'UB?**-K5FEN\0PF0Z3MR[F ^=1$I<R;6!DR)O8CR=6=X^V$#LY2E"4-PG
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ME _>8E?!SE_/LB^-<HH9NAQX..3E0=8:WT3C]#O&Y^*-J7SAQ"]53OE]^P&
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M<\,;\'REX4ISP0JZ;U-W_P%02P,$%     @ IC1C56[17\AS!   T@\  !D
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MZW$O[=%"+'E=F&NY_56T_C@#Y[+0;J5MPQN >5YK(\M6&!:4>=7L_*Z-PYY
MZO] @+4"S-G=*')6_LP-GXR4W)*RW$"SA'/52<.XO+))F1J%KSGDS.0W 9?T
M:&" 96\&\U;NHI%C/Y!+Z+.LS%K3+]5"+![+#V!#9PC;&7+!C@).Q:9/H>\1
M\QD[@A=VCH4.+SSJ&/UU/M-&(?=_/^=C Q$]#V'[X4QO^%R,>RAX+=2MZ$W>
MO0D2_\,1 Z/.P.@8^I'(OT2.;@05ED)G\(*$-MP(XM6"Q/<ZWZ!M#*%EJ09'
M7I&L%:&1%;>MH/OT92UH+LN-K,"H22Y;,'&';L=N10UXS%J)!E;G=U0V*1<V
MY82$&5'.A.JRYOA !+05"E(:, 6Z7I]!G\79+YDG\E/ '_E\<EG!%EEKJ-"G
MC3:GZ8'ZE%>\FN^B,I?:G-%Y*97)_W%>6R>5[='W<OG>AH5K+>#[3Y0DD5TC
MAC7P0I:YG:41758&GFA#$&]PBYS/\B(W.5(0Q92$E,440.3W)KK5:L\ H"3!
MT*YI2*''X@!K./1INH9=!.QRGQN?641I3%%"7[F"ID(\0AMZ?I!0$'A9EA++
M<(J)A5X29?1%&I1!A2F^)P W,B_,0DM$7A3X(,+0&PYC$"SUHF%*YR[[A\GT
M7/XQ]FK5>-O5R'X(#A+])%%_"JYL0FU</G,U7U,8>'NQ:HMYE[O&"Z@/Z>1:
MV'^*97I<>H^A+.^I=<L;)JG+6Y0$V&./(2GX&E'BI<PGYF6HE,P;1JY>$&0O
MCA%,+_8SL/A);*\3\ 7QD#)+L#BT=S:!*4*6^B"R.+;-@Z9;(GTVM;AX]R9E
M ?O0GAHG:EBJY[)&!2W:P&WX?>G:C?E>&@9.*_((^[(,D=":>&D%'D+=22CA
M)E#E@I;OJO($U9IEI]C3P*Y>G/JGK?Z6GVYY48MG$%UM1"%SL4K3H:V(V N#
MS,V&K?N;P7)^BU2M[)399:/!<;5K^_V <^<V*3N1#@KDF;%Q\R)E)_>H)934
MDT;3%/:3)]V/"/?1* >XCTU[!BB(Z.TA%#K\[9&!'W<#/_Z/ _\E<J\#_W7@
MOP[\UX'_.O#_OX$_V'MGE4*MW&M2DU/1/+FZV^[!>MZ\TQ[8F]<N"GJ55QHZ
MEQ#U^T/\ U3S@FP.1F[<JVTF#=Z CESCT2V49<#WI91F=[ *NF?\Y%]02P,$
M%     @ IC1C5;N--[7. @  4@8  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&ULE97;BMLP$(9?97!+:<&LSW:2)H&D![K0I6&7MA>E%XH]CD5DRY64
MS>[;=V0G;A:20&]L2?//IQG),Y[NI=KJ"M' 4RT:/7,J8]J)Y^F\PIKI&]EB
M0Y92JIH9FJJ-IUN%K.B<:N&%OI]Z->.-,Y]V:RLUG\J=$;S!E0*]JVNFGI<H
MY'[F!,YQX9YO*F,7O/FT91M\0/.]72F:>0.EX#4VFLL&%)8S9Q%,EK'5=X(?
M'/?Z9 PVD[646SNY+6:.;P-"@;FQ!$:O1_R 0E@0A?'GP'2&+:WCZ?A(_]SE
M3KFLF<8/4OSDA:EFSLB! DNV$^9>[K_@(9_$\G(I=/>$?:^-(@?RG3:R/CA3
M!#5O^C=[.IS#B</(O^ 0'AS"+NY^HR[*C\RP^53)/2BK)IH==*EVWA0<;^RE
M/!A%5DY^9O[-5*A@D>=JAP5\Y6S-!3<<]=0SA+<B+S^@ECTJO(!*X4XVIM+P
MJ2FP>.GO45A#;.$QMF5X%?B [0U$O@NA'X97>-&0:]3QH@N\%7MF:X$:6%/T
M*3.AX==BK8VBK^/WN91[8GR>:"MFHEN6X\RADM"H'M&9OWD5I/[[*_'&0[SQ
M-?K_W<U5U/E +_*AM["#19Q8<DGUJ W($D@#I114UKS93.#M;4-+<J?I=/4[
MH,LS6*\)<[Q!N&,JKR *#M/CQM0,MFB(07!M-+R&*'+346P'J1O$XT&9RYJ:
MD69=/??BS V#$01C-QEE@VZMY)8V)GG-M6T?&D+7STCG!MD8;ANR(!CV1 FU
M_4<!0>C&24*Z-/,'4*MDB1V!"2B1Y(D;A!G$;I"\4!6[_"2HR,VR!&P2Z96C
M3-TTSNQS'%*JF>^.NYPS@@<1G/M^O),ZKU%MNFYF[V37F+[DA]6A82[Z/O%/
MWG=;NHL-IW,16)*K?Y,E#JB^@_43(]NN:ZREH1[4#2MJ^JBL@.REE.8XL1L,
MOY'Y7U!+ P04    " "F-&-5W'3CT*P$   Q"P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6R=5FUOVS80_BL'->L2P+4E^25N:ANPFPY+D:Q!TFT8
MAGV@I;--E")5DLK+?OWN*%MV$L<;]L7FB;SGGN.]\$;WQGYS*T0/#X72;ARM
MO"_/.AV7K; 0KFU*U+2S,+80GD2[[+C2HLB#4J$Z:1P/.H60.IJ,PK=K.QF9
MRBNI\=J"JXI"V,<9*G,_CI)H\^%&+E>>/W0FHU(L\1;]K^6U):G3H.2R0.VD
MT6!Q,8ZFR=FLQ^?#@=\DWKN=-; G<V.^L7"1CZ.8":'"S#."H+\[_(A*,1#1
M^+[&C!J3K+B[WJ#_%'PG7^;"X4>C?I>Y7XVC800Y+D2E_(VY_QG7_O09+S/*
MA5^XK\^FIQ%DE?.F6"L3@T+J^E\\K.]A1V$8OZ*0KA72P+LV%%B>"R\F(VON
MP?)I0N-%<#5H$SFI.2BWWM*N)#T_N31Z^>XKV@+.<>Y''4^8O-/)UOJS6C]]
M17\ 5T;[E8-/.L?\J7Z'N#2$T@VA67H0\!;+-G3C%J1QFA[ ZS8.=@->]Q4\
M=@O.I<N4<95%^',Z=]Y2,ORUS]D:J[<?BPODS)4BPW%$%>#0WF$T>?LF&<0?
M#C#M-4Q[A]#_0R@.ZN]G]Q04@NA9S%G,#%67\P[, OP*86$45:G4RQ:(YF,N
M/#J0.I<9K?(S.+[0M&$J)W3N6H /&98>2K09:D^5[$Z HNBQF*-M0@E7PF8K
MZ"9KD7X2.J:EL?"+80MS%)9,DR4BB,Z#\-!MG_;C'UI4%'ZUW2C%HY@K!*KJ
M:6FE@@2("GS)O&&3"3-'0=8>";(-7\F)E^:HHCD?MAA,K)NTX0@&<=R*XWAG
ME<;)^W]GVV\G:?\0V\]"5]3Z(.D'PI\K%=;[Z#ZWMZ6[!0E7.6Q#;\VRMV6;
M0@CZ[%V?8B[T?KX<W9FQE*=H?Z1XEW6C](#D %WDY<7LRPV4JG(@B(!=2LU<
MTW;<Q$2L#RV4(:JT&;=#P$@0!*7(F*:L"9T3+*]>P"4,Q^E#&KHJ6I!7M9_A
M=AH?^_W:Q_?]K8_3V27<X)U1=Z3]?SP4+XB5I:(\YWAM&#Z]A^?[;9CJ1ZAT
M*61.8$KH#$&ZC1/GF-5UD-2>]-KP]LTP3=(/S?^SFDQ:&U=IM7;V$IT[(R.B
M,-;+OS'?E"_7[G$R: T&Z0DMAJUNCQ9/$5N@Z7$_8K@N'>@.Z_4I:?6',/5[
MBI6"B[ 2.6C3^$0ONO.4M7S%1H>;?1&#5DAKNM1PY7PR$]21I'_D0!\EO??M
MA%XQI2@*='&AQ>RS+I9+BTL.RJ(*:4\5JC-9"L751#,!N6WQ>R4M787DMSTS
M-@\T0U8R.?:_Z6%[*J*U)X68/1^G9D<VR+"#I:$-S:[PAJM+LM(.LXJ-ZU"<
M'&QN'G#,AZ(7S28Z:: /(J3#!N%9_3,"W0-UY;I'NV=M^ 3^H/3G5YBI;GOM
MM#"5]@S=A6.+/*;Q 2<?H*@?;GRNPF=/*$<V^<E9NROT=X7!KG#:"-3#:$1<
M>$[\)I^/=M;[WLO.SAA3H%V&8<U1EI,']433?&WFP6D]!FV/U\/D5:A-!PH7
MI!K3*Q*!K0>T6O"F#$/1W'@:L<)R13,M6CY ^PM#M[X6V$ S)4_^ 5!+ P04
M    " "F-&-5VZ4KWS,%  "'#   &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6R55]N.VS80_96!4@1;P/%%OF2O!NQ-@P9(BC1.TH>B#[0TMMA(HD)2
M]KI?WT-2LKU9>XN^K"5RYO#,F8NXMUNEOYF,V=)#D9?F+LJLK:Y[/9-D7 C3
M5167V%DI70B+5[WNF4JS2+U3D??B?G_2*X0LH^FM7_NHI[>JMKDL^:,F4Q>%
MT+LYYVI[%PVB=N&37&?6+?2FMY58\X+ME^JCQEMOCY+*@DLC54F:5W?1;' ]
M'SE[;_!5\M8</9.+9*G4-_?R+KV+^HX0YYQ8AR#PL^%[SG,'!!K?&\QH?Z1S
M/'YNT=_ZV!'+4AB^5_D?,K7977094<HK4>?VD]K^RDT\8X>7J-SXO[0-ML-1
M1$EMK"H:9S H9!E^Q4.CPY'#9?^,0]PXQ)YW.,BS?".LF-YJM27MK('F'GRH
MWAOD9.F2LK :NQ)^=OI62$U?15XS?6!A:LU0W)K;G@6X,^DE#= \ ,5G@";T
M094V,_1+F7+ZV+\'4GMF<<ML'C\+N."J2\-^A^)^'#^#-]Q'.O1XP_^.](TT
M2:Y<L(;^G"V-U2B.OT[%'"!'IR%=PUR;2B1\%Z$C#.L-1].7+P:3_LTSA$=[
MPJ/GT/]/:IX%.DWS##JAUBEA;='/I%:D:DTK68HRD2(G64*KVAMV\)+D=2K+
M-27"9!TT6*)J!Z$Y8;D1RYR/%BNQ<RLDRI24S1BGU%H#B7(IEC*75C) L0,X
MK7<.5Q3!5U255@\2/<C. ,011L6^H6GE MFX0 REB,8J#Z(Y%VX_WY')E+9H
M&EMK:7<N*A@8;N&[]':VF-,L,'7G+BQ8"IT:NE>I7,E$^ ER$<T6]]'/=!FC
M*L_IU\')WVOI2NO S)%:,J:%98TFYM1/$@A1>J[\D&2B7#-56B8N1&$QS.H\
M=4Y!31AC D,]$L9@5N.Y$C+UT6I1FA4$%7LI=TB.1P8@,E<A=7 HE+$DTHTH
M+>:MJ@TTT=\ !LBZ\((CYSIE#=$\J@BC<\EVRURVYI705CI4+QXT<8H0&XL$
M2XRBM#6\4$M7;3[OLJQJ:W[&60TQ!F4-6X,20]#(RD&O3B/82N7X:CBY=KX2
M/='*<3*/'0YZ9KO*E1<((NBC( Q=U.4)/HU0 CMEH'%DU,01;+LT]X?4E6I]
MU(9#R0:B3L(C3IED+722[6B+J!-\,RVGU_2>494TH%?T>ZWL02V??./3+%/4
MDH_@J.,<U? 1:SS,38,5'[".0(PL9"[T\Q =EY M/HKN]_L3C .1\X -4BA;
MH9E*92F!XG!V"0X'WOC.#WR'X/OE:3+0']C%?</G&^59&Z<H"LNWOO$(QR6
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MY 2:''-GL4^&!9YYP%>?^^*H&^.#]I&6R">*QYG?=\%K-]/DOVSDV7P?"J=
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M#6\@^5I3C^P6;.#PJ)[_!U!+ P04    " "F-&-58_UK96 *  "!&P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6S-6=ERV\@5_94NCCR1JB@(*Q=9
M5I7DL6><BLLJR9YY2.6A"33)CK%PT TM^?J<>QL 08F2E>0E#R2V[MMW/?<T
M<'97U=_-6BDK[HN\-.]&:VLWIR<G)EVK0AJOVJ@23Y9574B+RWIU8C:UDAE/
M*O*3T/<G)X74Y>C\C.]=U>=G56-S7:JK6IBF*&3]<*GRZN[=*!AU-Z[U:FWI
MQLGYV4:NU(VRWS97-:Y.>BF9+E1I=%6*6BW?C2Z"T\N8QO. W[6Z,X-S098L
MJNH[77S*WHU\4DCE*K4D0>)PJ]ZK/"=!4.//5N:H7Y(F#L\[Z1_9=MBRD$:]
MK_(_=&;7[T:SD<C44C:YO:[N?E.M/0G)2ZO<\+^X<V/C:"32QMBJ:"=#@T*7
M[BCO6S\,)LS\9R:$[820]78+L9:_2"O/S^KJ3M0T&M+HA$WEV5!.EQ24&UOC
MJ<8\>WZSEK4ZOH1=F7A?%8BUD>2NLQ,+Z33F)&TE73I)X3.2)N)S5=JU$1_*
M3&6[\T^@5:]:V*EV&;XH\$9M/!'Y8Q'Z8?B"O*@W-6)YT2M,O9(/R"PK+NI:
MEBO%YW^_6!A;(TW^L<]X)SO>+YM*Y]1L9*K>C5 ;1M6W:G3^\T_!Q'_[@N9Q
MKWG\DO3_*$C_G23QJ11I599MK=QINQ954PM=:JME+C;-(M>IJ)9+5>MR-19V
MK<1E)>L,]\0ONL;$JC9"9M7&0C8]!BXDXF]5N3K^JNI"?/BST?8!"Z5P-BI1
M7.6R%(<T\N>?9F'HO^4)=)>O@[='8W&WUNE:;.KJ5B.I!$!(K! Q:VC99B-L
M)225@RZ:@FXEGH\JR7,RPI"M/! '6^N4%$-!I=_'[B"@*P::L;B^^0;=2Q@#
M=6JA6-7C!;M)WL%*XY&'_MJ49%80/V__AG15V9BE:9J2/[13R)^\[KK*,X7!
M-5R_U&XPQJ8 5:-('BYEEFE2#KX/O-D>FTA:6A4%W61CR#?:F$;"P:)!#=;;
M*)!3GZQ"3SO7E4VQP 3<;5<PS>*?L(D<O.,KS)(6"S=Y)A;*.8?BC3B4#Z*"
M?S:RMCK5&T1IGQHB:RB#>/A2FY0,#(\+@@ZQ07)5B')=%;!Z&TE(#[WDD1.<
MBR%0W=NV2;1&64JW]GR[[N(!#TKQH&2-N1#Y42WJ!HV(\"7QMD$<4YKKE"(T
M2(EBDU</ROF>!%/UD T<9\L.,SK3LM:LFA%WZ#1TY/F&;*,62J83/$"^X9 -
M9"'=5:V$RO5*+W(US/8]CO3$ERXC(\9(_U55>47%H%>T:(E.#*F_*9G;=0J?
M4G%Z+&I0MR\6+$8."]837UG%]C8R))4%+ )L</=%@HB+9H6V)N).YV9#$<8T
M5SO(ASYTO9B')\6SSWJ)J%HW/QS/PNDX#/PNG]FS\E;J7':NW5LLW9*'J*U-
MK0D 6)SO^_03)7A&*W*3-T8\6H:K@]=J2I*/Z7M"!S]=(#F6C6THW@X8'<X
M>O%D0969*5<).XJYK!\F($\H*^M2A>MJ !ZMU+WY0[%:5CEX&66E9<>T4&N
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MTQU\HSZ]D><;O9H>G'.3"65:C?#]=&&L)D/\>"[EP#A^GM$5R8EI6(;3B*K
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M#=]/$W!=4^\6P3:QD6YMH+8<IQ6]@^C8@,Y+:\-QP1?T+^OJ+U!+ P04
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MNX!Z#8J\^/L\]PB_"/_L"SKI/-BODQOFF6]D0:<C=(0G=TVCLU]_F1U.?W_
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M&0F7/B*D&^SJ\<4=VS,F0KS$X,->SP?P.UZI0G_#!H8O.6?_ E!+ P04
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MUN=%:O8SIJS@A2ESHT.(T#D190=,0?,6A*(7,[HB4H2K]JF2T'YA*<=3KI4
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M\3U-P/.'$-+3!;U@>W)Z_0M02P,$%     @ IC1C5;ER1#>2"@  +QT  !D
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M2^UH&(5E0=,?C0\@_TIKM]WX [K_D_E?4$L#!!0    ( *8T8U5+&99]D@(
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MDQ-M".#]%9%_=<(!W2R>_0502P,$%     @ IC1C56BWH%Y2 P  00<  !D
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MAX*ML0:'L;A2SDTI$KSPJ!0,Z@?T)F_?!$/_PQ&F@Y;IX!CZY)XJ+ZUR!+4
M=S]V<S^'F![%.LQT"YKRH22*:LQ8P_[L"F&A<JK53"Z[(-J/J;!H()-IEI"4
MGL/IE:0-51DA4],%?$RPM%"B3E!:JF?3 ;I"B\4<=7N/<"-TLH(H:);T"$A-
M9DK#KXH]S%%H<DV>B" :"\)"U#N+_9^Z5!IVM=THQ1,G*U!M3TN=Y1  48&O
MB57L,F#F*,C;$T'VX!L%\=(=U34GPQ:#B45!#TY@Z/M=W_=WI- /WO\WV[@7
MA/$QME^$K*@!0A [PE^JW,F'Z.[[V]+=@KBC'/5@T+ <;-F&X$I[]BZF1!+R
M,%^^W9G2E*2H?Z;[+NMV:0$I #K(ZZO9USLH\\J ( )ZF4GF&O;\]DY$H[3(
M%5&E3;_G+HP6@J!R<B8I:US_!,W2"[B X3A]R$)611?2JH[3G4X;8QS7,;Z/
MMS%.9]=PAP\J?R#K_Q.A>$&L+'/*<[ZO#</GY["_WX.I?()*EB)+"2P7,D'(
MS":(2TSJ.@CJ2 8]>/MF% ;AA_:]5Y-!=Q,J24VPUVC,.3D1A=(V^P?33?ER
M[9X&P^YP&'9(&'6C 0G/$;L@Z1=_PG 1*42C6CXCJW@$1[I6W':M^&C7FBZ7
M&I=\A)\KEZ2W= ])5HH<;L43_<>M.=2^CH(>;E]3UY1>-A=J5RV'1<VA;#F4
M#0>:)'Y4F:;#RW@F2)1.W66Y/.9$X1-KN]Z!&NH>2#HN8U:G]D@^R+&!I:(-
MR9G(&Z8NXDH:3"IV+ETY<WIPNX%35O)>M">OTT(?10A'+<)>QV $.@?JXW57
M-WN-NP-_4L'P3YNI;KOSM%"5M P=P:E&'N]8P62/4-3_>=PW8=T.9=4FHSG/
M=Q?Q[F*XNSAK%]3U:+1<6"Z5M@).=N1#B=K?&7\*U$LWY!FJ"XJ@GH3:K^T<
M.:W'IZUZ/83>N&HVD.."3'WZ[WB@Z\&N7EA5NF%JKBR-9DY<T2R,FA5H?Z'H
MU)L%.VBGZ\F_4$L#!!0    ( *8T8U4  ':ZWP(  )<&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;(55;4_;,!#^*Z=L0B!UY+U0:"NU,#0DF! P
M]F':!S>Y-A9)W-E.R_[]SG8:BM1V7^*S?<_CY^[LRW MY*LJ$#6\566M1EZA
M]?+"]U568,74J5AB33MS(2NF:2H7OEI*9+D%5:4?!4'?KQBOO?'0KCW(\5 T
MNN0U/DA0354Q^7>*I5B/O-#;+#SR1:'-@C\>+MD"GU#_6#Y(FOD=2\XKK!47
M-4B<C[Q)>#%-C+]U>.&X5ELVF$AF0KR:R6T^\@(C"$O,M&%@-*SP"LO2$)&,
M/RVGUQUI@-OVAOW&QDZQS)C"*U'^Y+DN1MZY!SG.65/J1['^AFT\J>'+1*GL
M%];.-XT]R!JE1=6"24'%:S>RMS8/6X#S8 \@:@&1U>T.LBJOF6;CH11KD,:;
MV(QA0[5H$L=K4Y0G+6F7$TZ/;QB7\,+*!N$>F6HD4L:U@N-G-BM1G0Q]3:<8
M7S]K&:>.,=K#V(=[4>M"P=<ZQ_PCWB=UG<1H(W$:'21\PN4IQ$$/HB"*#O#%
M7<BQY8O_'_(U5UDI3-0*?DUF2DNZ);]WQ>PHD]V4YN5<J"7+<.31TU H5^B-
MCSZ%_>#R@."D$YP<8A\_N0<#8@Y73)(QJ41CBL3J'/84<%<,!T_9'<-S@9OW
M"C/S@NG&:\9+!9IV,J.&UPM@6X)0:4ZO!7.8&VDK(TT9[810"+RF+#?NDC$-
M5%R-U0QE5V%+<L]D5D <NJ7376X?7>#XMJ831*,(KDY<HHPTEYJM+.W?(9Z0
M3JJYD/!=:%+]&?I!T N"@*RDW^^EUGI?2^/$6E$0#CXBD]8G[H=V[.:#LPTB
M@F>4%4R_I' G6$V8-'6^:=R+!@DD@W8^B'MADCC,9'H'C[@2Y8J2<?3I/ JC
MR[WCKLOG;S6+"N7"MD0%F:F@ZQO=:M=U)Z[9O+N[EDTE6% ]H<0Y08/3L]0#
MZ=J@FVBQM*UG)C0U,FL6].= :1QH?RXH6>W$'-#]B\;_ %!+ P04    " "F
M-&-5?4^U<0@#  "D!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R5
M56U/VS 0_BNG;$*M5)$T?0%!6XG"-I!@0RW;/DS[X":7QL*Q,]LAW7[]SDZ;
MM1)4VI?$%]\]]]QK)K72SR9'M+ IA#33(+>VO A#D^18,'.J2I1TDRE=,$NB
M7H>FU,A2;U2(,(ZB<5@P+H/9Q'][U+.)JJS@$A\UF*HHF/X]1Z'J:= /=A\6
M?)U;]R&<34JVQB7:K^6C)BEL45)>H#1<2="838.K_L5\Z/2]PC>.M=D[@XMD
MI=2S$^[2:1 Y0B@PL0Z!T>L%KU$(!T0T?FTQ@]:E,]P_[] _^M@IEA4S>*W$
M=Y[:?!J<!Y!BQBIA%ZJ^Q6T\(X>7*&'\$^I&=TS*266L*K;&Q*#@LGFSS38/
M>P;GT1L&\=8@]KP;1Y[E#;-L-M&J!NVT"<T=?*C>FLAQZ8JRM)IN.=G9V0UJ
M_L)<9N!.&JLK2K@UT'EB*X&F.PDM.7&J8;(%G#> \1N 8WA0TN8&/L@4TT/[
MD,BU#.,=PWE\%'")Y2D,HA[$41P?P1NT$0\\WN#_(F8RA5M,UURNX<JU"K<<
M#=QPDPAE*HWPXVI%ZM1&/U_+2N-T^+I3-UH7IF0)3@.:'8/Z!8/9R;O^.+H\
M$M*P#6EX#'VVI%%-*X&@,HK)(GFPL& 685FSTO3@,TTWW3VQS6O4CX,_Y0B9
M$C2]+C76]<5VA/D?2I"J-/"=3^U\FL:G;'Q:MNF1O09+."7E7J4&3*YJ>0%/
MN48\Z!>@:ELL5JA]R9=\<^RZ<R<)5E6&BF>Z<*\2YD?==8I[]/=.GVA!P0(3
MM9;$.R7.\(4H:;A6!94D=WN&6N)>&>I^S#+TZP)*I1UD=ZN<'"AS23)"AQJ$
MW+^'DW?G<3^^I--H%!W(_5YT%C7@Q$$P8WC&B46F54'MEE1%)2AWZ=N<*,>*
MBNL=MC7&#2UG@P>N.F>#^)!,I]\;CJ+N:XT6[FV. O7:[T=#85;2-DND_=JN
MX*MF\_Q3;_;W ],T/ 8$9F0:G9Z- M#-3FP$JTJ_AU;*TE;SQYQ^(ZB= MUG
M2MF=X!RT/Z;97U!+ P04    " "F-&-52SL>YQ<#  !*!P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6R555V/TSH0_2NCL.*"5.6K:6A+6VEW =W[
ML+"B"SP@'MQDVOBN$P?;:7?_/6.GS0:4K<1+XH^9,^=X/./%0:I[72 :>"A%
MI9=>84P]#P*=%5@R[<L:*]K92E4R0U.U"W2MD.7.J11!'(9I4#)>>:N%6[M5
MJX5LC. 5WBK035DR]7B%0AZ67N2=%C[S76'L0K!:U&R':S1?ZEM%LZ!#R7F)
ME>:R H7;I7<9S:\2:^\,OG(\Z-X8K)*-E/=V\E^^]$)+" 5FQB(P^NWQ&H6P
M0$3CYQ'3ZT):Q_[XA/[!:2<M&Z;Q6HIO/#?%TIMZD..6-<)\EH=_\:AG8O$R
M*;3[PJ&U';_Q(&NTD>71F1B4O&K_[.%X#CV':?B,0WQTB!WO-I!C^8X9MEHH
M>0!EK0G-#IQ4YTWD>&63LC:*=CGYF=7:R.R^D")'I?^!]S\;;A[AU1W;"-2O
M%X&A$-8PR(YP5RU<_ Q<"C>R,H6&]U6.^>_^ 5'K^,4G?E?Q6< UUCZ,PQ'$
M81R?P1MW>L<.;_PW>C]*@_#]<J.-HEOR8TAVBYH,H]K*F>N:9;CTJ#0TJCUZ
MJY<OHC1\>X9STG%.SJ&OK@73&N06[JCL=*,>P:D8HGD6:)CFIX9JM& *J<;J
M1F4%W7$-F:2ZTP9S&]<4"%LIJ(!YM9O#7:$0?TLT4)H,EAM4+E=K_G!NVZ;2
M?J+>:&T9Z!Z%'&BD&U89,-(QJ)7<<]L,](G3GBDN&PU8UD(^HE5 *>29I:WM
M$0$[,)7K.7QL7'3RTVV@ER^F<12_[?ZSV2B.9I".1VF4P.4>%;4D"LDS^N+I
MA"XZ^]YHDOBS!"Z2U \3N).&"6"E;(AX7\VPJS^AHA;"]J>+V)]UDX'CX)5-
MRO]-U;:S S<%R('<V7/:*58.B(['Z2B=1D^BHV1$:]W\>=F3R)]._A"=SGH+
MS^N.8G_\)+*'$/KAP/I0O02]_E:BVKDN;N\H!6M;7;?:/127;7]\,F]?F1NF
M=IQND, MN8;^FXD'JNW<[<3(VG7+C334>]VPH,<.E36@_:VD9G&<V #=\[GZ
M!5!+ P04    " "F-&-5>CW@FM\"  ![!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6R-5>]OVC 0_5=.6;6!A)J?4,H "=BF55JWJJS;AVD?3'*0
MK(Z=VDYI]]?O[  #B:)^27SVO>=WOOAEN);J7N>(!IY*+O3(RXVI!KZOTQQ+
MIL]EA8)6EE*5S%"H5KZN%++,@4KN1T'0\TM6"&\\=',W:CR4M>&%P!L%NBY+
MIIZGR.5ZY(7>=N*V6.7&3OCC8<56.$=S5]THBOP=2U:4*'0A!2A<CKQ).)@F
M-M\E_"APK??&8"M92'EO@ZMLY 56$'),C65@]'K$&7)NB4C&PX;3VVUI@?OC
M+?LG5SO5LF :9Y+_+#*3C[R^!QDN6<W-K5Q_QDT]7<N72J[=$]9-;G+I05IK
M(\L-F!24A6C>[&ES#GN ?O "(-H (J>[V<BI_, ,&P^57(.RV<1F!ZY4AR9Q
MA;!-F1M%JP7AS'B2IG59<V8P@V\F1P4S65)[<WONCPA?I-;0^LX6''5[Z!O:
MT@+]=$,_;>BC%^A[<"V%R35\%!EFAWB?I.[T1EN]T^@DX1RK<XB##D1!%)W@
MBW?UQXXO?HG/R/0^ESQ#I=_!QX>Z,,_P51J$7Y.%-HJ^FM_'RFY8D^.L]B8-
M=,52''ETEAK5(WKCMV_"7O#^A.9DISDYQ3Z>T\W,:HX@E_":_AW3?WJ'?5;I
M6-,#5FZ_BE12H%W*$B@)EI+3'2_$"I@!:I3!<D'0;;> B0RNF4ISB,-F:@"M
M*T%866M:U.UCJ$.$*T\*%$:_MGR8-2DVIH8*;<?6$+(_=+_(8 R<02ON=?I)
MV+;#*.A$0=*&.Z$PE2M1_"5V00:Y(I,#0E8;4ZHXL77<DCT"]F1?9ZTP)+ M
M]JP5=X-VA\Q+5^CLAS]#W(\@[(07$;SFE _8&YE)]]+)#"\[01RUCWU0_IXA
ME*A6SO9LQVIA&F_8S>Z<==(8RO_TQI;I^%>%T,!Q2=#@_*+K@6JLK@F,K)R]
M+*0ALW+#G/X.J&P"K2\EW:9-8#?8_6_&_P!02P,$%     @ IC1C5;NS<E]5
M P  EP<  !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&ULC551;]LX#/XK
MA'<8-B"(9=G.DBX)T+0[; \;BJ5W]W"X!\6F8Z&VY9/DIOOW1\F.FZ)I<"\F
M98H?/XH4M3PH_6!*1 M/==6855!:VUZ%H<E*K(69JA8;LA1*U\+24N]#TVH4
MN7>JJY S-@MK(9M@O?3_[O1ZJ3I;R0;O-)BNKH7^M<%*'59!%!Q__)3[TKH?
MX7K9BCUNT?[1WFE:A2-*+FMLC%0-:"Q6P75TM4G<?K_A3XD'<Z*#RV2GU(-;
M?,M7 7.$L,+,.@1!XA%OL*H<$-'X=\ ,QI#.\50_HO_N<Z=<=L+@C:K^DKDM
M5\$\@!P+T57VISI\Q2&?U.%EJC+^"X=^;\H#R#IC53TX$X-:-KT43\,YG#C,
MV1L.?'#@GG<?R+.\%5:LEUH=0+O=A.84GZKW)G*R<4796DU627YV_47H1C9[
M W>H85L*C?#A7NPJ-!^7H:4 ;EN8#6";'HR_ 3:#[ZJQI8$O38[Y2_^0B(WL
M^)'=AE\$W&([A9A-@#/.+^#%8[:QQXO_?[9_7^^,U=0<_YS+MX=+SL.Y"W-E
M6I'A*J ;85 _8K!^_RZ:L<\7R"8CV>02^OI&U6UGA6]>5<!&&)F!:'*XE55G
M,8?7V9Q+X6*0\RG<EPB%JNC"$CQ8UPY@T!KZJ6T)ELS92W*[D5P^D,,CN9;(
M&4?N"NY+C?BB1X J;+'>T1Y7YJU\NF3^\*VAX*HS%,A, )\R,C\'@)QNP$??
M*^X3G6@_NAJUL$K##QITLB'Z"+]!&DT8CTE)TDG,4U(B-IOP1:_%$S9G<(N-
MHHOGG4]U.HLA[=>IPOMW<Q[QSW#P4X$2$8\4?X^]V0"-1V,I"W>^R6(R9PFD
M;,)C[@2+8R>B^:PO-8TMP**@.>:.NFL>T3A(PK%:9DZE,9$]D$52C5P15.L*
M8T :TY'9*L"ZK=0O1#,421.:T@:2601INB!),9/T589OE],3GJ5.?%I$3B2+
MF5_%T7-KNNW4R#6UR;9O@LU;9T9'/F6<!)LN& D^C;@7+!U;_K+;?-&[1;U;
M#.=N87@R+*DI]OY),-3076/[N3G^'5^=ZW[8/F_OGZSO0N\E'7.%!;FRZ:<T
M -T_ _W"JM:/WIVR-,B]6M++B=IM('NAE#TN7(#Q+5[_!U!+ P04    " "F
M-&-5LP-VF1,&  #E#P  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R-
M5UEOVS@0_BL#]T ".+1$W6EB(,FVW3X4#>*T?5CL RW1MA!)]))TCOWU.T/)
MBKUQU;Q(/+\Y./,->?:@])U926GAL:X:<SY:6;L^G4Q,OI*U,$RM98,S"Z5K
M8;&KEQ.SUE(4;E-=3;CGQ9-:E,UH>N;&KO7T3&UL53;R6H/9U+703Y>R4@_G
M(W^T';@IERM+ Y/IV5HLY4S:[^MKC;U)CU*4M6Q,J1K0<G$^NO!/+Q-:[Q;\
M*.6#V6D#63)7ZHXZ7XKSD4<*R4KFEA $_N[EE:PJ D(U_NDP1[U(VKC;WJ)_
M<K:C+7-AY)6J?I:%79V/TA$4<B$VE;U1#W_*SIZ(\')5&?>%AW9M&(P@WQBK
MZFXS:E"73?L7CYT?=C:DWB\V\&X#=WJW@IR6?P@KIF=:/8"FU8A&#6>JVXW*
ME0T=RLQJG"UQGYW.5D++DTNTJX K5>-9&^'<=70KYI4TQV<3BV)H\23O("];
M2/X+R!B^JL:N#'QL"EGL[Y^@>KV.?*OC)1\$G,DU@\ ; _<X'\ +>IL#AQ>\
MPN9K\80A9N%":]$LI6O_=3$W5F.\_'W(^!8[/(Q-.71JUB*7YR-,$B/UO1Q-
MW[_Q8^_#@.9AKWDXA#[=.Z&/C]26\*5I<Q/'#ND[B'A8W]N5A(6J,&'+9@F6
M @'66MV7A310/HO#K%P*7= BM<%,MRJ_.YD[O^8[FI["[4I+N1<6@(=J93V7
MVIWLK'P<FC[ZTH!=J8T136&.71S0Q]]I7>.16O$(QAWN2R6P8ZR!'*>7."66
M2%C&HC6X2,);",9A'+L_]S/\)^. !_B/QEZ6H(_=,A(PEXU<E!9MS]6R*?]%
M,(?^0A1B!2E]8\)+DXC0? ZWRHH*%J+4<"^JC02U +6FC0;0/KB9?3=P+XU%
MY&*CW1'@@:RE+E6!&'&(GRQ(\.M[8YZVVF9A %?"K$@OB417P$*KVNV4CU+G
MI7&"W!GUXM["^S<I]_D'4LTC<_UQZ #Y./$2N'VVUR"PJ)RY+3!.X4%M\A8)
M8P=YD'1ULV@#E,9L1)/+UJI=P;U&^QH$D><DIUGD_E[BPT#21'W21(-),VOK
M#5E_@U[594Z>=21@#B7,(-KAA+G8%C420BYW9[A$2B%1&XQH[8:Q5$9P78G&
MN:0=X5X[4AIP@&[+G*KE:0O3:@I'Y5X._'3UA@P93AV7'-^;+IZ$A:]"YRL(
M_&XJC!+FN5AE$8?/G<I^XK$4YUC X4>[]<B/.0N.(> LRP!+XD*6;IR'+,9A
MCT7AGJ #>H2AQS((4A9&6]C#"_T(99%.&7^%@?S7!O).YMM.:F]@F.)H%#$O
MI.36CODQ+3'+'+UAW+948B#D+.RC=.L,SG'4.0-/=-!JU,#+R)D)\\,AJSFF
M<\HBY ORY$#@QWW@QX.!_XDHYL>68KYU.=]YX%#D#\(-E(H]*I,"O2\>L"Y0
M2*.Y)1:+EB0IX OLT#*7'+ Q6WJ[K 06CUF^4GCKZ)1%4B]S6O!5%;+"98)V
MX#1M$$@O=6?3B\1Y3<RX0*,BZOC@7E5(WE5IGRB4TW=P0O_L'082\UW/IUZ_
MOBBI'&(J[E'8MM4OLU+76&3@20IM(,94LPHHXW::-Z6Y.UE0A=3D'$[2<8J3
M/)]YKN.SX-USSHM[J?'*W#G1N?1P/=E2$-*IQWS*<S]D:3(474D?7<DPK3I"
M[P[J@B[7Z+M#434(\PH^[6J&Z$2\GDZ%Z6XQYK2/_M^0:=^X6"[I<H..?0V_
M?MM88Q&*8O4EQ?IC'[WN."@A0MMR$ ]"1OS$DA #IJV(2"UITO%IYN_2K!^P
MY)@0TH#"J]1N+8N.(8I9'/Q?AT.D.N9!1K2:L2C% $Q<6(RC+!@FXR3*<"WN
M\F+ BD!!%(R]V'M5E@VYAI-KO):>D:7CG?J3H1,@"EF8[KH&=?"/B<F1M7]G
M+X%SU#PD D_)WKB],67QH+T<TL 5/X^D1,S=ML8AWHX.)<UDY^E52[Q:T@,3
MKYEJT]CV%=:/]F_8B_;I]KR\?0"C:Y9X)X5*+G"KQQ*\B.CV4=EVK%J[A]Q<
M67P6NN8*W^%2TP*<7RAEMQT2T+_LI_\!4$L#!!0    ( *8T8U4E=2ZNSP(
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M%4)=%+N -[KXGMH"$JO;IDC:(-YM'XH^T-+8)D*)6I**-T4_OJ2DR%:LL'7
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MF>L7"80)T/,;SM5+QQ2]X8U+_@!02P,$%     @ IC1C544;P"@_ @  -P4
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M@4[/N><KC'+ARW9M[,?SB!5;AZ;JP'2#2NIV%<]='0X X[-7 $D'2/X5D':
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M,#?TLH'U 72^,@;WCA^>_JW,?P-02P,$%     @ IC1C58_O-9<:!   3!,
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MNT!^OTX2\7R0)2@W$,__!5!+ P04    " "F-&-5,+&E^24%  "6+0  &0
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M223Y)N#\1(EEMJ7T7B@EHNQPP=F4)VD#_?M,"/5RD@8HMV*/_@=02P,$%
M  @ IC1C5>@<4H:[ @  ,0<  !D   !X;"]W;W)K<VAE971S+W-H965T-3 N
M>&ULA971;ILP%(9?Q6+5U$IM 9,0TB5(;:-VO9A4->UV,>W"@9-@U=C,=I)N
M3[]C2%FVD.0&;.-SOO\W]O%HK?2K*0 L>2N%-&.OL+:Z\GV3%5 R<ZDJD/AE
MKG3)+';UPC>5!I;70:7P:1#$?LFX]-)1/?:HTY%:6L$E/&IBEF7)]*\;$&H]
M]D+O?>")+PKK!OQT5+$%3,&^5(\:>WZ;)><E2,.5)!KF8^\ZO+H9NOGUA*\<
MUF:K39R3F5*OKO.0C[W "0(!F749&+Y6< M"N$0HX^<FI]<B7>!V^SW[7>T=
MO<R8@5LEOO'<%F,O\4@.<[84]DFM/\/&3]_ERY0P]9.L-W,#CV1+8U6Y"48%
M)9?-F[UMUF$K@-(] 7030&O=#:A6.6&6I2.MUD2[V9C--6JK=32*X]+]E*G5
M^)5CG$T?I&5RP6<"R+4Q8,TYD;@5+LC=TBXU#I9*6_Z;U4NHYF1G/CF=@&5<
MF#-R0K@DSX5:&B9S,_(MZG,4/]MHN6FTT#U:IE!=DB@X)S2@E+Q,)^3TY.S?
M-#[::SW2UB.M\T9[\MXKE:^Y$ 1E=1B8<),)99S;[]<S8S7NE!]=ZAM*KYOB
M3L^5J5@&8P^/AP&] B_]^"&,@T\'/$2MA^A0]A27)"*G&MPYXW)!#'\CI9*V
M, 1D#CGYPG16D"BL5R\ZZ]+?$.*:X [K*@U#&@8C?]4AK-<*ZQT3UNN"-5']
M+1BE41)VP_HMK'\,UN^"]7=A0423;EC<PN)CL+@+%N_ PB38YVS0P@;'8(,N
MV& 7%O=Z>_Y9TL*2@[#G K" SRWH+F2RBPP'".UF#EOF\"#S#O>MA0N!-3C'
M.M$>0O:WZG2)&>[L61K$0?*_&'^K KK+!$_#@DM#!,PQ,+@<H!W=%.BF8U55
M%\69LEABZV:!=QIH-P&_SY6R[QU79]M;,OT#4$L#!!0    ( *8T8U5K%;"#
M>0,  %@,   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;*V776_;-A2&
M_PJA%4,++-'W5V8+2&P7*[!B0=UV%\,N:)NVB$JB1M)QMU^_0TI1;8I1@RTW
MMD2]YSU\#BGZ>'9B_(LH"9'H:UTU8NZ44K8WKBNV):FQN&8M:>#)GO$:2[CE
M!U>TG."=#JHK-_"\Q*TQ;9QBIL?N>3%C1UG1AMQS)(YUC?G?=Z1BI[GC.X\#
M'^BAE&K +68M/I UD9_:>PYW[N"RHS5I!&4-XF0_=V[]FU6N]%KPF9*3.+M&
MBF3#V!=U\VXW=SPU(5*1K50.&+X>R()4E3*":?S5>SI#2A5X?OWH_E:S \L&
M"[)@U>]T)\NYDSEH1_;X6,D/[/0+Z7EBY;=EE="?Z-1IX]A!VZ.0K.Z#808U
M;;IO_+6OPUF _U1 T <$9D#T1$#8!X3/S1#U =%S,\1]@$9W.W9=N"66N)AQ
M=D)<J<%-7>CJZVBH%VW4/EE+#D\IQ,GB5P)5%N@*Z0NT8$*BUTLB,:W$&QC^
MM%ZBUZ_>H%>(-NACR8X"-SLQ<R7D5@[NML]SU^4)GL@3HO>LD:5 JV9'=I;X
MY71\,A'O O, 'CR"WP63AFO27J/0^PD%7A!8YK-X?KAOP_E_V5?_.?M%,<)A
M%X3:+YS>!7_<;H3D\.[^:5O@SB*R6ZCS[$:T>$OF#AQ8@O 'XA0__N GWL^V
MZKZDV?(ES58O9':Q#M&P#M&4>W%;,R[I/UB?H6R/N#KFKMC^Z@CO)A:"2.NK
MUYDFVE3],#P421+-W(?S@ELT47"I68XU?ACDEZ*5111DW[)=<,<#=SS)_:Z1
M!*HI$6!7^B"J*-[0BDI*K,2=77PVB2@V@,>2)#1XQY+<<%F-)?Y912Y@DP$V
MF83]K24<5K@Y]*A;.'-MC,DX=>*G!J5-E)F<8U$8Q+Y!:A&%J6='30?4=!)U
M7<)^1K"V]7=8TU%R<WZ+L20P]OAR+,G,]1Q+HL3.F V,V23C9\QAKU;D.X39
M>*%2ST\,2(O*S_/,X!RK@MSS352+*DRB)S9O/M#FD[0?F<05:J"!G<;-QZ=$
M'N;&QEQ85%'D>P;N6 4[,S5QQRHXEM+,P'7/6J6:\(/N405@'!O9_5X.HT,;
M?*N[/V/\SK]9^);Q);3-79?[S;[KN=]C?J"-@,+M(95WG<+2\*Z/[6XD:W6C
MMF$2VCY]64+K3[@2P/,]8_+Q1B48_DP4_P)02P,$%     @ IC1C5?F%VIGO
M P  3Q(  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULO9AA;^,F&,>_
M"O).4ROM:O,X=NPNB;1>==JD.ZUJ[[;7-"$Q.MMXAB2];S_ KLF=(=UR2M\T
M@/T\_S\8?E!F>]Y^$06E$CU592WF02%E<QV&8EG0BH@KWM!:/5GSMB)25=M-
M*)J6DI4)JLH0HB@-*\+J8#$S;7?M8L:WLF0UO6N1V%85:;_>T)+OYP$.GAON
MV::0NB%<S!JRH0]4?F[N6E4+ARPK5M%:,%ZCEJ[GP6_X^B8V >:-OQC=BX,R
MTEUYY/R+KORQF@>1=D1+NI0Z!5$_._J.EJ7.I'S\TR<-!DT=>%A^SO[>=%YU
MYI$(^HZ7?[.5+.9!%J 579-M*>_Y_G?:=RC1^9:\%.8OVG?O)A"@Y59(7O7!
MRD'%ZNZ7//4#<1  O@#H \#X[H2,RULBR6+6\CUJ]=LJFRZ8KIIH98[5^JL\
MR%8]92I.+CY0U26!WB)30!^)W+9,,M5T<4LE8:6X1&\0J]&G@F\%J5=B%DJE
MJZ/#9:]QTVF 1^.!-E<HCGY!$ &@SP^WZ.+-Y;=I0F5[\ Z#=S!Y8T_>/QO:
M$LGJ36?>Z:S+,'%GT%/^6C1D2>>!FM."MCL:+'[^":?1KT?\Q8._^%CVA>IN
MC"[NJ5X<VJ5@3ZCBM2P$HO5*MWPD[;) ,39#$U^Z.M!)I$9"+['=(IZFV2S<
M.8Q-!F.3EXQ-7%I=5'*@E680N;6202MY22MQ:24CK4F2I&ZM=-!*7])*75KI
M2 MP,G5K30>MZ4M:4Y?6=*2%LVGBULH&K>RHUJ>"*N*N)6U=BME8,4T\BOF@
MF!]7Y)*4:*MFJ5CR;2WI"I4&$ WYJI@LG6LM'P]SE,78[01'EE#142\?J!"(
M5-H&XNOO?*B=P:S<VG" *:>J)IV,BD;VWN(XSSWV#@"*_\-0]2;0CI1;.K;I
M-(3''RZ?Q. Q9*F(CV/Q/:M)O:0=%)W"YX BME3$KX#%7N.;P9NDOKEFP8A/
M(R,>HQ%R\'TJRT9\&ASQF(XXB7Q3U>(1G\9'/ 9D[D$QMGS$IP$2CPF9>?88
M; &)?X20>(Q(GZ(%)#X#(?$8D6GDV\W!$A)>A9#@(F3F65-@ 0EG B2, 9ED
MF6??AH-3XW$^&C].O7-P$2P7X16X"&,N)@ ><H#E(IS&11AS,9]./%P$RT4X
MC8LPYJ):/YZS#E@NPFE<!,?!$9+8(V?)"*>1$1QGQ]QWD@/+1O@1-L+_.3Z"
MQ2.< 8_@.$&FF>^(%EL^QJ_"Q]C%Q\2W><46D/&9 -GG/?SG4$U/_/UXA0?7
M _JJ16%DPVJA!-8J+KJ:JAZUW>U%5Y&\,3<&CUQ*7IEB0<F*MOH%]7S-N7RN
MZ$N(X0YI\2]02P,$%     @ IC1C54+$Z3Q9 @  >08  !D   !X;"]W;W)K
M<VAE971S+W-H965T-3,N>&ULM95O:]LP$,:_BO!@=+#%CO*OR1Q#TU)6V%AH
MV/I:L2^QJ"QYDI(TW[XGV3'9<#Q&V1M;DO4\][N3.,<'I9]-#F#)2R&DF0>Y
MM>4L#$V:0\%,3Y4@\<M&Z8)9G.IM:$H-+/.B0H0TBL9AP;@,DMBO+742JYT5
M7,)2$[,K"J:/"Q#J, _ZP6GAD6]SZQ;")"[9%E9@?Y1+C;.P<<EX =)P)8F&
MS3RXZ<\6$[??;_C)X6#.QL1ELE;JV4T>LGD0.2 0D%KGP/"UAUL0PADAQJ_:
M,VA".N'Y^.1^[W/'7-;,P*T23SRS^3RX#D@&&[83]E$=OD"=S\CYI4H8_R2'
M:N]P')!T9ZPJ:C$2%%Q6;_92U^%,0(<7!+064,]=!?*4=\RR)-;J0+3;C6YN
MX%/U:H3CTAW*RFK\RE%GDZ^ *1GRB=QD&7=U8H(\R.JP7=6N[L R+LR'.+08
MSHG"M+9>5-;T@O4*RAX91!\)C2C]71XB98-*&U3J_087_)Y\A2$C; \:+PS>
M"7?KN-P2X;(@%G1!KH[ =#MN93]LMW>W?V9*EL(\P.MM0.\A2-Z_ZX^CSQWP
M@P9^T.6>?"^1V3:LIHVOVV% ?&9D0@HE;6[(E&3L:#K8A@W;L-/YGDLF4^@@
MZ];3FJQ?D1%Z_3>R44,V^K<CS[A)U4Y:@L6$-M+1?SCC<4,[?O,95PY3[^ :
MYCZ)>M&@/XS#?4OD21-Y\L83G+3%I=/1'W'#LT[BFO(WIK=<&C3>H##J3;"^
MNFITU<2JTC>7M;+8JOPPQW\#:+<!OV^4LJ>)ZU?-WR9Y!5!+ P04    " "F
M-&-5OF1$A18#  "A"0  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6RM
MEFMOVC 4AO^*E553*VW-_4('D7K1M$J;ADJ[?9CVP20'L'#BS#;0_OO924@I
M,8A)^P)V<L[KYSV.+\,-XTNQ )#HN:"E&%D+*:LKVQ;9 @HL+ED%I7HS8[S
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MU0%=-Q?J#@5<!ZCW,\;DMJ-/Z>Y6EOX%4$L#!!0    ( *8T8U7F"(X(X00
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MHXI0X+24D2.14WW3OX=D0HUD0G;)=+3?S+&@ I0_K &6@2WF%,\3<G+CJ1:
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MR=+B<JU:G'!MH.XO&9,O [U ?< V_@]02P,$%     @ IC1C50P<-5EK @
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MG"SI&]XFTVNV%1WUB]K"N-8U36'NX<W7H#;@)5^_#,;!]R.6AYWEX3'U!-_
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M(O07$'ZK4O8#_ JV?$'&588 WH$[5%8D2G@V8K!-($$47 2(P32CE]ST?AN
MBP^7X /0 :UOIP6X+U)&/_).?OTUP16%14R7.N-3%@/K43.]FWIZUC/3L\$7
M7+"$@K"(43SB'TS[>Q/^.@]5&R_K*5XWUB1PB\H9L(V/P#(L:V0^F]>[FV-R
MWC=Z^+]'[P3#;A>/+7GV,[Q-!BD52T2N(O#/'_P^^,Q03O\=2W4-<\9AHB)>
MT1)&:*7QDD<1.2!M_?-/IF?\-A9GE;! )2Q4!.MDQ&DSXDS1UU\Q@QF .:X*
MQNMX^^".I:,F>9(DWB>'M6E9<WNI'\[C/#G>6^,\'-)U'=?H#AD.K2S?]%JC
M3F#<-C#N9&!DX3HK9>"6X#V!^5A@)DEO7:<J88%*6*@(UDF'UZ;#4UDY/)49
M40D+5,)"1;!.1N9M1N:3#\B?5?Z B$A)_1(?2T--<,\?3-OS%F:O9 S->D]X
M,+3P38>S>H5@"M01N6A%+B9%7A\0X=M?4)(TXK]<KQ0++L2.A>]CVI[+,?DU
M>WY>O<S9PNVI7PRJ5U_]",>9>7Y/_!2G(]YOQ?O*W@W^R+O!-GI"-D.KOM2A
MA6L8?4XXQ>E(-8W3MM:8%'N'*.-)9NV>=73O.<EX:UU12@N4TD)5M&XVSCXR
M3)7EOJ&IRHM*6J"4%JJB=?-BG?)BO;OH-XB)<KYYV208,?%]R^P7O1$SS_9,
MYYER</I0,2=WW>\L_ U\HM!M7C8)&I->W?>=?@B&9HXW,YX+P>G+P%3W:6 .
MM^ #P2^:!",FKCLH_B-6EF_T7P#ZV1%'CLA>GBU1$ DU]0=KV]N>7UW+4YM>
M_XUYM3%'^@-QWB6/5$[X^K#L"R3[M* @0SL^E#&;\]5)ZO.GNL%P*0]8'C!C
M.)>7"8(Q(L* W]]AS)X:8H#V%'#]'U!+ P04    " "F-&-5.D XEL0$  "+
M'@  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6R]F6]OJS84QK^*Q:JM
ME=KR-Y!T::2V!&ZG6]WJ=MU>3'OA@A/8!9R+G:9WGWXV4!JH@Y+IJ&\2(.?Y
MV=B/CV-[NJ'E-Y80PM%+GA7L4DLX7UWH.HL2DF-V3E>D$+\L:)EC+F[+I<Y6
M)<%Q)<HSW3(,5\]Q6FBS:?7LOIQ-Z9IG:4'N2\36>8[+']<DHYM+S=1>'WQ-
MEPF7#_39=(67Y('PQ]5]*>[TEA*G.2E82@M4DL6E=F5>A*8C!57$'RG9L*UK
M)%_EB=)O\N8VOM0,62.2D8A+!!9?S^2&9)DDB7I\;Z!:6Z84;E^_TH/JY<7+
M/&%&;FCV9QKSY%(;:R@F"[S.^%>Z^42:%QI)7D0S5GVB31-K:"A:,T[S1BQJ
MD*=%_8U?FH;8$@B.6F U JLO<'<([$9@]P7.#H'3")Q]!:-&,-I7X#8"=U^!
MUPB\JK/JUJVZQL<<SZ8EW:!21@N:O*CZMU*+'DD+:<4'7HI?4Z'CLZLH6N?K
M#',2HR\\(26ZH;DP=2+=]DS09\H8.D-[A1W[A.,T8R="\/C@H^.C$W2$T@+]
MGM UPT7,ICH7=98EZU%3O^NZ?M:.^KGHCA8\86A>Q"16Z&^&]:8U -!%8[4M
M9KVVV+4U2'P@JW-D&Z?(,BQ+5:%A^1TNA=S<*?>'Y;^MB\'2Y_M7WE3(@_U+
M5\G#_=_='.@*NS6O7?'L_VG>VR*B.4''TITGZ*_/0HYN.<G9WRHCUF4YZK+D
ME'#!5C@BEYHH@9'RF6BSGW\R7>-7E0D@83XD; X)"R!A(1"L8R6GM9(S1)\]
M)%CXAF8Q*=DOB'Q?I_R'RB0UQ:TH<II_GIFN.1D[PL[/V_VOB!MYGFOVXGQ5
MW-CQ'+L;-U?$.:[I.EXW+E#%F:[5CPL5<?9H;$W&;5RG&4=M,XX&FW%[1-)J
M1$:=$9F)D7B*"O$7BRX0QR^J)AXLX=!Q" GS(6%S2%@ "0N!8!T#N:V!W ],
MZ2ZDE2!A/B1L#@D+(&$A$*QC):^UD@>2TFO*:"L5GMFN,YKT,KHBS)P8MM5+
MZ-Z[Q'IF3>S^_#!7A3F.9?32N2K,\+S>[! JPL2D9)CJ9#YN&W \V( W]4B4
MPXZ7N&#R6JX>XW_$ND0L1[FJ-0>1APXY2)@/"9M#P@)(6 @$ZSAFTCIF\H'9
M>P)I)4B8#PF;0\("2%@(!.M8R33>=B8,D/S=8'H)_/U?<E6<6(@:3B^##U?K
MT-X%I06@M!"*UNW@K:TG<["#'XN21'19I/^*="'7!$N<%DC,,*MFJW.5B5EG
M>[D@OXZ.3=,Y0;B(Q:4],DY.D:C<BE1[FIG:(8/U.#23@-)\4-H<E!: TD(H
M6M=MUIO;K ^<FYK"H"P%2?-!:7-06@!*"Z%H74N];3^:@UM2^\]0]KN9QQY;
M_>GI?9!I>OWEQ7"-#NY;T,U 4%H(1>OV[=M^H#F\(?AEY^Y5A%F"%ID )B1>
M$CG]1!EF+%VD4;U"VK&Q9;[?=#L3<UG?!XHH,<WU?3!8^X-] $D+0&DA%*WV
M@;YU5):3<EF=@C+1S^N"UZ=F[=/VI/6J.E_4W\+K8]H[7"[3@J&,+(34./?$
MT"WKD\_ZAM-5=?#V1#FG>769$"R2A0P0OR\HY:\WLH#V_'GV'U!+ P04
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MY#=V^)TT#@6*+V&9T'_1H;%U+)140K*\ <,;Y+2H?_&/1H@. 'C, *\!>'W
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M:X.5,^I_I 8C;^3VJ&*CE7/A0W4[-P[W]4QW^=-\@Q#NFX0XMW)&TS,ESJU
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M$86\4I0P6 DDJZ+ XO<<*-]-G:%S6+@GFUR9!3<*2[R!-:BOY4KHF=NRI*0
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MTC>N'>:ZZP)A#/3WC'-UF!@';1\7_0%02P,$%     @ IC1C56M?A43_"
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MM !*"QO:=E?..1[O* A:9(RBF4K;>OKL6I7F)ZK?)0O1J2)KZ,$J0M)\*"V
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MMY=_L!RAU@V4%D!I(90606EQ0S/DN#/&,^78NC+4[LJT<ESE6GJJV>MJ!G]
MAE!_!DKSH;0 2@NAM A*BQO:M@RMC6+KT%#[(WW[2(;\84Z[J/39J3FHX0*E
M^5!: *6%4%H$I<4HFJG,UG.AD_<>WD#-&2C-A]("*"V$TB(H+4;13-&VY@Q]
MY5T7+<;Z:7:U*,G+K\7;00>+;_^ECM'X9'AB/M+SH84&4%H(I4506HRBF2N'
MM.Z)9W=/7DW2;YD_67_1O%?3I4A[)0Y5))3F0VD!E!9":1&4%J-HIG!;/\9S
MWSF'>U#?!DKSH;0 2@NAM A*BU$T4[2MN>/9S9VWYW [Z&#QT?T</ASKM:N,
M' XM-(#20B@M@M)B%,U4U=;R7_97:%[-X:_G9^P"7]@5OK!+?&'7^,(N\H5=
MY>NO<&.\UHWQ!N^=GZ$6#93F0VD!E!9":1&4%J-HIFA;'\>S^S@_]#*BG7FP
M#O== ?=D.*2CW5P-=5V@M!!*BZ"T&$4S%=9:,Y[=FNE4V-%F+0JR5&-M7BE.
M+T6K%T6LE-<M/*@;T]#&VU,.!\>#\:[NH#8+E!9":1&4%J-HM>[Z6VLB9US,
MJ_6Q2S(M5KFL%P#>[-VLP7U1K3R]LS]T/T?U2MHMIE[8^RL3\T1I-.7W"ND<
MC]4/1]1K9=<;LEA6*R_?%5(66?5QP=F,"WV ^OZ^*.3SABY@LV+Y^9]02P,$
M%     @ IC1C5=T1_U?6 P  ;PP  !D   !X;"]W;W)K<VAE971S+W-H965T
M-C@N>&ULK9?;;N,V$(9?A5 7Q2[0C<Z2D]H&XL.BN5@@B#?M1=$+6AI;1"11
M)2D[VZ?OD%*TMJ0809N;A"+_&9(?A\/Q],C%D\P %'DN\E+.K$RIZL:V99)!
M0>45KZ#$D1T7!57X*?:VK 30U!@5N>TY3F07E)76?&KZ[L5\RFN5LQ+N!9%U
M45#Q?0$Y/\XLUWKI>&#[3.D.>SZMZ!XVH!ZK>X%?=N<E9064DO&2"-C-K%OW
M9CW1>B/XG<%1GK2)WLF6\R?]<9?.+$<O"')(E/9 \=\!EI#GVA$NX^_6I]5-
MJ0U/VR_>OYB]XUZV5,*2YW^P5&4S:V*1%':TSM4#/_X&[7Y"[2_AN31_R;'5
M.A9):JEXT1KC"@I6-O_I<\OAQ #]C!MXK8'7-PA>,?!; _^M,P2M0?#6&<+6
MP&S=;O9NP*VHHO.IX$<BM!J]Z8:A;ZR1%RMUG&R4P%&&=FJ^R:B SPM$G9(E
M+S#\)#4G^)EL%$^>R,C07=G$IVY_7(&B+)>?T.!QLR(?/WPB'P@KR;>,UY*6
MJ9S:"M>I9[.3=DV+9DW>*VORR5=>JDR2=9E".F*_NFP?7;"WD4\'R7N!M/ N
M.MQ =45\YQ?B.9XWLI[EV\W=L>W\O]G7_WGV,QA^%S&^\>>_(6+NZ7?,&8K<
M"D'+/9CVG[=;J00F@+_&3K[Q'8S[UDGQ1E8T@9F%64^".( U__DG-W)^'</^
MGLY6[^EL_4[.S@XHZ XHN.1]?H_'H^@SD>:@MN:@DM/[FW"I)$EP>(]#=(^O
MB51X9U$$8V?63!>9Z?2[<YC[011-[</I68R(//?Z7+0:BF+?\\]%ZZ$H=*[C
M3G3&).R8A!>9W)G-$8UE"R7LF,)'+N'[DOV#" R3/J Q$LTDX>DF_4D/Q(@F
MZG,8:B9QV,,PU(2N-TXAZBA$%RE\XXKF9$>9( >:UT#XCO!*;UD23-7D8?,H
MR0&D0B9I+5BY)RH#4H%@?"P/+Z+!&J.@AV,HN?;C'HZAQG6\20_:>JB*KP-_
MG$C<$8DO$EE2F>E( *Q64K(3O# [AF<0"9,&D#3/8(MI#$(\6)?38S!4A$XO
MZE=#C1L,$ Q%7NR\<C4F'8+)Y:#X<2<DHJ"YN1(-"AS"%[1.FA#!5(7EEXX*
M,XK10IB4-2T3:.+G%%7'<)399'#'^\R&"C_L:59##49-_QZ-B)S8[3&S3RJH
M C OZM(5<R2O2]4\C5UO5QW?FJ*PU[]P;Y;N2/\*J^FF^/WAOBG%OV(:Q@1,
M<MCA5,Y5C,<KFO*V^5"\,O7;EBNL!DTSPU\$(+0 QW><JY<//4'W&V/^+U!+
M P04    " "F-&-5_#!^E04$  "G$   &0   'AL+W=O<FMS:&5E=',O<VAE
M970V.2YX;6RU6%MSVC@4_BL:[\Y..A-\OT 6F EDV^U#9S-ADCXKM@!-;(F5
M!+3_?B79&(-EE[3L2[#L<XZ^[UQT=#+>4_;&UP@)\*W("9]8:R$V=X[#TS4J
M(+?I!A'Y94E9 85<LI7#-PS!3"L5N>.[;NP4$!-K.M;O'MET3+<BQP0],L"W
M10'9]QG*Z7YB>=;AQ1->K85ZX4S'&[A""R2>-X],KIS:2H8+1#BF!#"TG%CW
MWMW<2Y2"EGC!:,\;ST!1>:7T32T^9Q/+58A0CE*A3$#YLT-SE.?*DL3Q;V74
MJO=4BLWG@_6/FKPD\PHYFM/\*\[$>F(-+9"A)=SFXHGN_T85H4C92VG.]5^P
MKV1="Z1;+FA1*4L$!2;E+_Q6.:*A(.V8%?Q*P3]7"#L4@DHAT$1+9)K6 Q1P
M.F9T#YB2EM;4@_:-UI9L,%%A7 @FOV*I)Z:+-61H,)..R,"<%C([.-3^'8 G
MQ 7#J9!?%H*F;^"98,'!O7(\%M_!S0,2$.?\0[?LS=/B67__'3B JZWXV!$2
MMMK<22N(LQ*BWP$Q!E\H$6L._B(9RD[U'4FWYNP?.,_\7H,+M+%!X-X"W_5]
M Y[YY>I>#YR@#D&@[05](3#ZI=0+S7JJP._X!J9H8LD*YHCMD#7]XS<O=O\T
MD;J2L1.*84TQ[+,^_6<KN( DPV1U"U[1"A,B'P%=@@UBF&;@!I,J/SZ8'%%:
MC[1U=3#MIF'HCEQW[.R:% UB4>(VQ$[ 1S7XJ!?\)P:)2NP?8(Q:FWOAL(W1
M():XPRZ,<8TQ[L7XF:0,R=-5P%RY5!_O)$4]-1>W?>6'+;2]N_YDTB0UIZ27
MTXL\4W[L]J3%8^#[!B8&.2_V@R['#VN0PUZ0LI<L$;X 9Z^9]];RT$ ZC+NX
MC&HNH\NK%)'L\OH<M9/)'0U;,3"(G9;Q"6S//?8P]X),>2?FRN9));K#J 7:
M)!=U)X[7Z+Q>[[G_55\Q9.;<[Q"35R:@#YJ!;.,(?(28@1>8;Y$1NG?-9+J6
MM5,W^$<W^+_4&V[!OG+4 %:.6FE'9<I12^6HG7*4CO?SXD&IE7$WA[U$DS3"
M&0SM,#J/ND$LL"._(^C'7N_U]ME#,[DVJ7)3+VC C2+;#<]9&>3"R ZZ:!W[
MN]??X \5>%U681MMX-MN*U9FN=&H@]6Q\7O]G;\^W*]-K'?;=]=O9*#OVE'8
M0?]XI_#Z+Q7=_>#:_H@-:9G87BM]#7*GQ7O*]'C3\"ZY:OS/))/VB1(WHU1Q
M-(@%]NB\0IW&R%<@MM*3, <IW1)13D+UVWK:OM<SYMG[F9K"]2AY-%..\%\@
MDX<Q!SE:2I.NG<@\8^547"X$W>C!\I4*.:;JQS6"&6)*0'Y?4BH."[5!_;^)
MZ7]02P,$%     @ IC1C5610:C:P P  $0\  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S N>&ULQ5=MC]HX$/XK5NYTVDJ%Q('E90^0@.W=5>JJJT7M?3C=
M!T,&L#:)<[:!Y=_?V,F&)!M26B'U"\3VS.-YGG@FGM%!R&>U!=#D)0IC-7:V
M6B=WKJM66XB8:HL$8EQ9"QDQC4.Y<54B@076*0I=W_-Z;L1X[$Q&=NY13D9B
MIT,>PZ,D:A=%3!YG$(K#V*'.Z\03WVRUF7 GHX1M8 'Z2_(H<>3F* &/(%9<
MQ$3">NQ,Z=V<WAH':_&5PT$5GHFALA3BV0P^!F/',Q%!""MM(!C^[6$.86B0
M,([_,E GW],X%I]?T?^PY)',DBF8B_!O'NCMV!DX)( UVX7Z21S^@HR0#7 E
M0F5_R2&S]1RRVBDMHLP9(XAXG/ZSETR(@@/BU#OXF8-?=>B><>AD#AU+-(W,
MTKIGFDU&4AR(--:(9AZL-M8;V?#8O,:%EKC*T4]/%ELFH35#(0(R%Q&>#L6L
MOBVRT&+U3#XG=OB5A;MT8:KPE=M)16[N03,>JG<5<X7C+XM[<O/KNY&K,4RS
MF;O*0IJE(?EG0NJ1!Q'KK2(?X@""LK^+]'*._BO'F=\(N("D33K>>^)[OE\3
MS_QR=]H03B>7O&/Q.HV2+]]*/I62Q1O )-%D>21%NT=VM-/3 Y,!^><30I*/
M&B+U;YV^Z?[=^OU-8;A3"5O!V,',5R#WX$Q^^X7VO-_KQ+D26$FJ;BY5MPE]
M\N$EP71'_@'?\P#B0-7133%Z%L.4K?W$&[G[(H<FBU)@MWE@MXV!_8EO"N-Z
M3PZV3D#08GN06/?(QJRT J:!K!F79(^) ^2&QS8A$L 2:MYK;5ZD>_8+8?I>
MFU:XO#6BW?:@7\^GE_/I-?)YX#&/=E%=4(V.WWN8K@16XMC/.?9_<M[UKRG5
ME<!*4@URJ0:7Y=U>A*A1R/6QCF\*,BRF5;OC#2H'MM:*TOH#.\PC'%X6H089
M$<RN(S!96QV:<7IG'><_X%BB0KW3-]AKQ'KBZKFUE@!$8MVH_6)Z-2)Z?E7J
MS(S2LMT9K6GADD";RP-[.5<>FCV_]]!?"ZW,TS_Q]']RB<@"N)9<5T(KRW6Z
MR-#&C_^E92)#J=:)8?7PUIK1X9G#>[I#T LO$=\L%=\ ZI^O%3_B6:9SNGG0
MYJO'!<7BMK98O-&[UHQV*GJ[A>8B KFQ/9<B*[&+=7H'SV?SOFYJNYG*_,ST
M>[9I.<&DS>(#DQN.34,(:X3TVGV,3*;]5SK0(K$MS%)H;(CLXQ9[5I#& -?7
M0NC7@=D@[X(G_P-02P,$%     @ IC1C55!GR?CX!   "1<  !D   !X;"]W
M;W)K<VAE971S+W-H965T-S$N>&ULM5C;;N,V$/T5PET4NT BB=0]M0W$R6[;
MA\4&ZZ;[S$BT340279*V$Z ?7U*2)=NZQ-K&+Q8ESPS/.;S,D.,=X\]B18@$
M+VF2B<EH)>7ZQC1%M"(I%@9;DTS]LV \Q5*]\J4IUIS@.'=*$Q-9EF>FF&:C
MZ3C_]L"G8[:1"<W( P=BDZ:8O\Y(PG:3$1SM/WRGRY74'\SI>(V79$[DX_J!
MJS>SBA+3E&2"L@QPLIB,;N'-';*U0V[Q-R4[<= &FLH38\_ZY<]X,K(T(I*0
M2.H06#VVY(XDB8ZD</Q3!AU5?6K'P_8^^I><O"+SA 6Y8\D/&LO59!2,0$P6
M>)/([VSW!RD)N3I>Q!*1_X)=:6N-0+01DJ6ELT*0TJQXXI=2B ,'I\L!E0[H
M7 >[=,B5,PMD.:U[+/%TS-D.<&VMHNE&KDWNK=C03 _C7'+U+U5^<CI?84ZN
M9TJ(&-RQ5,T.@7-]K\%<LN@9?%OGK[=:;BI?P<=[(C%-Q"?P 9A :'<!: 8>
M,RK%E?JHVG^MV$;@+!9C4RJ,NB<S*O',"CRH X\'OK),K@3XG,4D/O8W%;>*
M(-H3G*'>@'.R-H!M70%D(00>Y_?@XX<C[,6C!>G=^8'AN8&/*-C5&-EY3W;?
M&+5J6?@Y[7YZ![@1:QR1R4@M<4'XEHRFO_X"/>NW-KKO%.R(HE-1=/JB3[]M
MI)!JQM!L>06>R))FF6H"M@!KPBF+P4<UK0I!/X%_N\=L5G3CYMWH+6P[A="R
M0LL:F]M#LFUVT#FT.^+A5CS<7AZ_<YQ)<CY<MPDC]+T&VJ89LAW4!=:KP'J]
M8#^_$!Y1,0"NU\!Q;8>P ;?%+#AB=037K^#ZO7#5MKT@=(BZO?&&+@^_20K:
M?A>IH"(5O#$&:\H'4.J--I12T#).;A>CL&(4GK^421;_Q"(.FZL"N:'3F&=M
M=G9H=S& 5IT4K7-6!GY*R,]R*'LX!!?85M#@T&+GNV'GO(('B1WV9HT?>06C
MIM;MEG!5D8']<@</G$:D%3-\S]GU7M&.^:.:/_I?*>4*[$J%KG&I$-DKM-8*
MY4.M\[JR+P9:CWB=X%L5+##Y!Z/I6(:'3@>]:6;[1H@ZQKPN%&!ODMZGG\M0
M*[J&]@%HUS&<X)1;BYWC&+[30:XN$6!_C5"EJ\O0<YJP[<"PG%-Z;7:6$<(.
M>G7E /M+ARJ]789>;^>#E[;;(H)O!':'"'5% M\J2?)T>!D)>KL>+('7LAP\
MP^N2H*YR8'^9TYT_+Z.*W[)<D1$TEG6+G1T:;M#!MRZ X%L54%>NO0S?H&V'
M;B[SIIEB:WD=;.OB"(:]6;DX3JN#\FT<4]W$";BG(DJ8V"C$-ZV0>PNNP1/W
MG:(=G\;KT@KUEU:#IC<G^B9*I^V(99+C2&Z47I+PM$VG-WKVP"O!7  ?I,45
M@P=B_-I^\C\O4K"/!%%+J&.!ZKH-]=9%P];#0('Z>W9+6LZ>%G*Z%3HOE%TI
M%+RI4%W9H0&5W8E">+GD9(DE 53I03-!([#%R8;HC:%5DZ(O[_ 0884'VWC)
MMVF&+#?LV.U17;&A_HJM;[2'<[$;(-6IJ4&E:05MRSL]<)@'EXHIX<O\KE6H
M>;;)9'']5GVM[G-O\UO,D^\S>'-7W,K688I+XJ^8J[)<@(0L5$C+\%59P8M[
MU^)%LG5^=?G$I&1IWEP1'!.N#=3_"\;D_D5W4-U^3_\#4$L#!!0    ( *8T
M8U7^!A;/>@(  *H'   9    >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;*V5
M;6_3,!#'OXH5) 02JO/$!B6-M#9%[,6D:>/A!>*%FUP::XX=;+<=WQX_I*&=
MLC+!WC2V<__?^>[2NVPGY)UJ #2Z;QE7LZ#1NIMBK,H&6J(FH@-NWM1"MD2;
MK5QCU4D@E1.U#,=A>(9;0GF09^[L6N:9V&A&.5Q+I#9M2^2O.3"QFP51L#^X
MH>M&VP.<9QU9PRWH+]VU-#L\4"K: E=4<"2AG@47T7296GMG\)7"3AVLD8UD
M)<2=W5Q6LR"T%P(&I;8$8AY;6 !C%F2N\;-G!H-+*SQ<[^D?7>PFEA51L!#L
M&ZUT,PO>!:B"FFR8OA&[3]#'\];R2L&4^T4[;YLD 2HW2HNV%YL;M)3[)[GO
M\W @,)QQ0=P+XH>"]!%!T@N2IWI(>T'Z5 ]O>X$+'?O87>(*HDF>2;%#TEH;
MFEVX[#NUR1?E]CNYU=*\I4:G\TM>BA;09W(/"KTJ0!/*U.L,:\.V%KCL.7//
MB1_A).A*<-THM.055"/ZXK3^[(0>FYB&P.)]8//X)/ 6N@E*PC<H#N-XY#Z+
MI\NCL7#^S_ORG[T?)2,9JIPX7O+7*J."JI()M9& OE^LE);FK_ICK-Z>F(X3
M;?N:JHZ4, M,?U(@MQ#D+U]$9^&'L60_)ZQX3MCRF6!'94F'LJ2GZ/FRKL$U
M2D1]@;0ID"0:QNKA4>\=RG;_;1Y.XB3-\/8PT=XJBH[-'E@5HZSX_-AJ.6J5
MQH.5CQD?-)\6Y-IU?85*L>':?Z'#Z3!8+EP_?7 ^CZ:+:.2\,(/(SXT_>#_%
MKHA<4ZX0@]JX"B?GIC=*/QG\1HO.M;Z5T*:1NF5CABE(:V#>UT+H_<8Z&,9S
M_AM02P,$%     @ IC1C52D+A!<8 P  R@D  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S,N>&ULK59=;]HP%/TK5E9-K32:#TC:,H@$A&E]Z(3*NCU,>S#)
MA5A-[,PVT/[[V4[((*2LVOH"_CCGW'NN'=N#+>./(@60Z"G/J!A:J91%W[9%
MG$*.Q24K@*J9)>,YEJK+5[8H..#$D/+,]APGL'-,J!4.S-B,AP.VEAFA,.-(
MK/,<\^<Q9&P[M%QK-W!/5JG4 W8X*/ *YB ?BAE7/;M624@.5!!&$8?ET!JY
M_6F@\0;PC<!6[+61=K)@[%%W;I.AY>B$((-8:@6L_C8P@2S30BJ-7Y6F58?4
MQ/WV3OV3\:Z\++" "<N^DT2F0^O:0@DL\3J3]VS[&2H_OM:+62;,+]I66,="
M\5I(EE=DE4%.:/F/GZHZ[!&43CO!JPA>D]![@="M"-W71NA5A-YK(_@5P5BW
M2^^F<!&6.!QPMD5<HY6:;ICJ&[:J%Z%ZG\PE5[-$\60XS8N,/0.@>Y"$@]H!
M$LTR3 7JH.E3H983$CVWYA2I==53:"0$2('.(Y"89.)"01_F$3H_NT!GB%#T
M-65K@6DB!K94*>I =ERE,R[3\5Y(IXON&)6I0%.:0-+"CT[S@Q-\6Y6FKH^W
MJ\_8.RDXA^(2=9T/R',\KR6?R>OI;IN=_XL^_>?H!\7HUINE:_2Z+^FEF$-G
MK+[+!,WPL]DL(\XQ794;Y\=H(217W_[/MI4OM7OMVOH\[(L"QS"TU($G@&_
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MG,LKM4*\?#F4'<D*<S4NF%07K6FFZK$%7 /4_)(QN>OH /7S+?P-4$L#!!0
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M'L_81'$_XGJ2 13GAR03/!@O;!?=R\V*1;D6H$7"Y@!38UJ?M !8$/IZ\F(
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M'C'+)=A]0#C(?9@XV'V N(/N@PYU&K77:4^N+%&@7"+,9_HR&H3#(:?ZVA*
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M(3%KA@G3F#"#!'-JI@XU4Q<ZQ&Z\./IE;7ZA4^(9!*"*&4L]?^BJ)!'<8QE
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MS:V2#:IBY'97@9I:46D:E6:P:&[E;&H5E[:[BF[G*27'[>K[]QB0T23U=W\
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MP&[$$<P!>,"0.+;OP;WW4=2\IZ+-_R?'?P!02P,$%     @ IC1C59>*NQS
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M%[(J+IUH_W1KLJ(D;==E+9NJ.H%MW\R%E>7FYQ.;GWY\^ E02P,$%     @
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M2SZ;_VM\_1M02P$"% ,4    " "F-&-5!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *8T8U6@7C\-
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( *8T8U697)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ IC1C552@Q2+?!0  V1X
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M965T-2YX;6Q02P$"% ,4    " "F-&-5*7._\A0(  "S(P  &
M    @(&\+0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
MIC1C52.VO8<'$   XBH  !@              ("!!C8  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( *8T8U58?927"08   (.   8
M          " @4-&  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    " "F-&-5SR$I9XH"  ":!0  &               @(&"3   >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ IC1C5<M80%^<!@  S0X
M !D              ("!0D\  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    " "F-&-5L-?^F- '  "G$@  &0              @($55@
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *8T8U5NT5_(
M<P0  -(/   9              " @1Q>  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ IC1C5;N--[7. @  4@8  !D
M ("!QF(  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "F
M-&-5W'3CT*P$   Q"P  &0              @('+90  >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( *8T8U7;I2O?,P4  (<,   9
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M970Q.2YX;6Q02P$"% ,4    " "F-&-58_UK96 *  "!&P  &0
M    @($U@   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M *8T8U5US9H-$0,  (X'   9              " @<R*  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ IC1C5?8UM>4Y P  90<  !D
M             ("!%(X  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    " "F-&-56O)*NE($  "\"0  &0              @(&$D0  >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( *8T8U56WSCA@ 8
M -41   9              " @0V6  !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ IC1C5?+_<SE$!P  114  !D              ("!
MQ)P  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "F-&-5
MN7)$-Y(*   O'0  &0              @($_I   >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( *8T8U42KX0SZ@(  %L&   9
M      " @0BO  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ IC1C54L9EGV2 @  EP4  !D              ("!*;(  'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "F-&-5:+>@7E(#  !!!P
M&0              @('RM   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( *8T8U6+; ,(900  ) -   9              " @7NX  !X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ IC1C50G9[/UT
M!   &@T  !D              ("!%[T  'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    " "F-&-5B"@7W-,"  !!!@  &0
M@('"P0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( *8T
M8U50OH"WI00  &D+   9              " @<S$  !X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ IC1C50  =KK? @  EP8  !D
M         ("!J,D  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
M    " "F-&-5?4^U<0@#  "D!@  &0              @(&^S   >&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( *8T8U5+.Q[G%P,  $H'
M   9              " @?W/  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
M4$L! A0#%     @ IC1C57H]X)K? @  >P8  !D              ("!2],
M 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "F-&-5N[-R
M7U4#  "7!P  &0              @(%AU@  >&PO=V]R:W-H965T<R]S:&5E
M=#,X+GAM;%!+ 0(4 Q0    ( *8T8U6S W:9$P8  .4/   9
M  " @>W9  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
MIC1C525U+J[/ @  %08  !D              ("!-^   'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    " "F-&-585;0N<L&   V%   &0
M            @($]XP  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( *8T8U53!@]76@0  %<8   9              " @3_J  !X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ IC1C5>%$?'?0 P
M>A(  !D              ("!T.X  'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    " "F-&-5NKFW9Y<"  #O!@  &0              @('7
M\@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( *8T8U5%
M&\ H/P(  #<%   9              " @:7U  !X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ IC1C58_O-9<:!   3!,  !D
M     ("!&_@  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *8T8U5K%;"#>0,  %@,   9              "
M@?P. 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ IC1C
M5?F%VIGO P  3Q(  !D              ("!K!(! 'AL+W=O<FMS:&5E=',O
M<VAE970U,BYX;6Q02P$"% ,4    " "F-&-50L3I/%D"  !Y!@  &0
M        @('2%@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0
M   ( *8T8U6^9$2%%@,  *$)   9              " @6(9 0!X;"]W;W)K
M<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ IC1C5>8(C@CA!   ;!L
M !D              ("!KQP! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q0
M2P$"% ,4    " "F-&-5#!PU66L"  "$!@  &0              @(''(0$
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( *8T8U6B*GW-
MG0(   @'   9              " @6DD 0!X;"]W;W)K<VAE971S+W-H965T
M-3<N>&UL4$L! A0#%     @ IC1C57'VI71T!   &AP  !D
M ("!/2<! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "F
M-&-5 3#D*X "  "8!@  &0              @('H*P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( *8T8U5-JA&%M0,  $41   9
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M970V-"YX;6Q02P$"% ,4    " "F-&-5_00?'"T$  "U$   &0
M    @('H00$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    (
M *8T8U6$#>*GT0(  -,)   9              " @4Q& 0!X;"]W;W)K<VAE
M971S+W-H965T-C8N>&UL4$L! A0#%     @ IC1C56M?A43_"   O5P  !D
M             ("!5$D! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"
M% ,4    " "F-&-5W1'_5]8#  !O#   &0              @(&*4@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( *8T8U7\,'Z5!00
M *<0   9              " @9=6 0!X;"]W;W)K<VAE971S+W-H965T-CDN
M>&UL4$L! A0#%     @ IC1C5610:C:P P  $0\  !D              ("!
MTUH! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " "F-&-5
M4&?)^/@$   )%P  &0              @(&Z7@$ >&PO=V]R:W-H965T<R]S
M:&5E=#<Q+GAM;%!+ 0(4 Q0    ( *8T8U7^!A;/>@(  *H'   9
M      " @>EC 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%
M  @ IC1C52D+A!<8 P  R@D  !D              ("!FF8! 'AL+W=O<FMS
M:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " "F-&-5]RD5&X4#  "W#@
M&0              @('I:0$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+
M 0(4 Q0    ( *8T8U6*TM9!: 0  "H>   9              " @:5M 0!X
M;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ IC1C5>/YX:KA
M!@  @RH  !D              ("!1'(! 'AL+W=O<FMS:&5E=',O<VAE970W
M-BYX;6Q02P$"% ,4    " "F-&-5P&5VSG$+  #N=@  &0
M@(%<>0$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( *8T
M8U4OI!+40P,  *P4   -              "  02% 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ IC1C59>*NQS     $P(   L              ( !<H@!
M %]R96QS+RYR96QS4$L! A0#%     @ IC1C568\=C/.!0  ?C(   \
M         ( !6XD! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *8T8U5Z
M[4YM5@(  (XM   :              "  5:/ 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( *8T8U55J+EG$@(  ',L   3
M      "  >21 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !5 %4 2A<
' ">4 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>296</ContextCount>
  <ElementCount>356</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income and Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation</Role>
      <ShortName>Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Acquisition</Role>
      <ShortName>Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnet</Role>
      <ShortName>Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Other Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</Role>
      <ShortName>Other Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Employee Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</Role>
      <ShortName>Employee Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Concentrations of Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</Role>
      <ShortName>Concentrations of Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Business Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegments</Role>
      <ShortName>Business Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Business and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies</Role>
      <ShortName>Business and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionTables</Role>
      <ShortName>Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Acquisition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Goodwill</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables</Role>
      <ShortName>Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssetsnet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Other Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</Role>
      <ShortName>Other Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebt</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstruments</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquity</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Employee Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</Role>
      <ShortName>Employee Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Business Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</Role>
      <ShortName>Business Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Acquisition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails</Role>
      <ShortName>Acquisition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Inventories - Summary of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails</Role>
      <ShortName>Inventories - Summary of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Inventories - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails</Role>
      <ShortName>Inventories - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Goodwill - Schedule of Changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails</Role>
      <ShortName>Goodwill - Schedule of Changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, net - Activity Affecting Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Intangible Assets, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Intangible Assets, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, net - Future Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Leases - Lease Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases - Lease Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Other Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails</Role>
      <ShortName>Other Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt - Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Derivative Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails</Role>
      <ShortName>Derivative Instruments - Summary of Interest Rate Swaps (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Repurchased Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Accumulated Other Comprehensive Loss - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Earnings Per Share - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Earnings Per Share - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Share-Based Compensation - Stock Based Compensation Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails</Role>
      <ShortName>Share-Based Compensation - Stock Based Compensation Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation - Stock Option Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxes</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Employee Retirement Plans - Expected Return on Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails</Role>
      <ShortName>Employee Retirement Plans - Expected Return on Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Employee Retirement Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails</Role>
      <ShortName>Employee Retirement Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Concentrations of Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails</Role>
      <ShortName>Concentrations of Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Business Segments - Information on Operating and Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails</Role>
      <ShortName>Business Segments - Information on Operating and Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="pbh-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Business Segments - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails</Role>
      <ShortName>Business Segments - Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DerivativeNumberOfInstrumentsHeld -  pbh-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="pbh-20220930.htm">pbh-20220930.htm</File>
    <File>exhibit101-pbhdirector2022.htm</File>
    <File>exhibit3112022-09x30.htm</File>
    <File>exhibit3122022-09x30.htm</File>
    <File>exhibit3212022-09x30.htm</File>
    <File>exhibit3222022-09x30.htm</File>
    <File>pbh-20220930.xsd</File>
    <File>pbh-20220930_cal.xml</File>
    <File>pbh-20220930_def.xml</File>
    <File>pbh-20220930_lab.xml</File>
    <File>pbh-20220930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pbh-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="954">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>97
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pbh-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "contextCount": 296,
   "dts": {
    "calculationLink": {
     "local": [
      "pbh-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pbh-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pbh-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pbh-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pbh-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pbh-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 580,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 6
   },
   "keyCustom": 47,
   "keyStandard": 309,
   "memberCustom": 27,
   "memberStandard": 39,
   "nsprefix": "pbh",
   "nsuri": "http://www.prestigebrandsinc.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.prestigebrandsinc.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Goodwill",
     "role": "http://www.prestigebrandsinc.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Intangible Assets, net",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnet",
     "shortName": "Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Leases",
     "role": "http://www.prestigebrandsinc.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Other Accrued Liabilities",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities",
     "shortName": "Other Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Long-Term Debt",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Fair Value Measurements",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Derivative Instruments",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Earnings Per Share",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Income and Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:CostOfSalesExclusiveOfDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Share-Based Compensation",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Income Taxes",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Employee Retirement Plans",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans",
     "shortName": "Employee Retirement Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Commitments and Contingencies",
     "role": "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Concentrations of Risk",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk",
     "shortName": "Concentrations of Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Business Segments",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegments",
     "shortName": "Business Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Business and Basis of Presentation (Policies)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies",
     "shortName": "Business and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Acquisition (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionTables",
     "shortName": "Acquisition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Inventories (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Goodwill (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Intangible Assets, net (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables",
     "shortName": "Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Leases (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Other Accrued Liabilities (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables",
     "shortName": "Other Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Derivative Instruments (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Employee Retirement Plans (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables",
     "shortName": "Employee Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Business Segments (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables",
     "shortName": "Business Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Acquisition - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
     "shortName": "Acquisition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i192e8e182aea4cce836bb141b1a95cac_D20210701-20210701",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisition - Allocation of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ic95a52a138104e5393a29cb3a5612fa0_I20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Inventories - Summary of Inventories (Details)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails",
     "shortName": "Inventories - Summary of Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Inventories - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails",
     "shortName": "Inventories - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Goodwill - Schedule of Changes (Details)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
     "shortName": "Goodwill - Schedule of Changes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Goodwill - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia313af41482841d0aadf96bac88e4b64_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Intangible Assets, net - Activity Affecting Intangible Assets (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
     "shortName": "Intangible Assets, net - Activity Affecting Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Intangible Assets, net - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
     "shortName": "Intangible Assets, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia313af41482841d0aadf96bac88e4b64_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ifd7dc8e8f3b642559cfd89d9830a9388_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ifd7dc8e8f3b642559cfd89d9830a9388_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Intangible Assets, net - Future Amortization of Intangible Assets (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails",
     "shortName": "Intangible Assets, net - Future Amortization of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Leases - Lease Cost (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Leases - Lease Maturities (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases - Lease Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Leases - Additional Information (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Other Accrued Liabilities (Details)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails",
     "shortName": "Other Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Long-Term Debt - Schedule of Long-term Debt (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia708754131aa4c4cadfdb34847429103_I20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Long-Term Debt - Maturities of Long-term Debt (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
     "shortName": "Long-Term Debt - Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "iffd6d7d6775d456aab43522e8641590d_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "iffd6d7d6775d456aab43522e8641590d_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ife7c577cd8d34acd9e144f85556f13fe_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Derivative Instruments - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
     "shortName": "Derivative Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ife7c577cd8d34acd9e144f85556f13fe_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Derivative Instruments - Summary of Interest Rate Swaps (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails",
     "shortName": "Derivative Instruments - Summary of Interest Rate Swaps (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i39f948f5963c423aa59b916bd733f299_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pbh:VotingRightsNumberOfVotesPerCommonShareOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Stockholders' Equity - Schedule of Repurchased Shares (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails",
     "shortName": "Stockholders' Equity - Schedule of Repurchased Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i810dbd51386f4f1894a85343c5088368_D20220701-20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia7ac391963f848548a601af9567fbba9_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Accumulated Other Comprehensive Loss - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share - Computation of Basis and Diluted Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Earnings Per Share - Antidilutive Securities (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails",
     "shortName": "Earnings Per Share - Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ia1222d2b9b304ddda0b8f5fc40e12cb9_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "if59663672a2242a89e285a8508bacf1c_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "if59663672a2242a89e285a8508bacf1c_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Share-Based Compensation - Stock Based Compensation Information (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails",
     "shortName": "Share-Based Compensation - Stock Based Compensation Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "if3f0f5de01544b1488a49d521bd4e50f_I20220331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Share-Based Compensation - Restricted Stock Units Activity (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
     "shortName": "Share-Based Compensation - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "if3f0f5de01544b1488a49d521bd4e50f_I20220331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Business and Basis of Presentation",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation",
     "shortName": "Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i2063782252c94eed817587f0ac1d141a_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Share-Based Compensation - Stock Option Valuation Assumptions (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
     "shortName": "Share-Based Compensation - Stock Option Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i2063782252c94eed817587f0ac1d141a_D20220401-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i44a33afb528b42678a75f8d868dc2b94_I20220331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Income Taxes (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Employee Retirement Plans - Expected Return on Plan Assets (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails",
     "shortName": "Employee Retirement Plans - Expected Return on Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Employee Retirement Plans - Narrative (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
     "shortName": "Employee Retirement Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i7e78fc711fb14c3494d63203d4920083_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:NumberOfThirdPartyManufacturers",
      "reportCount": 1,
      "unitRef": "manufacturer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Concentrations of Risk (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
     "shortName": "Concentrations of Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ic9ff1becf0f84b77a14626c31518df01_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Business Segments - Information on Operating and Reportable Segments (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
     "shortName": "Business Segments - Information on Operating and Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ie7d803f9c2b74a248885b8ca603a34f7_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Business Segments - Revenue (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
     "shortName": "Business Segments - Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "ibd5a4e1b1ddb48f58b2cba888ead4b2a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Acquisition",
     "role": "http://www.prestigebrandsinc.com/role/Acquisition",
     "shortName": "Acquisition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Inventories",
     "role": "http://www.prestigebrandsinc.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220930.htm",
      "contextRef": "i8b1d7a82bc594f38ad571283f5ae1661_D20220401-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 67,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pbh_A2019SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Senior Notes",
        "label": "2019 Senior Notes [Member]",
        "terseLabel": "2019 Senior Notes"
       }
      }
     },
     "localname": "A2019SeniorNotesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_A2021SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Senior Notes",
        "label": "2021 Senior Notes [Member]",
        "terseLabel": "2021 Senior Notes"
       }
      }
     },
     "localname": "A2021SeniorNotesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AblRevolver2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Revolver 2012 [Member]",
        "label": "ABL Revolver 2012 [Member]",
        "terseLabel": "2012 ABL Revolver"
       }
      }
     },
     "localname": "AblRevolver2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AccruedAndOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued and Other Liabilities, Current",
        "label": "Accrued and Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Total other accrued liabilities"
       }
      }
     },
     "localname": "AccruedAndOtherLiabilitiesCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AccruedProductionCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Production Costs, Current",
        "label": "Accrued Production Costs, Current",
        "terseLabel": "Accrued production costs"
       }
      }
     },
     "localname": "AccruedProductionCostsCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AdditionsToOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions To Operating Lease Right-Of-Use Assets",
        "label": "Additions To Operating Lease Right-Of-Use Assets",
        "terseLabel": "Non-cash operating lease cost"
       }
      }
     },
     "localname": "AdditionsToOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AkornOperatingCompanyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Akorn Operating Company LLC",
        "label": "Akorn Operating Company LLC [Member]",
        "terseLabel": "Akorn Operating Company LLC"
       }
      }
     },
     "localname": "AkornOperatingCompanyLLCMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AnalgesicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analgesics [Member]",
        "label": "Analgesics [Member]",
        "terseLabel": "Analgesics"
       }
      }
     },
     "localname": "AnalgesicsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Amortizable Intangible Assets, Allocated Amount",
        "label": "Business Combination, Amortizable Intangible Assets, Allocated Amount",
        "terseLabel": "Business combination, amortizable intangible assets, allocated amount"
       }
      }
     },
     "localname": "BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Non-Amortizable Intangible Assets, Allocated Amount",
        "label": "Business Combination, Non-Amortizable Intangible Assets, Allocated Amount",
        "terseLabel": "Business combination, non-amortizable intangible assets, allocated amount"
       }
      }
     },
     "localname": "BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves",
        "terseLabel": "Reserves for sales allowances"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "label": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "terseLabel": "Number of new shares for future issuance under 2020 long-term incentive plans"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceNewShares",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "terseLabel": "Number of unissued shares reserved for 2020 long-term incentive plans"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Margin",
        "label": "Contribution Margin",
        "totalLabel": "Contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CostOfSalesExclusiveOfDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.",
        "label": "Cost Of Sales Exclusive Of Depreciation",
        "terseLabel": "Cost of sales excluding depreciation"
       }
      }
     },
     "localname": "CostOfSalesExclusiveOfDepreciation",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CoughAndColdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cough and Cold [Member]",
        "label": "Cough and Cold [Member]",
        "terseLabel": "Cough &amp; Cold"
       }
      }
     },
     "localname": "CoughAndColdMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_DebtInstrumentVariableRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate, Minimum",
        "label": "Debt Instrument, Variable Rate, Minimum",
        "terseLabel": "Debt instrument, variable rate, minimum"
       }
      }
     },
     "localname": "DebtInstrumentVariableRateMinimum",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Settlement, Lump Sum",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Settlement, Lump Sum",
        "terseLabel": "Payment for settlement, lump sum"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForSettlementLumpSum",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Settlement, Purchase Of Annuity Contract",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Settlement, Purchase Of Annuity Contract",
        "terseLabel": "Payment for settlement, purchase of annuity contract"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForSettlementPurchaseOfAnnuityContract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DermatologicalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dermatologicals [Member]",
        "label": "Dermatologicals [Member]",
        "terseLabel": "Dermatologicals"
       }
      }
     },
     "localname": "DermatologicalsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "terseLabel": "Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EyeAndEarCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eye and Ear Care [Member]",
        "label": "Eye and Ear Care [Member]",
        "terseLabel": "Eye &amp; Ear Care"
       }
      }
     },
     "localname": "EyeAndEarCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FinanceLeaseLiabilityToBePaidDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, Due after Year Four",
        "label": "Finance Lease, Liability, to be Paid, Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "negatedLabel": "Accumulated amortization, effects of foreign exchange rates"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedTradenamesandCustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Tradenames and Customer Relationships [Member]",
        "label": "Finite Lived Tradenames and Customer Relationships [Member]",
        "terseLabel": "Finite-Lived Trademarks and Customer Relationships"
       }
      }
     },
     "localname": "FiniteLivedTradenamesandCustomerRelationshipsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization [Roll Forward]"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAccumulatedAmortizationRollForward",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_GastrointestinalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gastrointestinal [Member]",
        "label": "Gastrointestinal [Member]",
        "terseLabel": "Gastrointestinal"
       }
      }
     },
     "localname": "GastrointestinalMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative, and Depreciation and Amortization Expense",
        "label": "General and Administrative, and Depreciation and Amortization Expense",
        "verboseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeAndDepreciationAndAmortizationExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IncreaseDecreaseInOperatingLeasesLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Leases Liabilities",
        "label": "Increase (Decrease) In Operating Leases Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeasesLiabilities",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IndefinitelivedTradenamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Tradenames [Member]",
        "label": "Indefinite-lived Tradenames [Member]",
        "terseLabel": "Indefinite- Lived Trademarks"
       }
      }
     },
     "localname": "IndefinitelivedTradenamesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_IntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Acquired",
        "label": "Intangible Assets, Acquired",
        "terseLabel": "Intangible assets, additions"
       }
      }
     },
     "localname": "IntangibleAssetsAcquired",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IntangibleAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Gross [Abstract]",
        "label": "Intangible Assets, Gross [Abstract]",
        "terseLabel": "Intangible Assets, Gross [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsGrossAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_IntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Roll Forward]",
        "label": "Intangible Assets [Roll Forward]",
        "terseLabel": "Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "IntangibleAssetsRollForward",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "label": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "totalLabel": "Totals, effects of foreign currency exchange rate"
       }
      }
     },
     "localname": "IntangibleAssetsTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_InternationalOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International OTC Healthcare [Member]",
        "label": "International OTC Healthcare [Member]",
        "terseLabel": "International OTC Healthcare"
       }
      }
     },
     "localname": "InternationalOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due after Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LoansPayableTermB5AmendmentNo6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-5 Amendment No. 6",
        "label": "Loans Payable, Term B-5 Amendment No. 6 [Member]",
        "terseLabel": "2012 Term B-5 Loans"
       }
      }
     },
     "localname": "LoansPayableTermB5AmendmentNo6Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Four",
        "label": "Long-Term Debt, Maturity, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LongTermIncentivePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Incentive Plan, 2020",
        "label": "Long-term Incentive Plan, 2020 [Member]",
        "terseLabel": "Long-term Incentive Plan, 2020"
       }
      }
     },
     "localname": "LongTermIncentivePlan2020Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongtermEquityIncentivePlan2005Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Equity Incentive Plan, 2005 [Member]",
        "label": "Long-term Equity Incentive Plan, 2005 [Member]",
        "terseLabel": "Long-term Equity Incentive Plan, 2005"
       }
      }
     },
     "localname": "LongtermEquityIncentivePlan2005Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ManufacturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufactures",
        "label": "Manufactures [Member]",
        "terseLabel": "Manufactures"
       }
      }
     },
     "localname": "ManufacturesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NorthAmericanOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North American OTC Healthcare [Member]",
        "label": "North American OTC Healthcare [Member]",
        "terseLabel": "North American OTC Healthcare"
       }
      }
     },
     "localname": "NorthAmericanOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NumberOfThirdPartyManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers",
        "label": "Number of Third-party Manufacturers",
        "terseLabel": "Number of third-party manufacturers"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturers",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_NumberOfThirdPartyManufacturersWithLongTermContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers with Long-term Contracts",
        "label": "Number of Third-party Manufacturers with Long-term Contracts",
        "terseLabel": "Number of third-party manufacturers with long-term contracts"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturersWithLongTermContracts",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease Liability",
        "label": "Operating And Finance Lease Liability",
        "totalLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiability",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment, Due",
        "label": "Operating And Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDue",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment Due",
        "label": "Operating And Finance Lease, Liability, Payment Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDueAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due after Year Four",
        "label": "Operating And Finance Lease, Liability, Payments, Due after Year Four",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year",
        "label": "Operating And Finance Lease, Liability, Payments, Remainder of Fiscal Year",
        "totalLabel": "2023 (Remaining six months ending March 31, 2023)"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Care [Member]",
        "label": "Oral Care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_OtherOtcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other OTC [Member]",
        "label": "Other OTC [Member]",
        "terseLabel": "Other OTC"
       }
      }
     },
     "localname": "OtherOtcMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)",
        "label": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RestrictedStockUnitsRSUsStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) &amp; Stock Options",
        "label": "Restricted Stock Units (RSUs) &amp; Stock Options [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) &amp; Stock Options"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsStockOptionsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Accrued and Other Liabilities [Table Text Block]",
        "label": "Schedule Of Accrued And Other Liabilities [Table Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Line Items]",
        "label": "Schedule of Intangible Assets [Line Items]",
        "terseLabel": "Schedule of Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsLineItems",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table]",
        "label": "Schedule of Intangible Assets [Table]",
        "terseLabel": "Schedule of Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTable",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Incremental Performance Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Incremental Performance Shares",
        "terseLabel": "Incremental performance shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncrementalPerformanceShares",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "terseLabel": "Vested, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, end of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "terseLabel": "Extension of plan term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "terseLabel": "Total fair value of options and RSUs vested during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SupplyCommitmentTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply Commitment, Term of Agreement",
        "label": "Supply Commitment, Term of Agreement",
        "terseLabel": "Supply commitment, term of agreement"
       }
      }
     },
     "localname": "SupplyCommitmentTermOfAgreement",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_TopFiveBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top Five Brands [Member]",
        "label": "Top Five Brands [Member]",
        "terseLabel": "Top 5 brands"
       }
      }
     },
     "localname": "TopFiveBrandsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_TotalOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.",
        "label": "Total Other Income (Expense)",
        "negatedTotalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "TotalOtherIncomeExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_VotingRightsNumberOfVotesPerCommonShareOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting Rights, Number of Votes Per Common Share Owned",
        "label": "Voting Rights, Number of Votes Per Common Share Owned",
        "terseLabel": "Voting rights, number of votes per common share owned"
       }
      }
     },
     "localname": "VotingRightsNumberOfVotesPerCommonShareOwned",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "pbh_WalgreensMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walgreens",
        "label": "Walgreens [Member]",
        "terseLabel": "Walgreens"
       }
      }
     },
     "localname": "WalgreensMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_WalmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart [Member]",
        "label": "Walmart [Member]",
        "terseLabel": "Walmart"
       }
      }
     },
     "localname": "WalmartMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_WeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Discount Rate",
        "label": "Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "WeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Shares Outstanding [Abstract]",
        "label": "Weighted Average Shares Outstanding [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Women's Health [Member]",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ZaditenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zaditen",
        "label": "Zaditen [Member]",
        "terseLabel": "Zaditen"
       }
      }
     },
     "localname": "ZaditenMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220930",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r107",
      "r159",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179",
      "r183",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r260",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r107",
      "r159",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179",
      "r183",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r260",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r188",
      "r326",
      "r328",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r268",
      "r298",
      "r406",
      "r408",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r616",
      "r619",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r268",
      "r298",
      "r406",
      "r408",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r616",
      "r619",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r188",
      "r326",
      "r328",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r185",
      "r244",
      "r245",
      "r326",
      "r327",
      "r583",
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r185",
      "r244",
      "r245",
      "r326",
      "r327",
      "r583",
      "r615",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r236",
      "r243",
      "r244",
      "r245",
      "r246",
      "r268",
      "r298",
      "r351",
      "r406",
      "r408",
      "r441",
      "r442",
      "r443",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r616",
      "r619",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r236",
      "r243",
      "r244",
      "r245",
      "r246",
      "r268",
      "r298",
      "r351",
      "r406",
      "r408",
      "r441",
      "r442",
      "r443",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r616",
      "r619",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r190",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r35",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r191",
      "r192"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $20,673 and $19,720, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r16",
      "r589",
      "r603"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Accrued marketing costs"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r8",
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Accrued broker commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r50",
      "r56",
      "r64",
      "r65",
      "r66",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Unrecognized net gain on pension plans, net of tax of $(114) and $(350), respectively"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r53",
      "r55",
      "r56",
      "r605",
      "r624",
      "r625"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r64",
      "r65",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r52",
      "r56",
      "r64",
      "r65",
      "r66",
      "r109",
      "r110",
      "r111",
      "r500",
      "r568",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss, net of tax",
        "verboseLabel": "Accumulated Other Comprehensive (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r48",
      "r56",
      "r64",
      "r65",
      "r66",
      "r500",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r21",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r453",
      "r454",
      "r455",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r411",
      "r456",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Pre-tax share-based compensation costs charged against income"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r27",
      "r193",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts receivable, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r95",
      "r281",
      "r288",
      "r289",
      "r550"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt origination costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r95",
      "r218",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Accumulated amortization, additions"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r14",
      "r103",
      "r167",
      "r174",
      "r181",
      "r195",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r497",
      "r501",
      "r539",
      "r570",
      "r572",
      "r587",
      "r602"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r34",
      "r103",
      "r195",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r497",
      "r501",
      "r539",
      "r570",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r405",
      "r407",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r405",
      "r407",
      "r481",
      "r482",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r489",
      "r490",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r486",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Acquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r10",
      "r97"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r90",
      "r97",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r540"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r592",
      "r609"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies \u2014 Note 17"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r247",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 54,690 shares at September 30, 2022 and 54,430 shares at March 31, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r60",
      "r62",
      "r63",
      "r70",
      "r595",
      "r612"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive income, net of tax:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r69",
      "r79",
      "r594",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r188",
      "r536",
      "r537",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r188",
      "r536",
      "r537",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r188",
      "r536",
      "r537",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r148",
      "r149",
      "r188",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r145",
      "r148",
      "r149",
      "r150",
      "r536",
      "r538",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r188",
      "r536",
      "r537",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Services Sold [Abstract]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r72",
      "r232"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Cost of sales depreciation"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r74",
      "r103",
      "r195",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r539"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales",
        "totalLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r146",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r102",
      "r107",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r286",
      "r287",
      "r288",
      "r289",
      "r551",
      "r588",
      "r590",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r283",
      "r590",
      "r601"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total long-term debt (including current portion)",
        "totalLabel": "Total long-term debt (including current portion)",
        "verboseLabel": "Long-term debt outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r102",
      "r107",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r286",
      "r287",
      "r288",
      "r289",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r102",
      "r107",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r286",
      "r287",
      "r288",
      "r289",
      "r313",
      "r316",
      "r317",
      "r318",
      "r548",
      "r549",
      "r551",
      "r552",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r272",
      "r284",
      "r286",
      "r287",
      "r550"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r104",
      "r466",
      "r471",
      "r472",
      "r473"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r344",
      "r352",
      "r354",
      "r398",
      "r400",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r398",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Expected employer contributions, remainder of fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r329",
      "r366",
      "r393",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r329",
      "r333",
      "r365",
      "r392",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r363",
      "r390",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit expense (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r384",
      "r385",
      "r388",
      "r389",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r95",
      "r162"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r47",
      "r507",
      "r509",
      "r512",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r518",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Derivative, number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r414",
      "r415",
      "r447",
      "r448",
      "r450",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r319",
      "r599"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r71",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r122",
      "r124",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r521",
      "r522",
      "r596",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings per Common Share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r71",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r124",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r521",
      "r522",
      "r596",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r540"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effects of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation costs related to nonvested awards, weighted average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit recognized on compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r64",
      "r65",
      "r66",
      "r109",
      "r110",
      "r111",
      "r113",
      "r119",
      "r121",
      "r138",
      "r196",
      "r312",
      "r319",
      "r453",
      "r454",
      "r455",
      "r467",
      "r468",
      "r520",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r568",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r274",
      "r286",
      "r287",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Summary of Carry Amounts and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r524",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r274",
      "r286",
      "r287",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r400",
      "r525",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r274",
      "r286",
      "r287",
      "r524",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r524",
      "r525",
      "r527",
      "r528",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r274",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value, Disclosure Item Amounts [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r274",
      "r286",
      "r287",
      "r352",
      "r354",
      "r359",
      "r400",
      "r525",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r274",
      "r286",
      "r287",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r400",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r555",
      "r557",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r554",
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (Remaining six months ending March 31, 2023)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r556",
      "r561"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r555",
      "r557",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r12",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "periodEndLabel": "Accumulated amortization, ending balance",
        "periodStartLabel": "Accumulated amortization, beginning balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining six months ended March 31, 2023)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r221",
      "r224",
      "r228",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Finite-lived trademarks and customer relationships, effects of foreign currency exchange rate"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r224",
      "r585"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "periodEndLabel": "Finite-lived trademarks and customer relationships, ending balance",
        "periodStartLabel": "Finite-lived trademarks and customer relationships, beginning balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Gross [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r224",
      "r584"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetFutureAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Finite-Lived Intangible Assets [Roll Forward]",
        "terseLabel": "Finite-lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r95",
      "r290",
      "r291"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Areas, Revenues from External Customers [Abstract]",
        "terseLabel": "Geographic Areas, Revenues from External Customers [Abstract]"
       }
      }
     },
     "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r11",
      "r201",
      "r203",
      "r210",
      "r215",
      "r572",
      "r586"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net, ending",
        "periodStartLabel": "Goodwill, net",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r211",
      "r213",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r203",
      "r210",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill, gross, ending",
        "periodStartLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r203",
      "r210",
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment loss, ending",
        "negatedPeriodStartLabel": "Accumulated impairment loss, beginning"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r95",
      "r202",
      "r207",
      "r214",
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "negatedTerseLabel": "Goodwill, transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r73",
      "r103",
      "r167",
      "r173",
      "r177",
      "r180",
      "r183",
      "r195",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r539"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r506",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r95",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r66",
      "r75"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r234",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r463",
      "r464",
      "r465",
      "r469",
      "r474",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r106",
      "r120",
      "r121",
      "r165",
      "r461",
      "r470",
      "r476",
      "r614"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r92",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effects from acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r131",
      "r413"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r220",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "periodEndLabel": "Indefinite-lived trademarks, ending balance",
        "periodStartLabel": "Indefinite-lived trademarks, beginning balance"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Indefinite lived trademarks, effects of foreign currency exchange rate"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r220",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Indefinite-Lived Intangible Assets [Roll Forward]",
        "terseLabel": "Indefinite-lived Intangible Assets [Roll Forward]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "periodEndLabel": "Totals, gross, ending balance",
        "periodStartLabel": "Totals, gross, beginning balance"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r217",
      "r222"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetActivityAffectingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestAndDividendsPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest and Dividends Payable, Current",
        "terseLabel": "Accrued interest payable"
       }
      }
     },
     "localname": "InterestAndDividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r89",
      "r91",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r159",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r28",
      "r199"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r33",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r33",
      "r199"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Packaging and raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r33",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves related to obsolete and slow-moving inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r29",
      "r199"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesSummaryofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r564",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (Remaining six months ending March 31, 2023)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r103",
      "r175",
      "r195",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r498",
      "r501",
      "r502",
      "r539",
      "r570",
      "r571"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r103",
      "r195",
      "r539",
      "r572",
      "r591",
      "r607"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r39",
      "r103",
      "r195",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r498",
      "r501",
      "r502",
      "r539",
      "r570",
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.",
        "label": "Lines of Credit, Fair Value Disclosure",
        "terseLabel": "2012 ABL Revolver"
       }
      }
     },
     "localname": "LinesOfCreditFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loans"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r273",
      "r285",
      "r286",
      "r287",
      "r590",
      "r604"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Long-term debt, net",
        "verboseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate Future Principal Payments"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, senior notes and term loans"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r107",
      "r248",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r107",
      "r248",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r107",
      "r248",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r107",
      "r248",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining six months ending March 31, 2023)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r41",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Advertising and marketing"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r93",
      "r96"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r58",
      "r61",
      "r66",
      "r68",
      "r96",
      "r103",
      "r112",
      "r114",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r128",
      "r167",
      "r173",
      "r177",
      "r180",
      "r183",
      "r195",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r263",
      "r264",
      "r522",
      "r539",
      "r593",
      "r610"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonqualifiedPlanMember": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r385",
      "r386",
      "r387",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Nonqualified Plan [Member]",
        "terseLabel": "Non-qualified Plan"
       }
      }
     },
     "localname": "NonqualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r167",
      "r173",
      "r177",
      "r180",
      "r183"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r558",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r562",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r3",
      "r108",
      "r154",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Business and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r51",
      "r53",
      "r495",
      "r499"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Net loss on termination of pension plan"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r495",
      "r496",
      "r499"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r49",
      "r53",
      "r508",
      "r510",
      "r517"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain Recognized in Other Comprehensive Loss (effective portion)",
        "verboseLabel": "Unrealized gain on interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r53",
      "r57",
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Loss Reclassified from Accumulated Other Comprehensive Loss into Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsSummaryofInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r53",
      "r57",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "negatedTerseLabel": "Settlement loss, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r59",
      "r62",
      "r495",
      "r496",
      "r499"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive loss",
        "verboseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r54",
      "r64",
      "r69",
      "r461",
      "r475",
      "r477",
      "r541",
      "r544",
      "r547",
      "r594",
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other comprehensive loss, cash flow hedge, reclassification tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r76",
      "r95",
      "r232"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r80",
      "r83"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Fair value of shares surrendered as payment of tax withholding"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r81",
      "r492"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Acquisition of Akorn"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r351",
      "r353",
      "r359",
      "r377",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r400",
      "r402",
      "r403",
      "r404",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Retirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from refinancing of Term Loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r85",
      "r102"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under revolving credit agreement"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r84",
      "r452"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r233",
      "r572",
      "r598",
      "r608"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QualifiedPlanMember": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r385",
      "r386",
      "r387",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Qualified Plan [Member]",
        "terseLabel": "Qualified Plan"
       }
      }
     },
     "localname": "QualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r56",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification from accumulated other comprehensive loss into earnings"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r87",
      "r102"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments under revolving credit agreement"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Term loan repayments"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r319",
      "r572",
      "r606",
      "r623",
      "r625"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r109",
      "r110",
      "r111",
      "r113",
      "r119",
      "r121",
      "r196",
      "r453",
      "r454",
      "r455",
      "r467",
      "r468",
      "r520",
      "r620",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r385",
      "r386",
      "r387",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Axis]",
        "terseLabel": "Retirement Plan Tax Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "auth_ref": [
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r385",
      "r386",
      "r387",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Domain]",
        "terseLabel": "Retirement Plan Tax Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r158",
      "r159",
      "r172",
      "r178",
      "r179",
      "r185",
      "r186",
      "r188",
      "r325",
      "r326",
      "r583"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r56",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r481",
      "r482",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of Primary Components of Net Periodic Benefits"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r41",
      "r107",
      "r286",
      "r288",
      "r313",
      "r316",
      "r317",
      "r318",
      "r548",
      "r549",
      "r552",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r507",
      "r512",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Swaps, Net of Tax"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Compensation Expense Information"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenues from Similar Product Groups"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r219",
      "r223",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r219",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Finite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Indefinite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Aggregate Future Principal Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r167",
      "r170",
      "r176",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r167",
      "r170",
      "r176",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Operating and Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r410",
      "r412",
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r418",
      "r433",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Shares"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r100",
      "r139",
      "r140",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r305",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Class of Treasury Stock"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r188",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r215",
      "r238",
      "r239",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r167",
      "r171",
      "r177",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss):"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Share grants in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, end of period, weighted-average grant-date fair value (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per participant, 12 month period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the Plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Options, Additional Disclosures:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, end of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value",
        "terseLabel": "Stock options granted, exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Stock options granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period, weighted-average exercise price (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r415",
      "r416",
      "r417",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r559",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r188",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r215",
      "r235",
      "r238",
      "r239",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenueDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r46",
      "r64",
      "r65",
      "r66",
      "r109",
      "r110",
      "r111",
      "r113",
      "r119",
      "r121",
      "r138",
      "r196",
      "r312",
      "r319",
      "r453",
      "r454",
      "r455",
      "r467",
      "r468",
      "r520",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r568",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r138",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Awards"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r319",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r312",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r46",
      "r312",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r24",
      "r25",
      "r103",
      "r194",
      "r195",
      "r539",
      "r572"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "totalLabel": "Total Stockholders' Equity",
        "verboseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossAccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r297",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r319",
      "r324",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosure [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r45",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r20",
      "r312",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury share repurchases (in shares)",
        "verboseLabel": "Number of shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r45",
      "r320",
      "r323"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 5,164 shares at September 30, 2022 and 4,151 shares at March 31, 2022"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r312",
      "r319",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Treasury share repurchases",
        "terseLabel": "Total amount repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofRepurchasedSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r144",
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r560",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r123",
      "r131"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Denominator for diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r122",
      "r131"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Denominator for basic earnings per share \u2014 weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CondensedConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/EarningsPerShareComputationofBasisandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r631": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r632": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r633": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r634": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r635": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r636": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>98
<FILENAME>0001295947-22-000032-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001295947-22-000032-xbrl.zip
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M;^"(I!IF;#*UAU#95"6Q]TQ*XFGC?[6:^(05X.;%2]'\N(;(<.<ID (+]SN
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M!%>Z]2I?N)):_0T79/U5W=,_ %!+ P04    " "F-&-5#W%0D!4(  !O*P
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M>(ZKTMT!<P=Q,:XT4X_$W&!T%HU/QH-^-)Y.X,G#G9V?S<_[DPBBZ9/'&AS
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M,B1?JD@;IW@P?/$#% ]6 J84VQ!!<^V3TZ6>8Q+.V9A<],*4O<6L7^F ;Y(
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MIK4%%*9DK$SC4BE:(P8I5>2&,RL<A\J[W ]85%<FIPHF9TKCV 5E9$PQVN@
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M@ZE*H'YE^&X6J'G,_"0',5HL000!W";/H^;.^*"L3JX" K4R?(LD4)"02?#
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MN&@.+JYBDBL=G23OUFOEA3<YIU(12?ODJF]'EAF\Z%7RSAK@]+^.RA(\FFA
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M''^UB1=:(^<TQ5FPHA?C^VU/?.$KXWXCTB_U#MWSN%Q6CWA>/T_8KZ=N)17
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MDKJFOK_HC6NSO'*\&NOO.XB5[EG.3GU*3)4\_3+#]4OMXLNEF<1NO/SI:6M
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MNA@]4A)*W GK<])6X$DW$IE;=,YL*^C;<MM4T"\9]//!*92I:#P%BX*!L$F
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MINZXEAM?M@KP=>Z?YZE_-OQY-O%5Z6Z/B)XMJ DL""J),N"\+RU=-8>L'W#
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MW:(G9(O!WY;.4L&_9/#/Z2B&.J%4T& (4R"X"N!49""HE4H$FA!% ;_4.A/
MVH!_&YPD,P7F0O_W)@CI.@K--9N.SY[N(<\RB*-3?XQ?1'0WHNO<3/[G/4[0
MQNP ;:E_%Q;THV&L^\$R]X.PH P*;B*22( Z3T#XI, &R_,K(:65HK0FV-GE
M_;S#]R5MRV9M#T_W[,2JS%J9M;.Z=676E3+KG*8=2-:F'5&@ W<@4.EL9K,
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M4B3CI4]"$>]TDI@51HXD"6]]I;F.T-Q<A0>,.C!&%8B F>9\]&!#$I"XU-D
MIBG*IMZK-**O15L=1.^[EEJK$?KURGIEIZY<ZT*"U]N9FFT"O"LU&DH)%!Q.
MFDC_3>FY<+U9^*__,(RRGVH9_2JE*J75Z;K$J:0<I\$Y)I@SGBG)@Q(\&*NT
MD7\^;G3=K#_!]<I'/HIO3R?3IK+,X>AK[FU)O7TV/$N\;<Z^&\+[^0+?_8I9
M1YX,IO@2QQ\& 9_G9Q_%7S&,W@R;NZQ/P\BU4*'W7RX$S:!4/H5(P%M#FAK$
M^943P+6UR3*')MI2(TVH.SL)*B=4YJY2JE*J4NJ E)9AUU7)KX/D-U)*-]!_
M44=#>+*!>2VR"FR,D=X$IPAW7"1=]=]-UG\77,@$&0O<*D"I/63Y>_"12[!.
M>Z$]I3*$[BG U4-<K]S:*^OBKU=N[95U\=<KM_;*+2B_\J7:8I.>UAOC^]-Q
M.,J6P^TZLE\R >MAT=W.[KY<WIT(TZU2JE*J4JI2:JNHE)2"\L1MC%0DZFQP
MQIK@0^2$*65N[,;Z)F-YEJO\*/SOZ6",L3J9;N!D.GBYD):L"89HA8287 "A
M'0<; X5$B _(*#$R[.RRUN*P*V17!-F;I*$M%["-I_@<KS^/)M,]G!Z-8O4=
MMPCK^0Q<DZ5ET E@GGH0PG,P05A0PAL7,&71EC;NK,_T8NCQC?/2*JBKMG3O
M"8)5\FLE^8V4TDTVW=8/>^NFN^)-=^' UC'G?>0!O*<22D(_."(8"*ZH=<D*
MU*I;NVYUV=<KM_;*NOCKE5M[95W\]<JMO;(N_GKEUEZY!5G,^SCM#89A=')U
M1ZF-C#6O&0%52E5*54I52E5*54I52ELNI56?+JZMY&]P;*68%L%K8Y Y$:)U
M+ACA4D 2I4));GQLE77U9XVJ7KJ)U_.IUFK2';Z8[AW^-IU5+-[[O/_YS:<_
MH^;1&R_!.\E .*? <Z9 2RHM$1&M"3N[DO8)NW-%N@[SPK9CN/6CYXKA)6(X
M?(MA2M$GA@8T\S9C."2P5E(PB:1 E(GH:0<Q7%VN]<JMO;(N_GKEUEZY!9F1
MI7+*&(]P.!E\P-YQ5H)J1N2/M8L:G5JE5*54I52E5*54I;2]4KI)UD1@WEH=
M W/,"1^2LT0K%GF2%FV2X1JNJRM:YQU,CW#\C2+WU:6UC].#=.@^/A^-RP ?
M3:?C@3^=.G^,AZ/G;HS#:?5ZM>?U"M.]63KC!:^73R9Q(R%PY4 (2L%RP4$$
MEZP)6E#I=G9UG]+%]LD;D<^XZK.LM663ROGK(*459\I5SE\'SI\[Z2"&&(E.
M@XI29Z;7"9R+&IQPD2O-D\;4*<ZO;MYZY=9>N05AY?]TQVX8\NW<M/<2WT_Q
MQ..XQTF_5_:=NX2:G_7MFSW<0Y[Y)XY.\T[SI7??W?I^=F[[OUE!*>12)\N-
M16:%Y=$PZ5U2+@1IK%3QK ?F#\,4\DY_,AI>J")U<#J=3-VP3%[=R]O;R]]-
MY_ND:V&)<-)"$++T2><</%H$9#Y%I 1-4CN[4O25)2T%+;0'J7L.6[IG[N@:
M"5^_9W#[\[.>G'J)1=42H5[65+@RY<V8<JZ&B+2Z1'$I2)0S$%(F,$(D(!&1
MN, %NEB84E>:K#19:7*I-&F4<X:@-TE&P:@V,5 6I,[$R'SPX2XT6;7-]CAT
M?T[;=)I'3G0 0S%"UCLY.&T)(!>IG!J1A")S*!-];EGET=M'R5>S]7MF:V0B
M>J*-XXA"<;2$6L9<9$0Q2I.^+GU\4]CMS(8]^[[*(BVRR)PF%DE*T@0)SMG,
M(L9I,)H2X$IQ@RS9Z J+]*D2E4.J+E9UL>6> MZ>3:\X_*M:V7+Y]&!.*TLN
M)46#!V9< B&D!JN(!,\22X1%07CF4VILG]B['.A5,JUD6LGT^V2:T<918H:<
M\<(EZ7DRWBD?B5-*>JQDVC$R70B(BS0F%M! 0EX"XJ0$PU4"1:W,NR07$=G.
M+E=](6TETZ4>D%>"K@3=LN>1!Z9H(E2DB"(XZY@R'*-*(ENE4J;J>>P*+<]7
MV!#)2>\U:,HL9!(V8$O$LHS1>64=D2QF);?/&;F4F:OCH%)II=(VJ52C-BEH
M2I.G(G!A1509?3P*RP@QO%)I5ZAT+OR7!4NM51J\H5G#96C!:AN &(=&J2Q0
MD@J59HVW;P3=&"IM BG_W@2:Y]]Q\&'W'_G'^< OW"M@7N;C,P#N_L./_[[[
MY6FO\['F*[Y,R.RQ\F0<N_<3?'C^XJ=SI7<P;&#8?.BG$S=^,QB>SY)\O_!(
MS??-WO[IKT&<'CVT]H&1O&#W+$CT[(MG[]('#:SGI'3VGGS K+GR;?* 7OW1
M[]Q6/U!&W.JNWW]/<K;58S4/!%5K,E;]@%B[-F.5_'8H6/U8*7V0-]3['>P2
M3?UK34!6]==$6N8!T_):=_U!D/\/O2Y"+EQ[B1H^VZ'N1]_4E^J;AT=CQ-Y>
MONYHTGLRC!@7$P#H-ZK&V4R=C_/\;J*9EUO.GOUJ6-U ">GVS,[B&7J-=GUE
M!@6_V8-_S^DW'OVU$-ZR,9/Y*(^UZ+[NN/?<#2(,AKV?W?O!U!TO?6HW<6V>
M!][4U=G.Z@SA].3TV$TS>S;62I-^.WOY;06MWM]*!N["*<4R9GP967(;+<5?
M<>KR/\9&;$_<>)A'?G6YLXJ-:U+-*)/TY!H:!./7T""ZX=IL;OBP[#Z#\,,I
MF(TU8AB-7=G"'IYF+6M<KMK9_=NS86]Z-#K-7Q?;8X6U6!>S0,\5$N'F3-US
M=[:W-+V0KS&%-YBEK9S0NA9OK_J<C$Z'TWM;@]?7;BZ]Z194<+V8VO^OTR%>
M;M1?-SWB[/FW._O!*Z(5ETD9*RAR(Z0B:*5*1IM(9\E3E*B:M/_=$[B3)Y_V
M\V?RM>SUR0OR^NV+SWM/7XC]S_]ZN\?R]7GLKTY^SV/Z]6C^!.[5X3/VZO-O
M9/_QZY/7CW\]V7^\E\?TAN^=['U^_?CH9)_],GC]Q^]O]Y_^DKZDH;XDG_<^
M!['WYD\G+1<Z!?!,>1 A*?"$.F NED[VGG D3<X^HW<^?+LI8.ZY-M=R@=\U
M;KQ^%,*-'W\]^>Z2Y(26R&Y3$^I7QV*?YUC,6&-5$@$TD10$1P2CE0#AO9?.
M<2?1%Q:[<QYHI;!*8>M,88X8J0*U7*(13#E'9&+>LD2]H,SXNU!8U=):XS<Z
MSV]!>2() XLD:VG"27#:&;#&)VVH9X2RS&^$]Z59S*K:;(ZKMMHU;;5D7=XE
MB9.4,2%XL$(H1H,F6OM$#;DN]K<Y4WUU%,#G*$!%ZX)3&I1(#H2U-*LX:, +
MS,JH+]F5<F=7]*FL=EI5<C9/R;E)XN/MF:XF/MX'U\DYKN,EA8;K!";;VR""
MRNJ.,0Z"9,8H[P2C?&>7<MY7HH6JT)7H*M%UY[EOE.'-O"-((S4R*P$J&4(U
ME99*';60PE6BZQ;1?9POF<L$=U%KA*"% !&)!6-0 ==:262)&V]W=AGI:[W8
MYW=CB6ZE^=N5/#>(/&_ G2)K%"YZP8G3PECG@E11\*QB8(H4576%=8,RY^L^
M!JX5,4D#)N-+:_0 1E&9K6&2/$T"-?,E8Y HU9=\V[QAE>8JS7U;WC:#(FN)
M@2&/@F;"0ZJH"(QX&4-@MM)<1VANKC!EEI#DG"$X&F@I_8-@* F FC@>4>?5
M3 K-9;6_S^Y>*'Q5-%>[)]4KM_;*NOCKE5M[Y1:T#FMT)/!N@N413][C<-*D
MN=RE:=CZG4K?KC?KY=+N1!7!*J4JI>X;>HH:0Z5";KD5^9?WCJ-RUH3(I-"\
M::!+SQOHTA_7PGH4WYY.IB<XG$X.1U^3SDO.^;/A6<9Y$_C1$-[/%_CN5\P&
MXF0PQ9<X_C (^#P_^RC^BF'T9MC<I4G6JO9C6_;C_F A8LRYJ%@,"21%!H)H
MF\U'I4!1Y005W 3J=W9YG]&VRA-63JC,7:54I52EM"$5KZODUTKR&RFE&^B_
MEE-!N"-.:9GU7S1"!Q49B\F$I*.N^N\FZ[\+YR=)&DUIP*SQ!@4"&0&;U5Y0
MREC%1- DA>XIP%N0A/_D(X[#8(*]4<K?/ KO>J/W9=:OKCEQC<2.#6*VR_/L
M-9KHHM=:2B$]ED;.FE@1G8Y)\7AC<FM<E<\FDU.,CT_'>>IF'#5+Y&C>/)A)
MY5Q<L3+231AI,=,^)::MC0R4L!Q$4@$<M0:BHP8E2<Z86$+]6CK)[5!,RF8#
M^7:*9)521^AV!8[4*[BV40(KU;9 M?/.SQ@RLUJ?"=9K 8);#R:1",XY1)^H
M4U0TZ;*5:]<+Q95KJY2JE*J4.N'ZK)+OBN0W4DKWZ?JL&NNRG0,+[DKBDXD4
M@=,LI;PB$AA&7*G(%U@*,>NPOFLJ:PUGK5=N[95;$,Y:-H!2+[?QU#>.X=X8
M9YT=IJ/\<C(=#T+Y:_+=SAG;=3#9 ??]KU\DTUSVZ"\WCOLX/4B_C,8)!]/3
M9H!UP[[VAGWP<L&;[_.>+)6P0*B.()@78*D.(+6V0G$47.J=7:HZ=+98 PYJ
M6$B54I52E5*54I52E5(-5*V2K_C<<&_M]6S!BX&H:? 1(WS&\:C:B#>T$>>=
MNEHPYVQ,V3Z,#(0R$8SC#A0Q(A+OD[3F"\ [9"E6QVZ]<FNOK(N_7KFU5];%
M7Z_<VBNW(/DFJ_Z]P3",3JYNE;N1P30UY*E*J4JI2JE*J4JI2JE*:<NE5$/E
MVW?KT\@M38Q8B4SDNQG.>$R:*\&98,S=V*V?=?5GC:K^[]%D4HM%M%9L^W!O
MNG?XVW36BF7O\_[G-Y_^5$:RF*P!C]:#D"J"IYR"%BR+T#OB0]K9%;+/F>Q0
M!'9E[XX?S54,+Q'#X5L,\^ C*J>!9S"#4)R!=2:"DX3KP(*0@G00P]7E6J_<
MVBOKXJ]7;NV59XO__))SI44TNMG<;<:COWZLHJU?BE&IFC?&(QQ.!A^P=YR5
MI.U*(ZK!?55*54I52E5*54I52E5*-Y/235J%.R$BQ221TB1$<C8B<4$*'JFG
M+(AKN+:NZ!E^,#W"\3>*W%>75Q-J?N@^/A^-RP ?3:?C@3^=.G^,AZ/G;HS#
M:?6*M><5>S7=FZ4I?_6*!<T<XS)"EJ@"X5&"HY%"5$:)I(BCCI<ZR.J2'I+7
M;S#>8>371*/*^1LDI9MP?@O'&97SUX'SYTY"@L_$KK@'8Z3-G,\)F&0B:!M$
MC,B"T=@ISJ]NX'KEAEVY!<'D_W3'I3S4I.>FO9?X?HHG'L<]3OJ]LIO<)<#\
MK WY[.$>\LPJ<72:]X\OK<BOW:=\/3;UFU630J,8#S88A4$8ESQ:[;CEDE,9
MA< _GUTO."'OWR>C89,7/"L<=7 ZG4S=L$Q>W:';VZ'?G.W.%ZH]&JH8]1PL
M15*Z,U(PM*0(:Q=5I,QY'W=VI>BS2W;HVX4JM >I>PY6NF?NZ!H)_^?]+80;
M+( N<>JBG=06H394>C0ZSM,W>?*_IX/II\J4-V7*N1(*7EG#,RT"#=*#2":!
MRW9L)DYC'15:1B,+4[)*DY4F*TTNE2:U99%:Q_)X4"0:G:#%P8"><"D-8W>A
MR:IMML>A^W/:IL3 +6;F3$2;K&/&""8KH! PA2PPH8UWI;:X[G/:5ONQC>'1
M:K:V9;9RG[QC3&GKB2!..42GK31)*F:I%=>EC\,QNLGI^%-#(V<V[-GW519I
MD47F-#'.!=*@! 0?'0B;^<2@D'EAN22]%4*3DB+3IY)6#JFZ6-7%EGNV=WLV
MO>)(KVIER^73@WFM+%"/"AFD$ D(Y278P VPH(W52:(B=F>7\G),9^YP3%?)
MM))I)=/ODRF325D6,N8T%S(;LU%I871T7FL:OF?95C*]'S?A?)B;-51BXA1<
M\!R$X &\L HT-\%3I#(FL;/+1%]<TF%[>\ET&0?DE: K0;?L>8P)J>!.(9=1
MN$0,)S+)B(QS11@QU?/8%5J>JZN!U"'1!$%P7G[HHN2*K.Y23Y7+FZMF(2NY
M?4IIWZBVFAMN##U7*JU4VC*5<JZIXQHS ).PT?C@I=;)1.9$(MY7*NT*E<X%
M]:*TS!#!P!-C,I4B@K.92CTJ)GTJ.R0I5"H4O32P=UVIM,8&URNW]LIF\?^]
MR9W(O^/@P^X_\H_S3UP 4L#,\>.SW6?W'W[\]]TO4&_I8V<[CF /M,R[TOO1
M9%"(Y6'3$W;P 7_Z:Q"G1^<[TH4/GI$'^?H1YS-/G$ZO_LA50VQM7Z7D1QLK
M*V," =_.Q\6?1U]*=[QW;Q#\&-T[<"F/]J$[_LM]FNS\_9N'.AD,86X2YY__
MNX*X^LUKB;A915]ETM!VGL=C]WZ"#\]?_'2^"@?#9C::#_UTXL9O\N#/!%D&
M/D?9S??-WO[Z3 _([+G.R/OLF\_>?M"\-;<-G;TG'S MKGR;/*!7?_0[M]4/
ME+[ZD]^[Z_??D_SJ[[SM6-6#O+6OR5C- R;5FHQ5/R!&K\E8S0,I[)J,E=('
MEMXSN);HR[S6!!!^.\ZZ%\0J<ZV[_D#Y_J%;6<B%:R_Q,\RVJ/LQJ/6E!O7+
MP<?>7K[J:-)[,HP8%_.;V#>6U$U*>5UW[NQ7O]$-;*QNS^LL7*O7. ^N3!#C
M-WOP[YUI7%8V;6,F\U$>:U&GW7'ON1M$& Q[/[OW@ZD[7OK4;N+:/(\KK*NS
MG=49PNG):38-,WLV)DM3,V#V\MNR?W\K50,6SF"7,>'+L-XW6HB_XM3E?XR-
MU)ZX\3"/?-*KV+@KU8PR24^NH4%P>0T-HALG-\T-'Y;=9Q!^. 6SL48,H[%K
M/$*G6<L:EZMV=O_V;-B;'HU.\]?%]FAA+=;%+(Y]A4RX.5/WW)WM+4W;ZVM,
MX0UF:2LGM*[%VZL^)Z/3X?3>UN#UU9M+;[IEE4OVW#@<]3B]Q*J_7?K7=F9W
M!8&*4&&9DD(HP;S6RF*47J68")F%T/Y_]MZTJ8UD:1O^*PKB_C 3H?*I??'<
M001C>^;F/ -XP<>O_<51*PB#Q-%B&W[]F]7=6I# !B- H(J8P:!N=5=55EYU
M959F%L6,D5*4Y <1!M"NO9<[!)Y)/^U_9!_/W[!=^DI\//KK!-IWMO?AX]GN
MA[<GGXY>G<]'&.SM'T [WD/[/QWO'H6CW9<>VGW<V?GP\=O.RVWQZ6B;?/H;
M6K2_FR9I]N_P^<ZYYSL'GQWC,B6JD$Z$($X]058Y@J*RF"4=F8NXJDG"V9*3
M1)]*&-::1UFM41#5LL#NJ18,N3\4.Y]#,:*D( E;1+BK4 SPC#J&B*2!2(\C
MD56]$%X@K$#8.D,8UU@+G[0@2G'LF>46H"MP2Y+FD<;;0%AA:4O#-S+/TI(0
M7&&)G$\!<<4B<H8[I+&RFGAA;"" ;T2TA5YR./W*8URQU:Y;0-);@P7/ZR'F
MF&J=.+?6",I3U)S8Z^K^.E?BN#\(8/,0H(*1(J2JG#/B@DAD@J#(,,L$<<I*
M1^ZD$,?* T A.>M <FZ2V/WK2%<2NQ\"Z\0<UK'HC&&8(*\516!K.^0 _9 U
M@1.34I3&+K](1@&ZE5+X G37..I#)<$#]XD$P#7'=)"$*BJP8%2#65" ;K6
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MXD09I+7UB$7L5%0D8BN!AA>5?EPJ?9-Z/$O8.OI189ZBW/>FW/.[1@#3QIL
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MAY@55G9G>#I?FE1KJ2WG%J7$%>)2"V2C,0ASF7+M62M-W-@DC+4EU[<_NJR
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MM08*I9A%U@>/%+9>"N6<YJRJ<,%N'5)]?RZF)[#]]LA]8E6E&N1LSOK/A3K
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M"=]Y80>'.3TN ^!8Z@4 ;P2 .XL44Z9(*  @4]@B+IU$FE&/I#7P*:52!@P
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M6L1%#B?UP6)B8)KB9U>QF/$T79Q=OBF'?[%^\XUA3L? 0%M8L-SR""#'$TZ
MS!P^)E*0,H4>< KE I\P23@UV"'&@T9<8>#"-DI$O8T1^T"8YQN;YAFY\0R:
MXA. W(=8W=& T^2$L\;D#S]&K<S;;"[@;3.C0YG=Y8+3N63*U[SIUIT<KQQ:
M-0O,3\R5LP]B/DTEC;(7-L4[K$ UM@?_RD6VXS_Y6+>Y6?F^:L<_T(Q+2U'E
M"DMK-P,/R.Z;SPR4'ULK02,9K+64&"!JS"-#<7(16)+0 &*$3M?:20&J^AR*
M:6TW<4EMM\=EIWR(U7D>_5Q [Z!Q$MRTINAMJ>6OI;ZM'WY^^;;S[;,(&JM
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MOK%)=%NQQ7(,JY8I\M-7SJ\*!:B>*%!Q;AFSR0FJ':=2::M$TD%+'3QUAC=
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MK:?"*P%M.=LYWR:[^P=X;PL6'2ZCL 9Y1H"E!^:1PUHBZ:V3WB7-J,H38[$
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M_//Y86GIO_A7V?]\8SJ=QJ@#/..O^#NT?FS\-_R83NG"N_+9?RN=3KAUHVP
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M!M&0*]Y)SY%AC"/-,;6)!BXE7ML@>GV^V-TY2>3=KT!X9@CK=Q?OST4MN'A
M7,2?Q[$+,N+$#N[$^%$%C5DRGCK%+>5::^&TMQ(SRWA2D\A,=5UDIEA&1M-K
M@X#ZX3L!UYS6S[;)SM8[6M_\[F 7"$L4,2)!R>>!(Z<B1R2"P6:X9#B!D!#K
M\S&5YWAP5QGPT"#=BA06(@T\_ZY9]%H(C7SPN=$W5\AIQY$$V>R8=PJTLIR9
MMCY?"OF2-,AJ^;#9!Y4_T\*@];/HP(8W!T7L!E :YT]&:T4_#HZSYODCMD]K
M=R8APP@'X,!6*L%EC)HK+P.E(6F?5%"SJF5%0LM'$]$X^&X),5%:B:RD O'
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MP^J@Y\ZK_,>JF4I?+UC)[WYZN'2SI($*(Q>&D?.)*XX"38M  ",E!XP$A<F
MK82\=M$EYQPS9057=@5$SM7/K]S"KYFYKU1UKF?JBF_OPK=SAHZ3(>136BU]
M0IQY@2P5 F$;.!;"6)Q MR%ZWME1<6W%M;<U5"J1_ BL/6NV6,NT\PK,%DLD
MXM(Q9(/GB"7LA(R&R% &EHDK@D:?A+E?ST'.Q/(H?MCV*,[;)D_83^CJSL'X
MIN;!MW+FK-Q&++8E^=T6:+6EQQ.H?-=8<I5X6%CIQMW-8;V%?Y8BXJS.=K:V
MOSO"N%8V@D P8+)YYI!FR2)OK":&2ZM3+HQD:IP]N'CCPGGH>;3EN&L?]@I*
M*QQ=N.E<H>@B4;3QUV4494Y:;*U%#*SE'!;)D'8I(2=8XC39Y$S9KD/K!U=L
M62SW5 BZ.E!1(>A3(^BMW!@5DBX426?T49:(X-H(I!P!)&74Y_YO&"4A>+":
M!YX 2:FH,;+@8]:G@M+2X?&OH84WPO^A]6-C.J_&J ,LX^?_+B\:3S)WJ#Z?
M</EY^0-NR)S1ZH[*GN=C6I2"*H&]EI)Z3D'K9\Y&PDAD)@"+N,=G<#K)L"O&
M%\106%@K>Q"+_GGCY;%79!C[G<)VP_R54Z=B 6R;']2/A1T C[;;O9/!F^G:
ME.M[3@KC/84)MNWQ(+Z9_O(G/.NX;4_?M+KE,,N;_NS8_D&K.Z4/<3RWG^5^
MC[_^\Z05ALV,7.MXC%X35];DS9.OU\NO9@AT_)U<QY)=^RU>)]=^=]-3%5DG
ME-[KL3=_)]CU+[WO8(E>5UK<ZK&_\1;>HR?[<BY]'IW>O\3C8>RXV"\8+KN:
MT]^W?9<ORS7[[59 ],=IM/W!4EJ^W^49OV_@?.GI#PWWN==0GV'(T+D*.-[R
M^WGB'V?M5E9=G^@J]]?/;_(-3YET<\RCGZ<L6GZY"PQ*+BGI,!7_)HSZIV77
MTN>KEL,]]0][9/]P\[3^X=/I_M:G$_A?[.SN_025F^]U]L1^'MN'?UJS:OG>
M6?UD__"?3GUK&\;R\:BQM0G_'XG&X;N?C;-F:_^P#?=].MG_]C&W(SV;#7ZT
MW.$@"#+42,1S$+2V2B(E:&)*6.&Y6=M@Z[\Z,__277\G0!X)*Y\3 $WLSH?
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MY:ZWWWD ,O:6H6!L E7&"&1%+H1J50@L2<X]GJU\&G4"< U8$NEXT%;GCC5
M4S'!_9&JV<J5>;%17NTB+_=ORYU>42GR]V6=KZR$^MN!+JL2ZI3,?E5#S3/?
M[@Y@03H@2@:OE^8V\7</.Q(=R<=8U&6:8\AYS1%L$N%:4@6 M3K53TOJ+1MA
M!MC#:<G3P5S-TUKNQ#OY,-@A#*#5#8#\PQC>S-'X;PI</YL&O@JO4[Z<TJ5+
M:+5+;UVZ=$4&:ZHZJ[>LLUHKXD\?00T['K>VL ?Q3K577UQATJI,ZV+*M*[>
M"?KJGK4_A8PNMQ<VE11?8K?5ZQ>-7I:]+MI^+D?;RJ08!\/"#HN[=>21%JPD
M++@!&.8^$B<\L]8Q[0T-D8JK_;3;C?>S2N!EU6][,J#<AN?+,&L'_SY'K)7I
MQW-?O7#B13B@^YU/I'[HX?I-&-LGUCC<X_N[]=/Z6?NPOO7N9/_;5[K_[=W)
MG!=A:[^SO_7UM'&V_;.^];;9V/*T<=ALU\^VSW:^U4_JNV_;^[O[[3W0)>LM
M?'(I2JIE\/[_-K'O_-.UW\QHI[,M]K= #]UMMV LHG'XB3;.OO*]LT8;GL_K
MG3W03]_AO<,#\K]GGTZ_.QEANVU #O1]Q+55R.)H$.RX#]22)%G93$U=$6/^
MG[7BI#5L_J*W2;YV 72V>=QOM0M2@)PJ=ORPET&99%4Q6@"EW"MUO2AV06V<
M)^..'8[Z%Q^2 8R1]9F^)U7MTJIVZ?*\J_=#POD#_<M ^)?M]T]AL38[N7?-
MLW"N/A=8/)T)'I5.)6V4S+:V!6!3&CF6ZWQXZIC@@N 4UC8DQC6@N>=2O+3"
MNPKOEH-W1BL2; K:2,M%Y(;YZ%1(4AE!O"*W#6"J\.Z1\ [/X!U)*ED9/1*"
M$,1#X,APPI&S-FIK,+>*/3N\>^S4O"<TYHA9M#%'?3X#B$8&J7BDQN@037!4
M!8JE=I4Q]^1<?/H;8^YPF^_GYK"[>[31V8=G?#Z$Y_ &W3_<V7IWNO,!/CL\
M$ WZZ:PTYIA5EFMI$1,ZUR=T!EF".<),9STV",[UVH98)W0^Z^TF8^ZC[8YL
M_[0@HK3G/H[:Y>]76G.S=/S+FOOUE-(CI1]BT%49<+>4Z_<#@4JN/QDBS-HQ
ME/'()17 R5(CS@5#(,E=+E4HI8Y4ITC6-OABY'J5R[JZG*R-]32GFFCEN3;4
M &-KIHP+DII@;:6AKQ@GSVKH20ECJ1*(*&\0U\0C1Z1!B@9.E!:YX-\J<G)U
M6/02#HL(+<IPI+=(%'_WX%%76A@YD.-MK]_OG<3^_S<H>L<E*L$7L57F=_Z]
M_7;G<W'<'@T*6XS#+K(:>#?#A$6%/3-*$8VYQP;,4\J\\%9Y4%*POC+(Z X6
MREL[: V^'/>C#3O=?V"268_-Y@JI[).[8%CCR^_L$YA39YO O$_J9^]P_>P3
MWS^L"Q@3V=\Z@G7Z!./XI]4X\_A_SX[$=^LBD<HQQ)P+V3[1*'<A1]2RP!V7
M*CD+M+I^!?Q-S1,[(<'4[H&)\82DE\.G+Y/=14JKM[JMSJA3T=O3T=N[T\:G
M[\1S::Q+R$M:MA#AR& 2D07SQUABI H@<_'ZU:>;0&$ U;8-^-B%32V<'<2B
MGW][( (2SFW VN$D$C<V64LH=0'(D5KB_-5AEA4"/G>*9/E<"A!("4$1BUPA
M;KE#VFB&,/6&2T8)5;FIS948F .]@"*!I&I%&(V=*J4OYN$.E2K3^Y9F&/9!
MYQ3&J+7G@283/(XJ 9)8 !5F*H?*BC'PK$,EZNB%( H%:1SBA =D!  M3])3
MJZ*E-($9)L0"#TI6Z.RWXN3SI&3O-5$J$!PB-V -&2-T<HX%J5A0KG*HK!@G
MSSI4I(OPCRFDI0'^Q30@%\"Z(,;(,H_%:@J<;%:-DU]#P='2X;#Y]N_B<_S1
M:\/([N5NL',J]_%Q&Z:8SZ6FNO=EI\3L]^M%L=D]!1@XMJT 3VO;KH]%:S#5
MG[:B'T>,D[$2Q==O$3)>>;'O#;I,>P?&-@[41ZZI! ,<)"Y3*6!/X./%JT^I
M]3,&=!;[O0IO[X*W\R%U3IBDD_5(<+"C>:ZLJK74B#+/$H6=]!&,Z?_W_]%@
MQ/RY0@[LBHD7K3D%EIAS#N R<9FL(9:*0("!H^3>QL5K3A43WY>)YY0F&H&.
MB$ ^48DX]67RLT$Q8($5,=+D*E>KQ\2O]Q1J]0:\N@=L3P&<EY.E[Z4^+M!F
MOS8F\Z7+I 454[U8):/1Z_IG5 ?G68BDG7F/G,141PMV//8X@4AB'AE&,$HN
M&!9!J:#,YFZLB_7)W8Y1GI&W[K5R_J)JKU:<OW3.GU5&-2.!8.*1)2[[XEU$
M.BB*J'=:*\-XPJ'D_(7Z\);+^:_!N_=W' S> $_:3@\&=1;#M$[,32V%*M/[
MNN7\XPGTG,NV]]=?6[G5&OAL@/^['SNM46>S&\I+!X-1=IV6S4\:L8+%Q46*
M[FX.ZZW+A0&CQ(E;0Q$1H =Q'1AR)!FD<4Y;E=B2Z $794W*^5K4<R5@*A_;
M<V3T1:DU%:.O$*.?=X&?,+I)UC-I,<)6YSYE5",3G$>,F*A,XL8X HRN:XRO
M"*-7SJH7Y*RJ%=VX%(_5+57PJ\O0/L227;D%OV_Q@8<MS6J+P2=VZU4B;7$B
M;7M>=V6.@^YBD,H93F#!:Z2I"LARRDV*,MJH2YN>@51C>K$V_8.XYGE49:DP
ML\+,QW>(5IBY2,R<-0.82=@H#V8 %0SQD!+2T1G$HN;*,Z^XYR5F*C#YQ4O
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ML["-46D6-0;I*Z6UGC$1B")84P.&?<G"R\+"4P$T6A(%M@_R,E?<%PXC&U1
M(L<+4D6QMB&S,%N'95PB%GXC 1K7Z_*4 1I/"6+&"\5"#$$'PSESAH 8@T\I
M.$XTUO<V)6 0_9WTOA=#<S"C6O32MR]:"2B;;AZ2DI%1 H Q*GU.8].@C1"!
M9 [2<,XS0+=E[,A6,O*"&1DG[BWA7GNK.0W2J2!Q9)A1(JU4M&3DY6+D2<^
M@64SA@(/4YP9&8-.8KD!E0\42(D59YJ7C/P&&%D3+B27EDN*.9?>,>>D-\I2
MQYCC]T] *AGY61AY.@V)<LJ515;:W/=9>V2U]0B#DL6#ED*SI>QD7S+R@AF9
M.\D$9E90X4 QPS;2Q(US*??1D4R5C+Q<C#SI)4@D*A=\R"'/!B2RDD@;HY$(
MF%/M99 B+",CEX$;+W[F]=9=4^U.[M$&9>6+1<^N,'MW^X[-N4OAKE=.8B4T
M0U$BO:A(;3MGH]X-_5QA_4KWFQGUG4D^A56G5^,!G80>V5@M-R]YX<9J!%=O
M[&[VM-6NM^"N/XL./[^:+/8W.^&_8SC(?19S4?9B#7\)OF4I>[WS_D*^?3NJ
M'?TX!YERM-?XRG<;G\ENXZ_#W:--LK.U!_(*9-CY =_Y]'&J[/7>]]H9R+6C
M&JVWZHW#P_K6M\-:^V.SMO65U]L@KV@-QGC =[]_3+7S'V0?9%#P2@D4B!>(
MPW0C*WS.U&$@FR(CALK)HM?8$<:D,"P:S@,+<(&GWB0M>#+6F,FBU[_6I')E
M4>XL/#UG"Z [1[6< />^Z"-3-&MHYE* L3^H](JF O'T./<-&/9S9Y5>L_\C
MU[%O="N'L75<*5K!=.Q!')<!+X[G5E^5ORQ,2^\L8QK.D%84&"R@"FYC)YY2
MZ9_8XWS_0^ /0#SX.,@-)5+E/^;:A59>*.6##HQ;'TPD.1Y5""$386D458PQ
MF5!1Q<W,6^_F9]K6/'U1Y5OCW\8!V7?486,Y18$[CWCN_^RBB A$HQ'24ID$
MS[LAN#J]B5P!<F[EI1VWC_MI>\UQUXLQB83H!B 7#YO^L )R<- :=62X(+%?
M5>0KWT%V=@O1.>SGMDD7"SEJV##HV:+_W/&PEVEZLI/;(UJ!/:$H^<<#4PQ;
M<2?-%"J?;+/S/]U^?[OSSP X*?^VDSY>=.#[._8*FNWXMRQ?Z'Y*'*@P141(
M /F"G0/Z) 8YS+2 =5'1XDEYL90XW;C6,6K<OZ#HY  WZ1?\,XVL@,B=W/HK
MP06GZR-6R)VT8 C=T,_]#D\ZBV\N-?.ZY^VX0#+@C#P=\[9<H*1*I7Z"6ON@
M'"^^UCZI&O+0 3W[8'F5X(?=]O9'*GSS0Q\\6%8U8F7(8-4&*\6R]8=XZJX3
M-U:>6;'JW(W#7HR5&IQWV*]\Z 30R*ZUJ%AL=XK7,FO_-$_O.V=E'XN%][&8
MFU: WEZ(4/ZG.^JA^TP=%E:,C>[9_N;NUWU;<T9*:BJIZ8FHZ9F2>Y\#D6=O
ME6<_2^4+R*R#3M$P%;[M@!'=J[SOMH][\3!V^MFSG%TQE=_@S<9]5X^[O8SC
M]Y%D#T]>N,<]'D1XR[4"H^GVUZ:[V8'OL?);"Z;]2>9X,?/ZUNK,OM(BL\PD
MPW421C+/*;-6&&=RLU;%6*+&C+VYZIHW][9@F(*DKP'(=D'0&47>V_[AQU;W
M)&\9Q@LO[Y\Q=7L18*AE^_UF:HZTQ,U.:-C3I8^<>:#G=QPY\^%TYWL=QO-7
M<^?3Y]/=\R_-W?,_X=@'L7OT ZZOMW<:?[5WSW?/IB)G&G ._8IWV]M\;^OC
M$=P#GO&QN=MH-7<:WPYK=%?4VGM']:._9K4<P#Q&[[E%RFB'N%(.V> BXBEI
M;0QQ4=*%1<[,"]<K68:[Q,;7AXW.4XVYU3Y0S'6.!HG.6D^D%-X9/=KI(A?8
M2)X=&TL,G <#IRJW4<F]<P(%+@'Y1(C(2F]14,30Q'/CG%RD6SQY@>X2_TK\
M6TK\$U9YX WE'4^<&>:\"58QP:@P\"?-W.DO=<,5P\7)J&H7M-6.&V0<T8A+
MS7+(BT#&:T88-4QH4^J&)3:^;6R,48+5S)+U6/)HI6/>YHKL41! 2FG&NB%_
M*=UP%8I3K A GM;>X],"),]K;&=K>Y\2(2+V$DF2"X9JXQ#0 D&)8"TH=D0P
MM;9!UL$R6 E\?*:J%2_G9BT\V+\X)89*ZG7;E4WOA^UARP[@AQL=WT5P[X@5
MG[30Q6N:[^V+<+UX>@QS^203]^C4Q166N;->\=5(5IU8="$ 3&K,C28F*",Q
M$\1:'1P33^^1GI2I(TE;FAP+DJC3I16"$RR*Q,'DX )QJA@RTBJD7"#<4&5@
ML9<QD;.$LC<(9;_-TY2;2T,!P8RGEAMK=*2$2XZU=$)+B>_A0>[#"\.GIP2U
M$KSF :\I/S)V5D:CD"TJQH*T0I9XL :2D8)Q&K%V:QN*T2G@FMK=+S&KQ*R7
M5K^,YT99CZD7F$=#G/11$NJH25Y;39_>Z5NJ7T^,8),>7UAQ8C#FR%,2$3=)
M(^>I1XI'PBW'"2=?JE\EE"W%N\VC?N7D=">3BQR4+F&#UM0J:X1F\$%3=0\G
M[3.H7Z6K=F'(-NVJQ40S%R52.BK$B77(6)4M2Q.HDT[&Y+*KEL_8YG\1]:RL
M#?0JS[Q>;^BRNM"U(AVSJ@TMHFR-Y$M0MH9<%B9XB13S&TOF/,N89D_)4]=8
M&'3]C\-N*\1>_\._A\W!6>ZFOG2U>6C]0K(<;=.=K;\.=[9^D)U/VR!90!(T
M#@]K1P=G.Y]VS_:^?VG5&@<GM?,O[<G:";6C75YK?^ [62(='1[60?KL?/IP
M!A* [QW]U=K[]/44QG->_[27=AJ?3_?!,*<FUY<G.H!84#H@(RA!@>0*@)@X
M$_%D;9Y ,,V57H7+/5H)-3*9Q*-0FI$4IFOS7%V _U<9+<&B*_/</:;K[Y D
M4\+2',4HN3$2L")0;B0CT6)/[))6B/@>*[8'_PX'A]U>D:HRZ%::_?XP5F[4
M!ON'<$E_0B%44>GD%2')$>X9-SQ(1C$+W%",-9M=@WF[_G&2NT#U:W<[Q1+_
M4SQH\W)L*U%2Y]G9KMXXV+<B>*VQ193HE+LZ"*03%8ARCCV0;)!2K6U0<6M%
MG=&ZYL(?OE@#H$58A/7;JRK]'7O%,CT#.?QM>SN]HFY-*,J _GKT>.7Q&UOY
MG:VO^]9I W*+(H9Y +P-&!F50!<WUC(-<LUYO[8!ZTZF%_[8YOI),).YN,MH
M^=>+2H,OQ/I_]V**O5X,)???FP9JC0_G^S@WLP3!BI(+%G$7/0A=;Q$AGF"K
MM&4X!US?C_F/+U9A*?C_.DV4$#"U_)_/]XTPD2L9D9-$(E!=-;*$$\0DY2Q[
M9W"2<V# M3*8N834GUW;"YDTMIJ]Z ?=7J[C=U8)Q;>B.%36&'+9L*)J%'S/
M-1JR?Z<( )H@J)P,"_9;KCW:[H+ND347H+R,.R$.8J\-2LKXF@BW[*_#E^;/
M9BL>C,_*\2^@XN7Q]_/3>K&;%E2<;1E5M \V%[++"S,IFBN'MIB 2N']R)K;
MC9SZ$RR41;/HL3M\]ZT+.O#!E_S\/JC>+O9V$OP6^W\73KPLNO/(=TXZ$P .
ML^$SB)]T>Z$?.V^7@<\/SO9CQ-G&((A$@Q'W.A?>9AR!_&:.$2^8P6L;P#33
M_)L7-I<WM*T6,.4 ^*=?Z0]=NSD8C)1Y.SXEC6AF;#9-\?CX]RD2*ZR#5K^;
M2W(VBUJ*N;!G]#&'\0&[-$/LA'[EY#!VXD] D#3,7_-5P+ PJ+.*_6F;K:*0
M6V;>?&(FIY;-@.#."OJ=!ICU_!)'!;QT,_\#6!1$7@SPRECS:Q?NWY'LZ@X'
M_0$\)I>[NV"1GT41QWP+,!,O[F*+ J67XZ_.J/9[KXBJAW@3;I5W6Q=#NJ+X
MWKD[]]:8IGZ^B?<),=YIF%F22,BU?SWPBY;(XR@YL(WS1*QMU+O3//.+;(N2
MV2Y>)4F@M&/;+$J&YOJ(UYAA<-CK#@\.;ZK2/2&$GJ3(^5@T<%I5N:CA<;??
M+*HB]6*K*/;YJY;A?UYW.8PK(>)?EUC7[[:&@YLOF:HJ\D(2$!&.)J;VRM_#
MWJ]R- >@ _6B_8%L@N&^LZT3>]9?^]>UMP+] DW,XN0$W+H2-Q^\Q9VTHNZA
MK6&OJ!QZF$LVYQIN&<+[S5/0W(JZ9'&Z+MFO>O5YXZ\H4-^+Q\.>!V4EJX"7
M=L84=XUT.Y\#\D-^9+M Z5Y1MOYL=$ZU4GFV KJ-\9,+"/[S['V6,F_7M5LC
M^]H%X8RB2(#.B+A@#MF<VQN%E%XF+6F8+KLN0B(*J%\[QW.G=HN95LH:DA@+
MF$RZ=G>&8R/D"M'T\SW[S7Y6:,;VQ651VW=W^GV?Q Z87<S]KG==H8*VC%>%
MHJM2S157!7N":JXP!YR5@WVBP=ZO].QCJ[F:J5-7HV;:7253*_?(_'FUD[/X
MRJAOJQK??2H8OLV9*:M>EC13UK:\-4QTM"]WS:B#3]G_7SCKBEX1O>[/9K_P
MSX\5]MRFI3L$@[%]W.J>Q7CIQ+_<%; GMA?Z[^XCUQZ1S/V8JIC/4UFS'.&"
M1_CJ<_!'^RZ%A[]@S1LYZ(VUI9T9K(!ID&"4\\"2X%9Y8Y@+D5#KO>;$QCMR
MH&=X[*_YB<9!"_[?PV9O,F3AJN-^%;U'XY#S^M%>^Z_#O2U_5FO7:'WK,]NE
MGWGM*%__];S>V(1[^O-:X_/)5,@YK;=WVQ]_U,^WSW;/=W%]*QSM;1V<U;+W
MJ5$CM:U=7C^OG=:W_BQ"SB>;TC)&/<$<A1 9XMXFI(VSB/JDC-0&NYA><3)-
MR<97V5@DXB,)BGC));=:"L$P%L1$SX2XJX!DR<;/Q\;G$VS,8W!42X.<I"17
MAW3(!!41YIYIZTB(EI=L_#;86-C(/3:!*BRXB])()G72%@N7D@UR_OWS>[/Q
M5 !AR<MW\S*9X&43H["6,R2YRIT2N4;&,H^$H9)88&:2MSV,6:?$E*S\JEE9
MYA[F.6K):\FC4XY8IW&R*7JN7+PK([1DY6=F93;!RM$*:8C1*+@4<]-3C5PR
M%!&BJ6>4Z)#PVH9DZY+P)6+E5^]NVX21Y);9Q[VFOQ*D.V^=P]><:C_K%5<4
M6F^.J'^DXX+>BJX7N#HFMO?=_N#7,$KCYX$H6W\_Y</P@AL334)<2E"8/-@]
MFJ:$J!8I!"RUSBB[V!+0*U3HN42I97JWAZ#4X_PR)4J]"$I-NFBH5I1K;E *
MF@-4A923N"6*QDI&M1:2Q%>,4@O2(Y>/H1^2R?=(%\TC.+KDW+LY=](AHPTH
MB<%KA%4 *XX+ADS^I"/\&+6@7)JU#<&K9MJ(>^FNDZ^>E1[I(BE9Z4E9:=(A
MPJ)7SI&(J(P&5'6AD>6>HZB5%=Y8$;E;V^"RBN]@I5<?@-#H#FRK8MOP#H.K
M<4&/JI7WRK3_U2L'.$<:Y"-]$TC<BFQ%IO\%O&5<J\7!8?>67=G5+@7QO+CW
MSY2+(H#J#XH]1U;37%'$8V0(,2A2IYG*2RW<*]Z?+4'JM8+4XUP3)4B])$A-
M>B@\F#8\<8L\$;FO14Q(<R>0X)Y@$8TA"VRSO'P@M2 U<OGX^5:S:K&>B44P
M]"NK0O7<7#WIO9""DI!#.D-4%/$4'7)4)>14T$DFZ;WRN8Z5N+&.U1(W$EMM
M9GND[Z)DMA=GMDG_AE3<@7GF$+8\%QT"/=]E8<I"\H&)0)3C:QNT.AVX-9/9
MQEZ.B3HE1!2L](+>Q/(>*W"/5^\BFY$TU^QDA#T:=D;8>](<'!8U42;+7^1L
MNH.>;;];%ME6WN.)[_'J8]H6DK%VWY"1Y=.[Y@NLU00'%P1A6B:>B#;<:L$X
M\P)K#1;/$V:LE8&U\^I9.],A7YAR;)D+* FK$)=4(A<]03$Z[0THU,QD/8O)
M=:FG"[2^GF"*DI>!EZD5DG(9>- \6>.P9E3XR.";DY&6:6M+P\:3'D>C8I0D
M"22HH#E\,_LFK$"*4FJP252;Q66?EFR\U&R,P3XF7C(CE. J1!>-\8Y)'A7S
M-/DR;6VY>'G2S^AB)$%;AXB)N2TC=\@ZR1 7FDB&)>'>K&T8PM=!+)>\_*IY
M66+,'4G P51RZHQ-SDM"G)842R?8$^:ME2)Y/C:>]&!Z1B15DB#-/6C6.!!D
MO;/(>"8"92R"BK6,(OG5>[L>F[-6AEJL$JS>'/#Z2-=%&?#ZA' Z'?C%"//1
MA]P[*+>1D9$@(W-]_6B5##(9[?':AB!5/;W_NO(1%246O78L>ISKI<Q,>Q&,
MFO3"N$@X=DXCXH1'G&B.+-48%3$(R7"=K"CCOEY9*,I-N::/\\*4VL63<NZD
MST4!^A)I-#),!L0Y#\CHF!"F@+^<:IJT*C+3Y'3 R5/L?)<"_Y4+_$<Z=DJ!
M_R*P,>GC(3)X&J5 . J'N',4614%2A$S2;U5PB[.Q[- @?_J8SCNF_3W-C.
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M&!YW.Z-9.HT]W^S'?.W52;CV"L4(AYV?L<@ES:->KQ3+/7KAHD5KOEFXF3)
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M=9DRB\_TIB^=Z;W4]W@+P'UCOO;#2*/T%LYAZ+*$DP@1$\&Y(UQKRTT0E+C
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M%3V*7BO.L% 4BV7$Y3>U!36(O7:EV:F<1=M[F#+^!,7N7XUC;&;(WX.VE6;
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M-3CMN5_;,'I=3<'Z5-!U&2WZERG'+T&W&XMX5>_F  .3ZIVEG&J>$0%\U 0
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MX_G 8>/*=O>',SR>!WQ^M]<\OE&G\7:H-1R,MD)OR!LT)'G$?[7+QAX4=K.
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M4JY:V_C'V^*%.CD?E%JI>]'%/H""8<%WS[16VYQQWW3664W'K:S@+W):IZR
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M:$O-ER5KN99\53R<#QYJXR" =,(I#UE3&R2++H6<P5(E>,7#)</#J:XE,:G
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MZOR>]'0[J#HWNWS0\JEW\J4U.#\Z<GV\0ZO[;<>TG#\Y/VN=G/>GV":&&O@
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MMB%MFYI% H]5B'%^1($X_M^#UC#X7CN/WDH>EZ.*ED)B08!DP65CHW&:.R&
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M[0<&Q)74"%R'&G;@^HEI1W80A1=O:*!#3-N70]J/NXNIS.'YF$/79A:+"1.
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M2=F,N)GI$I8/-@PAO>JN)&$="_[?&9!(].%>8SUVW1F*O9*(UR#0C8 ^:8*
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MN6I'FG9!?4%['2@W1;\>60/W1+S&)5B/$;DB:OP!<;N_">P\F[GLPX#+>GT
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MYML\$PLBJ_B=<R2V#%[D+%Y9L+;&^2P<<[FX/B+&ZQRM=CY<[B"DZ7;81/U
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MPFH.Q72F8CK"]5C^!>HS.#@HLR 1J-.5B"Z:=:2),G2TPLTO<27B+!J)VV$
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M7=GBKK+% K?8_$%B0&UFRR4L/&,)OF:1U[B:*+X<3ET<9YDOK:5<-(4+"[<
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MTU-V\T3LYJ;0L(=V\^N(%UQ4@9U;Q[EN.XX.W^B8[=LA];!U<?]R@*:*^X]
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MG!^-#<8DC4 "BF^\%AEQTH\\IVFYG@VKGILSC<8IQ\%-Y&3'HL0#QR3+G^6
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MO!2I-ZSVFNM FDUGE;RT,]J1XN .' 37O9A-YPY1.9M.!7RM)D'98FV8Y])
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MMW6K=&O!BU/<?TKNRYIZY!ZOPV,FW5J,H^<.=@3$S"<8::,/!'>(DA.QD=B
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M&7-1EZ0OE2&)!,&\CGZ!UY#=MM*_\N%YUX_8K0,+RF 2B5*^)V7OY1)(1AM
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MI?ITM/381BPUX$Y(J9[)?R^3WU/:$G&)_;;F1A36[3.M6V'?"OL6V#?^I]J
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M;0G#P2#^L^: 9#^-0=U.%!ZNWJSZ<//G:@6N8Y,!S4>L4!%UI6 'CC7L*NQ
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MYEG+=QY4_B=UCXR=S*7S9"=SI[$E<Z<\LLT7]J^).YO^_G]02P,$%     @
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M_HRM. A)!=G[XSH"!7;?S-E#S\.DBN)GB\L?<E0=4<H"55\^B9^M5H3.6/0
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M]6>(&=%(4HX_O,:,%_3MU(V$;1%I'Q&GA,[%+>9W"\3KY^4T ",EFLN<0#B
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M\TK^KAU0MZL*V'TNT8<?_@]02P,$%     @ IC1C5=A$@,\++@  -=X! !0
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M$NF6?@O*D@#P?S M)E[F8%UIX).BP#L*!SD4 SI45R,Y\*IQJT\&LL=@W =
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M  *C'#9TI2_>[S]R6N+?_O1_ 5!+ P04    " "F-&-5? [;QXI:  !]!00
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M:Q43#Z+T(7+M$-BY /;WM94SD:Z^KA20%FMFJ:#A>6%!6QY]2:4HUKHFV#4
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M@# H\*$H;CQC4;;/HKB.X>D38B^I=U@L-MB*ZS539"V3-81(15>+?V9PODA
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MF?.W#:ZO->=OD,ZVSO7:0>!CYORAM,4& H0H'2A7J[?3D@0BZFR2%XZGOK=
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MGT3N '6(8[JQ6'4[.Z:EAKI4WOL,<%Z5$$XNRHPSD9@7R4.@=8%\9>L@>&'
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M6)&Y,.9=.NB,N0'XVR09?9+L0YF&Y2[[ZX-44'!*8_V\@Z+@R7E$<CE1UR6
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MZJYUA!6HRQ6LUK>X4BUD -?=H!#H\9R?HNA^1@512;EUL<YU@WP-MG4T'Z%
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M&_#AH 8!<)7W/0&P;C)* .S3@-OA13W? XC"]# L.I!ZT?J<*,NP88=8U"0
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M*[7A7#,6V'S@\E[A>O7MDCBN'MQQ N(LY5?-OLH')T;)YM"7[ST[.3*6K$:
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MFZ^;V/C0L:.!AD3YR\_%H7?,J,+:H<P.I.YV<8^;:VBY?'&,:T>E^>VAS^D
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M(L+,SN"UEA?<Y:#+N+,D#V$UB>"==&!(\5QRI,QWRL8?:>KA$^;7P2R!&CE
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MTVN5 QL[OU@761<N5!0M'N'DT%_1'V!#KK0/SMWI/<U)_>^Q?_BHK^-M&3G
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M>_/@GK:I0B$:WF$<^.'!J_2+MVWW>!@.[^>[1Q(G&59HA-\52KL +H_B_#I
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MG#PW[)@R"DN]<]HS"WH&*G:'@.@:;3UX3E$E=%AE(/D*H 2AB2%?8OG<L<F
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M,JU@#".A86)J'[6;8:S7A.?M7HM+Y(C<7[J_*B>O8'3(R@&, =]:?$:[2IS
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MW\;INL$W<N8+-3G0QIM@=9Y&C<40N2[@0C->3$+\=:+G[#%*3"&R[>=7X-$
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MW8P%Y*-\MM3."+KY&- !04#5C8PQE+3)KONVM8P([Y$>PZ<ANG1 F3E"&26
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M0S8O',9^$P^QI7&O6OXK]6](9O]'2E2+,<GSOZWS6Y%F>)%L[XOK(\75%G1
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M:D20OV6R%P92=]GYLH.E5-0M.@8;_NTK^+6,5-FN9%R!SUC,\<_5D8!<H1>
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M3L9'+BKKMY-*36T:(70*,UNG)ZFF32?3RH-=6\=O-*.9<\(=1A@FXKL2DK>
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MKSS 6EB/&[ KH/*U*>LCPK@;M2M .MJ\7?,L'X%P5<8--NM5"@J@2B, I<P
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MID1"$QP?$P)@ D. ,TI Q'DF"<QBF4971WF>&'AJMIE^)S,/<9VG(+9T- T
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MR[??9<'S4E-APF2:8),F0Y%F21QG0%L^"$A.-5W&219"IPPZ=Q&F1I<;P4Q
M755;+EC6$IL&)DV9.<>&)3WF126$I:88<<8B!B"+.6"1C '4IBF$B5(T#'MX
M\P::GO$=>EOY1IT5NV_5L&M@:#/82 E>40/MZ^7#HUR4]<'I;5$8RZZRB=ES
MT+ZNV8D%MZ:[H6D+5VEW$VST*TW06 V"QPSPWBC[2OYV%V#<O._> !VE?/=_
MDGNZPW](4YU9BMLG6=![^46:#^.F09VIV;--Y4FY% 1)8]Q#JFW]- 4D1A%
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M]JC&YDFU#LW TQ?U6Z@?Y<HX8BN'BY#BU?.OI4F-VY7,Y:O\J?F*"1REL5)
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MCK]/B#K1X^]M'?>7.P _-:_C'(#WG:8_WP'XR2+KTSD [YB(B1R GY+P3W4
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M7_GYCJ./FZ'?#YJC'/V>CW$W,(<[6/E'=:JB+>8F!0Q#&?,D)H"J,-/TF<4
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M??V UKK7/^W6?/>S1UGT5NIM5KW=Q7T[IGW])N=SXW6AB^>9P$HQAA7@%"D
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M>V+(_6>/RH@GU3IDP-,7C=VHH_J?.SWJ[4(81^)'_1HT^08LS2*100@4D0I
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M/7BN<KH]EFPBN(66\\.N?'E56-XDDSSIZY?%LS8YB4 AI@##5)N<F"+ 4ID
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M7[SPKQ\0#@WAARO_:QT4NP:\+OC./ODWMKXOEG.&,R9TG@"*4PY0+!/ D<Y
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M7[4J*P'NTS_.#VKWC;M@D(^TIS<\]%X[?[W@Z]@4]'O>:/N%O<QL;R7V>\!
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MEYA+!27Q"AN&PWN4=-0V9ZDKR91]X'4+(X8#+?!T_0ROL@'WT90P7&3AALE
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MQ8KE*2+8Z\3!95E3\S*?-\RT?M/VP7Q$MA^C796]JWHSMCX?S\,#':B[<=%
M6 8FH$9+"V"C9_3GM[*\5Y"M=0=8ADJ=[Y T;NK[=9-/4M<=;NGM=BKS FWM
M^6Y;^8YF60Q)EAKBH':+*[&'EHQ_J942&B5YEB O"CEZ_M1HHU$O>C+Z>7LJ
MSY!S=DGZXA'>]ZB@J$HQ'!R.-^RI,/Y=5>^OOF@6M7*8*Y(MAMT>/PO3<*['
MLZ>/[6.<,^V,,W'VLIZ]SMG:QD2;SVK=G'$IQ!Q3(1'7#$@3Q@!$8@DX4QHD
M:88D2U.<$J^6-V>E3.V3+Y6*7A7+Z(^O;VU=A>I@X65WV@-0H1A13*> YID
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M0 )5(C074@JOS647H5.CB<.:T,RN1M5Z1Z7B4:.YGT?A-09N4=K0R 8FDV%
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M:D0&=<XDE!(D&;:]CI,44"PH2/*4*2SS/(:IU_)B/SVF1B/^/>#Z#L#ML=Y
ML+YDP&?[T-AF$T?!7IBN<#=B.4+TUZ7%9$) !ZA\XD"7Q_6CQL_VR:OEW7:_
M<KK_R^&X2WWN@D,FLTQ"H%!F*[ *#3C,3#3(E,X(HDCD3IDN/61/C0)KU2.V
M;>7D1K\91W97]2_UXT>?47#CQ$#8!N;!J[ &:/;2 ZF!6,Y'\JC,U@.28S;K
M\XA^#/9%;9GM(=/TO*\_$P*E5DF:@IA2;GPWG -"- **2@HIDA(GQ(>LSHN9
M&B\U6D:-FGX\= %+-\JY':' ['("3@ VZ09A(.*X(&14CN@V])@.KES=\_2>
MNK=SPA?U9,EF>?]AJ5?KQ])+^FB$?=BJQ\U<9D@*FN4 QS2QV6,8F.\? V3B
MMUAID7/NY;2X")T:*]0Z1WNEHY;6T9]6[ZA4W#,_Q&D W,AC:%@#4\D B/H?
MU/* :*AC5"XBQSWDY '"R1$DGWO[45+9W?O-:K.=QX3F4L<2J%P;WJ%Q9OR/
ME!A/)(4QR63&4NU3"6W_9"]R&:T FMWR6I3[,\+HZ$<C!]#<N*(7%($)H=3)
M'O'I,-[[BS\Q=*#/^O#<4;_=$W../]#3"_HVN-H?_*D]V)0CF L&@4 Z!TB;
M:(#F.@5$2ITC)F/I%PV<2)C:E.]TULP1/+>O\B9( G^=;30"./T731^L']7Q
M\T?N0G7!O-/>4Y<N[.G@[P^<O'M\6JQ^*O55K;\7-JGS[&'B13E49=?M0P.%
MJNNV997-H?!5)B$G4$O *<H,'V0,4($UX!G*<)RH6'.O-G?!-)T@KQP*(=1K
MT6W?US. "#; CE''%(8M=*ARKCS%X=C]K!E%6;?#*7,OK%TSN]UDF^)4:>Y1
MD"IHP4=@J$@HF)[CAD^AX3Z)N8(+[#>UE$4DK.2U>C#"R^)O3=;![VK[27]C
M/_9KV(>$D&^K*AUD#F$B=$XPR @W01WC.6 RR8& /#&_T40KXA/>W:C/-(/"
M55GK1K2MBA;&(+])XM:A(B(7,<LU$!E' ,4L!2PA,= YHQ1!Q'/B69UXQ,$:
MIY3QFQ<>(K?9>D38 \_)51&HYZ@_RT*;1;]7.<3&I%G4;(N&+J(\$, #3;FW
M:C/JQ#H0=,?3YU"/O7$ULW0 #\ZU)%K&,6- I-!V>1 ,$)E)D"4:JU0H1%*O
MY-D+<J88^ZR6914W\V662C?.<\\%SR-</9<_^Z,UWF)HT.#A"A)#KY8>27F9
MM=/SIEY<2;UP><]DL2I\M!77OJ@G\[8\&"F?=+MF%\UAHB'.08SR!"#,%. B
MT8 KGB"4(T8$F2_5O3W3],TC5>RJ9*?7GU:O_XG\D#D'C;:6,_H72'. WHT]
M!D)RI'RP6MFR,]]S*,,44W-'9Z@<L.L"QTW]<@;@)./+_<Z1BS57?50_Z:J[
MW]UW5BPL*QI%RP*1\RR#S+@NJ0GC8U257B<T,U%BG*<2,Z9YYK<8'$C1J?E#
M=?M,UNA9?J5%W5(QVBUE6>A619_-764MY:I[[5A%E*\-N^,2\00&<\05XIZ%
MC@^MBNN7XN[92U%:/(&2Q8YC\M)%B*^I^?<H*^P(]F"%@EWE^9< +5<SRU"\
MBK[KH&^><(:H74\44F9F]H 24$X2P-(4RCRCL:!\[^Q>7PON$-7'NQUYF5=5
MFI:GW]T+5UZ"MIN<;T5J'%ZMT*G6^IK5O5I+QSFP"R'WDIX#(#52*<]OQENP
MF62LVG@TTTGU;A45>G:#LG[-HK\>"O$0&>&[Q;[$PE(4BP5;_XSX;E,LU68#
MUJJN6'-H[,06FU7TS^7JKV7$-O7SEZOEH:K#JTK:+WM1Z_U&5#F969>FJKKS
MK]%O[*=5;K&39FS9+Y$\5'M^Q6V! N.'J<VV-L#\4+1^N/]B7LE?2K/O6;'<
M_)M=?C=ZVCA1B=VZUMJ8_LKH5.G[6&R$,J8NU6JWN8Q183,:_W68TJ=77J*.
MDJ>7[ARMU.D5U=LE3J]=VK=1KGD)[>=35<RC& O%<PZ@"2\ 2E ">*[LL3J"
MLI1(#(57P?CGCY]<E-!HUZ\&X1%VCDY[;T1"N]K.8/3H@'G.YL&Z7SY[^,B=
M+\\9=MKU\NQ5_3[87U<K^9>92[X9QW&CS4<R3['QKTA" !=* :02"!B+C;^7
MQX2D"4$TSWJL:YX(FN@R9J/G+-HVFOI]QJ>(NGW)_0 :YV,^@/+M*BC>G_-%
MPP?ZHD^?/^I'?=&\X^_Z\H7^<5P3(7Y[*-8F=%QO?_[&ECMMG,/=VCSYOXKM
MP\?5\MY\4(]O5LNR\HCY\I.<P90F@&A;8SB&$' E"4@P9IJC/,ZU<W^'/@I,
M;3X_+/5LK17@R9H1/;;MB/XRAD0+8PDP&CU&HK'%/>KI-537@\;0 Q"8<0[8
M?VMA_]LI]A_WV+\9"7OW<#3T&(P4JP89"Z^0[!8@.^*U7H\=+9B[Q>AVI'?3
M<_P[7+RM7\K_LS.BU'KQLSJ%.,_2-)5$VZK0MC0T%Q*P1,8 XC1.8Z5)SK1K
M<XL+,J8V@31J1GL]ZV.T[ATM+J'9/0$,A%%@CO>'QZN#Q14 >C6ON/3,T?I6
M7#&JW;+BVJ7] L:J3E/=^6)?(A$Q)G"<I@ 3;()&R@4@(A8@-BXE@SJ5+(8^
M"SUGI4SM\Z[5JXOC^D6)YV%TBQ1O!B?P=]T4[V[P"5%0LA.#@0+'\S)&#1X[
MS3P.(+LO[GEZI-DL*//L/M:UGW_^;M1OFE9!(@3/$S.;,_/I9V9*YU@)D$BH
M$LTECU/N\^E?E3@U&CAXO8>=E:I P+E2V;41T5.5R^QY^N#J:+@QR* 8!V:3
M0]WK.MEVK^XL.B@\X-$ 5VR&2OZ_*F_<]'Y7\T\2^)UOO/6(]+=U62;O9YEJ
M]_KGFX69@ ^IY9C 5.<Q!R)-4KN*)0'A4@,E:$)YG'&:^>TYN<F=&BN5VI4Q
M>ZUUGPH)KI@[[E4-CV1@[KD XDCGA)U0&OS4;[?4%SK#ZP3%Y1.Y;K</>[[V
MK=*V#MQKM31_V=K,T,V=_._=9FMC,I>C@C11B$AJ%TQ$#E":<$"UX36L<2R$
MXEPE>8^-N%#Z3G0_SYXNM'DF-LO$.FG%LLKX-!^U37BP?WTR-PQS"O3F,7=T
MWUYR"%_NW.BK#W6ZDCT3.(MJ:Z/:W#+Y>A8Q;4;9'B8M\X.^*&&_]4(7HD[T
MW>,Q>[%#ID,-4^#3IS>K.8ECJ4.![7I>=3!Y?K/19KV=?[%YPW<_BLV<)1QE
M*E. 480 4GD*S&R!@!EZG A"TC1S*@+V[*E3\W!M'DRQV9HO>_&\<+95UC'W
MZCELW>S;&XS 5-D3!V<Z.VMW%_>8&UJ\8_YUX)SGSQJ%(,ZJWWS-YW\Y>+[%
M7",.)9,*(!)G "4D!QS'"<@1A(K"..?2J;.[@ZRI?:8.612#;=C?GA<QH>_:
M8=M].. &2VKX>^8OC)*F<'M&PF22#WKD&0RQ[WAW:"WY=O7("MO&6!E7)V9
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M@AC &;2'_A$%A!M7&\HX2Y6956.HZH%ZMY13&:9&E1<:)+64XXV0VXP1$O/
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MC[SU>-ZXT_W&"]?U^W;?LV+]#[;8J5:"LXV63(A4+._KUY*9V5UEPDSU6L<
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MSPY*03/"8@ IB>TB.0$DP3%0DF&84)FF;L6F>\J?&O6531S=B\#T0;R;Z$;
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M@CD5,35:KS8GK)I^'O 9\-S<VML@"<S#I7)1K5V %93+Q@_D3IX1,*J/>-G
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M6_9CP>)<ZBQC4"4Q@RB+8\@PSLV#PD5F%]?,?WEN!_KT/[<O0,O\)BU#M!T
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MF^AU9_$5>&IL!J4Q^@K<UV:[2SCTX]U-U<%1')EN*P _M@#<F0N^5@#^'AY
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M-ZXZU#;W%,KT =R-E<:"<61FVIE=3>'W:()VT>'PQV6'8!5*T-*GZVEE*P>
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M?22W^X'M7T8*!M?XT4J%U,'06F>[/VKQ?1:=UYB"03?1:M-P"+V6G9Q@Z5B
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M1Y#'5$)*$RQU'LL<.ZD9]G4TMPBQLA4<C 6-M9[?TW.P.H9@ <":(A@Z@=.
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M=)KIIQH.'(ZL2P+&Z7QY4@ =(NK#<3)?X5D3G/QE,5\NWRWF9;J:1(]9>%7
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M2TSS<G6+F5\S\<$U9\D(4*DVS$0D%FI:#&W$S!AIG,+6)N@Q6L:-S1JK?#Z
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M'%@;-1,.F;:M+^'OD##RY*(AU'RO[O5PF7<!F<MNXC6K;IHF20NC%=E68KF
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MB XU@8\\:-C17P,:N$<'/QF3,/*H@,50:B8LJSFQ!EP@-SXS+VBK;+R2AQH
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MNT#]Y\1(CY%I!]%X3@S0.O5""\A%JD &.Q<>=M@(GWG-N$YY<]"T%NS(&'D
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M^MJTCJ;O$='+V(UVN]5Q<NX(*._G9V>_S!>_XR)-O' L&._!9N:K]\[ (_F
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MB>##)_)>I'ID7ZV+G/21=7_*:+_?_>+5Y<77^6+ZOY@G.K-H@M$011WJK3$
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M:8FSD[+GATJ^![BL^TDDFT*NYP$ID;.B=+W;7VH_"<6M]]6GL=@*,&.V^SA
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MS+=.4S0A_*1]TUVP^K*A'5KM';BP]^W1Y_#]#]+UY7(U_]2*+*22"7C0K-[
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M:7)E8W1O<C(P,C(N:'1M4$L! A0#%     @ IC1C53D_PD@5"   !2P  !@
M             ( !&PX  &5X:&EB:70S,3$R,#(R+3 Y>#,P+FAT;5!+ 0(4
M Q0    ( *8T8U4/<5"0%0@  &\K   8              "  686  !E>&AI
M8FET,S$R,C R,BTP.7@S,"YH=&U02P$"% ,4    " "F-&-5%=7+"YH$  #C
M%   &               @ &Q'@  97AH:6)I=#,R,3(P,C(M,#EX,S N:'1M
M4$L! A0#%     @ IC1C56^%A1&%!   $A4  !@              ( !@2,
M &5X:&EB:70S,C(R,#(R+3 Y>#,P+FAT;5!+ 0(4 Q0    ( *8T8U7#M?F0
M<3L" $C!'@ 0              "  3PH  !P8F@M,C R,C Y,S N:'1M4$L!
M A0#%     @ IC1C52#I#(,6$P  ;N<  !               ( !VV," '!B
M:"TR,#(R,#DS,"YX<V102P$"% ,4    " "F-&-5V$2 SPLN   UW@$ %
M            @ $?=P( <&)H+3(P,C(P.3,P7V-A;"YX;6Q02P$"% ,4
M" "F-&-5? [;QXI:  !]!00 %               @ %<I0( <&)H+3(P,C(P
M.3,P7V1E9BYX;6Q02P$"% ,4    " "F-&-52S=DUN7)  !9 @$ $P
M        @ $8  , <&)H+3(P,C(P.3,P7V<Q+FIP9U!+ 0(4 Q0    ( *8T
M8U4.P?#&=P\! ()Y"P 4              "  2[* P!P8F@M,C R,C Y,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( *8T8U5,2/$?[Y\  *IR!P 4
M  "  =?9! !P8F@M,C R,C Y,S!?<')E+GAM;%!+!08     #  , "D#  #X
%>04    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
